1990 •½¬Œ³”N“x –k—¢‘åŠwˆãŠw•”E‘åŠw•a‰@Œ¤‹†‹ÆÑW
i’Fo”Å•¨‚ÅŒäŠm”F‰º‚³‚¢j
<<101 Á‰»Ší>>
1. mŒ´’˜n The Concepts, Procedures and Problems Related in Endoscopic
Laser Therapy of Early Gastric Cancer.
”äŠé”\Ž÷C“ˆ”ömCŽR”ö“N•FC¬—ÑLsC‘ •ÀŸC‹e’rŽj˜YCˆ”üƒ•vCŽOd–슰ŠìC‚‹´r‹BC匴÷iŠOj: Surg. Endosc., 3:
1`6, 1989.
2. mŒ´’˜n Arterial Infusion of Combination Therapy Using Dibutyryl
Adenosine 3',5'-monophosphate and Mitomycin C for Hepatocellualr
Carcinoma Occluding Main Portal Vein: Case studies.
ΈäŒö“¹CŠ¡•”‚ЂƂÝCŽÄ“c‹v—YC‰ª•”Ž¡–íi“àjC‰œ•½‰ë•Fi•a—jCMasaharu TsuchiyaiŒc‘åj: Angiology,
40(12): 1072`1078, 1989.
3. mŒ´’˜n Roles of Microfilaments in Exocytosis: A New Hypothesis.
£ì²‹vCŽR‰È³•½i‰ðj: Cell Structure and Function, 14(5): 531`544, 1989.
4. mŒ´’˜n Mouse Strain Variations in the Magnitude of Induction of Liver
DT-Diaphorase and Hereditary Transmission of the Trait.
–x]Ž •vC“n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqC‚ŽR‹v”üŽqi¶‰»ŒnjC’r“c•ä‚i¶‰»jC‘ëàV’¼’èi¶—j: Comp. Biochem.
Physiol., 93B(2): 493`498, 1989.
5. mŒ´’˜n Rat Strain Variations in Liver Cytosolic DT-Diaphorase Activity
and Possible Significance of the Trait in Carcinogenesis by Azo Dyes.
–x]Ž •vC’r“c•ä‚i¶‰»jC‹ÊˆäL–¾i“àjC‘¾“cŒ°¬i•új: Comp. Biochem. Physiol., 93B(4):
673`677, 1989.
6. mŒ´’˜n t•s‘S‚̈ݔS–ŒƒwƒLƒ\ƒTƒ~ƒ“‚É‹y‚Ú‚·‰e‹¿|—c‹ŒŒ‰t’ŠoÜ‚Ì—\–hŒø‰Ê‚ðŠÜ‚ß‚Ä|.
‹TŽRmˆêiŽRŒ`‘åjC‘¼4–¼CÎŒ´˜a•Fi‰»jC¼ŽRŒ›Žqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: Cyto-Protection and Biology,
7: 133`138, 1989.
7. mŒ´’˜n ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà[’B“xf’f‚ÉŠÖ‚·‚é—Õ°•a—Šw“IŒ¤‹†|Š×‰šŒ^ˆÝŠà‚ð’†S‚É|. –Ø“cŒõLC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: Gastroenterological Endoscopy, 31(5): 1141`1155, 1989.
8. mŒ´’˜n ‹}«ˆÝ”S–Œ•a•Ï‚Ì—Õ°“I¥“àŽ‹‹¾“IŒŸ“¢|“Á‚É‘O’ë•”‹}«‘ÎÌ«’×ᇂɂ‚¢‚Ä|.
¼Œ³Ž›Ž—çCˆêŒ´—ºC“©ŽRaˆê˜NC‰ª•”Ž¡–íi“àjCˆ×‹ß‹`•viŽRŒû‘åj: Gastroenterological Endoscopy,
31(7): 1783`1793, 1989.
9. mŒ´’˜n ’¼’°ƒJƒ‹ƒ`ƒmƒCƒh12—á‚Ì—Õ°•a—Šw“IŒŸ“¢|“Á‚É“àŽ‹‹¾“Iƒ|ƒŠƒyƒNƒgƒ~[‚Ì—L—p«‚ɂ‚¢‚Ä|.
¬—Ñ´“TCŸ–””º‰hC‹e’n–FtCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC£ìŒªˆêC’†‰p’ji•a—j:
Gastroenterological Endoscopy, 32(1): 67`73, 1990.
10. mŒ´’˜n ”|—{×–EŠ”‚ÌЉîiÁ‰»ŠíjKE-24. ŽR‰º˜a–çi“Œ•a‰@•a—jC’†‰p’ji•a—j: Human Cell, 2(3): 340, 1989.
11. mŒ´’˜n ”|—{×–EŠ”‚ÌЉîiÁ‰»ŠíjKE-43. “n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: Human Cell, 2(4): 463, 1989.
12. mŒ´’˜n Genotypes of Alcohol Dehydrogenase and Aldehyde Dehydrogenase
Loci in Japanese Alcohol Flushers and Nonflushers. a’J–¾—²i“àjCMichio
YasunamiCAkira Yoshida (City of Hope): Human Genetics, 82: 14`16, 1989.
13. mŒ´’˜n Development of Cellular Polarity and Tight Junctions in
Parotid Acinar Cells of Postnatal Rat. ‹Ê–؉p–¾i‰ðjC‹g”ö’miŽ¨jCŽR‰È³•½i‰ðj: J.
Electron Microsc., 38(5):340`351, 1989.
14. mŒ´’˜n Intracellular Accumulation of Basement Membrane Components
during Morphogenesis of Rat Submandibular Gland. –å’J—TˆêCŽR‰È³•½i‰ðj: J.
Histochem. Cytochem., 37(9): 1387`1392, 1989.
15. mŒ´’˜n The Growth Promoting Effect of Transforming Growth Factor-ƒ¿ in
Human Breast Cancer Cell Lines. ‘ •ÀŸiŠOjCYamaguchi, K.C Asanuma, F.C
Suzuki, M.C Abe, K.: Jpn. J. Clin. Oncol., 19(4): 360`366, 1989.
16. mŒ´’˜n Microcirculatory Responses to Estradiol Benzoate in
"Irreversible" Stage of Macronodular Liver Cirrhosis in the Rat.
ΈäŒö“¹CŠ¡•”‚ЂƂÝC“¡“c–F–MCŽÄ“c‹v—Yi“àjC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[jC‰œ•½‰ë•Fi•a—jCYasuo
Fujishiroi“Œ“d•a‰@jCMasaharu TsuchiyaiŒc‘åj: Microcirculation Annual 1989:
123`124, 1989.
17. mŒ´’˜n Pathogenesis of Water-Immersion Stress-Induced Gastric Ulcers
in Rats with Renal Failure.
—é–Ø—SŽqC‹TŽRmˆêiŽRŒ`‘åjC‘¼2–¼C¼ŽRŒ›Žqi¶‰»ŒnjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: Scand. J.
Gastroenterol., 24(Suppl. 162): 127`130, 1989.
18. mŒ´’˜n Effect of the Proton Pump Inhibitor, NC-1300, on Gastric Mucus
Secretion in Rats. ¬Œ´iC‘å씎”Vi¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±ŽqC¬Žº—Tˆêi¶‰»jC‰ª•”Ž¡–íi“àj: Scand.
J. Gastroenterol., 24(Suppl. 162): 186`189, 1989.
19. mŒ´’˜n VƒsƒŠƒhƒ“ƒJƒ‹ƒ{ƒ“Ž_Œn‡¬R‹ÛÜT-3262 (Tosufloxacin
tosilate)‚Ì’_`’†ˆÚs‹y‚Ñ’_”X‰Š‚ɑ΂·‚é—L—p«.
›“c•¶•vC‘åŒI–ΖFiº˜a‘åjC‚—W—T‘¾˜YC•x‰iÃ’ji‰¡•lŽs‘åjCŠâ‘ºŒ’ˆê˜YCŽR“c‘ñŽii“ŒŠC‘åjCŽÄ“c‹v—YCŽR“cL•vi“àjC‰ª•”˜a•FC‰Á“¡s—Yi¹
ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: The Japanese Journal of Antibiotics, 42(9): 1873`1881, 1989.
20. mŒ´’˜n H2Žó—e‘ÌhR–òŽ¡—ÃÁ‰»«’×ᇂ̓AÄ”—vˆö‚ÌŒŸ“¢. ¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: Therapeutic Research, 10(2): 156`164, 1989.
21. mŒ´’˜n Ž_•ª”åŽhŒƒÜ‚̈ݔS‰t“œ’`”’Ž¿‚É‹y‚Ú‚·‰e‹¿i‘æ2•ñj. ¬Žº—TˆêC‘å씎”VC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»jC‰ª•”Ž¡–íi“àj: Therapeutic Research, 10(5): 1967`1971, 1989.
22. mŒ´’˜n Ž_‚ƈݔS‰t“œ’`”’Ž¿•Ï“®. –x“c‹±ŽqC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC⨳—YCŒK“c”£C‘å씎”Vi“àjC¬Žº—TˆêCX‰ºŒOi¶‰»jC‰ª•”Ž¡–íi“àj: Therapeutic Research, 10(8): 3208`3215, 1989.
23. mŒ´’˜n ‚wüŽB‰e‚Ì—§ê‚©‚ç|ƒ|ƒŠ[ƒv‚¨‚æ‚Ñ‘å’°Šàf’f‚É‚¨‚¯‚é’’°‘¢‰e‚Ì–ðŠ„|.
ŒÜ\—’³LCŸ–””º‰hCŽR–{‰À³C¬—Ñ´“TC‰ª•”Ž¡–íi“àjC‘å’J„³C‚‹´r‹BiŠOjCˆä“›–rC‘–쳈êi•újC£ìŒªˆêC’†‰p’ji•a—j:
Therapeutic Research, 10(Suppl. 1): 36`42, 1989.
24. mŒ´’˜n Á‰»ŠíŠàŠ³ŽÒ––½ŒŒè÷—±‹…‚É”F‚ß‚ç‚ê‚éATPaseŠˆ«‚Ì•Ï“®. ’JŒû–ÒC‰ª“c–LŽŸC‘å–ì—²C‘OìŒö’jC¼Œ³Ž›Ž—çi“àj: Šà‚Ɖ»Šw—Ö@, 16(10): 3491`3493, 1989.
25. mŒ´’˜n ‘ŠúˆÝŠà‚ɑ΂·‚郌[ƒU[+OK-432‹Ç’•¹—p—Ö@. “ˆ”ömC”äŠé”\Ž÷C¬—ÑLsCŽR”ö“N•FCã–쑈ê˜YC“Œ”ŽC‰Á“¡NsCŽOd–슰ŠìC匴÷iŠOjC‰ªTˆê˜YC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾, 1(2): 191`196, 1989.
26. mŒ´’˜n ‘å’°Šà‚Ì’´‰¹”g‘œ‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†. ‘å’J„³C–ÈŠÑ•¶•vCH“¡N¶C‹g“c@‹ICŽOd–슰ŠìCˆ”üƒ•vC‘å‹{“Œ¶C‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 1(4): 723`730, 1989.
27. mŒ´’˜n ¬ˆÝŠà‚Ì—Õ°•a—Šw“IŒŸ“¢. ŽR“cŽŠlC‰¡ŽR–õC¼Œ³Ž›Ž—çCˆÀ’BŒ£C“c•Ó‘CâŒû“NÍC–Ø“cŒõLC¬ò˜aŽO˜YC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 155`159, 1989.
28. mŒ´’˜n ‘½”ˆÝŠà91—á‚ÌŒŸ“¢.
ˆÉ“¡‹ÏC¬ò˜aŽO˜YC²–ìG–íCˆ°Œ´‹BCˆÀ’BŒ£C“c•Ó‘C“©ŽRaˆê˜NCâŒû“NÍCŽR“cŽŠlC–Ø“cŒõLC‰¡ŽR–õC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC
匴÷C”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 160`164, 1989.
29. mŒ´’˜n ‘å’°Villous tumor‚Ì—Õ°•a—Šw“IŒŸ“¢.
¬—Ñ´“TCŒÜ\—’³LC‹e’n–FtC—é–Ø—TCŽR–{‰À³CŸ–””º‰hC‰ª•”Ž¡–íi“àjCH“¡N¶iŠOjC£ìŒªˆêC’†‰p’ji•a—jC‚‹´r‹BiŠOj:
Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 180`183, 1989.
30. mŒ´’˜n ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é–«äX‰Š‚ÌŒŸ“¢. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½Cˆ°Œ´‹BC¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·CˆÀŠC‹`—jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 197`201, 1989.
31. mŒ´’˜n ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ’×ᇂ̌Ÿ“¢|“Á‚Ɉݒ×ᇂÌEUSŽž‘Š‚ÆŽ¡–ü”»’è‚ɂ‚¢‚Ä|.
–Ø“cŒõLC¼Œ³Ž›Ž—çCŽR“cŽŠlCâŒû“NÍCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCˆÀŠC‹`—jC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†
‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 45`50, 1989.
32. mŒ´’˜n oŒŒ«’×ᇂ̒·ŠúŒo‰ß‚ÌŒŸ“¢|“Á‚ÉÄoŒŒ‚ɂ‚¢‚Ä|.
²–ìG–íC‰¡ŽR–õC“c•Ó‘CˆÉ“¡‹ÏCˆ°Œ´‹BCŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC“ˆ”ömCŽOd–슰ŠìC”äŠé”\Ž÷
iŠOj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 120`124, 1989.
33. mŒ´’˜n ’_”X‘B‹ØŽîÇ‚Ìf’f‚É‚¨‚¯‚é’´‰¹”g“àŽ‹‹¾‚Ì—L—p«.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½Cˆ°Œ´‹BC‰¡ŽR–õC•›“‡TˆêCŽR“cL•vC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C
”äŠé”\Ž÷iŠOjCΈä‰pºC–{‹§C’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 196`200, 1989.
34. mŒ´’˜n ICG•¹—p‘¢‰e‰º‚Ìd‰»ÜŒŒŠÇ“à’“ü–@‚ÌŒŸ“¢. “c•Ó‘C‘•ª–ΔŽCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 72`76, 1989.
35. mŒ´’˜n •a—¶ŒŸ•W–{‚É‚¨‚¯‚鎉–bŠÌ‚ÌŒv‘ªŠw“IŒŸ“¢. Žs£‹I‘ã”üCˆÉ“¡—R”üŽqC“n•ÓiŽqi“Œ•a‰@•a—jCŽsì‚‚íi•a‰@•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 22(1): 44`47, 1987.
36. mŒ´’˜n ŠeŽíõF–@‚ð—p‚¢‚½ˆÝ‰©FŽî‚Ì•a—‘gDŠw“IŒŸ“¢. ‰¡‘ò³ŽuCŽR‰º˜a–çC“n•Óˆê]CŽÂ“cGi“Œ•a‰@•a—jC’†‰p’ji•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(3): 164`167, 1988.
37. mŒ´’˜n ‘å’°ƒƒ‰ƒm|ƒVƒX‚É‚¨‚¯‚éF‘f•Û—L×–E‚Ì•a—Šw“IŒŸ“¢. ŽR‰º˜a–çCŽÂ“cGC‰¡‘ò³ŽuC“n•Óˆê]C‘êì—T”üCŒÃ‘º‚¢‚³‚Ýi“Œ•a‰@•a—jC’†‰p’ji•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(4): 210`215, 1988.
38. mŒ´’˜n ’_”XƒRƒŒƒXƒeƒ|ƒVƒX‚Ì•a—‘gDŠw“IŒŸ“¢. “n•Óˆê]C‰¡‘ò³ŽuCŽR‰º˜a–çCŽÂ“cGi“Œ•a‰@•a—jC’†‰p’ji•a—j: _“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 24(1): 13`16, 1989.
39. mŒ´’˜n ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾ƒŒ[ƒU[ÆŽË+OK432‹Ç’•¹—p—Ö@. “ˆ”ömC”äŠé”\Ž÷C¬—ÑLsCŽR”ö“N•FCã–쑈ê˜YC“Œ”ŽC‰Á“¡NsCŽOd–슰ŠìC匴÷iŠOj: “ú–{ƒŒ[ƒU[ˆãŠw‰ïŽ, 10(3): 151`154, 1989.
40. mŒ´’˜n Orthotopic Liver Transplantation with Use of Mizoribine,
Cyclosporine and FK506 in Dogs.
²“¡ŒõŽjC‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jC“à“c‹v‘¥Cˆ¢‘]OˆêiŠOjC‘å•”½C‰œ•½‰ë•Fi•a—j: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 20:
56`59, 1989.
41. mŒ´’˜n ‘ŠúˆÝŠà‚É‚¨‚¯‚郌[ƒU[‚̉ž—p|Endoscopic Surgery‚ɂ‚¢‚Ä|. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsiŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ïŽ, 21: 176`178, 1989.
42. mŒ´’˜n \“ñŽw’°’×ᇋً}Žèp—á‚Ì—Õ°“IŒŸ“¢. ’Ë–{GlC÷–{MˆêCˆ”üƒ•vC‘ •ÀŸCŽOd–슰ŠìC‚‹´r‹BC匴÷C”äŠé”\Ž÷Cˆ¢‘]OˆêiŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(8): 2004`2008, 1989.
43. mŒ´’˜n ”S–Œ‰º‘wZ‘å’°Šà‚¨‚æ‚ьŗL‹Ø‘wZ‘å’°Šà‚Ì—Õ°•a—Šw“IŒ¤‹†|‚Æ‚‚Ép‘Op’†’´‰¹”gf’f‚Æ‚ÌŠÖ˜A‚É‚¨‚¢‚Ä|. ‘å’J„³iŠOj: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(9): 2283`2291, 1989.
44. mŒ´’˜n ƒ‰ƒbƒgˆÝ”S‰t“œƒ^ƒ“ƒpƒNŽ¿‹y‚шݔS–Œ’ïR«‚ɑ΂·‚éŽ_•ª”åŽhŒƒ‚̉e‹¿. ¬Žº—TˆêC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(3): 11`17, 1990.
45. mŒ´’˜n ’°Œ^ƒx[ƒ`ƒFƒbƒg•a‚ɑ΂·‚é‰h—{—Ö@‚Ì—Õ°“IŒ¤‹†. ¬—Ñ´“TCŒÜ\—’³LC‹e’n–FtC—é–Ø—TCŽR–{‰À³CŸ–””º‰hC‰ª•”Ž¡–íi“àj: “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 42(7): 1265`1271, 1989.
46. mŒ´’˜n
Á‰»ŠÇ‰^“®‚ÌV‚µ‚¢‰ðÍ•û–@|ƒ}ƒEƒX“Eo’°ŠÇ‰^“®‚É‚¨‚æ‚Ú‚·Scoporamine-N-butylbromide‚¨‚æ‚ÑMetoclopramide‚Ì
Œø‰Ê. ‰Á“¡NsCã–쑈ê˜YC“Œ”ŽiŠOjC‘ëàV’¼’èC‘åŠÑMi¶—jC”äŠé”\Ž÷iŠOj: –k—¢ˆãŠw, 19(4): 440`444, 1989.
47. mŒ´’˜n
–³ŠÌŠú‚ÉBio-pump‚É‚æ‚éƒoƒCƒpƒXŽè‹Z‚ð—p‚¢‚½ƒCƒk“¯Š«“¯ŽîŠÌˆÚA|ŽèpŽè‹Z‚ÌŠm—§‚ÆV–Ɖu—}§ÜFK506‚̖Ɖu—}§Œø‰Ê‚ɂ‚¢‚Ä|.
‰¡“c˜a•FC‘듇í‰ëC²“¡ŒõŽjC’†ŽR‹`‰îCŒY•”P’jC¡ˆäŒ‰C“à“c‹v‘¥Cˆ¢‘]OˆêiŠOjC‘å•”½C‰œ•½‰ë•Fi•a—jC^è‹`•FiŽÀ“®Œnj: –k—¢ˆãŠw,
19(5): 501`509, 1989.
48. mŒ´’˜n ’_”XŒ‹Î‚ɑ΂·‚é‘ÌŠOŽ®ÕŒ‚”g‚É‚æ‚é”jÓp‚ÌŠî‘b“I—Õ°“IŒ¤‹†. –å˜eŒ›iŠOj: –k—¢ˆãŠw, 19(5): 518`527, 1989.
49. mŒ´’˜n ƒ‰ƒbƒgŽ¨‰º‘B‘B–[×–E‚Ì”¶‚ÉŠÖ‚·‚é“dŽqŒ°”÷‹¾“IŒ¤‹†. ‹g”ö’miŽ¨•@jC‹Ê–؉p–¾CŽR‰È³•½i‰ðj: –k—¢ˆãŠw, 19(6): 594`603, 1989.
50. mŒ´’˜n V‚µ‚¢ŒoŒû’°ŠÇôòÜ‚É‚æ‚é‘å’°“àŽ‹‹¾ŒŸ¸–@‚ÌŒŸ“¢|—Ê“Š—^–@‚Æ‚Ì”äŠr‚àŠÜ‚ß‚Ä|. ŽO•xO”Vi“àjC‘åˆä“c³li‘åˆä“c•a‰@jCŸ–””º‰hC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: –k—¢ˆãŠw, l9(3): 317`320, 1989.
51. mŒ´’˜n –{‰@‚É‚¨‚¯‚é‘å’°ƒ|ƒŠ[ƒvÇ—á‚ÌŒŸ“¢. ŽO•xO”Vi“àjC‘åˆä“c³li‘åˆä“c•a‰@j: –k—¢ˆãŠw, l9(4): 421`425, 1989.
52. mŒ´’˜n Œ€ÇŠÌ•s‘SC—nŒŒ«•nŒŒ‚Ŕǂµ‹~–½‚µ“¾‚½ Wilson •a‚Ì1—á. ‘å“c„•äC^“º‘¾˜YC¬“‡–M•FiŽ™j: –k—¢ˆãŠwC20(1): 26`30, 1990.
53. mŒ´’˜n ŽÀŒ±’×ᇂɑ΂·‚éŽ_•ª”å—}§Ü‚Æ–hŒäˆöŽq‘BÜ•¹—p“Š—^‚ÌŒø‰Ê|Cimetidine‚ÆCetraxate‚É‚æ‚錟“¢|.
Žs쑸•¶i“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—Tˆêi¶‰»jC¬“‡—m“ñi“àjC¬Œ´iC–x“c‹±Žqi¶‰»j: –ò—‚ÆŽ¡—Ã, 18(3):
1065`1070, 1990.
54. m’Z•ñn Microcirculatory Injury of Rat Gastric Mucosa by Ethanol and
Its Prevention of Endogenous PGE2. ŽŽæMC¼ŽR˜a’jC¬“c—²Ž¡Cã–ìWŒ›i–ò—j:
Microcirculation Annual 1989, p.105`106, 1989.
55. m’Z•ñn ‘ÌŽ¿«‰©átŠÌ‚É‚¨‚¯‚郊ƒKƒ“ƒfƒBƒ“‚ÌŒŒ‰t‘gDŠw“IŒŸ“¢. ˆÀ•”ˆä½lA¼è–õŽiC“c’†’¼Œ©C‘å›r–¾i’}”g‘åjC™–{Œ³Mi“Œ–M‘åjCŽÄ“c‹v—Yi“àj: ŠÌ‘Ÿ, : 1040, 1989.
56. m’Z•ñn 90”N‘ã‚Ì•a—‚Ö‚ÌŠú‘Ò. ”äŠé”\Ž÷iŠOj: •a—‚Æ—Õ°, 8(2): 181, 1990.
57. mŒ¤‹†•ñn ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“uŠÌ—\”õ”\v‚Í‚¶‚ß‚É. ŽÄ“c‹v—Yi“àj: “Œ•”ŠÌ‘ŸƒtƒH[ƒ‰ƒ€ '89‘æ2‰ñ‹L˜^W, 1990.
58. mŒ¤‹†•ñiŒú¶Èjn –å–¬ŒŒs“®‘ÔŒŸ“¢ˆÏˆõ‰ï•ñ.
‰œ•½‰ë•Fi•a—jC–Øt•vi•ÛŒ’‰q¶‘åjCrì³”Ži‹v—¯•Ä‘åjC“à“cr˜ai“ú‘åjC‘å•”½i•a—jC–Ø’JŒ’ˆêi“Œ‹ž“sjCŒKŒ´‹I”Vi‡‘åjC’†ÀˆÀ“ñ
i‹à‘åjC“ñìr“ñi‡‘åjCXˆÀŽj“Ti‹ž‘åj: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.16`18, 1989.
59. mŒ¤‹†•ñiŒú¶Èjn “Á”«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•Ç×–E‚Ì“®‘Ô|‚Æ‚‚ÉŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä. ‰œ•½‰ë•FC‘å•”½i•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.53`56, 1989.
60. mŒ¤‹†•ñiŒú¶Èjn ŠÌÖ¬‘ŠŒÝŠÔ•«‡‚Ì•a—Šw“IŒŸ“¢. ‰œ•½‰ë•FC‘å•”½C“n•Ó´Ž¡i•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.57`59, 1989.
61. mÇ—á•ñn ’˜–¾‚È’á’`”’ŒŒÇ‚ð’悵‚½•³ü’ŽÇ‚Ì1—á.
ŽO•xO”Vi“àjC쑺½C‘åˆä“c³lC¼–ì„C’|‘©³“ñ˜YC‘åˆä“c“ñ˜Yi‘åˆä“c•a‰@jC¬ò˜aŽO˜YCŒÜ\—’³LCŸ–””º‰hC‰ª•”Ž¡–íi“àj:
Gastroenterological Endoscopy, 31(11): 3021`3031, 1989.
62. mÇ—á•ñn ‹}«ˆÝ”S–Œ•a•Ï‚ɑ΂·‚é”S–Œ•ÛŒìÜ‚¨‚æ‚ÑH2ƒuƒƒbƒJ[‚ÌŒø‰Ê‚Ì”äŠr. ¼Œ³Ž›Ž—çi“àj: Medical Tribune, 1989.
63. mÇ—á•ñn ΊD‰»’_”XŠà‚Ì1—á. ˆÉ“¡‹`–çC”ª\ì—v•½C¬”g‘qŽjŽqC’Ë–{GlC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjCó”ö•Žmi‘—§‘Š–ÍŒ´•a‰@j: ˆã—Ã, 43(11): 1186`1189, 1989.
64. mÇ—á•ñn ˆÀ‘§Ž_ƒGƒXƒgƒ‰ƒWƒI[ƒ‹‚ª‘tŒø‚µ‚½–³ÇŒó«Œ´”«’_`«ŠÌd•Ï‚Ì1—á.
¼–Ø–ÎŽ÷CΈäŒö“¹C”’èŒh“ñC™–{’¼CVˆäd‹ICŠ¡•”‚ЂƂÝC‘•ª–ΔŽCŽR“cL•vCŽÄ“c‹v—YC‰ª•”Ž¡–íi“àjC‘å•”½C‰œ•½‰ë•Fi•a—j: ŠÌ‘Ÿ,
29(12): 1638`1642, 1988.
65. mÇ—á•ñn ƒeƒKƒt[ƒ‹¥ƒEƒ‰ƒVƒ‹”z‡Ü(UFT)‚Ìp‘O“Š—^‚ª’˜Œø‚µ‚½Borrmann 2Œ^isˆÝŠà‚Ì1Žèp—á.
ã™G‰iCˆÀŠC‹`—jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìiŠOjC–{‹§i•a—j: Šà‚Ì—Õ°, 35(8): 963`969, 1989.
66. mÇ—á•ñn ‘å’°“àŽ‹‹¾ŒŸ¸’¼Œã‚ɔǂµ‚½‹•ŒŒ«‘å’°‰Š‚Ì1—á.
ŒÜ\—’³LCŸ–””º‰hCŽO‹´—˜‰·C¼ŽR˜a’jCŽO•xO”VC¬—Ñ´“TCŽR–{‰À³C¼Œ³Ž›Ž—çi“àjC£ìŒªˆêC’†‰p’ji•a—jC”äŠé”\Ž÷iŠOj:
Á‰»Ší“àŽ‹‹¾, 1(5): 731`735, 1989.
67. mÇ—á•ñn H“¹ˆ««•FŽî. ŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC‰¡ŽR–õC¬ò˜aŽO˜Yi“àj: Á‰»Ší“àŽ‹‹¾, 2(1): 94`95, 1990.
68. mÇ—á•ñn L”Í‚Èœ‘“]ˆÚ‚ð‚«‚½‚µ‚½H“¹¬×–EŠà‚Ì1—á. “c•Ó‘C¡‘º´ŽqC“c•Ó—R”üC‘“c‰p–¾CˆË“c•qC²“‡Œh´C’j‘S³ŽOC’†‘ºé¶C²–ìm—EC‰i‰ª’å’ji“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34: 232`235, 1989.
69. mÇ—á•ñn ”S–Œ‰ºŽîá‡ó‚ÌŒ`‘Ô‚ðŽ¦‚µRLH‚Æ‚µ‚ÄŒo‰ßŠÏŽ@‚³‚ꂽˆÝˆ««ƒŠƒ“ƒpŽî‚Ì1—á.
‰ª“c‘ìŽqC‰–’J—z‰îC’r“c“TŽŸC¡‘º´ŽqCˆË“c•qC‘“c‰p–¾C‹e’n–FtC²“‡Œh´C’j‘S³ŽOC–Ø“cŒõLi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35:
256`259, 1989.
70. mÇ—á•ñn Šg‘å• o‹¾‚É‚æ‚èŠÌ•\–Ê‚Ì–Ñ׌ŒŠÇŠg’£‚ðØ–¾‚µ‚½Rendu-Osler-Weber•a‚Ì1—á.
ŽOŽ}MC¼–Ø–ÎŽ÷C‘ºã‹§lCŽR“cŽŠlC™–{’¼CŽR“cL•vCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾‚Ìi•à, 35: 370`372,
1989.
71. mÇ—á•ñn ŠÌ‹æˆæ‚ÉŒÀ‹Ç‚µ‚½‘±”«’_`«ŠÌd•Ï‘œ‚ð’悵‚½ŠÌ–å•”’_ŠÇŠà‚Ì1—á. a’J–¾—²C™–{’¼CâŒû“NÍC¼–{ˆÌ’jC‘ºã‹§lC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ’_“¹, 4(1): 62`67, 1990.
72. mÇ—á•ñn ˆÝGlomusŽîᇂÌ1—á. –x]˜aLC‰¡“c˜a•FC¡ˆäŒ‰Cˆ¢‘]OˆêiŠOjCŒK”ö’èmi•a—j: “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(12): 2833`2836, 1989.
73. mÇ—á•ñn ‰¡sŒ‹’°‚É•Ç“àá‘‚ðŒ`¬‚µC•a—‘gDŠw“I‚ÉŠm”F‚µ“¾‚½Crohn•a‚Ì1—á.
£ìŒªˆêC’†‰p’jC‰œ•½‰ë•Fi•a—jCŸ–””º‰hCŽR–{‰À³CŒÜ\—’³LC‰ª•”Ž¡–íi“àjCH“¡N¶iŠOj: “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(2):
243`247, 1990.
74. mÇ—á•ñn Œ´”‘ƒ‚ª—Ç‚ŠÇ—‚³‚ê”x“]ˆÚ‚Ì‚È‚©‚Á‚½ŠÌ×–EŠà‚Ì”]“]ˆÚ‚Ì1—á.
Œ‹éL‘×i‰º“s‰ê‘‡•a‰@jC^‹ÊŽõ”ü¶C“¡ˆä•ÛŽ¡C‰J‹{Œ«ˆêC–Ø“c–FŽ÷C›’m–çC–ì“o½i“àjC—é–Ø‚—SCŒÜŒŽ—–Îi‰º“s‰ê‘‡•a‰@j:
—Õ°‚ÆŒ¤‹†, 66(4): 1207`1212, 1989.
75. mÇ—á•ñn ˆÝ‘O’ë•”‘O•Ç‚̇UcŒ^‘ŠúˆÝŠà. ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: —Õ°ˆã, 15(11): 1902`1904, 1989.
76. m—Õ°Ž¡Œ±n ’_Ηn‰ð—Ö@‚Ì’·Šú—\Œã. ‘•ª–ΔŽi“àj: Medical Tribune, '89(11.2): 50`51, 1989.
77. m—Õ°Ž¡Œ±n Sucralfate‚É‚æ‚éˆÝ’×ᇂÌÄ”‚Æ‚»‚̈öŽq‚ÌŒ¤‹†; •aˆã‰@¥f—Ê‚É‚æ‚鑽Ž{Ý“ˆêƒvƒƒgƒR[ƒ‹ŽŽŒ±.
‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC¬ì’¨–çiˆ¤•Q‘åjCìãŸiO‘O‘åjCˆäãCˆêiH“c‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@j: Therapeutic
Research, 10(4): 1593`1606, 1989.
78. m—Õ°Ž¡Œ±n ƒtƒBƒ“ƒK[¥ƒs[ƒX–@‚É‚æ‚éICGŽŽŒ±‚Ì‘½Ž{Ý‚É‚¨‚¯‚錟“¢.
˜Q‹v—˜•FCˆ¾’ÖM’jC“ì•”ŸŽii‡“V“°‘åjCŽÄ“c‹v—Yi“àjC…–{—´“ñiŽOd‘åjC’Òˆä³i“ޗLjã‰È‘åjC‚“cºi‹à‘òˆã‰È‘åjCŽ…“‡’B–çi‰ª‘åjCìè
Š°’†i’¹Žæ‘åjC‰v‘ò›{i‘—§‘åã•a‰@jC’Jì‹vˆêi‹v—¯•Ä‘åjC¼“ˆ‹ªi–k‘åjC•½–쳌›i“Œ‹žŒxŽ@•a‰@jC¼è¼•½i“ŒŠC‘åj: ŠÌ’_äX,
20(2): 347`351, 1990.
79. m—Õ°Ž¡Œ±n Œû‘¤ØœüŒˆ’è‚Ì‚½‚߂̈ݶŒŸ‚Æ“àŽ‹‹¾ƒNƒŠƒbƒsƒ“ƒO–@. ŽOd–슰ŠìC¬—ÑLsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOjC¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: Á‰»Ší“àŽ‹‹¾, 2(2): 135`143, 1990.
80. m—Õ°Ž¡Œ±n ˆÝ’×ᇂɑ΂·‚éRioprostil‚Ì‘æ2‘Š—Õ°ŽŽŒ±|“ñd–ÓŒŸ–@‚É‚æ‚é—p–@—p—Ê‚ÌŒŸ“¢|.
ŽODH”niɪŒ§—§‘‡•a‰@jC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC’J“àºiŽD–yˆã‰È‘åjCŒã“¡—R•vi“Œ–k‘åjC³@Œ¤iH“c‘åjC¼”ö—TCŠâè—L—Çi“ú‘åjC
XŽ¡Ž÷i“Œ—ˆã‘åjC•Ÿ•x‹v”Vi’}”g‘åjC’j‘S³ŽOi‰¡•lŽs—§Žs–¯•a‰@jCŽO—Ö„CŒ´àV–Îi“ŒŠC‘åjC’†àVŽO˜Yi–¼ŒÃ‰®‘åjC’†“‡•q•viŽs—§–L’†•a‰@jC
Š™“c•Miã‘åjCŠÝ´ˆê˜Yi“¿“‡‘åjC”ª”öP—Çi•Ÿ‰ª‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@jC¬ì’¨–çiˆ¤•Q‘åj: “à‰È•ó”Ÿ, 36(4):
77`91, 1989.
81. m—Õ°Ž¡Œ±n \“ñŽw’°’×ᇂɑ΂·‚éRioprostil‚Ì‘æ2‘Š—Õ°ŽŽŒ±|“ñd–ÓŒŸ–@‚É‚æ‚é—p—Ê‚ÌŒŸ“¢|.
ŽODH”niɪŒ§—§‘‡•a‰@jC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC’J“àºiŽD–yˆã‰È‘åjCŒã“¡—R•vi“Œ–k‘åjC³@Œ¤iH“c‘åjC¼”ö—TCŠâè—L—Çi“ú‘åjC
XŽ¡Ž÷i“Œ—ˆã‘åjC•Ÿ•x‹v”Vi’}”g‘åjC’j‘S³ŽOi‰¡•lŽs—§Žs–¯•a‰@jCŽO—Ö„CŒ´àV–Îi“ŒŠC‘åjC’†àVŽO˜Yi–¼ŒÃ‰®‘åjC’†“‡•q•viŽs—§–L’†•a‰@jC
Š™“c•Miã‘åjCŠÝ´ˆê˜Yi“¿“‡‘åjC”ª”öP—Çi•Ÿ‰ª‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@jC¬ì’¨–çiˆ¤•Q‘åj: “à‰È•ó”Ÿ, 36(5):
161`176, 1989.
82. m—Õ°Ž¡Œ±n ˆÝ‰Š‚ɑ΂·‚éRioprostil‚Ì‘æ2‘Š—Õ°ŽŽŒ±|“ñd–ÓŒŸ–@‚É‚æ‚é—p—Ê‚ÌŒŸ“¢.
ŽODH”niɪŒ§—§‘‡•a‰@jC‰ª•”Ž¡–íC¼Œ³Ž›Ž—çi“àjC’J“àºiŽD–yˆã‰È‘åjCŒã“¡—R•vi“Œ–k‘åjC³@Œ¤iH“c‘åjC¼”ö—TCŠâè—L—Çi“ú‘åjC
XŽ¡Ž÷i“Œ—ˆã‘åjC•Ÿ•x‹v”Vi’}”g‘åjC’j‘S³ŽOi‰¡•lŽs—§Žs–¯•a‰@jCŽO—Ö„CŒ´àV–Îi“ŒŠC‘åjC’†àVŽO˜Yi–¼ŒÃ‰®‘åjC’†“‡•q•viŽs—§–L’†•a‰@jC
Š™“c•Miã‘åjCŠÝ´ˆê˜Yi“¿“‡‘åjC”ª”öP—Çi•Ÿ‰ª‘åjC‘ìŸäi“úÔ’·èŒ´”š•a‰@jC¬ì’¨–çiˆ¤•Q‘åj: “à‰È•ó”Ÿ, 36(7):
255`270, 1989.
83. m‘àn “àŽ‹‹¾‚É‚æ‚éˆÝŠà‚Ì[’B“x‚ÆŽ¡—Ã. ”äŠé”\Ž÷iŠOj: Clinician, 90(387): 66`72, 1990.
84. m‘àn Ä”–hŽ~–Ê‚©‚ç‚Ý‚½ˆÝ’×ᇂ̎¡—Ã. ¼Œ³Ž›Ž—çi“àj: Kyo, (84): 9`13, 1989.
85. m‘àn nj󂩂çf’f‚Öu“fŒŒv. ¼Œ³Ž›Ž—çi“àj: Medic, 24(9): 21`24, 1989.
86. m‘àn Á‰»«’×á‡. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: Medicament News, (1282): 19`23, 1990.
87. m‘àn ã•”Á‰»ŠÇoŒŒ. ‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: Medicina, 26(7): 1216`1217, 1989.
88. m‘àn ’·ŠúˆÛŽ—Ö@‚ňݥ\“ñŽw’°’×ᇂÌÄ”—\–h‚͉”\‚©H ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: Medicina, 27(2): 208`211, 1990.
89. m‘àn ‘ŠúˆÝŠà‚Í”ñŽèp“I‚ÉŽ¡—ɔ\‚©H ”äŠé”\Ž÷C“ˆ”ömiŠOj: Medicina, 27(2): 222`224, 1989.
90. m‘àn Á‰»«’×ᇂÌÄ”‘Îô. ¼Œ³Ž›Ž—çi“àj: Modern Medicine, 88(8): 33`37, 1989.
91. m‘àn H2-blocker‚̓I[ƒ‹ƒ}ƒCƒeƒB‚©. ^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: Modern Physician, 10(3): 311`314, 1990.
92. m‘àn ˆÝ‚ðl‚¦‚é|Á‰»«’×á‡. ¼Œ³Ž›Ž—çi“àj: ƒXƒYƒPƒ“PHC, (5): 37`46, 1989.
93. m‘àn ‹}«ˆÝ”S–Œ•a•Ï(AGML)‚̬ˆö|ŠO‰È‚Ì—§ê‚©‚ç|. ’Ë–{GlC”äŠé”\Ž÷CŽOd–슰ŠìiŠOjC“©ŽRaˆê˜NCˆêŒ´—ºC¼Œ³Ž›Ž—çi“àj: ˆÝ‚Æ’°, 24(6): 645`651, 1989.
94. m‘àn ’Ž‚‰Š‚ª‹^‚í‚ꂽ’Ž‚ŠàA‚±‚ÌÇ—á‚ÌŽ¡—Õûj. H“¡N¶C”äŠé”\Ž÷iŠOj: ŠO‰È, 51(8): 772`775, 1989.
95. m‘àn ŠÌ×–E•Ï«E‰óŽ€‚Ì•a—. ‰œ•½‰ë•FC‹àŽq‘C²“¡³Ž÷i•a—j: ŠÌ’_äX, 19(2): 173`177, 1989.
96. m‘àn –ò•¨«ŠÌáŠQ‚Ì•a—. ‘å•”½C‰œ•½‰ë•Fi•a—j: ŠÌ’_äX, 19(4): 767`774, 1989.
97. m‘àn ‹}«ˆÝ”S–Œ•a•Ï(AGML)‚Æ‚Í|ŠO‰È‚Ì—§ê‚©‚ç|. ’Ë–{GlC”äŠé”\Ž÷iŠOj: ÅVˆãŠw, 44(10): 2017`2021, 1989.
98. m‘àn ‹}«ˆÝ”S–Œ•a•Ï(AGML)‚Æ‚»‚ÌŽü•Ó|”S‰t‚ÆAGML. –x“c‹±Žqi¶‰»jCÎŒ´˜a•Fi‰»j: ÅVˆãŠw, 44(10): 2152`2156, 1989.
99. m‘àn “àŽ¤ŠjŽèp‚ÌŒŸ“¢. ’©’·“N–íC‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC‹g“cŸ–¾C’r‰i½C’†‘ºG•viã”ö’†‰›‘‡•a‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 24(3): 713`715, 1989.
100. m‘àn ‘å’°ŠàŠÌ“]ˆÚ—á‚ÌŒŸ“¢. ’r‰i½iŠOjC‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC‹g“cŸ–¾C’©’·“N–íC’†‘ºG•viã”ö’†‰›‘‡•a‰@j: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 24(3): 717`720, 1989.
101. m‘àn Á‰»«’×ᇂÌNatural History. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: Ž¡—Ã, 71(10): 2065`2070, 1989.
102. m‘àn ˆÝ”S–Œ–hŒä‚É‚¨‚¯‚é”S‰t¥d’YŽ_‚̈Ӌ`. –x“c‹±Žqi¶‰»j: Ž¡—Êw, 23(3): 264`268, 1989.
103. m‘àn “ÁW: ˜Vlf—Ã|f’fŠî€|m˜V”NŽÒ‚É‚¨‚¯‚éf’fŠî€nÁ‰»«’×á‡. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ŽÀŒ±Ž¡—Ã, (617): 176`178, 1989.
104. m‘àn ’_“¹•a•Ï‚Ì’´‰¹”gf’f. ‘•ª–ΔŽC™–{’¼CâŒû“NÍCŽÄ“c‹v—Yi“àj: Á‰»Ší‰È, 11(6): 698`706, 1989.
105. m‘àn ‘å—Ê“fŒŒ‚ɑ΂·‚é”ñŽèp“I—Ö@‚Æ‚»‚ÌŒÀŠE. ’Ë–{GlC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 13(2): 163`168, 1990.
106. m‘àn ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚é‹Ù‹}“àŽ‹‹¾Ž~ŒŒ. –Ø“cŒõLC¼Œ³Ž›Ž—çC“c•Ó‘C²–ìG–íC‘•ª–ΔŽC‰¡ŽR–õC‰ª•”Ž¡–íi“àj: Á‰»Ší“àŽ‹‹¾, 1(3): 278`284, 1989.
107. m‘àn Á‰»ŠÇoŒŒ‚ɑ΂·‚é“àŽ‹‹¾“IƒŒ[ƒU[Ž~ŒŒ–@|—ðŽj“I•Ï‘J‚©‚ç‚Ý‚½Ä•]‰¿|. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsiŠOj: Á‰»Ší“àŽ‹‹¾, 1(3): 293`299, 1989.
108. m‘àn ‘å’°ƒ|ƒŠƒyƒNƒgƒ~[‚Ì•]‰¿‚ÆŽ¡–ü”»’è. Ÿ–””º‰hCŒÜ\—’³LCŽO•xO”VC¬—Ñ´“TCŽR–{‰À³C¼Œ³Ž›Ž—çi“àjC‚‹´r‹BC”äŠé”\Ž÷iŠOjC£ìŒªˆêC’†‰p’ji•a—j: Á‰»Ší“àŽ‹‹¾, 1(7): 937`946, 1989.
109. m‘àn Šà‚Ì“àŽ‹‹¾“IŽ¡—Â̕]‰¿. ”äŠé”\Ž÷C“ˆ”ömiŠOj: Á‰»Ší“àŽ‹‹¾, 1(7): 987`991, 1989.
110. m‘àn ˆÝ’×ᇂ̒´‰¹”g“àŽ‹‹¾f’f. –Ø“cŒõLC¼Œ³Ž›Ž—çCŽR“cŽŠlCâŒû“NÍC–ì“o½C‰¡ŽR–õC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: Á‰»«’×á‡|—Õ°‚ÆŠî‘b, 8(2): 132`141, 1989.
111. m‘àn ŒŸ¸Œv‰æ–@|—Õ°ŒŸ¸‚ÌŒöŽ®W|‡X.Á‰»ŠÇŽ¾Š³; 9. ˆÝ¥\“ñŽw’°’×á‡. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: ‘‡—Õ°, 38(‘Š§): 1312`1316, 1989.
112. m‘àn Á‰»«’×á‡iˆÝ¥\“ñŽw’°’×á‡j. ‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: “ú–{ˆãŽt‰ïŽGŽ, 103(3): 351`355, 1990.
113. m‘àn ’_ÎESWL‚Ì•›ì—p¥‡•¹Ç. –å˜eŒ›C÷–{MˆêiŠOjCˆêŒ´—ºi“àjCã–ìˆê–çC•½“cMlC”äŠé”\Ž÷iŠOj: “ú–{—Õ°, 47(12): 2758`2761, 1989.
114. m‘àn 5'-ƒkƒNƒŒƒIƒ`ƒ_[ƒ[. ŽÄ“c‹v—Yi“àj: “ú–{—Õ°, 47(‘Š§): 313, 1989.
115. m‘àn ˆÝ‚É‚¨‚¯‚é“àˆö«ƒGƒCƒRƒTƒmƒCƒh‚Ìì—p‚ÆR‰ŠÇ–òCR’×ᇖò. ŽŽæMC¼ŽR˜a’ji–ò—jC—é–Ø—Ti“àjCã–ìWŒ›i–ò—j: •a‘Ô¶—, 8(8): 657`665, 1989.
116. m‘àn ŠÌŠà—ÞŽ—•a•Ï‚Ì•a—Šw“I‘¤–Ê. ‰œ•½‰ë•FC‘å•”½C‹àŽq‘C‚ˆä’qŽqC–{‹´ˆèŽqC–Ø“c–FŽ÷i•a—j: • •”‰æ‘œf’f, 10(1): 7`14, 1990.
117. m‘àn ‰º•”Á‰»ŠÇ“®Ã–¬ŠïŒ`|—Õ°•ª—Þ‚ÉŠÖ‚·‚élŽ@‚Æ–{–M•ñ—á‚ÌWŒv. ‘–쳈êCˆä“›–rC‰““¡‚i•új: • •”‹~‹}f—ÂÌi•à, 10(1): 134`139, 1990.
118. m‘àn ‹}«• Ç‚Ìf’f‚ÆŽèp“K‰ž. ”äŠé”\Ž÷C“ˆ”ömiŠOj: –ˆ“úƒ‰ƒCƒt, 90(3): 26`29, 1990.
119. m‘àn lHäX‘Ÿ‚Æ‚»‚Ì—˜—p. ‰¡“c˜a•FC²“¡ŒõŽjiŠOjC“¡“c–F–Mi“àj: –ò‹Ç, 40(3): 965`969, 1989.
120. m‘àn “f‰ºŒŒ‚Ì•aˆö. ^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: —Õ°‚ÆŒ¤‹†, 66(12): 3706`3711, 1990.
121. m‘àn ‘ÌŠOÕŒ‚”g—Ö@. ŽÄ“c‹v—YCˆêŒ´—ºi“àj: —Õ°‚ÆŒ¤‹†, 66(8): 110, 1989.
122. m‘àn i“ÁWj’_΂ƒ_ÎÇ:f’f–@A¸–§ŒŸ¸. ‹g“c@‹IC”äŠé”\Ž÷Cˆ”üƒ•vC‘å‹{“Œ¶iŠOj: —Õ°‚ÆŒ¤‹†, 66(8): 2404`2411, 1989.
123. m‘àn R’×ᇖò. ¼Œ³Ž›Ž—çi“àj: —Õ°‚ÆŒ¤‹†, 67(1): 61`64, 1990.
124. m‘àn ˆÝŠà‚Ì“àŽ‹‹¾Ž¡—Ã. ”äŠé”\Ž÷C¬—ÑLsC“ˆ”ömiŠOj: —Õ°ˆã, 15(11): 1854`1858, 1989.
125. m‘àn ˆÝ’×ᇂÌÄ”—vˆö. ŽO‹´—˜‰·C‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: —Õ°‰ÈŠw, 26(1): 43`49, 1990.
126. m‘àn ”S–Œ–hŒä‹@\‚ÌV‚µ‚¢“W–]|”S‰t‚Ì—§ê‚©‚ç|. ¬Žº—Tˆêi¶‰»jCÎŒ´˜a•Fi‰»jC‰ª•”Ž¡–íi“àj: —Õ°‰ÈŠw, 26(1): 61`65, 1990.
127. m‘àn H“¹“à‘}ŠÇ–@. “ˆ”ömC”äŠé”\Ž÷iŠOj: —Õ°ŠO‰È, 44(11): 1573`1575, 1989.
128. m‘àn H“¹Šg’£–@. “ˆ”ömC”äŠé”\Ž÷iŠOj: —Õ°ŠO‰È, 44(9): 1141`1143, 1989.
129. m‘àn ˆÝŠà¥oŒŒ«’×á‡. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsC匴÷iŠOjC“c•Ó‘C‰¡ŽR–õi“àj: —Õ°ŠO‰È, 45(2): 177`186, 1990.
130. m‘àn –ò•¨«ŠÌáŠQ‚Ì•a—. ‘å•”½C‰œ•½‰ë•Fi•a—j: —Õ°Á‰»Ší“à‰È, 4(11): 1783`1791, 1989.
131. m‘àn ˆÝŽèpŒã‚Ì•a•Ï‚Æ‚»‚Ì‘Îô,@‡Z.•«‡•”’×á‡;(4)Ž¡—Õûj|–ò•¨—Ö@‚ÆŽèp“K‰ž‚ð‚ß‚®‚Á‚Ä. ŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àjC’Ë–{GliŠOj: —Õ°Á‰»Ší“à‰È, 5(1): 81`86, 1990.
132. m‘àn ‘Þ‰@Œã‚̶ŠˆŽw“±;Á‰»«’×á‡. ‰¡ŽR–õC‰ª•”Ž¡–íi“àj: —Õ°¬l•a, 19(9): 146`148, 1989.
133. muÀn “]“|‚É‚æ‚é‘Å–oÇ‚ÅNSAID•ž—pŒã‚Ì‹}«ˆÝ‰Š. ¼Œ³Ž›Ž—çi“àj: Clinician, 36: 20`21, 1989.
134. muÀn ˆÝ’°“§Ž‹‚Æ’ÁázÜ. ¼Œ³Ž›Ž—çi“àj: ƒhƒNƒ^[ƒTƒƒ“, 34(3): 195`198, 1990.
135. muÀn “ljeuÀ|‚±‚ê‚ð‚Ç‚¤‚æ‚Þ‚©H ¼Šª”ŽC›Mˆêi•újC–x’rdŽ¡i‹~–½jC“cŠŽŒÈC’r“crºC¬—Ñ–ÎŽ÷C’J“c—ˆê˜YC¼—Ñ—²i•új: ‰æ‘œf’f, 9(6): 731`737, 1989.
136. muÀn Œûo“à‰ŠÇ|‚Í‚¶‚ß‚É|. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°, 82(11): 1511, 1989.
137. muÀn Œûo“à‰ŠÇ; Š´õÇ 2.ƒEƒBƒ‹ƒXŠ´õ‚É‚æ‚éŒû“à‰Ši’Pƒáv]C…“—Cƒwƒ‹ƒpƒ“ƒM|ƒiC–ƒ]CŽè‘«Œû•aj|f’f‚ÆŽ¡—Ã|. ‚‹´œAbCÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°, 82(11): 1514`1517, 1989.
138. muÀn –«•Ö”éA–ƒáƒ«ƒCƒŒƒEƒX. ŒÜ\—’³LCŸ–””º‰hC‰ª•”Ž¡–íi“àj: Á‰»Ší‰È, 11(1): 90`98, 1989.
139. muÀn ŠÌ’_äX‚ÌCTf’f|CT“lje‚É•K—v‚ÈŠî‘b’mŽ¯|1990. ‘–쳈êi•új: Á‰»ŠíŠO‰È, 13(1): 83`93, 1990.
140. muÀn ŠÌ’_äX‚ÌCTf’f|ŠÌ‘Ÿ(1)ŠÌ×–EŠà. ‘–쳈êCˆä“›–rC’J“c—ˆê˜Yi•újC’†‰p’ji•a—jC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 13(2): 201`210, 1990.
141. muÀn ŠÌ’_äX‚ÌCTf’f|ŠÌ‘Ÿ(2)“]ˆÚ«ŠÌŠà. ‘–쳈êCˆä“›–rC‰““¡‚i•újC’†‰p’ji•a—jC”äŠé”\Ž÷iŠOj: Á‰»ŠíŠO‰È, 13(3): 363`370, 1990.
142. muÀn ã•”Á‰»ŠÇ“àŽ‹‹¾‘}“ü–@;‚¿‚å‚Á‚Æ‚Ì‹C”z‚è‚Å”’iãŽè‚É‚È‚é–@. ‰¡ŽR–õi“àjC”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 1(3): 381`386, 1989.
143. muÀn äXŠO‚É‚¨‚¯‚é‹Ù‹}ERP. ‘•ª–ΔŽC‰¡ŽR–õi“àjC‘Oì˜a•Fi‹~–½j: Á‰»Ší“àŽ‹‹¾, 1(4): 553`561, 1989.
144. muÀn ˆÝ’×ᇂ̕aŠúf’f‚Æ—\Œã. ‰¡ŽR–õC¼Œ³Ž›Ž—çC²–ìG–íC“c•Ó‘i“àj: Á‰»Ší“àŽ‹‹¾, 1(9): 1191`1197, 1989.
145. muÀn —pŒê‰ðà. ”äŠé”\Ž÷iŠOj: Á‰»Ší“àŽ‹‹¾, 2(1): 89`91, 1990.
146. muÀn ‚Ñ–«ŠÌŽ¾Š³‚ÌCT. ‰““¡‚C‘–쳈êi•új: • •”‰æ‘œf’f, 9(10): 833`840, 1989.
147. muÀn ‘ŸŠíˆÚA‚͂ǂ̂悤‚Éi•à‚µ‚½‚©iŠÌ‘ŸAäX‘ŸˆÚAj. ²“¡ŒõŽjiŠOj: •½¬Œ³”N“x_“Þ쌧‘åŠwŒöŠJu‹`—vj, p.30`36, 1989.
148. muÀn Scope-–«ˆÝ‰Š. ¼Œ³Ž›Ž—çi“àj: —Õ°‚Ì‚ ‚ä‚Ý, 28: 16`17, 1989.
149. mÀ’k‰ïn Á‰»«’×ᇂɂ¨‚¯‚éÄ”–hŽ~‚Ì–ò•¨—Ö@. ¼”ö—Ti“ú‘åjC¼Œ³Ž›Ž—çi“àjC•½’ËG—Yi•½’ˈݒ°•a‰@j: Clinic Magazine, (7): 81`94, 1989.
150. mÀ’k‰ïn Á‰»«’×á‡|Ä”|. ¼Œ³Ž›Ž—çi“àjCŽO—Ö„i“ŒŠC‘åjC¼‘ºD—YiŒú–Ø’†‰›ˆã‰@jC“c’†é’ji‘‡‚’Ã’†‰›•a‰@j: Medical Partner, 1(2): 2`10, 1989.
151. mÀ’k‰ïn ˆÝ¥\“ñŽw’°oŒŒ‚ð‚ß‚®‚é”–â‘è|•û–@˜_‚ð’†S‚É|.
¼Œ³Ž›Ž—çi“àjC²“¡²i“Œ–k‘åjC’‡hŽkiŽD–y¼‹æ•a‰@jC²X•”³Fi“Œ‹žˆã‰ÈŽ•‰È‘åjCŒ´“cˆê“¹iˆ®ìˆã‰È‘åjC‰iˆä—SŒái˜a‰ÌŽRˆã‰È‘åjC—LŽR
åõi‡“V“°‘åjC•À–س‹`iˆ®ìˆã‰È‘åjC¬‰z˜a‰hiŒ§—§‚ª‚ñƒZƒ“ƒ^[VŠƒ•a‰@j: ˆÝ‚Æ’°, 24(4): 396`411, 1989.
152. mÀ’k‰ïn ‹}«ˆÝ”S–Œ•a•Ï(AGML).
¼Œ³Ž›Ž—çi“àjC²“¡²i“Œ–k‘åjC–öˆäG—YiŽRŒû‘åjCó“cC“ñi‘åãˆã‰È‘åjCŒS‘å—Ti•Ÿˆäˆã‰È‘åjC¼‰º•¶—YiŽŽ™“‡Œ§–ì“c’¬—§•a‰@jC•À–س‹`
iˆ®ìˆã‰È‘åj: ˆÝ‚Æ’°, 24(6): 674`686, 1989.
153. mÀ’k‰ïn Á‰»ŠíŽ¾Š³‚Ì–ò•¨—Ö@‚Æ‚»‚ÌŒÀŠE. ‰ª•”Ž¡–íi“àjCoŒŽN•vi“Œ‘åjC‘½‰ê{K’jiŠÖ“Œ’üM•a‰@jCŽO—Ö„i“ŒŠC‘åj: “ú–{ˆãŽt‰ïŽGŽ, 103(3): 315`328, 1990.
154. mŠwp‘n i•ÒWj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27”s.
155. mŠwp‘n iŽ·•Mj ŽY‹Æ“à‰È‘S‘C_Œo¥‹ØŒn/Á‰»Ší¥‘ãŽÓŒn; ’†“Å«ŠÌáŠQ‚Ì•a—C2: 553`562,
‰œ•½‰ë•FC‘å•”½i•a—j. •ÒW
‘c•ƒ]ˆí˜Yi–¼‘åjC—é–ØŒp”üi“Œ‘åjC‘º“c—R”ViŽY‹Æˆã‘åjC’r“c³”Vi‹ž‘åjCŒ“‚’BæÆi“Œ‹ž’üMjC“¡‘òŸ®iŽœ‘åj•ÒC ˆãŽ•–òo”Å, “Œ‹ž,
89.05.25”s.
156. mŠwp‘n iŽ·•Mj Gastrointestinal Function, Regulation and Disturbance,
Vol.7; Relation between Gastric Acid Secretion and Gastric Mucous
Glycoproteins,
–x“c‹±ŽqC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC⨳—YC‘å씎”VCŒK“c”£i“àjC¬Žº—TˆêCX‰ºŒOi¶‰»jC‰ª•”Ž¡–íi“àj. •ÒW Nagao,
F.iŽœŒbˆã‘åjCMatsuo, Y.i“ú‘åjCKasuya, Y.i¯–ò‘åjCTsuchiya, M.iŒc‘åj•ÒC Excerpta
Medica, “Œ‹ž, 89.00.00”s.
157. mŠwp‘n iŽ·•Mj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; …ZS‘©ƒXƒgƒŒƒX’×ᇂɂ¨‚¯‚郉ƒbƒgˆÝ”S–Œ”S‰t“œ’`”’Ž¿‘ª’è‚̈Ӌ`,
p.17`22, ‘å‹v•Û„C“n•Ó—mŽOC匴éi‡‘åjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j. •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•ÒC
“ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27”s.
158. mŠwp‘n iŽ·•Mj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`;
ˆÝ”S‰tŠÜ—Ê‘ª’è–@‚Æ‚µ‚ẴwƒLƒ\ƒTƒ~ƒ“’è—Ê|ƒqƒgˆÝ”S–Œ•W–{‚É‚æ‚éŠî‘b“IŒŸ“¢‚¨‚æ‚ÑHPLC‚ð—p‚¢‚½‚Š´“x’è—Ê–@‚ÌŠJ”, p.11`16,
ÎŒ´˜a•Fi‰»jCX‰ºŒOC¬Œ´iC‘å씎”VC–x“c‹±Žqi¶‰»jCˆÀŠC‹`—jC‰ª•”Ž¡–íi“àjCHŽRŒ›‹`iŠOj. •ÒW
X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•ÒC “ú–{ˆãŠwŠÙ, “Œ‹ž, 89.09.27”s.
159. mŠwp‘n iŽ·•Mj ’_ÎÇ; ¶ŠˆŽw“±A–ò•¨—Ö@AHŽ–—Ö@, p.78, ŽÄ“c‹v—YC‘•ª–ΔŽi“àj. •ÒW ‘å“¡³—Yiç—t‘åj•Ò, “ì]“°, “Œ‹ž, 90.01.00 ”s.
160. mŠwp‘n iŽ·•Mj ‘ÌŠOÕŒ‚”gF’_ΔjӗÖ@; ÕŒ‚”g”¶‘•’u‚ƃƒJƒjƒYƒ€, p.42`46, ŽÄ“c‹v—Yi“àj. •ÒW ‘å“¡³—YC“y‰®K_iç—t‘åj•Ò, ˆãŠw}‘o”Å, “Œ‹ž, 89.00.00 ”s.
161. mŠwp‘n iŽ·•Mj Á‰»ŠíŽ¾Š³ÅV‚ÌŽ¡—Ã; ˆÝ’×á‡|Ž¡–üŠú‚ÌŽ¡—Ã, p.117`120, ¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj. •ÒW ‰ª”Ži“Œ‹žŒxŽ@•a‰@j,‘¼•Ò, “ì]“°, “Œ‹ž, 89.05.15 ”s.
162. mŠwp‘n iŽ·•Mj Á‰»Ší“àŽ‹‹¾‹ZŽtŽŽŒ±–â‘è‰ðà; ‘å’°, p.398`407, Ÿ–””º‰hi“àj. •ÒW è“c—²•viº˜a•a‰@j,‘¼•Ò, ˆãŠw}‘o”Å, “Œ‹ž, 89.11.18 ”s.
163. mŠwp‘n iŽ·•Mj ˆÝ”S‰t•ª”å‚Ì•ªÍ¥‘ª’è‚̈Ӌ`; Á‰»«’×ᇂɂ¨‚¯‚éˆÝ‰t’†”S‰t“œ’`”’Ž¿‘ª’è‚̈Ӌ`, p.3`9,
ˆÀŠC‹`—jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCÎŒ´˜a•Fi‰»ŠwjC–x“c‹±Žqi¶‰»j. •ÒW X‰ê–{Ki‹ž‘åjC–x“c‹±Žqi–k—¢‘åj•Ò, “ú–{ˆãŠwŠÙ,
“Œ‹ž, 89.09.27 ”s.
164. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŠÌ‘Ÿ•aŠw '89; ƒAƒ‹ƒR[ƒ‹«ŠÌáŠQ‚Ì”¶‚Æi“W‚É‹y‚Ú‚·”ˆöŽqi”Ç‚É‹y‚Ú‚·ŒÂl·‚Ì–â‘è‚ɂ‚¢‚Äj,
p.44`45; —«ƒAƒ‹ƒR[ƒ‹«ŠÌáŠQ‚ÌŽÀî p.56`57, Š¡•”‚ЂƂÝi“àj. •ÒW “¡‘òŸ®iŽœŒbˆã‘åj•Ò, “ú–{ˆãŠwŠÙ, “Œ‹ž,
89.10.14 ”s.
165. mŠwp‘n iŽ·•Mj • o‹¾Peritoneoscopy No.10uŽ‰–bŠÌ‚Æ• o‹¾ŒŸ¸v;
Ž‰–bŠÌ‚É‚¨‚¯‚éŠÌ•\–ʔ햌‰ºŒŒŠÇ\’z|ŽÀŒ±“IŽ‰–bŠÌ‚Ƃ̑Δ䌟“¢|, p.45`47;
Š¡•”‚ЂƂÝi“àjCŒú“cKˆê˜Yi–òÜ•”jCŽR“cL•vCŽÄ“c‹v—Yi“àjC‰œ•½‰ë•Fi•a—j. •ÒW Šâ‘ºŒ’ˆê˜Yi“ŒŠC‘åj•Ò, “ú–{ˆãŠwŠÙ, “Œ‹ž,
89.11.18 ”s.
166. mŠwp‘n iŽ·•Mj }à“à‰Èf’fŽ¡—ÃuÀ‚V; Á‰»«’×á‡; Ž©‘RŽj‚Æ’·Šú—\Œã, p.232`239; ¼Œ³Ž›Ž—çi“àj. •ÒW ŽO—Ö„i“ŒŠC‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.01.20 ”s.
167. mŠwp‘n iŽ·•Mj ƒuƒbƒNƒKƒCƒh: “à‰Èˆã‚Ì‚½‚ß‚ÌÁ‰»Ší•aŠw 150û; The Crohn's Disease and
Ulcerative Colitis Fact Book, ‘æ2”Å, p.119, Ÿ–””º‰hC‰ª•”Ž¡–íi“àj. •ÒW ŽODH”niL“‡‘åj•Ò,
Excerpta Medica, “Œ‹ž, 89.08.00 ”s.
168. mŠwp‘n iŽ·•Mj ‰h—{Ž¡—Êw; ˆÝ’°Ž¾Š³AÁ‰»‹zŽûáŠQ, ‘æ1ü, p.104`119,
Ÿ–””º‰hC‰ª•”Ž¡–íi“àjC…“ˆ‹žŽqCéˆä”üŽqi‰h—{‰Èj. •ÒW ”ª–Øš •vi–¼ŒÃ‰®‘åjCŒÜ“‡—Yˆê˜Yi“ŒŠC‘åj•Ò, u’kŽÐƒTƒCƒGƒ“ƒeƒBƒtƒBƒbƒN,
“Œ‹ž, 89.11.20 ”s.
169. mŠwp‘n iŽ·•Mj —Õ°ŒŸ¸MOOK, No.31, ƒAƒCƒ\ƒUƒCƒ€; ƒRƒŠƒ“ƒGƒXƒeƒ‰[ƒ[(ChE), p.88, ŽÄ“c‹v—Yi“àj. •ÒW ŽR•”Šwi“Œ‘åj‘¼C•Ò, ‹àŒ´o”Å, “Œ‹ž, 88.12.20 ”s.
170. mŠwp‘n iŽ·•Mj Selenium in Biology and Medicine; Ebselen, a
Seleno-Organic Compound, Inhibits Leukocyte Aggregation and Reduced the
Plasma Leukotriene B4 Level in Humans and Rats, ŽÄ“c‹v—Yi“àj. •ÒW A. Wendel
(Fovulfot fur Biologie, Universitat Konstanz)•Ò, Springer, Berlin,
89.00.00 ”s.
171. mŠwp‘n iŽ·•Mj ÅVÁ‰»ŠíŠO‰ÈƒVƒŠ[ƒY 2. ˆÝŠà(1); Ž¡—Õûj|”ñŠÏŒŒ“IŽ¡—Ã, p.99`106,
“ˆ”ömC”äŠé”\Ž÷iŠOj. •ÒW ˆ¢•”—ß•FiŒc‘åjCoŒŽN•vi“Œ‘åjC¬‘ò˜aŒbi‹ž‘åjC匴éi‡“V‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž,
89.09.25”s.
172. mŠwp‘n iŽ·•Mj äX“ª\“ñŽw’°Øœp; äXŽüˆÍ‰Š‚𔺂Á‚ÄØœ‚É“ïa‚µ‚½“û“ª•”Šà‚Ì1—á, p.308`310;@¡‰iŽ®‚Æ‚Ìo‰ï‚¢,
p.460`463, ‘å‹{“Œ¶iŠOj. •ÒW ‹{èˆí•vi‹à‘ò‘åjC‚“c’‰Œhi’é‹ž‘åj•Ò, ˆãŠw}‘o”Å, “Œ‹ž, 89.10.31”s.
173. m‹³‰È‘n iŽ·•Mj f—Óà‰ÈŠw; ’_“¹Ž¾Š³, p.154`161, ŽÄ“c‹v—Yi“àj. •ÒW ˆ¢•”—Tiã‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.01.00 ”s.
174. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—FˆãŠw¥ˆã—ј_ ‡Y.ŒŸ¸; “àŽ‹‹¾ŒŸ¸, p.192`209, ”äŠé”\Ž÷C“ˆ”ömiŠOj.
•ÒW ‹´–{M–çiŽœŒbˆã‘åjCŠÛŽR—Y“ñi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.05.10”s.
175. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—FˆãŠw¥ˆã—ј_CÁ‰»ŠÇC• •ÇC• –ŒŽ¾Š³;
H“¹•¬–å’oŠÉÇCMallory-WeissÇŒóŒQ, ‡W.43`45, ”äŠé”\Ž÷C“ˆ”ömiŠOj. •ÒW ŠÛŽR—Y“ñi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj•Ò,
ˆãŽ•–òo”Å, “Œ‹ž, 89.10.10”s.
176. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj Œo’°‰h—{ŽÀŽ{ƒ}ƒjƒ…ƒAƒ‹; ²“¡ŒõŽjC‹à鳉ÀC¡ˆäŒ‰iŠOjC‘Oì˜a•Fi‹~–½jC‘åê³–¤iŠÅŒìŠw•”j. •ÒW ‘åê³–¤i–k—¢‘åj•Ò, –k—¢‘åŠw•a‰@, 89.09.00”s.
177. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Á‰»Ší•aƒZƒ~ƒi|36CŠÌd•ÏÇ: •a‘Ô‚Æ‘Îô; ŠÌd•ÏÇ|•a—Šw“IŠT”O, p.1`12, ‰œ•½‰ë•Fi•a—j. •ÒW Œ´“c®i“Æ‹¦ˆã‘åj•ÒC ‚Ö‚é‚·o”Å, “Œ‹ž, 89.09.00”s.
178. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj “Œ•”ŠÌ‘ŸƒtƒH|ƒ‰ƒ€E1989”N‘æ2‰ñ‹L˜^W; ŠÌ—\”õ”\|Œ`‘Ô‚Æ‹@”\‚̉ð—£, p.118`129, ‰œ•½‰ë•Fi•a—j. •ÒW Œ´“c®i“Æ‹¦ˆã‘åj•ÒC ˆãŽ–o”ÅŽÐ, “Œ‹ž, 90.03.15”s.
179. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Annual Review Á‰»Ší 1990; Á‰»Ší“àŽ‹‹¾Ž¡—Ã, p.63`66,
“ˆ”ömC”äŠé”\Ž÷iŠOj. •ÒW ‰ª”Ži“Œ‘åjCŽO—Ö„i“ŒŠC‘åjCoŒŽN•vi“Œ‘åjC‘å“¡³—Yiç—t‘åjCŒË“c„‘¾˜Yi“Œ‘åj•ÒC ’†ŠOˆãŠwŽÐ,
“Œ‹ž, 90.01.10”s.
180. mŠwpÜn ƒEƒCƒ‹ƒXŠÌ‰ŠŒ¤‹†à’cCŒ¤‹†§—ãÜuƒAƒ‹ƒR[ƒ‹«ŠÌŽ¾Š³‚Ì‘fˆö‚ÉŠÖ‚·‚镪Žqˆâ“`Šw“IŒ¤‹†v. a’J–¾—²i“àj.
181. mŠw‰ïn ih‘è•ñj ˆÝ¥\“ñŽw’°oŒŒ‚Ì—Õ°. ”äŠé”\Ž÷iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï i89.10.05), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 1870, 1989.
182. mŠw‰ïn i“Á•Êu‰‰j ˆÝ•a•Ï‚Ì’´‰¹”g“àŽ‹‹¾f’f. ¼Œ³Ž›Ž—çi“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‹ãB’n•û‰ï (89.11.17), ²‰ê.
183. mŠw‰ïn i“Á•Êu‰‰j H“¹Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾“Id‰»—Ö@|Å‹ß‚ÌŠÌ¥’_“¹ŒnŽ¾Š³‚Ì’mŒ©‚ðŠÜ‚ß‚Ä|. ‘•ª–ΔŽi“àj: Î쌧—Õ°“à‰Èˆã‰ïŠwpu‰‰‰ï (90.03.22), ¬¼.
184. mŠw‰ïn i‹³ˆçu‰‰j Á‰»«’×ᇖò•¨—Ö@‚ÌŒ»ó. ¼Œ³Ž›Ž—çi“àj: ‘æ206‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (89.09.16), Š‘ò.
185. mŠw‰ïn i‹³ˆçu‰‰j Preoperative Staging of T by Endoscopy and Endoscopic
Ultrasonography. “ˆ”ömC”äŠé”\Ž÷iŠOj: Staging and Treatment of Gastric Cancer:
Postgraduate Course on Digestive Oncology i89.09.22), Verona, Italy.
186. mŠw‰ïn i‹³ˆçu‰‰j Endoscopic Treatment of Gastric Cancer. “ˆ”ömC”äŠé”\Ž÷iŠOj:
Staging and Treatment of Gastric Cancer: Postgraduate Course on
Digestive Oncology i89.09.23), Verona, Italy.
187. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’_Ηn‰ð—Ö@‚Ì’·Šú—\Œã|’_ÎÇ‚ÌŽ¡—ƒ·Šú—\Œã|. ‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ75‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (89.03.28), ‰¡•l, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 427, 1989.
188. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Investigation of the Safety of Famoxidine. ¼Œ³Ž›Ž—çi“àj:
21st Congress of European Association for Gastroenterology (89.05.04).
189. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝ‰Š‚Í‚Ç‚¤‘¨‚¦‚ç‚ê‚Ä‚¢‚é‚©. ¼Œ³Ž›Ž—çi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.12), –¼ŒÃ‰®.
190. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà[’B“xf’f. –Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï
(89.05.13), –¼ŒÃ‰®, Gastroenterol. Endosc., 31(10): 2797`2799, 1989.
191. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ICG•¹—p‘¢‰e‰º‚Ìd‰»ÜŒŒŠÇ“à’“ü’“ü–@‚ÌŒŸ“¢. “c•Ó‘C‘•ª–ΔŽCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.03), ‘O‹´.
192. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’´‰¹”g‚É‚æ‚é’_”XŒŸf‚ÌŒ»ó‚ÆŒo‰ßŠÏŽ@‚ÌŒŸ“¢. ”’èŒh“ñC‘•ª–ΔŽi“àj: ‘æ38‰ñ“ú–{Á‰»ŠíW’cŒŸfŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.09.17), b•{.
193. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Á‰»«’×ᇂ̒·Šú—\Œã‚ɂ‚¢‚Ä. ŽO‹´—˜‰·Cˆ°Œ´‹Bi“àj: ‘æ22‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï (89.11.04), ‰¡•l.
194. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ã•”Á‰»ŠÇ‘å—ÊoŒŒ—á‚Ì—Õ°“IŒŸ“¢. “c•Ó‘C–Ø“cŒõLC‘•ª–ΔŽi“àjC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž, ‹~‹}ˆãŠw, p.701, 1989.
195. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éäX’_“¹Žîá‡f’f. âŒû“NÍCŽR“cŽŠli“àj: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž, —\•ñW, p.11, 1989.
196. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŠÌŠà‚Ìinterventional
radiology|zŠÂ‚Ì“Á«‚ƧŒä|:ŠÌd•Ï‡•¹ŠÌ×–EŠà‚ÌŒŒŠÇ\’z‘œ‚ÆŽ¡—Ã. ΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï
(90.02.24), “Œ‹ž, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 8(5): 370, 1990.
197. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j H2Žó—e‘ÌhR܈ێ—Ö@‰ºˆÝ’×ᇂÌÄ”ˆöŽq|“àŽ‹‹¾‘œ‚É‚æ‚錟“¢|. ¼Œ³Ž›Ž—çi“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, ´˜^W, p.97, l990.
198. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝ[’B“xf’f‚Ìi•à. ”äŠé”\Ž÷iŠOj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.05.12), –¼ŒÃ‰®.
199. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝŠà‚Ì“àŽ‹‹¾Ž¡—Â̌»‹µ‚Æ«—ˆ. “ˆ”ömC”äŠé”\Ž÷iŠOj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.05.12), –¼ŒÃ‰®.
200. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘ŠúˆÝŠà‚É‚¨‚¯‚郌[ƒU[‚̉ž—p|Endoscopic Surgery‚ɂ‚¢‚Ä |. ”äŠé”\Ž÷C“ˆ”ömC¬—ÑLsiŠOj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ï‘æ14‰ñŠwpW‰ï i89.06.21), ‘åã.
201. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j “àŽ‹‹¾Ž¡—Â̗§ê‚©‚ç|‚—îŽÒ‚É‚¨‚¯‚é‘ŠúˆÝŠàŽ¡—Â̖â‘è“_|. ˆÉ“¡Žºiˆ¤’mŒ§‚ª‚ñƒZƒ“ƒ^[jC”äŠé”\Ž÷iŠOj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï i89.10.25), –¼ŒÃ‰®.
202. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝŠà‚Ì“àŽ‹‹¾“IƒŒ[ƒU[Ž¡—ÃÇ—á‚ÌŒŸ“¢. ¬—ÑLsC“ˆ”ömiŠOj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.11.23), “Œ‹ž, ´˜^W, p.116, 1989.
203. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ˆÝŠà‚Ì“àŽ‹‹¾“IŽ¡—Â̕]‰¿. ¬•”ªŽµ˜Yi‘—§‚ª‚ñƒZƒ“ƒ^[jC”äŠé”\Ž÷iŠOj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï i89.11.23), “Œ‹ž, ´˜^W, p.16, 1989.
204. mŠw‰ïn iƒpƒlƒ‹j oŒŒ«’×ᇂ̒ZŠú‚¨‚æ‚Ñ’·Šú—\Œã‚ÌŒŸ“¢. “c•Ó‘C¼Œ³Ž›Ž—çi“àj: ‘æ75‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (89.03.28), ‰¡•l.
205. mŠw‰ïn iƒpƒlƒ‹j ¬Ž™‚ÌŒŒ’†ƒyƒvƒVƒm|ƒQƒ“’l‚ÌŒŸ“¢. ^“º‘¾˜YC‘å“c„•äC¬“‡–M•FiŽ™jCΈ䟌Èi•új: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒ, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 564, l989.
206. mŠw‰ïn iƒpƒlƒ‹j Usefulness of the Endoscopic Examination for Diagnosis
of the Rare upper Gastrointestinal Tumor in Children.
^“º‘¾˜YCדc‚Ì‚¼‚ÝC‘å“c„•äC¬“‡–M•FiŽ™j: 19th International Congress of Pediatrics
(89.07.26), Paris,
207. mŠw‰ïn iƒpƒlƒ‹j ŠÌd•Ïǂɑ΂·‚éŒoŒû‚¨‚æ‚Ñ”ñŒoŒû•ªŽ}½ƒAƒ~ƒmŽ_“Š—^‚Ì’·Šú—\Œã‚ɑ΂·‚éŒø‰Ê. ¼–Ø–ÎŽ÷i“àj: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 27, 1989.
208. mŠw‰ïn iƒpƒlƒ‹j Edmondson‡UŒ^ŠÌ×–EŠà‚ÌÄŒŸ“¢(2)ŒuŒõŒ°”÷‘ªŒõ‘•’u‚ð—p‚¢‚Ä.
‚ˆä’qŽqi•a—jCŒÃ’J–[Ž}i•a‰@•a—•”jC‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ,
30(Suppl.2): 112, 1989.
209. mŠw‰ïn iƒpƒlƒ‹j Á‰»ŠíŠàŠ³ŽÒ––½ŒŒè÷—±‹…‚Ìcathepsin DŠˆ«. ’JŒû–ÒC‘OìŒö’jC‘å–ì—²C‹k“c‹P—YCŠô¢‹´“ÄC¼Œ³Ž›Ž—çi“àj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.25°27), –¼ŒÃ‰®.
210. mŠw‰ïn iƒpƒlƒ‹j ‘ŠúˆÝŠà‚Ìf’fŒÀŠE‚É’§‚Þ|Pharmacoendoscopy‚É‚æ‚é‘ŠúˆÝŠà‚Ìf’f|. ¬ò˜aŽO˜YC¼Œ³Ž›Ž—çi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž, —\•ñW, p.135, 1989.
211. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ’×ᇫ‘å’°‰Š‚ÌŽ¡—Ã|“à‰È¥ŠO‰È‚ÌÚ“_.
Ÿ–””º‰hC¬—Ñ´“TCŽO•xO”VCŽR–{‰À³CŒÜ\—’³Li“àjC‚‹´r‹BiŠOj: ‘æ44‰ñ“ú–{‘å’°ãè–å•aŠw‰ï‘‰ï (89.11.17), “Œ‹ž,
‘å’°ãè–åŽ, 42(5): 751, 1989.
212. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ˆÝŽ¾Š³‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‚ÌŽÀÛ. –Ø“cŒõLC¼Œ³Ž›Ž—çi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.22), “Œ‹ž.
213. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Total colonoscopy‚ÌŽè‹Z|‹Ù‹}ŒŸ¸‚Æ’Ê팟¸|. ŽR–{‰À³CŸ–””º‰hi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.22), “Œ‹ž, —\•ñW, p.144, 1989.
214. mŠw‰ïn iˆê”Êu‰‰j ’_ÎÇ‚É‚Ä“Eo‚³‚ꂽ’_”X“à’_`‚ٌ̈^×–E‚ÌŒŸ“¢. “cŠ‰xŽqi•a‰@•a—jC’†‰p’ji•a—j: ‘æ6‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ïŠwpu‰‰‰ï (87.08.29), ˆÉ¨Œ´, ´˜^W, p.24, 1987.
215. mŠw‰ïn iˆê”Êu‰‰j A Study on the Healing Process of Gastric Ulcer Using
Endoscopic Ultrasonography (EUS). –Ø“cŒõLC¼Œ³Ž›Ž—çC•›“‡TˆêC‰¡ŽR–õC‰ª•”Ž¡–íi“àj: ‡Y
European Congress of Digestive Endoscopy (88.09.08), Rome, Endoscopy,
20(Suppl.): 91, 1988.
216. mŠw‰ïn iˆê”Êu‰‰j ŠÌd•ÏÇ‚Ì—Õ°“IŒŸ“¢. ¼–Ø–ÎŽ÷C”’èŒh“ñC™–{’¼CVˆäd‹ICŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—YC‰ª•”Ž¡–íi“àj: ‘æ30‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (88.10.21), ŽŽ™“‡.
217. mŠw‰ïn iˆê”Êu‰‰j ŠÌ“à’_ŠÇ‘BŽí(Intrahepatic Bile Duct Adenoma)‚Ì•a—‘gDŠw“IŒ¤‹†.
‹àŽq‘C‘å•”½CŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ78‰ñ“ú–{•a—Šw‰ï‘‰ï (89.03.30), ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 78(‘‰ï†):
278, 1989.
218. mŠw‰ïn iˆê”Êu‰‰j ‰º•”Á‰»ŠÇ“®Ã–¬ŠïŒ`(AVM)‚Ìf’f‚ÆŽ¡—Ã.
‘–쳈êC‹àˆä¹ŒPC¼ŽR³ŒáC¬—ѬŽiC‹àˆä’Ë•¶–¾C–{‹´CC¼–{—æŽqCˆä“›–ri•új: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05),
_ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): s72, l989.
219. mŠw‰ïn iˆê”Êu‰‰j Á‰»ŠíŒn‘ŸŠí‚É‚¨‚¯‚éEpithelial Membrane Antigen—z«×–E‚Ì•ª•z“Á«‚ɂ‚¢‚Ä.
‰¡‘ò³ŽuCŽÂ“cGCŽR‰º˜a–çC“n•Óˆê]C‘êì—T”üCŒÃ‘º‚¢‚³‚Ýi“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï
(89.04.30), •Ÿ“‡, ‰q¶ŒŸ¸, 38(3): 352, 1989.
220. mŠw‰ïn iˆê”Êu‰‰j äXŠà‚ɑ΂·‚é’´‰¹”g“àŽ‹‹¾‚ÌŒŸ“¢.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlCˆ°Œ´‹BC¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷
iŠOjC–{‹§C’†‰p’ji•a—j: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.11), –¼ŒÃ‰®, —\eW, p.252, 1989.
221. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«ˆÝA\“ñŽw’°’×ᇂ̒·Šú—\Œã‚ÌŒŸ“¢i“Á‚ÉÄoŒŒ—á‚ɂ‚¢‚Äj.
²–ìG–íC‰¡ŽR–õC“c•Ó‘Cˆ°Œ´‹BCŽR“cŽŠlC–Ø“cŒõLC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC“ˆ”ömCŽOd–슰ŠìC”äŠé”\Ž÷iŠOj:
‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.12), –¼ŒÃ‰®.
222. mŠw‰ïn iˆê”Êu‰‰j Á‰»«’×ᇂ̒·Šú—\Œã‚ɂ‚¢‚ÄiƒAƒ“ƒP[ƒg—á‚Ì—Õ°“IŒŸ“¢j.
ˆ°Œ´‹BC–Ø“cŒõLC‰¡ŽR–õCˆÀŠC‹`—jCŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.12), –¼ŒÃ‰®,
—\eW, p.269, 1989.
223. mŠw‰ïn iˆê”Êu‰‰j “f‰ºŒŒ‚ð’悵‚½Schonlein-HenochŽ‡”Á•a‚Ì1—á.
ŽOŽ}MCΈäŒ\‘¾Cã™G‰iC‘OìŒö’jC–Ø“cŒõLC‰¡ŽR–õCŸ–””º‰hC‰ª•”Ž¡–íi“àjC’†‰p’ji•a—j: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
(89.05.13), “Œ‹ž.
224. mŠw‰ïn iˆê”Êu‰‰j “àŽ‹‹¾‚ÅŠÏŽ@‚µ‚½’¼’°ƒJƒ‹ƒ`ƒmƒCƒh‚ÌŒŸ“¢.
¬—Ñ´“TCŒÜ\—’³LC‹e’n–FtC—é–Ø—TCŽR–{‰À³CŸ–””º‰hC‰ª•”Ž¡–íi“àjCH“¡N¶iŠOjC£ìŒªˆêC’†‰p’ji•a—j:
‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.13), –¼ŒÃ‰®, —\eW, p.207, 1989.
225. mŠw‰ïn iˆê”Êu‰‰j H2ƒuƒƒbƒJ[Ž¡—ɺˆÝ’×ᇂ̓¥Ä”—vˆö‚ÉŠÖ‚·‚錟“¢.
¼Œ³Ž›Ž—çCŽO‹´—˜‰·Cˆ°Œ´‹BC‰¡ŽR–õC¬ò˜aŽO˜YCˆÀŠC‹`—jC‰ª•”Ž¡–íi“àj: ‘æ37‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.05.13),
–¼ŒÃ‰®, —\eW, p.214, 1989.
226. mŠw‰ïn iˆê”Êu‰‰j
123I-iodoamphetamine‚ð—p‚¢‚½Œo’¼’°–å–¬ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚É‚æ‚é–å–¬ŒŒs“®‘Ô‚ÌŒŸ“¢|“Á‚ÉH“¹Ã–¬áŽ”j’]‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä.
”’èŒh“ñCΈäŒö“¹C‘•ª–ΔŽC‘ºã‹§lC™–{’¼C¼–Ø–ÎŽ÷CVˆäd‹ICŠ¡•”‚ЂƂÝCŽR“cL•vCŽÄ“c‹v—Yi“àjC‘º“cWˆê˜YCΈ䟌Èi•új:
‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.01), ‹à‘ò.
227. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ‹ƒR[ƒ‹’E…‘fy‘f‚ƃAƒ‹ƒfƒqƒh’E…‘fy‘f‚ÌGenotype‚ƃAƒ‹ƒR[ƒ‹«ŠÌŽ¾Š³‚̈â“`“I‘fˆö‚ɂ‚¢‚Ä.
a’J–¾—²i“àjC‹g“cºiCity of HopejCŽÄ“c‹v—Yi“àj: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.01), ‹à‘ò, ŠÌ‘Ÿ,
30(Suppl. 1): 118, 1989.
228. mŠw‰ïn iˆê”Êu‰‰j ֬ᎌŒ‰tƒKƒX•ªÍ‚É‚æ‚éH“¹Ã–¬áŽ‚Ì‚Ž_‘f•ªˆ³‚̬ˆö‚ÉŠÖ‚·‚錟“¢.
‘•ª–ΔŽC”’èŒh“ñCŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—Yi“àjC‘Oì˜a•Fi‹~–½j: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï (89.06.01), ‹à‘ò, ŠÌ‘Ÿ,
30(Suppl. 1): 96, 1989.
229. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«ˆÝA\“ñŽw’°’×ᇂ̒·Šú—\Œã‚ÌŒŸ“¢.
²–ìG–íC‰¡ŽR–õC“c•Ó‘Cˆ°Œ´‹BCˆÉ“¡‹ÏC“©ŽRaˆê˜NCŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC’Ë–{GlC“ˆ”ömCŽOd–슰ŠìC”ä
Šé”\Ž÷iŠOj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.02), ‘O‹´.
230. mŠw‰ïn iˆê”Êu‰‰j ŠÌd•Ï‚ÌŽ¡—Âɂæ‚éŒ`‘ÔŠw“I•Ï‰»|‰Â‹t«‰ß’ö‚ª”F‚ß‚ç‚ꂽ6—á‚ÌŒŸ“¢.
ΈäŒö“¹CŽR“cL•vC”’èŒh“ñC™–{’¼CVˆäd‹ICŠ¡•”‚ЂƂÝCŽÄ“c‹v—Yi“àjC‰œ•½‰ë•Fi•a—j: ‘æ25‰ñ“ú–{ŠÌ‘ŸŠw‰ï‘‰ï
(89.06.02), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl. 1): 181, 1989.
231. mŠw‰ïn iˆê”Êu‰‰j “Á”«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•Ç×–E‚Ì“®‘Ô|ŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä|.
‘å•”½C“ñã—æŽqC‹àŽq‘C‚ˆä’qŽqC²“¡³Ž÷C“n•Ó´Ž¡CŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ25‰ñŠÌ‘ŸŠw‰ï (89.06.02), ‹à‘ò, ŠÌ‘Ÿ,
30(Suppl.): 172, 1989.
232. mŠw‰ïn iˆê”Êu‰‰j Šg‘å• o‹¾ŒŸ¸‚É‚æ‚èŠÌ•\–Ê‚Ì–Ñ׌ŒŠÇ‚ÌŠg’£‚ðØ–¾‚µ“¾‚½Rendu-Osler-Weber•a‚Ì1—á.
ŽOŽ}MC¼–Ø–ÎŽ÷C‘ºã‹§lCŽR“cŽŠlC™–{’¼CŽR“cL•vCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï
(89.06.03), ‘O‹´.
233. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é’_”X‘B‹ØŽîÇ‚ÌŒŸ“¢.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½Cˆ°Œ´‹BC‰¡ŽR–õC•›“‡TˆêCŽR“cL•vC¼Œ³Ž›Ž—çCŽÄ“c‹v—YC‰ª•”Ž¡–íi“àjC‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C”ä
Šé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ48‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.06.03), ‘O‹´, Á‰»Ší“àŽ‹‹¾‚Ìi•à, 34:
197`201, 1989.
234. mŠw‰ïn iˆê”Êu‰‰j ’_“¹•Â½ÇpŒã‚ÌH“¹Ã–¬áŽ‚ɑ΂·‚é“àŽ‹‹¾ŒŸ¸‚ƃAƒCƒ\ƒg[ƒvŒŸ¸‚̈Ӌ`.
Š™Œ`³ˆê˜YC‘¼i“s—§´£¬Ž™•a‰@jCΈ䟌Èi•új: ‘æ26‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï (89.06.07`09), ç—tC
“ú–{¬Ž™ŠO‰ÈŠw‰ïŽC25(3): 499, l989.
235. mŠw‰ïn iˆê”Êu‰‰j •W€‹Èü–@‚ð—p‚¢‚½ˆöŽq•ªÍ‚É‚æ‚é’_“¹•Â½ÇpŒã‚Ì’_`—¬o󋵂̕]‰¿.
ΓcŽ¡—YC‘¼i“s—§´£¬Ž™•a‰@jCΈ䟌Èi•új: ‘æ26‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï (89.06.07`09), ç—tC
“ú–{¬Ž™ŠO‰ÈŠw‰ïŽC25(3): 539, l989.
236. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝPGE2ŽY¶‚ɑ΂·‚éƒVƒƒ`ƒWƒ“‚Ìì—p. ¼ŽR˜a’jC쑺“¹Žqi–ò—jC—é–Ø—Ti“àjCã–ìWŒ›CŽŽæMi–ò—j: ‘æ80‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (89.06.10), ç—tC —\eW, p.75, 1989.
237. mŠw‰ïn iˆê”Êu‰‰j Differential Diagnosis between Gastric Cancerous
Invasion and Fibrosis of Co-existing Ulcer Using Endoscopic
Ultrasonography. –Ø“cŒõLC¼Œ³Ž›Ž—çCŽR“cŽŠlCâŒû“NÍC‰ª•”Ž¡–íi“àj: 75th Holland Digestive
Disease Week (89.06.22), Amsterdam.
238. mŠw‰ïn iˆê”Êu‰‰j A Study of Endoscopic Ultrasonography in the Diagnosis
of Cancer the Pancreas. âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: 75th Holland
Digestive Disease Week (89.06.23), Amsterdam, —\eW, p.132, 1989.
239. mŠw‰ïn iˆê”Êu‰‰j ’_“¹‹¾‚Åf’f‚µ“¾‚½’_ŠÇ“àZ‚ð‚Æ‚à‚È‚¤ŠÌ×–EŠà‚Ì1—á.
“c’†”ŽŽuCŽOŽ}MCˆÉ“¡‹ÏC‘ºã‹§lC™–{’¼CâŒû“NÍC–Ø“cŒõLC‘•ª–ΔŽC^‹ÊŽõ”ü¶CΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj:
‘æ205‰ñ“ú–{Á‰»ŠíŠw‰ïŠÖ“Œ’n•û‰ï (89.07.08), “Œ‹ž, —\eW, p.16, 1989.
240. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éäXŠà‚ÌŒŸ“¢.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlCˆ°Œ´‹BC¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷
iŠOjC–{‹§C’†‰p’ji•a—j: ‘æ20‰ñ“ú–{äX‘ŸŠw‰ï (89.07.18), “Œ‹ž, äX‘Ÿ, 4(2): 300, 1989.
241. mŠw‰ïn iˆê”Êu‰‰j ƒGƒ^ƒm|ƒ‹ˆÝ”S–ŒáŠQ‹@˜‚Æ‚»‚ê‚ɑ΂·‚é“àˆö«ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚Ìì—p. ¼ŽR˜a’jCã–ìWŒ›C쑺“¹ŽqCŽŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.176, 1989.
242. mŠw‰ïn iˆê”Êu‰‰j ’_”XŽûk“ú“à•Ï“®|“Á‚ÉŠÌd•ÏÇ‚É‚¨‚¯‚é’_”XŽûk“®‘Ԃɂ‚¢‚Ä.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC‘•ª–ΔŽCŽR“cL•vCŽÄ“c‹v—Yi“àj: ‘æ25‰ñ“ú–{’_“¹Šw‰ï‘‰ï (89.08.24), ‹{è, ’_“¹,
3(3): 327, 1989.
243. mŠw‰ïn iˆê”Êu‰‰j ‹}‘¬“€Œ‹ƒf²|ƒvƒGƒ`ƒ“ƒO–@‚É‚æ‚é‘Á‰t‘B×–E‚Ì×–EœŠi‚ÌŠÏŽ@. £ì²‹vCŽR‰È³•½i‰ðj: ‘æ31‰ñŽ•‰ÈŠî‘bˆãŠw‰ï (89.09.01), “¿“‡, Ž•‰ÈŠî‘bˆãŠw‰ïŽGŽ, 31(•â): 39, l989.
244. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚È’áƒJƒ‹ƒVƒEƒ€ŒŒÇ‚𗈂µ‚½‹}«äX‰Š‚Ì1—á. ’†ˆä‹v—YC‘•ª–ΔŽCâŒû“NÍC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ44‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïW’k‰ï (89.09.10), “¡‘ò.
245. mŠw‰ïn iˆê”Êu‰‰j ˆÝŠïŒ`Žî‚Ì‚P“ûŽ™—á. ^“º‘¾˜YC‘å“c„•äC¬“‡–M•FiŽ™j: ‘æ16‰ñ“ú–{¬Ž™‰h—{Á‰»Ší•aŠw‰ï (89.09.30), “Œ‹ž, —\eW, p.98, 1989.
246. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«’×á‡A“Á‚É‘å—ÊoŒŒ—á‚ÌŒŸ“¢. “c•Ó‘C–Ø“cŒõLC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.05), ˆ®ì.
247. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éŠÌŠO’_ŠÇŠà‚ÌŒŸ“¢|‰º•”’_ŠÇŠà‚ÆäX“ª•”Šà‚ÌŠÓ•Ê‚ð’†S‚É|.
ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j:
‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.05), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2076, 1989.
248. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é–«äX‰Š‚ÌŒŸ“¢.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêCŽO‹´—˜‰·C^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj:
‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.05), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2090, 1989.
249. mŠw‰ïn iˆê”Êu‰‰j •ÖöŒŒ”½‰ž‚Ì—Õ°“I–â‘è“_.
”ª–؈ê•vC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjCät“n’‰’jC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—jCˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï
(89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 59, 1989.
250. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝPGŽY¶‚ɑ΂·‚éƒVƒƒ`ƒWƒ“‚Ìì—p.
¼ŽR˜a’jC쑺“¹Žqi–ò—jC—é–Ø—Ti“àjCã–ìWŒ›CŽŽæMi–ò—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï (89.10.05°07), ˆ®ìC
“ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86: 337, 1989.
251. mŠw‰ïn iˆê”Êu‰‰j CCl4‹y‚ÑD-galactosamineŠÌáŠQ‚ɑ΂·‚édibutyryl cyclic AMP
(DBcAMP)‚Ì—}§Œø‰Ê. ¼–Ø–ÎŽ÷i“àjC’|“à“ÖŽqi“Œ•a‰@Œ¤‹†ŒnjC™–{’¼CŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—Yi“àj:
‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.
252. mŠw‰ïn iˆê”Êu‰‰j Á‰»«’×ᇂ̒·Šú—\Œã‚ɂ‚¢‚Ä. ˆ°Œ´‹BCŽO‹´—˜‰·C‰¡ŽR–õC¬ò˜aŽO˜YCˆÀŠC‹`—jC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.
253. mŠw‰ïn iˆê”Êu‰‰j
’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà‚ÌŠÔŽ¿”½‰ž‚ÌŒŸ“¢|SSŠà‚ÆSŠà‚ÌŠÓ•Ê‚ðŠÜ‚ß‚Ä|.–Ø“cŒõLCŽR“cŽŠlCâŒû“NÍCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õCŽO‹´—˜
‰·C¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.
254. mŠw‰ïn iˆê”Êu‰‰j •ÂÇ«‰©át‚É‚¨‚¯‚éPTCD‚ÌŒŸ“¢.
¡òOC–Ø“cŒõLCâŒû“NÍCŽR“cŽŠlC‘•ª–ΔŽC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjC‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶iŠOjC’†‰p’ji•a—j:
‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì.
255. mŠw‰ïn iˆê”Êu‰‰j NSAID“Š—^‚É‚æ‚éˆÝ”S‰t—Ê‚Ì•Ï“®|Indomethacin“Š—^Œã‚̈ݔS–ŒŠe•”ƒwƒLƒ\ƒTƒ~ƒ“—Ê‚ÌŒŸ“¢.
ÎŒ´˜a•Fi‰»jC¼ŽRŒ›ŽqC‰Y“c’ËMŽqi¶‰»ŒnjC¬Žº—TˆêC¬Œ´iC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06),
ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(‘): 1994, 1989.
256. mŠw‰ïn iˆê”Êu‰‰j Mild Irritanti0.35N‰–Ž_jŒoŒû“Š—^Œã‚̃‰ƒbƒgˆÝ”S‰t“œ’`”’Ž¿‚Ì•Ï“®.
D”¨“¹Gi‡‘åjC‘¼3–¼CÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì,
“ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(‘): 1995, 1989.
257. mŠw‰ïn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚Æ”DP‚ÉŠÖ‚·‚錟“¢.
¬—Ñ´“TCŸ–””º‰hCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC“‡“cMGiŽY•wj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï
(89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2124, 1989.
258. mŠw‰ïn iˆê”Êu‰‰j ŠÌŽ¾Š³‚É‚¨‚¯‚é”A’†ƒlƒIƒvƒeƒŠƒ“‚Ì“®‘Ô.
™–{’¼C‘ºã‹§lC”’èŒh“ñC¼–Ø–ÎŽ÷CVˆäd‹ICŠ¡•”‚ЂƂÝC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï
(89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2137, 1989.
259. mŠw‰ïn iˆê”Êu‰‰j Pirenzepine (Pz)‚ÌR’×á‡ì—p‚ɑ΂·‚éˆÝ”S‰t“œ’`”’Ž¿‚ÌŠÖ—^|Rat
Aspirin’×ᇂÌê‡|.
¬“‡—m“ñi“àjC¬Žº—Tˆêi¶‰»jCÎŒ´˜a•Fi‰»ŠwjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j:
‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 235, 1989.
260. mŠw‰ïn iˆê”Êu‰‰j Ž_•ª”åŽhŒƒ‚É”º‚¤ˆÝ”S–Œ’ïR«‚ÌŒŸ“¢i‘æ2•ñj.
¬Žº—TˆêC‘å씎”VC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï
(89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86i‘j: 2030, 1989.
261. mŠw‰ïn iˆê”Êu‰‰j •Ç“àá‘‚ðŒ`¬‚µ‚½Crohn•a3Ç—á‚ÌŒŸ“¢.
£ìŒªˆêC’†‰p’jC›’m–çCΈä‰pºC–{‹§C‰œ•½‰ë•Fi•a—jC¬—Ñ´“TCŽO•xO”VCŽR–{‰À³CŒÜ\—’³LCŸ–””º‰hi“àjCH“¡N¶C‘å’J„³
iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽC86(—Õ‘): 2126, 1989.
262. mŠw‰ïn iˆê”Êu‰‰j äXŽ¾Š³‚É‚¨‚¯‚é–Ɖu‰»Šw“I‘ª’è–@‚̉ž—p‚ɂ‚¢‚Ä.
÷ˆäŒc‘¢CˆÀ“¡‹v”üŽqC”ª–؈ê•vC”·—EŽŠi—ÕŒŸjCät“n’‰’jC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.06),
‹ž“sC —Õ°•a—, 37(•â): 332, 1989.
263. mŠw‰ïn iˆê”Êu‰‰j ¬’°‹•ŒŒŽÀŒ±ƒ‚ƒfƒ‹‚Ì컂Ƃ»‚ê‚ç‚Ì–â‘è“_. ’†‰p’jC£ìŒªˆêC–{‹§C‰œ•½‰ë•Fi•a—j: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì.
264. mŠw‰ïn iˆê”Êu‰‰j H“¹ŠÂó֬ᎂ̑¶Ý‚Æ‚»‚̈Ӌ`.
‘•ª–ΔŽC“c•Ó‘C‰¡ŽR–õC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC‘åˆä“c³li“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì,
“ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2070, 1989.
265. mŠw‰ïn iˆê”Êu‰‰j ˆÝ’×ᇂ̕¹—p—Ö@‚É‚¨‚¯‚éH2Žó—e‘ÌhRÜ‘ŠúŒ¸—Ê–@‚¨‚æ‚шێ—Ö@‚ÌŒŸ“¢.
ˆÀŠC‹`—jC‰¡ŽR–õCŽO‹´—˜‰·C¼Œ³Ž›Ž—çi“àj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï (89.10.07), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ,
86(—Õ‘): 2161, 1989.
266. mŠw‰ïn iˆê”Êu‰‰j •Û‘¶“IŽ¡—ÂŌy‰õ‚µ‚½ƒCƒŒƒEƒXÇ—á‚Ì—Õ°“IŒŸ“¢.
ŽO•xO”VCŸ–””º‰hC¬—Ñ´“TC¼ŽR˜a’jC—é–Ø—TCŽR–{‰À³C¼Œ³Ž›Ž—çi“àjC–ÈŠÑ•¶•vCH“¡N¶C‘å’J„³iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï
(89.10.07), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 404, 1989.
267. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ•Ç‚ÌŒú‚³‚ÉŠÖ‚·‚錟“¢.
ŽR“cŽŠlC‰ª•”Ž¡–íC–Ø“cŒõLCâŒû“NÍC–ì“o½C‰¡ŽR–õC¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{’´‰¹”gˆãŠw‰ï (89.10.18), •Ÿ‰ª,
“ú–{’´‰¹”gˆãŠw‰ïu‰‰˜_•¶W, 16(2): 153`154, 1989.
268. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é–«äX‰Š‚ÌŒŸ“¢.
âŒû“NÍC–Ø“cŒõLCŽR“cŽŠlC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC•›“‡TˆêC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: ‘æ55‰ñ“ú–{’´‰¹”gˆãŠw‰ï
(89.10.18), •Ÿ‰ª, “ú–{’´‰¹”gˆãŠw‰ïu‰‰˜_•¶W, 16(2): 481`482, 1989.
269. mŠw‰ïn iˆê”Êu‰‰j •W€‹Èü‚ð—p‚¢‚½Factor Analysis ‚É‚æ‚éTc-99m PMT‚̉ðÍ‚Æ’_“¹•Â½Ç‚ÌŒo‰ßŠÏŽ@.
ΓcŽ¡—Yi“s—§´£¬Ž™•a‰@jC‘¼CΈ䟌ÈC–x’rdŽ¡i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19`21), ‘å’Ã, ŠjˆãŠw,
26(8): 1055, 1989.
270. mŠw‰ïn iˆê”Êu‰‰j “úíŠÌ¶ŒŸ‘gDŒŸõ‚É‚¨‚¯‚éHBeAg—z«Ç—á‚̖Ɖu‘gDŠw“I‚ÈŒŸ“¢. ’†‰p’jC£ìŒªˆêCΈä‰pºC–{‹§C‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì.
271. mŠw‰ïn iˆê”Êu‰‰j ‘å’°ŠàŠÌ“]ˆÚ‚ɑ΂·‚éŒoƒJƒe[ƒeƒ‹“®–¬ÇðpŽ{s—á‚ÌŒŸ“¢.
‰““¡‚C‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC’J“c—ˆê˜Yi•új: “ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.20), ’·–ì, ŠÌ‘Ÿ,
30(Suppl. 2): 51, 1989.
272. mŠw‰ïn iˆê”Êu‰‰j –«ŠÌŽ¾Š³‚É‚¨‚¯‚éHbF‚̈Ӌ`.
™–{’¼C‘ºã‹§lC”’èŒh“ñC¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²CŠ¡•”‚ЂƂÝC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï
(89.10.20), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 61, 1989.
273. mŠw‰ïn iˆê”Êu‰‰j DBcAMP, MMC“®’—Ö@‚ª‘tŒø‚µ‚½–å–¬Žîá‡Çð‡•¹ŠÌ×–EŠà‚Ì1—á.
”’Šñ‚ ‚©‚ËC¼–Ø–ÎŽ÷C‘ºã‹§lC™–{’¼CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àjC‘–쳈êi•új: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï
(89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl. 2): 123, 1989.
274. mŠw‰ïn iˆê”Êu‰‰j Ž©ŒÈ–Ɖu«ŠÌ‰Š‚Ì‘gDŠw“IŒŸ“¢. ‘å•”½C‹àŽq‘C‚ˆä’qŽqC“n•Ó´Ž¡C‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl.2): 100, 1989.
275. mŠw‰ïn iˆê”Êu‰‰j Œ‹ßŒ^ŠÌ×–EŠà‚É‚¨‚¯‚éŠÌ“àƒŠƒ“ƒpŠÇ\’z‰ü•Ï‘œ‚ÌŒŸ“¢(1).
“n•Ó´Ž¡CŽOŽ}MC–Ø“c–FŽ÷C“ñã—æŽqC‚ˆä’qŽqC‹àŽq‘C²“¡³Ž÷CŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï
(89.10.21), ’·–ì, ŠÌ‘Ÿ, 30(Suppl.2): 112, 1989.
276. mŠw‰ïn iˆê”Êu‰‰j p‘O‚Éf’f‚µ“¾‚½‰ñ–Ó•”ˆ««ƒŠƒ“ƒpŽî‚É‚æ‚é’°dÏ‚Ì3Ç—á.
ã™G‰iCŽR–{‰À³CΊ_“¿]CŽOŽ}MC¬—Ñ´“TCŽO•xO”VCŒÜ\—’³LCŸ–””º‰hC¼Œ³Ž›Ž—çi“àjCH“¡N¶C‘å’J„³C”äŠé”\Ž÷iŠOjC£ìŒªˆêC
’†‰p’ji•a—j: ‘æ22‰ñ_“Þ쌧Á‰»Ší•aˆãŠw‰ï‘‰ï (89.11.04), ‰¡•l.
277. mŠw‰ïn iˆê”Êu‰‰j H2ƒuƒƒbƒJ[Ž¡—ɺ‚É‚¨‚¯‚éˆÝ’×ᇂ̓‰»—vˆö‚ÌŒŸ“¢. ¼Œ³Ž›Ž—çCˆ°Œ´‹BC‰¡ŽR–õCŽO‹´—˜‰·CˆÀŠC‹`—ji“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.22), “Œ‹ž.
278. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ•Ç‚ÌŒú‚³‚ÉŠÖ‚·‚錟“¢.
ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC–{‹§C’†‰p’ji•a—j:
‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.23), “Œ‹ž, —\•ñW, p.207, 1989.
279. mŠw‰ïn iˆê”Êu‰‰j Šg‘å• o‹¾‚É‚æ‚éŠÌ•\–ÊŠŒ©‚ÌŒŸ“¢. ”’èŒh“ñC‘ºã‹§lC™–{’¼C¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž.
280. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é‘ŠúˆÝŠà‚ÌŽÀ‘Ô|ÇóA”Œ©Œo˜H‚ð’†S‚Æ‚µ‚Ä|.
ˆÀ’BŒ£C¬ò˜aŽO˜YCˆ°Œ´‹BC“c•Ó‘CâŒû“NÍC–Ø“cŒõLC‰¡ŽR–õCˆÀŠC‹`—jCŽO‹´—˜‰·C^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj:
‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž, —\•ñW, p.190, 1989.
281. mŠw‰ïn iˆê”Êu‰‰j ‘å’°G•½Žîᇂ̗հ•a—Šw“IŒŸ“¢.
¬—Ñ´“TCŸ–””º‰hCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjCH“¡N¶C‘å’J„³iŠOjC£ìŒªˆêC’†‰p’ji•a—j:
‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ï (89.11.24), “Œ‹ž, —\•ñW, p.241, 1989.
282. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éã•”Á‰»ŠÇ”S–Œ‰ºŽîᇂ̌Ÿ“¢.
ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍCˆ°Œ´‹BC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j:
‘æ38‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ï‘‰ïA‘æ1‰ñÁ‰»ŠíŽîᇂ̒´‰¹”g“àŽ‹‹¾f’f‚ÉŠÖ‚·‚錤‹†‰ï (89.11.24), “Œ‹ž, —\•ñW, p.377,
1989.
283. mŠw‰ïn iˆê”Êu‰‰j Angiographic Spectrum of Intrahepatic Bile Duct
Stones. ‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C‰““¡‚i•újC’†‰p’ji•a—j: 75th Scientific Meeting of
Radiological Society of North America (89.11.26), Chicago, Radiology,
173(Suppl.): 520, 1989.
284. mŠw‰ïn iˆê”Êu‰‰j H“¹Ã–¬áŽd‰»—Ö@‚ª‹Nˆö‚Æ‚È‚Á‚½‚ÆŽv‚í‚ê‚é”]”^ᇂÌ1—á.
‰¡ŽR‰xŽqC“c•Ó‘C–Ø“cŒõLC–kˆä‘¥•vi“àjC‰““¡¹FC‘Oì˜a•FC‘å˜a“c—²i‹~–½jC‘•ª–ΔŽC¼Œ³Ž›Ž—çC”¨—²ŽuC“cè‹`ºi“àj:
‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (89.12.02), ‰¡•l.
285. mŠw‰ïn iˆê”Êu‰‰j ‰EŠá“à‰Š‚𕹔‚µAŽ¸–¾‚ÉŽŠ‚Á‚½ŠÌ”^ᇂÌ1—á.
Ä“¡rŽiC‘•ª–ΔŽC‹e’nVC‘ºã‹§lC“c’†”ŽŽuC¼–{ˆÌ’jC™–{’¼Ca’J–¾—²C^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj:
‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï (89.12.02), ‰¡•l.
286. mŠw‰ïn iˆê”Êu‰‰j ã•”Á‰»ŠÇ–À“üäX‚Ì—Õ°‹y‚Ñ“àŽ‹‹¾“IŒŸ“¢|Doubling time‚Ì‘ª’è‚ðŠÜ‚ß‚Ä|.
ã™G‰iC–Ø“cŒõLCˆ°Œ´‹BCŽR“cŽŠlCâŒû“NÍC¬ò˜aŽO˜YC‰¡ŽR–õC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjC–{‹§C’†
‰p’ji•a—j: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž.
287. mŠw‰ïn iˆê”Êu‰‰j Lipiodol•¹—pd‰»—Ö@’†‚Ɉê‰ß«‚̈ӎ¯ÁŽ¸‚ð”F‚ß‚½ŠÌŠà‡•¹H“¹Ã–¬áŽ‚Ì1—á.
”\¨C‘•ª–ΔŽC‹{舤ŽqC“c•Ó‘C‘ºã‹§lCŽ™‹ÊW¹C^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï
(89.12.08), “Œ‹ž.
288. mŠw‰ïn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚ɇ•¹‚µ‚½‘Šú’¼’°Šà‚Ì1—á.
rìä•vC¬—Ñ´“TCŸ–””º‰hCŽO•xO”VCâŒû“NÍC—é–Ø—TC–Ø“cŒõLCŽR–{‰À³CŒÜ\—’³LC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC£ìŒª
ˆêC’†‰p’ji•a—j: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.08), “Œ‹ž.
289. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚é‘å’°Šàf’f‚ÌŒŸ“¢.
¬—Ñ´“TCŸ–””º‰hCŽO•xO”VCâŒû“NÍCŽR“cŽŠlC—é–Ø—TC–Ø“cŒõLCŽR–{‰À³CŒÜ\—’³LC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àjC‘å’J„³iŠOjC£ìŒª
ˆêC’†‰p’ji•a—j: ‘æ49‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŠÖ“Œ’n•û‰ï (89.12.09), “Œ‹ž.
290. mŠw‰ïn iˆê”Êu‰‰j ˆôA“ªˆÙ튴‚ðŽå‘i‚Æ‚µ‚½Plummer-VinsonÇŒóŒQ‚Ì1—á. ¼‰ª–¾—TC”óŒû²GCŒÃì_ŽOiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.
291. mŠw‰ïn iˆê”Êu‰‰j Á‰»«’×á‡úEÇ—á‚Ì•Û‘¶“IŽ¡—Ã. ¡ˆäPC“c’†•üŽqC¬–쎛½ŒåC“c•Ó‘C–Ø“cŒõLC™–{Ÿ•FC‘Oì˜a•Fi‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.
292. mŠw‰ïn iˆê”Êu‰‰j ‹}Œƒ‚ÈŒo‰ß‚ÅŽ€–S‚µ‚½dǃAƒ‹ƒR[ƒ‹«ŠÌd•Ï‚Ì1—á.
—ÑO”üCa’J–¾—²C‘ºã‹§lC™–{’¼C^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC¼–{ˆÌ’ji“àj: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï
(90.02.17), “Œ‹ž, —\eW, p.54, 1990.
293. mŠw‰ïn iˆê”Êu‰‰j ƒ\ƒ}ƒgƒXƒ^ƒ`ƒ“‚É‚æ‚鎡—Ã‚ðŽŽ‚Ý‚½ƒ]ƒŠƒ“ƒWƒƒ[¥ƒGƒŠƒ\ƒ“ÇŒóŒQ‚Ì1—á.
“c’†”ŽŽuC^‹ÊŽõ”ü¶C‘ºã‹§lC²–ìG–íCˆÉ“¡‹ÏCâŒû“NÍCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àj: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï
(90.02.17), “Œ‹ž, —\•ñW, p.15, 1990.
294. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚Ȉݓà“Ëo‚ð’悵‚½ˆÝŠà‚Ì1—á.
ŽRãp‚³‚ä‚èCâŒû“NÍC¬ò˜aŽO˜YC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çCŽÄ“c‹v—Yi“àjC‰¡“c^“ñC“¡–ì’Wli”åjC‹àŽq‘C‹T’J“Oi•a—j:
‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï (90.02.26), “Œ‹ž, “ú–{‰æ‘œˆãŠw‰ïŽGŽ, 8(5): 428, 1990.
295. mŠw‰ïn iˆê”Êu‰‰j Vasoconstrictive Effect of LTC4 on the Gastric
Collecting Venules in Ethanol-Induced Gastric Mucosal Lesion.
ŽŽæMC¼ŽR˜a’jCã–ìWŒ›i–ò—j: The 3rd Taisho International Symposium on
Gastroenterology (90.03.15-16), “Œ‹žC —\eWCp.23, 1990.
296. mŠw‰ïn iˆê”Êu‰‰j ƒGƒ^ƒm|ƒ‹‚É‚æ‚郉ƒbƒgˆÝ”S–ŒáŠQ‚É‚¨‚¯‚郃CƒRƒgƒŠƒGƒ“C4‚ÌŠÖ—^. ¼ŽR˜a’jCã–ìWŒ›CŽŽæMi–ò—j:
‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J. Pharmacol., 52(suppl.): 137,
1990.
297. mŠw‰ïn iˆê”Êu‰‰j ˆÝ”S‰tƒQƒ‹‰ñŽû‚¨‚æ‚Ñ”S‰t—Ê‘ª’è–@‚ÌŒŸ“¢.
¬Žº—Tˆêi¶‰»jCÎŒ´˜a•Fi‰»jC¬Œ´ii¶‰»jCŽs쑸•¶C¬“‡—m“ñC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j:
‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.29), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(‘): 656, 1990.
298. mŠw‰ïn iˆê”Êu‰‰j ‰–Ž_‚ÌAdaptive Cytoprotection‚É‚¨‚¯‚éˆÝ”S‰t“œ’`”’Ž¿‚Ì•Ï“®‚ɂ‚¢‚Ä.
D”¨“¹Gi‡‘åjC‘¼4–¼CÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.29), “Œ‹ž,
“ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(‘): 658, 1990.
299. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝ•Ç‚ÌŒú‚³‚ÉŠÖ‚·‚錟“¢.
ŽR“cŽŠlC–Ø“cŒõLCâŒû“NÍC–ì“o½Cˆ°Œ´‹BC‰¡ŽR–õC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjCŽOd–슰ŠìC”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j:
‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, ´˜^W, p.625, 1990.
300. mŠw‰ïn iˆê”Êu‰‰j NSAID“Š—^‚É‚æ‚éˆÝ”S‰t—Ê‚Ì•Ï“®|Na Salicylate“Š—^Œã‚̈݊e•”ƒwƒLƒ\ƒTƒ~ƒ“—Ê‚ÌŒŸ“¢.
ÎŒ´˜a•Fi‰»jC¼ŽRŒ›ŽqC‰Y“c’ËMŽqi¶‰»ŒnjC¬Žº—TˆêC¬Œ´ii¶‰»jCŽs쑸•¶C¬“‡—m“ñi“àjC–x“c‹±Žqi¶‰»j:
‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(‘): 576, 1990.
301. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚é‘ŠúˆÝŠàf’f‚ÌŽÀ‘Ô|‚wü‚Æ“àŽ‹‹¾‚̑Δä‚ð’†S‚É|.
ˆÀ’BŒ£C¬ò˜aŽO˜YCˆÉ“¡‹ÏC²–ìG–íC‘åŒIŒ’•FCˆ°Œ´‹BC“c•Ó‘CŽR“cŽŠlCâŒû“NÍC–Ø“cŒõLC‰¡ŽR–õCˆÀŠC‹`—jCŽO‹´—˜‰·C^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—ç
i“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 206, l990.
302. mŠw‰ïn iˆê”Êu‰‰j Œ€ÇŠÌ‰Š‚ɑ΂·‚錌Ÿ÷ŒðŠ·‚ÌŠJŽnŽžŠú‚ÌŒŸ“¢.
‘ºã‹§lCa’J–¾—²C”’èŒh“ñC™–{’¼C¼–Ø–ÎŽ÷CVˆäd‹IC‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC“c•Ó‘C–Ø“cŒõLi“àj:
‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 229, l990.
303. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgˆÝ”S‰t“œ’`”’Ž¿¶‡¬Šˆ«‚É‹y‚Ú‚·ƒqƒXƒ^ƒ~ƒ“‚̉e‹¿.
Žs쑸•¶i“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—Tˆêi¶‰»jC¬“‡—m“ñi“àjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j:
‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 575, l990.
304. mŠw‰ïn iˆê”Êu‰‰j Pirenzepine (Pz)‚ÌR’×á‡ì—p‚ɑ΂·‚éˆÝ”S‰t“œ’`”’Ž¿‚ÌŠÖ—^i‘æ2•ñj|Rat
Ethanol’×ᇂÌê‡|.
¬“‡—m“ñi“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—Tˆêi¶‰»jCŽs쑸•¶i“àjC¬Œ´ii¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àjC–x“c‹±Žqi¶‰»j:
‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.30), “Œ‹ž, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 577, l990.
305. mŠw‰ïn iˆê”Êu‰‰j ŠÌ‘Ÿ•”•ªØœpŒã‚É‚¨‚¯‚éŠÌĶ‰ß’ö‚ÌŒŸ“¢|ŠÌ•”•ªØœpŒã24ŽžŠÔ‚܂ł̉Šú•Ï‰»|.
“ñã—æŽqC‰œ•½‰ë•Fi•a—jC–kì’msiŠàŒ¤j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.30), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1):
235, 1990.
306. mŠw‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‚ÌŠiŽqüˆÛ\’z‚Ì“Á«‚ɂ‚¢‚Ä. ‹àŽq‘C“n•Ó´Ž¡C²“¡³Ž÷C‚ˆä’qŽqCŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j:
‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.30), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 238, 1990.
307. mŠw‰ïn iˆê”Êu‰‰j ’°ŠÇ‚É”¶‚µ‚½“®Ã–¬ŠïŒ`5Ç—á‚Ì•a—Šw“IŒŸ“¢. ’†‰p’jC£ìŒªˆêCΈä‰pºi•a—jC›’m–çi“àjC–{‹§C‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.31), •Ÿ‰ª.
308. mŠw‰ïn iˆê”Êu‰‰j ŒŒ´‹y‚у¿-L-Fucosidase‚ÉŠÖ‚·‚錟“¢.
™–{’¼CVˆäd‹IC¼–{ˆÌ’jC‹àŽR“ñ˜YCa’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ76‰ñ“ú–{Á‰»Ší•aŠw‰ï‘‰ï (90.03.31), “Œ‹ž,
“ú–{Á‰»Ší•aŠw‰ïŽGŽ, 87(—Õ‘): 611, l990.
309. mŠw‰ïn iˆê”Êu‰‰j —Þ“VávጂɈ݊à‚ð‡•¹‚µ‚½1—á. X£¹Ž÷iŠOjCŒE’n~C—LX³Ž÷i‘—§“Œ‹ž‘æ2•a‰@j: “ú–{Á‰»Ší•aŠw‰ï’n•û‰ï i89.01.00), “Œ‹ž.
310. mŠw‰ïn iˆê”Êu‰‰j ‘å’°ŠàŠÌ“]ˆÚ—á‚ÌŒŸ“¢. ’r‰i½iŠOjC‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC‹g“cŸ–¾iã”ö’†‰›‘‡•a‰@jC’©’·“N–íC’†‘ºG•viŠOj: é‹ÊŒ§ŠO‰Èˆã‰ï i89.02.19), é‹Ê.
311. mŠw‰ïn iˆê”Êu‰‰j ×–E•ª—ô‰ß’ö‚ÌŽ¨‰º‘B‘B–[×–E‚É‚¨‚¯‚éƒSƒ‹ƒW‘•’u‚Ì“®‘Ô. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 427, l989.
312. mŠw‰ïn iˆê”Êu‰‰j ¶‚«‚½×–E‚ÌŠJŒû•ª”å‚ðŒ©‚é|ƒ‰ƒbƒg‘Á‰t‘B‚Å‚ÌŠÏŽ@|. £ì²‹vCŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 433, l989.
313. mŠw‰ïn iˆê”Êu‰‰j •‚—VƒRƒ‰|ƒQƒ“ƒQƒ‹“à”|—{–@‚É‚æ‚é‘Á‰t‘B‘BŠÇ\‘¢Œ`¬ƒ‚ƒfƒ‹ƒVƒXƒeƒ€‚ÌŠJ”. –å’J—TˆêCŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 434, l989.
314. mŠw‰ïn iˆê”Êu‰‰j •ª—ôŠú‚Ì‘B×–E‚É‚¨‚¯‚é×–E‚Ì‹É«. ‹Ê–؉p–¾CŽR‰È³•½i‰ðj: ‘æ45‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpu‰‰‰ï i89.06.02), ‘åã, J. Electron Microsc., 38(4): 279, l989.
315. mŠw‰ïn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ|ƒiƒ‹R‘Ì–@‚ð—p‚¢‚½ŠÌ‘Ÿ—R—ˆã”ç×–EŠ”‚Ì‘gD“à—R—ˆ‚Ì“¯’è.
–å’J—TˆêCŽR‰È³•½i‰ðjC]ŒûŒá˜NiŠî¶Œ¤j: ‘æ22‰ñ“ú–{”¶¶•¨Šw‰ï i89.06.23), ŽD–y, Development Growth
and Differntiation, 31(4): 415, l989.
316. mŠw‰ïn iˆê”Êu‰‰j –³ŠÌŠú‚ÉBio-pump‚É‚æ‚éƒoƒCƒpƒXŽè‹Z‚ð—p‚¢‚½“¯Š«“¯ŽíŠÌˆÚAp.
‰¡“c˜a•FC‘듇í‰ëC²“¡ŒõŽjC’†ŽR‹`‰îCŒY•”P’jCˆ¢‘]OˆêC“à“c‹v‘¥iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä,
“ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1314, 1989.
317. mŠw‰ïn iˆê”Êu‰‰j CiclosporineAV–Ɖu—}§ÜFK506’P“Æ“Š—^‚È‚ç‚Ñ‚É‘½Ü•¹—p“Š—^‚É‚æ‚éƒCƒkäX\“ñŽw’°ˆÚA.
¡ˆäŒ‰C²“¡ŒõŽjC’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FCˆ¢‘]OˆêC“à“c‹v‘¥iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13),
‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1448, 1989.
318. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«‹}«ˆÝ’×ᇂɑ΂·‚鞶óØœp‚¨‚æ‚Ñ–D‡Ž~ŒŒp‚ÌŒŸ“¢.
’Ë–{GlCŽOd–슰ŠìC÷–{MˆêCã–쑈ê˜YC¬—ÑLsC‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1660, 1989.
319. mŠw‰ïn iˆê”Êu‰‰j ’×ᇫ‘å’°‰Š‚ÌpŽ®‚ÌŒŸ“¢|IRA‹y‚ÑIAA‚ð’†S‚Æ‚µ‚Ä|.
‘å’J„³C‚‹´r‹BC‘êK‹ÏCˆäŒ´ŒúC–ÈŠÑ•¶•vCÎì~CŒÃ”g‘qŽjŽqCH“¡N¶C‹g“c@‹ICˆ”üƒ•vCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj:
‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1989.
320. mŠw‰ïn iˆê”Êu‰‰j ‘å’°úE—á‚ÌŒŸ“¢.
’r‰i½iŠOjC‘哇s•FC´…³•vCŒã“¡‹I•viã”ö’†‰›‘‡•a‰@jC“n•Ó—´•FC‹g“cŸ–¾C‹{“à–M_C’©’·“N–íC’†‘ºG•viŠOj:
‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 1989.
321. mŠw‰ïn iˆê”Êu‰‰j ’¼’°Šà‘¼‘ŸŠíZ—á‚ÌŒŸ“¢.
H“¡N¶C‘å’J„³C–ÈŠÑ•¶•vCÎì~C–x]˜aLC“c’†~ŽiCŒÃ”g‘qŽjŽqC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
i89.07.13), ‹v—¯•Ä, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 22(6): 243, 1989.
322. mŠw‰ïn iˆê”Êu‰‰j “¯• ŒZ’팢ŠÔ‚Å‚ÌäX\“ñŽw’°ˆÚA‚ÌŒ¤‹†.
’†ŽR‹`‰îC¡ˆäŒ‰C‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FC²“¡ŒõŽjiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.11), “Œ‹ž,
ˆÚA, 24(—Õ‘): 171, 1989.
323. mŠw‰ïn iˆê”Êu‰‰j Œ¢ŠÌˆÚAŽèp–³ŠÌŠú’†‚Ì“ûŽ_¥ƒsƒ‹ƒrƒ“Ž_¥’_`Ž_‚Ì„ˆÚ‚ÉŠÖ‚·‚錟“¢.
‘듇í‰ëC‰¡“c˜a•FC²“¡ŒõŽjC’†ŽR‹`‰îCŒY•”P’jiŠOjC^è‹`•FiŽÀ“®ŒnjC“à“c‹v‘¥Cˆ¢‘]OˆêiŠOj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï
i89.09.12), “Œ‹ž, ˆÚA, 24(—Õ‘): 241, 1989.
324. mŠw‰ïn iˆê”Êu‰‰j CiclosporineAV–Ɖu—}§ÜFK506’P“Æ“Š—^‚È‚ç‚Ñ‚É‘½Ü•¹—p“Š—^‚É‚æ‚éƒCƒkäX\“ñŽw’°ˆÚA.
¡ˆäŒ‰C²“¡ŒõŽjC’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž,
ˆÚA, 24(—Õ‘): 270, 1989.
325. mŠw‰ïn iˆê”Êu‰‰j CiclosporineAFK506“Š—^‚É‚æ‚éƒCƒkäX\“ñŽw’°“¯ŽíˆÚAiŽå‚ɈÚAäX‚Ì‘gD‘œ‚ð’†S‚Éj.
²“¡ŒõŽjC¡ˆäŒ‰C’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž,
ˆÚA, 24(—Õ‘): 271, 1989.
326. mŠw‰ïn iˆê”Êu‰‰j oŒŒ«‚ˆÊˆÝ’×ᇎèp—á‚ÌŒŸ“¢.
’Ë–{GlCŽOd–슰ŠìC÷–{MˆêCã–쑈ê˜YC¬—ÑLsC‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ“ú–{Á‰»Ší•aŠw‰ï‘å‰ï
i89.10.06), ˆ®ì, “ú–{Á‰»Ší•aŠw‰ïŽGŽ, 86(—Õ‘): 2157, 1989.
327. mŠw‰ïn iˆê”Êu‰‰j ‘ŠúˆÝŠà‚Ì“àŽ‹‹¾“IƒŒ[ƒU[ÆŽË+OK-432‹Ç’•¹—p—Ö@.
“ˆ”ömC”äŠé”\Ž÷C¬—ÑLsCŽR”ö“N•FCã–쑈ê˜YC‰Á“¡NsCŽOd–슰ŠìC匴÷iŠOj: ‘æ10‰ñ“ú–{ƒŒ[ƒU[ˆãŠw‰ï‘å‰ï i89.10.13),
ˆ®ì, ´˜^W, p.49, 1989.
328. mŠw‰ïn iˆê”Êu‰‰j Á‰»ŠÇ‰^“®‹Lq‚ׂ̈̊ȕւȑª’è–@‚ð—p‚¢‚½Metoclopramide‹y‚ÑCisapride‚Ì–ò•¨Œø‰Ê.
‰Á“¡NsCã–쑈ê˜YC”äŠé”\Ž÷iŠOj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï i89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘):
164`165, 1989.
329. mŠw‰ïn iˆê”Êu‰‰j ’·ŠúŒŒ‰t“§ÍŠ³ŽÒ‚Ì• •”Žèp.
‰¡“c˜a•FCŒY•”P’jC’†ŽR‹`‰îC²“¡ŒõŽjCŒY•”“ŒŽ¡CΓc˜a•vC’Ë–{GlC”äŠé”\Ž÷iŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï
i89.10.31), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽ, 1989.
330. mŠw‰ïn iˆê”Êu‰‰j Pancreaticoduodenal Allotransplantation with Use of
FK506, Ciclosporine and Triple Regimen Immunosuppression.
¡ˆäŒ‰C²“¡ŒõŽjC‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jC‰¡“c˜a•FC“à“c‹v‘¥C”äŠé”\Ž÷iŠOj: ‡W Congress of the European
Society for Organ Transplantation i89.11.1`4), Barcelona, Spain,
Abstract, p.256, 1989.
331. mŠw‰ïn iˆê”Êu‰‰j Gastrointestinal Complications Following Renal
Transplantation. ‰¡“c˜a•FCOotsubo,
O.C’†ŽR‹`‰îC²“¡ŒõŽjCŒY•”P’jC‘듇í‰ëC“à“c‹v‘¥iŠOjC‘å‹v•Û[li“àjC‰““¡’‰—Yi”åjC“n•”_“ñi‘ŸˆÚj: 1st Congress
of the Asian Transplantation Society i89.11.22), ƒoƒŠ, ƒCƒ“ƒhƒlƒVƒA, ´˜^W,
p.207, 1989.
332. mŠw‰ïn iˆê”Êu‰‰j ’°dςŔǂµ‚½‚r󌋒°ŠàÇ—á‚ÌŒŸ“¢.
“n•ÓˆêC‘å’J„³C²“¡KˆêC‰¡ŽR‹žŽqCŒ´‰pC‘êK‹ÏC²X–͖ؔ¾C÷–{MˆêCˆäŒ´ŒúC’r‰i½C–ÈŠÑ•¶•vCH“¡N¶C匴÷C”äŠé”\Ž÷iŠOj:
‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), ‰¡•l.
333. mŠw‰ïn iˆê”Êu‰‰j ’_“¹‹·ó‚ɑ΂·‚é“àᑉ»ƒ`ƒ…[ƒu‚É‚æ‚Á‚ÄŠÌ“®–¬¥’_ŠÇᑂ𗈂µ‚½•ÂÇ«‰©át‚Ì1—á.
²“¡KˆêC‹g“c@‹IC’Ò—ºìC–ØìŽOŽl˜YC‰J‹{–¾•¶C¼ˆäŒ’Cˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ207‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•û‰ï
i89.12.02), ‰¡•l, —\eW, p.40, 1989.
334. mŠw‰ïn iˆê”Êu‰‰j \“ñŽw’°Á‰»«’×á‡úE‚Ì•Û‘¶“IŽ¡—ÃŒoŒ±. ‹{“à–M_C‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC¼ˆäŒ’C’r‰i½C‹g“cŸ–¾iŠOj: é‹ÊŒ§ˆãŠw‰ï‘‰ï i90.01.21), ‰Y˜a.
335. mŠw‰ïn iˆê”Êu‰‰j –«“Á”«‹U«’°•ÂÇÇ‚Ì1—á‚Æ–{–M¬lÇ—á‚ÌŒŸ“¢. ‹{“à–M_C‘哇s•FC´…³•vCŒã“¡‹I•vC“n•Ó—´•FC¼ˆäŒ’C’©’·“N–íiŠOj: ‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•ûŽx•”—á‰ï i90.02.17), “Œ‹ž.
336. mŠw‰ïn iˆê”Êu‰‰j —L‹@—nÜ‚É‚æ‚éˆÝ’×ᇂÌ1Žèp—á.
‰J‹{–¾•¶C“ˆ”ömC•Ð“c‰Ä–çC¼ŽR•Û”äŒÃCã–쑈ê˜YC‰Á“¡NsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjC’†‰p’ji•a—j:
‘æ208‰ñ“ú–{Á‰»Ší•aŠw‰ïŠÖ“Œ’n•ûŽx•”—á‰ï i90.02.17), “Œ‹ž, —\eW, p.5, 1990.
337. mŠw‰ïn iˆê”Êu‰‰j ‘å’°úEÇ—á‚ÌŒŸ“¢.
ˆäŒ´ŒúC‘å’J„³C–ÈŠÑ•¶•vC¬—ÑLsCH“¡N¶C—é–س“¹C‘êK‹ÏC“n•ÓˆêC²“¡KˆêCŒ´‰pC‰¡ŽR‹žŽqC‹g“c@‹IC“ˆ”ömC‰Á“¡NsCˆ”üƒ•vCŽOd
–슰ŠìC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.23), ˆÉ¨.
338. mŠw‰ïn iˆê”Êu‰‰j Ciclosporine, FK‚È‚ç‚Ñ‚É‘½Ü‚ð—p‚¢‚½ƒCƒkäX\“ñŽw’°ˆÚA.
¡ˆäŒ‰C²“¡ŒõŽjC’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jC”äŠé”\Ž÷C‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
i90.02.23), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 301, 1990.
339. mŠw‰ïn iˆê”Êu‰‰j Ciclosporine,
FK506‚È‚ç‚Ñ‚É‘½Ü‚ð—p‚¢‚½ƒCƒkäX\“ñŽw’°ˆÚA‚É‚¨‚¯‚éˆÚAäX‚Ì•a—‘gDŠw“IŒŸ“¢.
²“¡ŒõŽjC¡ˆäŒ‰C’†ŽR‹`‰îC¼ŽR•Û”äŒÃC‘듇í‰ëCŒY•”P’jC”äŠé”\Ž÷C‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï
i90.02.23), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 302, 1990.
340. mŠw‰ïn iˆê”Êu‰‰j H“¹ŠàØœŒã‘ŠúŽ€–S—á‚ÌŒŸ“¢.
¬—ÑLsC–å˜eŒ›Cã–쑈ê˜YC‰Á“¡NsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.23),
ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 447, 1990.
341. mŠw‰ïn iˆê”Êu‰‰j ˆÝŠà‚Ì\“ñŽw’°Z‚ɑ΂·‚é“àŽ‹‹¾“I‹…•””½“]–@‚Ì—L—p«‚ɂ‚¢‚Ä.
÷–{MˆêCŽOd–슰ŠìCã–쑈ê˜YC¬—ÑLsC’Ë–{GlC‰Á“¡NsC“ˆ”ömC匴÷C”äŠé”\Ž÷iŠOjC¬ò˜aŽO˜YC‰¡ŽR–õi“àjC–å˜eŒ›iŠOj:
‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.24), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 413, 1990.
342. mŠw‰ïn iˆê”Êu‰‰j ˆ««•ÂÇ«‰©át‚ɑ΂·‚éŒo”çŒoŠÌ’_“¹ƒhƒŒƒi[ƒWp‚ÌŒŸ“¢.
‹g“c@‹ICˆ”üƒ•vC—é–س“¹C‰¡“c“™C‘å‹{“Œ¶C匴÷C”äŠé”\Ž÷iŠOj: ‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.24), ˆÉ¨,
“ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 569, 1990.
343. mŠw‰ïn iˆê”Êu‰‰j isŠàŠ³ŽÒ‚ɑ΂·‚éÝ‘îÖ¬‰h—{‚Ì—L—p«‚Æ“K‰ž‚ÉŠÖ‚·‚錟“¢.
ã–쑈ê˜YC‘å’J„³C“Œ”ŽC’[ŽR䎟CˆÉ“¡‹`–çC—é–س“¹C²“¡–ÎC²X–͖ؔ¾C‰Á“¡NsC“ˆ”ömCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj:
‘æ35‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï i90.02.24), ˆÉ¨, “ú–{Á‰»ŠíŠO‰ÈŠw‰ïŽGŽ, 23(2): 585, 1990.
344. mŠw‰ïn iˆê”Êu‰‰j Endoscopic Treatment of Early Gastric Cancer.
”äŠé”\Ž÷C¬—ÑLsC“ˆ”ömiŠOj: 2nd World Congress of Endoscopic Surgery i90.03.16),
ƒAƒgƒ‰ƒ“ƒ^.
345. mŒ¤‹†‰ïn i“Á•Êu‰‰j –å–¬ˆ³˜´iÇ‚Ì•a—. ‰œ•½‰ë•Fi•a—j: ‘æ4‰ñ‹ß‹EŠÌ‘Ÿ•aŒ¤‹†‰ï, ‹ž“s, ‘æ4‰ñ‹ß‹EŠÌ‘Ÿ•aŒ¤‹†‰ï˜_•¶W,@p.7`11, 1989.
346. mŒ¤‹†‰ïn i“Á•Êu‰‰j Indocyanine green‚ɂ‚¢‚Ä. ŽÄ“c‹v—Yi“àj: ŠÌ‘ãŽÓŒ¤‹†‰ï (88.10.00), ŽŽ™“‡.
347. mŒ¤‹†‰ïn i“Á•Êu‰‰j • •”‹~‹}Ž¾Š³‚ÆERCP|“Á‚ÉäXŠO‚É‚¨‚¯‚é‹Ù‹}ERP‚ð’†S‚Æ‚µ‚Ä. ‘•ª–ΔŽi“àj: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.09), ‹à‘ò.
348. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆÝŠà‚ɑ΂·‚郌[ƒU[Ž¡—Â̓K‰ž‚ÆŒÀŠE. ”äŠé”\Ž÷iŠOj: ‘æ9‰ñ“Œ‹ž’n‹æ‘—§•a‰@ŠO‰ÈŒ¤‹†‰ï i89.07.15), “Œ‹ž.
349. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒŒ[ƒU[‚É‚æ‚éŠà‚ÌŠO‰È“IŽ¡—Ã. ”äŠé”\Ž÷iŠOj: ‘æ17‰ñ_“Þ쌧‰›ŽOŽl‰ï‘‰ï i89.09.02), Œú–Ø.
350. mŒ¤‹†‰ïn i“Á•Êu‰‰j Endoscopic Surgery‚ÌŒ»‹µ|‘ŠúˆÝŠà‚Ì“àŽ‹‹¾‚ɂ‚¢‚Ä. ”äŠé”\Ž÷iŠOj: ‘æ4‰ñ•xŽRŽîᇖƉuŒ¤‹†‰ï i89.11.30), •xŽR.
351. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ã•”Á‰»ŠÇoŒŒ‚ɑ΂·‚éŒo“®–¬“IÇðp|Ç𕨎¿‚ÌŒŸ“¢FƒGƒ`ƒ‹°2°ƒVƒAƒmƒAƒNƒŠƒŒ[ƒg(ECA; ƒAƒƒ“ƒAƒ‹ƒtƒ@A)‚Ì—L—p«. ^‹ÊŽõ”ü¶i“àj: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.09), ‹à‘ò.
352. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ã”ç•t’…‚ɑ΂·‚é×–E¶•¨Šw“IƒAƒvƒ|ƒ`. £ì²‹vi‰ðj: ‘æ20‰ñŒä’ƒ‚Ì…Ž•ŠwŒ¤C‰ï i89.04.09), “Œ‹ž.
353. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠJ‹Æˆã‚É•K—v‚ÈÁ‰»ŠíŽ¾Š³‚Ì’mŽ¯|‰Ê‚µ‚Ĉ݊à‚ÍŽèp‚µ‚È‚¢‚ÅŽ¡‚¹‚é‚©. ”äŠé”\Ž÷iŠOj: ‘æ224‰ñ‘å˜a—Õ°ˆã’k˜b‰ïŒ¤C‰ï i89.11.15), ‘å˜a.
354. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Endoscopic SurgeryFÅ‹ß‚Ìi•à|‘ŠúˆÝŠà‚Ì“àŽ‹‹¾“IŽ¡—Ã|. ‰¡ŽR–õi“àjC“ˆ”ömiŠOj: ‘æ34‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï (89.06.10), ¬“cŒ´.
355. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j IVR‚̇•¹Ç|—\–h‚Æ‘Îô|Á‰»ŠÇoŒŒ. ˆä“›–ri•új: ‘æ1‰ñŠÖ“ŒInterventional
RadiologyŒ¤‹†‰ï (89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2):
158, 1989.
356. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ICGÖ¬áŽ“à’“üŽž‚Ì“àŽ‹‹¾ŠŒ©‚ÌŒŸ“¢|‘¢‰eŠŒ©‚Ƃ̑Δ䂩‚ç|.
‘•ª–ΔŽC‘OìŒö’jC“c•Ó‘C‰¡ŽR–õC^‹ÊŽõ”ü¶CŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷iŠOj: ‘æ9‰ñH“¹Ã–¬áŽd‰»—Ö@Œ¤‹†‰ï
(90.01.13), “Œ‹ž.
357. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒƒbƒPƒ‹ŒeŽº12—á‚ÌŒŸ“¢. ‘å“c„•äC^“º‘¾˜YC¬“‡–M•FiŽ™jCΓc˜a•viŠOjC™–{Ÿ•FC–x’rdŽ¡C‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ14‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (90.03.09), “Œ‹ž.
358. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Á‰»ŠíŠà‚Ì“àŽ‹‹¾“IŽ¡—ÃGƒŒ[ƒU[Ž¡—Ã. ”äŠé”\Ž÷iŠOjC¬àV—Ñ‘¾˜YiVŠƒ‘åj: ‘æ50‰ñVŠƒÁ‰»Ší•aŒ¤‹†‰ï i89.07.29), VŠƒ.
359. mŒ¤‹†‰ïn iƒpƒlƒ‹j Edmondson‡UŒ^ŠÌ×–EŠà‚ÌÄŒŸ“¢(1). ‚ˆä’qŽqi•a—jCŒÃ’J–[Ž}i•a‰@•a—•”jC‰œ•½‰ë•Fi•a—j: ‘æ25‰ñŠÌŠàŒ¤‹†‰ï (89.05.31), ‹à‘ò.
360. mŒ¤‹†‰ïn iƒpƒlƒ‹j H2Žó—e‘ÌhRÜ“Š—^‰º‚É‚¨‚¯‚éˆÕŽ¡«‹y‚ѓ«’×ᇂ̈ݕª”å‚ÌŒŸ“¢. ˆÀŠC‹`—jC¼Œ³Ž›Ž—çi“àj: ‘æ22‰ñˆÝ•ª”匤‹†‰ï (90.03.29), “Œ‹ž.
361. mŒ¤‹†‰ïn iˆê”Êu‰‰j •›tˆÚ“]‚ð‚Æ‚à‚È‚Á‚½ƒGƒ^ƒm[ƒ‹‹Ç’’·Šúi3”NˆÈãj¶‘¶’†‚ÌŠÌ×–EŠà‚Ì1—á. ‘•ª–ΔŽC™–{’¼Ca’J–¾—²CŽR“cL•vCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ26‰ñ‰ë–‰€ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.05.18), “Œ‹ž.
362. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÙŽž•ûŒü‚ÌH“¹Ã–¬áŽ‚ª‚»‚ꂼ‚ꉓŠÌ«A‹ŠÌ«‚ÌŒŒ—¬•ûŒü‚ðŽ¦‚µ‚½IPH‚Ì1—á.
‘•ª–ΔŽCˆÉ“¡‹ÏC“c•Ó‘C‰¡ŽR–õC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çCŽÄ“c‹v—Yi“àj: ‘æ8‰ñH“¹Ã–¬áŽd‰»—Ö@Œ¤‹†‰ï (89.07.01), ˆ®ì.
363. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÝŠïŒ`Žî‚Ì‚P“ûŽ™—á. ^“º‘¾˜YC¬“‡–M•FC‘å“c„•äiŽ™jC¼Œ³Ž›Ž—çi“àjCΓc˜a•vC”äŠé”\Ž÷iŠOj: ‘æ16‰ñ“ú–{¬Ž™“àŽ‹‹¾Œ¤‹†‰ï (89.07.01), ‹ž“s, —\eW, p.22, 1989.
364. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž_•ª”åŽhŒƒÜ‚̈ݔS‰t“œ’`”’Ž¿‚É‹y‚Ú‚·‰e‹¿i‘æ3•ñj.
¬Žº—TˆêC‘å씎”VC¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»jC¼Œ³Ž›Ž—çC‰ª•”Ž¡–íi“àj: ‘æ9‰ñƒqƒXƒ^ƒ~ƒ“ƒŒƒZƒvƒ^|Œ¤‹†‰ï
(89.07.28), ‹ž“s, ´˜^W, p.11`12, 1989.
365. mŒ¤‹†‰ïn iˆê”Êu‰‰j
ˆÝ”S‰tŠÜ—Ê‚©‚ç‚Ý‚½ƒ‰ƒbƒgƒGƒ^ƒm|ƒ‹’×ᇂɑ΂·‚éSucralfate‚ÌŒø‰Ê|ˆÝ”S–ŒƒwƒLƒ\ƒTƒ~ƒ“‘ª’è–@‚ð—p‚¢‚½ŒŸ“¢.
ÎŒ´˜a•Fi‰»jC¬Žº—Tˆêi¶‰»jC¬“‡—m“ñi“àjC¬Œ´iC–x“c‹±Žqi¶‰»j: ‘æ40‰ñƒyƒvƒVƒ“Œ¤‹†‰ï (89.08.05), “Œ‹ž, ´˜^W,
p.9, 1989.
366. mŒ¤‹†‰ïn iˆê”Êu‰‰j Metallic stent‚ÅŽ¡—µ‚½Budd-ChiariÇŒóŒQ‚Ì1—á.
‘–쳈êi•újCŒÃˆäŽ i–h‰qˆã‘åj: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï (89.08.05), “Œ‹ž,
“ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 127, 1989.
367. mŒ¤‹†‰ïn iˆê”Êu‰‰j Á‰»ŠÇoŒŒ‚ÌIVR. ‘–쳈êi•új: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï
(89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 136, 1989.
368. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒGƒ^ƒm|ƒ‹‚É‚æ‚éˆÝ”S–Œ”÷¬zŠÂáŠQ‚Æ“àˆö«ƒƒCƒRƒgƒŠƒGƒ“C4CƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“E2‚Ì–ðŠ„. ŽŽæMi–ò—j: ¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï (89.08.24), ‰ªè.
369. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÌd•Ï‚ɇ•¹‚·‚鉩át‚ɑ΂·‚éDOA‚ÌŽŽ‚Ý. ‘ºã‹§lC™–{’¼C¼–Ø–ÎŽ÷Ca’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ6‰ñ_“ÞìŠÌ‰ŠƒZƒ~ƒi[ (89.09.02), ‰¡•l.
370. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”xŒ´”‚Ì“]ˆÚ«¬’°Žîᇂɂæ‚é’°dÏ‚Ì1—á. Žðˆä’C•FC“c•Ó‘C–Ø“cŒõLi“àjC‘Oì˜a•FC–x’rdŽ¡i‹~–½jC‹àŽq‘i•a—j: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.08), ‹à‘ò.
371. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÂÇ«‰©át‚𗈂½‚µ‚½äX“à’_ŠÇ‘¹‚Ì1—á. Ί_“¿]C‘•ª–ΔŽCâŒû“NÍC^‹ÊŽõ”ü¶CŽOŽ}MC’†ˆä‹v—YCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‘Oì˜a•Fi‹~–½j: ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.08), ‹à‘ò.
372. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰º•”Á‰»ŠÇ“®Ã–¬ŠïŒ`. ‰““¡‚C‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC‹àˆä¹ŒPi•új:
‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (89.09.08), ‹à‘ò, ‘æ13‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï´˜^W, p.97, 1989.
373. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ€ÇŠÌ‰ŠFdNJ̉Š‚Ì• o‹¾‘œ‚Æ’·Šú—\Œã. ‘ºã‹§lC”’èŒh“ñC¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCŽÄ“c‹v—Yi“àj: ‘æ26‰ñ• o‹¾§˜b‰ï (89.09.28), “Œ‹ž.
374. mŒ¤‹†‰ïn iˆê”Êu‰‰j H“¹Ã–¬áŽŒŒ‰tƒKƒX•ªÍ‚Ì—Õ°“IˆÓ‹`. ‘•ª–ΔŽC“c•Ó‘CΈäŒö“¹CŽÄ“c‹v—Yi“àjC”äŠé”\Ž÷iŠOjC‰œ•½‰ë•Fi•a—j: ‘æ22‰ñ“ú–{–å–¬ˆ³˜´iÇŒ¤‹†‰ï (89.09.30), “Œ‹ž.
375. mŒ¤‹†‰ïn iˆê”Êu‰‰j ICG‚ð—p‚¢‚½H“¹Ã–¬áŽ‚É‚¨‚¯‚錌s“®‘Ô‚ÌŒŸ“¢. ‘•ª–ΔŽC“c•Ó‘C”’èŒh“ñC™–{’¼C¼–Ø–ÎŽ÷CŽÄ“c‹v—Yi“àj: ICGŒ¤‹†‰ï (89.10.04), ˆ®ì.
376. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Á”«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•ÇgŽqüˆÛ‚̕ω»‚ɂ‚¢‚Ä|ŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä|. ‘å•”½C‰œ•½‰ë•Fi•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”LJ“¯•ª‰È‰ï (89.10.11), ’·–ì.
377. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒoŒû’°ŠÇôò‰t‚É‚æ‚é‘å’°“àŽ‹‹¾‘Oˆ’u–@i2000 ml–@j‚ÌŒŸ“¢.
¬—Ñ´“TCŸ–””º‰hCŽO•xO”VC—é–Ø—TCŽR–{‰À³CŒÜ\—’³LC¼Œ³Ž›Ž—çi“àjC¬ìK—YC“‡“cŽœ•Fi–òÜj: ‘æ7‰ñ‘å’°ŒŸ¸–@Œ¤‹†‘‰ï
(89.10.21), ‘å‹{.
378. mŒ¤‹†‰ïn iˆê”Êu‰‰j V‚µ‚¢Žîᇃ}[ƒJ[span-1a‚Ì—Õ°“IŒŸ“¢. ˆÉ“¡‹ÏC^‹ÊŽõ”ü¶CŸ–””º‰hC“©ŽRaˆê˜NCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjCΈ䟌Èi•új: ‘æ37‰ñ_“Þ쌧Á‰»Ší•aŒ¤‹†‰ï (89.11.04), ‰¡•l.
379. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgEthanol’×ᇂɑ΂·‚éCimetidine,
Cetraxate•¹—p“Š—^Œø‰ÊiˆÝ”S‰tŠÜ—ʕω»‚É‚æ‚錟“¢j.
Žs쑸•¶i“àjCÎŒ´˜a•Fi‰»ŠwjC¬Žº—TˆêC¬“‡—m“ñi¶‰»jC¼Œ³Ž›Ž—çi“àjC–x“c‹±Žqi¶‰»j: ‘æ17‰ñŽÀŒ±’×ᇌ¤‹†‰ï
(89.12.01), “Œ‹ž, ´˜^W, p.54, 1989.
380. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’´‰¹”g“àŽ‹‹¾‚É‚æ‚éˆÝŠà‚Ì[’B“xf’fAStage f’f. –Ø“cŒõLCâŒû“NÍC–ì“o½C¬ò˜aŽO˜YC‰¡ŽR–õC^‹ÊŽõ”ü¶C¼Œ³Ž›Ž—çi“àj: ‘æ54‰ñˆÝŠàŒ¤‹†‰ï (90.01.00), ‰¡•l.
381. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’_”XŒ‹Î‚ɑ΂·‚é‘ÌŠOÕŒ‚”g”jӗÖ@(ESWL)‚Ì—Õ°“IŒŸ“¢|”jÓŒã‚ÌŒo‰ß‚©‚ç‚Ý‚½“K‰ž|.
ˆêŒ´—ºCã–ìˆê–çi“àjC–å˜eŒ›iŠOjCˆäŒ´ŒúC“c’†~ŽiCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC”äŠé”\Ž÷C•½“cMliŠOj:
‘æ20‰ñÁ‰»Ší‘ÌŠOÕŒ‚”g—Ö@Œ¤‹†‰ï (90.01.13), “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.3, 1990.
382. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’ÊíŒ^֬ᎈȊO‚ÌÁ‰»ŠÇ֬ᎂ̌Ÿ“¢.
^‹ÊŽõ”ü¶C‘•ª–ΔŽCŽRãp‚³‚ä‚èC–Ø“c–FŽ÷CŽÄ“c‹v—YC¼Œ³Ž›Ž—çC“c•Ó‘i“àj: ‘æ9‰ñH“¹Ã–¬áŽd‰»—Ö@Œ¤‹†‰ï (90.01.13),
“Œ‹ž, ´˜^W, p.11, 1990.
383. mŒ¤‹†‰ïn iˆê”Êu‰‰j Šg‘å• o‹¾‚É‚æ‚éŠÌ•\–ÊŠŒ©‚ÌŒŸ“¢. ”’èŒh“ñC‘ºã‹§lC™–{’¼C¼–Ø–ÎŽ÷CVˆäd‹ICa’J–¾—²C‘•ª–ΔŽCΈäŒö“¹CŽÄ“c‹v—Yi“àj: ‘æ27‰ñ• o‹¾§˜b‰ï (90.02.01), “Œ‹ž.
384. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Á”«–å–¬ˆ³˜´iÇ‚É‚¨‚¯‚é—Þ“´•ÇüˆÛ\’z‚ÌŒŸ“¢|ŠÌd•ÏÇ‚Æ‚Ì”äŠr‚ð’†S‚Æ‚µ‚Ä|i‘æ2•ñj. ‘å•”½C‰œ•½‰ë•Fi•a—j: Œú¶È“Á’莾Š³–å–¬ŒŒsˆÙíÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘‰ï (90.02.07), “Œ‹ž.
385. mŒ¤‹†‰ïn iˆê”Êu‰‰j Aspirin\‘¢ŠÖ˜A•¨Ž¿“Š—^‚É‚æ‚郉ƒbƒgˆÝ”S‰t—Ê‚Ì•Ï“®|ƒwƒLƒ\ƒTƒ~ƒ“ŠÜ—Ê‘ª’è‚É‚æ‚錟“¢.
ÎŒ´˜a•Fi‰»jC¼ŽRŒ›Žqi¶‰»ŒnjC¬Žº—TˆêC¬Œ´iC–x“c‹±Žqi¶‰»jCŽs쑸•¶C¬“‡—m“ñi“àj: ‘æ41‰ñƒyƒvƒVƒ“Œ¤‹†‰ï
(90.02.17), ‹ž“s, ´˜^W, p.1, 1990.
386. mŒ¤‹†‰ïn iˆê”Êu‰‰j 0.35N‰–Ž_ŒoŒû“Š—^Œã‚̈ݔS–Œ‚̕ω»‚ɂ‚¢‚Ä.
“c’†‰ë•FCD”¨“¹Gi‡‘åjC‘¼3–¼CÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: ‘æ8‰ñ Cytoprotecion Œ¤‹†‰ï (90.02.17),
‹ž“s, ´˜^W, p.18, 1990.
387. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«äX‰Š‚ÌPrimam/Care; —A‰t—Ö@‚Æt‹@”\. ¡ˆäPCó—˜–õC¬–쎛½ŒåC“c’†•üŽqCŽá—Ñ–õ‹vC™–{Ÿ•FCŒY•”P’jC‘Oì˜a•Fi‹~–½j: ‘æ28‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (90.03.08), ‘åã.
388. mŒ¤‹†‰ïn iˆê”Êu‰‰j “àŽ‹‹¾“IäXŠÇƒhƒŒƒi[ƒW‹y‚ÑEST‚ª‘tŒø‚µ‚½äX”X–E‡•¹–«äX‰Š‚Ì1—á.
¡òOC‹{舤ŽqC‘•ª–ΔŽC^‹ÊŽõ”ü¶C”\¨CâŒû“NÍCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC¡ˆäPC‘Oì˜a•Fi‹~–½j:
‘æ14‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï (90.03.09), “Œ‹ž.
389. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚‚à–Œ‰ºoŒŒ‚É‚¨‚¯‚邃Aƒ~ƒ‰[ƒ[ŒŒÇ‚ÌŒŸ“¢.
¬–쎛½Œåi‹~–½jC–Ø“cŒõLC“c•Ó‘i“àjC–kˆä‘¥•vC“c’†ç•FC‰““¡¹FC–kŒ´F—YC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j:
‘æ14‰ñ“ú–{• •”f—ÃŒ¤‹†‰ï (90.03.09), “Œ‹ž.
390. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©—¥_Œo‚̈ݔS–Œ‚É‹y‚Ú‚·‰e‹¿|“Á‚ɈݓàpH,ˆÝ”S–ŒƒwƒLƒ\ƒTƒ~ƒ“‚ɂ‚¢‚Ä.
—é–Ø—SŽqC‹TŽRmˆêiŽRŒ`‘åjC‘¼2–¼CÎŒ´˜a•Fi‰»jC¼ŽRŒ›Žqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: ‘æ22‰ñˆÝ•ª”匤‹†‰ï (90.03.29),
“Œ‹ž, ˆÝ•ª”匤‹†‰ïŽ, 22: 81`84, 1990.
391. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’_“¹oŒŒ‚𗈂µ‚½•ÂÇ«‰©át‚Ì1—á. ‰J‹{–¾•¶C‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ30‰ñ’_“¹‚ÌW‚¢ i89.06.30), “Œ‹ž.
392. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å’°‘¼‘ŸŠíd•¡Šà‚ÌŒŸ“¢. ‘êK‹ÏC‘å’J„³CˆäŒ´ŒúC–ÈŠÑ•¶•vCÎì~CŒÃ”g‘qŽjŽqCH“¡N¶C‹g“c@‹ICˆ”üƒ•vCŽOd–슰ŠìC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ‘å’°ŠàŒ¤‹†‰ï i89.07.00), ‘åã.
393. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’¼’°ŠàpŒã‹ÇŠÄ”Ç—á‚ÌŒŸ“¢. ˆäŒ´ŒúC‘å’J„³C‘êK‹ÏC–ÈŠÑ•¶•vC¬—ÑLsCˆ¢‘]˜a“NCã–쑈ê˜YCH“¡N¶C“ˆ”ömC‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ‘å’°ŠàŒ¤‹†‰ï i89.07.00), ‘åã.
394. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÂÇ«‰©át‚ɑ΂·‚éŒo”çŒoŠÌ’_“¹ƒhƒŒƒi[ƒWp‚ÌŒŸ“¢. ‹g“c@‹IC—é–س“¹C‰¡“c“™C‹à“cŒå˜YCˆ¢‘]˜a“NCˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ11‰ñ_“ÞìŠÌ’k˜b‰ï i89.07.22), ‰¡•l.
395. mŒ¤‹†‰ïn iˆê”Êu‰‰j ––ŠúŠàŠ³ŽÒ‚ɑ΂·‚éÝ‘îÖ¬‰h—{‚Ì—L—p«‚ÉŠÖ‚·‚錟“¢.
ã–쑈ê˜YC‘å’J„³C“Œ”ŽC’[ŽR䎟CˆÉ“¡‹`–çC—é–س“¹C²“¡–ÎC‰Á“¡NsCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOjCŠp“c‡ŽqCŽRè—R‹IŽqiŠÅŒì•”j:
‘æ4‰ñÝ‘îÖ¬‰h—{Œ¤‹†‰ï i89.09.02), ‘åã.
396. mŒ¤‹†‰ïn iˆê”Êu‰‰j äX“ª\“ñŽw’°Øœp‚ðs‚Á‚½•¡ŽGäX’_ŠÇ‡—¬ˆÙí‚Ì1—á. ‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ2‰ñ_“ÞìäX§˜b‰ï i89.11.28), ‰¡•l.
397. mŒ¤‹†‰ïn iˆê”Êu‰‰j “àŽ‹‹¾V•aŒ^iˆÄj‚É‚æ‚é‚O°‡UŒ^Ç—á|Ç—á‚U|. ¬—ÑLsiŠOj: ‘æ20‰ñH“¹•\ÝŠàǗጟ“¢‰ïiH“¹F‘fŒ¤‹†‰ïj i89.12.09), “Œ‹ž.
398. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘’_ŠÇŒ‹Î‚ɑ΂·‚éESWL‚ÌŒoŒ±.
–å˜eŒ›CˆäŒ´ŒúC“c’†~ŽiiŠOjCˆêŒ´—ºCã–ìˆê–çCŽÄ“c‹v—YC¼Œ³Ž›Ž—çi“àjC‘å‹{“Œ¶C”äŠé”\Ž÷C•½“cMliŠOj:
‘æ2‰ñÁ‰»ŠíŠO‰È‘ÌŠOÕŒ‚”g—Ö@Œ¤‹†‰ï i90.01.13), “Œ‹ž, ƒvƒƒOƒ‰ƒ€, p.4, 1989.
399. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆô“ªH“¹“EopŽ{sŠ³ŽÒ‚̉h—{ó‘Ô‚ÌŒŸ“¢.
X“c‰À‘ãŽqC²“¡‘•cC–ؖí¶i‰h—{‰ÈjC²“¡ŒõŽjCŽOd–슰ŠìiŠOjC‘åê³–¤iŠÅŒìŠw•”jC–Ø‘º—˜”üCˆÉ“¡—msC²ìŒ«ˆêC‰Á‰ê’J”£i–òÜ•”jC–û
’J˜aŽqC¼èƒ^ƒcƒGiŠÅŒì•”j: ‘æ5‰ñ“ú–{Ö¬Œo’°‰h—{Œ¤‹†‰ï i90.01.26), “Œ‹ž, “ú–{Ö¬Œo’°‰h—{Œ¤‹†‰ïŽ, 5: 278,
1990.
400. mŒ¤‹†‰ïn iˆê”Êu‰‰j WŠw“IŽ¡—Âɂĉü‘P‚µ‚½”ñØœŠÌ’_ŠÇ”X–E‘BŠà‚Ì’·Šú¶‘¶—á. ‹g“c@‹ICˆ”üƒ•vC‘å‹{“Œ¶C”äŠé”\Ž÷iŠOj: ‘æ31‰ñ’_“¹‚ÌW‚¢ i90.01.27), ˆÉ“Œ.
401. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]Ž€ƒhƒi[‚ÌäX‘gD‚ÌŒŸ“¢. ’†ŽR‹`‰îC¡ˆäŒ‰CŒY•”P’jC²“¡ŒõŽjCE“cÍC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ16‰ñäXˆÚA’k˜b‰ï i90.02.08), ‹à‘ò, —\eW, p.23, 1989.
402. mŒ¤‹†‰ïn iˆê”Êu‰‰j ciclosporine‚È‚ç‚Ñ‚ÉV–Ɖu—}§ÜFK506‚ð—p‚¢‚½ƒCƒkäX\“ñŽw’°ˆÚA.
²“¡ŒõŽjC¡ˆäŒ‰C’†ŽR‹`‰îC‘듇í‰ëCŒY•”P’jCE“cÍC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ16‰ñäXˆÚA’k˜b‰ï i90.02.08),
‹à‘ò, —\eW, p.25, 1989.
403. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’¼’°pmŠàÇ—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ‘å’J„³CˆäŒ´ŒúC‰ªTˆê˜YC‘êK‹ÏC’r‰i½CŒÃ”g‘qŽjŽqC–ÈŠÑ•¶•vCÎì~CH“¡N¶C‚‹´r‹BC匴÷C”äŠé”\Ž÷iŠOj: ‘æ32‰ñ‘å’°ŠàŒ¤‹†‰ï i90.02.17), ‘åã.
404. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’¼’°Šàp‘OpŒã‚É‚¨‚¯‚éƒ`[ƒ€ˆã—Âɂ‚¢‚Ä|“Á‚ɸ_“IƒPƒA[‚ɂ‚¢‚Ä|.
•ÐŸºŒ[ŽqCŠp“c‡ŽqCŽRè—R‹IŽqC²•ª–õŽqC’†‘ºG‘ãiŠÅŒì•”jC–ÈŠÑ•¶•vCH“¡N¶C‘å’J„³iŠOjCŠ}Œ´—FKi¸j:
‘æ12‰ñ_“Þ쌧ƒXƒg[ƒ}Œ¤‹†‰ï i90.03.03), _“Þì.
405. mŒ¤‹†‰ïn iˆê”Êu‰‰j Á‰»ŠÇ‰^“®‹Lq‚Ì‚½‚ß‚ÌŠÈ•Ö‚È‘ª’è–@‚ð—p‚¢‚½ŠeŽí–òÜ‚Ì–ò•¨Œø‰Ê. ‰Á“¡NsCã–쑈ê˜YC÷–{MˆêiŠOjC‘ëàV’¼’èC‘åŠÑMi¶—jC”äŠé”\Ž÷iŠOj: ‚f‚h‚l‚cƒNƒ‰ƒu i90.03.03), ‰¡•l.
406. mŒ¤‹†‰ïn iˆê”Êu‰‰j p‘O‚ÉTcO4-ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ðs‚¢WÏ‚ðŽ¦‚µAØœp‚ðŽ{s‚µ‚½oŒŒ«¬’°•½ŠŠ‹ØŽî‚Ì1—á.
X£¹Ž÷iŠOjC“c•Ó‘C¡ˆäPCˆäŒ…^—R”üC–Ø“cŒõLi“àjCŒY•”P’jiŠOjC‘Oì˜a•FC–x’rdŽ¡C‘å˜a“c—²i‹~–½j:
‘æ14‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï i90.03.08), “Œ‹ž.
407. mŒ¤‹†‰ïn iˆê”Êu‰‰j •…H«H“¹‰ŠpŒãiƒoƒCƒpƒXpj‚ÉŽc‘¶H“¹‚Ì”j—ô‚ð‹N‚±‚µ‚½‚ÆŽv‚í‚ê‚é1—á. X£¹Ž÷CŽOd–슰ŠìC“ˆ”ömC¬—ÑLsC”äŠé”\Ž÷iŠOj: ‘æ2‰ñ_“ÞìH“¹Ž¾Š³§˜b‰ï i90.03.15), _“Þì.
408. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éoŒŒ«ˆÝ’×ᇎèpÇ—á‚ÌŒŸ“¢. ’Ë–{GlC÷–{MˆêCã–쑈ê˜YC¬—ÑLsC“ˆ”ömC‰Á“¡NsCˆ”üƒ•vCŽOd–슰ŠìC匴÷C”äŠé”\Ž÷iŠOj: ‘æ19‰ñˆÝŠO‰ÈŒ¤‹†‰ï i90.03.17), ŽŽ™“‡.
409. mŒ¤‹†‰ïn iŒöŠJuÀj ‰ŠÇ«’°Ž¾Š³‚Ì“àŽ‹‹¾f’f. Ÿ–””º‰hi“àj: ‘æ14‰ñ“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïƒZƒ~ƒi[ (89.07.23), “Œ‹ž, —\eW, p.91`94, 1989.
410. mŒ¤‹†‰ïn iŒöŠJuÀj ŠàŽ¡—ÂÌÅ‘OüiˆÝŠàA‘å’°Šà“™‚ɂ‚¢‚Äj. ”äŠé”\Ž÷iŠOj: _“Þ쌧‘åŠwŒöŠJuÀ i89.11.25), ‘Š–ÍŒ´.
<<102 SE–¬ŠÇ>>
411. mŒ´’˜n Responsiveness of the Ductus Arteriosus to Prostaglandin E1
Assessed by Combined Cross Sectional and Pulsed Doppler
Echocardiography. •½Î‘C“¡–ì‹X”VCÄ“¡KˆêC¬ŒûO‹BC–åˆäL‹ÅCãp—z‘¾˜YC–xŒû‘דTiŽ™jC•äÏŒ³i—ÕŒŸjC”ª‘ãŒö•viŽ™j:
Br. Heart J.,62: 140`147, 1989.
412. mŒ´’˜n The Role of Specific Granules in Ventricles on Atrial
Natriuretic Peptide (ANP) Secretion in Acute Heart Failure.
²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC^è‹`•FiŽÀ“®ŒnjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄LC˜Iè‹P•vi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC–Øì“c—²ˆê
i“àj: Diuretics ‡V: Chemistry, Pharmacology, and Clinical Applications,
p.615`617, 1990.
413. mŒ´’˜n ˜V”NŽÒ‚É‚¨‚¯‚éŽûkŠú‚ŒŒˆ³‚¨‚æ‚ÑŠg’£Šú‚ŒŒˆ³‚ÌŒŒs“®‘Ô‚ÆS‹@”\. ‘º¼€C™ŽRŠx•FC’ËŒ´Œª”VCˆÀ’B¥ºC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: Geriatric Med., 27: 1494`1498, 1989.
414. mŒ´’˜n A Computer-Based Model of Parasystolic Activity Modulated by
Ventricular Activation in the Open-Chest Dog.
¯–ìˆê–çC’r“cŒ›ºiˆã—pî•ñjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC‹{Œ´‰p•viˆã—pî•ñj: J. Electrocardiol., 22(4):
277`283, 1989.
415. mŒ´’˜n No Specific Organ Removes Atrial Natriuretic Peptide from the
Human Plasma. •‘ò—˜˜YC•½¼T‰EC‰Á“¡—zˆêC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: Jpn. Circ. J.,
53(7): 779`785, 1989.
416. mŒ´’˜n Reentrant Arrhythmias Generated by a Computer-Based Model of
the Modulated Parasystole in an Open-Chest Dog.
¯–ìˆê–çC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: Jpn. Heart J., 30(6): 885`894, 1989.
417. mŒ´’˜n Biphasic Accumulation of Leukocytes in Rat Cardiac Infarct
Tissue Caused by Leukotriene B4 and Complement. ŽŽæMi–ò—jCT.
KameyamaiŽO•H‰»¬jC²X–ØK“ñi“àjCã–ìWŒ›i–ò—jC‚–Ø”ü˜aŽqi¶‰»ŒnjCŽR‰È³•½i‰ðj: Jpn. J.
Pharmacol., 50: 234`238, 1989.
418. mŒ´’˜n Hemodynamic and Neuroendocrine Adaptations of the Preterm
Lamb Left Ventricle to Acutely Increased Afterload. Barry G. Baylen
(Penn. State Univ.)Cãp—z‘¾˜Y(Ž™)CJames F. PadburyCMachiko IkegamiCAlan
JobeCGeorge C. Emmanouilides (Penn. State Univ.): Pediatr. Res., 26(4):
336`342, 1989.
419. mŒ´’˜n ŠJSp‚É‚¨‚¯‚鶎ºŒ¸ˆ³venting‚Ì•K—v«‚ÌŒŸ“¢. •—ŠÔ”ÉC¼ŽR´ŒhC¡ˆäŠ°C’¬ˆä³lC‰€“c˜a•FCÎŒ´ºi‹¹ŠOj: ‹¹•”ŠO‰È, 42(7): 537`540, 1989.
420. mŒ´’˜n ‘ÏŒŒŠÇ•ÇCollapse«‚ðl—¶‚µ‚½”“®—¬ƒ|ƒ“ƒv‚ÌÖ¬ƒJƒjƒ…|ƒŒ“üŒûŒ`ó.
‹´–{¬Li¶‘ÌHjCˆÉ“¡’‰OCŽç‰®“llC–ö‘òG–¾CÎŒ´ºi‹¹ŠOjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: lH‘ŸŠí,
12(1): 245`248, 1983.
421. mŒ´’˜n ŒŒð‚̬’·‚ð—}‚¦‚鉓Sƒ|ƒ“ƒv—¬˜HŒ`óÝŒv. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCó—˜G’jCÎŒ´ºi”]ŠOjCù“c’¼C…–ìŸi“ŒH‘åj: lH‘ŸŠí, 17(3): 879`882, 1988.
422. mŒ´’˜n ”“®—¬ƒ|ƒ“ƒv‚ɑ΂·‚é‹à‘®ƒxƒ|ƒY‚̉ž—p. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjCù“c’¼i¶‘ÌHj: ¶‘ÌÞ—¿, 1(1): 53`60, 1983.
423. mŒ´’˜n ŽíX‚Ìæ“V«SŽ¾Š³‚É‚¨‚¯‚é“®–¬ŠÇ‚ÌŒ`‘Ԃƕ½‰ß’ö‚ɂ‚¢‚Ä‚ÌSƒGƒR|}Cƒhƒvƒ‰–@‚ð—p‚¢‚½Œ¤‹†. •äÏŒ³i—ÕŒŸjC•½Î‘iŽ™jCŒÃ–ؗʈê˜YC’ß–ì˜a‘¥i—ÕŒŸj: “ú–{’´‰¹”gˆãŠw‰ïŽGŽ, 16(6): 538`545, 1989.
424. mŒ´’˜n ”]Ò‘‰t‚É‚¨‚¯‚éƒCƒkS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“‚Ì‘¶Ý‚Æ‚»‚Ì—R—ˆ‚ÉŠÖ‚·‚錟“¢. ‘“c‘ìi‹~–½jC²“¡´‹Mi“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: “ú–{“à•ª”åŠw‰ïŽGŽ, 65(10): 1159`1170, 1989.
425. mŒ´’˜n ‰Â‹t“IS•s‘S‚É‚¨‚¯‚錌’†‚¨‚æ‚ÑS–[ANP“®‘Ô. ²“¡´‹MC’·’J쉄LC–Øì“c—²ˆêi“àjC‘“c‘ìi‹~–½jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: “ú–{“à•ª”åŠw‰ïŽGŽ, 65(8): 794`806, 1989.
426. mŒ´’˜n –k—¢Ž®ƒsƒXƒgƒ“¥ƒxƒ|ƒYŒ^lHS‘Ÿ|‚»‚ÌÝŒv‚ƃCƒk‚Ö‚Ì“K—p|. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OC¼ŽR´ŒhCŽç‰®“llCÎŒ´ºi‹¹ŠOjCX“c^ŽjCù“c’¼i¶‘ÌHj: –k—¢ˆãŠw, 12(3): 206`216, 1982.
427. mŒ´’˜n Ö¬ŒŒŽ_‘f•ªˆ³‚©‚ç‚Ý‚½‰ºŽˆÃ–¬áŽ‚É‚¨‚¯‚铮Ö¬•«‡‚Ì–ðŠ„‚Æ‚±‚ê‚É‹y‚Ú‚·d–ŒŠO–ƒŒ‚̉e‹¿‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ‹à鳉ÀiŠOj: –k—¢ˆãŠw, 20(1): 83`95, 1990.
428. mŒ´’˜n ‚¤‚ÁŒŒ«S•s‘S‚𔺂¤‚ŒŒˆ³Ç‚É‚¨‚¯‚é‹N—§ŽŽŒ±‚ƈÙí‚ÈzŠÂ—ÍŠw“I”½‰ž ¬‹Ê•q‰›C˜Iè‹P•vC”öŒ`’·—YCò–Ø‹|C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(5): 490`500, 1989.
429. mŒ´’˜n –{‘Ô«‚ŒŒˆ³Ç‚Éhydralazine‚ð—p‚¢‚½‚³‚¢‚É‚¨‚¯‚é‘Sg‚ÌzŠÂ“®‘Ô‚ÆtzŠÂ“®‘ÔA‚Æ‚‚ÉRBF‚Æ‚ÌŠÖŒW. ò–Ø‹|CŠpN•vC˜Iè‹P•vC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(6): 551`556, 1989.
430. mŒ´’˜n –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é‘Sg‚ÌzŠÂ“®‘Ô‚ÆtzŠÂ‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä. ò–Ø‹|CŠpN•vC˜Iè‹P•vC¬‹Ê•q‰›C–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(6): 557`564, 1989.
431. mŒ´’˜n ‰EŽº‘¢‰e‚É‚¨‚¯‚é‰ES‹@”\‚Æ‚‚ɉEŽº‹ìo•ª‰æ‚Ì•]‰¿‚¨‚æ‚Ѷ‰ESŽº‚Ì‘ŠŒÝŠÖŒW. ì–ì—´•FC–ì˜C’‰ŽœC–Øì“c—²ˆêi“àj: –k—¢ˆãŠw, l9(6): 565`574, 1989.
432. mŒ´’˜n ‰Æ‘°«‚ƒRƒŒƒXƒeƒ|ƒ‹ŒŒÇƒzƒ‚Ú‡‘̬Ž™‚ÌSŒŒŠÇ•a•Ï. –xŒû‘דTiŽ™jCŽR–{ÍC_’J“N˜Ni‘—§zŠÂŠí•aƒZƒ“ƒ^|j: –k—¢ˆãŠwC19(5): 483`489, 1989.
433. mŒ´’˜n “SŒ‡–R«•nŒŒ‚É‚¨‚¯‚éS‹@”\‚ÌŒŸ“¢. ‚‹´‚Ý‚Ç‚èC˜Iè‹P•vC–Øì“c—²ˆêi“àj: –¬ŠÇŠw, 29(11): 1199`1205, 1989.
434. mŒ´’˜n t“®–¬’¼‰º‚É‚¨‚¯‚é• •”‘å“®–¬ŽÕ’f‚Ìt“àŒŒ—¬•ª•zAt‹@”\‚É‹y‚Ú‚·‰e‹¿‚ÉŠÖ‚·‚錟“¢. ª–{EiŠOj: –¬ŠÇŠw, 29(4): 305`311, 1989.
435. mŒ´’˜n ASO‚ɑ΂·‚錌sÄŒšp‚Ì“K‰žŒˆ’èˆöŽq. ¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmCª–{ECˆ¢‘]OˆêiŠOj: –¬ŠÇŠw, 29(Suppl.): 25, 1989.
436. mŒ´’˜n rHUEPO‚ÌzŠÂ“®‘Ô‰ü‘PŒø‰Ê. ŠÛ–Ε¶ºC‚Œ³r•Fi“Œ‹žˆã‰ÈŽ•‰È‘åjC²“¡´‹Mi“àj: —Õ°“§Í, 5(6): 919`928, 1989.
437. mŒ´’˜n Extra Corporeal Circulation Influence on Plasma Atrial
Natriuretic Peptide Concentration in Cardiac Surgery Patients.
ó—˜G’jC‹ß“¡‡‹`CÎŒ´ºi‹¹ŠOjC‘¼: Chest, 96: 757`760, 1989.
438. m’Z•ñn ƒhƒvƒ‰|ƒJƒe|ƒeƒ‹(DC-101)‚É‚æ‚銥“®–¬ƒoƒCƒpƒXƒOƒ‰ƒtƒg“à‚ÌŒŒ—¬•ªÍ. ”¼’J×YC‰Í‡–õC‹ß“¡‡‹`C¼ŽR´ŒhCÎŒ´ºi‹¹ŠOj: ŠO‰ÈŽ¡—Ã, 60(5): 604`605, 1989.
439. mŒ¤‹†•ñn ‘å“®–¬‰ŠÇŒóŒQ‚ÉŠÖ‚·‚錤‹†•ñGŒz“®–¬ŒŒsÄŒšpŒã”]áŠQ‚ÌŒ´ˆö‚ÉŠÖ‚·‚éŽÀŒ±“IŒŸ“¢. ª–{EiŠOj: _“Þ쌧“Á’莾Š³Ž¡—ÃŒ¤‹†•ñ‘, 1990.
440. mŒ¤‹†•ñi•¶•”Èjn S‹Ø‘¹‚É‚¨‚¯‚鶑̖hŒäŒn‚Ì”½‰ž|S‹Ø[Ç‚Ö‚Ì‘½Œ`Šj”’ŒŒ‹…‚Ì—U“±‚·‚é‘–‰»ˆöŽq‚̘AŠÖ.
ŽŽæMCŒ´“c–FÆCã–ìWŒ›C쑺“¹ŽqC”n“ˆ³—²C¬“c—²Ž¡i–ò—j:
•¶•”ȉȊwŒ¤‹†”ïd“_—̈挤‹†i•½¬Œ³”N“xjS‹Ø×–EáŠQ‚̬ˆö‚Æ–hŒä‚ÉŠÖ‚·‚éŠî‘b“IŒ¤‹†iŒo‰ß•ñj.
441. mŒ¤‹†•ñi‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àjn LTB4‚É‚æ‚鑽Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚ÆS‹Ø[ÇŠg‘å‚É‚¨‚¯‚é–ðŠ„. ŽŽæMi–ò—j: ‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àŒ¤‹†‹ÆÑWCŒŒðÇ‚Ì•a‘Ô‚ÆŽ¡—ÂɊւ·‚鋤“¯Œ¤‹†i‘æ3•ñj, 16: 20`22, 1989.
442. mŒ¤‹†•ñi–k—¢‘åŠw‘‡Œ¤‹†jn S–[«Na—˜”Aƒzƒ‹ƒ‚ƒ“’è—Ê«‚̖ƉuŠw“IŒŸ“¢. ìã³–çi•ª¶j: ‘‡Œ¤‹†•ñ‘¥S–[«Na—˜”Aƒzƒ‹ƒ‚ƒ“‚ÌŠî‘b“IŒ¤‹†‚Æ‚»‚Ì—Õ°“I‰ž—p, p.5`7, 1990.
443. mÇ—á•ñn ’˜‚µ‚¢”x‚¤‚ÁŒŒ‚ð’悵‚½‹}«”xÇðÇ‚Ì2—á. –Øì“c—²ˆêC´…Š®‰xCìŒû’|’jCŠpN•vi“àj: zŠÂ‰ÈŠw, 9(5): 552`558, 1989.
444. mÇ—á•ñn ‚‚à–Œ‰ºoŒŒ‚É‘±”‚µ‚½‹}«”x…Žî‚Ì1—á||S‹@”\áŠQ‚ÌŠÖ—^‚ɂ‚¢‚Ä.
²“¡´‹MC‘“c‘ìC¬—Ñ–¾–FC’r“c‘׎qCV’Ã’J^li“àjC‚–ì½CÄ“¡Œ³—Çi”]ŠOjCŒK”ö’èmi•a—jC‘å˜a“c—²i‹~–½jC–Øì“c—²ˆêi“àj:
–k—¢ˆãŠw, l9(3): 340`345, 1989.
445. mÇ—á•ñn S•s‘S‚𕹔‚µ, ŽOë•Ù•Â½•s‘S‚ð‡•¹‚µ‚½S–[’†ŠuŒ‡‘¹Ç|S–[’†ŠuŒ‡‘¹‚Ì“ÁŽê•Â½–@‚Æ Polydioxanone
‹zŽû«–D‡Ž…‚É‚æ‚éŽOë•Ù—ÖŒ`¬p‚ðŽŽ‚Ý‚½1—cŽ™—á|. ‚ŽRri‹¹ŠOjCŽðˆäÍCŽè’ËŒõ—mC–k‘º¹–çC¬o¹HC‘å‘òŠ²•vi¹—ê•l¼•a‰@j:
—Õ°‹¹•”ŠO‰È, 9(3): 301`304, 1989.
446. mÇ—á•ñn ŒŒŠÇ—Ö‚Æ”x‚ŒŒˆ³‚𔺂¤SŽº’†ŠuŒ‡‘¹Ç‚̈êŠú“IŽèpŽ¡Œ±—á. ‚—²½i‹¹ŠOjC‘å‘òŠ²•vC£”ö˜aGC쇖¾•FC¬o¹Hi¹—ê•l¼•a‰@j: —Õ°‹¹•”ŠO‰È, 9(4): 392`395, 1989.
447. m—Õ°Ž¡Œ±n
–{‘Ô«‚ŒŒˆ³‚ɑ΂·‚éV‚µ‚¢ƒ¿1ƒuƒƒbƒJ[G‰–Ž_ƒuƒiƒ]ƒVƒ“iƒfƒ^ƒ“ƒg[ƒ‹Rj‚Ì—Õ°“IŒŸ“¢||‚Æ‚‚É‚P“ú2‰ñ“Š—^‚Ì~ˆ³Œø‰Ê‚¨‚æ‚шÀ‘S«‚É‹y‚Ú‚·‰e‹¿
||.
‘º¼€C㓈\˜YC씨˜alC’èG•vCˆßìGˆêC•‘ò—˜˜YC²“¡´‹MC‚‹´‚Ý‚Ç‚èC‰“ŽR”ŽC•½¼T‰ECŽO—Ö—SˆêC’†_Œ¹ˆêC¬ã”Ž•¶C”ª“‡—ǘaCŽá—Ñ–õ
‹vC–Øì“c—²ˆêi“àj: Progress in Medicine, 9(7): 2113`2126, 1989.
448. m—Õ°Ž¡Œ±n LC80‚Ì‹•ŒŒ«SŽ¾Š³‚ɑ΂·‚é—Õ°“IŒŸ“¢||‘½Ž{Ý‚É‚¨‚¯‚éƒI[ƒvƒ“ƒgƒ‰ƒCƒAƒ‹||.
‹g—˜˜ai“ú–{Ô\ŽšŽÐˆã—ÃZƒ“ƒ^[jC”Ñ‘ºUiŽD–yˆã‰È‘åjCV’J”Žˆêiº˜a‘åjC‘ –{’zi“Œ‹ž“s˜Vlˆã—ÃZƒ“ƒ^[jC’·“c—m•¶iº˜a‘åjCŽRè¸i•l¼
ˆã‰È‘åjC…–ìNi“¡“cŠw‰€jCŒË“ˆ—T“¿i‹v—¯•Ä‘åjCŽá—щ›iŽD–yzŠÂŠíƒNƒŠƒjƒbƒNjC‰¡ŽR–«iŽD–y‘æˆê•a‰@jCˆÀˆäº“ñiŽRŒ`‘åjC‘º“c˜a•FiŒQ”n
‘åjCדcºˆêiŽ©Ž¡ˆã‰È‘åjCŠÖŽ”üi²–ìŒú¶‘‡•a‰@jC‘ìOˆêi“ú–{ˆã‰È‘åjC”ª”¦_“ñi“ú–{ˆã‰È‘å•t‘®‘½–€‰iŽR•a‰@jC™–{P–¾C–îè‹`—Yi“Œ
‘åjC‰i–ìˆòiŽœŒbˆã‰È‘åjC‘ºŽR³”ŽiŠÖ“Œ’üM•a‰@jC¬oŒjŽOi‘—§‰¤Žq•a‰@jCÎìáÁˆê˜Yi‘—§“Œ‹ž‘æ“ñ•a‰@jC¬‘ò‹»i“Œ‹ž‘Dˆõ•ÛŒ¯•a‰@jCŠÖŒ°
iŒÕ‚Ì–å•a‰@jC‘º¼€i–k—¢‘åE“àjC’zŽR‹vˆê˜Yi_“Þ쌧—§‚ª‚ñƒZƒ“ƒ^[jC—ѳ”ŽiŠÖ“Œ˜JЕa‰@jCŠO”¨ŠÞC¬ìGˆêi–¼ŒÃ‰®‘åjC“n•Ó–±iˆ¤’mˆã
‰È‘åjC“s’z‰ëliˆ¤’mŒ§Ï¶‰ï•a‰@jC“à“¡‰Ã”ViŠ ’J‘‡•a‰@jCŽá¼—Ç—²iŒö—§“©¶•a‰@jC‹g“c—íŒÈi’Ó‡Žs–¯•a‰@jC—é–Ø“¹¶i–L‹´Žs–¯•a‰@jC“n
•Ó‰À•Fi–¼‰w‘Of—Ê•ÛŒ¯ˆã—ÃZƒ“ƒ^[jC…’JŒbŽŸi–¼é•a‰@jC²XŠ°ŒÈi‘åŠ_Žs–¯•a‰@jCˆÉ’n’mà_•vi‹ž“s•{—§ˆã‰È‘åjC“n•ÓrŒõi‹ž“s•{—§—^ŽÓ‚ÌŠC
•a‰@jC—Ž‡³˜ai‹ž“s•{—§—Œ“Œ•a‰@jCŠÖˆê˜Yi‘åãˆã‰È‘åjC—ÑŸi“ú¶•a‰@jCà_“cˆÌ•¶i“ì‘åã•a‰@jCˆäã’Ê•qi‘åã‘åjCŽ™‹Ê˜a‹vi‘åãŒxŽ@•a
‰@jC‰º‘ºŽ˜Ni‘—§zŠÂŠí•aƒZƒ“ƒ^[jCÎŽR‘¾˜Ni‘—§ò–k•a‰@jC•ŸèPi_ŒË‘åjC‰ª–{—ÇŽOi•ºŒÉŒ§—§”Œ´•a‰@jCŒ´‰ªºˆêi‰ªŽR‘åjCŒËŽŸ‹v•q
i‘å–´“cŽs—§•a‰@jC‚ŽRˆê¬i–k‹ãB’†‰›•a‰@jC‹´ê–M•i’·è‘åjC•ÐŽR’m”Vi’·èŽs—§Žs–¯•a‰@j: –ò—‚ÆŽ¡—Ã, 17(4):
1689`1711, 1989.
449. m—Õ°Ž¡Œ±n LC°80‚Ì‹·Sǂɑ΂·‚é—Õ°“IŒŸ“¢||‘½Ž{Ý‚É‚¨‚¯‚éƒI[ƒvƒ“ƒgƒ‰ƒCƒAƒ‹||.
‹g—˜˜ai“ú–{Ô\ŽšŽÐˆã—ÃZƒ“ƒ^[jC”Ñ‘ºUiŽD–yˆã‰È‘åjCV’J”Žˆêiº˜a‘åjC‘ –{’zi“Œ‹ž“sˆã—ÃZƒ“ƒ^[jC’·“c—m•¶iº˜a‘åjCŽRè¸i•l¼ˆã‰È
‘åjC…–ìNi“¡“cŠw‰€jCŒË“ˆ—T“¿i‹v—¯•Ä‘åjCŽá—щ›iŽD–yzŠÂŠíƒNƒŠƒjƒbƒNjC‰¡ŽR–«iŽD–y‘æˆê•a‰@jCˆÀˆäº“ñiŽRŒ`‘åjC‘º“c˜a•FiŒQ”n‘åjC
דcºˆêiŽ©Ž¡ˆã‰È‘åjCŠÖŽ”üi²–ìŒú¶‘‡•a‰@jC‘ìOˆêi“ú–{ˆã‰È‘åjC”ª”¦_“ñi“ú–{ˆã‰È‘å•t‘®‘½–€‰iŽR•a‰@jC™–{P–¾C–îè‹`—Yi“Œ‘åjC
‰i–ìˆòiŽœŒbˆã‰È‘åjC‘ºŽR³”ŽiŠÖ“Œ’üM•a‰@jC¬oŒjŽOi‘—§‰¤Žq•a‰@jCÎìáÁˆê˜Yi‘—§“Œ‹ž‘æ“ñ•a‰@jC¬‘ò‹»i“Œ‹ž‘Dˆõ•ÛŒ¯•a‰@jCŠÖŒ°iŒÕ‚Ì
–å•a‰@jC‘º¼€i–k—¢‘åE“àjC’zŽR‹vˆê˜Yi_“Þ쌧—§‚ª‚ñƒZƒ“ƒ^[jC—ѳ”ŽiŠÖ“Œ˜JЕa‰@jCŠO”¨ŠÞC¬ìGˆêi–¼ŒÃ‰®‘åjC“n•Ó–±iˆ¤’mˆã‰È
‘åjC“s’z‰ëliˆ¤’mŒ§Ï¶‰ï•a‰@jC“à“¡‰Ã”ViŠ ’J‘‡•a‰@jCŽá¼—Ç—²iŒö—§“©¶•a‰@jC‹g“c—íŒÈi’Ó‡Žs–¯•a‰@jC—é–Ø“¹¶i–L‹´Žs–¯•a‰@jC“n•Ó
‰À•Fi–¼‰w‘Of—Ê•ÛŒ¯ˆã—ÃZƒ“ƒ^[jC…’JŒbŽŸi–¼é•a‰@jC²XŠ°ŒÈi‘åŠ_Žs–¯•a‰@jCˆÉ’n’mà_•vi‹ž“s•{—§ˆã‰È‘åjC“n•ÓrŒõi‹ž“s•{—§—^ŽÓ‚ÌŠC•a
‰@jC—Ž‡³˜ai‹ž“s•{—§—Œ“Œ•a‰@jCŠÖˆê˜Yi‘åãˆã‰È‘åjC—ÑŸi“ú¶•a‰@jCà_“cˆÌ•¶i“ì‘åã•a‰@jCˆäã’Ê•qi‘åã‘åjCŽ™‹Ê˜a‹vi‘åãŒxŽ@•a
‰@jC‰º‘ºŽ˜Ni‘—§zŠÂŠí•aƒZƒ“ƒ^[jCÎŽR‘¾˜Ni‘—§ò–k•a‰@jC•ŸèPi_ŒË‘åjC‰ª–{—ÇŽOi•ºŒÉŒ§—§”Œ´•a‰@jCŒ´‰ªºˆêi‰ªŽR‘åjCŒËŽŸ‹v•q
i‘å–´“cŽs—§•a‰@jC‚ŽRˆê¬i–k‹ãB’†‰›•a‰@jC‹´ê–M•i’·è‘åjC•ÐŽR’m”Vi’·èŽs—§Žs–¯•a‰@j: –ò—‚ÆŽ¡—Ã, 17(4):
1713`1730, 1989.
450. m‘àn S•s‘S‚Ì—\–hA¶ŠˆŽw“±‚Ì‚ ‚è‚©‚½. ‘º¼€C‰º—¢Œöºi“àj: Medical Practice, 6(6): 959`963, 1989.
451. m‘àn ‚¤‚ÁŒŒ«S•s‘S‚É‚¨‚¯‚é‰ES•s‘S‚̈Ӌ`. –Øì“c—²ˆêi“àj: Medical Practice, 6(7): 1164, 1989.
452. m‘àn SŽ¾Š³‚ÌŒo‰ß’†‚ɶ‚¸‚éˆÙí‚ȸ_”½‰ž. –Øì“c—²ˆêi“àj: Medical Practice, 6(8): 1362, 1989.
453. m‘àn ‹N—§«‚ŒŒˆ³Ç. –Øì“c—²ˆêi“àj: Medical Practice, 7(1): 131, 1990.
454. m‘àn ’ጌˆ³Ç‚ւ̃Aƒvƒ[ƒ`;@1.’ጌˆ³‚Æ‚Í|‚»‚̉uŠwA¬ˆöA•a‘ÔAf’fAŽ¡—Â̌»ó‚È‚Ç. –Øì“c—²ˆêC•½–콈ê˜YC”öŒ`’·—Yi“àj: Medicament News, (1283): 2`7, 1989.
455. m‘àn S•s‘SŽ¡—Öò‚Ì‘I‘ð. ‘º¼€i“àj: Medicina, 26(9): 1442`1443, 1989.
456. m‘àn zŠÂŠí–ò‚ÌŽg‚¢•û. ‘º¼€i“àjC“yŽtˆê•vi‘—§zŠÂŠí•aƒZƒ“ƒ^[jC”ÑÀG”ViS‘ŸŒŒŠÇŒ¤‹†ŠjCŽRŒû“OiŽOˆä‹L”O•a‰@j: Medicina, 26(9): 1561`1576, 1989.
457. m‘àn •Ù–ŒÇ; Ž¾Š³•ÊƒtƒHƒ[‚Ì‚½‚߂̃`ƒFƒbƒNƒŠƒXƒg‚ÆŠ³ŽÒŽw“±‚̃|ƒCƒ“ƒg. ‘º¼€C‘£’qLi“àj: Modern Physician, 9(5): 596`600, 1989.
458. m‘àn ’ጌˆ³. –Øì“c—²ˆêC–ì˜C’‰ŽœC•½–콈ê˜Yi“àj: Modern Physician, 9(5): 619`622, 1989.
459. m‘àn ‚ŒŒˆ³«SŽ¾Š³. –Øì“c—²ˆêC˜Iè‹P•vi“àj: Œ»‘ãˆã—Ã, 21(7): 1915`1920, 1989.
460. m‘àn Š´õ«ánæÒ. ‘º¼€C’·’J쉄LC’r“c‘׎qC¬‚L]i“àj: Œ»‘ãˆã—Ã, 21: 1856`1861, 1989.
461. m‘àn •sˆÀ’è‹·SÇ. ‘º¼€C¬—Ñ–¾–Fi“àj: Ž¡—Ã, 71(12): 2501`2508, 1989.
462. m‘àn –{‘Ô«‚ŒŒˆ³‚É‚¨‚¯‚錌s“®‘Ô‚Æ~ˆ³–ò‚Ì‘I‘ð. ‘º¼€i“àj: Ž¡—Êw, 22(6): 598, 1989.
463. m‘àn S‹Ø‰ŠAS“à–Œ‰ŠAS–Œ‰Š. ‘º¼€i“àj: ‘Ž‡—Õ°, 38(‘): 1197`1201, 1989.
464. m‘àn ‹}«S•s‘Si“ÁW:S‘Ÿ”ì‚Ì—\–hj. ‘º¼€i“àj: —Õ°¬l•a, 20(1): 55`59, 1990.
465. muÀn “úŒoƒƒfƒBƒNƒCƒYi67Η«A‘O‹¹’É¥”w’Éj. ‘º¼€i“àj: Nikkei Medical, (1989.10.25): 1989.
466. muÀn ‘æˆêü‚̬Ž™zŠÂŠíŠwA‡U.f’fGSƒv[ƒ‹¥S‹ØƒXƒLƒƒƒ“. Έ䟌Èi•új: ¬Ž™‰Èf—Ã, 52(4): 700`710, 1989.
467. mŠwp‘n iŽ·•Mj Blood Flow in the Heart and Large Vessels; Application
of Pressure-loss Coefficient, p.105`118, Aortic Stenosis|Blood Flow in
the Aorta Measured with a Multisensor Catheter, p.119`123, Aortic
Regurgitation| Measurement with a Multisensor Catheter, p.133`138,
Pulmonary Regurgitation, p.138`142, The Multisensor Catheter,
p.189`195, ”¼’J×Yi‹¹ŠOj. •ÒW Motoaki Sugawarai“Œ—ˆã‘åjCFumihiko
Kajiyaiìèˆã‘åjCAkira Kitabatakeiã‘åjCHirohide Matsuoiìˆã‘åj•ÒC
Springer-Verlag, 90.06.00”s.
468. mŠwp‘n iŽ·•Mj Annual ReviewCzŠÂŠí 1990; V¶Ž™Šú‚Ì“®–¬ŠÇC •½Î‘iŽ™j. •ÒW ™–{P–¾C¼–{º•FC™‰º–õ˜YC–åŠÔ˜a•vC•ÒC ’†ŠOˆãŠwŽÐC90.01.10.”s.
469. mŠwp‘n iŽ·•Mj –ƒŒ¥W’†Ž¡—ÂƃRƒ“ƒsƒ…|ƒ^; ‘̉t¥Ž_‰–Šî•½t‚̃Rƒ“ƒsƒ…|ƒ^ƒ‚ƒfƒ‹Cp.1`16C ’r“cŒ›ºiˆã—pî•ñj. •ÒW “c’†—ºi–ƒj•ÒC Ž½“°o”Å, “Œ‹ž, 89.07.20”s.
470. mŠwp‘n iŽ·•Mj ŒðŠ´_Œo—}§–ò‚Æ‚ŒŒˆ³ƒnƒ“ƒhƒuƒbƒN; ŒŒs“®‘Ô‚Æ~ˆ³–ò, p.41`52, ˜Iè‹P•vi“àj. •ÒW ‘•{’B˜Yiˆ¤•Q‘åj•Ò, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ, ‘åã, 89.07.31 ”s.
471. mŠwp‘n iŽ·•Mj Advances in Vascular Pathology 1989 Excepta Medica,
International Congress Series 868; Change in Damping Factor of
Windkessel System and Cardiovascular Dynamics by Aging in Essential
Hypertension, p.913`917, ‘º¼€C’·’J쉄LC¬—Ñ–¾–FC’ËŒ´Œª”VC•½¼T‰EC•‘ò—˜˜YC–Øì“c—²ˆêi“àj. •ÒW
Strano, A.CNovo, S.•Ò, Elsevier Science Publisher, B.V., Excerpta
Medica, International Congress Series, 89.09.17 ”s.
472. mŠwp‘n iŽ·•Mj VŽå—v’¥Œó‚©‚ç‚Ý‚½ŒŸ¸‚Ìi‚ß•û; zŠÂŠíŒn’¥Œó|’ጌˆ³, p.58`63, –Øì“c—²ˆêC–ì˜C’‰ŽœC•½–콈ê˜Yi“àj. •ÒW ¼“cdŽOi’é‹ž‘åj•Ò, V‹»ˆãŠwo”Å, “Œ‹ž, 90.01.10 ”s.
473. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; ƒ`ƒAƒm[ƒ[, 3Šª: p.58`60, ˜Iè‹P•vi“àj. •ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj•Ò, u’kŽÐ, “Œ‹žC89.11.20 ”s.
474. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; ŒÄ‹z¢“ï, 3Šª: p.61`63, ˜Iè‹P•vC¬‚L]i“àj. •ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj, u’kŽÐ, “Œ‹žC89.11.20 ”s.
475. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; –¬”ˆÙí, 3Šª: p.68`69, ˆÓŽ¯áŠQ, p.70`71, ‘º¼€i“àj.
•ÒW ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj•Ò, u’kŽÐ, “Œ‹žC89.11.20 ”s.
476. mŠwp‘n iŽ·•Mj zŠÂŠí‰Èf’fŽ¡—ÑåŒn; –{‘Ô«’ጌˆ³Ç, 2Šª: p.106`107;
‹N—§«’ጌˆ³ÇCp.108`109,@’˜ŽÒiŠ‘®j–Øì“c—²ˆêi“àj. •ÒW
ŠŒ´’·—Yi“ú‘åjCˆîŠ_‹`–¾iç—t‘åjC™–{P–¾i“Œ‘åjC“¡“‡³•qi‹ã‘åj•Ò, u’kŽÐ, “Œ‹žC89.11.20 ”s.
477. mŠwp‘n iŽ·•Mj ’ጌˆ³Ç‚Ìf’f‚ÆŽ¡—Ã; ’ጌˆ³Ç‚Æ‚»‚Ì–â‘è“_, p.12`37,@ –Øì“c—²ˆêi“àj. ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“ŽÐ, “Œ‹žC90.02.28”s.
478. mŠwp‘n iŽ·•Mj ’ጌˆ³Ç‚Ìf’f‚ÆŽ¡—Ã; ŒŒs—ÍŠw“IˆöŽq‚©‚ç‚Ý‚½’ጌˆ³Ç, p.38`47,@ –ì˜C’‰Žœi“àj. ƒƒfƒBƒJƒ‹ƒgƒŠƒrƒ…[ƒ“ŽÐ, “Œ‹žC90.02.28”s.
479. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium
Series Vol. 3); Molecular Forms of Immunoreactive ANP in Human Plasma
and Urine, p.223`225, ˆÀ“¡Œ¤ŽiCKihira,
K.i–k—¢ƒ‰ƒ{jC‰Á“¡—zˆêi“àjC‘“c‘ìi‹~–½jC•‘ò—˜˜Yi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò,
Raven Press, New York, 89.00.00”s.
480. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium
Series Vol. 3); Plasma Atrial Natriuretic Peptide Level and Molecular
Forms in Dogs with Acute Heart Failure Induced by Experimenatal Aortic
Regurgitation, p.445`447, ‘“c‘ìi‹~–½jC²“¡´‹Mi“àjC^è‹`•FiŽÀ“®ŒnjCAndo,
K.i–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò, Raven Press, New York,
89.00.00”s.
481. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium
Series Vol. 3); Plasma Atrial Natriuretic Peptide Level and Molecular
Forms in Dogs with Acute Heart Failure Produced by Experimenatal Mitral
Regargitation, p.447`449, ²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC^è‹`•FiŽÀ“®ŒnjCAndo,
K.i–k—¢ƒ‰ƒ{jC’·’J쉄LC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M. Brenner•Ò, Raven
Press, New York, 89.00.00”s.
482. mŠwp‘n iŽ·•Mj Progress in Atrial Peptide Research (ASH Symposium
Series Vol. 3); Change of Molecular Forms of Atrial Natriuretic Peptide
in Treated Congestive Heart Failure, p.501`503,@
•‘ò—˜˜YC’|“c’è¶C’·’J쉄Li“àjCAndo, K.i–k—¢ƒ‰ƒ{jC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj. •ÒW Barry M.
Brenner•Ò, Raven Press, New York, 89.00.00”s.
483. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽ¡—âS‘Ÿ¥ŒŒŠÇ‚Ì‹~‹}£; ŒŒˆ³ˆÙí, p.115`132, –Øì“c—²ˆêC˜Iè‹P•vi“àj. •ÒW ðSˆêi“Œ—ˆã‘åj, ‰iˆä‘“X, “Œ‹ž, 88.04.15”s.
484. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽY•wl‰ÈŽ¡—ÃŽwj; ƒmƒ“ƒXƒgƒŒƒXƒeƒXƒg (NST), p.251`252, ¼“‡³”ŽiŽY•wj. •ÒW ¬–쳕Fi“Œ‘åjC•“c‰À•Fi“Œ—ˆã‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.06.01 ”s.
485. mŠwp‘n iŽ·•Mj VŠO‰ÈŠw‘åŒnA‘æ13Šªi‹~‹}ŠO‰Èj; ––½ŒŒŠÇŠO‰È—̈æ, 13: 271`283, ª–{EiŠOj. •ÒW oŒŽN•vi“Œ‘åjC‘¼•ÒC ’†ŽR‘“X, “Œ‹ž, 89.12.28”s.
486. m‹³‰È‘n iŽ·•Mj V—Õ°ŠO‰ÈŠw; ¬Ž™ŠO‰ÈA• •Ç|‘lŒaƒwƒ‹ƒjƒAA’â—¯áΊÛAÒ‘‘–ŒáŽAPilonidal
SinusAŒ‹‡‘ÌAŽvtŠú‘O•Ð‘¤«“û‘B”ì‘å, p.790`798, Γc˜a•viŠOj. •ÒW X‰ª‹±•Fi“Œ‘åjC‘¼•ÒC ˆãŠw‘‰@, “Œ‹ž,
90.02.00”s.
487. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ƒTƒNƒZƒX¥ˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ¬—Ñ–¾–Fi“àj. •ÒW ²“¡“oŽu˜Yi–k—¢‘åj•ÒC “ú–{ˆãŽ–V•ñŽÐ,@“Œ‹ž,@89.11.15 ”s.
488. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1990; æ“V«SŽ¾Š³, p.322`324, ‘º¼€i“àj. •ÒW ˆîŠ_‹`–¾iç—t‘åj‘¼•Ò, ˆãŠw‘‰@,@“Œ‹ž,@90.02.15 ”s.
489. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj }‚Å‚Ý‚ézŠÂ“®‘Ô; ‘̈ÊC‰^“®‚Ì‚à‚½‚ç‚·zŠÂ“®‘Ô, p.26`29, ‘º¼€i“àj. ƒƒWƒJƒ‹ƒrƒ…[ŽÐ,@“Œ‹ž,@90.03.20 ”s.
490. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŠÄCj V‰SŽÒ‚Ì‚½‚ß‚ÌS“d}‚Ì‚æ‚Ý‚©‚½; ‘º¼€C’·’J쉄Li“àj. V‹»ˆãŠwo”Å,@“Œ‹ž,@89.10.20 ”s.
491. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj S“d}ƒ}ƒjƒ…ƒAƒ‹; S“d}”gŒ`‚©‚ç‚Ìf’f, p.42`80, ‘º¼€C’ËŒ´Œª”VCˆÀ’B¥ºi“àj. •ÒW ‘ìOˆêi“úˆã‘åj•Ò, Æ—ÑŽÐ,@“Œ‹ž,@89.12.20 ”s.
492. m–|–ón iŽ·•Mj zŠÂ‚̶—; p.1`362,
‘º¼€C–ÎÝȈêC‰Á“¡—zˆêCX‹vPC‚’¹°sC㓈\˜YC’·’J쉄LCdL¢‹IŽqC•ìMŒåC¬—Ñ–¾–FC–î’[K•vC씨˜alC‹g“càˆi“àj. ŠÄC
‘º¼€i–k—¢‘åE“àj, ˆãŠw‘‰@,“Œ‹ž, 89.04.01 ”s.
493. mŠw‰ïn i“Á•Êu‰‰j S‘Ÿ“Ë‘RŽ€‚Æ‘Îô. ‘º¼€i“àj: ‘æ31‰ñ_“Þ쌧ˆãŠw‰ï‘‰ïŠwp‘å‰ï (89.11.23), ‰¡•l.
494. mŠw‰ïn i‹³ˆçu‰‰j S””‚Ì’²ß. ¼“‡³”ŽiŽY•wj: ‘æ25‰ñV¶Ž™Šw‰ï (89.07.02), “Œ‹ž.
495. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j SŽ¾Š³‚ðl‚¦‚é; ‹~–½‹~‹}‚Ì—§ê‚Å. ¬—Ñ–¾–Fi“àj: ‘æ5‰ñ_“Þì•úŽËüŠwp‘å‰ï (89.06.11), ‰¡•l.
496. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Fluid Dynamical Mechanism of Anacrotic Notch in
Great Arteries. ‹ß“¡‡‹`C”¼’J×YCÎŒ´ºi‹¹ŠOjC‘¼: 2nd International Symposium on
Biofluid Mechanics and Biorheology (89.06.27), Munich.
497. mŠw‰ïn iƒVƒ“ƒzƒWƒEƒ€j Transitional circulation in newborn infant. •½Î‘iŽ™j:
‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5: 39, l989.
498. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j dǃNƒ‚–Œ‰ºoŒŒ‚É•¹”‚·‚éSzŠÂ‡•¹Ç‚Ì‹}«ŠúŠÇ—‚Ìd—v«. ¬—Ñ–¾–Fi“àjC–kŒ´F—YC‰““¡¹FC‘å˜a“c—²i‹~–½j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.
499. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j DOCA°H‰–‚ŒŒˆ³ƒ‰ƒbƒg‚̉ŠúŒŒˆ³‘‰Á‚ɑ΂·‚é“àˆö«ƒJƒŠƒNƒŒƒCƒ“°ƒLƒjƒ“Œn‚ÌŠÖ—^.
”n“ˆ³—²i–ò—jC‰Ô’ËŒõ’jCaãiCŽŽæMi–ò—jC‘åÎKŽqi–òŠw•”j: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC
Jpn. J. Pharmacol., 52(suppl.): 138, 1990.
500. mŠw‰ïn iƒpƒlƒ‹j
’PSŽºC¶‘¤–[Žº•Ù•Â½C“®–¬ŠÇŠJ‘¶C—LˆÓ‚ÈS–[ŠÔŒð’Ê‚ð”F‚ß‚È‚¢•¡‡SŠïŒ`2Ç—á‚ÌSŒŒs“®‘Ô‚Ì•]‰¿‚É‚¨‚¯‚éƒhƒvƒ‰SƒGƒR|–@‚̈Ӌ`.
‰Í‘º½ŽŸC•½Î‘C–xŒû‘דTC“¡–ìé”VC¬ŒûO‹BCˆäŒ…^—R”üC”ª‘ãŒö•viŽ™jC’†]¢–¾C¡ˆäŠ°C“c’†Ž•FC•x‰i½ˆêi‹¹ŠOj:
‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.06), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 94, l989.
501. mŠw‰ïn iƒpƒlƒ‹j Pulmonary Edema Following Subarachnoid
Hemorrhage|Evidence for a Cardiogenic Factor|.
¬—Ñ–¾–FC’r“c‘׎qC‰¬Œ´“ÄC–Øì“c—²ˆêi“àjC™–{Ÿ•FC–kŒ´F—YC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: 5th World Congress
on Intensive and Critical Care Medicine (89.09.07), ‹ž“s, WCICCM
Abstracts, p.269, 1989.
502. mŠw‰ïn iƒpƒlƒ‹j Change of Molecular Form of Atrial Natriuretic Peptide
(ANP). •‘ò—˜˜YC’·’J쉄LC’|“c’è¶C•½¼T‰EC²“¡´‹MC‘º¼€C–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: 15th World
CongressCInternational Union of Angiology (89.09.17), ƒ[ƒ}, Abstracts,
p.256, 1989.
503. mŠw‰ïn iƒpƒlƒ‹j Vasodilator Therapy for Right Ventricular Failure of
Acute Myocardial Infarction. •½¼T‰EC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: 15th World
CongressCInternational Union of Angiology (89.09.17), ƒ[ƒ}, Abstracts,
p.287, 1989.
504. mŠw‰ïn iƒpƒlƒ‹j “™—e«SŽûkŠú‚É‚¨‚¯‚é‘m–X•Ù‹t—¬‚Ìf’fŠw“I“ÁˆÙ«‚ɂ‚¢‚Ä.
’ËŒ´Œª”VC‘º¼€C‘£’qLC™ŽRŠx•FC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.10.30), ‹ž“s,
‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.57, 1989.
505. mŠw‰ïn iƒpƒlƒ‹j ‰EŽº[Ç‚ÉŠÖ‚·‚é•a—Šw“IŒ¤‹†. ŒK”ö’èmi•a—jC²“¡giŒ`‘ÔŒnjC‹T’J“Oi•a—jCV’Ã’J^li“àj: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.29), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 360, 1990.
506. mŠw‰ïn iˆê”Êu‰‰j 4‰ñ‚ÌlH•Ù’uŠ·p‚ðs‚Á‚½1Ç—áD ‚—²½C•—ŠÔ”ÉC¼ŒûŽ•FC‰€“c˜a•FC“‡“cŒúCÎŒ´ºCi‹¹ŠOj: ‘æ70‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ïC “Œ‹ž.
507. mŠw‰ïn iˆê”Êu‰‰j A Study on Flow Control in a Piston-Bellows Type of
Artificial Heart Pump. ‹´–{¬Li¶‘ÌHjCù“c’¼i“ŒH‘åjC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOj: 27th
Annual Meeting of the American Society for Artificial Internal Organs
(81.05.06`08), AnaheimC Abstracts, 10: 5, 1981.
508. mŠw‰ïn iˆê”Êu‰‰j Œ¢‚É‚¨‚¯‚élHS‘Ÿ‚Ì—¬—Ê”gŒ`‚Æ—¬—ʧŒä.
ˆÉ“¡’‰Oi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘CX“c^Žji¶‘ÌHjC¡•ª–ÎCÎŒ´ºi‹¹ŠOjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: ‘æ19‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï
(81.11.18), ‹à‘ò, —\eW, p.159, 1981.
509. mŠw‰ïn iˆê”Êu‰‰j ƒsƒXƒgƒ“¥ƒxƒ|ƒYŒ^lHS‘Ÿ‚Ì—¬—Ê”gŒ`.
‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰Oi‹¹ŠOjCX“c^Žji¶‘ÌHjC¡•ª–ÎCÎŒ´ºi‹¹ŠOjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj:
‘æ19‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (81.11.18), ‹à‘òC —\eW, p.160, 1981.
510. mŠw‰ïn iˆê”Êu‰‰j Practical Application of the Welded Metal Bellows to a
Pulsatile Pump. ‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjCù“c’¼i“ŒH‘åj: 28th Meeting of
the American Society for Artificial Internal Organs (82.04.14`15),
ChicagoC Abstracts, 11: 4, 1982.
511. mŠw‰ïn iˆê”Êu‰‰j ‘ÏŒŒŠÇ•ÇCollapse«‚ðl—¶‚µ‚½”“®—¬ƒ|ƒ“ƒv‚ÌÖ¬ƒJƒjƒ…|ƒŒ“üŒûŒ`ó.
‹´–{¬Li¶‘ÌHjCˆÉ“¡’‰OCŽç‰®“llC–ö‘òG–¾CÎŒ´ºi‹¹ŠOjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj:
‘æ20‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (82.09.14), “Œ‹žC —\eW, p.100, 1982.
512. mŠw‰ïn iˆê”Êu‰‰j A Newly Designed Cannula Entrance in Pulsatile
Pump|With Special Consideration about Venous Wall Collapse.
‹´–{¬Li¶‘ÌHjCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjCˆÀ‹vˆäLÍCù“c’¼i“ŒH‘åj: 29th Annual Meeting of the
American Society for Artificial Internal Organs (83.04.28`30), Toronto,
Abstracts, 12: 5, 1983.
513. mŠw‰ïn iˆê”Êu‰‰j ‰ESƒoƒCƒpƒXŽž‚Ì—¬—Ê”gŒ`‚Ì”x‚ւ̉e‹¿.
Žç‰®“llCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘Ci¶‘ÌHjCù“c’¼C‘O“c_‹`i“ŒH‘åj: ‘æ21‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï
(83.09.14), ŽD–y, —\eW, p.26, 1983.
514. mŠw‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚ÌŒŒðŒ`¬‚ɑ΂·‚邹‚ñ’f‘¬“x‚̉e‹¿.
‹´–{¬Li¶‘ÌHjCŽç‰®“llCÎŒ´ºi‹¹ŠOjCù“c’¼i“ŒH‘åj: ‘æ36‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ï‘‰ï (83.11.12), ‹ž“sC
“ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 31(—Õ‘): 1852, 1983.
515. mŠw‰ïn iˆê”Êu‰‰j The Effect of Right Ventricular Bypass on the
Intrapulmonary shunt: A Comparison of Pulsetile and Nonpulsatile Flows.
‹´–{¬Li¶‘ÌHjCŽç‰®“llCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC•½ˆä–@”Ži“àjC‘O“c_‹`Cù“c’¼i“ŒH‘åj: 4th
Congress of the International Society for Artificial Organs (83.11.16),
‹ž“sC Artificial Oragans, 7(Abstracts): 7, 1983.
516. mŠw‰ïn iˆê”Êu‰‰j ‰“Sƒ|ƒ“ƒv‚É‚¨‚¯‚é—nŒŒ.
‹´–{¬Li¶‘ÌHjCó—˜G’jC¼ŽR“¿‘åCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC•½ˆä–@”Ži“àjC•ŽR½Ž÷C™‰Y—f‰îCù“c’¼i“ŒH
‘åj: ‘æ22‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (84.11.09), ‘åãC —\eW, p.36, 1984.
517. mŠw‰ïn iˆê”Êu‰‰j Plasma Atrial Natriuretic Peptide (ANP) Level and
Molecular Forms in Canines with Heart Failure Induced by Experimental
Aortic Regurgitation (AR).
‘“c‘ìi‹~–½jC²“¡´—²i“àjC^è‹`•FiŽÀ“®ŒnjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: 3rd American
Society of Hypertension (88.00.00), New York, Am. J. Hypertension,
1(3): 131`132, 1988.
518. mŠw‰ïn iˆê”Êu‰‰j ‰Â‹t“I‘å“®–¬•Ù‹t—¬‚É‚¨‚¯‚錌’†ANP“®‘Ô‚Æ‘¶Ý—lŽ®. ‘“c‘ìi‹~–½jC²“¡´‹Mi“àjC^è‹`•FiŽÀ“®ŒnjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ65‰ñ“ú–{¶—Šw‰ï‘å‰ï (88.04.04), ˜a‰ÌŽR.
519. mŠw‰ïn iˆê”Êu‰‰j CARDIOLOGIST; A CAI System for Heart Failure Based on
Simulation of Cardiovascular System. ’ß“c—z˜aC’|“ດŽC’r“cŒ›ºiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j:
6th World Congress of Medical Informatics (89.02.11), Singapore.
520. mŠw‰ïn iˆê”Êu‰‰j –«t•s‘S‚Ì‚ŒŒˆ³‡•¹—á‚Æ”ñ‡•¹—á‚É‚¨‚¯‚铧͑OŒã‚Ì“™ŽÚ«•‰‰×‚É‚æ‚锽‰ž«‚Ì·ˆÙ‚ɂ‚¢‚Ä.
”ª“‡—ǘaC’ËŒ´Œª”VC‘£’qLC–ÎÝȈêC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ86‰ñ“ú–{“à‰ÈŠw‰ï (89.04.01), ‹ž“s, “ú–{“à‰ÈŠw‰ïŽGŽ,
78(2): 232, 1989.
521. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíSŽ¾Š³‚ÆS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚ÌŠÖŒW‚ɂ‚¢‚Ä.
’·’J쉄LC•‘ò—˜˜YC²“¡´‹MC™ŽRŠx•FC‘º¼€C–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ86‰ñ“ú–{“à‰ÈŠw‰ï (89.04.02),
‹ž“s, “ú–{“à‰ÈŠw‰ïŽGŽ, 78(2): 263, 1989.
522. mŠw‰ïn iˆê”Êu‰‰j The Role of Specific Granules in Ventricles on Atrial
Natriuretic Peptide (ANP) Secretion in Acute Heart Failure.
²“¡´‹Mi“àjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄LC˜Iè‹P•vi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC–Øì“c—²ˆêi“àj: 3rd
International Conference on Diuretics (89.04.04), Mexico, —\eW,
p.615`617, 1989.
523. mŠw‰ïn iˆê”Êu‰‰j RISƒv[ƒ‹ƒf[ƒ^‚̈ʑŠ‰ðÍ‚É‚æ‚éŠO«S‹ØÁ‚ÌŒŸ“¢.
¼Šª”ŽC’r“crºC“cŠŽŒÈC–x’rdŽ¡C’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•újC¬—Ñ–¾–Fi“àj: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05),
_ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): 595, l989.
524. mŠw‰ïn iˆê”Êu‰‰j Beta-atrial Natriuretic Polypeptide (Beta-ANP) Like
Immunoreactivity in Canine Plasma.
²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC^è‹`•FiŽÀ“®ŒnjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄LC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj:
‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): s218, 1989.
525. mŠw‰ïn iˆê”Êu‰‰j Hemodynamic Alteration by Recombinant Human
Erythropoietin Administration in Hemodialyzed Patient with Normal
Cardiac Function. ‚Œ³r•FCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC²“¡´‹Mi“àjC‘“c‘ìi‹~–½j: 4th American
Society of Hypertension (89.05.10), New York, Am. J. Hypertension,
2(5): 79A, 1989.
526. mŠw‰ïn iˆê”Êu‰‰j Beta-human Atrial Natriuretic Peptide (ANP) in
Congestive Heart Failure (CHP). ˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC²“¡´‹Mi“àjCMasayoshi
ShichiriCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: 4th American Society of Hypertension
(89.05.11), New York, Am. J. Hyopertension, 2(5): 98A, 1989.
527. mŠw‰ïn iˆê”Êu‰‰j The Role of Specific Granules in Ventriculus on Atrial
Natriuretic Peptide (ANP) Secretion in Acute Heart Failure.
²“¡´‹Mi“àjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’·’J쉄Li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC–Øì“c—²ˆêi“àj: 4th
American Society of Hypertension (89.05.11), New York, Am. J.
Hypertension, 2(5): 79A, 1989.
528. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g’f‘w–@‚É‚æ‚éŽíX‚Ìæ“V«SŽ¾Š³‚ɇ•¹‚·‚é“®–¬ŠÇ‚Ì•`o–@|’f–ʂ̊»‚Æ‚»‚̑Ó–«|.
•½Î‘C–xŒû‘דTC“¡–ìé”VCãp—z‘¾˜YCÄ“¡KˆêC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC
“ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 534Cl989.
529. mŠw‰ïn iˆê”Êu‰‰j ŽhŒƒ“`“±˜H‚Ì•Ï’²‚ÉŠî‚–[ŽºƒuƒƒbƒN‚Ì”Šwƒ‚ƒfƒ‹.
’r“cŒ›ºC’ß“c—z˜aC‹{Œ´‰p•vC’|“ດŽiˆã—pî•ñjC—ŠZF“ñi“àjC”’‘é‘’jiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï
(89.05.24), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 334, 1989.
530. mŠw‰ïn iˆê”Êu‰‰j ‰Â‹t“I‘å“®–¬•Ù‹t—¬‚ÌANP•ª”å‚É‚¨‚¯‚éSŽº‚ÌŠÖ—^.
²“¡´‹MC¬‚L]C•‘ò—˜˜YC’·’J쉄LC–Øì“c—²ˆêi“àjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj:
‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.01), “Œ‹žC “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 254, 1989.
531. mŠw‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×‚É‚¨‚¯‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚ÌŒŒ’†“®‘Ô.
¬‚L]C²“¡´‹MC•‘ò—˜˜YCˆ¢•”éC’|“c’è¶C•ìMŒåC’·’J쉄LC–Øì“c—²ˆêi“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj:
‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.01), “Œ‹žC “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 255, 1989.
532. mŠw‰ïn iˆê”Êu‰‰j –UŒŸS‚É‚¨‚¯‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚Ì‹ÇÝ‚Æ•Ï“®.
V’Ã’J^li“àjCŒK”ö’èmC‹T’J“Oi•a—jC‘“c‘ìi‹~–½jC’J²]Žqi“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï
(89.06.03), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 411, 1989.
533. mŠw‰ïn iˆê”Êu‰‰j S‘Ÿ•Ù–ŒÇ‚¨‚æ‚ÑŠg’£Œ^S‹ØÇ‚ÌTreadmill‰^“®ŽŽŒ±‚ɑ΂·‚éST’ቺ‚Ì‹•ŒŒ«SŽ¾Š³‚Æ‚Ì·ˆÙ.
–kŠp”Ž“¹C´…Š®‰xCìŒû’|’jCVȈê•vC‰Í–쓹¢Cì–ì—´•FC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ132‰ñ“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï
(89.06.04), ‰¡•l.
534. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[ǂɇ•¹‚µ‚½¶ŽºŽ©—R•Ç”j—ô‚ÌŒŸ“¢.
Îì’¼Ž÷C¬—Ñ–¾–FC‰¬Œ´“ÄC¬‚L]C‰º—¢ŒöºCV’Ã’J^lC’r“c‘׎qC–Øì“c—²ˆêi“àjC¼ŽR´Œhi‹¹ŠOjCŒK”ö’èmi•a—j:
‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.08), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 125, 1989.
535. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[ǂɇ•¹‚µ‚½SŽº’†ŠuúE‚ÌŒŸ“¢.
‰¬Œ´“ÄC¬—Ñ–¾–FCÎì’¼Ž÷C‰º—¢ŒöºC¬‚L]C’r“c‘׎qCV’Ã’J^lC–Øì“c—²ˆêi“àjC¼ŽR´Œhi‹¹ŠOjCŒK”ö’èmi•a—j:
‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.08), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 81, 1989.
536. mŠw‰ïn iˆê”Êu‰‰j FontanŒ^ŽèppŒã‚Ì”x“®–¬‹t—¬(PR)‚Ì•ªÍ. ‰Í‡–õCéŠÔŒ«“ñC{–K‘ i“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.08), ŽD–y, ´˜^W, p.98, 1989.
537. mŠw‰ïn iˆê”Êu‰‰j Vitamin E ‚ÌS‹Ø•ÛŒìŒø‰Ê‚ÌŒŸ“¢.
•—ŠÔ”ÉC¼ŽR´ŒhC“ü‘ò²mC¼ŒûŽ•FC‚ŽRrCˆ¢•””\–¾C’¬“c³lC‹ß“¡‡‹`C‚—²½CÎŒ´ºi‹¹ŠOj: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï
(89.06.08), ŽD–y, “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 19(3): 536`538, 1989.
538. mŠw‰ïn iˆê”Êu‰‰j ‘å“®–¬•Ù’uŠ·Ç—á‚É‚¨‚¯‚銥“®–¬ŒŒ—¬•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.08), ŽD–y, “ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŽGŽ, 19(4): 765`767, 1989.
539. mŠw‰ïn iˆê”Êu‰‰j ‚‚à–Œ‰ºoŒŒ‹}«Šú‚É‚¨‚¯‚éSzŠÂ“®‘Ô‚Æ_ŒoŒ´«”x…Žî‚ÌŒŸ“¢.
²“¡´‹MC¬—Ñ–¾–FC¬‚L]C’r“c‘׎qC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àjC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï
(89.06.09), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 243, 1989.
540. mŠw‰ïn iˆê”Êu‰‰j dÇ‚ŒŒˆ³‚É‚¨‚¯‚éƒJƒvƒgƒvƒŠƒ‹––㉺“Š—^‚É‚æ‚錌s—ÍŠw“I•Ï‰»‚Æ—Õ°“I—L—p«‚ɂ‚¢‚Ä.
‘£’qLC’ËŒ´Œª”VC¬ã”Ž•¶C”ª“‡—ǘaCŽá—Ñ–õ‹vCˆÀ’B¥ºC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.09),
ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 248, 1989.
541. mŠw‰ïn iˆê”Êu‰‰j ƒhƒbƒvƒ‰ƒJƒe|ƒeƒ‹‚É‚æ‚銥“®–¬ƒoƒCƒpƒXƒOƒ‰ƒtƒg“àŒŒ—¬•ªÍ|“Á‚ÉSVG‚ÆIMAG‚Æ‚Ì”äŠrŒŸ“¢|.
Žç‰®“llCˆ¢•”–«—Yi–¼ŒÃ‰®‘åjC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ19‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ïŠwpW‰ï (89.06.09), ŽD–y, ´˜^W,
p.230, 1989.
542. mŠw‰ïn iˆê”Êu‰‰j “ñ‘w‚Ì‹Uo‚𶂶‚½‰ð—£«‘å“®–¬áŽ‚Ì1—á. Žl‹{—R”üŽqCÎì’¼Ž÷C’r“c‘׎qCìŒû’|’jC’·’J쉄LCV’Ã’J^lC‘º¼€C–Øì“c—²ˆêi“àjCŒK”ö’èmi•a—j: ‘æ383‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.06.10), “Œ‹ž.
543. mŠw‰ïn iˆê”Êu‰‰j Œü¸_–ò‚ÌSzŠÂŒn‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä.
Ί_“¿]i“àjC’ç–M•FC“c’†•üŽqC™ŽRŒ’–çCŠp“c’厡C™ŽRˆêCŽO‰Y’å‘¥i¸jC¬—Ñ–¾–FCL£—²ˆêC“¡–ìé”VC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j:
‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï (89.06.10), ˆ®ì, ICU‚ÆCCU, 13(—Õ‘): 276, 1989.
544. mŠw‰ïn iˆê”Êu‰‰j S‘Ÿ•Ù–ŒÇ‚¨‚æ‚ÑŠg’£Œ^S‹ØÇ‚ÌTreadmill‰^“®ŽŽŒ±‚ɑ΂·‚éST’ቺ‚Ì‹•ŒŒ«SŽ¾Š³‚Æ‚Ì·ˆÙ.
–kŠp”Ž“¹C´…Š®‰xCìŒû’|’jCVȈê•vC‰Í–쓹¢Cì–ì—´•FC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àj:
“ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ132‰ñ—á‰ï (89.06.17), _“Þì.
545. mŠw‰ïn iˆê”Êu‰‰j Fontani‰E–[°”x“®–¬’¼Ú•«‡jpŒã”x“®–¬“àŒŒ—¬•ªÍ.
‰Í‡–õC—ÑF“ñCéŠÔŒ«“ñC{–K‘ i“Œ—ˆã‘åjC”¼’J×Yi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.06), ‹v—¯•Ä,
“ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 65, 1989.
546. mŠw‰ïn iˆê”Êu‰‰j
¶Œã6ƒJŒŽˆÈ“à‚ɉ‰ñ‚ÌŒo”ç“Iƒoƒ‹|ƒ“‚É‚æ‚é‹·ó‚ÌŠg‘åp‚ªŽ{s‚³‚ꂽ‘å“®–¬k󂨂æ‚Ñ‘å“®–¬•Ù‹·ó|6Ç—á‚̃tƒHƒ|ƒAƒbƒv.
“¡–ìé”VC•½Î‘C–xŒû‘דTCãp—z‘¾˜YC”ª‘ãŒö•viŽ™j: “ú–{¬Ž™zŠÂŠíŠw‰ï (89.07.07) ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ,
5(1): 143, 1989.
547. mŠw‰ïn iˆê”Êu‰‰j Žå”x“®–¬‚É‚¨‚¯‚éŠg’£Šú‡—¬”gŒ`‚̉ðÍ. ‹ß“¡‡‹`C”¼’J×YCÎŒ´ºi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 137, 1989.
548. mŠw‰ïn iˆê”Êu‰‰j ‹·ó‚Ì‚È‚¢Ç—á‚É‚Ý‚ç‚ê‚éanacrotic notch—lˆ³•Ï‰»‚̬ˆö‚ɂ‚¢‚Ä.
¡ˆäŠ°C”¼’J×Yi‹¹ŠOjC‘¼: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1):
137, 1989.
549. mŠw‰ïn iˆê”Êu‰‰j Š¥ŒŒ—¬Œv‘ª—pƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚Ì“Á«‚Æ‚»‚Ì—Õ°‰ž—p. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï (89.07.07), ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5(1): 138, 1989.
550. mŠw‰ïn iˆê”Êu‰‰j Standardization of Two-dimensional Echocardiographic
Planes for a Imaging of the Ductus Arteriosus Associated with Various
Congenital Heart Disease. •½Î‘C“¡–ìé”VC–xŒû‘דTC”ª‘ãŒö•viŽ™j: 19th International
Congress of Pediatrics (89.07.25), Paris.
551. mŠw‰ïn iˆê”Êu‰‰j Doppler Echocardiographic Indices for Evaluation of
Pulmonary Hypertension. —Ñ‘‘‘¾˜YC˜Iè‹P•vC¬‹Ê•q‰›C‚‹´‚Ý‚Ç‚èC•zìTˆê˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: XIth
Congress of the European Society of Cardiology (89.09.10`14), ƒtƒ‰ƒ“ƒX,
Eur. Heart J., Suppl., p.20, 1989.
552. mŠw‰ïn iˆê”Êu‰‰j Change in Damping Factor of Windkessel System and
Cardiovascular Dynamics by Aging in Essential Hypertension.
‘º¼€C’·’J쉄LC¬—Ñ–¾–FC’ËŒ´Œª”VC•½¼T‰EC•‘ò—˜˜YC–Øì“c—²ˆêi“àj: 15th World
CongressCInternational Union of Angiology (89.09.17), ƒ[ƒ}.
553. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚é123I-MIBG‚¨‚æ‚Ñ201TlS‹ØƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢.
ì–ì—´•FC–ì˜C’‰ŽœC´…Š®‰xC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YC‰Í–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\Ž¡
i•új: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ133‰ñ—á‰ï (89.09.30), VŠƒ.
554. mŠw‰ïn iˆê”Êu‰‰j S”X‰t‚Ì×–E•a—Šw“I‰ðÍ. ‰¡ŽR‘åC‘å–ì‰pŽ¡i•a‰@•a—•”jC‘ –{”ŽsiŽY•wj: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ï (89.09.30), ‰¡•lC ´˜^WCp.14, 1989.
555. mŠw‰ïn iˆê”Êu‰‰j ³íŒŒˆ³‚¨‚æ‚Ñ‚ŒŒˆ³ƒ‰ƒbƒg‚É‚¨‚¯‚éANP. –ö–Εvi‘‡—Õ°ŒnjC´…Š®‰xC–ì˜C’‰Žœi“àj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), “Œ‹ž, —Õ°•a—, 37(•âû): 109, 1989.
556. mŠw‰ïn iˆê”Êu‰‰j Hemodynamic Analysis of a New Angiotensin Converting
Enzyme Inhibitor Delapril Hydrochloride in Essential Hypertension.
˜Iè‹P•vC•zìTˆê˜YC¬‹Ê•q‰›C²“¡´‹MC—Ñ‘‘‘¾˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: The Second Saratoga
International Conference on Atherosclerosis in Towada (89.10.12), \˜a“c,
Abstracts, p.56, 1989.
557. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚ÌzŠÂ“®‘Ô‚É‹y‚Ú‚·‰–Ž_Delapril‚̉e‹¿.
•zìTˆê˜YC˜Iè‹P•vC¬‚L]C‚‹´‚Ý‚Ç‚èC–kŠp”Ž“¹C¬‹Ê•q‰›C—Ñ‘‘‘¾˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï
(89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 156, 1989.
558. mŠw‰ïn iˆê”Êu‰‰j ‚ŒŒˆ³‚É‚¨‚¯‚錌ˆ³‚ÌdÇ“x•ª—Þ‚ÆŒŒs—ÍŠw“I“Á’¥Œ^‚ÌŠÖ˜A‚ɂ‚¢‚Ä.
‘£’qLC’ËŒ´Œª”VC’r“c‘׎qC¬‚L]C²“¡´‹MC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï
(89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 156, 1989.
559. mŠw‰ïn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç—á‚É‚¨‚¯‚é”x“®–¬“à2•ô«‡—¬”gŒ`‚Ì•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.13), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 147, 1989.
560. mŠw‰ïn iˆê”Êu‰‰j ŽhŒƒ“`“±˜H‚Ì•Ï’²‚ÉŠî‚–[ŽºƒuƒƒbƒN‚Ì”Šwƒ‚ƒfƒ‹. ’r“cŒ›ºC‹{Œ´‰p•vC’|“ດŽC¯–ìˆê–çiˆã—pî•ñjC“yˆä˜a”üi¶•¨•¨—ŒnjC²“¡“oŽu˜Yi¶—j: ‘æ6‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (89.10.14), ŽRŒ`.
561. mŠw‰ïn iˆê”Êu‰‰j •s®–¬S“d}M†”¶‘•’u‚Æ‚»‚ê‚É‚æ‚éf’f«”\•]‰¿. ‹{Œ´‰p•viˆã—pî•ñj: ‘æ6‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (89.10.14), ŽRŒ`C S“d}C9(5): 658, 1989.
562. mŠw‰ïn iˆê”Êu‰‰j ’Pˆê–[ŽºŒ‹ß×–E‚ÅŠÏŽ@‚³‚ꂽWenckebachŽüŠú‚ÉŠÖ‚·‚錟“¢. ¯–ìˆê–çiˆã—pî•ñjCJustus
AnumonwoCMario DelmorCJose Jalifeiƒjƒ…|ƒˆ|ƒNB—§‘åj: ‘æ6‰ñ“ú–{S“dŠw‰ïŠwpW‰ï (89.10.14),
ŽRŒ`C S“d}C9(5): 674, 1989.
563. mŠw‰ïn iˆê”Êu‰‰j S‹Ø[ÇŒãÄŠÁ—¬ƒ‚ƒfƒ‹‚ÌŠJ”,ƒr|ƒY–@‚ƃoƒ‹|ƒ“–@‚Ì”äŠr‚ɂ‚¢‚Ä.
”¯N—YiŽÀ“®jC’†ŽR–ÎMCŠÛŽR–ΑPiŽÀ“®ŒnjC“ޗljÀ—mi¶•¨•¨—ŒnjCˆ°Œ´‹v‘ãC˜kì_ŽiiŽÀ“®ŒnjC—ŠZF“ñC‹{Œ´‰p•vC’r“cŒ›ºiˆã—pî•ñjC
²“¡“oŽu˜Yi¶—j: “ú–{S“dŠw‰ï (89.10.14), ŽRŒ`, “ú–{S“dŠw‰ïŽ, 9(5): 580, l989.
564. mŠw‰ïn iˆê”Êu‰‰j ‰EŽº‘¢‰e‚É‚æ‚é‰ES‹@”\‚Ì•]‰¿‹y‚Ѷ‰ES‹@”\‚Ì”äŠrŒŸ“¢.
ì–ì—´•FC–ì˜C’‰ŽœC´…Š®‰xC’·’J쉄LC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YC‰Í–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†
‘òŒ\Ž¡i•új: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 186`187,
1989.
565. mŠw‰ïn iˆê”Êu‰‰j S•s‘S‚É‚¨‚¯‚é‘m–X•Ù‹t—¬“®‘Ԃɂ‚¢‚Ä.
’ËŒ´Œª”VC‘º¼€C‘£’qLC’r“c‘׎qC¬‚L]C²“¡´‹MC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï
(89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(Suppl.): 197`198, 1989.
566. mŠw‰ïn iˆê”Êu‰‰j ŠúŠOŽûkŽž‚ÌŠ¥“®–¬“àŒŒ—¬”gŒ`‚Ì•ªÍ. æѳŠîC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 182, 1989.
567. mŠw‰ïn iˆê”Êu‰‰j ’PŠ¥ó“®–¬“à‚ÌŠ¥ŒŒ—¬•ªÍ. ¼ŽR´ŒhC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ, 19(—Õ‘): 182, 1989.
568. mŠw‰ïn iˆê”Êu‰‰j BentallpŒãÇ—á‚É‚¨‚¯‚銥“®–¬“àŒŒ—¬•ªÍ|“Á‚Éwater hammerˆ³—Í”g‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä|.
‹ß“¡‡‹`C”¼’J×Yi‹¹ŠOjC•OŽR‹P’ji“ŒŽæŽè•a‰@j: ‘æ26‰ñ“ú–{—Õ°¶—Šw‰ï‘‰ï (89.10.14), “Œ‹ž, “ú–{—Õ°¶—Šw‰ïŽGŽ,
19(—Õ‘): 185, 1989.
569. mŠw‰ïn iˆê”Êu‰‰j Œã•‰‰×‘‘å‚ɑ΂·‚é‘m–X•Ù‹t—¬“®‘Ԃ‚¢‚Ä|“™ŽÚ«•‰‰×–@‚É‚æ‚錟“¢|.
’ËŒ´Œª”VC‘º¼€C‘£’qLC‰º—¢ŒöºC™ŽRŠx•FC”ª“‡—ǘaC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: “ú–{’´‰¹”gˆãŠw‰ï‘æ55‰ñŒ¤‹†”•\‰ï
(89.10.17`19), •Ÿ‰ª.
570. mŠw‰ïn iˆê”Êu‰‰j 81mKr‚É‚æ‚é‰EŽºŽûk‹y‚ÑŠg’£‹@”\‚ÌŒŸ“¢.
ì–ì—´•FC–ì˜C’‰ŽœC´…Š®‰xC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YCì–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\Ž¡
i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19), ‘å’Ã, ŠjˆãŠw, 26(8): 989, 1989.
571. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚¨‚æ‚Ñ”ì‘åŒ^S‹ØÇ‚É‚¨‚¯‚é123I-MIBG‚¨‚æ‚Ñ201TlƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢.
´…Š®‰xCì–ì—´•FC–ì˜C’‰ŽœC•½–콈ê˜YC–]ŒŽr’¼C”öŒ`’·—YCì–쓹¢C–kŠp”Ž“¹CìŒû’|’jCVȈê•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\Ž¡
i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, “ú–{ŠjˆãŠw‰ïŽGŽ´˜^W, p.1063, 1990.
572. mŠw‰ïn iˆê”Êu‰‰j ƒCƒkS•s‘S‚É‚¨‚¯‚éƒÀ-ANP‚ɂ‚¢‚Ä.
²“¡´‹MC¬‚L]C•‘ò—˜˜YC’·’J쉄LC–Øì“c—²ˆêi“àjC^è‹`•FiŽÀ“®ŒnjC‘“c‘ìi‹~–½jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È
‘åj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ´˜^W, 65(9): 905, 1989.
573. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é“™ŽÚ«•‰‰×‚É‚æ‚éS—\”õ”\‚Ì•]‰¿‚ɂ‚¢‚Ä|S”ì‘å‚Ì—L–³‚É‚æ‚錟“¢|.
™ŽRŠx•FC•‘ò—˜˜YC’ËŒ´Œª”VC‰º—¢ŒöºC‘£’qLC¬—Ñ–¾–FC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï
(89.10.30), ‹ž“s, ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.60, 1989.
574. mŠw‰ïn iˆê”Êu‰‰j –«•nŒŒÇ‚É‚¨‚¯‚é“™ŽÚ«•‰‰×‚ɑ΂·‚锽‰ž. ‚‹´‚Ý‚Ç‚èC•ìMŒåC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.10.31), ‹ž“s, ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.150, 1989.
575. mŠw‰ïn iˆê”Êu‰‰j ACƒoƒCƒpƒXpŒã‚̃Oƒ‰ƒtƒg“àŒŒ—¬•ªÍ.
‰Í‡–õCˆä㌒Ž¡CéŠÔŒ«“ñC{–K‘ i“Œ—ˆã‘åjCÎŒ´ºC‹ß“¡‡‹`C¼ŽR´ŒhC”¼’J×Yi‹¹ŠOjC‘¼: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï
(89.10.31), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 50(9): 1870, 1989.
576. mŠw‰ïn iˆê”Êu‰‰j ‘å“®–¬•Ç‚̉𗣌»Û‚ÉŠÖ‚·‚é•a—‘gDŠw“IŒŸ“¢.
V’Ã’J^lC–Øì“c—²ˆêi“àjCŒK”ö’èmi•a—jC²“¡giŒ`‘ÔŒnjC‹T’J“Oi•a—j: ‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï (89.11.01), ‹ž“s,
‘æ37‰ñ“ú–{S‘Ÿ•aŠw‰ï—\eW, p.218, 1989.
577. mŠw‰ïn iˆê”Êu‰‰j ‹Ù‹}‚ÉŒo”ç“Iƒoƒ‹[ƒ“ƒJƒe[ƒeƒ‹‚É‚æ‚é‹·ó‚ÌŠg‘åp‚ðŽ{s‚µ‚½‘å“®–¬k󂨂æ‚Ñ‘å“®–¬•Ù‹·ó‚Ì“ûŽ™—á‚ÌŒŸ“¢.
“¡–ìé”ViŽ™jC¼ŽR´Œhi‹¹ŠOjC¡ˆäPC”~Œ´ŽÀC™–{Ÿ•FCV“¡³‹PC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï
(89.11.08), “Œ‹ž, ´˜^W, s-826, 1989.
578. mŠw‰ïn iˆê”Êu‰‰j “àˆö«DOAÇ—á‚ÌŒŸ“¢.
¬—Ñ–¾–FCŠpN•vC’r“c‘׎qCV’Ã’J^lC‰¬Œ´“ÄC’†_Œ¹ˆêC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àjC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j:
‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.09), ‹~‹}ˆãŠw,i—Õ‘j: S853, 1989.
579. mŠw‰ïn iˆê”Êu‰‰j S‹Ø‰Š‚ðŒJ‚è•Ô‚µ‹}Œƒ‚ÈŒo‰ß‚ð‚Æ‚Á‚½1—á. ŠpN•vC’·’J쉄LCV’Ã’J^lCŠ“c”ü—æ”TC‰Í–쓹¢C‘º¼€C–Øì“c—²ˆêi“àjCŒK”ö’èmi•a—j: ‘æ387‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.11), “Œ‹ž.
580. mŠw‰ïn iˆê”Êu‰‰j Postrepolarization Refractoriness and Wenckebach
Periodicity Occur in Single Atrioventricular Nodal Cells.
¯–ìˆê–çiˆã—pî•ñjCJustus AnumonwoCMario DelmorCJose Jalifeiƒjƒ…|ƒˆ|ƒNB—§‘åj:
American Heart Association 62nd Scientific Sessions (89.11.13), New
Orleans, Circulation, 80(4): ‡U-133, 1989.
581. mŠw‰ïn iˆê”Êu‰‰j
–{‘Ô«‚ŒŒˆ³‚ɑ΂·‚éCaptopril‚ƃÀŽÕ’f–ò‚Ì•¹—pŽ¡—Ã||Propranolol‚Æpindolol‚̑Δ䌟“¢.
‘º¼€i“àjC’zŽR‹vˆê˜YiŒ§—§ŠàƒZƒ“ƒ^[jCŒ“–{¬•ki“ŒŠC‘åj: ‘æ10‰ñ“ú–{—Õ°–ò—Šw‰ï (89.11.14), “Œ‹ž.
582. mŠw‰ïn iˆê”Êu‰‰j ˜V”NŽÒ‚ŒŒˆ³‚É‚¨‚¯‚錌ˆ³‚ÌŒ^‚¨‚æ‚ÑdÇ“x‚É‚æ‚錌s“®‘Ԃ̕ω»‚ɂ‚¢‚Ä.
‘º¼€C’ËŒ´Œª”VC™ŽRŠx•FC‘£’qLC‰º—¢ŒöºC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï (89.11.14),
–¼ŒÃ‰®, “ú–{˜V”NˆãŠw‰ïŽ, 26: 97, 1989.
583. mŠw‰ïn iˆê”Êu‰‰j dÇ‚ŒŒˆ³‚É‚¨‚¯‚éƒJƒvƒgƒvƒŠƒ‹––㉺“Š—^‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä. ”ª“‡—ǘaC‘£’qLC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ10‰ñ“ú–{—Õ°–ò—Šw‰ï (89.11.14), “Œ‹ž, —vŽ|W, p.89, 1989.
584. mŠw‰ïn iˆê”Êu‰‰j Šg’£Šú‚ŒŒˆ³1480—á‚É‚¨‚¯‚錌s“®‘Ô‚¨‚æ‚ÑS‹@”\‚ɂ‚¢‚Ä.
’ËŒ´Œª”VC‘º¼€C‘£’qLC¬‚L]C’r“c‘׎qC¬—Ñ–¾–FC’·’J쉄LC–Øì“c—²ˆêi“àj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï (89.11.20),
‹ž“s, ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï—\eW, p.967, 1989.
585. mŠw‰ïn iˆê”Êu‰‰j PGE1“®’‚É‚æ‚é–å–¬ŒŒ—¬‚̕ω»|Œ´”«ŠÌŠà‚Æ“]ˆÚ«ŠÌŠà‚Ì”äŠr.
¼ŽR³ŒáC‘–쳈êC‹àˆä¹ŒPC‰““¡‚C‹àˆä’Ë•¶–¾C¬—ѬŽiC¼–{—æŽqCˆä“›–ri•új: “ú–{–¬ŠÇŠw‰ï (89.11.20), ‹ž“s, –¬ŠÇŠw,
29(10): 1989.
586. mŠw‰ïn iˆê”Êu‰‰j ‚ŒŒˆ³‚É‚¨‚¯‚é‰Á—î‚É‚æ‚éWindkessel Œn‚ÌDamping
factor‚̕ω»‚ÆSzŠÂ“®‘Ô‚ÌŠÖŒWA‚Æ‚‚É«•Ê“ÁˆÙ«‚ɂ‚¢‚Ä.
‘º¼€C’·’J쉄LC¬—Ñ–¾–FC•ìMŒåC’ËŒ´Œª”VC’r“c‘׎qC¬‚L]C‘£’qLC–Øì“c—²ˆêi“àj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï
(89.11.22), ‹ž“s.
587. mŠw‰ïn iˆê”Êu‰‰j ‚¤‚ÁŒŒ«S•s‘S‚ð‡•¹‚µ‚½‚ŒŒˆ³Ç‚ɑ΂·‚é‹N—§•‰‰×‚̉e‹¿.
ŠpN•vC¬‹Ê•q‰›C˜Iè‹P•vC”öŒ`’·—YCò–Ø‹|C•zìTˆê˜YC´…Š®‰xC–Øì“c—²ˆêi“àj: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ134‰ñ—á‰ï
(89.12.02), “Œ‹ž.
588. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™Šú‚Éf’f‚µ‚½‹Ø«•”SŽº’†ŠuŒ‡‘¹‚Ì—Õ°‘œ. –ì“n³•FC•½Î‘CŠ—Œ´FC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.l0.28), ‘å‹{.
589. mŠw‰ïn iˆê”Êu‰‰j ‰EŽº“à‚Ì‹‘å‚È vegetative mass ‚𕹔‚µ‚½V¶Ž™S“à–Œ‰Š‚Ì1—á.
•—’£KŽiCˆäŒ…^—R”üC‘åι–çC–ì“n³•FCŠÖª“OiŽ™jC¼“c—zi—Õ•a—jCŠ—Œ´FC”ª‘ãŒö•vC¬ŒûO‹BiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï
(89.l0.28), ‘å‹{.
590. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™Ž‘±«”x‚ŒŒˆ³Ç(PPHN)‚É‚¨‚¯‚éƒhƒvƒ‰ƒGƒR|–@‚É‚æ‚ézŠÂ“®‘Ô‚Ì•ªÍ. Š`À—R•FC¬ŒûO‹BC–ì“n³•FCŠ—Œ´FC•½Î‘C”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.l0.28), ‘å‹{.
591. mŠw‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[ÇÇ‚É‚¨‚¯‚é123I-MIBG‹y‚Ñ201TlS‹ØƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÌŒŸ“¢.
¼Šª”ŽCΈ䟌ÈC’†‘òŒ\ŽiC“cŠŽŒÈC¬—Ñ–ÎŽ÷C¼ŽR³ŒáCˆË“cˆêdC‹e’rŒhi•újC´…Š®‰xCì–ì—´•FC–ì˜C’‰Žœi“àj: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï
(90.02.00), “Œ‹ž, “ú–{‰æ‘œˆãŠwŽGŽ, 8(5): 415, 1990.
592. mŠw‰ïn iˆê”Êu‰‰j –{‘Ô«‚ŒŒˆ³Ç‚É‚¨‚¯‚é‘Sg‚ÌzŠÂ“®‘Ô‚ÆtzŠÂ‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä.
¬‚L]Cò–Ø‹|CŠpN•vC•zìTˆê˜YC´…Š®‰xC˜Iè‹P•vC–Øì“c—²ˆêi“àj: “ú–{zŠÂŠíŠw‰ïŠÖ“ŒbM‰z’n•û‰ï‘æ135‰ñ—á‰ï
(90.02.17), “Œ‹ž.
593. mŠw‰ïn iˆê”Êu‰‰j IABP‚ª—L—p‚Å‚ ‚Á‚½PTCA’†‹}«Š¥•ÂÇ‚Ì2—á. •½¼T‰ECÎì’¼Ž÷i“àjC‰iˆä‡CŽR–{_–¤iÀ’ÃŽs—§•a‰@j: ‘æ81‰ñ“ú–{zŠÂŠíŠw‰ï“ŒŠC’n•û‰ï (90.02.17), –¼ŒÃ‰®.
594. mŠw‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚Ì“Á«‚Æ‚»‚Ì—Õ°‰ž—p|CFR‚É‚æ‚éA-CƒoƒCƒpƒXp‚Ì•]‰¿|. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ20‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (90.02.22), ‰ªŽR, ´˜^W, p.122, 1990.
595. mŠw‰ïn iˆê”Êu‰‰j Annulo-Aortic-EctasiaÇ—á‚ɑ΂·‚éBentallp‘OŒã‚̶Š¥“®–¬“àŒŒ—¬•ªÍ.
‹ß“¡‡‹`C”¼’J×Yi‹¹ŠOjC•OŽR‹P’ji“ŒŽæŽè•a‰@jCÎŒ´ºi‹¹ŠOj: ‘æ20‰ñ“ú–{S‘ŸŒŒŠÇŠO‰ÈŠw‰ï‘‰ï (90.02.24), ‰ªŽR,
´˜^W, p.295, 1990.
596. mŠw‰ïn iˆê”Êu‰‰j VSD‚Ì•”ˆÊ•Êf’f‚É‚¨‚¯‚éƒhƒvƒ‰ƒGƒR|‚Ì–ðŠ„.
‘å]‰ëGCìˆä°”üC“•ûLˆêCŒÃ–ؗʈê˜Yi—ÕŒŸjC•½Î‘iŽ™j: ‘æ15‰ñ“ú–{’´‰¹”gˆãŠwŒŸ¸Œ¤‹†‰ïŒ¤‹†”•\‰ï (90.02.25), “Œ‹žC
’´‰¹”gŒŸ¸‹Zp, l5(1): 35`36, l990.
597. mŠw‰ïn iˆê”Êu‰‰j VSDi‡TŒ^j‚ÌŒo‰ßŠÏŽ@’†‚Ƀoƒ‹ƒTƒ‹ƒo“´“®–¬áŽ”j—ô‚ð”F‚ß‚½‚P’jŽ™—á‚̃hƒvƒ‰SƒGƒR|}ŠŒ©.
“•ûLˆêCìˆä°”üC‘å]‰ëGCŒÃ–ؗʈê˜Yi—ÕŒŸjC•½Î‘iŽ™j: ‘æ15‰ñ“ú–{’´‰¹”gˆãŠwŒŸ¸Œ¤‹†‰ïŒ¤‹†”•\‰ï (90.02.25), “Œ‹žC
’´‰¹”gŒŸ¸‹Zp, l5(1): 37`38, l990.
598. mŠw‰ïn iˆê”Êu‰‰j Effect of Protocol and Disease on the Kinetics of
Oxygen during Exercise Testing. Myers, J.CWalsh, D.CBuchanan,
N.CMcCauley, P.CKraemer, M.(Long Beach VA Medical
Center)C´…Š®‰xi“àjCFroelicher, V.F.(Long Beach VA Medical Center): 39th
Annual Scientific Session of American College of Cardiology (90.03.22),
New Orleans, USA, JACC, 15(2): 237A, 1990.
599. mŠw‰ïn iˆê”Êu‰‰j ”x‚ŒŒˆ³Ç(PH)‚É‚Ý‚ç‚ê‚é2•ô«”x“®–¬‹ìo—¬‘¬”gŒ`‚̬ˆö‚ÉŠÖ‚·‚錤‹†. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.27), •Ÿ‰ª, Abstracts‡U, p.97, 1990.
600. mŠw‰ïn iˆê”Êu‰‰j S‹@”\’ቺ—á‚É‚¨‚¯‚é‰^“®•‰‰×Žž‚ÌS–[«Na—˜”Aƒyƒvƒ`ƒh(ANP)‚ƶŽº‹ìo—¦(EF)‚Æ‚ÌŠÖŒW.
‰Í–쓹¢C–ì˜C’‰ŽœC´…Š®‰xCì–ì—´•FC–]ŒŽr’¼C•½–콈ê˜YC”öŒ`’·—YC–kŠp”Ž“¹CìŒû’|’jCVȈê•vC¼ŽRŒcŽqCC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†
‘òŒ\Ž¡i•új: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.27), ”Ž‘½, Jpn. Circ. J., 54(´): 34, 1990.
601. mŠw‰ïn iˆê”Êu‰‰j S‹Ø[Ç‚É”º‚¤‹@ŠB“I‡•¹Ç‚Ì—Õ°•a—Šw“IŒŸ“¢.
¬—Ñ–¾–FC‰¬Œ´“ÄCÎì’¼Ž÷C’r“c‘׎qCV’Ã’J^lC’ËŒ´Œª”VC’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï
(90.03.27), ”Ž‘½, Jpn. Circ. J., 54(´): 40, 1990.
602. mŠw‰ïn iˆê”Êu‰‰j L”͈ÍS‹Ø[Ç‚Å‚ÌPulsed
Doppler–@¶ŽºŠg’£“®‘ÔŽw•W‚̈ꌩ³í‰»pattern‚ð‚«‚½‚·‹@˜‚ɂ‚¢‚Ä.
ìŒû’|’jC´…Š®‰xC–kŠp”Ž“¹CVȈê•vC‰Í–쓹¢C¼ŽRŒcŽqC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àj: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï
(90.03.28), ”Ž‘½, Jpn. Circ. J., 54(´): 159, 1990.
603. mŠw‰ïn iˆê”Êu‰‰j ”|—{ŒŒŠÇ•½ŠŠ‹Ø×–E‚É‚¨‚¯‚éƒGƒ“ƒhƒZƒŠƒ“‚É‚æ‚éPI‘ãŽÓ‰ñ“]‚¨‚æ‚уAƒ‰ƒLƒhƒ“Ž_‚Ì—V—£‚ɑ΂·‚éì—p.
•ìMŒåi“àj: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.28), ”Ž‘½, Jpn. Circ. J., 54(´): 266,
1990.
604. mŠw‰ïn iˆê”Êu‰‰j Ventricular Gradient‚ÌŒoŽž“I•Ï“®‚ÆSŽº×“®è‡’l.
¯–ìˆê–çC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC—ŠZF“ñi“àjC²“¡“oŽu˜Yi¶—j: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.28), •Ÿ‰ª,
Jpn. Circ. J., 54(‘): 123, 1990.
605. mŠw‰ïn iˆê”Êu‰‰j ”ñ•ÂÇ«”ì‘åŒ^S‹ØÇ‚ÌŒŒŸ÷S–[«—˜”Aƒyƒvƒ`ƒh‚Ɖ^“®•‰‰×Žž‚ÌS‹@”\‚Æ‚ÌŠÖŒW.
–kŠp”Ž“¹CìŒû’|’jCVȈê•vC¼ŽRŒcŽqCì–ì—´•FC‰Í–쓹¢CŠpN•vC•zìTˆê˜YC”öŒ`’·—YC–ì˜C’‰ŽœC˜Iè‹P•vC–Øì“c—²ˆêi“àjCΈ䟌ÈC’†‘òŒ\
Ž¡i•új: ‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.29), ”Ž‘½, Jpn. Circ. J., 54(´): 239, 1990.
606. mŠw‰ïn iˆê”Êu‰‰j ANP•ª”å‚É‚¨‚¯‚éƒSƒ‹ƒW‘•’u‚̕ω».
²“¡´‹Mi“àjC‘“c‘ìi‹~–½jC’·’J쉄LC–Øì“c—²ˆêi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j:
‘æ54‰ñ“ú–{zŠÂŠíŠw‰ïŠwpW‰ï (90.03.29), ”Ž‘½, Jpn. Circ. J., 54(´): 292, 1990.
607. mŠw‰ïn iˆê”Êu‰‰j DiscreteŒ^‘å“®–¬•Ù‰º‹·óÇiKelly ‡UŒ^j‚Ì1¬l—á.
‚ŽRri‹¹ŠOjC‘å‘òŠ²•vCŽè’ËŒõ—mC–k‘º¹–çC¬o¹Hi¹—ê•l¼•a‰@j: ‘æ67‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.09.10j,
“Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 37(12): 2612, 1989.
608. mŠw‰ïn iˆê”Êu‰‰j ”x‚ŒŒˆ³‚ÆS•s‘S‚𕹔‚µ,ŽOë•Ù•Â½•s‘SÇ‚ð‡•¹‚µ‚½S–[’†ŠuŒ‡‘¹Ç.
‚ŽRri‹¹ŠOjCŽðˆäÍCŽè’ËŒõ—mC–k‘º¹–çC¬o¹HC‘å‘òŠ²•vi¹—ê•l¼•a‰@j: ‘æ68‰ñ“ú–{‹¹•”ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï
i88.12.10j, “Œ‹ž, “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 37(12): 2622, 1989.
609. mŠw‰ïn iˆê”Êu‰‰j t“®–¬ãA• •”‘å“®–¬ŽÕ’f‚É‚æ‚é‹•ŒŒŒãÄŠÁ—¬‚Ìt‚É—^‚¦‚é‰e‹¿. “y‰®“ÖC–쌩ŽREC’|’†’qºC•lè‚—TC“c’†—ºi–ƒŒj: ‘æ4‰ñ“ú–{ShockŠw‰ï‘‰ï i89.04.22j, ‘åã.
610. mŠw‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰SƒGƒR|–@‚É‚æ‚éV¶Ž™—‘‰~E•”ŒŒ—¬‚ÌŒŸ“¢. •½Î‘C¬ŒûO‹BCÄ“¡KˆêC–åˆäL‹ÅCŠ—Œ´FC–xŒû‘דTC”ª‘ãŒö•viŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï‘‰ï i89.07.04j, “Œ‹ž.
611. mŠw‰ïn iˆê”Êu‰‰j æ“V«SŽ¾Š³‚𔺂¤‹É¬–¢nŽ™l3—á‚ÌŒŸ“¢. –ì“n³•FC¬ŒûO‹BCŠ—Œ´FC”ª‘ãŒö•viŽ™jCG.C. Emanuilides (UCLA): ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï i89.07.04j, “Œ‹ž.
612. mŠw‰ïn iˆê”Êu‰‰j ƒhƒbƒvƒ‰|SƒGƒR|–@‚É‚æ‚é”xŒŒ—¬Œ¸Œ^SŽ¾Š³‚É‚¨‚¯‚é’Z—pŒã‚̃Vƒƒƒ“ƒgŒŒŠÇ‚Ì•`o‹y‚ÑŠÇ“àŒŒ—¬‚Ì•]‰¿.
–xŒû‘דTC•½Î‘C“¡–ìé”VCãp—z‘¾˜YC”ª‘ãŒö•viŽ™jC’†]¢–¾C¡ˆäŠ°C“c’†Ž•Fi‹¹ŠOj: ‘æ25‰ñ“ú–{¬Ž™zŠÂŠíŠw‰ï‘‰ï
i89.07.06j, ‹v—¯•Ä, “ú–{¬Ž™zŠÂŠíŠw‰ïŽGŽ, 5: 89, l989.
613. mŠw‰ïn iˆê”Êu‰‰j —¼‘¤‹}«Žw“®–¬•ÂÇ‚ð‚«‚½‚µ‚½Œ´”«ŒŒ¬”ÂŒŒÇ‚Ì1—á.
ŒÃì—T‰îC‹à鳉ÀCª–{EC—§ÎWC’©’·“N–íC“‡“cŒªC“n•ÓŒ’Ž™C¼ŽR•Û”äŒÃCX£¹Ž÷C‰J‹{–¾•¶C¼ˆäŒ’C¡ˆäŒ‰iŠOjCŽR‰º‚¦‚èŽqC“¡–ì—R”ü
i“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.
614. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ‹ƒuƒ~ƒ“preclotting‚µ‚½DacronlHŒŒŠÇ‚É‚æ‚ébypassp‚Ì—Õ°“IŒŸ“¢.
¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmCª–{EiŠOj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 646,
1989.
615. mŠw‰ïn iˆê”Êu‰‰j p‘O”畆Á“Å‚ÌlHŒŒŠÇŠ´õ—\–hŒø‰Ê‚ÉŠÖ‚·‚錟“¢. ª–{EC¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmiŠOj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.11.02), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 50(9): 374, 1989.
616. mŠw‰ïn iˆê”Êu‰‰j ŒŒ‰tƒKƒX•ªÍ‚É‚æ‚鉺ŽˆÃ–¬”÷¬zŠÂ‚ÌŒŸ“¢. ‹à鳉ÀCª–{EC¡ˆäŒ‰CˆÉ“¡—ÇmiŠOj: ‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.11.02), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽGŽ, 50(9): 375, 1989.
617. mŠw‰ïn iˆê”Êu‰‰j • •”‘å“®–¬áŽ”j—ô—á‚̉摜‚É‚æ‚錟“¢|ᎂɋy‚Ú‚·˜’Åœž™‚̉e‹¿|.
‹à鳉ÀCª–{EC¡ˆäŒ‰CˆÉ“¡—ÇmiŠOjC¡ˆäPC™–{Ÿ•FC“‡’÷ˆêC‘Oì˜a•Fi‹~–½j: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i89.11.20),
‹ž“s, –¬ŠÇŠw, 29(10): 906, 1989.
618. mŠw‰ïn iˆê”Êu‰‰j Myonephropathic-metabolic
syndrome‚ÉŠÖ‚·‚錟“¢|‚Æ‚‚É‹•ŒŒ‹Ø‚Ìreperfusion injury‚ɂ‚¢‚Äi‘æ3•ñj|.
ª–{EC¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmiŠOj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i89.11.20), ‹ž“s, –¬ŠÇŠw, 29(10): 927,
1989.
619. mŠw‰ïn iˆê”Êu‰‰j •«‡•”“à–Œ”ìŒú‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ª–{EiŠOj: ‘æ2‰ñŒŒŠÇáŠQŒ¤‹†‰ï i89.11.25), “Œ‹ž.
620. mŠw‰ïn iˆê”Êu‰‰j “®–¬d‰»«‹}«‰ºŽˆ“®–¬•ÂÇ‚É‚æ‚émyonephropathic-metabolic
syndrome‚ÉŠÖ‚·‚錟“¢. ª–{EC¡ˆäŒ‰C‹à鳉ÀCˆÉ“¡—ÇmiŠOj: ‘æ24‰ñ“ú–{¬l•aŠw‰ï i90.01.15), “Œ‹ž,
“ú–{¬l•aŠw‰ï‰ïŽ, 16: 75, 1990.
621. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ˜V”NŽÒ‚ŒŒˆ³‚ÌŠÇ—‚Ì‚µ‚©‚½. ‘º¼€i“àj: Chronic Disease Œ¤‹†‰ï (89.09.09), “Œ‹ž.
622. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒŒŠÇŠO‰È‚ÆŠ´õ. ª–{EiŠOj: ‘æ4‰ñ_“Þ쌧ŒŒŠÇŠO‰ÈŒ¤‹†‰ï i89.09.22), ‰¡•l.
623. mŒ¤‹†‰ïn iƒpƒlƒ‹j Œo”ç‹zŽûŒ^»Ü‚Ì•]‰¿•û–@;@‘æ“ñ•”—Õ°ŽŽŒ±. ‘º¼€i“àj: Œo”ç‹zŽûŒ^»ÜƒVƒ“ƒ|ƒWƒEƒ€ (89.10.05), “Œ‹ž.
624. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj
V¶Ž™C“ûŽ™‚Ì‘å“®–¬•Ù‹·ó‚ɑ΂µ‚ÄŒo”ç“Iƒoƒ‹|ƒ“Šg‘åp‚ðŽ{s‚µ‚½3ǗႨ‚æ‚ѬŽ™Šú‚ÉŽ{s‚µ‚½l—á‚ÌŒŸ“¢.
–xŒû‘דTC•½Î‘C“¡–ìé”VC–î‘òŒ’ŽiCŽO‘òmŽiCãp—z‘¾˜YC”ª‘ãŒö•viŽ™j: ‘æ1‰ñPediatric Interventional
Cardiology Œ¤‹†‰ï (90.01.13), “c.
625. mŒ¤‹†‰ïn iˆê”Êu‰‰j –k—¢Ž®lHS‘Ÿ‚Ì“Á’¥‚Æ–â‘è“_.
‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCˆÉ“¡’‰OC¡•ª–ÎC“c’†”Ž”VCÎŒ´ºi‹¹ŠOjCX“c^Žji¶‘ÌHjCù“c’¼i“ŒH‘åj: ‘æ7‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï
(82.02.05), ‘Š–ÍŒ´C –k—¢ˆãŠw, 12(2): 180, 1982.
626. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚Ì—¬—Ê”gŒ`|”x“àƒVƒƒƒ“ƒg‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä|.
‹´–{¬Li¶‘ÌHjCŽç‰®“llCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC•½ˆä–@”Ži“àjC‘O“c_‹`Cù“c’¼i“ŒH‘åj:
‘æ8‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï (83.02.04), ‘Š–ÍŒ´C –k—¢ˆãŠw, 13(2): 152, 1983.
627. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚É‚¨‚¯‚錌ðŒ`¬‚Æ‘¬“xŒù”z.
‹´–{¬Li¶‘ÌHjCŽç‰®“llCó—˜G’jCÎŒ´ºi‹¹ŠOjC”nŸº´Ž‘i¶‘ÌHjC•½ˆä–@”Ži“àjC—é–Ø”ŽŽqiˆãŠw‰ÈjC‘O“c_‹`Cù“c’¼i“ŒH‘åj:
‘æ9‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï (84.02.01), ‘Š–ÍŒ´C –k—¢ˆãŠw, 14(2): 120, 1984.
628. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHS‘Ÿ‚É‚¨‚¯‚錌‹…”j‰ó‚Æ‘¬“xŒù”z.
‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCó—˜G’jCÎŒ´ºi‹¹ŠOjC—é–Ø”ŽŽqiˆãŠw‰ÈjC™‰Y—f‰îCù“c’¼i“ŒH‘åj: ‘æ10‰ñ‘ã—p‘ŸŠíŒ¤‹†‘‰ï
(85.01.28), ‘Š–ÍŒ´C –k—¢ˆãŠw, 15(2): 138, 1985.
629. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«S‹Ø[Ç‚É‚¨‚¯‚é¶S•s‘S‚ƉES•s‘S•a‘Ô‚ÌŠÖ˜A‚¨‚æ‚ÑŒŒŠÇŠg’£Ü—Ö@‚É‚æ‚é•Ï‰». •½¼T‰EC¬—Ñ–¾–FC‘º¼€C–Øì“c—²ˆêi“àj: ‘æ9‰ñ—Õ°S‘Ÿ•aŒ¤‹†‰ï (88.04.23), ‘åã.
630. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰SƒGƒR|–@‚É‚æ‚鶖[“à–Œ—l\‘¢•¨‚ÌŠÓ•Ê.
ìˆä°”üC‘å]‰ëGC•äÏŒ³CŒÃ–ؗʈê˜Yi—ÕŒŸjC•½Î‘iŽ™j: “ú–{’´‰¹”gˆãŠwŒŸ¸Œ¤‹†‰ï (89.02.26), –¼ŒÃ‰®C ’´‰¹”gŒŸ¸‹Zp,
l4(2): 80`81, 1989.
631. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}Œƒ‚ÈSŠg‘å‚ÆS•s‘S‚ðŽå‘i‚ɔǂµ‚½ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á.
‰¬Œ´“ÄC¬—Ñ–¾–FC’·’J쉄LC´…Š®‰xC‘º¼€C–Øì“c—²ˆêi“àjCŒÃì—FC‘D”ö’‰Fi–@ˆãjCV’Ã’J^li“àjCŒK”ö’èmi•a—j:
—Õ°S‘Ÿ•aŒ¤‹†‰ï (89.04.10), ‘åã.
632. mŒ¤‹†‰ïn iˆê”Êu‰‰j DŽ_‹…‘‘½‚𔺂¤S‹Ø‰Š‚Ì1—á. ¬‚L]C’·’J쉄LC‘º¼€C–Øì“c—²ˆêi“àj: —Õ°S‘Ÿ•aŒ¤‹†‰ï (89.04.10), ‘åã.
633. mŒ¤‹†‰ïn iˆê”Êu‰‰j S‹ØÁ‚É‚¨‚¯‚éSƒv[ƒ‹ˆÊ‘Š‰ðÍ‚Ì—L—p«. ¼Šª”ŽCΈ䟌ÈC’†‘òŒ\Ž¡C¼—Ñ—²i•újC¬—Ñ–¾–Fi“àj: ‘æ593‰ñ•úŽËüf—ÃŒ¤‹†‰ï (89.05.00), “Œ‹žC —Õ°ŠjˆãŠwC22(4): 52, l989.
634. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å“®–¬‚É‚¨‚¯‚éŽ_«ƒ€ƒR‘½“œ‚ÌõF–@‚ÌŒŸ“¢.
‘å‹´‚ä‚©‚èCˆÉ“¡®ŽqC‹ß–ì´”üCŽsì‚‚íi•a‰@•a—jCV’Ã’J^li“àjCŒK”ö’èmC‰œ•½‰ë•Fi•a—j: ‘æ40‰ñ•a—‹ZpŒ¤‹†‰ï
(89.08.06), “Œ‹ž, •a—‹Zp,(40): 12`13,1990.
635. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚É‚æ‚ésingle coronary artery“à‚ÌŒŒ—¬•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ9‰ñ¬Ž™S‹@”\ŒŒs“®‘Ô’k˜b‰ï (89.10.14), “Œ‹ž.
636. mŒ¤‹†‰ïn iˆê”Êu‰‰j SzŠÂƒ‚ƒfƒ‹‚ÉŠî‚ÂS•s‘Sf’fŽ¡—ÃŽx‰‡ƒVƒXƒeƒ€CARDIOLOGIST.
’ß“c—z˜aC’|“ດŽiˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC“c’†—ºi–ƒj: ‘æ7‰ñ–ƒŒ¥W’†Ž¡—ÃRƒ“ƒsƒ…|ƒ^Œ¤‹†‰ï (89.11.18), •xŽR,
´˜^W, p.16, 1989.
637. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’´‰¹”gƒhƒvƒ‰ƒJƒe|ƒeƒ‹‚É‚æ‚éŠeŽíSŽ¾Š³‚ÌŠ¥“®–¬“àŒŒ—¬•ªÍ. ”¼’J×Yi‹¹ŠOjC‘¼: ‘æ3‰ñ’´‰¹”gŠ¥ŒŒ—¬Œv‘ªŒ¤‹†‰ï (89.12.02), ‘åã.
638. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×Žž‚É‚¨‚¯‚ézŠÂ“®‘ÔA‚Æ‚‚ɶŽº‹ìo—¦(EF)‚ÆS–[«Na—˜”Aƒyƒvƒ`ƒh(ANP)‚Æ‚ÌŠÖŒW.
‰Í–쓹¢Cì–ì—´•FC–]ŒŽr’¼C–kŠp”Ž“¹CìŒû’|’jC´…Š®‰xC–ì˜C’‰ŽœC–Øì“c—²ˆêi“àj: ‘æ30‰ñzŠÂŠí•‰‰×Œ¤‹†‰ï (90.02.03),
“Œ‹ž.
639. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«ŒŒˆ³ã¸‚ÌS‘Ÿ‘gDS–[«—˜”Aƒyƒvƒ`ƒh”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿FWKY ‚ÆSHR‚Å‚ÌŒŸ“¢.
´…Š®‰xC–kŠp”Ž“¹CìŒû’|’jCVȈê•vC¼ŽRŒcŽqCì–ì—´•FC‰Í–쓹¢C–ì˜C’‰ŽœC–Øì“c—²ˆêi“àjC–ö–Εvi‘‡—Õ°Œnj: ‘æ3‰ñANPŒ¤‹†‰ï
(90.02.23), ‘Š–ÍŒ´.
640. mŒ¤‹†‰ïn iˆê”Êu‰‰j ANP•ª”å‚É‚¨‚¯‚éƒRƒ‹ƒW‘•’u‚̕ω».
²“¡´‹MC’·’J쉄LC¬‚L]C•‘ò—˜˜YC–Øì“c—²ˆêi“àjCŽðˆäNOCŽR‰È³•½i‰ðjC‘“c‘ìi‹~–½jCŸ–”CiŒ`‘ÔŒnjC^è‹`•FiŽÀ“®ŒnjCŠÛ–Î
•¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´.
641. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×Žž‚É‚¨‚¯‚ézŠÂ“®‘ÔA‚Æ‚‚ɶŽº‹ìo—¦‚ÆS–[«Na—˜”Aƒyƒvƒ`ƒh‚Æ‚ÌŠÖŒW.
‰Í–쓹¢Cì–ì—´•FC–kŠp”Ž“¹C´…Š®‰xC–ì˜C’‰ŽœC–Øì“c—²ˆêi“àjC–ö–Εvi‘‡—Õ°Œnj: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23),
‘Š–ÍŒ´.
642. mŒ¤‹†‰ïn iˆê”Êu‰‰j • •”‘å“®–¬‹Ù‹}ŽèpŽž‚Ì–ƒŒŠÇ—. –쌩ŽREC‘ºã‰ëŽqCŒÜ\”¨mC•lè‚—TC¬‘òÍŽqC–î“c_C“¡Œ´ŒjŽqCóˆäŽõŽqi–ƒj: ‘æ12‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï i89.03.08`10j, –kŠC“¹.
643. mŒ¤‹†‰ïn iˆê”Êu‰‰j Paget-SchroetterÇŒóŒQ‚Ì2—á. “‡“cŒªC¡ˆäŒ‰C¼ˆäŒ’CŒÃ“cˆê“¿C‹à鳉ÀCª–{EiŠOj: ‘æ59‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.04.22), “Œ‹žC ŒŒŠÇŠO‰ÈCl990.
644. mŒ¤‹†‰ïn iˆê”Êu‰‰j • •”‘å“®–¬¥‰º‘åÖ¬ŠÔ‚ÉÄ”‚µ‚½ˆ««Œã• –ŒŽîᇂÌ1Žèp—á. ¡ˆäŒ‰Cã–쑈ê˜YC‹à鳉ÀCˆÉ“¡—ÇmCΓc˜a•vCª–{EiŠOj: ‘æ9‰ñŒŒŠÇŠO‰È‡“¯Œ¤‹†‰ï i89.05.20), ‘q•~.
645. mŒ¤‹†‰ïn iˆê”Êu‰‰j Š´õ‚𔺂Á‚½¶ãüâ|“®–¬”j—ô‚Ì1Žèp—á. X£¹Ž÷C¡ˆäŒ‰C‹à鳉ÀCª–{EiŠOj: ‘æ60‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.07.01), ç—t.
646. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ûŠàpŒã‚Ìãüâ|“®–¬”j—ô‚Ì1—á. X£¹Ž÷C‹à鳉ÀC²“¡KˆêC¡ˆäŒ‰Cª–{EiŠOj: ‘æ60‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.07.01), ç—t, ŒŒŠÇŠO‰È, 9(1): 1990.
647. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠO«ŽlŽˆŒŒŠÇ‘¹7—á‚ÌŒŸ“¢.
‹à鳉ÀCª–{EC¡ˆäŒ‰CˆÉ“¡—ÇmiŠOjCV“¡³‹PC™–{Ÿ•FC‘Oì˜a•Fi‹~–½j: ‘æ3‰ñLimb SalvageŒ¤‹†‰ï i89.07.07),
ˆ®ì, ´˜^W, 3: 10, 1989.
648. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”j—ô«• •”‘å“®–¬áŽpŒã‚É”¶‚µ‚½¶“à’°œ“®–¬áŽ‚Ì1Žèp—á. ’©’·“N–íC¡ˆäŒ‰C’|“cC¼ŽR•Û”äŒÃC¼ˆäŒ’C‹à鳉ÀCª–{EiŠOjC‘Oì˜a•Fi‹~–½j: ‘æ61‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i89.09.09), “Œ‹ž.
649. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŒŒŠÇ¥hŽå“®–¬•«‡•”‚Ì’·Šú—\Œã‚ÉŠÖ‚·‚錟“¢. ª–{EiŠOj: ‘æ1‰ñŒŒŠÇáŠQŒ¤‹†‰ï i89.09.12), “Œ‹ž.
650. mŒ¤‹†‰ïn iˆê”Êu‰‰j ASO‚ɑ΂·‚éRŒŒ¬”–ò‚ÌŒø‰Ê‚ÉŠÖ‚·‚錟“¢. ª–{EiŠOj: ‘æ4‰ñ_“Þ쌧ŒŒŠÇŠO‰ÈŒ¤‹†‰ï i89.09.22), ‰¡•l.
651. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¶‘’°œ“®–¬‹}«•ÂÇŒãA5ŽžŠÔ‚ÅŽ€–S‚µ‚½1—á. ™–ìŽOç’jCª–{EC‹à鳉ÀC¡ˆäŒ‰iŠOj: ‘æ63‰ñŒŒŠÇŠO‰ÈǗጟ“¢‰ï i90.01.20), “Œ‹ž, ŒŒŠÇŠO‰È, 1990.
652. mŒ¤‹†‰ïn iˆê”Êu‰‰j Paget-SchroetterÇŒóŒQ‚Ì3—á.
“‡“cŒªC¡ˆäŒ‰CŒÃ“cˆê“¿C¼ˆäŒ’C™–ìŽOç’jC‹à鳉ÀC‘å‹{“Œ¶Cª–{ECE“cÍiŠOj: ‘æ736‰ñŠO‰ÈW’k‰ï i90.03.10), “Œ‹ž,
´˜^W, p.24, 1990.
<<103 ŒÄ‹zŠí>>
653. mŒ´’˜n ‹C“¹‰ß•q«ŒŸ¸’†‚ÌŒz•”ŒÄ‹z‰¹‚̕ω».
“팴”Í”VC‰ØŽ÷¬CÎì—ºCˆäŒË“cÆ‹`C²“¡“ú²ŽqC‘q“c¬CŽR–{”Ž”VC•Ð‹Ë^lC–{‘½ƒC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj:
Therapeutic Research, 10(10): 429`433, 1989.
654. mŒ´’˜n Mouth Occlusion Pressure as a Useful Indicator for Wearing
from Mechanical Ventilation. ‘Š”nˆêˆåi‹~–½jC‘å’Ë—m‹vC•y“c—FKi“àj: Tohoku J. Exp.
Med., 156(Suppl.): 181`187, 1988.
655. mŒ´’˜n Œ´”«”xŠàØœ—á‚É‚¨‚¯‚é—\Œã‚ÌŒŸ“¢. ˆ¢•””\–¾C‹g‘º”Ž–MC•½ˆäŽO˜YC•i“cƒCÎŒ´ºi‹¹ŠOjC‹T’J“Oi•a—jCž`ŒE–LC–î“ߣM—Yi“àj: ŒÄ‹zŠíŠO‰È, 3(4): 396`401, 1989.
656. mŒ´’˜n ¬Ž™‚̉ߕq«”x‘Ÿ‰Š. –¥‰YŽ‘¥C’†“ˆ‰p•FiŽ™j: ¬Ž™‰ÈC30(9): 991`998Cl989.
657. mŒ´’˜n ‰ESƒoƒCƒpƒXŽž‚Ì—¬—Ê”gŒ`‚Ì”x‚ւ̉e‹¿. Žç‰®“llCˆÉ“¡’‰OCÎŒ´ºi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCù“c’¼C‘O“c_‹`i“ŒH‘åj: lH‘ŸŠí, 13(1): 100`103, 1984.
658. mŒ´’˜n ‹C“¹”M‚É‚¨‚¯‚é‹CŠÇŽx‹¾ŠŒ©‚ÉŠÖ‚·‚錤‹†|“Á‚É”ŠŒ©‚Ì—L–³‚Æ‹¹•”‚wüˆÙí¥•K—v—A‰t—Ê‚¨‚æ‚Ñ—\Œã‚Æ‚ÌŠÖŒW. •Ð‹Ë^li“àjC‰©‹àˆäN–¤C‘Š”nˆêˆåi‹~–½jC•y“c—FKi“àj: ”Mi“ú–{”MŠw‰ï‰ïŽj, 15(1): 8`14, 1989.
659. mŒ´’˜n Až‚ÝŒ^lHS‘Ÿ‚ÌŒ¤‹†. ˆÉ“¡’‰OCŽç‰®“llC–ö‘òG–¾CÎŒ´ºi‹¹ŠOjC‹´–{¬LC”nŸº´Ž‘i¶‘ÌHjCù“c’¼i“ŒH‘åj: –k—¢ˆãŠw, 12(‘): 108`109, 1982.
660. mŒ´’˜n ‚•p“x—zˆ³ŒÄ‹z‚Ì’áŽ_‘f«”xŒŒŠÇŽûk‚ɑ΂·‚é‰e‹¿. ›’J˜a]C“n•Ó•qC‚•¶‰Øi–ƒj: –ƒŒ, 38(11): 1492`497, 1989.
661. mŒ´’˜n ‹C“¹”MŽž‚Ì”xŒŒŠÇ“§‰ß«‚ÉŠÖ‚·‚錤‹†. •Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àjC‰FˆäŒª“ñC‰F’Öؗ´ˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‚èŒõ‹Ii—Õ•a—j: —Õ°ŒÄ‹z¶—, 21(2): 133`138, 1989.
662. mŒ´’˜n Ž‰–bÇðÇŒóŒQ‚ÌBALFŠŒ©. ‚èŒõ‹Ii—Õ•a—jCV“¡³‹PC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC•Ð‹Ë^li“àj: —Õ°ŒÄ‹z¶—, 21(2): 141`144, 1989.
663. mŒ´’˜n ‹CŠÇŽx”x–Eôò‰t‚É‚¨‚¯‚郿2|Macroglobulin”÷—Ê‘ª’è‚ÌŠî‘b“I‹y‚Ñ—Õ°“IŒŸ“¢.
‚èŒõ‹ICâ“Œ—R‹IC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—jC”~Œ´ŽÀiŽ™jC‘Š”nˆêˆåi‹~–½jCÎ삈êC•Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àj: —Õ°•a—,
37(7): 825`829, 1989.
664. m’Z•ñn Vanishing Tumor. ‘Š”nˆêˆåi‹~–½j: “úŒoƒƒfƒBƒJƒ‹, 18(14): 15`16, 1989.
665. mÇ—á•ñn TSS—ÞŽ—‚Ì•a‘Ô‚ð’悵‚½”x‰Š‹…‹Û”sŒŒÇ‚Ì1—á. ”Š_mCL£—²ˆêC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(1): 380`381, 1989.
666. mÇ—á•ñn ‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚ɇ•¹‚µ‚½”xƒ€ƒR[ƒ‹Ç‚Ì1Øœ—á. ‹ß“¡‡‹`C•i“cƒC•½ˆäŽO˜YCŽR–{‹LŒ°C‹g‘º”Ž–MCÎŒ´ºi‹¹ŠOj: “ú–{‹¹•”ŠO‰ÈŠw‰ïŽGŽ, 37: 734`737, 1989.
667. mÇ—á•ñn “Á”«“ûâô‹¹‚Ì1—á. ‚“cM˜aC‹{–{–”‹gi“àjC’†Œ´Ž•FC•ž•”¬•FC‘å–ØŽõ—²C‰¡ŽR„C¬‘òŠÞC‹e’rŒ÷ŽŸiŒx—F•a‰@j: “ú–{‹¹•”—Õ°, 49(1): 64`69, 1990.
668. mÇ—á•ñn ’˜‚µ‚¢‚CO2ŒŒÇA–³ŒÄ‹z‚ð’悵‚½’x”«ƒWƒXƒLƒlƒWƒA‚Ì1—á.
²“¡“ú²ŽqCŽR–{”Ž”VCÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àjC’ç–M•FCL£—²ˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j:
—Õ°ŒÄ‹z¶—, 21(1): 23`32, 1989.
669. m‘àn ¬Ž™‹CŠÇŽxƒtƒ@ƒCƒo|ƒXƒRƒs|‚Ì“K‰ž‚Æ–â‘è“_. ”~Œ´ŽÀC–¥‰YŽ‘¥iŽ™j: ¬Ž™‰ÈC30(6): 611`620Cl989.
670. m‘àn Ž¾Š³‚É‚æ‚é‰æ‘œf’f‚ÌŽí—Þ‚Æ“K‰ž: ŒÄ‹zŠí. ”~Œ´ŽÀiŽ™j: ¬Ž™‰Èf—Ã,@53(4): 1039`1048, 1990.
671. m‘àn ‹z“ü—Ö@. ”~Œ´ŽÀiŽ™j: ¬Ž™‰Èf—ÃC52(‘): 103`106Cl989.
672. m‘àn V‚µ‚¢¶—‹@”\ŒŸ¸i”x‹@”\j|ŠjˆãŠwŒŸ¸‚ð’†S‚Æ‚µ‚Ä|. ”~Œ´ŽÀC–¥‰YŽ‘¥C’†“ˆ‰p•FiŽ™j: ¬Ž™‰Èf—ÃC53(1): 100`106Cl989.
673. m‘àn ŒÄ‹z•s‘S. •½Î‘iŽ™j: ¬Ž™“à‰ÈC21: 352`356Cl989.
674. m‘àn lHŒÄ‹z‚Ì“K‰ž. –쌩ŽREi–ƒj: —Õ°ŠÅŒìCl5(7): 970`974Cl989.
675. muÀn ‹}«ŒÄ‹z•s‘S‚Ì•a‘Ô¶—. ‘Š”nˆêˆåi‹~–½j: Modern Physician, 9(3): 297`299, 1989.
676. muÀn ”ñ׋۫”x‰Ši1j. ‰œ•½‰ë•Fi•a—j: ŒÄ‹z, 9(3): 293`298, 1990.
677. muÀn ICU‚É‚¨‚¯‚錟¸‚ƃ‚ƒjƒ^ƒŠƒ“ƒO|‹¹•”‚̉摜f’f|. ‘Š”nˆêˆåi‹~–½j: W’†Ž¡—Ã, 1(3): 295`302, 1989.
678. muÀn ¬Ž™¶—Šw“I”x‹@”\ŒŸ¸‡T. –¥‰YŽ‘¥C”~Œ´ŽÀC’†“ˆ‰p•FiŽ™j: ¬Ž™‰Èf—ÃC52(12): 2717`2722Cl989.
679. mŠwp‘n iŽ·•Mj ‡–°Žž–³ŒÄ‹zÇŒóŒQ; ¬Ž™Ž¾Š³Cp.120`131, “n•Ó“oiŽ™j. •ÒW ‘꓇”Ci“Œ–k‘åj•ÒC ˆã–òƒWƒƒ|ƒiƒ‹ŽÐC‘åãC89.11.l0.”s.
680. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—;ˆãŠwŠe˜_ ‡U.ŒÄ‹zŠí¥‹¹•Ç¥cŠuŽ¾Š³; cŠuŽ¾Š³, p.149`156, •Ð‹Ë^lC•y“c—FKi“àj. •ÒW ‹à–ìŒö˜Yi“Œ—ˆã‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 90.01.10”s.
681. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj@‘æ8”Å; ”x•ª‰æÇCp.382, “n•Ó“oiŽ™j. •ÒW ”·‰Ã”Vi“Œ–M‘åjCŽO‰ÍtŽ÷i‹ž‘åjCd“cMi¬òd“c¬Ž™‰Èj•Ò, ˆãŠw‘‰@C“Œ‹žC89.09.l5”s.
682. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Critical Care,
Emergencies‚É‚¨‚¯‚é‹CŠÇŽx‹¾‚̉ž—p|—L“Å•¨Ž¿•ž—p‚É”º‚¤‹}«Šú‹C“¹•a•Ï‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢|.
‘Š”nˆêˆåCL£—²ˆêC’ç–M•Fi‹~–½jC¬—Ñ–¾–Fi“àjC‘å˜a“c—²i‹~–½jC•Ð‹Ë^lC–î“ߣM—Yi“àj: ‘æ12‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï
(89.07.08), “Œ‹ž.
683. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‹CŠÇŽxŠg’£Ü‹z“üŽž‚ÌŠ·‹C‹@”\‚Æ“®–¬ŒŒ‚̕ω». ”~Œ´ŽÀiŽ™j: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.11.29), •Ÿ‰ª.
684. mŠw‰ïn iˆê”Êu‰‰j ”x¬×–EŠà‚É‚¨‚¯‚éŽîᇊ֘A“œ½RŒ´”Œ»‚ÌŒŸ“¢. Š}ˆäŒ‰C‹T’J“Oi•a—jCät“n’‰’ji—Õ•a—j: ‘æ78‰ñ“ú–{•a—Šw‰ï‘‰ï (89.03.30), ‹ž“s, “ú–{•a—Šw‰ï‰ïŽ, 78: 139, 1989.
685. mŠw‰ïn iˆê”Êu‰‰j ‹¹‘BŽîᇂÌMRI.
“cŠŽŒÈC’J“c—ˆê˜YC¬—Ñ–ÎŽ÷C¼Šª”ŽC’r“crºC‘º“cWˆê˜YC÷ˆä´ŽqC–x’rdŽ¡C›MˆêC¼—Ñ—²i•új: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï
(89.04.05), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): s57, l989.
686. mŠw‰ïn iˆê”Êu‰‰j ”xRadionuclide Angiography ‚ÌFactor
Analysis‚É‚æ‚é”xŽ¾Š³Š³ŽÒ‚Ì”xŒŒ—¬“®‘Ô‚ÌŒŸ“¢. ’†‘òŒ\Ž¡CΈ䟌ÈC¼Šª”ŽC–x’rdŽ¡C’r“crºC“cŠŽŒÈC¼—Ñ—²i•új:
‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï (89.04.05), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽ¥‘æ48‰ñ´˜^WC49(—Õ‘): s65, l989.
687. mŠw‰ïn iˆê”Êu‰‰j ŠO«‰¡Šu–Œƒwƒ‹ƒjƒA‚Ì1Ž¡Œ±—á. “V–ì—²bC‹ß“¡‡‹`i‹¹ŠOjC‘¼: ‘æ144‰ñˆïéŠO‰ÈˆãŠw‰ï (89.05.00), …ŒË.
688. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™ŒÄ‹zŠíŽ¾Š³‚É‚¨‚¯‚é123I|IMP”xƒVƒ“ƒ`ƒOƒ‰ƒ€‚ÌŒŸ“¢.
”~Œ´ŽÀC–¥‰YŽ‘¥C²“¡—Y“ñCŽR“¿‚Ý‚ïC“n•Ó“oCΓc®”VC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï
(89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 768, l989.
689. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚É‚¨‚¯‚釖°Žž–³ŒÄ‹zƒ‚ƒjƒ^|‘•’uiƒAƒvƒmƒ‚ƒjƒ^| MAY-715j‚ÌŽg—p‚ÉŠÖ‚·‚錟“¢.
–¥‰YŽ‘¥C”~Œ´ŽÀC²“¡—Y“ñCŽR“¿‚Ý‚ïC“n•Ó“oCΓc®”VC’†“ˆ‰p•FiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.20), VŠƒC
“ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 768, l989.
690. mŠw‰ïn iˆê”Êu‰‰j Ž‰–bÇðÇŒóŒQ‚ÌBALFŠŒ©. ‚èŒõ‹Ii—Õ•a—jC•Ð‹Ë^li“àjCV“¡³‹PC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ62‰ñ—Õ°ŒÄ‹z¶—Œ¤‹†‰ï (89.06.17), “Œ‹ž.
691. mŠw‰ïn iˆê”Êu‰‰j ƒƒCƒRƒgƒŠƒGƒ“C4‚É‚æ‚é‹C“¹ôò‰t’†‚Ì‘B«ƒJƒŠƒNƒŒƒCƒ“Šˆ«‚Ì‘‘å‹@˜. ”n“ˆ³—²CHong Yong Jin
CŽŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.177, 1989.
692. mŠw‰ïn iˆê”Êu‰‰j Effects of Latex and Different Doses of Silica on
Behavior of Iron Particles in Rabbit Lungs.
‘ŠàVDŽ¡C‚“c™¦C‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qjC¬’J½i“Œ‹ž“d‹@‘åjCK. ChiyotaniiŒ]”x˜JЕa‰@j: 7th
International Conference on Biomagnetism (89.08.17), New York.
693. mŠw‰ïn iˆê”Êu‰‰j Accessory Muscle Activity in Patients with Cervical
Spinal Cord Injury. ‘Š”nˆêˆåCó—˜–õC‘å‚O–«C‘å˜a“c—²i‹~–½j: The 5th World Congress on
Intensive & Critical Care Medicine (89.09.06), ‹ž“s.
694. mŠw‰ïn iˆê”Êu‰‰j ƒƒCƒRƒgƒŠƒGƒ“C4Ö¬“à“Š—^‚É‚æ‚é‹C“¹“à‘B«ƒJƒŠƒNƒŒƒCƒ“Šˆ«—V—£‚Ì‘‘å. ”n“ˆ³—²CHong Yong
JinCŽŽæMi–ò—j: ‘æ39‰ñ“ú–{ƒAƒŒƒ‹ƒM|Šw‰ï‘‰ï (89.09.28°30), “Œ‹žC ƒAƒŒƒ‹ƒM|, 38: 1989.
695. mŠw‰ïn iˆê”Êu‰‰j A Newly Designed Pneumatic-Pulse-Pump-Membrane
Oxygenator. ‹´–{¬Li¶‘ÌHjC•x‰i½ˆêi‹¹ŠOjCMinoru YoshidaCYasunori Sasaki (NDK):
7th World Congress of the International Society for Artificial Organs
(89.10.04), ŽD–yC Artificial Organs, 13(4): 305, 1989.
696. mŠw‰ïn iˆê”Êu‰‰j Tracheotomies: A 15-Year Experience.
¼‰ª–¾—TC‚‹´œAbCŒÃì_ŽOCŒ´“cGˆêC‹àŽqŒ÷iŽ¨•@j: ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï (89.10.17), “Œ‹žC
‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï—\eW, p.78.
697. mŠw‰ïn iˆê”Êu‰‰j Radionuclide Angiocardiography‚Ì Factor
Analysis‚É‚æ‚éæ“V«SŽ¾Š³Š³ŽÒ‚Ì”xŒŒ—¬“®‘Ô‚ÌŒŸ“¢. ’†‘òŒ\Ž¡CΈ䟌ÈC¼Šª”ŽC’J“c—ˆê˜YC‹e’rŒhCˆË“cˆêdC¼—Ñ—²i•új:
‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw, 26(8): 1073, 1989.
698. mŠw‰ïn iˆê”Êu‰‰j Œz‘‘¹Š³ŽÒ‚̌ċzŠÇ—‚ÉŠÖ‚·‚錟“¢. ‘Š”nˆêˆåC‹e–ì—²–¾Có—˜–õC“c’†–ö…C‰““¡¹FC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž.
699. mŠw‰ïn iˆê”Êu‰‰j ‡TŠú‘BŠàÄ”—á‚Ì—Õ°•a—Šw“IŒŸ“¢.
•i“cƒC‹g‘º”Ž–MC•½ˆäŽO˜YCì~C•ŽR’¼Ž÷CÎŒ´ºi‹¹ŠOjCŠ}ˆäŒ‰C‹T’J“Oi•a—j: ‘æ30‰ñ“ú–{”xŠàŠw‰ï‘‰ï (89.11.10),
‰ªŽR, ”xŠà, 29(5): 461, 1989.
700. mŠw‰ïn iˆê”Êu‰‰j –³ŒŒ´”|’n‚É‚æ‚éhCGƒ¿-subunitŽY¶”xŠà×–EŠ”‚ÌŽ÷—§‚Æ‚»‚Ì«ó. Š}ˆäŒ‰C‹T’J“Oi•a—j: ‘æ30‰ñ“ú–{”xŠàŠw‰ï‘‰ï (89.11.10), ‰ªŽR, ”xŠà, 29(5): 517, 1989.
701. mŠw‰ïn iˆê”Êu‰‰j dÇ‹Ø–³—Íǂ̉摜f’f|MRI‚ÍCT‚É‘ã‚í‚éf’f–@‚©|.
“cŠŽŒÈC’J“c—ˆê˜YC¬—Ñ–ÎŽ÷C¼ŽR³ŒáC¼Šª”ŽC’r“crºC›MˆêC¼—Ñ—²i•újC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjC“팴”Í”Vi“àj:
‘æ30‰ñ“ú–{”xŠàŠw‰ï (89.11.11), ‰ªŽR, ”xŠài‘æ30‰ñ“ú–{”xŠàŠw‰ï‘‰ï†j, 29(5): 566, 1989.
702. mŠw‰ïn iˆê”Êu‰‰j ‹CŠÇŽxšb‘§Š³Ž™‚ɑ΂·‚é‰^“®•‰‰×ƒeƒXƒg‚ÌÄ•]‰¿. “n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC²“¡—Y“ñC–¥‰YŽ‘¥CŽl‘q³”ŽiŽ™j: ‘æ26‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM|Šw‰ï (89.11.17), ‘åã, ´˜^W, P.130, l989.
703. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™Šú‹C“¹‰ß•q«ŒŸ¸‚Ì•]‰¿–@‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
–¥‰YŽ‘¥C’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC²“¡—Y“ñCŽl‘q³”ŽCiŽ™j: ‘æ26‰ñ“ú–{¬Ž™ƒAƒŒƒ‹ƒM|Šw‰ï (89.11.17), ‘åãC
“ú–{¬Ž™ƒAƒŒƒ‹ƒM|Šw‰ïŽGŽ, 3(2): 67, l989.
704. mŠw‰ïn iˆê”Êu‰‰j –UŒŸ‚Å–¾‚ç‚©‚É‚È‚Á‚½‹¹–Œˆ««’†”çŽî‚Ì1—á.
“cŠ‰xŽqi“Œ•a‰@•a—jC–{‹§C’†‰p’ji•a—jC‘å–ì‰pŽ¡i•a‰@•a—j: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï (89.11.17),
‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 695, 1989.
705. mŠw‰ïn iˆê”Êu‰‰j ƒAƒfƒmƒEƒCƒ‹ƒX”x‰ŠŒã‚É–«ŒÄ‹zŠíÇó‚ð’悵‚½3Ç—á‚Ì—Õ°“IŒŸ“¢.
Žl‘q³”ŽC’†“ˆ‰p•FC“n•Ó“oCŽR“¿‚Ý‚ïC”~Œ´ŽÀC–¥‰YŽ‘¥C²“¡—Y“ñiŽ™jC–x’rdŽ¡i•új: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï
(89.11.30), •Ÿ‰ª.
706. mŠw‰ïn iˆê”Êu‰‰j ‹C“¹‰ß•q«ŽŽŒ±‚Ì standardization; ŠeŽí‹C“¹‰ß•q«•]‰¿•û–@‚É‚¨‚¯‚é‘ŠŒÝŠÖŒW. –¥‰YŽ‘¥iŽ™j: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.12.01), •Ÿ‰ª.
707. mŠw‰ïn iˆê”Êu‰‰j ¶”x‘S“Eop‚ðŽ{s‚µ‚½dÇ‹CŠÇŽxŠg’£Ç‚Ì‚P’jŽ™—á.
ŠÖª“OCˆäŒ…^—R”üCŽR“cr•FCŽl‘q³”ŽC–¥‰YŽ‘¥C”~Œ´ŽÀC“n•Ó“oC’†“ˆ‰p•FiŽ™jC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï
(89.12.01), •Ÿ‰ª.
708. mŠw‰ïn iˆê”Êu‰‰j ‹CŠÇŽxšb‘§Š³Ž™‚̉^“®‘Ï—e”\‚ɂ‚¢‚Ä‚ÌŒŸ“¢. “n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC²“¡—Y“ñC–¥‰YŽ‘¥CŽl‘q³”ŽiŽ™j: ‘æ22‰ñ“ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï (89.12.01), •Ÿ‰ª, ´˜^WCp.91C1989.
709. mŠw‰ïn iˆê”Êu‰‰j ‹CŠÇˆÙ•¨‚Ì1—á. ’†‘º—vC‹àŽqŒ÷CŒÃ‘òTˆêCŒÃì_ŽOiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.
710. mŠw‰ïn iˆê”Êu‰‰j Paraneoplastic Syndrome, ‹}«ŒÄ‹z•s‘S‚ðŽå’¥‚Æ‚µ‚½”xŠà‚Ì1—á.
V“cŒ’‘¾˜YiŽ¨jC“c’†•üŽqC¬–쎛½ŒåC–kˆä‘¥•vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17),
“Œ‹ž.
711. mŠw‰ïn iˆê”Êu‰‰j ‘O—§‘BŠà‚ð‡•¹C‰¡Šu–Œ‚ðŠÑ’Ê‚µ• o“ài“W‚𗈂½‚µ‚½¶‹¹–Œˆ««’†”çŽî‚Ì1–UŒŸ—á.
–{‹§C’†‰p’jCΈä‰pºC£ìŒªˆêi•a—jCA‘—˜Œöi‡“V‘åjC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.30), •Ÿ‰ª,
“ú–{•a—Šw‰ï‰ïŽ, 79(1): 231, 1990.
712. mŠw‰ïn iˆê”Êu‰‰j ‹C“¹‰ß•q«ŒŸ¸’†‚̘A‘±«ƒ‰‰¹‚ÌŒŸ“¢.
“팴”Í”VC‰Ô“cL‰pC‹v•Û“cŸCˆäŒË“cÆ‹`C²“¡“ú²ŽqC‘q“c¬C•Ð‹Ë^lCž`ŒE–LC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àj:
‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.05), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 268, 1989.
713. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@ŒÄ‹zŠí“à‰È‚É‚¨‚¯‚é”xŠàÇ—á‚ÉŠÖ‚·‚錟“¢iŠJ‰@Œã13”NŠÔ‚ÌÇ—á‚ɂ‚¢‚Äj.
–î“ߣM—YC²“¡“ú²ŽqCŽR–{”Ž”VCŽ›ˆä”ÉŸCÎ삈êC“팴”Í”VCŒ´•ŽjC•Ð‹Ë^lCž`ŒE–LCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àj:
‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.05), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 279, 1989.
714. mŠw‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚Ì‚Ñ‚Ü‚ñ«”xŽ¾Š³‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t•ªÍ‚ÌŽ¡—Âɑ΂·‚é—Õ°“IŒŸ“¢.
•Ð‹Ë^li“àjC‘Š”nˆêˆåi‹~–½jC‚èŒõ‹Ii—Õ•a—jCÎ삈êC²“¡“ú²ŽqCÎì—ºCŽR–{”Ž”VCž`ŒE–LC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FK
i“àj: ‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.06), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 386, 1989.
715. mŠw‰ïn iˆê”Êu‰‰j 111In-•WŽ¯”’ŒŒ‹…‚Ì”xŽ¾Š³‚É‚¨‚¯‚éf’f“IˆÓ‹`.
ŽR–{”Ž”VC“팴”Í”Vi“àjCΈ䟌Èi•újC—é–Ø“¹OC‹ß“¡‚¦‚èCÎì—ºC•Ð‹Ë^lCž`ŒE–LC–î“ߣM—YCˆ¢•”’¼C‘å’Ë—m‹vC•y“c—FKi“àj:
‘æ29‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ï‘‰ï i89.04.07), ‹ž“s, “ú–{‹¹•”Ž¾Š³Šw‰ïŽGŽ, 27(‘): 481, 1989.
716. mŠw‰ïn iˆê”Êu‰‰j ”x¬×–EŠà‚Æ‚ÌŠÓ•Ê‚ª¢“ï‚Å‚ ‚Á‚½Pseudolymphoma‚Ì1—á.
²“¡“ú²ŽqCˆäŒË“cÆ‹`C‘q“c¬CÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àj: ‘æ84‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï
i89.05.13), “Œ‹ž.
717. mŠw‰ïn iˆê”Êu‰‰j ‹C“¹”M‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰tŠŒ©‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
•Ð‹Ë^li“àjC‚èŒõ‹Ii—Õ•a—jC–î“ߣM—Yi“àjC‰©‹àˆäN–¤C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ15‰ñ“ú–{”MŠw‰ï‘‰ï
i89.05.20), O‘O, “ú–{”MŠw‰ï‰ïŽ, 15(3): 191, 1989.
718. mŠw‰ïn iˆê”Êu‰‰j ŠJ‹¹”x¶ŒŸÇ—á‚Ì—\Œã‹K’èˆöŽq‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢.
²“¡“ú²ŽqC•Ð‹Ë^lCŽR–{”Ž”VCÎì—ºC–î“ߣM—YC•y“c—FKi“àjC•i“cƒC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j:
‘æ16‰ñ“ú–{W’†Ž¡—ÈãŠw‰ï‘‰ï i89.06.08), ˆ®ì, ICU‚ÆCCU, 13(‘): 109, 1989.
719. mŠw‰ïn iˆê”Êu‰‰j Œ´”«½œ‰ºÃ–¬ŒŒðÇ‚ªŒ´ˆö‚Æ‚È‚Á‚½”x[Ç‚Ì1—á.
ˆäŒË“cÆ‹`C“팴”Í”VCÎì—ºC–î“ߣM—YCˆ¢•”’¼C•y“c—FKC“cè‹`ºi“àjC“‡“cŒªC¡ˆäŒ‰Cª–{EiŠOj: ‘æ384‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
i89.07.08), “Œ‹ž.
720. mŠw‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚Ì‚Ñ‚Ü‚ñ«”xŽ¾Š³‚É‚¨‚¯‚é‹CŠÇŽx”x–Eôò‰t•ªÍ‚ƃXƒeƒƒCƒhŽ¡—Â̗LŒø«‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢.
•Ð‹Ë^lC²“¡“ú²ŽqC“팴”Í”VC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½jC‚èŒõ‹Ii—Õ•a—j: ‘æ12‰ñ“ú–{‹CŠÇŽxŠw‰ï‘‰ï
i89.07.08), “Œ‹ž, ‹CŠÇŽxŠw, 11(‘): 109, 1989.
721. mŠw‰ïn iˆê”Êu‰‰j Auscultation over the Neck during Bronchial
Provocation Test in Asthmatics. “팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àj: 14th
International Congress on Lung Sounds i89.08.14), Winnipeg, Canada.
722. mŠw‰ïn iˆê”Êu‰‰j Šm’èf’f‚É‹ê—¶‚µ‚½ˆ¾—±Œ‹Šj‚Ì2Ç—á. ‚“cM˜aC²“¡“ú²ŽqCÎì—ºC•Ð‹Ë^lC“팴”Í”VC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àj: ‘æ86‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.
723. mŠw‰ïn iˆê”Êu‰‰j Combined Oat Cell Carcinoma‚Ì‘gDŒ^‚ð‚Æ‚Á‚½”x–å•”‘Šú”xŠà‚Ì1—á.
‘q“c¬CˆäŒË“cÆ‹`CÎì—ºC²“¡“ú²ŽqC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àjC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjCŠ}ˆäŒ‰C‹T’J
“Oi•a—j: ‘æ85‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.
724. mŠw‰ïn iˆê”Êu‰‰j šq“f‚É‚¨‚¯‚鉡Šu–Œ‚Ì“‚«|Š·‹C‰^“®‚Æ‚Ì”äŠr|.
²“¡“ú²ŽqC‰ØŽ÷¬i“àjC“c’†^Ÿi‘‡—Õ°ŒnjCÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKC“cè‹`ºi“àj:
‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.
725. mŠw‰ïn iˆê”Êu‰‰j Diaphragmatic Shortening during Vomiting.
ˆ¢•”’¼C‰ØŽ÷¬C²“¡“ú²ŽqC“팴”Í”VC“c’†‚lC•y“c—FKi“àj: International Symposium on Control of
Breathing and Dyspnea i89.10.28), å‘ä, Abstracts, p.53, 1989.
726. mŠw‰ïn iˆê”Êu‰‰j ‹¹•”‚wüŽÊ^㶉E·‚ð”F‚ß‚½‰ÄŒ^‰ß•q«”x‰Š‚Ì1—á.
—é–Ø“¹OC²“¡“ú²ŽqC‘q“c¬C“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKC“cè‹`ºi“àj: ‘æ387‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
i89.11.11), “Œ‹ž.
727. mŠw‰ïn iˆê”Êu‰‰j Acute Eosinophilic Pneumonia‚Ì1—á.
²“¡“ú²ŽqC‚“cM˜aC‘q“c¬CÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½j:
‘æ88‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i90.02.17), “Œ‹ž.
728. mŠw‰ïn iˆê”Êu‰‰j Dermadrome‚ª‘Šú”Œ©‚ÌŒ_‹@‚Æ‚È‚Á‚½”xŠà‚Ì1—á.
‚“cM˜aC‘q“c¬C“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àjC’ËŒ´“NÆCŠâè‰ëi”çjC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOj: ‘æ390‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
i90.03.10), b•{.
729. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¬Ž™”x‹@”\ŒŸ¸–@‚ÌŠî‘bCV¶Ž™‚æ‚èŽvtŠú‚Ü‚Å‚Ì”x‹@”\‚Ì•]‰¿G“ûŽ™ŠúŒÄ‹zƒpƒ^|ƒ“‚̉ðÍ.
–¥‰YŽ‘¥iŽ™j: “ú–{¬Ž™ŒÄ‹zŠíŽ¾Š³Šw‰ï¬Ž™”x‹@”\ŒŸ¸uK‰ï (89.05.l8), VŠƒC ¬Ž™”x‹@”\ŒŸ¸uK‰ïƒeƒLƒXƒgCp.21`27,
l989.
730. mŒ¤‹†‰ïn iˆê”Êu‰‰j ARDS‚Ì•a‘ԉ𖾂Ɋւ·‚錤‹†. ‘Š”nˆêˆåi‹~–½j: ‘æ5‰ñŽ_‘f—R—ˆƒ‰ƒWƒJƒ‹Œ¤‹†‰ï (89.05.17), ‘Š–ÍŒ´.
731. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒðœ‹Žp’†‚É Massive Air Leak ‚ð’悵‚½‰E”x“®–¬’P“ÆŒ‡‘¹Ç‚Ì1’jŽ™—á.
ã–ìM–íC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥C“‡–{—R‹IŽqCŽl‘q³”ŽiŽ™jCó—˜G’ji‹¹ŠOj: ‘æ3‰ñ“ú–{¬Ž™‹~‹}ˆãŠwŒ¤‹†‰ï
(89.06.17), “Œ‹žC ¬Ž™‰È—Õ°, 43(2): 410, l990.
732. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«ŒÄ‹z¢“ï‚ð’悵‚½ Bronchial cast ‚Ì3—á.
Žl‘q³”ŽC”~Œ´ŽÀC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡i•új: ‘æ3‰ñ“ú–{¬Ž™‹~‹}ˆãŠwŒ¤‹†‰ï (89.06.17), “Œ‹žC
¬Ž™‰È—Õ°, 43(2): 411, l990.
733. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÂÇ«ŒÄ‹zŠíŽ¾Š³Š³Ž™‚̉^“®•‰‰×ƒeƒXƒg‚É‚¨‚¯‚éƒpƒ‹ƒXƒIƒLƒVƒ|ƒ^|‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
Žl‘q³”ŽC’†“ˆ‰p•FC“n•Ó“oC”~Œ´ŽÀC–¥‰YŽ‘¥iŽ™j: ‘æ4‰ñƒpƒ‹ƒXƒIƒLƒVƒƒgƒŠ|Œ¤‹†‰ï (89.06.24), “Œ‹žC ƒpƒ‹ƒXƒIƒLƒVƒƒgƒŠ|,
3: 95`97, l989.
734. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™ŒÄ‹zŠíŽ¾Š³‚É‚¨‚¯‚é123I-IMP”xƒVƒ“ƒ`ƒOƒ‰ƒ€‚ÌŒŸ“¢. ”~Œ´ŽÀCŽl‘q³”ŽC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™jC–x’rdŽ¡CΈ䟌Èi•új: ‘æ5‰ñŠÖ“Œ’n‹æŒÄ‹zŠíŠjˆãŠwŒ¤‹†‰ï (89.09.09), “Œ‹ž.
735. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¸_‰È—̈抳ŽÒ‚É‚Ý‚ç‚ꂽdÇ”x‰Š‚ÉŠÖ‚·‚錟“¢. “c’†•üŽqC¼ŽR’¼‹vC•½“cŒõ”ŽC’ç–M•FC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ26‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï (89.09.09), ‰¡•l.
736. mŒ¤‹†‰ïn iˆê”Êu‰‰j PDA‚É‹Nˆö‚µ‚½”xoŒŒ‚É‚¨‚¯‚éHFO‚ÌŽg—pŒoŒ±. –ì“n³•FC¬ŒûO‹BCŠp“cV•½iŽ™j: ‘æ3‰ñHFOŒ¤‹†‰ï (90.02.25), “Œ‹ž.
737. mŒ¤‹†‰ïn iˆê”Êu‰‰j šq“fŽž‚ÌŒ¢‰¡Šu–Œ‚Ì“®‚«|’´‰¹”g‚ð—p‚¢‚½‹Ø“÷‚Ì’·‚³‚ÌŒŸ“¢|. ‰ØŽ÷¬i“àjC“c’†^Ÿi‘‡—Õ°ŒnjC²“¡“ú²ŽqC“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àj: ‘æ9‰ñ_“ÞìŒÄ‹zƒJƒ“ƒtƒ@ƒŒƒ“ƒX i89.05.20), Œú–Ø.
738. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹C“¹‰ß•q«ŒŸ¸’†‚ÌŒz•”ŒÄ‹z‰¹‚̕ω».
“팴”Í”VC‰ØŽ÷¬CÎì—ºCˆäŒË“cÆ‹`C²“¡“ú²ŽqC‘q“c¬CŽR–{”Ž”VC•Ð‹Ë^lC–{‘½ƒC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àj:
‘æ13‰ñ”x‰¹iŒÄ‹z‰¹jŒ¤‹†‰ï i89.06.10), “Œ‹ž, Ther. Res., 10(10): 429`433, 1989.
739. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ¢‰¡Šu–Œ‚Ì”ñŠ·‹C‹@”\|šq“fŽž‚Ì“‚«|. ²“¡“ú²Žqi“àjC“c’†^Ÿi‘‡—Õ°ŒnjC‰ØŽ÷¬C“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àj: “ú–{MEŠw‰ïê–å•ÊŒ¤‹†‰ï‘æ5‰ñuŒÄ‹z‚Ì—Õ°MEvŒ¤‹†‰ï i89.06.16), “Œ‹ž.
740. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹C“¹”MŽž‚Ì”xŒŒŠÇ“§‰ß«‚ÉŠÖ‚·‚錤‹†. •Ð‹Ë^lC–î“ߣM—YC•y“c—FKi“àjC‰FˆäŒª“ñC‰F’Öؗ´ˆêC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC‚èŒõ‹Ii—Õ•a—j: ‘æ62‰ñ—Õ°ŒÄ‹z¶—Œ¤‹†‰ï i89.06.17), “Œ‹ž.
741. mŒ¤‹†‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@‚É‚¨‚¯‚éÝ‘îŽ_‘f—Ö@‚ÌŒ»ó‚Æ‚»‚Ì–â‘è“_.
Î삈êC‚“cM˜aC‘q“c¬C²“¡“ú²ŽqCÎì—ºC“팴”Í”VC•Ð‹Ë^lC–î“ߣM—YC–{‘½ƒCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½j:
‘æ10‰ñ_“ÞìŒÄ‹zƒJƒ“ƒtƒ@ƒŒƒ“ƒX i89.11.25), ‰¡•l.
742. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒÄ‹z¢“ïAšb–‚ðŽå’¥‚Æ‚µ•›t”玿ƒzƒ‹ƒ‚ƒ“Ü’ZŠúŽ¡—Ã’†‚ɔǂµ‚½P. Carinii”x‰Š‚Ì1—á.
‚“cM˜aC“팴”Í”VCˆ¢•”’¼C•y“c—FKi“àjC¬—Ñ–¾–FC–kŒ´F—YC‘Š”nˆêˆåi‹~–½j: ‘æ27‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï i90.02.03),
‰¡•l.
743. mŒ¤‹†‰ïn iˆê”Êu‰‰j –òÜ—U‹N«”x‰Š‚Ì‹CŠÇŽx”x–Eôò‰t‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢.
‘q“c¬C—é–Ø“¹OC‰Ô“cL‰pi“àjC‚èŒõ‹Ii—Õ•a—jCÎì—ºC•Ð‹Ë^lC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àjC‘Š”nˆêˆåi‹~–½j:
‘æ35‰ñFLDƒVƒ“ƒ|ƒWƒEƒ€ i90.03.10), “Œ‹ž.
<<104 _Œoi¸_‰ÈŠw‚ðŠÜ‚Þj>>
744. mŒ´’˜n Cerebral Blood Flow and Cerebral Hematocrit in Patients with
Cerebral Ischemia Measured by Single-photon Emission Computed
Tomography. âˆä•¶•FCŒÜ\—’‹v‰ÀC—é–ØGˆêC“cè‹`ºi“àj: Acta Neurol. Scand., 127(Suppl.):
9`13, 1989.
745. mŒ´’˜n A Newly Designed Flow-Regulating Device in Shunt Therapy of
Hydrocephalus. ‹´–{¬Li¶‘ÌHjCì–ìM”Vi”]ŠOj: Artificial Organs, 13(5): 483`485,
1989.
746. mŒ´’˜n Properties of Single Chloride Channels in Primary Neuronal
Cultures of Drosophila. Daisuke YamamotoiŽO•H‰»¬¶–½Œ¤jC—é–ØM”Vi¶—j: Biochimica
et Biophysica Acta, 986: 187`190, 1989.
747. mŒ´’˜n Two Components of Calcium Channel Current in Embryonic Chick
Skeletal Muscle Cells Developing in Culture.
‰Á”Z³–¾i¶—jC—N“c–MŽqi¶•¨•¨—jC²“¡—º•½i¶—j: Develop. Brain Res., 47(1): 101`112,
1989.
748. mŒ´’˜n Cranial Burr Hole for Revascularization in Moyamoya Disease.
‰““¡¹FCì–ìM”VC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: J. Neurosurg., 71: 180`185, 1989.
749. mŒ´’˜n Faster Firing Neurons of the Superior Central Raphe and
Ongoing Behaviors in Freely Moving Rats. ŽRèŽÌ•vi¶—j: Jpn. J. Physiol.
Psychol. Psychophysiol., 7(1): 27`38, 1989.
750. mŒ´’˜n The in Vivo Effects of Indomethacin on Reactivity of the Rat
Pial Arterioles. ‰¤”C’¼CXˆä½“ñC‘å‚O–«i”]ŠOj: Kitasato Med., 19(4): 426`435,
1989.
751. mŒ´’˜n ƒtƒ‹ƒ‰ƒ[ƒpƒ€AƒgƒŠƒAƒ]ƒ‰ƒ€Aƒ]ƒsƒNƒƒ“‚Ì‹L‰¯‚ɑ΂·‚éì—p. ‘ºèŒõ–Mi¸j: Medical Tribune, 22: 32, 1989.
752. mŒ´’˜n Responses of the Pial Arterioles to Hemorrhagic Hypotension
in Rat; A Possible Role of Adenosine. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCŽŽæMi–ò—j:
Microcircul. Annual.(Proceeding), p.47`48, 1989.
753. mŒ´’˜n Sodium valproate ‚Ì•¹—p‚ªcarbamazepine
‚¨‚æ‚Ñcarbamazepine-10,11-epoxide ‚Ì—V—£Œ^ŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿‚È‚ç‚Ñ‚É‚»‚Ì—Õ°“IˆÓ‹`.
”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: TDM Œ¤‹†, 6(1): 93`95, 1989.
754. mŒ´’˜n Radioreceptor Assay of Clonazepam and Diazepam in Blood for
Therapeutic Drug Monitoring.
¼ì—²C¼“c—zC‘å’J‰pŽ÷i—Õ•a—jC»‰ŸÂCŽO‰YŽõ’jiŽ™jC{“¡–F³i–k—¢ƒ‰ƒ{jC‹v•Û”Žºi–òŠw•”j: Therapeutic Drug
Monitoring, 11(4): 483`486, 1989.
755. mŒ´’˜n Clear Cell Ependymoma, A Histological Variant with Diagnostic
Implications. ì–ìM”VC–î“cŒ«ŽOi”]ŠOjC–ö‰ºŽO˜Yi•a—j: Virchows Archiv. A Pathol Anat.,
415: 467`472, 1989.
756. mŒ´’˜n “ª•”ŠO‚𔺂¤‘½”ŠO—á‚É‚¨‚¯‚铪ŠW“àˆ³ƒ‚ƒjƒ^[‚Ìd—v«. ‰““¡¹FC‚–ì½C“c’†ç•FC‹´–{—²i‹~–½jC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ˆã—Ã, 43(10): 1010`1013, 1989.
757. mŒ´’˜n Ž©ŽEŠé}Œë—p‚É‚æ‚é‹}«ƒjƒgƒ‰ƒ[ƒpƒ€’†“Å‚Ì—Õ°|68Ç—á‚ɂ‚¢‚Ä‚ÌŒŸ“¢Œ‹‰Ê‚©‚ç|. “‡“c‰hŽqCŽO‰Y’å‘¥i¸j: ÅVˆãŠw, 44(11): 2349`2359, 1989.
758. mŒ´’˜n Diazepam ¿Ü‚Ì””MŽžŠÔŸ[“Š—^–@‚É‚æ‚é”M«‚¯‚¢‚ê‚ñ‚ÌÄ”—\–hŠúŠÔ’†‚É‚Ä‚ñ‚©‚ñ‚ÖˆÚs‚µ‚½Ç—á‚̊댯ˆöŽq‚ÉŠÖ‚·‚錟“¢. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ¬Ž™‰È—Õ°, 42(11): 2419`2426, 1989.
759. mŒ´’˜n ‚¤‚Á•aŽ¡—Âɂ¨‚¯‚éMAD‘jŠQ–ò•œŠˆ‚̉”\«. ‘ºèŒõ–Mi¸j: _Œo¸_–ò—, 11: 763`779, 1989.
760. mŒ´’˜n •Ð“ª’É‚Ì—\–h“IŽ¡—ÂɊւ·‚錤‹†. ŒÜ\—’‹v‰ÀCâˆä•¶•FC“cè‹`ºi“àj: _Œo“à‰ÈŽ¡—Ã, 6(6): 555`560, 1989.
761. mŒ´’˜n “«‚¤‚•a‚ÌŽ¡—Ã|bó‘Bƒzƒ‹ƒ‚ƒ“—Ö@‚Æ“dŒ‚—Ö@‚ÌŒŸ“¢|. Žá“c•””Ž•¶CŽRéˆê˜YCŠ}Œ´—FKC΋½‰ªƒC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: _“Þì¸_–ò—, (2): 19`22, 1988.
762. mŒ´’˜n ƒjƒgƒ‰ƒ[ƒpƒ€‚Ì‹}«’†“ÅÇó‚ɂ‚¢‚Ä. “‡“c‰hŽqCŽá“c•””Ž•¶C‘å’J‹`•vCŽO‰Y’å‘¥i¸j: _“Þì¸_–ò—, (3): 37`44, 1989.
763. mŒ´’˜n V‚½‚ÉlˆÄ‚µ‚½…“ªÇƒVƒƒƒ“ƒgƒVƒXƒeƒ€—pƒAƒ“ƒ`¥ƒwƒbƒh•Ù. ‹´–{¬Li¶‘ÌHjCì–ìM”Vi”]ŠOj: lH‘ŸŠí, 17(2): 787`790, 1988.
764. mŒ´’˜n ”ñƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“ŒnR•sˆÀ–ò. ‘ºèŒõ–Mi¸j: ¸_‰ÈŽ¡—Êw, 5: 25`43, 1990.
765. mŒ´’˜n OverstretchÇ—á‚ÌŽ¡—Ã. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½j: Ò‘ŠO‰È, 3: 137`141, 1989.
766. mŒ´’˜n Ò‘ƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì—L—p«‚ɂ‚¢‚Ä. ‹kŽ ‘i”]ŠOj: Ò‘ŠO‰È, 3: 15`19, 1989.
767. mŒ´’˜n Ò‘‹ó“´Ç‚Ì”¶ƒƒJƒjƒYƒ€‚ɑ΂·‚él‚¦•û. ‹kŽ ‘C”Ñ“cG•vi”]ŠOj: Ò’ÅÒ‘ƒWƒƒ[ƒiƒ‹, 3(2): 113`118, 1990.
768. mŒ´’˜n ”X–EŒ`¬«”]ŽºŽüˆÍ«”’Ž¿“icystic PVLj‚Ì”’B—\Œã. –åˆäL‹ÅC–쑺ƒŽqCŒ´^lCŠ—Œ´FC»‰ŸÂC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC 94(1): 91`96, 1990.
769. mŒ´’˜n •”•ª”ì‚ɑ΂·‚é carbamazepine ’PÜŽ¡—Â̌ø‰Ê|carbamazepine ‚È‚ç‚Ñ‚É
carbamazepine-10,11-epoxide ŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`|. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j:
“ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(6): 1365`1373, l989.
770. mŒ´’˜n ”]ŽºŽüˆÍ«”’Ž¿“iPVLj‚ÌŽ¥‹C‹¤–‰摜ŠŒ©|‘æ‚PŽ™‚ªŒ’í‚Å‘æ‚QŽ™‚ªPVL‚Å‚ ‚Á‚½‘o‘Ù—á‚É‚¨‚¯‚é”äŠr|.
–åˆäL‹ÅCŠ—Œ´FCÄ“¡KˆêC•½Î‘C”ª‘ãŒö•viŽ™jC›Mˆêi•új: “ú–{V¶Ž™Šw‰ïŽGŽC25(3): 581`589, 1989.
771. mŒ´’˜n dÇ‚ŒŒˆ³«”]“àŒŒŽîpŒã‚Ì“ªŠW“àˆ³. ’†ŽRŒ«ŽiC‹{â‰À’jC²“¡Œ’CŽs앶•FC‰ªGGCŽRŒû»Žqi”]ŠOjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: ”]‚Æ_Œo, 41(11): 1149`1154, 1989.
772. mŒ´’˜n ”]‘²’†‹}«Šú‚Ì‚¨‚¯‚錌Ÿ÷MHPG‚Ì•Ï“®. “Œ–M•FC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ”]‘²’†, 11(4): 366`372, 1989.
773. mŒ´’˜n ‰„‘ŠO‘¤ÇŒóŒQ‚ð’悵‚½‰ð—£«’Åœ“®–¬áŽ‚Ì1—á|Ž¡—Ãã‚Ì–â‘è“_‚ɂ‚¢‚Ä. “ü‘qŽŒÈC‹{â‰À’jC‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCL£—²ˆêi“àj: ”]‘²’†, 11: 133`139, 1989.
774. mŒ´’˜n ”]“®–¬áŽªŽ¡Žèp‚ÉŽŠ‚炸Ž€–S‚µ‚½ƒNƒ‚–Œ‰ºoŒŒ—á‚ÌŒŸ“¢. –kŒ´F—YCÄ“¡Œ³—ÇC‘å˜a“c—²i‹~–½jC“ü‘qŽŒÈC–kŒ´s—YC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ”]‘²’†‚ÌŠO‰È, 17: 128`131, 1989.
775. mŒ´’˜n ƒ‰ƒbƒg”]‹•ŒŒŽž‚̃‚ƒmƒAƒ~ƒ“•úo‚ɂ‚¢‚Ä‚ÌŒ¤‹†. –약CC_“c’¼i“àj: –k—¢ˆãŠw, 19(6): 587`593, 1989.
776. mŒ´’˜n ¸_•ª—ô•aŠ³ŽÒ‚É‚¨‚¯‚éYM-09151‚Ì—Õ°–ò—Šw“IŒŸ“¢. Έä‘P‹PC‘ºèŒõ–Mi¸j: –ò—‚ÆŽ¡—Ã, 17(9): 153`167, 1989.
777. mŒ´’˜n ”]ŒŒŠÇ‰Š‚Ì‚P¬l—á|Ž©Œ±—á‚Ì•ñ‚Æ”]ŒŒŠÇ‰Š‚ɂ‚¢‚Ä|. Ä“¡–L˜aC‹{“c‰Ã¢ŽqCŒÃ˜a‹vKC“cè‹`ºi“àj: —Õ°_Œo, 29(4): 456`463, 1989.
778. mŒ´’˜n ˆê‰ß«‘SŒ’–Y”ì‚Ì2Ç—á|PETŠŒ©‚ð’†S‚Æ‚µ‚Ä|. ‰¬–ì—Ti“àjC‰¡ˆä•—Ž™C¼”öŒ’Ž‘CtŒ´Œo•FC—¢‹g‰c“ñ˜Yi‘—§¸__ŒoƒZƒ“ƒ^[j: —Õ°_Œo, 29(5): 599`605, 1989.
779. mŒ´’˜n ¬l”Ç‚Ì–«Š´Šo«ƒjƒ…[ƒƒpƒ`[‚Ì—Õ°“IŒŸ“¢. Ä“¡–L˜aC‹{“c‰Ã¢ŽqCדc–«C’¹‹‡ŽOCŒÃ˜a‹vKi“àj: —Õ°_Œo, 29(7): 859`865, 1989.
780. mŒ´’˜n HAMŠ³ŽÒ‚É‚¨‚¯‚鑉toligoclonal bands‚ÌŒŸ“¢. Ä“¡–L˜ai“àjC”[ŒõOC‰FhŒ÷Žs˜YC¼–{ŽÀCˆäŒ`ºOiŽŽ™“‡‘åj: —Õ°_Œo, 29(8): 976`981, 1989.
781. mŒ´’˜n Šá‹ØŒ^dÇ‹Ø–³—ÍÇ‚Æ‚µ‚ÄŠÏŽ@‚³‚ê‚Ä‚¢‚½mitochondria myopathy (cytochrome C
oxidase•”•ªŒ‡‘¹j‚Ì2—á. ¼“cs³i“àjCâ“cçŽíCtŒ´Œo•FC”W’†ªÆC—¢‹g‰c“ñ˜Yi‘—§¸__ŒoƒZƒ“ƒ^[j: —Õ°_Œo, 29(9):
1180`1182, 1989.
782. mŒ´’˜n ”]Š²[Ç‚Ì”]”gŠŒ©|MRIŠŒ©‚Æ‚Ì‘Ì”ä|. ”¨—²Žui“àjC™ŽRˆêi¸jC‹g–{gŽqi—ÕŒŸj: —Õ°”]”g, 32(1): 5`13, 1990.
783. m’Z•ñn Effectiveness and Plasma Levels of Sodium Valproate
Monotherapy in the Treatment of Epilepsies in Children: A Further
Study. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: Jpn. J. Psychiatr. Neurol., 43(3): 517`518,
1989.
784. m’Z•ñn Ò‘‘“àŽîá‡. ›Mˆêi•új: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 2(1): 39`39, 1989.
785. m’Z•ñn H‹G—Õ°‘å‰ï‹LŽ–;Ò‘Ò’Å. ›Mˆêi•új: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 49(4): 496, 1989.
786. m’Z•ñn ’s•ð|‹ÇŠ”]zŠÂ‚©‚ç‚̃Aƒvƒ[ƒ`. âˆä•¶•Fi“àj: ˜V”NŠú’s•ðŒ¤‹†‰ïŽ, 2: 18`20, 1989.
787. mŒ¤‹†•ñn •p‰ñ‚ÌŽîᇓàoŒŒ‚ð‚«‚½‚µ‚½’®_ŒoâŽî‚Ì1—á. ‘q“c²i”]ŠOjCÄ“¡•ŽuCԒ˽Æiˆä“c•a‰@jC›Mˆêi•újC‚–ØGi‘å˜aŽs—§•a‰@j: _ŒoŠO‰È, 29: 328`332, 1989.
788. mŒ¤‹†•ñi•¶•”Èjn ŠÌˆÚA‚̃VƒXƒeƒ€‰»‚Æ„i‚ÉŠÖ‚·‚錤‹†|”íŠkoŒŒ‚Ì“à‰ÈŽ¡—Âɂæ‚é—\Œã|. “cè‹`ºC_“c’¼C–kˆä‘¥•vi“àj: º˜a62°63”N“x‰ÈŠwŒ¤‹†”ï•â•‹àˆê”ÊŒ¤‹†(A)Œ¤‹†¬‰Ê•ñ‘, p.60`68, 1989.
789. mŒ¤‹†•ñi•¶•”Èjn ƒ‰ƒWƒIƒŒƒZƒvƒ^|ƒAƒbƒZƒC‚É‚æ‚éƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“ŒnR‚Ä‚ñ‚©‚ñ–ò‚Ì—LŒø”Z“xˆæ‚ÌŒŸ“¢. »‰ŸÂiŽ™j: º˜a63”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹ài§—㌤‹† AjŒ¤‹†¬‰Ê•ñ‘C1989.
790. mŒ¤‹†•ñiŒú¶Èjn ’s•ðŽ¾Š³‚Ì—\–h¥Ž¡—ÃA•û–@‚ÉŠÖ‚·‚錤‹†;
Œü¸_•a–ò‚â”]zŠÂ‘ãŽÓ‰ü‘PÜ“™‚É‚æ‚鎡—ÃA’s•ð‚É“Á—L‚ȸ_Çó‚â–â‘ès“®‚Ì—\–h¥Ž¡—Ó™‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸.
’·’JìP—YiˆÉ“¤”BŽR‰·ò•a‰@jC“cè‹`ºC‹àŽq®“ñi“àjCŠ‹’J•¶’jC‰““¡‰pri–¼ŒÃ‰®‘åjCA‘ºŒ¤ˆêC‘ë_Žui•l¼ˆã‘åjC’·’Jì˜a•vC¡ˆäK[i¹
ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: Œ¤‹†•ñ‘, p.100`108, 1989.
791. mŒ¤‹†•ñiŒú¶Èjn _Œo×–E‚̈Þk‚ª’˜–¾‚Å‚ ‚Á‚½’s•ðÇ—á. ’·’JìˆêŽqC¼“cs³CŒÃ˜a‹vKi“àjC–ö‰ºŽO˜YC–{‹§i•a—j: Œú¶ÈƒVƒ‹ƒo[ƒTƒCƒGƒ“ƒXŒ¤‹†•ñ‘, p.64`66, 1989.
792. mŒ¤‹†•ñiŒú¶Èjn ”]ŽåŠ²“®–¬•ÂÇǂɉ—‚¯‚é‹ÇŠ”]ŒŒ—¬‚Ì’·Šú—\Œã. âˆä•¶•Fi“àj: Œú¶ÈzŠÂŠí•aŒ¤‹†ˆÏ‘õ”ï‚É‚æ‚錤‹†•ñW, p.215, 1989.
793. mŒ¤‹†•ñiŒú¶Èjn Onion
bulb\‘¢‚ð—L‚·‚é’E‘«ƒjƒ…[ƒƒpƒ`[‚̔Nj@˜‚ÉŠÖ‚·‚錤‹†|—Õ°“I–ƉuŠw“I‚¨‚æ‚ѶŒŸäC• _Œo‘gD‘œ‚ÌŒŸ“¢|.
ŒÃ˜a‹vKCÄ“¡–L˜aCˆÉ“¡”Ž–¾C¼“cs³Ca’JŒb”üŽqi“àj: Œú¶È¸__ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïuƒjƒ…[ƒƒpƒ`[‚̬ˆö‹y‚ÑŽ¡—ÂɊւ·‚錤‹†,
p.133, 1989.
794. mŒ¤‹†•ñiŒú¶Èjn CJD”D•wŠ³ŽÒ‚Ì–UŒŸ”]‚©‚çƒ}ƒEƒX‚Ö‚ÌTransmission¬Œ÷—á.
‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»jC–k“‡—Œbi¶‰»ŒnjCìŒû‹BC‘å’J‹`•vCŽO‰Y’å‘¥i¸jC²“¡³Ž÷i•a—jC‘êŒûG–çC“cŒû•¶Íi‰q¶Šw•”jCÎŒ´DOi“s
—§_ŒoŒ¤j: Œú¶È“Á’莾Š³u’x”«ƒEƒCƒ‹ƒXŠ´õvŒ¤‹†”Ç•½¬Œ³”N“xŒ¤‹†•ñ‘, p.133`137, 1990.
795. mŒ¤‹†•ñiŒú¶Èjn ”ñ“TŒ^“I‚È•a—ŠŒ©‚ð”F‚ß‚½‰^“®ƒjƒ…[ƒƒ“•a—á. ŒÃ˜a‹vKC’·’JìˆêŽqC¼“cs³i“àjC–ö‰ºŽO˜Yi•a—j: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç1988”N“xŒ¤‹†•ñ‘, p.67, 1989.
796. mŒ¤‹†•ñiŒú¶Èjn ˜V”NŠú’s•ð‚Ì–ò•¨Ž¡—ÂɊւ·‚錤‹†.
’·’JìP—YiˆÉ“¤”BŽR‰·ò•a‰@jC“cè‹`ºC‹àŽq®“ñi“àjCŠq²˜YCŽ‰Æ—²i“ú–{ˆã‰È‘åjC•Ÿ“à–õ’jiŒc‰ž‘åjCr–،ܘYi“ŒŠC‘åjC‘å—F‰pˆêi—•—‰ï
•a‰@jCŠ‹’J•¶’jC‰““¡‰pri–¼ŒÃ‰®‘åj: Œú¶È“Á’莾Š³’s•ðŽ¾Š³‘Îô’²¸Œ¤‹†•ñ‘, 1989.
797. mŒ¤‹†•ñiŒú¶Èjn ’E‘«ƒjƒ…[ƒƒpƒ`[‚É‚¨‚¯‚éRganglideR‘Ì|ELISA‚É‚¨‚¯‚錟“¢|. Ä“¡–L˜aCa’J”üŒbŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†•ñ‘, p.192`196, 1989.
798. mŒ¤‹†•ñiŒú¶Èjn ‰^“®ƒjƒ…[ƒƒ“•aŠ³ŽÒŒŒ´’†‚ÌIgMƒNƒ[ƒ“R‘Ì‚ª”FŽ¯‚·‚é“œ½. Ä“¡–L˜aCˆÉ“¡”Ž–¾Ca’J”üŒbŽqCŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†•ñ‘, p.197`200, 1989.
799. mŒ¤‹†•ñiŒú¶Èjn zŠÂŠíê–å•a‰@‚É‚¨‚¯‚ézŠÂŠíŽ¾Š³“o˜^•[‚É‚æ‚éƒpƒCƒƒbƒgƒXƒ^ƒfƒB‚ÌŽŽs. _“c’¼C–약Ci“àj: º˜a63”N“xŒú¶ÈzŠÂŠí•aŒ¤‹†ˆÏ‘õ”ï‚É‚æ‚錤‹†•ñW, p.372`373, 1989.
800. mŒ¤‹†•ñi‰ÈŠw‹Zp’¡jn CJD ”LjöŽq‚Ì”Zk‚Æ”|—{×–EŒn‚Å‚Ì‘B‚ÌŽŽ‚Ý. ‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»j:
•½¬Œ³”N“x‰ÈŠw‹Zp’¡uƒvƒŠƒIƒ“ŠÖ˜AŽ¾Š³iƒNƒƒCƒcƒtƒFƒ‹ƒg¥ƒ„ƒRƒu•aj”Œ»‹@\‰ðÍ‹Zp‚ÌŠJ”vŒ¤‹†¬‰Ê•ñ‘, p.5`15, 1990.
801. mÇ—á•ñn —¼‘¤–¬—‘pŽ‰–bŽî‚𔺂Á‚½”]—ÀŽ‰–bŽî‚Ì1Ç—á|MRI‚Ì—L—p«‚ɂ‚¢‚Ä|. ‚‹´½C“¡–{ŽiCóˆäˆê˜YC•Ÿ“‡‹`Ž¡iº˜a‘åjC›Mˆêi•új: CTŒ¤‹†, 11(3): 341`345, 1989.
802. mÇ—á•ñn ƒNƒŠƒbƒsƒ“ƒO’¼Œã‘Α¤‚É”j—ô‚ð‚«‚½‚µ‚½—¼‘¤“àŒz“®–¬áŽ‚Ì1Žèp—á. “ü‘qŽŒÈC‚–ì½C“c’†ç•FCÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‹~‹}ˆãŠw, 13: 905`908, 1989.
803. mÇ—á•ñn ‘å–ƒ¸_•a‚Ì6—á. “¿ˆä’BŽiC•ÄŒ³—˜²CŠâ‰ºŠoC”óŽRŒõ‹³Cˆî“cr–çCŽO‘º«C—é–Ø‹`“¿i÷¹‹u•Û—{‰@jCìŒû‹Bi¸jCìˆä®CŒIŒ´˜a•Fi÷¹‹u•Û—{‰@j: ¸_ˆãŠw, 31(9): 919`929, 1989.
804. mÇ—á•ñn Ò‘ŽîᇂƂ̊ӕʂª¢“ï‚Å‚ ‚Á‚½Œz‘ŒŒŠÇŽî‚Ì1—á. “c’†–ö…C”Ñ“cG•vCŽOˆäŒö•FC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 2: 174`175, 1989.
805. mÇ—á•ñn ‘“à”ˆç‚ðŽ¦‚µ‚½Œz‘_ŒoüˆÛŽî‚Ì1—á. ‰ªGGCz–K’m–çC”Ñ“cG•vCŽOˆäŒö•FC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: “ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ïŽGŽ, 2: 180`181, 1989.
806. mÇ—á•ñn ‹}«d–Œ‰º”^ᇂÌ1Ž¡Œ±—á. ŽR“cŸCó—˜–õC™–{Ÿ•FC‘å‚O–«C–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(1): 236`238, 1989.
807. mÇ—á•ñn “Ý“IŠO‚É‚æ‚é’Åœ“®–¬‘¹‚ÌŒoŒ±. ”Ñ“cG•vCì–ìM”VC‰““¡¹FCÄ“¡Œ³—Çi”]ŠOjCL£—²ˆêi“àjC‘å˜a“c—²i‹~–½jC–î“cŒ«ŽOi”]ŠOj: ”]_ŒoŠO‰È, 17: 1051`1060, 1989.
808. mÇ—á•ñn ‹»–¡‚ ‚éCTŠŒ©‚ð’悵‚½‹}«”]Ç‚Ì‚P“ûŽ™—á. ŽO‰YŽõ’jC”~Œ´ŽÀiŽ™jC‘å•”½i•a—j: –k—¢ˆãŠwC19(4): 460`462, 1989.
809. m—Õ°Ž¡Œ±n ’·Šú“Š—^‚É‚¨‚¯‚éYM-09151‚̸_•ª—ô•a‚ɑ΂·‚éŒø‰Ê‹y‚шÀ‘S«‚ÌŒŸ“¢. ‘ºèŒõ–Mi¸j: ˆãŠw‚Æ–òŠw, 22: 733`746, 1989.
810. m—Õ°Ž¡Œ±n V‚µ‚¢ƒxƒ“ƒYƒAƒ~ƒhŒnR¸_•a–òYM-09151‚̉Šú‘æ‡U‘ŠŽŽŒ±. ‘ºèŒõ–MCŽRŠpxCZ‹gHŽŸC΋½‰ªƒi¸jC‘¼11–¼: V–ò‚Æ—Õ°, 38: 1385`1398, 1989.
811. m—Õ°Ž¡Œ±n V‚½‚ÈIminodibenzylŒn‰»‡•¨(Y-516)‚̸_•ª—ô•a‚ɑ΂·‚é—Õ°Œø‰Ê. ‹à–ìŽ C‚‹´—ÇiˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸jC‘¼10–¼: –ò—‚ÆŽ¡—Ã, 17(6): 2657`2671, 1989.
812. m—Õ°Ž¡Œ±n KB-831i‰–Ž_ƒgƒ‰ƒ]ƒhƒ“j‚ÌR‚¤‚ÂŒø‰Ê|‘½Ž{Ý‹¤“¯Œ¤‹†‚É‚æ‚éƒI[ƒvƒ“ŽŽŒ±|.
㓇‘—˜CŒIŒ´‰ë’¼C‚‹´—ÇCX‰·—C’·’Jì˜a•vC‰““¡r‹giˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸jC”óŒû‹P•FiˆÇ—Ñ‘åj: –ò—‚ÆŽ¡—Ã, 17(Suppl.
5): 1451`1463, 1989.
813. m—Õ°Ž¡Œ±n V‚µ‚¢R‚¤‚–òKB-831i‰–Ž_ƒgƒ‰ƒUƒhƒ“j‚Ì‚—îŽÒ‚¤‚•a‚ɑ΂·‚é—Õ°ŽŽŒ±. ΋½‰ªƒC‘ºèŒõ–Mi¸jC㓇‘—˜iˆÇ—Ñ‘åj: –ò—‚ÆŽ¡—Ã, 17(Suppl. 5): 1519`1527, 1989.
814. m—Õ°Ž¡Œ±n V‚µ‚¢BenzamideŒnR¸_•a–òYM-09151‚̸_•ª—ô•a‚ɑ΂·‚é‘æ‡U‘ŠŽŽŒ±.
‘ºèŒõ–Mi¸jCX‰·—C‚‹´—ÇC‰¼‰®“N•FC•—ÕŒ³iˆÇ—Ñ‘åjC”ª–Ø„•½iŒc‘åjC㓇‘—˜iˆÇ—Ñ‘åj: –ò—‚ÆŽ¡—Ã, 17: 4347`4365,
1989.
815. m—Õ°Ž¡Œ±n ¸_•ª—ô•a‚ɑ΂·‚éƒCƒ~ƒmƒWƒxƒ“ƒW[ƒ‹—U“±‘ÌY-516‚̃NƒƒJƒvƒ‰ƒ~ƒ“‘ÎÆ“ñd–ÓŒŸ”äŠrŽŽŒ±. ‰Á“¡LŸC‚‹´—ÇiˆÇ—Ñ‘åjC”ª–Ø„•½iŒc‘åjC•—ÕŒ³CX‰·—iˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸j: —Õ°•]‰¿, 17: 177`196, 1989.
816. m—Õ°Ž¡Œ±n ¸_•ª—ô•a‚ɑ΂·‚éV‚µ‚¢BenzamideŒnR¸_•a–òYM-09151‚ƃnƒƒyƒŠƒh[ƒ‹‚Ì“ñd–ÓŒŸ”äŠrŽŽŒ±.
X‰·—C•—ÕŒ³C‹à–ìŽ C㓇‘—˜C‰¼”ö“N•FiˆÇ—Ñ‘åjC‘ºèŒõ–Mi¸jC”ª–Ø„•½iˆÇ—Ñ‘åj: —Õ°•]‰¿, 17: 349`377, 1989.
817. m‘àn ‚µ‚‚Ý‚Æ“‚«: “®Šá_Œo¥ŠŠŽÔ_Œo. _“c’¼i“àj: Clinical Neuroscience, 8(2): 18`21, 1990.
818. m‘àn áŠQ‚Æ‚»‚Ìf‚©‚½: “®Šá_Œo¥ŠŠŽÔ_Œo. _“c’¼i“àj: Clinical Neuroscience, 8(2): 31`34, 1990.
819. m‘àn ”][Ç‚ÌŽ¡—ÂÆÄ”—\–h. _“c’¼i“àj: Medical Digest, 38(3): 7`12, 1989.
820. m‘àn ˆê‰ß«”]‹•ŒŒ”ì. _“c’¼i“àj: Medical Practice, 6(‘): 23`26, 1989.
821. m‘àn ”]oŒŒ. _“c’¼i“àj: Modern Physician, 9(5): 561`563, 1989.
822. m‘àn ƒ]ƒsƒNƒƒ“. ‘ºèŒõ–Mi¸j: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 7: 1893`1895, 1989.
823. m‘àn ˜’ŒŊԔƒwƒ‹ƒjƒA. ›Mˆêi•új: ‰æ‘œf’f, 9(6): 678`685, 1989.
824. m‘àn ‰–Ž_ƒXƒ‹ƒgƒvƒŠƒh. ‘ºèŒõ–Mi¸j: Œ»‘ãˆã—Ã, 22: 9`11, 1990.
825. m‘àn ƒƒCƒ‰ƒbƒNƒX. ‘ºèŒõ–Mi¸j: Žž‚ÌV–ò, 10: 37`38, 1989.
826. m‘àn ƒoƒ‹ƒlƒ`[ƒ‹. ‘ºèŒõ–Mi¸j: Žž‚ÌV–ò, 10: 41`42, 1989.
827. m‘àn ƒeƒgƒ‰ƒ“ƒhù 90 mg. ‘ºèŒõ–Mi¸j: Žž‚ÌV–ò, 11: 38`42, 1989.
828. m‘àn ‚—îŽÒ‚̉ŠúÇŒóA‰ŠúŽ¡—Ãmf—ẪRƒcn‚ß‚Ü‚¢. ŒÃ˜a‹vKi“àj: ŽÀŒ±Ž¡—Ã, 616: 6`7, 1989.
829. m‘àn ”][Ç‚ÌÄ”—\–h|“à‰È‚Ì—§ê‚©‚ç|. _“c’¼i“àj: zŠÂ‰ÈŠw, 9(7): 736`740, 1989.
830. m‘àn R‚Ä‚ñ‚©‚ñ–ò’PÜŽ¡—Ã. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: ¬Ž™‰Èf—Ã, 52(11): 2521`2530, 1989.
831. m‘àn R‚Ä‚ñ‚©‚ñ–ò‚ÌŽ¡—ÓI–ò•¨ƒ‚ƒjƒ^ƒŠƒ“ƒO. ŽO‰YŽõ’jiŽ™j: ¬Ž™“à‰ÈC22(1): 85`93, 1990.
832. m‘àn Guillain-Barre ÇŒóŒQ. Ä“¡–L˜aC‰¬–ì—Ti“àj: _Œo¸_–ò—, 12(2): 95`104, 1990.
833. m‘àn ‚ˆÀ•a‚Ì_ŒoÇó. ”¨—²Žui“àj: _Œo“à‰È, 31(4): 343`352, 1989.
834. m‘àn Cimetidine‚É‚æ‚é’†•_ŒoáŠQ. ΋½‰ªƒi¸j: _Œo“à‰ÈŽ¡—Ã, 6(4): 337`339, 1989.
835. m‘àn Vincristine‚É‚æ‚é”]ÇAŽ©—¥_ŒoáŠQ. ŒÃ˜a‹vKi“àj: _Œo“à‰ÈŽ¡—Ã, 7(1): 3`6, 1990.
836. m‘àn R•sˆÀ–ò‚Ìì—p‹@˜‚ð‚ß‚®‚Á‚Ä. ‘ºèŒõ–Mi¸j: _“Þ쌧¸_ˆãŠw‰ïŽ, 38: 3`16, 1989.
837. m‘àn ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚É‚æ‚éˆË‘¶‚Æ‹L‰¯áŠQ. ΋½‰ªƒi¸j: ¸_ˆãŠw, 32(3): 267`274, 1990.
838. m‘àn Ò’ÅAÒ‘ŠO‰È‚É‚¨‚¯‚éƒXƒeƒƒCƒh—Ö@. ŽOˆäŒö•Fi”]ŠOj: Ò’Å¥Ò‘ƒWƒƒ[ƒiƒ‹, 1: 417`419, 1989.
839. m‘àn Ò‘‘“àŽîᇂ̎èp. ŽOˆäŒö•FC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½j: Ò’Å¥Ò‘ƒWƒƒ[ƒiƒ‹, 2(12): 885`892, 1989.
840. m‘àn ”]ŒŒŠÇáŠQ‚Ì•a‘Ôf’f‚Æ•”ˆÊf’f. ”¨—²ŽuC“cè‹`ºi“àj: ‘‡—Õ°, 38(11): 2783`2794, 1989.
841. m‘àn ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŠm’èf’f‚ÆŽ¡—Ã. ŒÃ˜a‹vKC’·’JìˆêŽqCדc–«i“àj: ‘‡—Õ°, 38(5): 947`948, 1989.
842. m‘àn “ª’É‚ÌŠÓ•Êf’f‚ÆŽ¡—Ã. âˆä•¶•Fi“àj: “à‰È, 64(2): 229`233, 1989.
843. m‘àn ‹}«ŠúŒz‘i’Åj‘¹‚Ö‚Ì‘Îô. ‘å˜a“c—²i‹~–½j: “ú–{ˆãŽ–V•ñ, (3407): 13`14, 1989.
844. m‘àn Ò‘Žîá‡. ›Mˆêi•új: “úàÕˆã•ñ, 34(1): 35`45, 1989.
845. m‘àn ¬Ž™‚É‚¨‚¯‚éR‚Ä‚ñ‚©‚ñ–ò•¨—Ö@‚Ì“ÁˆÙ«. ŽO‰YŽõ’jiŽ™j: ”]‚Æ”’BC22(2): 154`159, 1990.
846. m‘àn R‚Ä‚ñ‚©‚ñ–ò•¨—Ö@|’PÜŽ¡—ÂƌŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚̈Ӌ`|. ŽO‰YŽõ’jiŽ™j: ”’B–ò—¥–ò•¨Ž¡—ÃŒ¤‹†‰ïŽGŽC2(1): 55`63, 1989.
847. m‘àn ƒNƒƒCƒcƒtƒFƒ‹ƒg¥ƒ„ƒRƒu•a‚Ì•aŒ´‘̂ƔNj@˜. ‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»j: •a‘Ô¶—, 9(10): 858`862, 1989.
848. m‘àn MRI —LŠŒ©Ç—á‚©‚ç‚Ý‚½‰fŽžŽå‘i‚Ì•ªÍ|Ò‘AÒ’ÅŽ¾Š³‚ɂ‚¢‚Ä|. ‘º“cWˆê˜Yi•új: –k‘«—§ŒSŽsˆãŽt‰ï‰ï•ñ, (129): 10`17, 1990.
849. m‘àn ’¹‚Ì”º|’®Šoi‡UjšFŠwK‚̌‘̔’B‹y‚Ñ”]‚ÌšF§Œä. ŽRèŽÌ•vi¶—j: –k—¢ˆãŠw, 19(1): 6`11, 1989.
850. m‘àn ”]ŒŒŠÇáŠQ–«Šú‚ÌŽ¡—Ã. ”¨—²ŽuC“cè‹`ºi“àj: —Õ°‚ÆŒ¤‹†, 66(6): 1900`1906, 1989.
851. m‘àn ŽŒøŒ^¸__Œo—pÜ. ŽO‰Y’å‘¥i¸j: —Õ°‚Æ–ò•¨Ž¡—Ã, 8(4): 484`487, 1989.
852. m‘àn ”]Žîá‡. ›Mˆêi•új: —Õ°‰æ‘œ, 5(12): 34`42, 1989.
853. m‘àn ˜’ɂ̉摜f’f; CT. ›Mˆêi•új: —Õ°‰æ‘œ, 5(9): 30`39, 1989.
854. m‘àn ‘‡•a‰@¸_‰È‚ÌŒ»ó‚Æ–â‘èi‡Tj|‘åŠwˆãŠw•”•t‘®•a‰@‚Ì—§ê‚©‚ç|. ’†“‡ß•vCŽO‰Y’å‘¥i¸j: —Õ°¸_ˆãŠw, 18(5): 589`596, 1989.
855. m‘àn Sˆö«‘½ˆù. ’†“‡ß•vi¸j: —Õ°¸_ˆãŠw, 18(9): 1379`1384, 1989.
856. m‘àn “ÁW:˜V”NŠú’s•ð‚̊댯ˆöŽqAlzheimer•a‚̊댯ˆöŽqg“ª•”ŠOh. ‹{â‰À’ji”]ŠOj: ˜V”NŠú’s•ð, 4: 75`78, 1989.
857. muÀn ”]ŒŒŠÇáŠQ–«Šú‚ÌŽ¡—ÂÌi‚ß•û. ‹àŽq®“ñC_“c’¼i“àj: Medicament News, (1286): 1`4, 1989.
858. muÀn ˆÓŽ¯áŠQ|¨‡|. ”¨—²Žui“àj: Medicina, 26(7): 1110`1114, 1989.
859. muÀn ‰æ‘œf’f‚Ì‚½‚߂̳í‰ð–U}•ˆ;“ªŠWҒňÚs•”¥Ò’Å¥Ò‘. ›Mˆêi•új: Modern Physician, 9: 797`802, 1989.
860. muÀn ”M«‚¯‚¢‚ê‚ñ‚Æ‚Ä‚ñ‚©‚ñ. ŽO‰YŽõ’jiŽ™j: Petit enfant, 9(12): 145`147, 1989.
861. muÀn ÉŽ_–ò‚Å“ª’É‚ª‚È‚º‹N‚±‚é. âˆä•¶•Fi“àj: ƒNƒŠƒjƒVƒAƒ“, 36(385): 49`52, 1989.
862. muÀn ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌV‚µ‚¢Ž¡—Â̎Ž‚Ý¥’·ŠúƒŒƒ{ƒhƒpÇŒóŒQ‚ɑ΂µ‚Ä. ’·’JìˆêŽqi“àj: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(13): 829, 1989.
863. muÀn ‚¤‚•a. ˆîŒ©ˆòºCŽO‰Y’å‘¥i¸j: ŒŽŠ§–òŽ–, 32(1): 77`82, 1990.
864. muÀn Ž©—¥ŒP—û–@. ’†“‡ß•vi¸j: Ž¡—Ã, 71(4): 941`946, 1989.
865. muÀn ‚Ä‚ñ‚©‚ñ|’PÜŽ¡—ÂƖò•¨ŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: ¬Ž™‰È—Õ°C42(4): 707`717, 1989.
866. muÀn ‹¹˜’ňÚs•”‚ÌÒ‘ŽîᇂÆÒ‘ŒŒŠÇáŠQ. ”Ñ“cG•vi”]ŠOjC‘å˜a“c—²i‹~–½j: Ò’ÅAÒ‘, 3: 421`427, 1990.
867. muÀn ’É‚Ý‚Ì—Õ°. âˆä•¶•Fi“àj: “à‰È, 64(2): 277`289, 1989.
868. muÀn ¬Ž™‚Ì”M«‚¯‚¢‚ê‚ñ|‚»‚ÌŠÇ—‚Æ—\Œã‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: •ÛŒ¯ˆã‚Ì—Õ°C(294): 2`11, 1989.
869. muÀn Sˆö«•p”Ç. ’†“‡ß•vi¸j: —Õ°–ƒŒ, 13(11): 1539`1541, 1989.
870. mÀ’k‰ïn ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ¡—Ã. –ö‘òM•viMB‘åjCŒÃ˜a‹vKi“àj: “à‰È, 63(5): 903`922, 1989.
871. mŠwp‘n iŽ·•Mj Brain Hypoxia; ‰–Ž_ƒtƒ‹ƒiƒŠƒWƒ“‚É‚æ‚é•Ð“ª’É‚Ì—\–h“IŽ¡—Ã, 3: 3`8, ŒÜ\—’‹v‰ÀCâˆä•¶•FC“cè‹`ºi“àj. •ÒW Œã“¡•¶’jC‘¼•Ò, ‚É‚ã[‚ë‚ñŽÐ, “Œ‹ž, 89.07.31”s.
872. mŠwp‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 15. ƒp[ƒLƒ“ƒ\ƒ“ÇŒóŒQ‚Æ—Þ‰Ž¾Š³; –ò•¨«ƒp[ƒLƒ“ƒ\ƒ“•a, p.210`215, ŒÃ˜a‹vKC’·’JìˆêŽqi“àj. •ÒW äÝ”N“Oi“Œ‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.11.01”s.
873. mŠwp‘n iŽ·•Mj Annual Review _Œo 1990; “ª’É‚ÌV‚µ‚¢‘Û•ª—Þ, p.372`377, âˆä•¶•Fi“àj. •ÒW Œã“¡•¶’jC‘¼•Ò, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 90.01.10”s.
874. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; ”]‘h¶–@, p.42`43, ‘å˜a“c—²i‹~–½j. ŠÄC “ú–쌴d–¾Cˆ¢•”³˜aŠÄC, ˆãŠw‘‰@, “Œ‹ž, 90.02.15”s.
875. mŠwp‘n iŽ·•Mj ––½_Œo‘¹‚É‚¨‚¯‚é“d‹Cf’fŠw; ‰^“®_Œo“`“±‘¬“x•ª•z‚Ì‘ª’è, p.1`9, ‹kŽ ‘i”]ŠOj. ƒG[ƒUƒC, “Œ‹ž, 88.04.10”s.
876. mŠwp‘n iŽ·•Mj ŠÌáŠQŠ³ŽÒ‚Ö‚Ì“Š–ò; Ö°’ÁÃÜEŒü¸_–ò, p.55`64, ΋½‰ªƒi¸j. ƒ~ƒNƒX, “Œ‹ž, 89.04.01”s.
877. mŠwp‘n iŽ·•Mj ¸_‰È Mook, ¸_‰È—̈æ‚É‚¨‚¯‚é–ò•¨—Ö@; _ŒoÇ, ‘Š§ 1: 303`314, ΋½‰ªƒi¸j. •ÒW ”ª–Ø„•½iŒc‰ž‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.12.20”s.
878. mŠwp‘n iŽ·•Mj ÅVMRIî•ñ; ”]¥_Œo;‰ŠÇ, p.82`91, ›Mˆêi•új. •ÒW ‰Í–ì“Öi“Œ‹ž—Žqˆã‘åjC¼ìˆêi“Œ‘åjC¬–ì—RŽqi“Œ‹ž—Žqˆã‘åjCŒ´“c‘¾iŽœŒbˆã‘åj•Ò, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 89.08.01 ”s.
879. m‹³‰È‘n iŽ·•Mj —Õ°•a‘ÔŠw; ¸_¥_ŒoŽ¾Š³, p.272`286, ’¹‹‡ŽOi“àj. •ÒW ²“¡—Ç’¨i_ŒËí”Õ’Z‘åjC¼Œ´‚Œ«i‹âˆÇ’Z‘åj•Ò, “ì]“°, “Œ‹ž, 89.04.10”s.
880. m‹³‰È‘n iŽ·•Mj _Œo•aŠw; ––½_ŒoáŠQ, p.427`441, ’¹‹‡ŽOi“àj. •ÒW “cè‹`ºi“àjC‹g“c[’jiŽ©Ž¡ˆã‰È‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.11.01”s.
881. m‹³‰È‘n iŽ·•Mj VŽå—v’¥Œó‚©‚ç‚Ý‚½ŒŸ¸‚Ìi‚ß•û; “ª’É, p.157`160, ŒÃ˜a‹vKi“àj. •ÒW ¼“cdŽOC•Ò, V‹»ˆãŠwo”Å, “Œ‹ž, 90.01.10”s.
882. m‹³‰È‘n iŽ·•Mj _Œo“à‰È Quick Reference; Ò‘Žîá‡, p.568`584; Ò‘ŠO, p.597`617, ‘å˜a“c—²i‹~–½j. •ÒW …–ì”ü–Mi‡“V“°‘åj•Ò, •¶Œõ“°, “Œ‹ž, 89.09.27”s.
883. m‹³‰È‘n iŽ·•Mj ”]_ŒoŠO‰È Quick Reference|‡—“I‚Èf’f‚ÆŽ¡—Ã|; Ò‘ŠO|‹}«Šú|, p.546`556, –î“cŒ«ŽOi”]ŠOj. •ÒW ŽR‰Y»iç—t‘åj•ÒC •¶Œõ“°, “Œ‹ž, 89.06.16”s.
884. m‹³‰È‘n iŽ·•Mj ŒûoSgˆãŠw—Õ°uÀC‘æ‡UŠª:f’f¥Ž¡—ÕÒ; ƒZƒlƒXƒgƒpƒ`[C¸_•ª—ô•aC‚»‚Ì‘¼, ‡U: 109`128, ’†“‡ß•vi¸j. •ÒW “à“cˆÀMi“Œ‹žˆã‰È‘åj•ÒC ‘—Ñ, “Œ‹ž, 89.11.10”s.
885. m‹³‰È‘n iŽ·•Mj ¸_•ÛŒ’iŒn“ŠÅŒìŠwuÀAê–åŠî‘b 11j; “ü‰@¶Šˆ‚̸_•ÛŒ’, 11: 167`195, ²“¡Šìˆê˜Yi¸j. •ÒW ‘â‘׎Ÿ˜Yi“Œ‹ž‘Û‘åjC‘¼•ÒC ˆãŠw‘‰@, “Œ‹ž, 90.01.06”s.
886. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW;@ •S“úŠPCWerdnig-Hoffmann •a
‘¼,@p.154, 240, 320, 387, 393`394, ŽO‰YŽõ’jiŽ™j. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄC, “ú–{ˆãŽ–V•ñŽÐ,
“Œ‹ž, 89.11.15 ”s.
887. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj V–ò•¨—Ö@; •Ð“ª’É, p.674`675; ŒQ”“ª’É, p.676`677, âˆä•¶•Fi“àj. •ÒW ã“c‘×C‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.12.25”s.
888. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; “ª’É, 31: 190`191, âˆä•¶•Fi“àj. •ÒW ˆîŠ_‹`–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.02.15”s.
889. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ‰^“®¥HŽ–¥‹x—{‚̃ŠƒYƒ€‚ƃ^ƒCƒ~ƒ“ƒO; ãŽè‚ȇ–°‚Ì‚Æ‚è•û, p.25`40, ‘ºèŒõ–Mi¸j. –¾Ž¡¶–½Œú¶Ž–‹Æ’c, “Œ‹ž, 89.00.00”s.
890. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj —D‚ꂽ”ì—}§Œø‰Ê‚Ƹ_Çó‰ü‘PŒø‰Ê|ƒfƒOƒŒƒg|ƒ‹Ç—áW|;
‘½“®CŠwKáŠQ‚ðŽ¦‚µ‚½9΂̒jŽq|•”•ª‚Ä‚ñ‚©‚ñ|, p.14`15, ŽO‰YŽõ’jiŽ™j. •ÒW ‘åÀ’îˆêi‘—§¸_¥_ŒoƒZƒ“ƒ^|j•ÒC
“ú–{ƒ`ƒoƒKƒCƒM|, •ó’Ë, 89.06.00”s.
891. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj e‚¤‚Âf‚ª‚í‚©‚é–{; ‘ºèŒõ–Mi¸j. ‚²‚Ü‘–[, “Œ‹ž, 90.01.31”s.
892. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ‚æ‚‚í‚©‚铧͗Ö@Aƒnƒ“ƒhƒuƒbƒN;
ƒ‰ƒCƒtƒTƒCƒNƒ‹•Ê‚É‚Ý‚½“§ÍŠ³ŽÒ‚Ì‹ê”Yi‘æ8Í:¸_ˆãŠw‚Ì—§ê‚©‚ç‚Ý‚½“§ÍŠ³ŽÒj, p.230`263, ²“¡Šìˆê˜Yi¸j. •ÒW
‘¾“c˜a•vi“Œ—ˆã‘åj•ÒC ƒƒfƒBƒJo”Å, ‘åã, 89.06.30”s.
893. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj “§ÍŠ³ŽÒ‚̸_ˆãŠw‚ÆS——Ö@; “§ÍŠ³ŽÒ‚̃\[ƒVƒƒƒ‹¥ƒCƒ[ƒW‚ÌŒŸ“¢|self-other
orientation method ‚É‚æ‚é|, p.152`162,
²“¡Šìˆê˜Yi¸jC•ŸŽR‰Ãji‘‡ˆã—ÑŠ’k•”jC÷ˆäŒšŽ¡i‹´–{ƒNƒŠƒjƒbƒNjCRobert C. ZillerC‘å‘q–LiƒtƒƒŠƒ_‘åj. •ÒW
ÔŠÔ—§Ž}iŒÕ‚Ì–å•a‰@j•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 89.07.05”s.
894. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj “§ÍŠ³ŽÒ‚̸_ˆãŠw‚ÆS——Ö@;
‰Æ‘°“à‚Ì–â‘è‚ÌŒ°Ý‰»‚É‚æ‚蓱“üŠú‚¤‚‚Ƒމ@Œã‚ɃqƒXƒeƒŠ[‚ð’悵‚½Ç—á, p.213`218, ²“¡Šìˆê˜Yi¸j. •ÒW
ÔŠÔ—§Ž}iŒÕ‚Ì–å•a‰@j•ÒC “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 89.07.05”s.
895. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1990”N”Å; ¬Ž™‚Ì‹}«”]‰Š¥”]Ç, p.734`735, ŽO‰YŽõ’jiŽ™j.
•ÒW ˆîŠ_‹`–¾iç—t‘åjC‘½‰ê{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜Yi“Œ‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 90.02.15 ”s.
896. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ¸_‰È Mook, No.24, SgÇ; SgÇ‚ÆÖ°—Ö@, p.125`132, ’†“‡ß•vi¸j. •ÒW •³ŒšˆêiˆÇ—Ñ‘åj•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.10.20”s.
897. mŠwpÜn ‘æ1‰ñ“ú–{Ž©—¥ŒP—ûŠw‰ïJMI‹L”OÜiŽ©—¥ŒP—û–@‚ÌŒ¤‹†‚Æ•‹y‚ÉvŒ£‚µ‚½jC ’†“‡ß•vi¸j.
898. mŠw‰ïn i“Á•Êu‰‰j Žq‚Ç‚à‚½‚¿‚ÌS‚É”—‚é|”Y‚ß‚éŽq‚Ç‚à‚½‚¿‚Ì—Õ°—á‚ð’Ê‚µ‚Ä|. ²“¡Šìˆê˜Yi¸j: ‘æ21‰ñŠwZ•ÛŒ’Šw‰ï‘‰ï (90.02.09), ‰¡•l.
899. mŠw‰ïn i“Á•Êu‰‰j Brain 89•ñ. âˆä•¶•Fi“àj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï i89.11.18), “Œ‹ž.
900. mŠw‰ïn i‹³ˆçu‰‰j Žîᇫ•a•ÏINƒZƒ~ƒi[e‹¹˜’ňÚs•”•a•Ï‚É‚æ‚é_Œo•a•Ïf. ‹kŽ ‘i”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.08), ŽD–y.
901. mŠw‰ïn i‹³ˆçu‰‰j Ò‘Ž¾Š³‚̃‚ƒjƒ^ƒŠƒ“ƒO. ‹kŽ ‘i”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.
902. mŠw‰ïn i‹³ˆçu‰‰j OPLL‚É‚æ‚éMyelopathy‚Ì•a‘Ô¶—. ‹kŽ ‘i”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.
903. mŠw‰ïn i‹³ˆçu‰‰j Œã“ª—tŽ‹’†•‚¨‚æ‚ÑŠá‹…‰^“®i”]Š²j‚ÉŠÖŒW‚µ‚½MRI. ›Mˆêi•új: ‘æ12‰ñ_ŒoŠá‰ÈuK‰ï (89.10.21), “Œ‹ž, _ŒoŠá‰È, 6(•â): 129, 1989.
904. mŠw‰ïn i‹³ˆçu‰‰j Arnold-Chiari ŠïŒ`‚É‚Æ‚à‚È‚¤Ò‘‹ó“´Ç. ‹kŽ ‘i”]ŠOj: ‘æ10‰ñ“ú–{”]_ŒoŠO‰ÈƒRƒ“ƒOƒŒƒX (90.03.30), “Œ‹ž.
905. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j The Effects of Triazolam, Flurazepam and Zopiclone
on Human Memory. ‘ºèŒõ–MC΋½‰ªƒi¸j: International Joint Meeting on Sleep
Research (89.05.00), Honolulu.
906. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j The Search for the Creutzfeldt-Jakob Disease Agent:
Subcellular Distribution of the Transmissible Agent in CJD Mouse Brain,
and Re-Examination of PrP Requirement for the CJD Infectivity.
‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»jC–k“‡—Œbi¶•¨‰»ŠwŒnjC“cŒû•¶Íi‰q¶Šw•”jC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: Canadian
International Neuroscience Symposium (89.06.05), Guelph (Canada),
Proceedings, p.18, 1989.
907. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¬Ž™‚É‚¨‚¯‚é‚Ä‚ñ‚©‚ñ–ò•¨—Ö@‚Ì“ÁˆÙ«iŽå‘è:‚Ä‚ñ‚©‚ñf—ÂÌÅ‹ß‚Ìi•àj. ŽO‰YŽõ’jiŽ™j: ‘æ31‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (89.07.08), ŽD–yC ”]‚Æ”’B, 21(‘‰ï†): s98, 1989.
908. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¸_•ÛŒ’–@Ž{sŒã‚ð‚ß‚®‚Á‚Ä|‘‡•a‰@‚Ì—§ê‚©‚ç|. ˆîŒ©ˆòºi¸j: _“Þ쌧¸_ˆãŠw‰ï (89.07.15), ‰¡•l.
909. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j The Newest Psychotropic Molecules under Development
in Japan. ‘ºèŒõ–Mi¸j: 6th Conference of Bio-Clinical Interface (89.09.00),
Rouffach, France.
910. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Ö°—Ö@‚Ƃ͉½‚©|Ž„‚ÌÖ°—Ö@|. ’†“‡ß•vi¸j: ‘æ35‰ñ“ú–{Ö°ˆãŠwS—Šw‰ï (89.09.16), “Œ‹ž.
911. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‰^“®_Œo“`“±‘¬“x‚Ì‘ª’è|‚Æ‚‚ÉSlow Component‚ɂ‚¢‚Ä. ‹kŽ ‘i”]ŠOj: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.07), ‹ž“s.
912. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”]oŒŒ‚Ì“à‰È‹~‹}ˆã—ÂƗ\Œã.
–kˆä‘¥•vC”’J‹`GC‹e–ì—²–¾C–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jC_“c’¼C“cè‹`ºi“àj: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï
(89.11.06), “Œ‹ž, ´˜^W, s-698, 1989.
913. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ’Pƒƒwƒ‹ƒyƒX”]‰Š‚Ì”]”g. ™ŽRˆêi¸jC”¨—²Žui“àjCŽí“c^»—Yi¸j: ‘æ19‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï (89.11.11), ‰ªŽR.
914. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ¸_‰È‹~‹}‚ɂ‚¢‚Ä; ‘åŠw•a‰@‚É‚¨‚¯‚é¸_‰È‹~‹}|–k—¢‘åŠw‚ÌŒoŒ±‚©‚ç|. ’†“‡ß•vCΈä‘P‹PCŠ}Œ´—FKC’ç–M•FCˆîŒ©ˆòºCŽO‰Y’å‘¥i¸j: ‘æ2‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï (89.11.11), ‹ž“s.
915. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒŠƒ‰ƒNƒZ[ƒVƒ‡ƒ“|ˆÙ‚È‚é‹Z–@‚Æ‚»‚ÌŒø‰Ê‚Ì“ÁF|Ž©—¥ŒP—û–@‚É‚¨‚¯‚郊ƒ‰ƒNƒZ[ƒVƒ‡ƒ“. ’†“‡ß•vi¸j: ‘æ2‰ñ“ú–{S—ˆã—ÔŠw‰ï˜A‡‘å‰ï (89.11.19), “Œ‹ž.
916. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žó“®“I’ˆÓW’†|‚»‚Ì‹³Ž¦‚ÌŽÀۂƈӋ`|. ’†“‡ß•vi¸j: ‘æ12‰ñ“ú–{Ž©—¥ŒP—ûŠw‰ï (89.11.26), L“‡.
917. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒ^[ƒ~ƒiƒ‹¥ƒPƒA‚ɂ‚¢‚Ä|‘åŠw•a‰@‚Ì—§ê‚©‚ç;ƒ^[ƒ~ƒiƒXƒPƒA[‚ÌŒ»ó‚Æ–â‘è“_|. ²“¡Šìˆê˜Yi¸j: ‘æ22‰ñ“ú–{ƒvƒ‰ƒCƒ}ƒŠ[ƒPƒAŠw‰ï_“ÞìŽx•”ŠwpW‰ï (90.03.24), ‘Š–ÍŒ´.
918. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒŒŠÇ«’s•ð‚Ì”]zŠÂ|ŒŒŠÇ”½‰ž«‚ÌŒŸ“¢|. ”¨—²Žui“àj: ‘æ14‰ñ“ú–{”]‘²’†Šw‰ï‘‰ï i89.03.03), “Œ‹ž.
919. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ‘SgŠÇ—‚ð—v‚·‚é¸_Ž¾Š³Š³ŽÒ‚Ì•a‘Ô‚Æ‚»‚Ì”FŽ¯.
“c’†•üŽqC’ç–M•FCL£—²ˆêC‹e–ì—²–¾C‘Š”nˆêˆåC‘å˜a“c—²i‹~–½jCΊ_“¿]C‰iŽR’¼“¹CŽRéˆê˜YCŽO‰Y’å‘¥i¸j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï
(89.11.06), “Œ‹ž.
920. mŠw‰ïn iˆê”Êu‰‰j ƒjƒgƒ‰ƒ[ƒpƒ€‚Ì‹}«’†“ÅÇó‚ɂ‚¢‚Ä. “‡“c‰hŽqCŽá“c•””Ž•¶C‘å’J‹`•vCŽO‰Y’å‘¥i¸j: ‘æ26‰ñ_“Þ쌧¸_–ò—§˜b‰ï (89.00.00), ‰¡•l.
921. mŠw‰ïn iˆê”Êu‰‰j An Activation Map of Dendrites in a Cochlear Nucleus
of Frog. ‘åŠÑMi¶—j: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.05`07), ‰ªŽRC Jpn. J. Physiol.,
39(Suppl.): S173, 1989.
922. mŠw‰ïn iˆê”Êu‰‰j Two Distinct Mechanisms are Responsible for single
Potassium Channel Block by Internal Tetraethylammonium Ions. Daisuke
YamamotoiŽO•H‰»¬¶–½Œ¤jC—é–ØM”Vi¶—j: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.05`07), ‰ªŽRC Jpn. J.
Physiol., 39(Suppl.): S59, 1989.
923. mŠw‰ïn iˆê”Êu‰‰j Allopurinol‚ª’˜Œø‚ðŽ¦‚µ‚½Œ´ˆö•s–¾‚̕Б¤«”]‰ŠŒã‚Ä‚ñ‚©‚ñ‚Ì1—á.
ˆÀ•ÛŒ«ˆêCãp—z‘¾˜YC”’ˆäGKiŽ™jC“cì•s’m•viŠƒ–è“¿B‰ï‘‡•a‰@jC‘å–î’B’ji¹˜H‰Á‘Û•a‰@j: ‘æ182‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï
(89.04.15), ‰¡•l, _“ÞìˆãŠw‰ïŽGŽ, l989.
924. mŠw‰ïn iˆê”Êu‰‰j Ò‘Œã³’†’†ŠuØŠJ–@‚ÌŒŸ“¢. ŽOˆäŒö•Fi”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ60‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ï (89.04.17), VŠƒ.
925. mŠw‰ïn iˆê”Êu‰‰j Sodium valproate
‚Ì•¹—p‚ªcarbamazepine‚¨‚æ‚Ñcarbamazepine-10,11-epoxide‚Ì—V—£Œ^ŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿‚È‚ç‚Ñ‚É‚»‚Ì—Õ°“IˆÓ
‹`. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ4‰ñ–ò•¨ƒ‚ƒjƒ^ƒŠƒ“ƒO‘S‘Œð—¬‰ï¥‘æ6‰ñ“ú–{TDMŠw‰ïŠwpW‰ï‡“¯ŠwpW‰ï (89.05.13),
“Œ‹ž, u‰‰—vŽ|WCp.23, 1989.
926. mŠw‰ïn iˆê”Êu‰‰j Œü¸_–ò’·Šú•ž—pŠ³ŽÒ‚É‚Ý‚ç‚ꂽ’áNaŒŒÇ‚ÌŒŸ“¢.
Ί_“¿]C’ç–M•FC™ŽRˆêCŽRéˆê˜YCŠp“c’厡C™ŽRŒ’ŽuC‰iŽR’¼Ž÷CŽO‰Y’å‘¥CŽOˆä—ÇŽ÷i¸jCL£—²ˆêi‹~–½j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï
(89.05.18), ‹à‘ò, ´˜^W, p.143, 1989.
927. mŠw‰ïn iˆê”Êu‰‰j “úíƒXƒgƒŒƒX‚Æ‚¤‚•aE‚¤‚Âó‘ÔE_ŒoÇ‹y‚Ñ“à‰ÈE”畆‰ÈŠO—ˆŠ³ŽÒ.
—Ñsˆê˜YC¡ˆä–¾—Yi‰q¶Šw•”jC’†“‡ß•vi¸jC•ŸŽR‰Ãji‘‡‘Š’k•”jCŽO‰Y’å‘¥i¸j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.18),
‹à‘ò, ¸__ŒoŠwŽGŽ, 91(9): 665, 1989.
928. mŠw‰ïn iˆê”Êu‰‰j _Œo«HŽv•sUǂɑ΂·‚és“®—Ö@|Ž©Œ±—á‚ÌŒŸ“¢|. ŒÃ’m‹MŒbŽqC‘å’J‹`•vC‚‹´–¾”äŒÃCŽO‰Y’å‘¥i¸j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.19), ‹à‘ò.
929. mŠw‰ïn iˆê”Êu‰‰j ‘åŠw•a‰@‚É‚¨‚¯‚é¸_‰ÈƒfƒCƒPƒA‚ÌŽŽ‚Ý.
’†“‡ß•vCŠ}Œ´—FKCŽO‰Y’å‘¥i¸jC—é–؃ŒbiŠÅŒì•”jC”’–ØŒ´—tŽqiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“jC¬–Ø‘]‰ÀŽqi‘‡‘Š’k•”jC”’–ØŒ´ŽsŽŸCŽR–{–¾”üiƒŠƒnƒr
ƒŠƒe[ƒVƒ‡ƒ“jC‘ê‘ò‚é‚ÝŽqi‘‡‘Š’k•”j: ‘æ85‰ñ“ú–{¸__ŒoŠw‰ï (89.05.19), ‹à‘ò, ¸__ŒoŠwŽGŽ, 91(11):
1989.
930. mŠw‰ïn iˆê”Êu‰‰j Œ‡_”ì‚Æ•¡ŽG•”•ª”삪‘OŒã‚µ‚Ä”F‚ß‚ç‚ꂽǗá‚ÌŒŸ“¢. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 474, 1989.
931. mŠw‰ïn iˆê”Êu‰‰j ™•ú«ƒoƒ‹ƒvƒŽ_»Ü(KW-6066N)‚ÌŒø‰Ê|ŒŒ’†”Z“x‚È‚ç‚Ñ‚É—Õ°–Ê‚©‚ç‚̈êlŽ@|.
ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 478,
1989.
932. mŠw‰ïn iˆê”Êu‰‰j ”]Ž¿ŽüˆÍ«”’Ž¿“(PVL)‚É‚¨‚¯‚鎥‹C‹¤–‰摜f’f‚Ì—L—p«‚ÌŒŸ“¢.
–쑺ƒŽqCŠ—Œ´FC’†‘ºP•äC¬ŒûO‹BCÄ“¡KˆêC–åˆäL‹ÅC”ª‘ãŒö•viŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC
“ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 629, 1989.
933. mŠw‰ïn iˆê”Êu‰‰j _Œo«HŽv•sUÇŒóŒQ‚ð’悵‚½ãó‰èŽî‚Ì1—á|Šù•ñ—á‚Æ‚Ì”äŠr|. ‰iŽR’¼“¹CâE–{–¾•FC²“¡Šìˆê˜Yi¸j: ‘æ85‰ñ“ú–{¸_ˆãŠw‰ï (89.05.20), ‹à‘ò.
934. mŠw‰ïn iˆê”Êu‰‰j Arnold-ChiariŠïŒ`‚ɇ•¹‚·‚éÒ‘‹ó“´Ç‚̬ˆö‚É‚¨‚¯‚鑉t“®‘Ô‚ÌŠÖ—^. ‹kŽ ‘CŽs앶•FC”Ñ“cG•vCŽOˆäŒö•FC–î“cŒ«ŽOi”]ŠOj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï (89.05.25), …ŒË.
935. mŠw‰ïn iˆê”Êu‰‰j OverstretchÇ—á‚ÌŽèpŽ¡—Ã. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï (89.05.25), …ŒË.
936. mŠw‰ïn iˆê”Êu‰‰j ‰„‘‚æ‚苹‘‚ɂ킽‚é‹‘åÒ‘Ž‰–bŽî‚Ì‚P—á. í”ՉÈêC‰ªGGCŽR“cŸCz–K’m–çC‹kŽ ‘i”]ŠOj: ‘æ34‰ñ“ú–{”]_ŒoŠw‰ïŠÖ“Œ’n•û‰ï (89.05.27), “Œ‹ž.
937. mŠw‰ïn iˆê”Êu‰‰j Possible Involvement of Adenosine in Vasodilatory
Response of the Rat Pial Arterioles to Hypotension.
Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCŽŽæMi–ò—j: The 14th International Symposium on
Cerebral Blood Flow and Metabolism (89.05.28`06.01), ƒ{ƒ[ƒjƒACƒCƒ^ƒŠƒA,
Journal of Cerebral Blood Flow and Metabolism, 9(Suppl.): S487, 1989.
938. mŠw‰ïn iˆê”Êu‰‰j The in Vivo Effect of Iloprost, a Stable Prostacyclin
Analogue, on the Caliber of the Cerebral Microvessels.
Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOj: The 14th International Symposium on Cerebral
Blood Flow and Metabolism (89.05.28`06.01), ƒ{ƒ[ƒjƒACƒCƒ^ƒŠƒA, Journal of
Cerebral Blood Flow and Metabolism, 9(Suppl.): S666, 1989.
939. mŠw‰ïn iˆê”Êu‰‰j ˆã—Ãî•ñƒVƒXƒeƒ€‚ƈãŽt‚̃XƒgƒŒƒX.
’†“‡ß•vC’ç–M•FCŽRéˆê˜YC”’싳li¸jC•ŸŽR‰Ãji‘‡‘Š’k•”jCŽO‰Y’å‘¥i¸jC‹v•Û“c_–çC¡ˆä•ÛŽŸi“ú–{¶ŽY«–{•”j:
‘æ30‰ñ“ú–{SgˆãŠw‰ï (89.06.10), –¼ŒÃ‰®.
940. mŠw‰ïn iˆê”Êu‰‰j Œz’ÅAŒz‘‘¹‚É”º‚¤ŠO«’Åœ“®–¬áŽ‚Ì1—á. ŽR“cŸCŽs앶•FC‰““¡¹Fi”]ŠOjCó—˜–õCV“¡³‹PC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ27‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.06.24), Š‘ò.
941. mŠw‰ïn iˆê”Êu‰‰j ‹—̓lƒIƒ~ƒmƒtƒ@[ƒQƒ“‚b‚É‚æ‚éƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN‚Ì1—á.
”’싳li¸jC“c•Ó‘C‘Š”nˆêˆåC–Ø“cŒõLC“¡–ìé”VC¡ˆäPC¼ŽR´ŒhC–kˆä‘¥•vC‘å˜a“c—²i‹~–½j: ‘æ27‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï
(89.06.24), Š‘ò.
942. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g’f‘w–@‚Åf’f‚µ‚½”]ŽºŽüˆÍ«”’Ž¿“(PVL)‚Ì”’B—\Œã.
–åˆäL‹ÅC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BiŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.03), “Œ‹žC
´˜^WCp.188, 1989.
943. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚̓«‚Ä‚ñ‚©‚ñ‚ɑ΂·‚éƒAƒƒvƒŠƒm|ƒ‹‚ÌŽg—pŒoŒ±.
ˆ¤b_ŽuC¼‰ª½Ž¡CX–{ŽCÎì”üC^•”~C‘å–î’B’jC¼‘ºVŽOi¹˜H‰Á‘Û•a‰@jC”’ˆäGKCãp—z‘¾˜YiŽ™j: ‘æ31‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï
(89.07.06), ŽD–yC ”]‚Æ”’B, 21(‘‰ï†): s113, 1989.
944. mŠw‰ïn iˆê”Êu‰‰j Carbamazepine ‚È‚ç‚Ñ‚É Carbamazepine-10,11-epoxide
‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚·‚錟“¢|ŒŒ´ƒ¿1-acid glycoprotein ”Z“x‚Æ‚ÌŠÖ˜A|. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j:
‘æ31‰ñ“ú–{¬Ž™_ŒoŠw‰ï‘‰ï (89.07.08), ŽD–yC ”]‚Æ”’B, 21(‘‰ï†): s129, 1989.
945. mŠw‰ïn iˆê”Êu‰‰j Treatment of West Syndrome with Gamma Globulin: A
Multicenter Study. Hashimoto, K.i“ú–{ˆã‰È‘åjCAriizumi, M.i“Æ‹¦ˆã‘åjCŽO‰YŽõ’jiŽ™jC‘¼:
19th International Congress of Pediatrics (89.07.24), Paris, Abstracts,
p.190, 1989.
946. mŠw‰ïn iˆê”Êu‰‰j Effectiveness and Plasma Levels of Valproic Acid with
Use of a Slow-Release Preparation. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: 19th International
Congress of Pediatrics (89.07.24), Paris, Abstracts, p.309, 1989.
947. mŠw‰ïn iˆê”Êu‰‰j Combination Therapy of Sodium Valproate and Clonazepam
in Patients with Intractable Epilepsy. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKiŽ™j: 19th
International Congress of Pediatrics (89.07.24), Paris, Abstracts,
p.457, 1989.
948. mŠw‰ïn iˆê”Êu‰‰j Periventricular Leukomalacia: Magnetic Resonance
Evaluation. –åˆäL‹ÅCŠ—Œ´FCÄ“¡KˆêC”ª‘ãŒö•viŽ™j: 19th International Congress of
Pediatrics (89.07.26), Paris, Abstracts, p.220, 1989.
949. mŠw‰ïn iˆê”Êu‰‰j Prevention of Recurrent Febrile Convulsions with
Rectal Diazepam and Development of Epilepsy. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: 19th
International Congress of Pediatrics (89.07.26), Paris, Abstracts,
p.439, 1989.
950. mŠw‰ïn iˆê”Êu‰‰j Ò‘‰ßL’£áŠQ‚É‚¨‚¯‚éÒ‘“àˆ³‚̕ω». ”Ñ“cG•vC‹kŽ ‘CŽs앶•FC“c’†–ö…CŽOˆäŒö•FC–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.07), ŽD–y.
951. mŠw‰ïn iˆê”Êu‰‰j ‰fŽžŠŒ©‚Å‹}«Œz‘‘¹Š³ŽÒ‚Ì—\Œã‚Í—\‘ª‚Å‚«‚é‚©H. ŽRè‹`‹éi”]ŠOjC‘å˜a“c—²C–kŒ´F—YC‰““¡¹Fi‹~–½jC‹kŽ ‘C”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.07), ŽD–y.
952. mŠw‰ïn iˆê”Êu‰‰j ‰„‘‚æ‚苹‘‚ɂ킽‚鋑厉–bŽî‚Ì1—á. í”ՉÈêi”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@jCŽR“cŸC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.07), ŽD–y.
953. mŠw‰ïn iˆê”Êu‰‰j Ò‘Œã³’†Šui“ü–@‚ÌŽÀÛ. ŽOˆäŒö•FC–kŒ´s—YC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjCóˆä²‹vC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï‘‰ï (89.09.08), ŽD–y.
954. mŠw‰ïn iˆê”Êu‰‰j 10”N‚ÌŒo‰ß‚Å‚‚à–Œ‰ºoŒŒ‚É‚ÄÄ”‚µA”]“®–¬áŽ‚ÌV‚½‚È”¶‚ð‚Ý‚½‘½”«”X–Et‚Ì1—á.
‘ˆä³„C“c’†ç•FC‹{â‰À’ji”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ35‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.09.09), “Œ‹ž.
955. mŠw‰ïn iˆê”Êu‰‰j ˆê‘¤«Šá‹…“Ëo‚Ŕǂµ‚½Žá”N«“ªŠWŠOi“W‘–ŒŽî‚Ì1—á.
óˆä²‹vi‘—§‘Š–ÍŒ´•a‰@jCŽOˆäŒö•Fi”]ŠOjC¼X–MºC퉪Š°i‘—§‘Š–ÍŒ´•a‰@jC‹v•Û’·¶i—Žqˆãj: ‘æ35‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
(89.09.09), “Œ‹ž.
956. mŠw‰ïn iˆê”Êu‰‰j ’ˆÓáŠQ¥‘½“®Ž™‚ɇ•¹‚·‚é_ŒoÇASgÇÇó‚Ì’²¸•ñ. Vˆä‘ìCˆÉ“¡ˆèŽqCX“c¶‹IŽqC—é–ؑבãC²“¡ç•äŽqCâE–{–¾•FC²“¡Šìˆê˜Yi¸j: ‘æ7‰ñ“ú–{¬Ž™SgˆãŠw‰ï (89.09.09), ‘åã.
957. mŠw‰ïn iˆê”Êu‰‰j uƒˆƒgƒ‰ƒ“ƒXv‚ÆuF‚¯‚ç‚ꂽƒgƒ‰ƒ“ƒXv‚̶—Šw“IŒŸ“¢|ƒT[ƒ‚EƒOƒ‰ƒtƒB[‚É‚æ‚é––½”畆‰·‚ðŽw•W‚Æ‚µ‚Ä|. ”’싳lC’†“‡ß•vi¸j: ‘æ35‰ñ“ú–{Ö°ˆãŠwS—Šw‰ï (89.09.15), “Œ‹ž.
958. mŠw‰ïn iˆê”Êu‰‰j The Role of Adenosine in Autoregulation of the
Cerebral Blood Flow; Effects of Caffeine on Vasodilatory Response of
the Rat Pial Arterioles to Hypotension. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C–î“cŒ«ŽOi”]ŠOjCŽŽæMi–ò—j:
The Symposium on Purine Nucleosides and Mucleotides in Cell Signalling
(89.09.17`20), Rockville,•Ä‘.
959. mŠw‰ïn iˆê”Êu‰‰j ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì“ª•”MRŠŒ©.
¬—Ñ–ÎŽ÷C›MˆêC’r“crºC“cŠŽŒÈC¼Šª”ŽC¼ŽR³ŒáC’J“c—ˆê˜YC‰¡ŽR‹v˜NC¼—Ñ—²i•új: “ú–{Ž¥‹C‹¤–ˆãŠw‰ï (89.09.18),
“Œ‹ž, “ú–{Ž¥‹C‹¤–ˆãŠw‰ïŽGŽ, 9(2): 251, 1989.
960. mŠw‰ïn iˆê”Êu‰‰j ÛHáŠQ‚𔺂¤’j«‚̃Aƒ‹ƒR[ƒ‹ˆË‘¶Ç‚Ì5—á.
ŽR“ckˆêC—é–ØŒ’“ñi‘—§—×{Š‹v—¢•l•a‰@jCX“c¶‹IŽqi¸jC”óŒûiC…’J—R”üŽqCˆî•x³Ž¡C¼â—˜”VC‰G–XŽq“c²C‰Í–ì—T–¾i‘—§—×{Š‹v—¢•l•a
‰@j: ‘æ24‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï‘‰ï (89.09.23), “Œ‹ž, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Æ–ò•¨ˆË‘¶, 24: 350, 1989.
961. mŠw‰ïn iˆê”Êu‰‰j —«ƒAƒ‹ƒR[ƒ‹ˆË‘¶ÇŽÒ‚ÆŽq‹Ÿ’B(1).
X“c¶‹IŽqi¸jC‘º‰ª‰p—YC—é–ØŒ’“ñC‰Í–ì—T–¾CV”ü—mˆêi‘—§—×{Š‹v—¢•l•a‰@j: ‘æ24‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï‘‰ï (89.09.23),
“Œ‹ž, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Æ–ò•¨ˆË‘¶, 24: 373, 1989.
962. mŠw‰ïn iˆê”Êu‰‰j Žá‚¢—«‚̃Aƒ‹ƒR[ƒ‹ˆË‘¶Ç|ÛHáŠQ‡•¹ŒQ‚ƃAƒ‹ƒR[ƒ‹ˆË‘¶Ç’P“ÆŒQ‚Ì”äŠr|.
…’J—R”üŽqC—é–ØŒ’“ñCŽR“ck“ñCˆî•x³Ž¡C¼â—˜”VC‰Í–ì—T–¾C”óŒûii‘—§—×{Š‹v—¢•l•a‰@jCX“c¶‹IŽqi¸j:
‘æ24‰ñ“ú–{ƒAƒ‹ƒR[ƒ‹ˆãŠw‰ï‘‰ï (89.09.23), “Œ‹ž, ƒAƒ‹ƒR[ƒ‹Œ¤‹†‚Æ–ò•¨ˆË‘¶, 24: 375, 1989.
963. mŠw‰ïn iˆê”Êu‰‰j Arnold-ChiariŠïŒ`‚É”º‚¤Ò‘‹ó“´Ç‚ÌŽèp. ‹kŽ ‘C‚–ì½C‰iˆä–ÎŽ÷Cz–K’m–çC”Ñ“cG•vC–î“cŒ«ŽOi”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.
964. mŠw‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ`“Eop’†‚Ì”]”玿ŒŒ—¬—Ê‘ª’è.
“c’†–ö…CŽRè‹`‹éC‰iˆä–ÎŽ÷C“c’†ç•FC“ü‘qŽŒÈC‹´–{—²C‚–쮎¡C‘q“c²C‰““¡¹FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j:
‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.
965. mŠw‰ïn iˆê”Êu‰‰j ‘åŒ^AVM‚ɑ΂·‚é“Eop‚̉”\«.
‹{â‰À’jC‰ªGGCŽR“cŸC“c’†–ö…C–kŒ´s—YC‘q“c²C‘å‚O–«C‰““¡¹FCÄ“¡Œ³—ÇC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j:
‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.
966. mŠw‰ïn iˆê”Êu‰‰j ˆ««¯äPŽîiGrade ‡V,‡Wj‚É‚¨‚¯‚é’·Šú¶‘¶—á‚Ì—Õ°‹y‚Ñ•a—Šw“IŒŸ“¢. ì–ìM”VCˆÉ“¡”ä˜CŽuCŽR“cŸCŽs앶•FC–î“cŒ«ŽOi”]ŠOjC–ö‰ºŽO˜Yi•a—j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.
967. mŠw‰ïn iˆê”Êu‰‰j –«d–Œ‰ºŒŒŽî‚Ì”¶¥‘ˆ«‚Í—\Œ©‚Å‚«‚é‚©. ¼X–MºCŽOˆäŒö•FC–kŒ´s—YCóˆä²‹vC‚–ì½i”]ŠOj: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27), ·‰ª.
968. mŠw‰ïn iˆê”Êu‰‰j ”]ŠÁ—¬ˆ³‚̕ω»‚ɑ΂·‚郉ƒbƒg”]“î–Œ”÷¬ŒŒŠÇ‚Ì”½‰ž«. Xˆä½“ñC‰¤”C’¼C‘å‚O–«C“c’†ç•FC‹´–{—²C–î“cŒ«ŽOi”]ŠOjC²“¡Œ’i‘‡‘å“c•a‰@j: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.27`29), ·‰ª.
969. mŠw‰ïn iˆê”Êu‰‰j “ªŠW’ê“‚æ‚ѓ÷Žî‚ÌŒoŒ±. Žs앶•FCŽR“cŸCˆÉ“¡”ä˜CŽuCì–ìM”VC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.
970. mŠw‰ïn iˆê”Êu‰‰j ”]”^ᇂƔ]ŽîᇂÌMRI.
í”ՉÈêi”]ŠOjC‚–ØGi‘å˜aŽs—§•a‰@jC‘å“ä’mC‘ˆä³„CŽRè‹`‹éCŽR“cŸCz–K’m–çC‹´–{—²CŽs앶•FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆê
i•új: ‘æ48‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï (89.09.29), ·‰ª.
971. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì•”•ª”ì‚ɑ΂·‚éCarbamazepine ’PÜŽ¡—Â̒·Šú—\Œã. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKiŽ™j: ‘æ23‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï (89.10.06), “Œ‹ž, ´˜^W, p.69, 1989.
972. mŠw‰ïn iˆê”Êu‰‰j GH3×–E‚ɑ΂·‚é×–E“àî•ñ“`’B•ªŽq‚ÌŠÖ—^.
—é–ØM”Vi¶—jC‚–Ø”ŽC‹g‰ª‹i‘‘åjCH“¡‰À‹viŽO•H‰»¬¶–½Œ¤j: ‘æ27‰ñ“ú–{¶•¨•¨—Šw‰ï (89.10.06`08), “Œ‹žC
¶•¨•¨—, 29: S296, 1989.
973. mŠw‰ïn iˆê”Êu‰‰j Clonazepam‚Ì—V—£Œ^ŒŒ’†”Z“x‚ÉŠÖ‚·‚錟“¢|ŒŒ´ƒ¿1-acid glycoprotein”Z“x‚Æ‚ÌŠÖ˜A.
”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ23‰ñ“ú–{‚Ä‚ñ‚©‚ñŠw‰ï (89.10.07), “Œ‹ž, ´˜^W, p.153, 1989.
974. mŠw‰ïn iˆê”Êu‰‰j Transient Type Calcium Channel in the Regulation of
Intracellular Calcium Level of GH3 Cells.
—é–ØM”Vi¶—jCH“¡‰À‹viŽO•H‰»¬¶–½Œ¤jC‚–Ø”ŽC‹g‰ª‹i‘‘åjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC‰Á”Z³–¾i¶—j: 7th
International Conference on Cyclic Nucleotides, Calcium, and Protein
Phosphorylation. (89.10.08`13), _ŒËC Abstract, p. 172, 1989.
975. mŠw‰ïn iˆê”Êu‰‰j Trans-sulcal Approach into the Spinal Cord. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ9‰ñ‘Û”]_ŒoŠO‰ÈŠw‰ï (89.10.09), ƒjƒ…[ƒfƒŠ[.
976. mŠw‰ïn iˆê”Êu‰‰j Changes in Brain Lipid Composition of an Adult Type
SSPE. ‘å’J‹`•vi¸jC‚ŽR‹v”üŽqi¶‰»ŒnjC‹Êˆä—mˆêC¬“ˆ‹vŽqi¶‰»jC¬Œû“OCΈä‘P‹PC–]ŒŽ•Û‘¥C›Œ´“¹ÆCŽO‰Y’å‘¥i¸j: 8th
World Congress of Psychiatry (89.10.13), Athens, Greece, Proceedings,
p.125, 1989.
977. mŠw‰ïn iˆê”Êu‰‰j The in Vivo Effects of Indomethacin on Reactivity of
the Rat Pial Arterioles. ‰¤”C’¼CXˆä½“ñC‘å‚O–«C–î“cŒ«ŽOi”]ŠOj: The lst International
Stroke Congress (89.10.15`19), ‹ž“s.
978. mŠw‰ïn iˆê”Êu‰‰j Retrograde Thrombosis of Feeding Arteries after
Removal of Arteriovenous Malformations.
‹{â‰À’jC‘q“c²C‘å‚O–«C‰““¡¹FCÄ“¡Œ³—ÇC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: The lst International
Stroke Congress (89.10.15`19), ‹ž“s.
979. mŠw‰ïn iˆê”Êu‰‰j Logoclonic Seizure Caused by Tumor Confined in the
SMA. –kŒ´s—YC“c’†–ö…i”]ŠOjC‘ºèŒõ–Mi¸j: 18th International Epilepsy Congress
(89.10.18), New Delhi, India.
980. mŠw‰ïn iˆê”Êu‰‰j Plasma Level to Dose Ratio and Protein Binding of
Clonazepam in Epileptic Children. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: 18th International
Epilepsy Congress (89.10.19), New Delhi, Abstracts, p.72, 1989.
981. mŠw‰ïn iˆê”Êu‰‰j 123I-IMP”]ŒŒ—¬ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[ƒOƒ‹[ƒvƒXƒ^ƒfƒB‚ÌŒŸ“¢i‹U—z«A‹U‰A«—á‚ɂ‚¢‚Äj.
’†“c“T¶Cì㌛ŽiiŽœŒbˆã‘åjC‘¼CΈ䟌Èi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8):
1026, 1989.
982. mŠw‰ïn iˆê”Êu‰‰j ”]oŒŒŠ³ŽÒ‚Ì123I-IMP SPECT‚ÆXüCT‚Ì”äŠrŒŸ“¢.
Έ䟌ÈC¼Šª”ŽC¼ŽR³ŒáC¬—Ñ–ÎŽ÷C’†‘òŒ\Ž¡CΈä‰s®CˆË“cˆêdC¼—Ñ—²i•újC—é–ØGˆêCâˆä•¶•Fi“àj: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï
(89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8): 996, 1989.
983. mŠw‰ïn iˆê”Êu‰‰j Influence of Concurrent Administration of Sodium
Valproate on the Plasma Concentrations of Carbamazepine and its
Epoxide. ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: 18th International Epilepsy Congress
(89.10.20), New Delhi, Abstracts, p.83, 1989.
984. mŠw‰ïn iˆê”Êu‰‰j R¸_•a–ò‚Ì’ZŠú‹L‰¯‚É‹y‚Ú‚·‰e‹¿. ΋½‰ªƒCìŒû‹BC‚‹´–¾”äŒÃCZ‹gHŽŸC—é–Ø–q•FC‘ºèŒõ–MCŽO‰Y’å‘¥i¸j: ‘æ19‰ñ“ú–{_Œo¸_–ò—Šw‰ï (89.10.25), •Ÿ‰ª.
985. mŠw‰ïn iˆê”Êu‰‰j ENG Study of Abnormal Eye Movement. Two Cases Report
of Opsoclonus in Acute Encephalitis. ‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: ‡W. Symposium fur
Neuro-Otologie. (89.10.26), Berlin, ‡W. Symposium fur Neuro-Otologie
Abstracts, p.13, 1989.
986. mŠw‰ïn iˆê”Êu‰‰j Šà––Šúáu’ɂɑ΂·‚éŒo”ç“IƒRƒ‹ƒhƒgƒ~[‚ÌŒoŒ±. ¼X–MºCŽOˆäŒö•FC–kŒ´s—YCóˆä²‹vi”]ŠOjC‰Í‘ºONC’Jì’B–çi—Žqˆã‘åj: ‘æ44‰ñ‘—§•a‰@—×{Š‘‡ˆãŠw‰ï (89.10.27), å‘ä.
987. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g’f‘w–@‚ňÙí‚ðŽw“E‚³‚ꂽ‚É‚à‚©‚©‚í‚炸áz«ƒ}ƒq‚ð’悵‚½’áo¶‘ÌdŽ™‚É‚¨‚¯‚鎥‹C‹¤–‰摜ŠŒ©.
–åˆäL‹ÅC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.10.27), ‘å‹{, ´˜^W,
p.59, 1989.
988. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™‘ƒó‹•ŒŒ«”]áŠQ‚É‚¨‚¯‚鎥‹C‹¤–‰摜ŠŒ©. –åˆäL‹ÅC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.10.27), ‘å‹{, ´˜^W, p.93, 1989.
989. mŠw‰ïn iˆê”Êu‰‰j ƒˆ[ƒhƒzƒ‹ƒ€ƒK[ƒ[‚É‚æ‚é‚ÆŽv‚í‚ê‚é¸_Çó‚ð’悵‚½2Ç—á. Š}Œ´—FKCìŒû‹BCŽá“c•””Ž•¶C΋½‰ªƒCŽO‰Y’å‘¥i¸j: ‘æ27‰ñ“Œ‹ž¸_ˆãŠw‰ï (89.10.28), “Œ‹ž.
990. mŠw‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ`dÇ—á‚ɑ΂·‚é‹~‹}ˆã—Ã.
‰iˆä–ÎŽ÷C‘ˆä³„C‚–ì½C‹{â‰À’jCŽRè‹`‹éCŽR“cŸC“c’†ç•FC“c’†–ö…C‹´–{—²C‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j:
‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.
991. mŠw‰ïn iˆê”Êu‰‰j ƒNƒ‚–Œ‰ºoŒŒ‹}«ŠúŽ¡—Â̌Ÿ“¢. ‚–ì½i”]ŠOjC¼ŽR’¼‹vi‹~–½jC•½“cŒõ”ŽC“c’†–ö…C‰iˆä–ÎŽ÷i”]ŠOjC–kŒ´F—Yi‹~–½j‰““¡¹Fi”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.
992. mŠw‰ïn iˆê”Êu‰‰j “ª•”ŠO‚ɇ•¹‚·‚éƒVƒ‡ƒbƒN‚ÌŒŸ“¢. ‰““¡¹FC‰iˆä¬Ž÷C“c’†–ö…i”]ŠOjC–kŒ´F—YC‘Oì˜a•FC‘å˜a“c—²i‹~–½jC‹´–{—²C‹{â‰À’ji”]ŠOj: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.
993. mŠw‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ^dÇ—á‚ɑ΂·‚é‹~‹}ˆã—Ã.
‰iˆä¬Ž÷C”’ˆä³‘¥C‚–ì½C‹{â‰À’jCŽRè‹`‹éCŽR“cŸC“c’†ç•FC“c’†–ö…C‹´–{—²C‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j:
‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž.
994. mŠw‰ïn iˆê”Êu‰‰j ƒNƒ‚–Œ‰ºoŒŒ‚É‚æ‚éDOAÇ—á‚ÌŒŸ“¢. –kŒ´F—Yi‹~–½jC‰““¡¹Fi”]ŠOjC•½“cŒõ”ŽC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.08), “Œ‹ž.
995. mŠw‰ïn iˆê”Êu‰‰j Ò‘¬”]•Ï«Ç‚É‚¨‚¯‚é‰^“®_Œo“`“±‘¬“x•ª•z‚ÌŒŸ“¢. •x‰p–¾CtŒ´ŒoFi‘—§¸_¥_ŒoƒZƒ“ƒ^[jC‹kŽ ‘i”]ŠOj: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï (89.11.10), ‰ªŽR.
996. mŠw‰ïn iˆê”Êu‰‰j ³’†¥ŽÚœ_ŒoŽhŒƒ‚É‚¨‚¯‚éSSEP”gŒ`‚Ì”äŠrŒŸ“¢. ŠŽi–r•¶C²‹´–M•FC‹gÜ‹vmŽqCŒ´“cGŽ÷C”·—EŽŠC‰LŽ”~Žqi—ÕŒŸjC‹kŽ ‘i”]ŠOj: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï (89.11.10), ‰ªŽR.
997. mŠw‰ïn iˆê”Êu‰‰j “úíƒXƒgƒŒƒX‚̃pƒ^[ƒ“(1)’ÇŽŽ‚É‚¨‚¯‚éŠî–{ƒpƒ^[ƒ“. ¡ˆä–¾—YC²“¡_MC—Ñsˆê˜Yi‰q¶Šw•”jC•ŸŽR‰Ãji‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ5‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (89.11.10), “Œ‹ž.
998. mŠw‰ïn iˆê”Êu‰‰j S—ƒXƒgƒŒƒX‘Έ‚ÌŒø‰Ê•ÊAŒ´ˆö•Ê’²¸. ²“¡_MC¡ˆä–¾—YC—Ñsˆê˜Yi‰q¶Šw•”jC•ŸŽR‰Ãji‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ5‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (89.11.10), “Œ‹ž.
999. mŠw‰ïn iˆê”Êu‰‰j “úíƒXƒgƒŒƒX‚̃pƒ^[ƒ“(2)’Êí¶Šˆ‚Æ”ñ’Êí¶Šˆ‚Å‚ÌŽx”z“IŒXŒü. —Ñsˆê˜YC²“¡_MC¡ˆä–¾—Yi‰q¶Šw•”jC•ŸŽR‰Ãji‘‡‘Š’k•”jC’†“‡ß•vi¸j: ‘æ5‰ñ“ú–{ƒXƒgƒŒƒXŠw‰ï (89.11.10), “Œ‹ž.
1000. mŠw‰ïn iˆê”Êu‰‰j ”ü—eŠO‰È‚ɑ΂·‚é¸_‰ÈƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“. ΋½‰ªƒCŽRéˆê˜YCŽá“c•””Ž•¶CìŒû‹BCâE–{–¾•FCŽO‰Y’å‘¥i¸j: ‘æ2‰ñ“ú–{‘‡•a‰@¸_ˆãŠw‰ï (89.11.11), ‹ž“s.
1001. mŠw‰ïn iˆê”Êu‰‰j ƒ‹[ƒ`ƒ“”]”gŒŸ¸’†‚É”F‚ß‚ç‚ꂽ—Õ°”ì‚Ɣ쎞”]”g‚ɂ‚¢‚Ä.
‹g‘º‹vmŽqi“Œ•a‰@Œ¤‹†ŒnjC‰LŽ”~ŽqC²‹´–M•FCŠŽi–r•¶i—ÕŒŸjCΈä‘P‹PC΋½‰ªƒCˆîŒ©ˆòºC‘ºèŒõ–Mi¸j: ‘æ19‰ñ“ú–{”]”gE‹Ø“d}Šw‰ï
(89.11.11), ‰ªŽR, ´˜^W, p.342, 1989.
1002. mŠw‰ïn iˆê”Êu‰‰j ”]zŠÂŽ©“®’²ß”\‚É‚¨‚¯‚éƒAƒfƒmƒVƒ“‚Ì–ðŠ„;ƒ‰ƒbƒg”]“ד®–¬‚̒ጌˆ³‚ɑ΂·‚锽‰ž«‚ƃJƒtƒFƒmƒ“‚̉e‹¿.
Xˆä½“ñC‰¤”C’¼C‘å‚O–«C‘q“c²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï (89.11.16`17), “Œ‹ž.
1003. mŠw‰ïn iˆê”Êu‰‰j ¶‘ÌtˆÚA‚̬Ž™¥Â”NŠú—á‚æ‚è‚Ý‚½‰Æ‘°.
²“¡Šìˆê˜YC—é–ؑבãi¸jC•ŸŽR‰Ãji‘‡ˆã—ÑŠ’k•”jCâE–{–¾•FCÔ¯ŒbŽqi¸j: ‘æ30‰ñ“ú–{Ž™“¶¥Â”N¸_ˆãŠw‰ï (89.11.17),
•l¼, ´˜^W, p.11, 1989.
1004. mŠw‰ïn iˆê”Êu‰‰j ˆË‘¶“I‚Ђ«‚±‚à‚èó‘Ô‚Æ‚¤‚Âó‘Ô|¶‘ÌtˆÚA¬Ž™¥Â”NŠú—á‚ÌŠÏŽ@‚©‚ç|. ²“¡Šìˆê˜YC—é–ؑבãCÔ¯ŒbŽqi¸j: ‘æ30‰ñ“ú–{Ž™“¶¥Â”N¸_ˆãŠw‰ï (89.11.18), •l¼Žs, ´˜^W, p.51, 1989.
1005. mŠw‰ïn iˆê”Êu‰‰j ’¼’°Šà‚ÌŽèpŒã‚ÉoŒ»‚·‚é¸_áŠQ‚ɂ‚¢‚Ä.
Š}Œ´—FKCìŒû‹BCŽá“c•””Ž•¶C΋½‰ªƒCŽO‰Y’å‘¥i¸jC‘å’J„³C‚‹´r‹BC”äŠé”\Ž÷iŠOj: ‘æ44‰ñ“ú–{‘å’°ãè–å•aŠw‰ï
(89.11.18), “Œ‹ž, “ú–{‘å’°ãè–å•aŠw‰ïŽGŽ, 42(5): 884, 1989.
1006. mŠw‰ïn iˆê”Êu‰‰j ‘O“ª—t—Þã”çŽî‚Ì1—á. ‰ªGGC²“¡Œ’C’†ŽRŒ«Žii”]ŠOj: ‘æ36‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.25), “Œ‹ž.
1007. mŠw‰ïn iˆê”Êu‰‰j ŠÌd•Ï‚ɇ•¹‚µ‚½”]”^ᇂÌ1—á. ‚–ì½C‹´–{—²Cì–ìM”Vi”]ŠOjC–쑺ƒŽqCדc‚Ì‚¼‚ÝiŽ™j: ‘æ36‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.25), “Œ‹ž.
1008. mŠw‰ïn iˆê”Êu‰‰j Žl‹u‘Ì‘…‚‚à–Œ”X–E‚Ì3¬l—á. ‹g“cF—FC–kŒ´s—YCŽOˆäŒö•FC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@jC‹´–{—²i”]ŠOj: ‘æ36‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.11.26), “Œ‹ž.
1009. mŠw‰ïn iˆê”Êu‰‰j Psychiatric Problems of Abusers of Bron, an OTC Cough
Cure Solution Containing Methylephedrine, Codein and Caffeine.
΋½‰ªƒC‹g“c–FŽqCΈä‘P‹PC‘ºèŒõ–MCŽO‰Y’å‘¥i¸j: 28th ACNP (89.12.11), Hawaii.
1010. mŠw‰ïn iˆê”Êu‰‰j Adversive Seizure Status: Case Reports.
‚‹´–¾”äŒÃC‘ºèŒõ–MCˆîŒ©ˆòºCZ‹gHŽŸCŽRŠpxi¸j: 12th International Congress of EEG and
Clinical Neurophysiology (90.01.19), Rio de Janeiro.
1011. mŠw‰ïn iˆê”Êu‰‰j The Role of the Substantia Nigra on Amygdaloid
Kindling. ‘ºèŒõ–MC‚‹´–¾”äŒÃC—é–Ø–q•Fi¸jC“n•ÓŽ i“Œ•a‰@Œ¤‹†Œnj: 12th International Congress
of EEG and Clinical Neurophysiology (90.01.19), Rio de Janeiro, EEG
Clin. Neurophysiol., 75: S148, 1990.
1012. mŠw‰ïn iˆê”Êu‰‰j Œo’±Œ`œ“´”]‰º‚‘Ì“EoŒã‚ÌMRIŠŒ©.
¼Šª”ŽC›MˆêC‰¡ŽR‹v˜NC¬—Ñ–ÎŽ÷C¼ŽR³ŒáC“cŠŽŒÈC¼—Ñ—²i•új: “ú–{Ž¥‹C‹¤–ˆãŠw‰ï (90.02.00), Šò•Œ,
“ú–{Ž¥‹C‹¤–ˆãŠw‰ïŽGŽ, 10(Suppl. 1): 90, 1990.
1013. mŠw‰ïn iˆê”Êu‰‰j Žs”̉tó’ÁŠP–ò‚Ì——pEˆË‘¶‚ÉŠÖ‚·‚é—Õ°¸_ˆãŠw“IŒ¤‹†. ‹g“c–FŽqC΋½‰ªƒC‘ºèŒõ–Mi¸j: Œú¶È¸__ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”¬Œ³”N“xŒ¤‹†•ñ‰ï (90.02.01), “Œ‹ž.
1014. mŠw‰ïn iˆê”Êu‰‰j ¸_•a—lÇó‚ɂĉf‚µ‚½‚Ä‚ñ‚©‚ñ‚Ì3—á. Šâ”öŒõ_i¸j: _“Þì‚Ä‚ñ‚©‚ñ (90.02.03), ‰¡•l.
1015. mŠw‰ïn iˆê”Êu‰‰j ƒrƒ^ƒ~ƒ“B6‘å—ʗÖ@‚ª‘tŒ÷‚µ‚½EIEE‚Ì1—á. ²“¡‰ë•FCŽO‘òmŽiC”’ˆäGKC–xŒû‘דTiŽ™jC‘å–î’B’ji¹˜H‰Á‘Û•a‰@j: ‘æ182‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.
1016. mŠw‰ïn iˆê”Êu‰‰j ‘½”ŠOŽ¡—Ã’†‚ÉŒoŒ±‚µ‚½Wernicke”]Ç‚Ì1—á.
•“cŒ[iŒ`ŠOjC–kŒ´F—Yi‹~–½jC–،Ҋ®miŒ`ŠOjC‰FˆäŒª“ñC’ç–M•FCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‰F’Öؗ´ˆêC‘å˜a“c—²i‹~–½j:
‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.
1017. mŠw‰ïn iˆê”Êu‰‰j ŠO4”NŒã‚ɔǂµ‚½‹C”]Ç‚Ì1—á. ‘ˆä³„C‰iˆä–ÎŽ÷C“c’†–ö…C‹´–{—²C‹{â‰À’ji”]ŠOj: ‘æ37‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (90.03.03), “Œ‹ž.
1018. mŠw‰ïn iˆê”Êu‰‰j Ò‘‘“à germ cell tumor ‚Ì1—á.
óˆä²‹vC‹g“cF—Fi‘—§‘Š–ÍŒ´•a‰@jC–kŒ´s—YCŽOˆäŒö•Fi”]ŠOjC¼X–Mºi‘—§‘Š–ÍŒ´•a‰@j: ‘æ37‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
(90.03.03), “Œ‹ž.
1019. mŠw‰ïn iˆê”Êu‰‰j ‘åŠw•a‰@ƒfƒCƒPƒA‚É‚¨‚¯‚é‰Æ‘°‰ïŠˆ“®.
Š}Œ´—FKi¸jC—é–؃ŒbiŠÅŒì•”jCŽR–{–¾”üiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC¼˜e~i¸jC¬–Ø‘]‰ÀŽqi‘‡‘Š’k•”jC”’–ØŒ´ŽsŽŸC”’–ØŒ´—tŽqiƒŠƒnƒrƒŠ
ƒe[ƒVƒ‡ƒ“•”jC‘ê‘ò‚é‚ÝŽqi‘‡‘Š’k•”jC’†“‡ß•vCŽO‰Y’å‘¥i¸j: ‘æ10‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï (90.03.10), ‹à‘ò.
1020. mŠw‰ïn iˆê”Êu‰‰j ƒfƒCƒPƒA’ÊŠŠ³ŽÒ‚Ì‘Ì—Í•]‰¿|‚Æ‚‚ɸ_•ª—ô•a‚ɂ‚¢‚Ä|.
”’–ØŒ´ŽsŽŸiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC—é–؃ŒbiŠÅŒì•”jCŽR–{–¾”üiƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC¬–Ø‘]‰ÀŽqi‘‡‘Š’k•”jC¼˜e~i¸jC”’–ØŒ´—tŽqiƒŠ
ƒnƒrƒŠƒe[ƒVƒ‡ƒ“•”jC‘ê‘ò‚é‚ÝŽqi‘‡‘Š’k•”jCŠ}Œ´—FKC’†“‡ß•vCŽO‰Y’å‘¥i¸j: ‘æ10‰ñ“ú–{ŽÐ‰ï¸_ˆãŠw‰ï (90.03.10),
‹à‘ò.
1021. mŠw‰ïn iˆê”Êu‰‰j Œã“ªŠWâ|”]ŒŒŠÇáŠQ‚É‚¨‚¯‚éŠáÇói‘æ1•ñj|”]Š²¬”][Ç‚ÆSkew deviation|.
“Œ–M•FC—é–ØGˆêCŒÜ\—’‹v‰ÀC–kˆä‘¥•vC‹àŽq®“ñC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ85‰ñ“ú–{“à‰ÈŠw‰ï‘‰ï i89.04.03),
‹ž“s.
1022. mŠw‰ïn iˆê”Êu‰‰j Familial Juvenile Neuronal Disease; A New Disease? ’·’JìˆêŽqCŒÃ˜a‹vKi“àj: 12th ISN Meeting i89.04.27), Algarve.
1023. mŠw‰ïn iˆê”Êu‰‰j ‘½”«“ªŠW“àΊD‰»‚𔺂¢f’f‚É‹ê—¶‚µ‚½‘O‰º¬”]“®–¬—̈æ[Ç‚Ì1—á. f‘ò’BŽuC²ŽRߎqCŽO•x“N˜YC‰¬–ì—TC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.05.13), “Œ‹ž.
1024. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇŽB‰eŠŒ©‚©‚ç‚Ý‚½”]Š²¥¬”][Ç‚Ì—Õ°“IŒŸ“¢.
ˆ¢‹v’Óñ•vi“àjC’|“àˆè’jC¯–ì–õ•FC‚–ؽC‚–ØNsi϶‰ï’†‰›•a‰@jCŠC˜VŒ´iˆê˜Yi϶‰ïŒü“‡•a‰@j: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï
i89.05.24), …ŒË.
1025. mŠw‰ïn iˆê”Êu‰‰j ㎈—DˆÊ‚Ì[•”Š´ŠoáŠQ‚ð’悵‚½ƒ~ƒGƒƒpƒ`[‚Ì—Õ°“IŒŸ“¢. ‰““¡ˆêÆC¼“cs³C’·’JìˆêŽqC‰¬–ì—TC¼‰ª¹‹ICÄ“¡–L˜aCŒÃ˜a‹vKi“àjC‹kŽ ‘i”]ŠOj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.24), …ŒË.
1026. mŠw‰ïn iˆê”Êu‰‰j One-and-a-halfÇŒóŒQ‚ÌŒoŽž“IŠÏŽ@ . ŠÛŽR”ŽŽuC“Œ–M•FC—é–ØGˆêC”¨—²ŽuC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1027. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ|ƒjƒ“°‡TR‘Ì‚É‚æ‚é‹ØüˆÛ‚̃^ƒCƒv•ª‚¯|ƒqƒg•a‘Ô‹Ø‚É‚¨‚¯‚錟“¢|. ¼–{MŽqC’¹‹‡ŽOC“cè‹`ºi“àjC’†‘ºŒ’iŠñjCˆÀˆä”ü]i‘‡—Õ°Œnj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1028. mŠw‰ïn iˆê”Êu‰‰j RMAGR‘Ì—z«IgM M’`”’ŒŒÇ‚É”º‚¤’E‘«‘½”_Œo‰Š‚ɑ΂·‚錌Ÿ÷ŒðŠ·—Ö@‚ÌŽ¡—ÃŒø‰Ê.
¼–{ŠÂCŽR‰º‡Íi¼ŽR“úÔjC‘å¼W¶iŽY‹Æˆã‘åjCÄ“¡–L˜ai“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1029. mŠw‰ïn iˆê”Êu‰‰j Four Cases of Myelopathy with Disturbed Deep
Sensation Dominantly in Upper Limb|Neurophysiological Consideration|.
¼“cs³C’·’JìˆêŽqC‰““¡ˆêÆC¼‰ª¹‹ICŒÃ˜a‹vKi“àj: International Symposium on Advanced
Evoked Potentials and Related Techniques in Clinical Neurophysiology
i89.05.25), Roma.
1030. mŠw‰ïn iˆê”Êu‰‰j Recurrent Neuropathy ‚Ì6—á|Š´ŠoáŠQ‚©‚ç‚Ý‚½ŒŸ“¢. ‘D–{‚ЂƂÝCÄ“¡–L˜aC¼‰ª¹‹IC¼“cs³Cדc–«CŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1031. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQ‚É‚Ý‚ç‚ê‚é‘ÌŽ²‚Ì‚Ë‚¶‚ê. ‘O“c^Ž¡C—ŠZF“ñCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1032. mŠw‰ïn iˆê”Êu‰‰j Onion bulb\‘¢‚ð—L‚·‚é’E‘«ƒjƒ…[ƒƒpƒ`[‚Ì”¶‹@˜‚ÉŠÖ‚·‚錤‹†|‘æ1•ñ.
—Õ°“IA—Õ°–ƉuŠw“I‚¨‚æ‚ѶŒŸäC• _Œo‘gDŠw“IŒŸ“¢. a’J”üŒbŽqCÄ“¡–L˜aC’¹‹‡ŽOCˆÉ“¡”Ž–¾Cדc–«C¼“cs³CŒÃ˜a‹vKi“àj:
‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1033. mŠw‰ïn iˆê”Êu‰‰j ‰^“®ƒjƒ…[ƒƒ“•aŠ³ŽÒŒŒ´’†‚ÌIgM’PƒNƒ[ƒ“R‘Ì‚ª”FŽ¯‚·‚é“œ½RŒ´. ˆÉ“¡”Ž–¾Ca’J”üŒbŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.25), …ŒË.
1034. mŠw‰ïn iˆê”Êu‰‰j ”ñ“TŒ^“I‚È•a—ŠŒ©‚ð”F‚ß‚½‰^“®ƒjƒ…[ƒƒ“•a‚Ì3—á.
’·’JìˆêŽqi“àjC–ö‰ºŽO˜Yi•a—jC‹{“c‰Ã¢ŽqCa’J”üŒbŽqCŽO•x“N˜YCf‘ò’BŽuC¼“cs³CÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï
i89.05.25), …ŒË.
1035. mŠw‰ïn iˆê”Êu‰‰j HTCV-1 associated uveitis. “ú–ì‰p’‰C¼‰ª³ŒhCˆî‘ºŠ²•vC²”ŒGŽOCÂŽR—FŽOi¬“cŒ´Žs—§•a‰@jCÄ“¡–L˜ai“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË.
1036. mŠw‰ïn iˆê”Êu‰‰j ‰ºŽˆ‰“ˆÊ‚É‹‚¢•Ð–ƒáƒ‚ð’悵‚½Ž‹°oŒŒ‚ɂ‚¢‚Ä‚ÌŒŸ“¢. –kˆä‘¥•vC–약CC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË, ´˜^W, p.320, 1989.
1037. mŠw‰ïn iˆê”Êu‰‰j ”íŠkoŒŒ’´‹}«Šú‚É‚¨‚¯‚錌ŽîŠg‘åˆöŽq‚ɂ‚¢‚Ä|ŒŒs—ÍŠw“IˆöŽq‚ð’†S‚Æ‚µ‚Ä|.
‹àŽq®“ñC–kˆä‘¥•vC”¨—²ŽuC—é–ØGˆêC“Œ–M•FCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË,
´˜^W, p.321, 1989.
1038. mŠw‰ïn iˆê”Êu‰‰j Ž‹°•a•Ï‚É”º‚¤‚ŽŸ_Œo‹@”\áŠQ‚Ì‹ÇŠ”]ŒŒ—¬. —é–ØGˆêCâˆä•¶•FCŒÜ\—’‹v‰ÀC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{_ŒoŠw‰ï‘‰ï i89.05.26), …ŒË, —Õ°_ŒoŠw, 29(12): 1582, 1989.
1039. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQŒã‚̉¼«‹…–ƒáƒ‚É‚æ‚鉉ºáŠQ‚̃ŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‘O“c^Ž¡C—ŠZF“ñCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ26‰ñ“ú–{ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ˆãŠw‰ï‘‰ï i89.06.02), å‘ä.
1040. mŠw‰ïn iˆê”Êu‰‰j ‘å”]”玿‚É‘½”‚̃Aƒ‹ƒcƒnƒCƒ}[Œ´üˆÛ•Ï‰»‚ð‚Ý‚éis«Šjã«–ƒáƒ‚ɂ‚¢‚Ä.
“V–ì’¼“ñCŠâ•£Œ‰C‰¡ˆäWi_“Þ샊ƒnƒrƒŠjC–ö‰ºŽO˜Yi•a—jCˆäŠÖ‰hŽOC’·—FGŽ÷C¼‰º³–¾i‰¡•lŽs‘åjC’·’JìˆêŽqCŒÃ˜a‹vKi“àj:
‘æ30‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i89.06.21), “Œ‹ž.
1041. mŠw‰ïn iˆê”Êu‰‰j ¬lHistiocytosis X—á. ’·’JìˆêŽqCŒÃ˜a‹vKC¼“cs³i“àjC’†‰p’jC–ö‰ºŽO˜Yi•a—j: ‘æ30‰ñ“ú–{_Œo•a—Šw‰ï‘‰ï i89.06.21), “Œ‹ž.
1042. mŠw‰ïn iˆê”Êu‰‰j Disconnection syndrome‚𗈂µ‚½‘O‘å”]“®–¬[Ç‚Ì1—á.
²ŽRߎqC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ‹´‹I‹vi“àjCd–ìKŽŸiˆÉ“¤”BŽR‰·ò•a‰@j: ‘æ109‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.07.01),
“Œ‹ž.
1043. mŠw‰ïn iˆê”Êu‰‰j ‘Sg‚±‚Þ‚ç•Ô‚è•a—lÇó‚ð’悵ŒŒ´ˆŸ‰”’á’lA«‘B‹@”\’ቺ‚ð”F‚ß‚½’¼’°Šà‚Ì1—á. ¼‰ª³ŒhC“ú–ì’‰‰pC㓈\˜Yi¬“cŒ´Žs—§•a‰@jCŒÃ˜a‹vKi“àj: ‘æ109‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.07.01), “Œ‹ž.
1044. mŠw‰ïn iˆê”Êu‰‰j ‘OÒ‘“®–¬ÇŒóŒQ‚Ì1Ç—á. ŽO•x“N˜YC‰¬–ì—TC’·’JìˆêŽqCÄ“¡–L˜aC¬ŽR“àŠ²_CŒÃ˜a‹vKi“àjCŽOˆäŒö•Fi”]ŠOjC›Mˆêi•újCŒK”ö’èmi•a—j: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i89.09.07), ŽD–y.
1045. mŠw‰ïn iˆê”Êu‰‰j Ò‘ƒ~ƒIƒNƒ[ƒkƒX‚Ì–ò•¨Ž¡—Âɂ‚¢‚Ă̈êlŽ@iŽ©Œ±2—á‚Æ•¶Œ£“IlŽ@j. ‰““¡ˆêÆC‹{“c‰Ã¢ŽqCדc–«C’·’JìˆêŽqCŒÃ˜a‹vKi“àjC–kŒ´s—Yi”]ŠOj: ‘æ24‰ñ“ú–{ƒpƒ‰ƒvƒŒƒWƒAˆãŠw‰ï i89.09.07), ŽD–y.
1046. mŠw‰ïn iˆê”Êu‰‰j •‘“¥•a—l•sˆÓ‰^“®‚ð’悵‚½Willis“®–¬—Ö•ÂÇÇ‚Ì1—á. Œ˘aŽqC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ385‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.09.09), “Œ‹ž.
1047. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇ•a•Ï‚ð—L‚·‚éÇ—á‚É‚¨‚¯‚é~ˆ³ŒÀŠE|”]zŠÂ“®‘Ô–Ê‚æ‚è‚ÌŒŸ“¢.
‹àŽq®“ñi“àjCàV“c“OCŒIŽR—ÇãEC¬•x”ŽÍi‘—§zŠÂŠí•aƒZƒ“ƒ^[jC“‚‘ò~i‘åã”]_ŒoŠO‰È•a‰@j: ‘æ12‰ñ“ú–{‚ŒŒˆ³Šw‰ï‘‰ï
i89.09.14), ŽD–y.
1048. mŠw‰ïn iˆê”Êu‰‰j ¶‘O‘å”]“®–¬—̈æ‚Ì[Ç‚É‚æ‚éu“¹‹ï‚Ì‹”—“IŽg—pv. ‘O“c^Ž¡C²ŽRߎqC‰¬–ì—TCŒÃ‹´‹I‹vi“àjC¬’r‘׎qCΖєü‘ãŽqiƒŠƒnƒrƒŠjCŽí“c^»—Yi¸j: ‘æ13‰ñ“ú–{_ŒoS—Šw‰ï i89.09.29), “Œ‹ž.
1049. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ|ƒjƒ“°I R‘Ì‚ð—p‚¢‚½¶ŒŸ‹Ø‚̃^ƒCƒv•ª‚¯|‰æ‘œ‰ðÍ‚É‚æ‚錟“¢|.
¼–{MŽqC’¹‹‡ŽOi“àjCˆÀˆä”ü]i‘‡—Õ°ŒnjC’†‘ºŒ’iŠñjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC¬¼”Ž‹`i‰q¶Šw•”j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï
i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.
1050. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒg‚É‚¨‚¯‚é”]‹•ŒŒŽž‚̃‚ƒmƒAƒ~ƒ“•úo‚ɂ‚¢‚Ä‚ÌŒ¤‹†. –약CC_“c’¼C“cè‹`ºi“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 645, 1989.
1051. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ|ƒjƒ“°I R‘Ì‚É‚æ‚霊i‹ØüˆÛ‚̃^ƒCƒv•ª‚¯|ATPaseõF‚ƈقȂé‘Ô“x‚ðŽ¦‚µ‚½Ç—á‚ÌŒŸ“¢|.
¼–{MŽqC’¹‹‡ŽOi“àjCˆÀˆä”ü]i‘‡—Õ°ŒnjC’†‘ºŒ’iŠñjC“c’†ŠÚ–¾”Ži¶•¨•¨—ŒnjC¬¼”Ž‹`i‰q¶Šw•”j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï
i89.10.06), ‹ž“s.
1052. mŠw‰ïn iˆê”Êu‰‰j MRI‚Åf’f‚µ“¾‚½”]’ê“®–¬ŒŒðÇ‚Ì1—á. ¡ˆä¸Cˆ¢‹v’Óñ•vC‹àŽq®“ñC_“c’¼C“cè‹`ºi“àj: ‘æ110‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.10.07), “Œ‹ž.
1053. mŠw‰ïn iˆê”Êu‰‰j Ž‹_ŒoˆÞkA_Œo«“ï’®A‘̘H’¥ŒóA’s•ð‚ð’悵‚½HMSN type ‡T’jŽq—á. ¼‰ª¹‹IC’––“‹vŠxC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ110‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.10.07), “Œ‹ž.
1054. mŠw‰ïn iˆê”Êu‰‰j ”]oŒŒ‚ðŒJ‚è•Ô‚µ‚½œŒ`¬•s‘SÇ‚Ì1—á. ŠÛŽR”ŽŽuCˆ¢‹v’Óñ•vC”¨—²ŽuC_“c’¼C“cè‹`ºi“àj: ‘æ386‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.10.14). “Œ‹ž.
1055. mŠw‰ïn iˆê”Êu‰‰j Cerebrospinal Fluid Levels of Noradrenaline
Metabolite in Acute Cerebral Infarction. “Œ–M•FC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: The
1st International Stroke Congress i89.10.16), ‹ž“s.
1056. mŠw‰ïn iˆê”Êu‰‰j Magnetic Resonance Brain Imaging of Migraine.
ŒÜ\—’‹v‰ÀCâˆä•¶•FC“cè‹`ºi“àjC›Mˆêi•új: ‡W International Headache Congress
i89.10.16), Sydney, Cephalolgia, 9(Suppl. 10): 189-190, 1989.
1057. mŠw‰ïn iˆê”Êu‰‰j Neurotransmitter Substances in Extrapyramidal
Disorder. ’·’JìˆêŽqCŒÃ˜a‹vKi“àj: International Conference in Alzheimer's
Parkinson's Disease i89.11.08), ‹ž“s.
1058. mŠw‰ïn iˆê”Êu‰‰j Flicker VECP‚É‚¨‚¯‚éU•Žü”g”“Á«. ‹g–{gŽqi—ÕŒŸjC”¨—²Žui“àjCŽRéˆê˜YCŽí“c^»—Yi¸j: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ï i89.11.10), ‰ªŽR.
1059. mŠw‰ïn iˆê”Êu‰‰j ‰·“x•Ï‰»‚Ì’mŠo_ŒoŠˆ“®“dˆÊ (SNAP) ‚É‹y‚Ú‚·‰e‹¿. Ä“¡]”üŽqCr”¦“Äi—ÕŒŸjC’¹‹‡ŽOi“àjC‹kŽ ‘i”]ŠOjC‰ª“‡dFiìèˆä“c•a‰@j: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï i89.11.10), ‰ªŽR.
1060. mŠw‰ïn iˆê”Êu‰‰j ‰¹Šy‚É‚æ‚é”]”g•Ï‰»‚Ì’è—Ê“IŒŸ“¢i‘æ2•ñj|Ž¸ŒêÇŠ³ŽÒ‚Å‚ÌŒŸ“¢|.
ŠC˜VŒ´iˆê˜YC¬ì’ÃŽqC‚–ØNsC¯–ì°•FC‹îƒP—䳃i϶‰ï’†‰›•a‰@jC”¨—²Žui“àj: ‘æ19‰ñ“ú–{”]”g¥‹Ø“d}Šw‰ïŠwp‘å‰ï
i89.11.10), ‰ªŽR.
1061. mŠw‰ïn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a”ǂɉ—‚¯‚é˜V‰»‚̉e‹¿i‘æ2•ñj. ’·’JìˆêŽqC’–ŒÒ‹vŠxC³–Ø‚©‚‚çCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.14), –¼ŒÃ‰®.
1062. mŠw‰ïn iˆê”Êu‰‰j ‚—î”Ç‚Ì–«is«‘½”ªƒjƒ…[ƒƒpƒ`[‚Ì2–UŒŸ—á. f‘ò’BŽuCÄ“¡–L˜aC‰¬–ì—TC³–Ø‚©‚‚çCדc–«CŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.14), –¼ŒÃ‰®.
1063. mŠw‰ïn iˆê”Êu‰‰j ”][ÇŠ³ŽÒ‚É‚¨‚¯‚錌ˆ³“ú“à•Ï“®‚ɂ‚¢‚Ä‚ÌŒŸ“¢. ’–ŒÒ‹vŠxCŠÛŽR”ŽŽuC‹àŽq®“ñC_“c’¼C“cè‹`ºi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.14), –¼ŒÃ‰®, ´˜^W, p.85, 1989.
1064. mŠw‰ïn iˆê”Êu‰‰j ƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“‘ãŽÓŽY•¨‚ƉÁ—î‚Æ‚ÌŠÖŒW. “Œ–M•FCŒÜ\—’‹v‰ÀC”¨—²ŽuCâˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.15), –¼ŒÃ‰®.
1065. mŠw‰ïn iˆê”Êu‰‰j “ú–{•a—–UŒŸS•ñ‚©‚猩‚½”]ŒŒŠÇŽ¾Š³Ž€‚Ì„ˆÚ. –약CC_“c’¼C“cè‹`ºi“àj: ‘æ31‰ñ“ú–{˜V”NˆãŠw‰ï‘‰ï i89.11.16), –¼ŒÃ‰®.
1066. mŠw‰ïn iˆê”Êu‰‰j NaHCO3•‰‰×‚É‚æ‚é”]ŒŒŠÇ”½‰ž«‚ÌŒŸ“¢. ˆ¢‹v’Óñ•vCâˆä•¶•FC—é–ØGˆêC“cè‹`ºi“àj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i89.11.16), “Œ‹ž.
1067. mŠw‰ïn iˆê”Êu‰‰j ”]ÇðÇ‚Ì123I-IMP SPECT. ’|“àˆè’jC”Š_mC¯–ì°•FC‚–ؽC‹îƒP—䳃C‚–ØNsCŠC˜VŒ´iˆê˜Yi϶‰ï’†‰›•a‰@jC”¨—²Žui“àj: ‘æ1‰ñ“ú–{”]zŠÂ‘ãŽÓŠw‰ï‘‰ï i89.11.17), “Œ‹ž.
1068. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒ—¬‚̉»Šw“I’²ß‚ɑ΂·‚éƒJƒ‹ƒ‚ƒWƒ…ƒŠƒ“‘jŠQ܂̉e‹¿. “Œ–M•FC”¨—²ŽuCŠÛŽR”ŽŽuC–k‘ººC˜°‰i”Câˆä•¶•FC_“c’¼C“cè‹`ºi“àj: ‘æ30‰ñ“ú–{–¬ŠÇŠw‰ï‘‰ï i89.11.22), ‹ž“s.
1069. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚È‚ƒ~ƒIƒOƒƒrƒ“ŒŒÇ‚𔺂Á‚½’Pƒƒwƒ‹ƒyƒX”]‰Š‚Ì1—á. ¡ˆä¸Cˆ¢‹v’Óñ•vC‹àŽq®“ñC_“c’¼C“cè‹`ºi“àj: ‘æ111‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), “Œ‹ž.
1070. mŠw‰ïn iˆê”Êu‰‰j 15”NŠÔfollow‚µ“¾‚½Shy-DragerÇŒóŒQ‚Ì1–UŒŸ—á. ¼“cs³C’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àjC–ö‰ºŽO˜Yi•a—j: ‘æ111‰ñ_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i89.12.02), “Œ‹ž.
1071. mŠw‰ïn iˆê”Êu‰‰j Downbeat nystagmus‚Ébaclofen‚ª—LŒø‚Å‚ ‚Á‚½1—á. ŽO•x“N˜YC’·’JìˆêŽqCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ112‰ñ“ú–{_ŒoŠw‰ïŠÖ“Œ’n•û‰ï i90.03.03), “Œ‹ž.
1072. mŒ¤‹†‰ïn i“Á•Êu‰‰j R•sˆÀ–ò‚Æ‹L‰¯áŠQ. ‘ºèŒõ–Mi¸j: ‘æ26‰ñ_“Þ쌧¸_–ò—§˜b‰ï (89.00.00), ‰¡•l.
1073. mŒ¤‹†‰ïn i“Á•Êu‰‰j Å‹ß‚Ì”’BáŠQ‚Ìl‚¦•û‚ÆáŠQŽ™‹³ˆç‚É–]‚Þ‚±‚Æ. ²“¡Šìˆê˜Yi¸j: ‘Š–ÍŒ´Žs“ÁŽê‹³ˆçŒ¤‹†‰ï‘‰ï (89.05.16), ‘Š–ÍŒ´.
1074. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‚Ä‚ñ‚©‚ñŽ¡—Âɂ¨‚¯‚éR‚Ä‚ñ‚©‚ñ–òŒŒ’†”Z“x‘ª’è‚Ì—Õ°“IˆÓ‹`. ŽO‰YŽõ’jiŽ™j: ‘æ11‰ñˆïé‚Ä‚ñ‚©‚ñ§˜b‰ï (89.05.27), “y‰Y.
1075. mŒ¤‹†‰ïn i“Á•Êu‰‰j ¬Ž™‚Ì”M«‚¯‚¢‚ê‚ñ|‚»‚ÌŠÇ—‚Æ—\Œã‚ð’†S‚É|. ŽO‰YŽõ’jiŽ™j: ‘æ271‰ñ_“Þ쌧•ÛŒ¯ˆã‹¦‰ïŒŽ—ጤ‹†‰ï (89.09.17), •ÛŒ¯ˆã‚Ì—Õ°, (294): 2`11, 1989.
1076. mŒ¤‹†‰ïn i“Á•Êu‰‰j Å‹ß‚ÌŒü¸_–ò‚ɂ‚¢‚Ä. ŽO‰Y’å‘¥i¸j: ‹à‘ò¸_‰Èˆã‰ï (89.11.04), ‹à‘ò.
1077. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒgƒ‰ƒ“ƒLƒ‰ƒCƒU[‚Ì’mŽ¯‚Æ‚»‚ÌŽg‚¢•û. ŽO‰Y’å‘¥i¸j: _“Þ쌧¸_•a‰@‹¦‰ï¥“à‰ÈˆãŠw‰ï‡“¯u‰‰‰ï (90.02.10), ‰¡•l.
1078. mŒ¤‹†‰ïn i“Á•Êu‰‰j ’·Šú“§ÍŠ³ŽÒ‚̸_‰q¶. ²“¡Šìˆê˜Yi¸j: ‘æ17‰ñŽR—œ“§ÍŒ¤‹†‰ï (90.03.04), •xŽm‹g“c, ŽR—œ“§ÍŒ¤‹†‰ï‰ï•ñ, 9: 1990.
1079. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Å‹ß‚Ì“oZ‹‘”Û‚Ìl‚¦•û‚Ɖ‡•‚ɂ‚¢‚Ä. ²“¡Šìˆê˜Yi¸j: •½’ËŽs“oZ‹‘”ÛŒ¤‹†‰ïi•½’ËŽs‹³ˆçˆÏˆõ‰ïj (89.08.28), •½’Ë.
1080. mŒ¤‹†‰ïn i‹³ˆçu‰‰j R‚Ä‚ñ‚©‚ñ–ò‚ÌTDM|Clinical Pharmacokinetics‚Ì—˜_‚ÆŽÀÛ|.
ŽO‰YŽõ’jiŽ™j: ‘æ7‰ñ–ò•¨Ž¡—ƒjƒ^ƒŠƒ“ƒOŒ¤‹†‰ï“Á•Êƒ[ƒ~ƒi|ƒ‹ (89.09.03), “Œ‹ž, u‰‰W, p.41`52, 1989.
1081. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ”]Žîá‡. ›Mˆêi•új: ‘æ4‰ñMR—Õ°uÀ (89.09.16), “Œ‹ž.
1082. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‚Ä‚ñ‚©‚ñ‚Ì–ò•¨—Ö@. ŽO‰YŽõ’jiŽ™j: ‘æ19‰ñ¬Ž™_ŒoŠwƒZƒ~ƒi|i“ú–{¬Ž™_ŒoŠw‰ïj (89.11.04), _ŒË, u‹`—pƒeƒLƒXƒg, p.51`57, 1989.
1083. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ¸_”–ŽãŽÒ‚̸_áŠQ‚Ì—\–h‚Æ‘Îô|¸_”–ŽãŽÒ‚Ƃ̃Rƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚ÌáŠQ|. ²“¡Šìˆê˜Yi¸j: •½¬Œ³”N“x_“Þ쌧¸_”–ŽãŽÒˆ¤Œì‹¦‰ïŒ¤C‰ï (89.12.06), ‰¡•l.
1084. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ˆê”Ê—Õ°‚ɉ—‚¯‚éŒü¸_–òŽ¡—Â̔–â‘è. ŽO‰Y’å‘¥i¸j: “ú–{ˆãŠw‹¦‰ï‘æ147‰ñf—ç˜b‰ï (90.01.08), “Œ‹ž.
1085. mŒ¤‹†‰ïn i‹³ˆçu‰‰j áŠQŽ™‚Ì”’B‚Æ•Ûˆç‚ɂ‚¢‚Ä. ²“¡Šìˆê˜Yi¸j: ‘æ1‰ñ’¬“cŽsáŠQŽ™•Ûˆç˜A—‹¦‹c‰ï (90.01.17), ’¬“c.
1086. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘åŒ^AVM‚ÌŽèp¬Ñ‚ÉŠÖ˜A‚·‚锈öŽq‚Æ‘Îô.
‹{â‰À’jC“c’†–ö…C“ü‘qŽŒÈCz–K’m–çC‘q“c²CÄ“¡Œ³—ÇC‰““¡¹FC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC’†ŽRŒ«“ñi‘å“c•a‰@j:
‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.22), “Œ‹ž.
1087. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j “ª•”ŠO‚É‚¨‚¯‚é”]zŠÂ‘ãŽÓáŠQ|Diffuse Brain
Injury‚Ì”]zŠÂ“®‘ÔG123I-IMP SPECT‚ɑ΂·‚錟“¢.
‰““¡¹FC“c’†ç•FC‚–ì½C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ13‰ñ“ú–{_ŒoŠOŒ¤‹†‰ï (90.03.28),
“Œ‹ž.
1088. mŒ¤‹†‰ïn iƒpƒlƒ‹j Strio-capsulo-thalamic AVMs‚ɑ΂·‚é“Eop‚ÌŒoŒ±.
“c’†–ö…C‰ªGGCŽRè‹`‹éCŽs앶•FC–kŒ´s—YC‘q“c²CÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j:
‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.22), “Œ‹ž.
1089. mŒ¤‹†‰ïn iƒpƒlƒ‹j Œ¤C‚Ì•]‰¿‚Æ‚»‚ÌŠˆ—p:Žw“±ˆã‚Ì•]‰¿‚ƈç¬. ŒÃ˜a‹vKi“àj: ‘æ7‰ñ—Õ°Œ¤CŒ¤‹†‰ï i89.04.22), “Œ‹ž.
1090. mŒ¤‹†‰ïn iˆê”Êu‰‰j Lithium Baby ‚Ì2—á|5΂܂ł̌o‰ßŠÏŽ@. ŽRéˆê˜YC’ç–M•FC’†“‡ß•vCŽO‰Y’å‘¥i¸j: ‘æ9‰ñƒŠƒEƒ}ƒ`Œ¤‹†‰ï (89.04.22), “Œ‹ž, —\eW, p.32, 1989.
1091. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì•ú’u‚Æ‹s‘Ò. Šâ”öŒõ_i¸j: –k—¢‘åŠw¸__Œo‰ÈŒ¤‹†‰ï (89.05.15), ‘Š–ÍŒ´.
1092. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]“®Ã–¬ŠïŒ`“EoŒã‚Ì“ªŠW“àˆ³‘ª’è‚̈Ӌ`‚Æ“ªŠW“àˆ³˜´i‚ÌŒ´ˆö.
“ü‘qŽŒÈi”]ŠOjCÄ“¡•Žuiˆä“c•a‰@jC“c’†ç•FC‹´–{—²C‘q“c²C‘å‚O–«C‰““¡¹FC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j:
‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.21), “Œ‹ž.
1093. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒŠÇŽÊã•`o•s”\‚È”]ŒŒŠÇŠïŒ`21—á‚ÌŒŸ“¢|“Á‚ÉA‚»‚Ìf’f•û–@A—Õ°“IˆÓ‹`AŽ¡—Âɂ‚¢‚Ä.
‘q“c²C“c’†–ö…C–kŒ´s—YCí”ՉÈêCŽs앶•FC‚–쮎¡CÄ“¡Œ³—ÇC‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½jC›Mˆêi•új:
‘æ18‰ñ“ú–{”]‘²’†‚ÌŠO‰ÈŒ¤‹†‰ï (89.05.21), “Œ‹ž.
1094. mŒ¤‹†‰ïn iˆê”Êu‰‰j _ŒoÇ‚Í•Ï‚í‚Á‚½. Ží“c^»—Yi¸j: –k—¢‘åŠwˆãŠw•”¸_‰ÈŒ¤‹†‰ï (89.06.05), ‘Š–ÍŒ´.
1095. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]Ž€”»’è‚ÌŽÀó. L£—²ˆêC–kˆä‘¥•vC‘å˜a“c—²i‹~–½j: ‘æ2‰ñ”]Ž€¥”]‘h¶Œ¤‹†‰ï (89.06.16), “Œ‹ž.
1096. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹”—ÇóC•s“oZ‚ð’悵‚½7ΗŽ™‚ÌÇ—á. ˆÉ“¡ˆèŽqi¸j: ‘æ7‰ñŽ™“¶¸_‰È—Õ°Œ¤‹†‰ï (89.06.23`24), –¼ŒÃ‰®.
1097. mŒ¤‹†‰ïn iˆê”Êu‰‰j Anterior Sacral Meningocele‚Ì2Ç—á|“Á‚ÉMRI‚Ìf’fã‚Ìd—v«‚ɂ‚¢‚Ä|.
‘å‚O–«CŽs앶•FCz–K’m–çC‹{â‰À’jC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•új: ‘æ6‰ñ“ñ•ªÒ’ÅŒ¤‹†‰ï
(89.07.01), “Œ‹ž.
1098. mŒ¤‹†‰ïn iˆê”Êu‰‰j Sodium valproate ‚Ì•¹—p‚ª carbamazepine ‚¨‚æ‚Ñ
carbamazepine-10,11-epoxide ‚Ì—V—£Œ^ŒŒ’†”Z“x‚É‚¨‚æ‚Ú‚·‰e‹¿‚È‚ç‚Ñ‚É‚»‚Ì—Õ°“IˆÓ‹`i•â“Uj.
”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂiŽ™j: ‘æ24‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï (89.07.15), ‰¡•l.
1099. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œz’Å‘¹‚ɇ•¹‚µ‚½ŠO«’Åœ“®–¬áŽ‚Ì1—á. ŽR“cŸi”]ŠOjC–kŒ´F—Yi‹~–½jCz–K’m–çCŽRè‹`‹éC–î“cŒ«ŽOi”]ŠOjC‘å˜a“c—²i‹~–½j: ‘æ15‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï (89.07.15), ‹{è.
1100. mŒ¤‹†‰ïn iˆê”Êu‰‰j Arnold-ChiariŠïŒ`‚ɇ•¹‚·‚éÒ‘‹ó“´Ç‚̬ˆö‚É‚¨‚¯‚鑉t“®‘Ô‚ÌŠÖ—^. ‹kŽ ‘CŽs앶•FC”Ñ“cG•vCŽOˆäŒö•FC–î“cŒ«ŽOi”]ŠOj: ‘æ4‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï (89.07.15), ‹{è.
1101. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ò‘Œã³’†Šui“ü–@‚É•K—v‚ÈÒ‘”÷¬ŠO‰È‰ð–U. ŽOˆäŒö•FC”Ñ“cG•vC‹kŽ ‘C–î“cŒ«ŽOi”]ŠOj: ‘æ4‰ñ“ú–{Ò‘ŠO‰ÈŒ¤‹†‰ï (89.07.15), ‹{è.
1102. mŒ¤‹†‰ïn iˆê”Êu‰‰j 5ÎŽž‚É‹”—Çó‚Å”•a‚µA‘½Ê‚ȃqƒXƒeƒŠ[Çó‚È‚Ç‚ð’悵‚½Ç—ái7ΗŽ™j. ˆÉ“¡ˆèŽqi¸j: ‘æ12‰ñ_“Þ쎙“¶¸_‰Èˆã§˜b‰ï (89.07.15), ‰¡•l.
1103. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠC–ÈÖ¬“´•”‘–ŒŽî‚ɑ΂·‚é“Eop‚̉”\«.
‹{â‰À’jC‰ªGGC‰iˆä–ÎŽ÷CŽRè‹`‹éCŽR“cŸC“c’†ç•FC“c’†–ö…C–kŒ´s—YCŽs앶•FCˆÉ“¡”ä˜CŽuC–î“cŒ«ŽOi”]ŠOj:
‘æ1‰ñ“ú–{“ªŠW’êŠO‰ÈŒ¤‹†‰ï (89.07.24), “Œ‹ž.
1104. mŒ¤‹†‰ïn iˆê”Êu‰‰j I-123-IMP SPECTŒŸ¸‚É‚ÄŽw“E‚µ“¾‚½’ጌˆ³‚É”º‚¤”]ŒŒ—¬ˆÙí‚Ì1—á.
¼Šª”ŽCΈ䟌ÈC“cŠŽŒÈC›MˆêC¼ŽR³ŒáC¬—Ñ–ÎŽ÷C‰¡ŽR‹v˜NC’†‘òŒ\Ž¡C‹e’nŒhCˆË“cˆêdC¼—Ñ—²i•új:
‘æ31‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.08.00), “Œ‹ž, ŠjˆãŠw, 26(11): 1462, 1989.
1105. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒEƒƒLƒi[ƒ[”]‘…ŠÁ—¬–@‚ÌŒø‰Ê‚ÆŒÀŠE. ‰““¡¹FC‰iˆä¬Ž÷C“c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jCÄ“¡Œ³—Çi”]ŠOj: ‘æ5‰ñƒXƒpƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€ (89.08.06), ‹ž“s.
1106. mŒ¤‹†‰ïn iˆê”Êu‰‰j Carbamazepine ‚Ì‘Ì“à“®‘Ô‚Æ 10,11-dihydroxycarbamazepine
ŒŒ’†”Z“x‘ª’èi—\•ñj. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKCדc‚Ì‚¼‚ÝiŽ™jC‘ˆä‹vKC‹v¼”üC{“¡–F³i–k—¢ƒ‰ƒ{j:
‘æ16‰ñ”’B–ò—¥–ò•¨Ž¡—ÃŒ¤‹†‰ï (89.08.19), ˆ®ì, ´˜^W, p.2, 1989.
1107. mŒ¤‹†‰ïn iˆê”Êu‰‰j ™•ú«ƒoƒ‹ƒvƒŽ_»Ü (KW-6066N) ‚ÌŒø‰Ê|ŒŒ’†”Z“x‚È‚ç‚Ñ‚É—Õ°–Ê‚©‚ç‚̈êlŽ@i•â“U|j.
ŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂiŽ™j: ‘æ4‰ñ_“Þ쬎™_Œo§˜b‰ï (89.09.02), ‰¡•l, ´˜^W, p.7, 1989.
1108. mŒ¤‹†‰ïn iˆê”Êu‰‰j ÛHáŠQ‚Ì–â‘è“_. Ží“c^»—Yi¸j: –k—¢‘åŠwˆãŠw•”¸_‰ÈŒ¤‹†‰ï (89.10.02), ‘Š–ÍŒ´.
1109. mŒ¤‹†‰ïn iˆê”Êu‰‰j SgÇŽ¡—Éߒö‚É‚¨‚¯‚é––½‰·‚̕ω». ’†“‡ß•vCŽRéˆê˜YC”’싳li¸j: Œú¶È: ¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïuSgÇ‚Ìf’f‹y‚ÑŽ¡—×\Œã‚ÉŠÖ‚·‚錤‹†v•½¬Œ³”N“x”ljï‹c (89.11.25), “Œ‹ž.
1110. mŒ¤‹†‰ïn iˆê”Êu‰‰j Š³ŽÒŽ©‚炪ƒ`[ƒ€ˆã—Ņ̃‚ð‚‚‚è‚ ‚°‚½ƒ^[ƒ~ƒiƒ‹ƒP[ƒX.
–@—R”üŽqCŽæo—ÁŽqC‰Á“‡–¾iˆã—ÑŠ’kŽºjC–û’J˜aŽqC–kŽR—æŽqC“àŽRŒúŽqC¬‘ò”ü˜aiŠÅŒì•”jCŽRéˆê˜YC²“¡Šìˆê˜Yi¸j:
‘æ13‰ñŽ€‚Ì—Õ°Œ¤‹†‰ï (89.11.25), “Œ‹ž, Ž€‚Ì—Õ°, 12(2):34`35, 1989.
1111. mŒ¤‹†‰ïn iˆê”Êu‰‰j Diazepam ¿Ü””MŽžŠÔŸ[“Š—^–@‚É‚æ‚é”M«‚¯‚¢‚ê‚ñ‚ÌÄ”—\–hŒø‰Ê‚ÌWŒv‚Æ“¯–@Ž{s‚ÌŽÀÛ. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝiŽ™j: ‘æ12‰ñ”M«‚¯‚¢‚ê‚ñ§˜b‰ï (89.12.16), “Œ‹ž.
1112. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]“®–¬áŽ‚Ì‘‘å‚Æ‚»‚Ì‹@˜. ‘ˆä³‘¥C“c’†–ö…C‹{â‰À’jC–î“cŒ«ŽOC‰““¡¹FC‰iˆä–ÎŽ÷i”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ”]_Œo CT Œ¤‹†‰ï (90.01.26), ‰ªŽR.
1113. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ªŠW’ê“‚æ‚ѓ÷Žî7—á‚ÌŒoŒ±. Žs앶•FCì–ìM”VCŽR“cŸC–î“cŒ«ŽOi”]ŠOjC–kŒ´F—Yi‹~–½jC›Mˆêi•újCˆÉ“¡”ä˜CŽui”]ŠOj: ‘æ13‰ñ”]_ŒoCTŒ¤‹†‰ï (90.01.27), ‰ªŽR.
1114. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒrƒ^ƒ~ƒ“B6‚ª’˜Œø‚µ‚½”N—îˆË‘¶«‚Ä‚ñ‚©‚ñ«”]Ç‚Ì3—á.
דc‚Ì‚¼‚ÝCŽO‰YŽõ’jC”’ˆäGKC»‰ŸÂC²“¡‰ë•FiŽ™jC‘å–î’B’ji¹˜H‰Á‘Û•a‰@j: ‘æ5‰ñ_“Þ쬎™_Œo§˜b‰ï (90.01.27),
‰¡•l, ´˜^W, p.7, 1990.
1115. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì•”•ª”ì‚ɑ΂·‚éCarbamazepine’PÜŽ¡—Â̒·Šú—\Œãi•â“Uj. »‰ŸÂCŽO‰YŽõ’jC”’ˆäGKCדc‚Ì‚¼‚ÝiŽ™j: ‘æ25‰ñ_“Þì‚Ä‚ñ‚©‚ñ§˜b‰ï (90.02.03), ‰¡•l.
1116. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œã“ªœŠÂ’Å’E‰P‚Ì•úŽËüŠw“IŒŸ“¢. ”Ñ“cG•vC‹kŽ ‘CŽR“cŸC“c’†ç•Fi”]ŠOjC–kŒ´F—YC‘å˜a“c—²i‹~–½jC›Mˆêi•újCˆÉ“¡”ä˜CŽui”]ŠOj: ‘æ19‰ñ“ú–{_Œo•úŽËüŒ¤‹†‰ï (90.02.22), “Œ‹ž.
1117. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]”^ᇂƔ]ŽîᇂÌMRIã‚ÌŠÓ•Ê“_|Low Intensity Rim‚Ìd—v«|.
í”ՉÈêC‚–ØGC‘å“ä’mC‘ˆä³„CŽRè‹`‹éCŽR“cŸCz–K’m–çCŽs앶•FC‹´–{—²C‹{â‰À’jC–î“cŒ«ŽOi”]ŠOjC›Mˆêi•új:
‘æ19‰ñ“ú–{_Œo•úŽËüŒ¤‹†‰ï (90.02.22), “Œ‹ž.
1118. mŒ¤‹†‰ïn iˆê”Êu‰‰j ÛHáŠQ‚ÆP300. ŒÃ’m‹MŒbŽqCŒÃ‰ê—Ç•FC’|“à”ŽlC‘ºèŒõ–Mi¸j: ERPƒA[ƒxƒ“ƒg (90.03.00), “Œ‹ž.
1119. mŒ¤‹†‰ïn iˆê”Êu‰‰j Sodium
Valproate•¹—pŽž‚ÌCarbamazepine‚È‚ç‚Ñ‚ÉCarbamazepine-10,11-epoxide‚Ì—V—£Œ^ŒŒ’†”Z“x‘ª’è‚Ì—Õ°“IˆÓ
‹`. ”’ˆäGKCŽO‰YŽõ’jC»‰ŸÂCדc‚Ì‚¼‚ÝiŽ™j: ‘æ17‰ñŠÖ“Œ¬Ž™_ŒoŠwŒ¤‹†‰ï (90.03.24), “Œ‹ž.
1120. mŒ¤‹†‰ïn iˆê”Êu‰‰j _ŒoŽ¾Š³‚É‚¨‚¯‚éŒo“àŽ‹‹¾“Iˆãá‘‘Ýp18—á‚ÌŒŸ“¢. ‰¬–ì—TC’·’JìˆêŽqCÄ“¡–L˜aCדc–«CŒÃ˜a‹vKi“àj: ‘æ7‰ñ_Œo“à‰ÈŽ¡—ÃŒ¤‹†‰ï i89.06.24), “Œ‹ž.
1121. mŒ¤‹†‰ïn iˆê”Êu‰‰j _Œo‹ØŽ¾Š³‚É‚¨‚¯‚élHŒÄ‹z—Ö@‚̃VƒXƒeƒ€‰». דc–«CˆÉ“¡”Ž–¾C¼‰ª¹‹IC‰¬–ì—TCÄ“¡–L˜aCŒÃ˜a‹vKi“àj: ‘æ7‰ñ_Œo“à‰ÈŽ¡—ÃŒ¤‹†‰ï i89.06.24), “Œ‹ž.
1122. mŒ¤‹†‰ïn iˆê”Êu‰‰j Migrainous infarction‚Ì4—á. “Œ–M•FCâˆä•¶•FCŒÜ\—’‹v‰ÀC“cè‹`ºi“àj: ‘æ17‰ñ“ª’ÉŒ¤‹†‰ï i89.10.08), “Œ‹ž.
1123. mŒ¤‹†‰ïn iˆê”Êu‰‰j 6”NŠÔ‚É“n‚èg‘ÌáŠQŽÒ‚Æ‚µ‚ÄŽÔˆÖŽq¶Šˆ‚ð‘—‚Á‚½‹•‹U«áŠQ‚Ì1—á. ŠÛŽR”ŽŽuCˆ¢‹v’Óñ•vC“Œ–M•FC”¨—²ŽuC_“c’¼C“cè‹`ºi“àjC’ç–M•Fi¸j: _“Þ쌧“à‰ÈW’k‰ï i89.11.25), ‰¡•l.
1124. mŒ¤‹†‰ïn iˆê”Êu‰‰j Hereditary Motor and Sensory Neuropathy‚Ì—Õ°‘œ|Dyck,
Lambert‚Ì—Õ°Œ^•ª—Þ‚Ì–â‘è“_‚ɂ‚¢‚Ä.
Ä“¡–L˜aC‰““¡ˆêÆC¼‰ª¹‹IC’–ŒÒ‹vŠxC‰¬–ì—TC¼“cs³Cדc–«CˆÉ“¡”Ž–¾C’·’JìˆêŽqCŒÃ˜a‹vKi“àj:
Œú¶È¸_¥_ŒoŽ¾Š³Œ¤‹†ˆÏ‘õ”ïƒjƒ…[ƒƒpƒ`[‚̬ˆö‚¨‚æ‚ÑŽ¡—ÂɊւ·‚錤‹†”Ç•½¬Œ³”N“x‘‰ï i90.01.13), “Œ‹ž.
1125. mŒ¤‹†‰ïn iˆê”Êu‰‰j
‰^“®ƒjƒ…[ƒƒ“•aŠ³ŽÒŒŒ´’†‚É‚Ý‚ç‚ê‚éGal(ƒÀ1-3)GalNAc‚ÆGal(ƒÀ1-3)GalNAc‚ð”FŽ¯‚·‚éR‘Ì|––½_Œo“œ’`”’‚Æ‚Ì”½‰ž|.
Ä“¡–L˜aCˆÉ“¡”Ž–¾C‰¬–ì”üŒbŽqC‰¬–ì—TCŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³A–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘‰ï i90.01.19),
“Œ‹ž.
1126. mŒ¤‹†‰ïn iˆê”Êu‰‰j Acute Axonal Form of Guillain-Barre Syndrome.
Ä“¡–L˜aC‰¬–ì—TC‰¬–ì”üŒbŽqCˆÉ“¡”Ž–¾CŒÃ˜a‹vKi“àj: Œú¶È“Á’莾Š³A–Ɖu«_ŒoŽ¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘‰ï i90.01.19),
“Œ‹ž.
1127. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a”Ç‚É‚¨‚¯‚é‰Á—î‚̉e‹¿. ‰““¡ˆêÆC’–ŒÒŠxC’·’JìˆêŽqCŒÃ‹´‹I‹vCŒÃ˜a‹vKi“àj:
•½¬Œ³”N“xŒú¶ÈƒVƒ‹ƒo[ƒTƒCƒGƒ“ƒXŒ¤‹†u˜V‰»‚É”º‚¤“ÁˆÙ•a‘Ԃ̉ð–¾vu‚—îŽÒ‚Ì_Œo¥‹Ø‹@”\‚Æ‚»‚ÌáŠQ‚ÉŠÖ‚·‚錤‹†v(I-1)
i90.02.02). –¼ŒÃ‰®,
1128. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚’¼Ž‹‰^“®ŠáUŒŸ¸‚Å‚Ý‚é‰Á—î‚̉e‹¿. ²‹´–M•FCˆ¢•”—EŸi—ÕŒŸjC’·’JìˆêŽqCŒÃ˜a‹vKi“àj:
•½¬Œ³”N“xŒú¶ÈƒVƒ‹ƒo[ƒTƒCƒGƒ“ƒXŒ¤‹†u˜V‰»‚É”º‚¤“ÁˆÙ•a‘Ԃ̉ð–¾vu‚—îŽÒ‚Ì_Œo¥‹Ø‹@”\‚Æ‚»‚ÌáŠQ‚ÉŠÖ‚·‚錤‹†v(I-1)
i90.02.02), –¼ŒÃ‰®.
1129. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒp[ƒLƒ“ƒ\ƒ“•a‚É‚¨‚¯‚é‰Ò“®«Šá‹…‰^“®Œn‚̉ðÍ. ŒÃ˜a‹vKCŽO•x“N˜YC’·’JìˆêŽqCÄ“¡–L˜ai“àj: Œú¶È“Á’莾Š³_Œo•Ï«Ž¾Š³’²¸Œ¤‹†”Ç1989”N“x”ljï‹c i90.02.23), “Œ‹ž.
1130. mŒ¤‹†‰ïn iŒöŠJuÀj ”N‚ð‚Æ‚é‚ƃ{ƒP‚é‚©H Ží“c^»—Yi¸j: ¸_•ÛŒ’ŒöŠJuÀ (89.07.07), ˆéŽq.
1131. mŒ¤‹†‰ïn iŒöŠJuÀj ¬Ž™‚̸_“I–â‘è|’ˆÓŒ‡Š×áŠQiŠwKáŠQj‚ÆÛHáŠQ|. ²“¡Šìˆê˜Yi¸j: _“Þ쌧ŒöŠJ‘åŠwuÀ (89.10.07), ‘Š–ÍŒ´.
1132. mŒ¤‹†‰ïn iŒöŠJuÀj S‚Ì•a‚Æ‚ÍH Ží“c^»—Yi¸j: ¸_•ÛŒ’ŒöŠJuÀ (89.11.20), ˆéŽq.
<<105 “à•ª”åŠí>>
1133. mŒ´’˜n ƒJƒ‹ƒ`ƒgƒjƒ“ŽY¶‚•ª‰»bó‘B‚b×–EŽîᇊ”‚Ì“Á«‚ƃzƒ‹ƒ‚ƒ“•ª”å“®‘Ô. ‹T’J“Oi•a—jC–å’J‹vmŽqiŒ`‘ÔŒnjCˆäŒû“Œ˜Yi‘—§•a‰@‹ãB‚ª‚ñƒZƒ“ƒ^|j: Human CellC2(3): 231`237, 1989.
1134. mŒ´’˜n Electron Microscopic and Immunoelectron Microscopic
Demonstration of Pancreatic Polypeptide Cells in Glucagonoma:
Colocalization of Pancreatic Peptide and Glucagon in Single Secretory
Granules. Akishi OoiCShogo KatsudaCIsao Nakanishi i‹à‘ò‘åjC‹T’J“Oi•a—jCKen
Yamaguchii‘—§‚ª‚ñƒZƒ“ƒ^|jCHideo Kitamura i•Ÿˆä•a‰@jCYukinori Hayakawa i“¡“c•a‰@j:
Ultrastructural Pathology, 13: 15`22, 1989.
1135. mÇ—á•ñn Primary Osteogenic Sarcoma of the Thyroid Gland: A Case
Report. ‘å•”½C‹T’J“OC˜a“c’m‰vC‰œ•½‰ë•Fi•a—jCŒÃ‘òTˆêCŒÃì_ŽOC‚‹´Lbi“àj: Surg. Pathol., 2(1):
67`72, 1989.
1136. muÀn ƒhƒNƒ^[ƒYƒCƒ“ƒ^ƒrƒ…[:“ûŠà‚ƃzƒ‹ƒ‚ƒ“|“ûŠà‚Ì‘B§Œä|. ‘ –{”ŽsiŽY•wjCƒƒo[ƒg‚a.ƒfƒBƒNƒ\ƒ“iƒWƒ‡[ƒWƒ^ƒEƒ“‘åj: Medical English, 6(10): 6`14; 49`51, 1989.
1137. mŠwp‘n i•ÒWj Endocrine Pathology Update vol. 1. •ÒW Juan
LechagoiƒeƒLƒTƒX‘åjC‹T’J“Oi–k—¢‘åj•ÒC Field & Wood, Philadelphia,U.S.A.,
90.00.00”s.
1138. mŠwp‘n iŽ·•Mj “à•ª”åŠw‚Ìi•ài‘æ7‰ñ•xŽmƒzƒ‹ƒ‚ƒ“ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX‹L˜^j; “à•ª”åŽîᇂƉߌ`¬‚Ì•a—, 7: 80`91, ‹T’J“Oi•a—j. •ÒW ´…’¼—e•Ò, iŠ”jƒgƒvƒRo”Å•”, “Œ‹ž, 89.00.00”s.
1139. mŠwp‘n iŽ·•Mj Endocrine Pathology Update ; Spectrum of
Neuroendocrine Marker Substance Production in Carcinoid Tumors Revealed
by Immunohistochemistry, 1: 151`169, ‹T’J“Oi•a—j. Field & Wood,
Philadelphia, U.S.A., 90.00.00”s.
1140. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒqƒgbó‘B‰‘ã”|—{Œn‚É‚æ‚é×–E–Œî•ñ“`’B‹@\‚ÌŒ¤‹†.
ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjC‹T’J“Oi•a—j: “ú–{‘gD”|—{Šw‰ï‘æ62‰ñ‘å‰ï (89.06.29), ‰¡•l, ‘gD”|—{Œ¤‹†, 8(1):
51, 1989.
1141. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒJƒ‹ƒ`ƒgƒjƒ“ŽY¶‚•ª‰»bó‘BC×–EŽîᇊ”‚Ì“Á«‚ƃzƒ‹ƒ‚ƒ“•ª”å“®‘Ô.
‹T’J“Oi•a—jC–å’J‹vmŽqiŒ`‘ÔŒnjCˆäŒû“Œ˜Yi‘—§•a‰@‹ãB‚ª‚ñƒZƒ“ƒ^|j: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), ‰¡•l,
‘gD”|—{Œ¤‹†, 8(1): 52, 1989.
1142. mŠw‰ïn iƒpƒlƒ‹j bó‘Bàh–EŠà‚Ì×–EŠw“IŒŸ“¢. ‰¡ŽR‘åC‘å–ì‰pŽ¡i•a‰@•a—•”jCŒY•”“ŒŽ¡iŠOjC‘ –{”ŽsiŽY•wj:
‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï i89.11.17), ‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 680, 1989.
1143. mŠw‰ïn iˆê”Êu‰‰j Transient Type of Ca2+ Current is Responsiple for the
Ca2+ Influx Induced by Thyrotropin-Releasing Hormone Stimulation.
—é–ØM”Vi¶—jCHiroshi TakagiCTohru Yoshiokai‘‘åjCYoshihisa KudoiŽO•H‰»¬¶–½Œ¤j:
‘æ12‰ñ_Œo‰ÈŠwŠwpW‰ï (88.12.07`09), –¼ŒÃ‰®C Neurosci. Res., 9(Suppl.): S119, 1989.
1144. mŠw‰ïn iˆê”Êu‰‰j Different Type of Ca2+ Currents are Responsible for
the Ca2+ Influx Induced by High K+ and Thyrotropin-Releasing
Hormone-Stimulation. —é–ØM”Vi¶—jCTohru YoshiokaCHiroshi
Takagii‘‘åjCYoshihisa KudoiŽO•H‰»¬¶–½Œ¤jC‰Á”Z³–¾i¶—j: ‘æ66‰ñ“ú–{¶—Šw‰ï (89.04.05`07),
‰ªŽRC Jpn. J. Physiol., 39(Suppl.): S64, 1989.
1145. mŠw‰ïn iˆê”Êu‰‰j ƒqƒg‚Ì‚•ª‰»Œ^C×–EŽîá‡×–EŠ”(TT-cell)‚É‚¨‚¯‚镪”å“®‘Ô‚Æ×–E“à‚ÌŒ`‘Ô.
‹T’J“Oi•a—jC–å’J‹vmŽqiŒ`‘ÔŒnjCˆäŒû“Œ˜Yi‹ãBƒKƒ“ƒZƒ“ƒ^|jC“ˆ‰ªŸ‘¾˜Yi•ú‰eŒ¤j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïHŠúŠwp‘å‰ï
(89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 33, 1989.
1146. mŠw‰ïn iˆê”Êu‰‰j ƒJƒ‹ƒ`ƒgƒjƒ“ŽY¶‚•ª‰»Œ^bó‘BC×–EŽîᇊ”‚É‚¨‚¯‚éexocytosis.
–å’J‹vmŽqiŒ`‘ÔŒnjC‹T’J“Oi•a—jCˆäŒû“Œ˜Yi‹ãBƒKƒ“ƒZƒ“ƒ^|jC“ˆ‰ªŸ‘¾˜Yi•ú‰eŒ¤j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.23),
–¼ŒÃ‰®, “ú–{ŠàŠw‰ï‘‰ïƒvƒƒOƒ‰ƒ€, p.49, 1989.
1147. mŠw‰ïn iˆê”Êu‰‰j Œ´”«ã”笑̋@”\˜´iÇ12—á‚ÌŒŸ“¢.
ŒY•”“ŒŽ¡C‰¡“c˜a•FC‰ª‘º—¥ŽqC“n•ÓŒ’Ž™CX£¹Ž÷C’Ë–{GlC’†ŽR‹`‰îCŒY•”P’jCΓc˜a•vC²“¡ŒõŽjC”äŠé”\Ž÷C¬—Ñ–ÎŽ÷iŠOjC“à“c‹v‘¥i“Œ‘åj:
‘æ51‰ñ“ú–{—Õ°ŠO‰ÈˆãŠw‰ï‘‰ï i89.10.31), _ŒË, “ú–{—Õ°ŠO‰ÈˆãŠw‰ïŽ, 1989.
1148. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠeŽíbó‘BŽ¾Š³‚É‚¨‚¯‚éThyroxin, Thyrogloblin ras oncogene
p21‚Ì‘gD“à•ª•z. ŒY•”“ŒŽ¡C”äŠé”\Ž÷C“à“c‹v‘¥iŠOjCˆ¢•”D•¶i“àjC‹T’J“Oi•a—j: ‘æ22‰ñbó‘BŠO‰ÈŒŸ“¢‰ï i89.11.12),
“Œ‹ž, —\eW, p.113. 1989.
<<106 ŒŒ‰tE‘¢ŒŒŠíEƒŠƒ“ƒp>>
1149. mŒ´’˜n Destruction of Erythrocytes under a Sinusoidally Fluctuating
Shear Rate. ‹´–{¬Li¶‘ÌHjCÎŒ´ºi‹¹ŠOjCù“c’¼i“ŒH‘åj: Advences in Biomaterials, 8:
291`296, 1988.
1150. mŒ´’˜n Erythrocyte Destruction under Periodically Fluctuating Shear
Rate; Comparative Study with Constant Shear Rate. ‹´–{¬Li¶‘ÌHj: Artificial
Organs, 13(5): 458`463, 1989.
1151. mŒ´’˜n Mutual Interaction of Eicosapentaenoic Acid and Arachidonic
Acid and Inhibition of the Formation of Lipoxygenase Products by
Indomethacin in Washed Human Platelets. 쑺“¹ŽqCŒ´“c–FÆC“c’†–M’jCŽŽæMi–ò—j: Asia
Pacific Journal of Pharmacology, 4(3): 189`196, 1989.
1152. mŒ´’˜n Common Fragile Sites in Chromosomes of Bone Marrow Cells and
Peripheral Blood Lymphocytes from Healthy Persons and Leukemia
Patients. ŒÃ’J—²i“àjCOchi, H.CWatanabe, S.i‘—§ŠàƒZƒ“ƒ^[j: Cancer Genet.
Cytogenet., 43: 131`138, 1989.
1153. mŒ´’˜n A Monoclonal Antibody 1A6 to T-cell Recognizes a Common
Antigen Expressed on Lymphocytes from Normal and Leukemic Patients, and
Inhibits NK Cell activity. Togashi, H.CGhoneum, M.CTakasugi,
M.CŠ}ˆäŒ‰i•a—jCet al.: Hemotological Oncology, 7: 233`242, 1989.
1154. mŒ´’˜n ŒŒðŒ`¬¥ŒŒ‹…”j‰ó‚ɑ΂·‚邹‚ñ’f‘¬“x‚̉e‹¿. ‹´–{¬Li¶‘ÌHj: ˆã—p“dŽq‚ƶ‘ÌHŠw, 27(Suppl.): 145, 1989.
1155. mŒ´’˜n ˆâ“`«‹…óÔŒŒ‹…ǂɑ΂·‚éŽèp—á‚ÌŒŸ“¢.
’Ë–{GlC”ª\ì—v•½C–ΖØ_ŽqCˆÉ“¡‹`–çCŒÃ”g‘qŽjŽqC–¥‰YG•FCHŽRŒ›‹`C‚‹´r‹BiŠOjC¼–{‰x—YCŽO“‡Œ’C“n•”K•vCˆÀ”{–¾˜Yi‘—§‘Š–ÍŒ´•a
‰@j: ˆã—Ã, 43(11): 1124`1128, 1989.
1156. mŒ´’˜n lHÞ—¿•\–Ê‚É‚¨‚¯‚錌ðŒ`¬‚Æ‘¬“x“õ”z. ‹´–{¬Li¶‘ÌHjC‘O“c_‹`Cù“c’¼i“ŒH‘åj: ¶‘ÌÞ—¿, 2(4): 229`234, 1984.
1157. mŒ´’˜n ŒŒðŒ`¬‚ɑ΂·‚邹‚ñ’f‘¬“x‚̉e‹¿G‰š“ʉ~Œ^ŽŽŒ±‹@‚ð—p‚¢‚½ŒŒðŒ`¬“x•]‰¿. ‹´–{¬Li¶‘ÌHjCŽR–{^i®ŠOjCŽR“àŒ’Cù“c’¼i“ŒH‘åj: “ú–{‹@ŠBŠw‰ïu‰‰˜_•¶WC890(38): 22`24, 1989.
1158. mŒ´’˜n lãG“‚Ì•a—‘gDŠw“IŒŸ“¢. Š™“c—˜•FCŒ´“cGˆêC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: “ú–{G“Œ¤‹†‰ï‰ïŽC28: 34`38, 1989.
1159. mŒ´’˜n “–‰@‚É‚¨‚¯‚鬎™“Á”«Ä¶•s—Ç«•nŒŒ‚Ì—\ŒãˆöŽq‚ÉŠÖ‚·‚錟“¢. ŽR–{OŽqC“‡–{—R‹IŽqC¡ˆäƒDC‰““¡‹I—YiŽ™j: –k—¢ˆãŠw, l9(2): 258`263, 1989.
1160. mŒ´’˜n ‘¢ŒŒŠíŽîᇂɂ¨‚¯‚éP“œ’`”’i‘½Ü‘Ï«ˆâ“`ŽqŽY•¨j”Œ»‚Ì—Õ°“IˆÓ‹`. ät“n’‰’jCâ“Œ—R‹IC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 37(7): 779`783, 1989.
1161. mŒ´’˜n Flow Cytometry‚É‚æ‚é‹}«”’ŒŒ•a‚É‚¨‚¯‚éP“œ’`”’‚Ì•ªÍ. ät“n’‰’jCâ“Œ—R‹IC‘å’J‰pŽ÷i—Õ•a—jC“¿O‰p¶i“àj: —Õ°•a—, 37(8): 899`904, 1989.
1162. m’Z•ñn Rapid Increase in the Intracellular Calcium Concentration by
Endogenous Thromboxane A2 in Aggregation Induced by Threshold Doses of
Thrombin. ŽŽæMCA. HuangCŒ´“c–FÆC쑺“¹Žqi–ò—j: Physiology and Pharmacology of
Transmembrane Signalling, p.289`295, 1989.
1163. mŒ¤‹†•ñi‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àjn ŒŒ¬”ÂŒŒð‚ƃvƒƒXƒ^ƒmƒCƒh. ŽŽæMi–ò—j: ‘ãŽÓˆÙ펡—ÃŒ¤‹†Šî‹àŒ¤‹†‹ÆÑWCŒŒðÇ‚Ì•a‘Ô‚ÆŽ¡—ÂɊւ·‚鋤“¯Œ¤‹†i‘æ3•ñj, 16: 13`15, 1989.
1164. mÇ—á•ñn ”ñ•ª”åŒ^‘½”«Žîᎌ`¬«Œ`Ž¿×–EŽî‚Ì2—á. —«éDCŽR‰º‚¦‚èŽqC‰Á“¡Ž¡ŽqC“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶i“àjC‹T’J“Oi•a—j: –k—¢ˆãŠw, l9(5): 532`536, 1989.
1165. mŠw‰ïn iƒpƒlƒ‹j ’˜–¾‚È’á’`”’ŒŒ•a‚ÆäB‘Ÿ‚Ì‘½”«Œ‹ß«•a•Ï‚𔺂Á‚½‘gD‹…Ç‚Ì1–UŒŸ—á. ŽOŽ}Mi“àjCŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.3l), •Ÿ‰ª.
1166. mŠw‰ïn iˆê”Êu‰‰j lHÞ—¿•\–Ê‚É‚¨‚¯‚錌ðŒ`¬‚Æ‘¬“xŒù”z. ‘O“c_‹`Cù“c’¼i“ŒH‘åjC‹´–{¬Li¶‘ÌHj: ‘æ5‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï (83.11.20), ‘åãC ˜_•¶W, p.67`68, 1983.
1167. mŠw‰ïn iˆê”Êu‰‰j —nŒŒ‚ð‚à‚½‚ç‚·‘¬“xŒù”z‚͈̔͂ɂ‚¢‚Ä.
‹´–{¬Li¶‘ÌHjC—é–Ø”ŽŽqiˆãŠw‰ÈjC”nŸº´Ž‘i¶‘ÌHjC•ŽR½Ž÷C™‰Y—f‰îCù“c’¼i“ŒH‘åj: ‘æ6‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï
(84.11.22), “Œ‹žC ´˜^W, p.69`70, 1984.
1168. mŠw‰ïn iˆê”Êu‰‰j ’PˆêŒŒ¬”‚Ì×–EŽ¿“àƒJƒ‹ƒVƒEƒ€”Z“x‚̃gƒƒ“ƒrƒ“ŽhŒƒŽž‚̕ω»|ƒfƒCƒWƒ^ƒ‹‰æ‘œŒ°”÷‹¾‚É‚æ‚é‰ðÍ|.
”n“ˆ³—²C‰©ˆ¤—æCŽŽæMi–ò—j: ‘æ4‰ñ“ú–{ƒVƒ‡ƒbƒNŠw‰ï‘‰ï (89.04.22), ‘åãC “ú–{ƒVƒ‡ƒbƒNŠw‰ïŽGŽC4(1): 65`66,
1989.
1169. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚Ì”pŠüŒŒ‰t‚ÌŒ»‹µ. ˆ¾–앶„i—ÕŒŸjC•x‰i½ˆêi‹¹ŠOj: ‘æ37‰ñ“ú–{—AŒŒŠw‰ï‘‰ï (89.05.00), _ŒË, “ú–{—AŒŒŠw‰ïŽGŽ, 35(2): 252, 1989.
1170. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é–«ƒŠƒ“ƒp«”’ŒŒ•a‚ÉŠÖ‚·‚錟“¢. ŽR‰º‚¦‚èŽqC“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶C–Øì“c—²ˆêi“àj: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.05.13), “Œ‹ž.
1171. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚É‚¨‚¯‚铪ŠW•úŽËüÆŽË‚Æ High-dose MTX
—Ö@‚Ì”äŠrŒŸ“¢‹y‚Ñ’·ŠúƒtƒHƒ|ƒAƒbƒvŠ³Ž™‚̸_”’B‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. “‡–{—R‹IŽqC¡ˆäƒDCŽR–{OŽqC‰““¡‹I—YiŽ™j:
‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 744, l989.
1172. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚鈟‹}«”’Ž¿”]Ç‹y‚ÑΊD‰»–Ñ׌ŒŠÇÇ‚Æ’†•_Œo”’ŒŒ•a‚Æ‚ÌŠÖ˜A‚ɂ‚¢‚Ä.
¡ˆäƒDC“‡–{—R‹IŽqCŽR–{OŽqC‰““¡‹I—YiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ,
93(3): 744, l989.
1173. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‹}«ƒŠƒ“ƒp«”’ŒŒ•a‚É‚¨‚¯‚é”]‘¹‚Ì•]‰¿‚ɂ‚¢‚Ä. ŽR–{OŽqC“‡–{—R‹IŽqC¡ˆäƒDC‰““¡‹I—YiŽ™j:
‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.20), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 93(3): 745, l989.
1174. mŠw‰ïn iˆê”Êu‰‰j ˆ««ƒŠƒ“ƒpŽî‚É‚¨‚¯‚éT×–ERŒ´Žó—e‘Ì”Œ»‚̖Ɖu‘gD‰»Šw“IŒŸ“¢.
Š}ˆäŒ‰CŒK”ö’èmC–{‹§CŠâŸºŒ[ˆêC‹T’J“Oi•a—j: ‘æ29‰ñ“ú–{–Ô“àŒnŠw‰ï‘‰ï (89.06.09), ‰ªŽR, “ú–{–Ô“àŒnŠw‰ï‰ïŽ,
29(•â): 92, 1989.
1175. mŠw‰ïn iˆê”Êu‰‰j ’˜–¾‚ÈŒŒ¬”ÂŒ¸‚Æt•s‘S‚𔺂Á‚½Multicentric Angiofollicular Lymph
Node Hyperplasia‚Ì1—á. ŠâŸºŒ[ˆêC“n•Ó´Ž¡CŠ}ˆäŒ‰CŒK”ö’èmi•a—j: ‘æ29‰ñ“ú–{–Ô“àŒnŠw‰ï‘‰ï (89.06.10),
‰ªŽR, “ú–{–Ô“àŒnŠw‰ï‰ïŽ, 29(•â): 80, 1989.
1176. mŠw‰ïn iˆê”Êu‰‰j Role of Thromboxane A2 in the Rate of Rise in
Intracellular Calcium Concentration in Thrombin-Induced Aggregation of
Rabbit Platelets. ŽŽæMCA. HuangC쑺“¹Žq CŒ´“c–FÆi–ò—j: ‡]‡Uth Congress of the
International Society on Thrombosis and Haemostasis (89.08.19-25), “Œ‹žC
Thrombosis and Haemostasis , 62(1): 102, 1989.
1177. mŠw‰ïn iˆê”Êu‰‰j Individuality of Platelets in Elevation of
Cytoplasmic Free Calcium Level by Thrombin; An Analysis by Digital
Imaging Microscopy. ”n“ˆ³—²CŽŽæMi–ò—j: ‡]‡Uth Congress of the International
Society on Thrombosis and Haemostasis (89.08.19-25), “Œ‹žC Thrombosis and
Haemostasis , 62(1): 103, 1989.
1178. mŠw‰ïn iˆê”Êu‰‰j Relationship of Phospholipase A2 to Phospholipase C
for Intracellular Calcium Mobilization in Aggregation of Rabbit
Platelets. 쑺“¹ŽqCA. HuangCŽŽæMi–ò—j: ‡]‡Uth Congress of the International
Society on Thrombosis and Haemostasis (89.08.19-25), “Œ‹žC Thrombosis and
Haemostasis , 62(1): 105, 1989.
1179. mŠw‰ïn iˆê”Êu‰‰j ƒƒCƒRƒgƒŠƒGƒ“B4‚É‚æ‚é”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚ƃfƒLƒTƒƒTƒ]ƒ“‚É‚æ‚é‚»‚Ì—}§‹@˜.
ŽŽæMC¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒj: ‘æ39‰ñ“ú–{ƒAƒŒƒ‹ƒM|Šw‰ï‘‰ï (89.09.28°30), “Œ‹žC ƒAƒŒƒ‹ƒM|, 38:
1989.
1180. mŠw‰ïn iˆê”Êu‰‰j AMLŠ°‰ð“±“ü—Ö@’†‚É‚Ý‚ç‚ꂽARDS‚ɑ΂µ‚Ämethylprednisolone‘å—ʗÖ@‚ª‘tŒø‚µ‚½1—á.
ŽR‰º‚¦‚èŽqCŒÃ’J—²C“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶i“àj: “ú–{—Õ°ŒŒ‰tŠw‰ï‘æ106‰ñ—á‰ï (89.09.30), ‰¡•l.
1181. mŠw‰ïn iˆê”Êu‰‰j ”“®—¬‰º‚É‚¨‚¯‚錌ðŒ`¬|ŽüŠú“I‚É•Ï“®‚·‚邹‚ñ’f‘¬“x‚̉e‹¿|.
‹´–{¬Li¶‘ÌHjC¼ŒûŽ•FC‚—²½C¡ˆäŠ°Cˆ¢•””\–¾C“c’†Ž•FC“V–ì—²bC‘å“àŠîŽjC–쑺—F´CX“c—TlCæѳŠîCì~C“‡“cŒúC•i“cƒC‚ŽRr
C¼ŽR“¿‘åC“ü‘ò²mCó—˜G’jC•—ŠÔ”ÉCÎŒ´ºi‹¹ŠOjCŽR“àŒ’Cù“c’¼i“ŒH‘åj: ‘æ27‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (89.09.30),
ˆ®ìC —\eW, p.140, 1989.
1182. mŠw‰ïn iˆê”Êu‰‰j Effect of Sinusoidally Fluctuating Shear Rate on Clot
Growth. ‹´–{¬Li¶‘ÌHjCŽR“àŒ’Cù“c’¼i“ŒH‘åj: 7th World Congress of the International
Society for Artificial Organs (89.10.04), ŽD–yC Artificial Organs, 13(4):
305, 1989.
1183. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é“Á”«ŒŒ¬”ÂŒ¸«Ž‡”Á•ai–«Œ^j‚ÌŽ¡—ìтȂç‚Ñ‚É—\Œã. “¿O‰p¶C‰–’J–ÎC“¡–ì—R”üCŒÃ’J—²CŽR‰º‚¦‚èŽqC–Øì“c—²ˆêi“àj: ‘æ386‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.10.14), “Œ‹ž.
1184. mŠw‰ïn iˆê”Êu‰‰j ”][Ç‚Ü‚½‚ÍTIA ‚ÌIn-111-•WŽ¯ŒŒ¬”ƒVƒ“ƒ`ƒOƒ‰ƒtƒB[|Œz•”Wςɂ‚¢‚Ä|.
¼Šª”ŽC’r“crºC“cŠŽŒÈCãˆä˜aŽqCˆË“cˆêdC’†‘òŒ\Ž¡C¼—Ñ—²i•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw,
26(8): 1071, 1989.
1185. mŠw‰ïn iˆê”Êu‰‰j œ‘ˆÚAŒã‚Ìrecipient‚Ì––½ŒŒƒŠƒ“ƒp‹…‚É‚¨‚¯‚éõF‘Ìfragile sites‚̕ω».
ŒÃ’J—²i“àjC“n•Ó¹C‚ŽR‡C‘啽–r˜Yi‘—§‚ª‚ñƒZƒ“j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.24), –¼ŒÃ‰®,
‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.114, 1989.
1186. mŠw‰ïn iˆê”Êu‰‰j VP-16‚É‚æ‚éK562×–E‚Ì‘B—}§‚ƃAƒ~ƒmŽ_×–E“à—A‘—’ቺ‚Æ‚ÌŠÖ˜A.
‰–’J–ÎCŽR‰º‚¦‚èŽqCŒÃ’J—²C“¡–ì—R”üC“¿O‰p¶C–Øì“c—²ˆêi“àj: ‘æ31‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï (89.11.09), –¼ŒÃ‰®, —Õ°ŒŒ‰t,
30(9): 1620, 1989.
1187. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚Ž÷—§‚µ‚½è÷—±‹…Œn×–EŠ”‚Æ‚»‚Ì«ó.
‰Á“¡Ž¡ŽqC–{‘º–ÎŽ÷C‘å‹v•Û—²’ji‰¡•lŽs‘åjCŽR‰º‚¦‚èŽqC‰–’J–ÎC“¿O‰p¶i“àjCät“n’‰’ji—Õ•a—j: ‘æ31‰ñ“ú–{—Õ°ŒŒ‰tŠw‰ï‘‰ï
(89.11.10), –¼ŒÃ‰®, —Õ°ŒŒ‰t, 30(9): 1653, 1989.
1188. mŠw‰ïn iˆê”Êu‰‰j ƒEƒTƒMŒŒ¬”‹ÃW‚É‚¨‚¯‚éPhospholipase C Šˆ«‰»‚ɑ΂·‚éThromboxane A2
‚Ì–ðŠ„. 쑺“¹ŽqCŽŽæMi–ò—j: ‘æ12‰ñ“ú–{ŒŒðŽ~ŒŒŠw‰ï (89.12.01°02), ‘åãC ŒŒ‰t‚Æ–¬ŠÇ, 20(5): 387,
1989.
1189. mŠw‰ïn iˆê”Êu‰‰j ”x¶ŒŸ‚ÅŠm’èf’f‚µ‚½ATL‚Ì1Ç—á. ’†”öCˆêCŽR‰º‚¦‚èŽqCŒÃ’J—²C“¡–ì—R”üC‰–’J–ÎC“¿O‰p¶i“àj: “ú–{—Õ°ŒŒ‰tŠw‰ï‘æ107‰ñ—á‰ï (89.12.02), “Œ‹ž.
1190. mŠw‰ïn iˆê”Êu‰‰j ƒEƒTƒMŒŒ¬”‹ÃWŽž‚É‚¨‚¯‚é×–E“àƒJƒ‹ƒVƒEƒ€“®ˆõ‚̃zƒXƒzƒŠƒp|ƒ[A2‚É‚æ‚é’²ß.
쑺“¹ŽqC‰©ˆ¤—æCŒ´“c–FÆCŽŽæMi–ò—j: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J.
Pharmacol., 52(suppl.): 300, 1990.
1191. mŠw‰ïn iˆê”Êu‰‰j K562×–E‚̃Aƒ~ƒmŽ_×–E“à—A‘—‚ɑ΂·‚écycloheximide‚Ì—}§ì—p.
‰–’J–ÎCŽR‰º‚¦‚èŽqC“¿O‰p¶i“àj: ‘æ52‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï (90.03.29), “Œ‹ž, “ú–{ŒŒ‰tŠw‰ïŽGŽ, 53(2): 245,
1990.
1192. mŠw‰ïn iˆê”Êu‰‰j ƒgƒƒ“ƒrƒ“ŽhŒƒŽž‚Ì’PˆêŒŒ¬”Â×–EŽ¿“àƒJƒ‹ƒVƒEƒ€”Z“x‚Ì‘‘å|ƒfƒWƒ^ƒ‹‰æ‘œŒ°”÷‹¾‚É‚æ‚é‰ðÍ.
”n“ˆ³—²CŽŽæMi–ò—j: ‘æ52‰ñ“ú–{ŒŒ‰tŠw‰ï‘‰ï (90.03.29-31), “Œ‹žC “ú–{ŒŒ‰tŠw‰ïŽGŽ, 53(2): 423,
1990.
1193. mŠw‰ïn iˆê”Êu‰‰j HTL-V1R‘̉¿‚ª‚’l‚ðŽ¦‚µ‘½”Œ‹ß«‰A‰e‚ª”F‚ß‚ç‚ꂽT×–E«ƒŠƒ“ƒpŽî‚Ì1—á.
‰Ô“cL‰pCŽR‰º‚¦‚èŽqC•Ð‹Ë^lC‰–’J–ÎC–î“ߣM—YCˆ¢•”’¼C•y“c—FKi“àjC•½ˆäŽO˜YC‹g‘º”Ž–Mi‹¹ŠOjCŠ}ˆäŒ‰i•a—j:
‘æ87‰ñ“ú–{‹¹•”Ž¾Š³Šw‰ïŠÖ“Œ’n•û‰ï i89.11.18), “È–Ø.
1194. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒðŒ`¬‚ɑ΂·‚鑬“xŒù”z‚̉e‹¿. ‘O“c_‹`Cù“c’¼i“ŒH‘åjC‹´–{¬Li¶‘ÌHj: “ú–{‹@ŠBŠw‰ïŠÖ“ŒŠw¶‰ï‘æ22‰ñŠw¶ˆõ‘²‹ÆŒ¤‹†”•\u‰‰‰ï (83.03.10), ‰Y˜aC u‰‰‘OüW, p.91`92, 1983.
1195. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©Œ±ITPi–«Œ^j‚Ì—\Œã‚ÌŒŸ“¢. “¿O‰p¶C‰–’J–ÎC“¡–ì—R”üCŒÃ’J—²CŽR‰º‚¦‚èŽqCŽl‹{—R”üŽqC²“¡ƒŽqi“àj: _“Þ쌌‰tŒ¤‹†‰ï‘æ21‰ñ—á‰ï (90.02.03), ‰¡•l.
<<107 t‘ŸE”A˜H>>
1196. mŒ´’˜n Comparative Analysis of DST Alone and DST with Intermittent
Coverage by Cyclophosphamide.
Š‹¼ŒMCŒF–ì˜a—YCŠâ‘º³ŽkC‹g“cˆê¬C^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC”Ñ‚Šì‹v—YiŽ™jC“à“c‹v‘¥iŠOjC“n•”_“ñi‘ŸˆÚj:
Trans. Proc., 21(1): 1837`1838, l989.
1197. mŒ´’˜n The Role for Reactive Oxygen Species in Cyclosporin A
Induced Nephrotoxicity in Rats.
ŒF–ì˜a—YC‹g“cˆê¬CŠâ‘º³ŽkC‰““¡’‰—YCŽðˆä‹Ši”åjC’†‘º‘‰qi•ª¶jCŒK”ö’èmi•a—j: Trans. Proc., 21(1):
941`942, l989.
1198. mŒ´’˜n t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‹g“c‹`Ki϶‰ï‰¡•l“ì•”•a‰@j: ¬Ž™t•s‘SŒ¤‹†‰ïŽC9: 149`155, 1989.
1199. mŒ´’˜n ŒoŒû‹z’…ÜAST-120‚Ìt•s‘Sƒ‚ƒfƒ‹‚É‚¨‚¯‚éŒø‰Ê|tŽ…‹…‘Ì‘gD‹y‚Ñglomerular
hypertrophy‚ɑ΂·‚é‰e‹¿|. ‹g“c‹`Ki϶‰ï‰¡•l“ì•”•a‰@jCŽðˆä‹Ši”åjCŒK”ö’èmi•a—j: ¬Ž™t•s‘SŒ¤‹†‰ïŽC9:
156`158, 1989.
1200. mŒ´’˜n ƒLƒ…ƒvƒ‰ƒAƒ“ƒ‚ƒjƒEƒ€ƒŒ[ƒˆƒ“–Œ\‘¢‚̈Ⴂ‚É‚æ‚éƒÀ2-microglobulinœ‹Ž“Á«‚Ì”äŠrŒŸ“¢.
ŒF–ì˜a—Yi”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jC‹g“cˆê¬CŽðˆä‹Ši”åj: lH‘ŸŠíC18(3): 1133`1136, 1989.
1201. mŒ´’˜n t•s‘Sƒ‚ƒfƒ‹‚É‚¨‚¯‚éŒoŒû‹z’…ÜAST-120‚Ì•a‘Ô‚Æt‘gD‘œ‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‹g“c‹`KiÏ¢‰ï‰¡•l“ì•”•a‰@j: t•s‘SC1(1): 135`140, 1989.
1202. mŒ´’˜n –«ˆÛŽ“§ÍŠ³ŽÒ‚ÌŒŒ´Ž_‰»”\. ŒF–ì˜a—Yi”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jCŽðˆä‹Ši”åjC’†‘º‘‰qi•ª¶j’|“ೋCi–]¯“¡‘òƒNƒŠƒjƒbƒNj: t•s‘SC1(1): 57`62, 1989.
1203. mŒ´’˜n ‘‡‰ï’Ã’†‰›•a‰@”å”AŠí‰È‚É‚¨‚¯‚é1986”N|1987”N‚Ì2”NŠÔ‚Ì“ü‰@Š³ŽÒ‚ÆŽèp‚Ì“Œv“IŒŸ“¢. ‹PºC“ü]Œ[CŠâ‘º³ŽkCò”ŽˆêC‹v•Û¯ˆêC¬ŽÄŒ’i”åj: ¼“ú”å”A, 51(3): 1029`1033, l989.
1204. mŒ´’˜n ¬Ž™tŽ¾Š³‚É‚¨‚¯‚é‰^“®ˆ•û‚Ì‚½‚ß‚ÌŠeŽí‰^“®•‰‰×ŽŽŒ±‚ÌŒŸ“¢. ŒÃ£º•vi‘—§—×{Š¼•Ê•{•a‰@jCŽðˆä‹Ši”åj: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(4): 884`889, 1989.
1205. mŒ´’˜n t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錤‹†|ƒƒTƒ“ƒWƒEƒ€‹@”\AŽ…‹…‘Ì”ì‘å‚ÉŠÖ‚·‚錟“¢|. ‹g“c‹`KiÏ¢‰ï‰¡•l“ì•”•a‰@jCŽðˆä‹Ši”åj: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 39, 1989.
1206. mŒ´’˜n ƒ‰ƒbƒgt•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢. Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‹g“c‹`Ki϶‰ï‰¡•l“ì•”•a‰@j: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 40, 1989.
1207. mŒ´’˜n t•s‘Sƒ‰ƒbƒg‚É‚¨‚¯‚éŒoŒû‹z’…ÜAST-120‚ÌŒø‰Ê|t•s‘Si“W‘jŽ~‚ÉŠÖ‚·‚élŽ@|. Žðˆä‹ŠCŒF–ì˜a—YC‚—Ç‘Žqi”åjCŒK”ö’èmi•a—j: “ú–{t‘ŸŠw‰ïŽCXXXI(4): 39`45, 1989.
1208. mŒ´’˜n MTT-assay‚ð—p‚¢‚½ƒqƒgäNã÷Šà×–EŠ”‚̧ŠàÜŠ´Žó«ŽŽŒ±. ‘ò‘º³”VC¬“c“‡–M’ji”åjC’·‘q˜a•FC’†‘ºGi–h‰q‘åj: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 80(8): 1195`1202, l989.
1209. mŒ´’˜n 50ΈÈã‚Ì’jŽq‚É‚¨‚¯‚é‘O—§‘BÇ‚ÌŒŸ“¢|‘æ2‰ñ’[–ì’¬‘O—§‘BŒŸf‚ÌŒ‹‰Ê‚ÌŒŸ“¢.
’Ë–{‘׎iCŒF–{‰x–¾C‚–Ø—Ç’jCŽRŒûNGC‹g‰ª‘ôiŽD–yˆã‘åjC‰¡ŽR‰p“ñi”åjC—ÑŒªŽ¡i–kŒ©Ô\Žš•a‰@jCŒÃ‰®¹Ž™C¬–¸Œ[iŒÃ‰®•a‰@j:
”å”A‹I—v, 35: 1701`1708, l989.
1210. mŒ´’˜n Kidney Transplant Nephrotic Syndrome with Minimal Histologic
Change in Focal Segmental Glomerulosclerosis: Clinical Recurrence?
Jon-De LeeCŽðˆä‹Ši”åjC”Ñ‚Šì‹v—YiŽ™jCŒF–ì˜a—YCŠâ‘º³Žki”åjC‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŒK”ö’èmi•a—j:
–k—¢ˆãŠwC19(6): 619`623, 1989.
1211. mŒ´’˜n Characterization of a Polyreactive Monoclonal Antibody to ds
DNA, Fx1A, and Heparan Sulfate Generated from BALB/c Mice Immunized
with Rat Renal Homogenates. Chen, X-M.i“àjCAozuka,
S.i‘—§ˆã—ÃZƒ“ƒ^[jCŠ™“cvŽõi“àjCOkamura, K.i‡“V“°‘åjC¬—Ñ–Li“àj: Clin. Immunol.
Immunopathol., 51: 326`337, 1989.
1212. mŒ´’˜n Tubulointerstitial Nephritis Induced by Monoclonal
Antiproximal Tubular Basement Membrane Antibodies in Mice. Chen,
X-M.i“àjCTanaka, T.i‡“V“°‘åjC¬—Ñ–Li“àjCShigematsu, H.iMB‘åjCOkamura, K.i‡“V“°‘åj:
Clin. Immunol. Immunopathol., 54: 40`52, 1990.
1213. mŒ´’˜n Abnormal Lipid Profiles at Various Stages of Uraemia.
’Ë–{—Y‰îCŽá—Ñ–õ‹vC‘å‹v•Û[li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: Nephrol. Dial. Transplant.,
4(Suppl.): 142`145, 1989.
1214. mŒ´’˜n Moderately Proteinuric IgA Nephropathy: Prognostic
Prediction of Individual Clinical Courses and Steroid Therapy in
Progressive Cases. ¬—Ñ–LC”äŠé”\”VC“¡ˆäˆêŽjC•ìºCŠÚ–샶i“àj: Nephron, 53: 250`256,
1989.
1215. mŒ´’˜n The Role of HLA-DR4 in the Long-term Prognosis of IgA
Nephropathy. ”äŠé”\”VC¬—Ñ–LC‘å‹v•Û[li“àjC”–Ø“oiˆÚ–Æj: Nephron, 54: 264`265, 1990.
1216. mŒ´’˜n New Zealand F1 ƒ}ƒEƒXtǂɑ΂·‚é15-deoxyspergualin ‚ÌŽ¡—ÃŒø‰Ê‚Æì—p‹@˜. ‘å‹v•Û[lCˆäãŒcˆêC”~’J’¼Ž÷CŠ™“cvŽõi“àj: ¡“ú‚̈ÚA, 2(6): 451`455, 1989.
1217. mŒ´’˜n tˆÚAŒã‚̃TƒCƒgƒƒKƒƒEƒCƒ‹ƒXŠ´õÇ. ã‘C”~’J’¼Ž÷CŠ™“cvŽõC‘å‹v•Û[li“àjC‚‹{t’ji—ÕŒŸj: ¡“ú‚̈ÚA, 2: 310`315, 1989.
1218. mŒ´’˜n ¬Ž™CAPDŠ³ŽÒ‚̬’·‚Ƈ•¹Ç. ”Ñ‚Šì‹v—YCˆÉ“¡–¯ŒbC–kžŠ‚Ý‚Ç‚èiŽ™jCŒF–ì˜a—YCŽðˆä‹Ši”åj: ¬Ž™t•s‘SŒ¤‹†‰ïŽC9: 38`41, 1989.
1219. mŒ´’˜n ŒoŒû“I1,25(OH)2D3ƒpƒ‹ƒX—Ö@’·ŠúŽ{s—á‚ÌŒŸ“¢. ’Ë–{—Y‰îC–쑺K”Íi“àjC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: t‚Æœ‘ãŽÓ, 3(1): 35`40, 1990.
1220. mŒ´’˜n ’·Šú“§Í—á‚É‚¨‚¯‚éƒAƒ~ƒƒCƒhœŠÖßÇ.
’†‘ò—¹ˆêC¬ìˆ¤ˆê˜YCŽO‰Y–õ•Fi‘—§²‘q•a‰@jCŠÚ–샶i“àjC“y“cOŠîC•lŒû‹ÓˆêC—é–Ø—mˆêC•Ûâ‰lˆêi‘—§²‘q•a‰@jCˆÀ“¡Œ¤C•ž•”‹`”ŽC‹g“c–L
•Fi‹ž—t”å”AŠíƒNƒŠƒjƒbƒNj: t‚Æœ‘ãŽÓ, 3(1): 91`100, 1990.
1221. mŒ´’˜n ’·Šú“§ÍŠ³ŽÒ‚Ì‚“x“ñŽŸ«•›bó‘B‹@”\˜´iǂɑ΂·‚éŒoŒû“I1,25(OH)2D3ƒpƒ‹ƒX—Ö@.
–쑺K”ÍC’Ë–{—Y‰îC‹g“càˆC‰i‰ª—²C–Øì“c—²ˆêi“àjC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jC‚–Ø—TC‚‹´—Tˆê˜Yi‘Š–Í‘ä•a‰@jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj:
t‚Æ“§Í, 27(5): 955`960, 1989.
1222. mŒ´’˜n 123I-orthoiodohippurate
(OIH)‚É‚æ‚ét“®‘Ô‹@”\ŒŸ¸‚Ì—Õ°“I•]‰¿|131I-OIH‚Æ‚Ì”äŠr‚¨‚æ‚Ñ—LŒøtŒŒ—¬—Ê‚Ì‘ª’è|.
Έ䟌ÈC“cŠŽŒÈC¼™É”ŽC’†‘òŒ\Ž¡C¼—Ñ—²i•újC΋´Wi”åjCΓcŽ¡—Yi“s—§´£¬Ž™•a‰@j: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 50(1):
68`75, 1990.
1223. mŒ´’˜n ¬Ž™tŽ¾Š³‚É‚¨‚¯‚é–Ɖu—}§Ü‘½Ü—Ê•¹—p—Ö@. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èCŠ—Œ´FC…–ì—@iŽ™jCŽðˆä‹Ši”åj: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 139, 1989.
1224. mŒ´’˜n Å‹ß5”NŠÔ‚ɔǂµ‚½¬Ž™SLE13—á‚Ì”Œ©“®‹@‚©‚ç‚Ý‚½—Õ°•a—Šw“IŒŸ“¢. –kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: “ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 25, 1989.
1225. mŒ´’˜n ‹}«ŠÔŽ¿«t‰Š‚É”º‚¤‹}«”ñ–R”A«t•s‘SŠ³Ž™‚Ì”A’†“d‰ðŽ¿‚̕ω». ‰Í¼‹IºC‘åι–çiŽ™j: •‘ –ì—Žq‘åŠw‹I—vC25: 143`146, 1990.
1226. mŒ´’˜n tˆÚA—Õ°‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG 4܇•¹“Š—^–@.
ŒY•”P’jCŒY•”“ŒŽ¡C‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø
“oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åˆã‰ÈŒ¤j: —Õ°ˆÚA–ƉuŒ¤‹†‰ïŽ, 12: 55`63, 1990.
1227. m’Z•ñn Œ§ˆãŽt‰ïŽ–‹ÆAtŽ¾Š³‘Îô‚Ì3”NŠÔ‚Ì‚Ü‚Æ‚ß. Žðˆä‹Ši”åj: _“Þ쌧“§ÍŽ{ݘA—‹¦‹c‰ï•ñ, (4): 11`12Cl989.
1228. m’Z•ñn 1988”N“xŽÀŽ{ƒAƒ“ƒP[ƒgu“§ÍŽ{Ý‚Å‚ÌЊQ‚É‚æ‚é‹Ù‹}Ž–‘Ԃւ̑Ήžv‚Ì•ªÍŒ‹‰Ê‚ɂ‚¢‚Ä. “ú‘ä‰p—Yi‰¡•l‘æˆê•a‰@jCŽðˆä‹Ši”åjC“¿“c”Ž³i‹î‰ª“¿“cƒNƒŠƒjƒbƒNj: _“Þ쌧“§ÍŽ{ݘA—‹¦‹c‰ï•ñ, (4): 5`10Cl989.
1229. mŒ¤‹†•ñiŒú¶Èjn ¬Ž™CAPDŠ³ŽÒ‚̎Љ‹A.
Žðˆä‹Ši”åjCˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èiŽ™jCŒF–ì˜a—Yi”åjC‰Í¼‹IºiŽ™j:
Œú¶ÈuSgáŠQŒ¤‹†v¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÔŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†º˜a63”N“xŒ¤‹†•ñ‘, p. 211`214, 1989.
1230. mŒ¤‹†•ñiŒú¶Èjn IgAt‰Š‚Æ‚»‚ÌŠÔŽ¿•a•Ï‚Ì•]‰¿. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŽðˆä‹Ši”åj: Œú¶ÈSgáŠQŒ¤‹†C¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†Cº˜a63”N“xŒ¤‹†•ñ‘, p.77`81, 1989.
1231. mŒ¤‹†•ñiŒú¶Èjn ”÷¶•¨“ñŽŸ‘ãŽÓŽY•¨‚̖Ɖu—}§ì—pA“Á‚Étǔǂ¨‚æ‚Ñi“W‚Ì—}§‚ɂ‚¢‚Ä||‚·‚łɔǂµ‚½New
Zealand Black/White F1 (NZB/W F1)ƒ}ƒEƒXSLEtǂɑ΂·‚é15-deoxyspergualin‚ÌŽ¡—ÃŒø‰Ê[[.
‘å‹v•Û[lC”~’J’¼Ž÷CˆäãŒcˆêCŠ™“cvŽõi“àj: Œú¶ÈV–òŠJ”Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.117`124, 1989.
1232. mŒ¤‹†•ñiŒú¶Èjn Œy“x‚Ì’`”’”A‚ð’æ‚·‚éIgAtÇ‚Ì—\Œã. ¬—Ñ–LC”äŠé”\”VC•ìºCãŽRŽO‘ãŽqC“¡ˆäˆêŽji“àj: Œú¶È“Á’莾Š³uis«táŠQv’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñW, p.7`16, 1989.
1233. mŒ¤‹†•ñiŒú¶Èjn ‚Z¶ŒŸ”A‚ÌŽÀ‘Ô. Žðˆä‹Ši”åj: Œú¶È“Á’莾Š³uis«táŠQ’²¸Œ¤‹†vº˜a63”N“xŒ¤‹†•ñ‘ Cp.102`104, 1989.
1234. mŒ¤‹†•ñiŒú¶Èjn _“Þ쌧‚Ìt‘Ÿ•aŒŸfƒVƒXƒeƒ€. Žðˆä‹Ši”åj: Œú¶È“Á’莾Š³uis«táŠQ’²¸Œ¤‹†vº˜a63”N“xŒ¤‹†•ñ‘ Cp.357`358, 1989.
1235. mŒ¤‹†•ñiŒú¶Èjn Œú¶ÈSgáŠQŒ¤‹†;
¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†u¬Ž™CAPDŠ³ŽÒ‚̬’·‚Æ…—n«ƒrƒ^ƒ~ƒ“‚ɂ‚¢‚Äv.
”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbiŽ™jCŽðˆä‹Ši”åj: º˜a63”N“xŒ¤‹†•ñ, p.200`201, 1988.
1236. mŒ¤‹†•ñiŒú¶Èjn Œú¶ÈSgáŠQŒ¤‹†; ¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†
¢¬Ž™CAPDŠ³ŽÒ‚̬’·‚Æ…—n«ƒrƒ^ƒ~ƒ“‚ɂ‚¢‚Ä£. ”Ñ‚Šì‹v—YC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbiŽ™jCŽðˆä‹Ši”åj:
º˜a63”N“xŒ¤‹†•ñ,@p.200`201, 1988.
1237. mÇ—á•ñn JRA ‚ð‹‚‹^‚킹‚銳Ž™‚ɇ•¹‚µ‚½‘ƒóŽ…‹…‘Ìd‰»Ç‚Ì1—á. ŽR–{OŽqC–kžŠ‚Ý‚Ç‚èC¯–ì—¤•vC‰Í¼‹IºiŽ™j: ŠÖ“Œ¬Ž™t‘ŸŒ¤‹†‰ïŽ,@5(1): 17`18, 1989.
1238. mÇ—á•ñn ƒlƒtƒ|ƒ[ÇŒóŒQ‚Ŕǂµ‚½IgAtÇ‚Ì1—á|IgA Nephropathy with Nephrotic
Syndrome or Idiopathic Nephrotic Syndrome with IgA Mesangial Deposits
?|. –kžŠ‚Ý‚Ç‚èC“à“¡„•FC‰Í¼‹IºiŽ™j: ŠÖ“Œ¬Ž™t‘ŸŒ¤‹†‰ïŽ,@5(1): 22`23, 1989.
1239. mÇ—á•ñn “ÁˆÙ‚ÈŽ…‹…‘Ì•a•Ï‚ð’悵‚½–Œ«‘B«Ž…‹…‘Ìt‰Š‚Ì1—á. “c‘º_ŽOC•ìºCãŽRŽO‘ãŽqC¬—Ñ–Li“àj: t‰ŠÇ—ጤ‹†, 5: 92`95, 1989.
1240. mÇ—á•ñn ‚“x‚ÌŽ…‹…‘Ìt‰ŠA”A׊ÇEŠÔŽ¿«t‰Š‚𔺂Á‚½ Castleman •a‚Ì1—á. ”äŠé”\”VC‰Ô“cL‰pC–쑺K”ÍC’Ë–{—Y‰îC•ìºCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àjCŠ}ˆäŒ‰i•a—j: t‰ŠÇ—ጤ‹†, 6: 120`124, 1990.
1241. mÇ—á•ñn Ä”R‚ðŒJ‚è•Ô‚µ‚½ƒ‹[ƒvƒXt‰Š‚Ì1—á. ãŽRŽO‘ãŽqC•ìºCŠ™“cvŽõC”äŠé”\”VC¬—Ñ–Li“àj: t‰ŠÇ—ጤ‹†, 6: 16`22, 1990.
1242. mÇ—á•ñn Ž‘±«—²‹N«g”ÁAŽá”N«ŠÖ߃ŠƒEƒ}ƒ`—l‚ÌŠÖ߉Š‚É‘ƒóŽ…‹…‘Ìd‰»Ç‚𔺂Á‚½1’jŽ™—á. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: t‰ŠÇ—ጤ‹†,@6: 115`119, 1990.
1243. mÇ—á•ñn ‰E‘å‘Úœ“ª‰óŽ€‚ð’悵‚½¬Ž™t•s‘SÇ—á. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbCƒŒƒCƒ‚ƒ“ƒh¥ƒtƒ‰ƒ“ƒVƒAC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: ‘æ10‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï•ñW,@10: 25`29, 1989.
1244. mÇ—á•ñn •úŽËü«ˆÞkäNã÷‚É‹Nˆö‚µ‚½äNã÷Ž©‘R”j—ô‚Ì1—á. ‹PºC“ü]Œ[C‘ê–{‰ë•¶CŠâ‘º³Žki”åj: ”å”AŠíŠO‰È, 2(4): 409`412, 1989.
1245. m—Õ°Ž¡Œ±n ¬Ž™tˆÚAŒã‚Ì‹}«‹‘┽‰ž‚ɑ΂·‚émuromonab CD3‚ÌŽ¡—ÃŒø‰Ê. ˆÉ“¡ŽŒÈi“Œ—‘åjCŽðˆä‹Ši”åj: ¬Ž™‰È—Õ°C42(7): 1551`1560, 1989.
1246. m—Õ°Ž¡Œ±n ¬Ž™t«•nŒŒ‚ɑ΂·‚érecombinant human erythropoietin
(EPOCH)‚Ì—Õ°•]‰¿|•Û‘¶Šú–«t•s‘SŠ³ŽÒ‚ɑ΂·‚é‰e‹¿‚ɂ‚¢‚Ä. ˆÉ“¡ŽŒÈi“Œ—‘åjCŽðˆä‹Ši”åj: ¬Ž™‰È—Õ°C43(3):
85`96, 1990.
1247. m—Õ°Ž¡Œ±n AN69HF‚ð—p‚¢‚½ŒŒ‰tàh‰ß“§Í‚ł̒ᕪŽq’`”’‚Ìœ‹Ž‚Æ‚»‚Ì‹@˜.
‚–Ø—Ti”åjC¬ŽR½C“ì•”³lCéˆä°”üC—Ñ‹v”üŽqC‘Š CˆêitƒZƒ“jC‹g“cˆê¬CŒF–ì˜a—YCŽðˆä‹Ši”åj:
t‚Æ“§Íi•ÊûjƒnƒCƒpƒtƒH[ƒ}ƒ“ƒXƒƒ“ƒuƒŒƒ“'89, 27: 100`103, 1989.
1248. m—Õ°Ž¡Œ±n –«ˆÛŽ“§ÍŠ³ŽÒ‚Ì•Ö”é‚ɑ΂·‚éH•¨‘@ˆÛŠÜ—LƒEƒGƒn[ƒX‚ÌŽg—pŒoŒ±. ŒF–ì˜a—YC“ü]Œ[CŽðˆä‹Ši”åjCHŽRŒbŽqC÷ˆäŒ’Ž¡i‹´–{ƒNƒŠƒjƒbƒNj: —Õ°“§ÍC5(8): 111`114, 1989.
1249. m—Õ°Ž¡Œ±n t«•nŒŒŠ³ŽÒ‚ɑ΂·‚é recombinant human ergthropoietin
(EPOCH)‚Ì—Õ°“IŒ¤‹†||“ñd–ÓŒŸ–@‚É‚æ‚é‚R—p—Ê”äŠrŽŽŒ±||.
•½‘ò—R•½iMŠy‰€•a‰@jC•½“ˆ–M–Òié‹Êˆã‰È‘åjCr쳺iVŠƒ‘åjC¬‚’Ê•viç—t‘åjC¬–¸—z‰îiŒÕ‚Ì–å•a‰@jC‹gìNsié‹Êˆã‰È‘åjC²’†Žy
i“Œ‹ž—Žqˆã‘åjCŽÂ“cëi‹à‘òˆã‰È‘åjCXˆä_¢i‘åãŽs—§‘åjC—é–سŽiiMŠy‰€•a‰@jCç—t‰hŽsiŽOŠ}Žs—§ŽOŠ}‘‡•a‰@jC‚‹´Žõiå‘äŽÐ‰ï•ÛŒ¯•a
‰@jC‹à“c_C‘O‘½—²‹gi‚¢‚í‚«Žs—§‘‡”Ö鋤—§•a‰@jC“à“cMˆêi϶‰ï‘O‹´•a‰@jCŽRŒ`—zi“ú—§‘‡•a‰@jCó–ì‘×C•“¡d–¾iŽ©Ž¡ˆã‰È‘åjC‰œ“cŒ’
“ñi‰œ“cƒNƒŠƒjƒbƒNjC”‘qsGié‹Êˆã‰È‘åjC“ˆ“crPiç—tŽÐ‰ï•ÛŒ¯•a‰@jC’†àV—¹ˆêi‘—§²‘q•a‰@jCŒIŒ´—åit“ú•”G˜a•a‰@jC¬o‹PCŒE“cŽÀ
i‡“V“°‘åjC•ì´i“Œ‘åjC¯–ì³Mi¹‹´ƒNƒŠƒjƒbƒNjC‰Ž“c‹’jC—é–Ø—m’ÊiŒc‘åjC¬˜H—Çi“ì‘åˆäƒNƒŠƒjƒbƒNjC™–ìM”ŽC”g‘½–쓹NCŒE“cŒ¤
“ñC²“¡FŽqi“Œ—Žqˆã‘åjCΓc®ŽuC‘å˜a“cŽ i¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åjC‰z캎OC‚‹´Œ’iº˜a‘åjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCŠ™“cvŽõi–k—¢‘åE
“à‰ÈjCâ–{M•vC“n•Ó—LŽOi–¼ŒÃ‰®‘åjCŽRèe—YiOωq•a‰@jCàV¼ŒªŽŸi‹ž‘åjC¬–ì—˜•Fi‹ž“s‘æˆêÔ\Žš•a‰@jCÜ“c‹`³iã‘åjC–k‰ª—˜
—YC‰ª‘ºŽÍC‰¡ì•üŽqiŠÖ¼˜JЕa‰@jCˆäã—²C“ú–ì‰ë”Vi‘“—´‰ïˆäã•a‰@jC‘Oì³MC“c’†Š°i‘åãŽs—§‘åjC”Ñ“cŠìri‘åã•{—§•a‰@jCÔŠ_—m“ñ
i‘å–ì•a‰@jC“¡“c‰ÃˆêCˆä㹎mCâˆä—ÚŽÀi•ºŒÉˆã‰È‘åjC¬–ìŽRŒOi‹ã‘åjC’†‘º’è•qi¬‘q‘æˆê•a‰@jC“¡Œ©œ·C•Û—˜Œhi•Ÿ‰ªÔ\Žš•a‰@jC¬ì’¨–ç
iˆ¤•Q‘åj: t‚Æ“§Í, 27(1): 157`177, 1989.
1250. m—Õ°Ž¡Œ±n AMSƒyƒj[ƒ‹ƒCƒ“ƒvƒ‰ƒ“ƒgAƒCƒ“ƒtƒŒ[ƒ^ƒuƒ‹Œ^ƒ‚ƒfƒ‹700‚Ì—Õ°ŽŽŒ±¬Ñ.
”’ˆä«•¶C‚”g^²Ž¡i“Œ–M‘åjC‹àŽq–Î’jiˆ®ìˆã‰È‘åjC“¡‰ª’mºC–،õiŠâŽèˆã‰È‘åjC‰ª–{dâXCŠÑˆä•¶•Fi¹˜H‰Á‘Û•a‰@jC“¡–ì’Wli”åjC–Ø
Œ´—T“ñiŒö—§–L‰ª•a‰@jC’†–씎iƒ}ƒcƒ_•a‰@jC–œ”g½C‘å¼—msiŽs—§‰F˜a“‡•a‰@jCã—ä—ŠŒ[C•½”ö”ŽC‰Á“¡‰ë‹vC“ú“cŠ¯CŽR“c—zŽii϶‰ï‰ºŠÖ‘‡•a
‰@j: ”å”A‹I—v, 35: 913`920, 1990.
1251. m—Õ°Ž¡Œ±n Ö¬«”A˜H‘¢‰e‚É‚¨‚¯‚é”ñƒCƒIƒ“«ƒˆ[ƒh‘¢‰eÜIohexol‚Ì—L—p«‚ÌŒŸ“¢|“_“HÃ’‚É‚æ‚é”A˜H‘¢‰e(DIP).
’¬“c–L•½iŽœŒb‘åjC¬–ö’m•Fi–k‘åjCŒF–{‰x–¾iŽD–yˆã‰È‘åjCÜŠ}¸ˆêi“Œ–k‘åjC¬ìHŽÀiMB‘åjCˆ¢‘]‰À˜Yi“Œ‘åjC“‡è~iç—t‘åjCŠÝ–{F
i“ú‘åjCHŒ³¬‘¾i“ú–{ˆã‰È‘åjCŽO–ؽi“Œ‹žˆã‰È‘åjC¬ŽÄŒ’i”åjC‘å“c•˜a¶i–¼ŒÃ‰®Žs—§‘åjC‹g“cCi‹ž‘åjC“n粌ˆi‹ž“s•{—§ˆã‰È‘åjC‹{ì
ª’ji’¹Žæ‘åjC‘åXO”Vi‰ª‘åjC“¡“cK—˜i‚’mˆã‰È‘åjC]“¡kìi‹v—¯•Ä‘åjC‘åˆäD’‰iŽŽ™“‡‘åjC‘åÎK•FiŽœŒb‘åj: —Õ°ˆã–ò,
5(8): 1703`1716, 1989.
1252. m‘àn “ú–{‚É‚¨‚¯‚étˆÚA‚ÌŒ»‹µ. Žðˆä‹Ši”åjCV‘º•¶’jiŽ™j: ˆãŠw‚Ì‚ ‚ä‚ÝC150(9): 609`612, 1989.
1253. m‘àn —˜”A–ò. Žðˆä‹Ši”åj: ŠO‰ÈC51(5): 481`486, 1989.
1254. m‘àn “ÁŽêƒPƒA‚ðŽó‚¯‚Ä‚¢‚銳ŽÒ‚Ì"ˆÀ‘S«‚ƈÀŠy«"|CAPDŽ{sŠ³ŽÒ|. ‹{“‡•Ÿ]itƒZƒ“j: ŒŽŠ§ƒi[ƒVƒ“ƒOC9(10): 76`77, 1989.
1255. m‘àn “ÁŽêƒPƒA‚ðŽó‚¯‚Ä‚¢‚銳ŽÒ‚Ì"ˆÀ‘S«‚ƈÀŠy«"|ŒŒ‰t“§ÍŽ{sŠ³ŽÒ|. ‹{“‡•Ÿ]itƒZƒ“j: ŒŽŠ§ƒi[ƒVƒ“ƒOC9(11): 78`81, 1989.
1256. m‘àn tŽ¾Š³¶ŠUŠÇ—‚̃|ƒCƒ“ƒg|Šw“¶Šú|. Žðˆä‹Ši”åj: ŒöO‰q¶C53(5): 301`304, 1989.
1257. m‘àn –«t‰ŠEt•s‘SŠ³ŽÒ‚̶ŠˆŽw“±|ŠwZŒŸf‚æ‚è|. Žðˆä‹Ši”åjCV‘º•¶’jiŽ™j: Ž¡—ÃC72(3): 119`126, 1990.
1258. m‘àn ‰æ‘œf’fut‘Ÿv. Žðˆä‹Ši”åjCV‘º•¶’jiŽ™j: ¬Ž™‰Èf—ÃC53(4): 1024`1030, 1990.
1259. m‘àn ¬Ž™t•s‘S‚ÌŽ¡—ÂÌi•à‚Æ”½È. Žðˆä‹Ši”åj: ¬Ž™‰Èf—ÃC53(6): 1368`1373, 1989.
1260. m‘àn ¬Ž™‚Ì“§Í‚Æ–â‘è“_. Žðˆä‹Ši”åjC”Ñ‚Šì‹v—YiŽ™jCŒF–ì˜a—Yi”åjCV‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: t‚Æ“§ÍC27(1): 33`40, 1989.
1261. m‘àn Ž‡”Á•a«t‰Š|¬Ž™|. Žðˆä‹Ši”åjCV‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: t‚Æ“§ÍC27(‘): 163`165, 1989.
1262. m‘àn • –Œ‰ŠEƒCƒŒƒEƒX. ŒF–ì˜a—Yi”åj: t‚Æ“§ÍitŽ¾Š³‚Ì–ò•¨—Ö@jC27: 457, 1989.
1263. m‘àn ”xŠà. ŒF–ì˜a—Yi”åj: t‚Æ“§ÍitŽ¾Š³‚Ì–ò•¨—Ö@jC27: 521`522, 1989.
1264. m‘àn ŽíX‚ÌŒŒ‰tò‰»—Ö@:@tˆÚA‚Æ“§ÍƒAƒ~ƒƒCƒh[ƒVƒX.
ŒF–ì˜a—YC‚–Ø—Ti”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jCŽðˆä‹ŠC‰““¡’‰—Yi”åjCŒüˆäLÆC‚‹´—Tˆê˜Yi‘Š–Í‘ä•a‰@jC÷ˆäŒ’Ž¡i‹´–{ƒNƒŠƒjƒb
ƒNjC‰¡“c^“ñi”åjC¬‘q—TKiŒú–؃NƒŠƒjƒbƒNj: t‚Æ“§Íi•ÊûjƒnƒCƒpƒtƒH[ƒ}ƒ“ƒXƒƒ“ƒuƒŒƒ“'89, 27: 39`43, 1989.
1265. m‘àn ”A˜HŒn‚ƶBŠíŽ¾Š³. Žðˆä‹Ši”åj: “ú–{ˆãŽt‰ïŽGŽi—Õ‘jC102(10): 180`193, 1989.
1266. m‘àn “ú–{‚É‚¨‚¯‚étˆÚA‚ÌŒ»ó. Žðˆä‹Ši”åj: “ú–{ˆãŽ–V•ñC(3415): 134`135, 1989.
1267. m‘àn t•s‘S•a‘ԂƬ’·áŠQ. Žðˆä‹Ši”åj: “ú–{¬Ž™i‰h—{Á‰»Ší•aŠw‰ïŽGŽjC3(1): 51`61, 1989.
1268. m‘àn tˆÚA‚É”º‚¤ŽÐ‰ï“I”–â‘è. Žðˆä‹Ši”åj: —Õ°“§ÍC5(11): 83`87, 1989.
1269. m‘àn S–[«Na—˜”Aƒzƒ‹ƒ‚ƒ“. ’Ë–{—Y‰îi“àj: Current Review “§Í—Ö@EtˆÚA, p.72`83, 1989.
1270. m‘àn ‘ƒóŽ…‹…‘Ìd‰»Ç‚̬ˆö‚Æ—Õ°‘œ. ¬—Ñ–LCŠÚ–샶C”äŠé”\”Vi“àj: Medical Practice, 6(10): 1637`1643, 1989.
1271. m‘àn IgA tÇ. ¬—Ñ–Li“àj: Medical Practice, 6(—Õ‘): 555`556, 1989.
1272. m‘àn ”D•w‚Ì…‘ãŽÓ‚Æt‹@”\. ‰¡“c^“ñCŒF–ì˜a—YCŽðˆä‹Ši”åj: ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA, 2ŒŽ†, 1990.
1273. m‘àn ’áNaE‚NaŒŒÇ. ’Ë–{—Y‰îi“àj: ˆãŠw‚Æ–òŠw, 22(2): 301`307, 1989.
1274. m‘àn —nŒŒ«”A“ÅÇÇŒóŒQ. ”Ñ‚Šì‹v—YiŽ™j: ¬Ž™‰Èf—Ã,@52(6): 1347`1352, 1989.
1275. m‘àn tŽ¾Š³‚Ì–ò•¨—Ö@: tˆÚA‚ÉŽg—p‚³‚ê‚é–òÜ||–R”A. ‘å‹v•Û[li“àj: t‚Æ“§Í, 27: 566`567, 1989.
1276. m‘àn i“ÁWj‘ÌŠOÕŒ‚”gŒ‹Î”jӗÖ@ESWL;”A˜HŒ‹ÎESWL‚̇•¹Ç. ^‰ºß•vCrìFC‹v•Û¯ˆêi”åj: “ú–{—Õ°C47(12): 40`44, 1989.
1277. m‘àn i“ÁWj‘ÌŠOÕŒ‚”gŒ‹Î”jӗÖ@ESWL;‘匋ÎESWL‚Æstone street‚ÌŠÇ—|tƒTƒ“ƒSóŒ‹Î‚ð’†S‚É|. rìFC‹v•Û¯ˆêC^‰ºß•vi”åj: “ú–{—Õ°C47(12): 60`64, 1989.
1278. m‘àn ŒŒ”A‚̉摜f’fGŠjˆãŠwŒŸ¸‚Ì–ðŠ„. ΋´Wi”åj: —Õ°‰æ‘œ, 5(8): 62`76, 1989.
1279. m‘àn ƒoƒiƒWƒEƒ€Aƒtƒb‘f‚È‚Ç‚Ì‘¼Œ³‘f. ’Ë–{—Y‰îi“àj: —Õ°“§Í, 5(11): 1743`1747, 1989.
1280. m‘àn ”]Ž€‚Ì¥”F‚Æ‘ŸŠíˆÚA‚̈ì˜H. ¬ŽÄŒ’i”åj: —Õ°“§ÍC5(3): 335`336, 1989.
1281. muÀn ”A’`”’. Žðˆä‹Ši”åj: Medicina, ‘Š§†C26(10): 1634Cl989.
1282. muÀn ”A“œ. Žðˆä‹Ši”åj: Medicina, ‘Š§†C26(10): 1635Cl989.
1283. muÀn »“œ‚Ɖ–‚ÌÛ‚è‰ß‚¬‚É‚æ‚éŠQ. Žðˆä‹Ši”åj: ”NŽÊ^V•·i¬Šw•ÛŒ’ƒjƒ…[ƒXjC(254): 1, 1989.
1284. muÀn ‘æ15‰ñˆãH§’k‰ï‚ÉoÈ‚µ‚Ä. Žðˆä‹Ši”åj: lH‘ŸŠíC18(4): 1518, 1989.
1285. muÀn Chance Proteinuria. Žðˆä‹Ši”åj: “à‰È, 63(6): 1070, 1989.
1286. muÀn ŠwZ‘̈ç‚É‚¨‚¯‚éê–åˆã‚̃AƒhƒoƒCƒX. ’·â—T”Ži‰¡•lŽs¬Ž™ƒAƒŒƒ‹ƒM[ƒZƒ“ƒ^[jCŽðˆä‹Ši”åj: —Õ°ƒXƒ|[ƒcˆãŠwC6(4): 413`417, 1989.
1287. muÀn ”r”AáŠQ‚ÌŽ¡—Â̎ÀÛ|–ò•¨—Ö@‚ÆŽèp“K‰ž|. ‰¡ŽR‰p“ñi”åjC¼‘ò—iH“c‘åjC“‡è~iç—t‘åj: Medic, 24(12): 1`9, 1989.
1288. muÀn ŒŸ¸‚ÌŽÀۂƃPƒA‚̃|ƒCƒ“ƒg|t¶ŒŸ|. ΋´Wi”åj: —Õ°ŠÅŒì, 16(3): 366`369, 1990.
1289. muÀn ƒCƒ“ƒXƒ^ƒ“ƒgƒJƒƒ‰‚ð—p‚¢‚½p’†“§Ž‹ƒ‚ƒjƒ^[‘œ‚Ì‹L˜^•û–@. ‹g“cˆê¬CŽu‘º“NC–å˜e˜abi”åj: —Õ°”å”AŠí‰È, 43(9): 821, 1989.
1290. mÀ’k‰ïn –«t‰Š‚Æt•s‘S‚Ìf—Âð‚ß‚®‚Á‚Ä. äGli“ŒŠC‘åjC‹g‘òMsi–h‰qˆã‘åjCŽðˆä‹Ši”åjC‚‹´ii“ú‘åj: Ž¡—ÃC72(3): 173`196, 1990.
1291. mŠwp‘n iŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj@‘æ8”Å; ŒŒŸ÷ŒðŠ·–@Cp.478`479, ”Ñ‚Šì‹v—YiŽ™j. •ÒW ”·‰Ã”Vi“Œ–M‘åjCŽO‰ÍtŽ÷i‹ž‘åjCd“cM•ÒC ˆãŠw‘‰@, “Œ‹ž, 89.09.15”s.
1292. mŠwp‘n iŽ·•Mj Recent Studies of IgA Nephropathy in Japan;
Therapeutic Approach in IgA Nephropathy, p.187`209, ¬—Ñ–LC”äŠé”\”Vi“àj. •ÒW
Arakawa, M.CGejyo, F.•Ò, Nishimura/Smith-Gordon, 89.10.00 ”s.
1293. mŠwp‘n iŽ·•Mj tŽ¾Š³‚Ì–ò•¨—Ö@; ‡Z. tˆÚA (3)‘ÎǗÖ@¥•nŒŒ, p.555`556, Š™“cvŽõi“àj. “Œ‹žˆãŠwŽÐ, “Œ‹žC89.11.30 ”s.
1294. mŠwp‘n iŽ·•Mj ¡“ú‚̬Ž™Ž¡—ÃŽwj;@@ ‹}«Ž…‹…‘Ìt‰Š, 8: 484`485, Žðˆä‹Ši”åj. •ÒW ”·‰Ã”Vi“Œ–M‘åjC‘¼, ˆãŠw‘‰@, “Œ‹ž, 89.09.15”s.
1295. mŠwp‘n iŽ·•Mj t‰Š¥ƒlƒtƒ[ƒ[;@@ ¬Ž™‚É‘½‚¢t‰Š¥ƒlƒtƒ[ƒ[, 5: 55`65, Žðˆä‹Ši”åjC”Ñ‚Šì‹v—YiŽ™j. •ÒW ’·‘òr•FiˆÇ—Ñ‘åj, “ì]“°, 89.12.01”s.
1296. mŠwp‘n iŽ·•Mj Annual Review t‘Ÿ 1990;@@ CAPD‚ÆtˆÚA, p.215`221, ŒF–ì˜a—YC¬ŽÄŒ’i”åj. •ÒW ‰z캎Oiº˜a‘åj,‘¼C ’†ŠOˆãŠwŽÐ, 90.01.10”s.
1297. m‹³‰È‘n iŽ·•Mj ƒvƒ‹ƒ~ƒGˆãŠwŠe˜_i“à‰ÈCŠO‰ÈC¬Ž™‰Èj¬’·¥”’B‚ÌáŠQCo¶‚É”º‚¤áŠQ;
‹}«t•s‘SCŒ´”«Ž…‹…‘ÌŽ¾Š³Cæ“V«ƒlƒtƒ|ƒ[Ct‚Ìæ“VˆÙíCp.137`140, ”Ñ‚Šì‹v—YiŽ™j. •ÒW –،p–«i“Œ–M‘åj•ÒC
ˆãŽ•–òo”Å, “Œ‹ž, 89.11.10”s.
1298. m‹³‰È‘n iŽ·•Mj Še‰È‚Ì‚½‚ß‚Ì’´‰¹”gŒŸ¸|(2)¬Ž™‰È¥ŠO‰È¥”å”AŠí‰È¥ŽY‰È¥•wl‰È|—Õ°ŒŸ¸Mook; …tÇ‚Æt”X–EÇ,
p.73`77, “¡–ì’WlC΋´Wi”åj. •ÒW “n•ÓŸ–i‹ž“s•{—§ˆã‘åj‘¼•Ò, ‹àŒ´o”Å, “Œ‹žC89.11.30”s.
1299. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—|”å”AŠí‰ÈŠe˜_; t•s‘S;t«‚ŒŒˆ³Ç;tŒŒŠÇ«•a•Ï;‚»‚Ì‘¼‚ÌtŽ¾Š³, p.204`217, ¬ŽÄŒ’i”åj. •ÒW ¡‘ºˆê’j •Ò ˆãŽ•–òo”Å, “Œ‹žC90.01.30”s.
1300. m‹³‰È‘n iŽ·•Mj “§ÍiXIXj;@@ ŒŒ‰t“§Í’†‚ÌŽ–ŒÌ‚Æ‘Îô, p.66`75, Žðˆä‹Ši”åj. •ÒW ¬‚’Ê•viç—t‘åj, ˆãŠw}‘, 89.07.08”s.
1301. m‹³‰È‘n iŽ·•Mj “§Í—Ö@ƒnƒ“ƒhƒuƒbƒN;@@ ¬Ž™‚Ì“§Í,@‰ü’ù‘æ5”Å, p.376`388, Žðˆä‹Ši”åj. •ÒW ‰z캎Oiº˜a‘åj,‘¼C ‹¤“¯ˆã‘o”ÅŽÐ, 90.01.15”s.
1302. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj TURP|”å”AŠí‰ÈŽ¡—Ãnƒ“ƒhƒuƒbƒN; p.296`300, ¬ŽÄŒ’i”åj. •ÒW “n•ÓŸ–@•Ò “ìŽR“°, “Œ‹žC89.06.00”s.
1303. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj V–ò•¨—Ö@ '90”N”Å; ‹}«ŠÔŽ¿«t‰Š, ¬—Ñ–Li“àj. •ÒW ã“c‘×C´…Šì”ª˜YCtŒ©Œ’ˆê•Ò, ƒƒWƒJƒ‹Eƒrƒ…[ŽÐ,@“Œ‹ž,@89.12.00 ”s.
1304. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj “à‰Èf—à Q & A; t¶ŒŸ‚Ì“K”Û|ˆ««‚ŒŒˆ³Ç|, 23: p.26`29, ŠÚ–샶i“àjC“y“cOŠîi‘—§²‘q•a‰@j. ˜Z–@o”Å, –¼ŒÃ‰®, 89.00.00 ”s.
1305. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¬Ž™ƒƒfƒBƒJƒ‹ƒ`ƒFƒbƒN‚Ɖ^“®Žw“±‚ÌŽÀÛ;@@ ‡Y.t‘Ÿ‚̃ƒfƒBƒJƒ‹ƒ`ƒFƒbƒN‚Ɖ^“®Žw“±,
p.115`121, Žðˆä‹Ši”åjC’·â—T”Ži‰¡•lŽs¬Ž™ƒAƒŒƒ‹ƒM[ƒZƒ“ƒ^[j. •ÒW ‘å‘^•Fi“ú‘åj•Ò, •¶Œõ“°, 89.06.01”s.
1306. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWj iŽ·•Mj‚±‚Ç‚à‚Ìt‘Ÿ•aƒKƒCƒh,‡T;@@ ŠwZŒŸ”A‚Ìi‚ß•û‚ÆŠÇ—¥Ž¡—Ã, p.23`37, Žðˆä‹Ši”åj. •ÒW –kìÆ’ji“ú‘åjCŽðˆä‹Ši–k—¢‘åj, “ú–{ŒöO‰q¶‹¦‰ï, “Œ‹žC89.08.30”s.
1307. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn i•ÒWEŽ·•Mj ‚±‚Ç‚à‚Ìt‘Ÿ•aƒKƒCƒh,‡U;@@ ŠwZŒŸ”A‚Ì•û–@‚ÆŽ–Œã‘[’u, p.68`91, Žðˆä‹Ši”åj. •ÒW –kìÆ’ji“ú‘åjCŽðˆä‹Ši–k—¢‘åj, “ú–{ŒöO‰q¶‹¦‰ï,“Œ‹žC89.08.30”s.
1308. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj Œ’Nf’f‚É‚¨‚¯‚é”AŒŸ¸|”»’è‚©‚玖ŒãŠÇ—‚Ü‚Å|;@@
’nˆæ‚É‚¨‚¯‚鑇“ItŽ¾Š³E—\–hŠÇ—‘Îô, p.47`50, Žðˆä‹Ši”åj. •ÒW ´…–}¶iL“‡‘åj, “ú–{¬Ž™•ÛŒ’Šw‰ï, “Œ‹ž,
89.11.03”s.
1309. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ŠwZŒŸ”A‚Ì‚·‚ׂÄ;@@ ŠÇ—‚ÆŽ¡—Ã, p.91`120, Žðˆä‹Ši”åj. •ÒW “ú–{ŠwZ•ÛŒ’‰ïC —\–hˆãŠwŽ–‹Æ’†‰›‰ï, 90.01.30”s.
1310. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ƒi[ƒX‚Ì‚½‚ß‚ÌŠíŠBŠí‹ï; ŒŸ¸, p.54`59, ”å”AŠí, p.236`260, ΋´Wi”åj. •ÒW ÷ˆäŒ’ŽiiŽœŒbˆã‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC89.06.10”s.
1311. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j DNA Fingerprints Detect Somatic DNA Changes in
Transitional Carcinoma of the Bladder (TCC). “à“c–LºCH. NeuwirthC N.C.
Cadavid: AACR (American Association Cancer Research) (89.05.00), San
Francisco.
1312. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j “«t‰Š¥ƒlƒtƒ[ƒ[–ò•¨—Ö@‚̎肪‚©‚è; IgAtǂɑ΂·‚é•›t”玿ƒXƒeƒƒCƒh—Ö@. ¬—Ñ–Li“àj: ‘æ24‰ñ“ú–{¬Ž™¥t‘Ÿ•aŠw‰ï (89.06.00), –¼ŒÃ‰®.
1313. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘ÌŠOÕŒ‚”g”A˜HŒ‹Î”jÓp(ESWL)‚ÌŒoŒ±. ^‰ºß•vi”åj: “ú–{ŠO‰ÈŒn˜A‡Šw‰ï (89.06.21), ‘åã.
1314. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Epidemiology and Treatments of Renal Diseases in
Asian Countries; Management of Congenital Hydronephrosis.
”Ñ‚Šì‹v—YCΊٕ•viŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï 2th Asian Symposium of Pediatric
Nephrology (ASPN) (89.06.28), –¼ŒÃ‰®.
1315. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Mizoribine‚ÌŽg—pŒoŒ±. Žðˆä‹Ši”åjCˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YiŽ™jCŒF–ì˜a—Yi”åjC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.06.30), –¼ŒÃ‰®.
1316. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Search for the Unknown Trace Element Abnormalities
in Uremia. ’Ë–{—Y‰îi“àj: 2nd Meeting of the International Society for Trace
Element Research in Humans (89.09.28), “Œ‹ž.
1317. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —cŽ™EŠw“¶ŒŸ”A‚Ì‚½‚ß‚Ì‘gD‚‚è. Žðˆä‹Ši”åj: ‘æ36‰ñ“ú–{¬Ž™•ÛŒ’Šw‰ï (89.11.05), L“‡.
1318. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Carcinoma of the Prostate Endocrine Therapy.
¬ŽÄŒ’C“¡–ì’Wli”åj: Pan-Pacific Surgical Association 20th Congress (90.02.13),
Hawaii.
1319. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Carcinoma of the Bladder: Staging Classification
and Patient Evaluation. ¬ŽÄŒ’C“¡–ì’Wli”åj: Pan-Pacific Surgical Association
20th Congress (90.02.14), Hawaii.
1320. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒŒs“®‘Ô‚É—^‚¦‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚ÌŒø‰Ê. Š™“cvŽõi“àj: ‘æ8‰ñ“ú–{MEŠw‰ïlH‘ŸŠí•”‰ï (90.02.17), ‘åã.
1321. mŠw‰ïn iƒpƒlƒ‹j CAPD and the Pediatric Patient. Žðˆä‹Ši”åj: Hakone CAPD Expert Meeting (89.09.03), ” ª.
1322. mŠw‰ïn iƒpƒlƒ‹j ”A˜HŒ‹Î‚ÌŽ¡—Õûj. ¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž, —\eW, p.69, 1989.
1323. mŠw‰ïn iƒpƒlƒ‹j ESWLiÕŒ‚”gŒ‹Î”jӗÖ@j‚Ì“K‰ž‚ÆŒÀŠE|Ž„‚Í‚±‚¤‚µ‚Ä‚¢‚é|. rìFi”åj: ‘æ37‰ñ_“Þ쌧”å”AŠí‰Èˆã‰ï (89.11.18), _“Þì.
1324. mŠw‰ïn iƒpƒlƒ‹j ESWL, New Type. C. Chaussy (FRG)C¬ŽÄŒ’i”åj: 7th World Congress on Endourology and ESWL (89.11.28), ‹ž“s.
1325. mŠw‰ïn iƒpƒlƒ‹j Treatment of Upper Urinary Tract Caliculi by ESWL with
Therasonic Lithotripsy Treatment System.
•ìƒCò”ŽˆêC¬ŽÄŒ’C^‰ºß•vCŠÑˆä•¶•Fi”åjC‰ª–{dâXC‰i“cŠ²’jC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jC{ŽRˆê•äi”åj: 7th World
Congress on Endourology and ESWL (89.11.28), ‹ž“s.
1326. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj t•s‘S‚Ö‚Ìis‚Æ–hŽ~;H‰a—Ö@‚ð’†S‚Æ‚µ‚Ä. ’Ë–{—Y‰îi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ18‰ñ“ú–{t‘ŸŠw‰ï“Œ•”•”‰ï (88.05.06`07), “Œ‹ž.
1327. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ¬Ž™‚¨‚æ‚Ѭl”Ç‚ÌIgAtÇ‚Ì•a—. d¼GˆêiMB‘åjC¬—Ñ–LC”äŠé”\”Vi“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.10), “Œ‹ž.
1328. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj
t•s‘SE“§Í—Ö@‚ÆŠˆ«Ž_‘f|–«t•s‘SŠ³ŽÒ‚ÌŒŒ´Ž_‰»”\(SOA)‚ÆŒŒ‰t“§Í‚ÌSOA‚ւ̉e‹¿‚ɂ‚¢‚Ä|.
ŒF–ì˜a—YC‚–Ø—TC“ü]Œ[i”åjC“ì•”³lC¬ŽR½C‘Š CˆêitƒZƒ“jCŽðˆä‹Ši”åjC’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶‰»Œnj:
‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.09), “Œ‹ž.
1329. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj PTH‚ÆCaƒ|ƒ“ƒv. ’Ë–{—Y‰îi“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.09), •l¼.
1330. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Management of Staghorn Calculi. ¬ŽÄŒ’i”åj: 7th World Congress on Endourology and ESWL (89.11.30), ‹ž“s.
1331. mŠw‰ïn iˆê”Êu‰‰j FUT(nafamostat mesilate)‚ð—p‚¢‚½–³ƒwƒpƒŠƒ“‰»“§Í‚Ì2Ç—á. –쑺ƒŽqiŽ™j:
‘æ172‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (88.04.16), ‰¡•l, “ú–{¬Ž™‰ÈŠw‰ïŽGŽ, 92(8): 149, 1988.
1332. mŠw‰ïn iˆê”Êu‰‰j • ˆ³«”AŽ¸‹Ö‚ɑ΂·‚éStamyŽèp‚ÌŒoŒ±. ìã’B‰›C‰F“s‹{‘ñŽ¡C_è—TC–å˜e˜abi”åj: ‘æ129‰ñ“ú–{”å”AŠí‰ÈŠw‰ïŒF–{’n•û‰ï (89.00.00), ŒF–{.
1333. mŠw‰ïn iˆê”Êu‰‰j Œ´”«Ž…‹…‘ÌŽ¾Š³‚̖Ɖuˆâ“`Šw“IŒŸ“¢.
¬—Ñ–LC”äŠé”\”VC•ìºCŠ™“cvŽõC’Ë–{—Y‰îC‘å‹v•Û[lC–Øì“c—²ˆêi“àj: ‘æ86‰ñ“ú–{“à‰ÈŠw‰ï (89.04.02), ‹ž“s,
“ú–{“à‰ÈŠw‰ïŽGŽ, 78(2): 287, 1989.
1334. mŠw‰ïn iˆê”Êu‰‰j ƒCƒk’Pƒ—â‹p•Û‘¶t‚̈ÚA¶’…ŠúŠÔ‚ÌANP‚É‚æ‚鉄’·Œø‰Ê.
^è‹`•FiŽÀ“®ŒnjC²“¡´‹MC’·’J쉄Li“àjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ66‰ñ“ú–{¶—Šw‰ï
(89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): s249, 1989.
1335. mŠw‰ïn iˆê”Êu‰‰j ‰·‘jŒŒ«‹y‚Ñ—â‘jŒŒ«‹}«t•s‘S‚É‚¨‚¯‚銈«Ž_‘f‚ÌŠÖ—^.
Šâ‘º³ŽkCŒF–ì˜a—YC‚–Ø—TC‹g“cˆê¬C^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC^è‹`•FiŽÀ“®Œnj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(89.04.19), ‘åã.
1336. mŠw‰ïn iˆê”Êu‰‰j RƒÁ-seminoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é‘O—§‘B‚̖Ɖu‘gD‰»Šw“IŒŸ“¢i‘æ2•ñj.
“¡–ì’WlC‘ºŽR‰ëˆêC¼‘º´ŽuCŒàŠ²ƒC‰¡ŽR‰p“ñC^‰ºß•vC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åjCŒK”ö’èmi•a—j: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(89.04.19), ‘åã.
1337. mŠw‰ïn iˆê”Êu‰‰j RƒÁ-seminoprotein‚ÆProstatic specific
antigen‚Ì‘ŠŠÖ«‚ɂ‚¢‚Äi‘æ1•ñj.
‘å–x—C“¡–ì’WlC{ŽRˆê•äCŠâ‘º³ŽkCŠ‹¼ŒMC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åjC–ؖF˜aCˆÉ“¡Œ[i‰q¶Šw•”j: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï
(89.04.20), ‘åã.
1338. mŠw‰ïn iˆê”Êu‰‰j tá±”AŠÇˆÚs•”Œ‹ÎÇ‚ÉŠÖ‚·‚éESWL‚ÌŽ¡—ÃŒoŒ±|pŒã”AŠÇƒXƒeƒ“ƒg—¯’u‚ð’†S‚É|. rìFC‹g‘òˆê•FC‹v•Û¯ˆêCΓc—T‘¥C¬ŽÄŒ’C^‰ºß•vi”åj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.21), ‘åã.
1339. mŠw‰ïn iˆê”Êu‰‰j äNã÷Šà×–E‚ɑ΂·‚éVR¶•¨Ž¿Kazusamycin A‚Ì‘B—}§Œø‰Ê. ‘ò‘º³”VC¬“c“‡–M’ji”åjC’·‘q˜a•FC‰Æ“c˜a•vC’†‘ºGi–h‰qˆã‘åj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.21), ‘åã.
1340. mŠw‰ïn iˆê”Êu‰‰j Œo”A“¹“I’´‰¹”g’f‘w–@‚É‚æ‚éäNã÷Žîá‡[’B“x‚Ìf’f. “ü]Œ[C’†žŠO—²Cìã’B‰›C¬—ÑŒ’ˆêC–{“c’¼NC‰¡“c^“ñC“à“c–LºC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åj: ‘æ77‰ñ“ú–{”å”AŠí‰ÈŠw‰ï‘‰ï (89.04.21), ‘åã.
1341. mŠw‰ïn iˆê”Êu‰‰j Allelic Deletion in Transitional Cell Carcinoma of
the Bladder (TCCB). Harry NaurithCBradiay FrasiorC“à“c–Lºi”åjCJohn White:
AUA Eighty Fourth Annual Meeting (89.05.07`11), ƒ_ƒ‰ƒX.
1342. mŠw‰ïn iˆê”Êu‰‰j ‚ƒJƒŠƒEƒ€ŒŒÇ‚Æ‘ãŽÓ«ƒAƒVƒh|ƒVƒX‚ð‚«‚½‚µ‚½3Ç—á‚ÌŒŸ“¢.
–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YCˆÉ“¡–¯ŒbCΊٕ•vC“n•Ó“oC›šà†‹ÊiŽ™jCŽðˆä‹Ši”åj: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï (89.05.19), VŠƒC
“ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 587, 1989.
1343. mŠw‰ïn iˆê”Êu‰‰j ƒƒTƒ“ƒMƒEƒ€‘B«t‰Š‚Ì—Õ°Œo‰ß‚ÆŽ¡—Ã|¬l‚ɃLƒƒƒŠ|ƒI|ƒo|‚µ‚½Ç—á‚ÌŒŸ“¢|.
‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YCƒŒƒCƒ‚ƒ“ƒh¥ƒtƒ‰ƒ“ƒVƒAiŽ™jCŽðˆä‹Ši”åj: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.19), VŠƒC
“ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 647, 1989.
1344. mŠw‰ïn iˆê”Êu‰‰j ‹ßˆÊ”A׊Ǒ¤’ê×–E–Œ‚É‚¨‚¯‚éCa2+/H+ pump‚Ì’²ß‹@˜. ’Ë–{—Y‰îi“àj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.01), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŠwp‘‰ï´˜^W, 65(4): 259, 1989.
1345. mŠw‰ïn iˆê”Êu‰‰j tˆÚA‚É‚¨‚¯‚ét•Û‘¶‚É‹y‚Ú‚·ANP‚ÌŒø‰Ê.
ˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC^è‹`•FiŽÀ“®ŒnjC²“¡´‹MC’·’J쉄Li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï
(89.06.02), “Œ‹žC “ú–{“à•ª”åŠw‰ïŠwpW‰ï´˜^W, 65(4): 353, 1989.
1346. mŠw‰ïn iˆê”Êu‰‰j ƒƒTƒ“ƒMƒEƒ€‘B«•Ï‰»‚ð‚Æ‚à‚È‚Á‚½‘ƒóŽ…‹…‘Ìd‰»Ç‚Ì1—á. ¬‹v•Û“§CŽá—Ñ–õ‹vC”äŠé”\”VC¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.
1347. mŠw‰ïn iˆê”Êu‰‰j ‚”N—î”Ç‚Ì‹}«Ž…‹…‘Ìt‰Š‚Ì4—á. •ìºCãŽRŽO‘ãŽqC“c‘º_ŽOCŠÔ’†‹v”üC‘ˆäL—mC²“¡’¼”VCŠ™“cvŽõC¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.
1348. mŠw‰ïn iˆê”Êu‰‰j
”DP’†Šú‚É“ž‚è‚Í‚¶‚ß‚Ä”DP‚É‹C•t‚‚Æ‹¤‚É“§Í“±“ü‚³‚êA•p‰ñ‚ÌŒŒ‰t“§Í(HD)‹y‚ÑŒŒ‰tàh‰ß“§Í(HDF)‚Ì‹–‚Å‹“Ž™‚µ“¾‚½‘½”«”X–Et(PCK)‚É‚æ
‚é–«t•s‘S(CRF)‚Ì1—á. •ìºCãŽRŽO‘ãŽqC“c‘º_ŽOCŠ™“cvŽõC–xˆäºC‘å‹v•Û[lC–Øì“c—²ˆêC‹g“càˆC“‡“c”£i“àj:
‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.
1349. mŠw‰ïn iˆê”Êu‰‰j S󌋒°Šà‚ð‡•¹‚µ‚½‘ƒóŽ…‹…‘Ìd‰»Ç(FGS)‚Ì1—á. Š™“cvŽõC’Å–¼³_CŽR“c³•vC•ìºCãŽRŽO‘ãŽqC¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.
1350. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ~ƒƒCƒhtÇ‚É‹}«Ž…‹…‘Ìt‰Š‚𕹔‚µ‚½1—á. ãŽRŽO‘ãŽqCŠÔ’†‹v”üC•ìºCŠ™“cvŽõC¬—Ñ–LC”äŠé”\”Vi“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.
1351. mŠw‰ïn iˆê”Êu‰‰j IgAtÇŒo‰ß’†‚É‹}«Ž…‹…‘Ìt‰Š‚ð‡•¹‚µ‚½1Ç—á. ”äŠé”\”VC“c‘º_ŽOC•ìºCãŽRŽO‘ãŽqCã‘C¬—Ñ–Li“àj: ‘æ19‰ñ“ú–{t‘Ÿ•aŠw‰ï“Œ•”•”‰ï (89.06.09), “Œ‹ž.
1352. mŠw‰ïn iˆê”Êu‰‰j Ž…‹…‘Ì‚Ì”¼ŒŽ‘ÌŒ`¬‚È‚ç‚Ñ‚ÉC3’¾’…‚ð”F‚ß‚½ŠÔŽ¿«t‰Š‚É‚æ‚é‹}«t•s‘S‚Ì1—á.
‘åι–çC“L–ØGC•½Î‘C–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ19‰ñ“ú–{t‘ŸŠw‰ï“Œ•”•”‰ï (89.06.10), “Œ‹ž.
1353. mŠw‰ïn iˆê”Êu‰‰j Subclinical‚ÉSjogrenÇŒóŒQ‚̇•¹‚ð‹^‚킹‚½Lupust‰Š‚Ì1¬Ž™—á.
–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ19‰ñ“ú–{t‘ŸŠw‰ï“Œ•”•”‰ï (89.06.10), “Œ‹žC —\eWCp.122,
1989.
1354. mŠw‰ïn iˆê”Êu‰‰j —Õ°“I‚ÉŠÔŽ¿áŠQ‚ð‚«‚½‚µ‚½Ž‡”Á•a«t‰Š2—á‚Ì—Õ°•a—Šw“IŒŸ“¢.
ˆäŒ…^—R”üC¬àV”ü˜aC‰©‹àˆä‚³‚‚«CŠÖª“OC^“º‘¾˜YC”~Œ´ŽÀC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: ‘æ179‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï
(89.06.17), ‰¡•l.
1355. mŠw‰ïn iˆê”Êu‰‰j äNã÷‚ð‰·‘¶‚µ“¾‚½‹‘åäNã÷ŽîᇂÌ1—á. ‰¡“c^“ñCŠâ‘º³ŽkC“ü]Œ[C‘ˆä‘¥ºC–{“c’¼NC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åj: ‘æ32‰ñ_“Þì”å”AŠí‰Èˆã‰ï (89.06.19), ˆÉ¨Œ´.
1356. mŠw‰ïn iˆê”Êu‰‰j t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錤‹†. ‹g“c‹`Ki϶‰ï‰¡•lŽs“ì•”•a‰@jAŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.06.29), –¼ŒÃ‰®.
1357. mŠw‰ïn iˆê”Êu‰‰j Å‹ß5”NŠÔ‚ɔǂµ‚½¬Ž™SLE13—á‚Ì”Œ©“®‹@‚©‚ç‚Ý‚½—Õ°•a—Šw“IŒŸ“¢.
–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.06.29), –¼ŒÃ‰®,
“ú–{¬Ž™t‘Ÿ•aŠw‰ïŽGŽC2(2): 147, 1989.
1358. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™tŽ¾Š³‚É‚¨‚¯‚é–Ɖu—}»Ü‘½Ü—Ê•¹—p—Ö@. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èCŠ—Œ´FC…–ì—@iŽ™jCŽðˆä‹Ši”åj: ‘æ24‰ñ“ú–{¬Ž™t‘Ÿ•aŠw‰ï (89.07.01), –¼ŒÃ‰®C —\eW, p.235, l989.
1359. mŠw‰ïn iˆê”Êu‰‰j ŒŒ‰t“§ÍŠ³ŽÒ‚ɑ΂·‚é1,25(OH)2D3ƒpƒ‹ƒX—Ö@‚ÌPTH•ª”å—}§Œø‰Ê‚Ì‹@˜‚ÉŠÖ‚·‚錟“¢.
’Ë–{—Y‰îC–쑺K”Íi“àjC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ7‰ñ“ú–{œ‘ãŽÓŠw‰ï (89.07.08`09), “Œ‹ž.
1360. mŠw‰ïn iˆê”Êu‰‰j 1ƒ¿(OH)D3/CaCO3ŒðŒÝ“Š—^–@‚É‚æ‚ét«œˆÙ‰h—{Ç‚ÌŽ¡—Ã. ’Ë–{—Y‰îC–쑺K”ÍCã‘C‘å‹v•Û[li“àj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.
1361. mŠw‰ïn iˆê”Êu‰‰j “§ÍŠ³ŽÒ‚É‚¨‚¯‚é’YŽ_ƒJƒ‹ƒVƒEƒ€(CaCO3)“Š—^‚ªŒ´ˆö‚ÆŽv‚í‚ꂽ“§ÍŠ³ŽÒ‚ÌtŒ‹ÎÇ—á.
ã‘C‹g“càˆC–쑺K”ÍC‰i‰ª—²C’Ë–{—Y‰îC‘å‹v•Û[lC–Øì“c—²ˆêi“àj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.
1362. mŠw‰ïn iˆê”Êu‰‰j ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“(EPO)“Š—^‚É‚æ‚èAS¥zŠÂŠíŒn‡•¹Ç‚Ì’˜–¾‚ȉü‘P‚ª‚¦‚ç‚ꂽˆÛŽ“§ÍÇ—á.
‹g“càˆC•ìºCãŽRŽO‘ãŽqCŠ™“cvŽõC‘å‹v•Û[lC–Øì“c—²ˆêi“àj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.
1363. mŠw‰ïn iˆê”Êu‰‰j CAPDŠ³ŽÒ‚Ì––½_Œo“`’B‘¬“x‚ɂ‚¢‚Ä. ‚–Ø—TCŒF–ì˜a—YCŽðˆä‹ŠC‚‹´—Tˆê˜Yi”åj: ‘æ34‰ñ“ú–{“§Í—Ö@Šw‰ï (89.07.10), “Œ‹ž.
1364. mŠw‰ïn iˆê”Êu‰‰j t”X–E‚𔺂Á‚½‹¹•”t‚Ì1—á. Žu‘º“NC‹g“cˆê¬C–å˜e˜abC¬—ÑŒ’ˆêC΋´Wi”åj: ‘æ464‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.07.13), “Œ‹ž, “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 81(1): 144, 1990.
1365. mŠw‰ïn iˆê”Êu‰‰j Early Detection of Renal Disease by Urinary NAG
Index. Igarashi SumikoCKaneko HarujiCYagisawa KatsumiCNagasaka
YasuhiroCTaguchi HirokazuCFujiwara YoshitoiŒ§—\–h‹¦‰ïC‰¡•lŽs‘åjCΊٕ•viŽ™jCŽðˆä‹Ši”åj:
8th Congress of the International Pediatric Nephrology Association
(89.08.27), Toronto, ´˜^†, 2020, 1989.
1366. mŠw‰ïn iˆê”Êu‰‰j Two Cases of Congenital Nephrotic Syndrome in 2 Days
of Life. ”Ñ‚Šì‹v’jC–kžŠ‚Ý‚Ç‚èCˆÉ“¡–¯ŒbiŽ™jCŽðˆä‹Ši”åj: 8th Congress of the International
Pediatric Nephrology Association (89.08.28), Toronto.
1367. mŠw‰ïn iˆê”Êu‰‰j Oral Adsorbent (AST-120) Reduces Mesangial Trappment
of Macromolecules, Glomerular Hypertrophy and Improves Renal Morphology
in the Rat Model of Subtotal Nephrectomy. Yoshida, Y.i
϶‰ï‰¡•lŽs“ì•”•a‰@jCŽðˆä‹Ši”åjCŒK”ö’èmi•a—j: ‘æ8‰ñ‘Û¬Ž™t‘Ÿ•aŠw‰ï (89.08.28), ƒgƒƒ“ƒg.
1368. mŠw‰ïn iˆê”Êu‰‰j Antiplatelet Agents and Fresh Frozen Plasma in
Hemolytic Uremic Syndrome(HUS)-Serum Creatinine Elevation Rate Per Hour
as an Indicator. –kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™j: 8th Congress of the International
Pediatric Nephrology Association (89.08.28), Toronto, Pediatric
Nephrology, 3(4): c185, 1989.
1369. mŠw‰ïn iˆê”Êu‰‰j Clinico-Histopathological Correlation in 50 Cases of
Henoch-Schoenlein Purpura Nephritis. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™j: 8th Congress of the
International Pediatric Nephrology Association (89.08.28), Toronto,
—\eWC9-084, 1989.
1370. mŠw‰ïn iˆê”Êu‰‰j Effect of Oral-adsorbent (AST-120) in Uremic Rats: A
Break in the Vicious Cycle. Žðˆä‹Ši”åjCŒK”ö’èmi•a—jCYoshida, Y.i ϶‰ï‰¡•lŽs“ì•”•a‰@j:
‘æ8‰ñ‘Û¬Ž™t‘Ÿ•aŠw‰ï (89.08.31), ƒgƒƒ“ƒg.
1371. mŠw‰ïn iˆê”Êu‰‰j Proteinuria Starts from Deep Nephrons in Experimental
Model of Focal Glomerulosclerosis. Ίٕ•viŽ™j: 8th Congress of the
International Pediatric Nephrology Association (89.08.31), Toronto,
´˜^†C9045.@l989.
1372. mŠw‰ïn iˆê”Êu‰‰j Castleman•a‚É‚æ‚è‹}«t•s‘S‚ð’悵ƒXƒeƒƒCƒh—Ö@‚ðŽ{s‚µ‚½1—á.
‰Ô“cL‰pC–쑺K”ÍC’Ë–{—Y‰îCŠÚ–샶C”äŠé”\”VC•ìºC“¡–ì—R”üC¬—Ñ–LC–Øì“c—²ˆêi“àjCŠ}ˆäŒ‰C‰œ•½‰ë•Fi•a—j:
‘æ385‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.09.09), “Œ‹ž.
1373. mŠw‰ïn iˆê”Êu‰‰j ƒ‹[ƒvƒXƒ‚ƒfƒ‹ƒ}ƒEƒX‚É‚¨‚¯‚é15-deoxyspergualin (DSP)‚Ìì—p‹@˜‚ÉŠÖ‚·‚錟“¢.
‘å‹v•Û[lCŠ™“cvŽõi“àjC^è‹`•FiŽÀ“®ŒnjC“àŽR’|•F: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž.
1374. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŒãŽ€–S—á‚É‚¨‚¯‚鎀–S—vˆö‚ÌŒŸ“¢.
“c‘º_ŽOCŽá—Ñ–õ‹vC’Ë–{—Y‰îCŠ™“cvŽõC‘å‹v•Û[lC–Øì“c—²ˆêi“àjC’†ŽR‹`‰îCŒY•”P’jC‰¡“c˜a•FC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰
—YCŽðˆä‹Ši”åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24(—Õ): 187, 1989.
1375. mŠw‰ïn iˆê”Êu‰‰j tˆÚA‚É‚¨‚¯‚é”A’†ƒCƒ“ƒ^[ƒƒCƒLƒ“2”Z“x‚Ì‘ª’èˆÓ‹`‚ɂ‚¢‚Ä.
“ü]Œ[CŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC‘å‹v•Û[li“àj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž,
ˆÚA, 24: 179, 1989.
1376. mŠw‰ïn iˆê”Êu‰‰j ‰·‘jŒŒt‚Ì’Pƒ•\–Ê—â‹p•Û‘¶‚ÉŠÖ‚·‚錤‹†. ŒF–ì˜a—YC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA, 24: 223, 1989.
1377. mŠw‰ïn iˆê”Êu‰‰j tˆÚA‚ª“§ÍƒAƒ~ƒƒCƒh[ƒVƒX‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä.
ŒF–ì˜a—YC“ü]Œ[C^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åjC‰¡“c˜a•FiŠOjC‘å‹v•Û[li“àj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï
(89.09.12), “Œ‹ž, ˆÚA, 24: 234, 1989.
1378. mŠw‰ïn iˆê”Êu‰‰j High Flux Membrane‚ð—p‚¢‚½ŒŒ‰tàh‰ß“§Í‚É‚¨‚¯‚é’ᕪŽq—Ê’`”’œ‹Ž”\‚ÌŒoŽž“I•Ï‰».
¬ŽR½itƒZƒ“ƒ^[jCŒF–ì˜a—Yi”åjC“ì•”³lC‘Š CˆêitƒZƒ“ƒ^[jCŽðˆä‹Ši”åj: ‘æ27‰ñ“ú–{lH‘ŸŠíŠw‰ï‘å‰ï (89.09.29),
ˆ®ì.
1379. mŠw‰ïn iˆê”Êu‰‰j Thromboxane-A2-Induced Calcium Mobilization and
Phosphoinositide Turnover in Cultured Rat Aorta Vascular Smooth Muscle
Cells. ‰¡“c^“ñCŒF–ì˜a—YCŽðˆä‹Ši”åjCElwood E. Reynolds (Cleveland Clinic
Foundation): ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 643, 1989.
1380. mŠw‰ïn iˆê”Êu‰‰j t”í–Œ‰ºt“Eop:‹‘┽‰ž‚ð‹N‚±‚µ‚½ˆÚAt‚Ì“Eo. ‰““¡’‰—YCŒF–ì˜a—YC“ü]Œ[C‹g“cˆê¬C‰¡“c^“ñC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.
1381. mŠw‰ïn iˆê”Êu‰‰j ‰Šúf’f‚ª¢“ï‚Å‚ ‚Á‚½¸‘ƒŽîᇂ̌Ÿ“¢. ¬“c“‡–M’jC‘ò‘º³”VCó–ì—F•FC’·‘q˜a•FC’†‘ºGi”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž, —\eW, p.222, 1989.
1382. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚É‚¨‚¯‚éI-123 Hippuran‚ð—p‚¢‚½tŒŒ—¬—Ê‘ª’è‚ɂ‚¢‚Ä.
“c‘ºˆè•vi“s—§–L“‡•a‰@jC‘¼CΈ䟌Èi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw, 26(8): 1087,
1989.
1383. mŠw‰ïn iˆê”Êu‰‰j p’†‚wüŽB‰e‚É‚¨‚¯‚éƒCƒ“ƒXƒ^ƒ“ƒgƒtƒBƒ‹ƒ€‚̉ž—p. ¬“c“‡–M’jC‘ò‘º³”VC’†‘ºGi”åj: ‘æ39‰ñ“ú–{”å”AŠí‰ÈŠw‰ï’†•”‘‰ï (89.11.04`05), •xŽR.
1384. mŠw‰ïn iˆê”Êu‰‰j Œy“x’`”’”AIgAtÇ‚Ì—Õ°Œo‰ß. ¬—Ñ–LC”äŠé”\”VC•ìºCŠÚ–샶i“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.09), •l¼.
1385. mŠw‰ïn iˆê”Êu‰‰j IgAtÇ‚É‚¨‚¯‚éIgARƒqƒgIgAR‘Ì‚Ì‘¶Ý. ”äŠé”\”VC¬—Ñ–Li“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.09), •l¼.
1386. mŠw‰ïn iˆê”Êu‰‰j ’·ŠúCAPDŠ³ŽÒ‚É‚¨‚¯‚é• –Œ‹@”\‚ÌŒoŽž•Ï‰». ‚–Ø—TCŒF–ì˜a—YCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.
1387. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgt•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢.
Žðˆä‹ŠCŒF–ì˜a—Yi”åjCV‘º•¶’jiŽ™jCŒK”ö’èmi•a—jC‹g“c‹`Ki϶‰ï‰¡•lŽs“ì•”•a‰@j: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09),
•l¼.
1388. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ“ƒWƒIƒeƒ“ƒVƒ“ŒðŠ·y‘f‘jŠQÜ(ACE1)‚Ì–«t•s‘S(CRF)is‘jŽ~‚Ö‚ÌŒø‰Ê.
ŒF–ì˜a—YC“ü]Œ[C‰¡“c^“ñCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼, —\eW, p.173, 1989.
1389. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™IgAtÇ‚Ì—Õ°•a—Šw“IŒŸ“¢. –kžŠ‚Ý‚Ç‚èCV‘º•¶’jC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘Ÿ•aŠw‰ï‘‰ï (89.11.09), •l¼, —\eWCp.129, 1989.
1390. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™tˆÚAŠ³ŽÒ‚É‚¨‚¯‚éNa, K”rŸ•‚ÌŒŸ“¢.
V‘º•¶’jiŽ™jCŒF–ì˜a—Yi”åjC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ32‰ñ“ú–{t‘Ÿ•aŠw‰ï‘‰ï (89.11.09),
•l¼, —\eWCp.171, 1989.
1391. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgt•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120‚̉e‹¿‚ÉŠÖ‚·‚錟“¢.
V‘º•¶’jiŽ™jCŒF–ì˜a—YCŽðˆä‹Ši”åjCŒK”ö’èmi•a—jC‹g“c‹`Ki϶‰ï‰¡•lŽs“ì•”•a‰@jCˆÉ¨“¹mC›–ìŽOŠì’jC㌴N•viŒà‰H‰»Šwj:
‘æ32‰ñ“ú–{t‘Ÿ•aŠw‰ï‘‰ï (89.11.09), •l¼, —\eWCp.173, 1989.
1392. mŠw‰ïn iˆê”Êu‰‰j ‚·‚łɔǂµ‚½ŽÀŒ±ƒ‹[ƒvƒXtǂɑ΂·‚é15-deoxyspergualin
(DSP)‚ÌŽ¡—ÃŒø‰Êi‡Uj‘gDŠw“IŠm”F. Š™“cvŽõCˆäãŒcˆêC‘å‹v•Û[li“àjC^è‹`•FiŽÀ“®Œnj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï
(89.11.10), •l¼.
1393. mŠw‰ïn iˆê”Êu‰‰j SLEtÇ‚É‚æ‚铧ÍÇ—á‚Ì—Õ°“I“Á’¥‚Æt•s‘S”Çi“W—vˆö‚ÌŒŸ“¢. “c‘º_ŽOi“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.
1394. mŠw‰ïn iˆê”Êu‰‰j 15-deoxyspergualin (DSP)‚É‚æ‚éNew
Zealandƒ}ƒEƒXiB/Wƒ}ƒEƒXjtÇ‚ÌŽ¡—ÃG‘æ2•ñ.@Œø‰Ê‚Ì—e—ʈˑ¶«‚ÉŠÖ‚·‚錟“¢.
‘å‹v•Û[lC‰J‹{Œ«ˆêCŠ™“cvŽõi“àjC^è‹`•FiŽÀ“®Œnj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.
1395. mŠw‰ïn iˆê”Êu‰‰j ’j«ƒ‹[ƒvƒXt‰Š‚Ì—Õ°•a—Šw“IŒ¤‹†. ŠÚ–샶C¬—Ñ–LC”äŠé”\”Vi“àjC“y“cOŠîC•lŒû‹Óˆêi‘—§²‘q•a‰@j: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.10), •l¼.
1396. mŠw‰ïn iˆê”Êu‰‰j ‘ƒóŽ…‹…‘Ìd‰»Ç‚ɑ΂·‚éƒXƒeƒƒCƒh”½‰ž«‚ɂ‚¢‚Ä. •ìºC”äŠé”\”VCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï (89.11.11), •l¼.
1397. mŠw‰ïn iˆê”Êu‰‰j Changes in Serum Albumin in Renal Transplant
Recipients. ŒF–ì˜a—YC“ü]Œ[C^‰ºß•vC‰““¡’‰—Yi”åjCEra, S.CSogami, M.iŠò•Œ‘åj: The lst
Congress of the Asian Transplantation Scciety (89.11.23), ƒCƒ“ƒhƒlƒVƒAEƒoƒŠ“‡.
1398. mŠw‰ïn iˆê”Êu‰‰j Kidney Transplantation, Nephrotic Syndrome with
Minimal Histologic Change in Focal Segmental Glomerulosclerosis:
Clinical Recurrence? Žðˆä‹ŠCŒF–ì˜a—Yi”åjC‰Í¼‹IºC”Ñ‚Šì‹v—YiŽ™jCLee,
J.D.C‰““¡’‰—Yi”åjCŒK”ö’èmi•a—j: The lst Congress of the Asian Transplantation
Scciety (89.11.24), ƒCƒ“ƒhƒlƒVƒAEƒoƒŠ“‡.
1399. mŠw‰ïn iˆê”Êu‰‰j Extracorporeal Shockwave Lithotripsy of Ureteropelvic
Junction Stones. ^‰ºß•vCrìFC‹v•Û¯ˆêC¬ŽÄŒ’i”åj: 7th World Congress on
Endourology and ESWL (89.11.28), ‹ž“s.
1400. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw‚É‚¨‚¯‚étˆÚA‚ÌŒ»‹µi‡]‡Xj. “n•”_“ñC”–Ø“oiˆÚA–Ɖuj: ‘æ808‰ñç—tˆãŠw‰ï—á‰ïC‘æ5‰ñ‘æ2ŠO‰È—á‰ï (89.12.00), ç—t.
1401. mŠw‰ïn iˆê”Êu‰‰j Heterogeneity of Calcium Pump Activity in Proximal
and Distal Tubules of Rat Kidney. ’Ë–{—Y‰îCã‘i“àj, Saitoh, M.CSugimura, K.:
22nd Ann. Meet. Am. Soc. Nephrol. (89.12.03`06), Washington, D.C.
1402. mŠw‰ïn iˆê”Êu‰‰j Arrest in Progression of Advanced Glomerular Disease
in New Zealand Mice (B/W Mice) by 15-deoxyspergualin (DSP).
ˆäãŒcˆêC‘å‹v•Û[lCŠ™“cvŽõCŽá—Ñ–õ‹vi“àj: 22nd Ann. Meet. Am. Soc. Nephrol.
(89.12.03`06), Washington, D.C., Kidney Int., 37(1): 417, 1990.
1403. mŠw‰ïn iˆê”Êu‰‰j Treatment of Heymann Nephritis (HN) by Bactobolin
(BN). Š™“cvŽõC’|“àN—YC“à“c–ž”üŽqC²“¡’¼”VC•ìºC¬—Ñ–LC‘å‹v•Û[li“àj: 22nd Ann. Meet. Am. Soc.
Nephrol. (89.12.03`06), Washington, D.C., Kidney Int., 37(1): 418,
1990.
1404. mŠw‰ïn iˆê”Êu‰‰j Oxidative Stress in Maintenance Dialysis Patients.
ŒF–ì˜a—Yi”åjC’†‘º‘‰qi•ª¶jC‘Š CˆêC“ì•”³litƒZƒ“jCŽðˆä‹Ši”åj: 22nd the American Society of
Nephrology (89.12.04), ƒƒVƒ“ƒgƒ“.
1405. mŠw‰ïn iˆê”Êu‰‰j Vo2 max‘ª’莞‚É‚¨‚¯‚é”A’†“d‰ðŽ¿‚ÌŒŸ“¢. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºC–åˆäL‹ÅC–¥‰YŽ‘¥C“n•Ó“oC’†“ˆ‰p•FiŽ™j: “ú–{‘̗͈ãŠw‰ïŠÖ“Œ’n•û‰ï (89.12.09), “Œ‹ž.
1406. mŠw‰ïn iˆê”Êu‰‰j ‘ÌŠOÕŒ‚”gŒ‹Î”jÓ‘•’u(Therasonics)Žg—p‚É‚æ‚éã•””A˜HŒ‹ÎŽ¡—ÃŒoŒ±. •ìƒCò”ŽˆêC¬ŽÄŒ’C^‰ºß•vCŠÑˆä•¶•FC‰ª–{dâXi”åj: ‘æ27‰ñé‹ÊŒ§ˆãŠw‰ï‘‰ï (90.01.21), é‹Ê.
1407. mŠw‰ïn iˆê”Êu‰‰j Once-A-Week Self Administered Subcutaneous (sc)
Erythropoietin (EPO): The Optimal Route of EPO for CAPD Patients.
‰¡“c^“ñCŒF–ì˜a—YC“ü]Œ[CŽðˆä‹Ši”åj: 10th Annual Conference on: Peritoneal Dialysis
(90.02.08), Dallas.
1408. mŠw‰ïn iˆê”Êu‰‰j Oxidative Stress in Patients with CAPD.
ŒF–ì˜a—YC‰¡“c^“ñi”åjC’†‘º‘‰qi•ª¶jC“ü]Œ[CŽðˆä‹Ši”åj: 10th Annual Conference on: Peritoneal
Dialysis (90.02.08), Dallas.
1409. mŠw‰ïn iˆê”Êu‰‰j Once-a-Week Self Administrated Subcutaneous
Erythropoietin: The Optimal Route of EPO for CAPD Patients.
‰¡“c^“ñC“ü]Œ[CŒF–ì˜a—YCŽðˆä‹Ši”åj: 10th Annual Conference on : Peritoneal Dialysis
(90.02.08`10), Texas.
1410. mŠw‰ïn iˆê”Êu‰‰j ŒŒŸ÷ŒðŠ·—Ö@‚ƃpƒ‹ƒX—Ö@‚É‚æ‚è‰ü‘P‚ª‚Ý‚ç‚ꂽRŽ…‹…‘ÌŠî’ê–ŒR‘Ì‚É‚æ‚é‹}‘¬is«Ž…‹…‘Ìt‰Š‚Ì1—á.
‰J‹{Œ«ˆêC’Ë–{—Y‰îC”äŠé”\”VCŠÚ–샶C¬—Ñ–LC–Øì“c—²ˆêi“àj: ‘æ389‰ñ“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (90.02.10), “Œ‹ž.
1411. mŠw‰ïn iˆê”Êu‰‰j ”A“¹ˆÙ•¨‚Ì1—á. {ŽRo•äC“à“c–LºCŒàŠ²ƒC“ü]Œ[CŒÃ”¨½”VC‘å–x—C^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ1‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.
1412. mŠw‰ïn iˆê”Êu‰‰j Œã• –ŒŽ‰–bŽî‚Ì1—á. Œ´–ì—TŽiC¯Ži´Žui”åjC¼èÍ“ñiŽ©‰q‘à‰¡{‰ê•a‰@j: ‘æ1‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.
1413. mŠw‰ïn iˆê”Êu‰‰j ƒ~ƒ…[ƒ‰[ŠÇ”X–E‚Ì1—á|Œo’¼’°“I’´‰¹”g’f‘w‘œ(TRUS), CT, MRIŠe‰æ‘œ‚̑Δ䌟“¢. {ŽRo•äCŒüˆäLÆCŒàŠ²ƒC“¡–ì’WlC΋´Wi”åj: ‘æ9‰ñ“ú–{‰æ‘œˆãŠw‰ï (90.02.26), “Œ‹ž.
1414. mŠw‰ïn iˆê”Êu‰‰j t«ã”笑̋@”\˜´iÇ‚É‚¨‚¯‚éCa•‰‰×ŽŽŒ±Ap‘O¶‰»ŠwŒŸ¸’l‚Æ“Eoã”笑Ìd—Ê‚Æ‚Ì‘ŠŒÝŠÖŒW.
“à“c‹v‘¥C¼‘º—mŽ¡CHŽRŽµç’jC™–{‹v”VC‰¡“c˜a•FCŒY•”“ŒŽ¡iŠOjCŠ™“cvŽõC‘å‹v•Û[li“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC‹T’J“Oi•a—j:
‘æ1‰ñ“ú–{“à•ª”åŠO‰ÈŠw‰ï i89.00.00), “Œ‹ž.
1415. mŠw‰ïn iˆê”Êu‰‰j tˆÚA—Õ°‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG
4܇•¹“Š—^–@.
ŒY•”P’jCŒY•”“ŒŽ¡C‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø
“oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.11), “Œ‹ž, ˆÚA, 24(—Õ‘): 149, 1989.
1416. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŠ³ŽÒŠJ• ŽèpÇ—á‚Ì—Õ°“IŒŸ“¢.
‰¡“c˜a•FC’†ŽR‹`‰îCŒY•”P’jC²“¡ŒõŽjC¡ˆäŒ‰C‘듇í‰ëiŠOjCŠ™“cvŽõC‘å‹v•Û[li“àjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjC“n•”_“ñi‘Ÿ
ˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï i89.09.12), “Œ‹ž, ˆÚA, 24(—Õ‘): 302, 1989.
1417. mŠw‰ïn iˆê”Êu‰‰j Advantages of Mizoribine over Azathioprine in
Combination Therapy with Cyclosporine for Renal Transplantation. Mita,
K.CŒY•”P’jC’†ŽR‹`‰îC‰¡“c˜a•FC²“¡ŒõŽjC“à“c‹v‘¥iŠOj: ‡W Congress of the European Society for
Organ Transplantation i89.11.1`4), Barcelona, Spain, Abstract, p.198,
1989.
1418. mŠw‰ïn iˆê”Êu‰‰j Preservation of Canine Kidneys with Simple Surface
Cooling Using Eurocollins Solution Added with a High Concentration of
Urokinase.
^è‹`•FiŽÀ“®ŒnjC‰¡“c˜a•FC²“¡ŒõŽjCŒY•”P’jC’†ŽR‹`‰îC‘듇í‰ëiŠOjC‰œ•½‰ë•Fi•a—jC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[jC“à“c‹v‘¥iŠOj:
1st Congress of the Asian Transplantation Society i89.11.22), ƒoƒŠ,
ƒCƒ“ƒhƒlƒVƒA.
1419. mŠw‰ïn iˆê”Êu‰‰j Advantage of Triple Therapy with Mizoribine,
Ciclosporine and Prednisolone over Other Types Triple and/or Double
Therapy Including Ciclosporine for Renal Transplantation.
“à“c‹v‘¥i“Œ‘åjCNishimura, Y.CMita,
K.CŒY•”P’jC’†ŽR‹`‰îC‰¡“c˜a•FC²“¡ŒõŽjiŠOjC‰““¡’‰—Yi”åjC‘å‹v•Û[li“àj: 1st Congress of the Asian
Transplantation Society i89.11.22), ƒoƒŠ, ƒCƒ“ƒhƒlƒVƒA, ´˜^W, p.180, 1989.
1420. mŒ¤‹†‰ïn i‹L”Ou‰‰j –«tŽ¾Š³‚Æ“§Í‚̇•¹Ç. Žðˆä‹Ši”åj: “Œt‹¦‘æ17‰ñ‘‰ï (89.04.02), “Œ‹ž.
1421. mŒ¤‹†‰ïn i“Á•Êu‰‰j –«t•s‘S‚Ì•Û‘¶Šú—Ö@‚ÆtˆÚA. ŒF–ì˜a—Yi”åj: ŒF’JŽsˆãŽt‰ïu‰‰‰ï (88.12.21), ŒF’JŽs.
1422. mŒ¤‹†‰ïn i“Á•Êu‰‰j Å‹ß‚Ìt•s‘SŽ¡—Âɂ‚¢‚Ä. ŒF–ì˜a—Yi”åj: ¼ŽRŽsˆãŽt‰ïu‰‰‰ï (89.03.20), ¼ŽRŽs.
1423. mŒ¤‹†‰ïn i“Á•Êu‰‰j t•s‘Sˆã—Âɂ¨‚¯‚éCAPDŽ¡—Ẩʂ½‚·–ðŠ„|ƒPƒAƒVƒXƒeƒ€‚ɂ‚¢‚Ä|. Žðˆä‹Ši”åj: H“cŒ§CAPD§’k‰ï (89.04.0l), H“c.
1424. mŒ¤‹†‰ïn i“Á•Êu‰‰j ’·Šú“§ÍŠ³ŽÒ‚Ìœ‡•¹Ç‚ɂ‚¢‚Ä. ŒF–ì˜a—Yi”åj: ‘æ1‰ñ‰ºŠÖ“§Íˆã—ÃŽ{ÝŠwpu‰‰‰ï (89.05.13), ‰ºŠÖ.
1425. mŒ¤‹†‰ïn i“Á•Êu‰‰j tŽ¾Š³ care system |t•s‘SŠÇ—‚É‚¨‚¯‚éCAPD‚̈ʒu‚¯|. Žðˆä‹Ši”åj: ‘æ1‰ñ‰ºŠÖ“§Íˆã—ÃŽ{ÝŠwpu‰‰‰ï (89.05.13), ‰ºŠÖ.
1426. mŒ¤‹†‰ïn i“Á•Êu‰‰j CAPD‚ÌŒ»ó. Žðˆä‹Ši”åj: ‘æ12‰ñ_“Þ쌧CAPDŠÅŒìŒ¤C‰ï (89.05.28), _“Þì.
1427. mŒ¤‹†‰ïn i“Á•Êu‰‰j ”ñƒlƒtƒ[ƒ[Œ^Ž…‹…‘Ìt‰Š‚̃XƒeƒƒCƒh—Ö@. ¬—Ñ–Li“àj: ‘æ2‰ñç—tŒ§tƒZƒ~ƒi[ (89.06.00), ç—t.
1428. mŒ¤‹†‰ïn i“Á•Êu‰‰j CAPDŠ³ŽÒ‚Ì• –Œ‰Š‚Ƹ_“IŽx‰‡‚ɂ‚¢‚Ä. ŒF–ì˜a—Yi”åj: ‘æ11‰ñŒQ”nŒ§CAPDŠÅŒìƒZƒ~ƒi[ (89.06.03), ŒQ”n.
1429. mŒ¤‹†‰ïn i“Á•Êu‰‰j t•s‘S‚̃g[ƒ^ƒ‹ƒPƒA[. Žðˆä‹Ši”åj: ‘æ3‰ñ‹ãB¬Ž™ƒlƒtƒƒƒW[Œ¤‹†‰ï (89.06.10), •Ÿ‰ª.
1430. mŒ¤‹†‰ïn i“Á•Êu‰‰j tŽ¾Š³Š³Ž™‚̶—¥•a—. Žðˆä‹Ši”åj: ‘æ5‰ñ—{ŒìŠwZ•ÛŒ’ŠÇ—uK‰ï (89.08.03), ‰¡{‰ê.
1431. mŒ¤‹†‰ïn i“Á•Êu‰‰j u‚¢‚܈ã—Â̢ŠE‚Å‚Ív|ˆã—Ãl‚Æ‚µ‚Ä‚Ì–ðŠ„‚ðl‚¦‚é|. Žðˆä‹Ši”åj: ƒ‚ƒ_ƒ“ƒ†ƒŠƒiƒŠƒVƒXu‰‰‰ï (89.10.22), H“cŽs.
1432. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆã—ÃVŽž‘ã‚̃jƒ…[ƒRƒ“ƒZƒvƒg‚ÍŠwZ•ÛŒ’‚É”@‰½‚È‚é‰e‹¿‚ð‹y‚Ú‚µ‚Ä‚¢‚é‚©. Žðˆä‹Ši”åj: ‘æ37‰ñ–k—¤ŽOŒ§ŠwZ•ÛŒ’Œ¤‹†‹¦‹c‰ï (89.10.28), ¬¼Žs.
1433. mŒ¤‹†‰ïn i“Á•Êu‰‰j “§ÍŠ³ŽÒ‚ւ̃GƒŠƒXƒƒ|ƒGƒ`ƒ“‚Ì“Š—^‚Æ•›ì—p‚ɂ‚¢‚Ä. Š™“cvŽõi“àj: •Ÿ“‡t«•nŒŒŒ¤‹†‰ï (89.11.18), •Ÿ“‡.
1434. mŒ¤‹†‰ïn i“Á•Êu‰‰j CAPD—Ö@. Žðˆä‹Ši”åj: ƒTƒeƒ‰ƒCƒgƒZƒ~ƒi[iŒŒ‰tò‰»‹ZpƒZƒ~ƒij (89.12.03), “Œ‹ž.
1435. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚Ìt•s‘S¥“§ÍŠ³ŽÒ‚Å‚ÌŽg—p¬Ñ‚Æ¡Œã‚Ì“W–]. Žðˆä‹Ši”åj: ‘æ2‰ñŠâŽèƒGƒŠƒXƒƒ|ƒGƒ`ƒ“Œ¤‹†‰ï (90.02.13), ·‰ª.
1436. mŒ¤‹†‰ïn i“Á•Êu‰‰j “§ÍƒAƒ~ƒƒCƒh[ƒVƒX. ŒF–ì˜a—Yi”åj: ŒF–{Œ§“§ÍŒ¤‹†‰ï (90.02.23), ŒF–{.
1437. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆã—ÃVŽž‘ã‚ÌCAPD—Ö@‚Ì‚ ‚è‚©‚½. Žðˆä‹Ši”åj: ‘æ5‰ñŠÖ¼¥’†¥Žl‘CAPDƒi[ƒXƒZƒ~ƒi[ (90.02.25), ‘åã.
1438. mŒ¤‹†‰ïn i“Á•Êu‰‰j ˆã—ÃVŽž‘ã‚̃jƒ…[ƒRƒ“ƒZƒvƒg|ˆã—Ãl‚µ‚Ä‚Ì–ðŠ„|. Žðˆä‹Ši”åj: ‘æ14‰ñ_“Þ쌧CAPDŠÅŒìŒ¤‹†‰ï (90.03.18), ‰¡•l.
1439. mŒ¤‹†‰ïn i“Á•Êu‰‰j ¬Ž™‚Ìt‘Ÿ•a|ŠÇ—‚ÆŽ¡—ÃAŋ߂̘b‘è|. Žðˆä‹Ši”åj: ¬“cŒ´ŽsˆãŽt‰ïŠwpu‰‰‰ï (90.03.29), ¬“cŒ´.
1440. mŒ¤‹†‰ïn i“Á•Êu‰‰j ¬Ž™t•s‘S‚É‚¨‚¯‚éƒGƒŠƒXƒƒ|ƒGƒ`ƒ““Š—^‚ÌŽÀÛ. Žðˆä‹Ši”åj: ‹ž“st•s‘SŽ¡—ç’k‰ï (90.03.31), ‹ž“s.
1441. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŒŒ‰t“§Í’†‚ÌŽ–ŒÌ‚Æ‘Îô. Žðˆä‹Ši”åj: ‘æ18‰ñ“§Í—Ö@]Ž–EˆõŒ¤C‰ï (89.07.21), “Œ‹ž.
1442. mŒ¤‹†‰ïn i‹³ˆçu‰‰j RODŽ¡—ÂÌV‚µ‚¢“WŠJ. ’Ë–{—Y‰îi“àj: ‘æ2‰ñ•ºŒÉŒ§ROD§˜b‰ï (89.09.09), _ŒË, t‚Æœ‘ãŽÓ, 3(1): 146, 1990.
1443. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ¬Ž™ŠútŽ¾Š³‚ÌŠÇ—‚ÆŽw“±. Žðˆä‹Ši”åj: ‘æ39‰ñ‘S‘ŠwZ•ÛŒ’Œ¤‹†‘å‰ï (89.11.17), …ŒËŽs.
1444. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “§ÍƒAƒ~ƒƒCƒh[ƒVƒX‚Ì—Õ°. Žðˆä‹Ši”åj: ‘æ35‰ñé‹ÊŒ§t•s‘S§’k‰ïŒ¤‹†”•\‰ï (89.12.01), ‘å‹{.
1445. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ¬Ž™‚Å‚ÌCAPD—Ö@‚ÌŒ»‹µ‚Æ“W–]. Žðˆä‹Ši”åj: Ý‘îˆã—ÃŒ¤‹†‰ï (90.02.27), “Œ‹ž.
1446. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Žq‹Ÿ‚Ìt‘Ÿ•a‚ÌŠÇ—‚ÆŽ¡—Ã. Žðˆä‹Ši”åj: t‘ŸŽ¾Š³u‰‰‰ï (90.02.28), ¬“cŒ´.
1447. mŒ¤‹†‰ïn i‹³ˆçu‰‰j tˆÚA|—Õ°ˆã‚Í‚Ç‚¤‚©‚©‚í‚é‚Ì‚©|. Žðˆä‹Ši”åj: _“Þ쌧•ÛŒ’ˆã‹¦‰ï’nˆæˆã—ÊwK‰ï (90.03.09), ‰¡•l.
1448. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒoŒû1,25(OH)2D3ƒpƒ‹ƒX—Ö@‚É‚æ‚é‚“x“ñŽŸ«•›bó‘B‹@”\˜´iÇ‚ÌŽ¡—Ã. ’Ë–{—Y‰îC–쑺K”Íi“àjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ8‰ñt‚Æœ‘ãŽÓŒ¤‹†‰ï (89.10.07), ‘åã.
1449. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j • ˆ³«”AŽ¸‹Ö‚ÌŽÀ‘Ô’²¸‚ÆäNã÷Œz•”‚Â‚è‚ ‚°p‚ÌŒoŒ±. ‰¡ŽR‰p“ñi”åj: _“Þì•p”A¥”AŽ¸‹ÖƒVƒ“ƒ|ƒWƒEƒ€ (89.11.11), ‰¡•l.
1450. mŒ¤‹†‰ïn iƒpƒlƒ‹j ¬Ž™‚ÌtˆÚA. ‰““¡’‰—Yi”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.21`22), VŠƒ.
1451. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj CAPD’·ŠúŽ{s—á‚Ì–â‘è“_;‚Æ‚‚Ét«œˆÙ‰h—{ǂƬ’·”ˆç‚ɂ‚¢‚Ä. ˆÉ“¡–¯ŒbiŽ™j: ‘æ3‰ñ¬Ž™CAPD•×‹‰ï (89.09.21), VŠƒ.
1452. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠwZŒŸ”AAŒp‘±ŠÇ—‚̈Ӌ`. Žðˆä‹Ši”åj: Œú¶È“Á’莾Š³’²¸Œ¤‹†”Çuis«táŠQv•½¬Œ³”N“xŒ¤‹†‹ÆÑ”•\‰ï”•\”NŒŽ“ú(90.02.09), “Œ‹ž.
1453. mŒ¤‹†‰ïn iˆê”Êu‰‰j
IgAtÇ‚É‚Äfollow’†‚ÉScholein-HenochŽ‡”Á•a‚ð‡•¹‚µAƒlƒtƒ[ƒ[ÇŒóŒQ‚ð’悵‚½1—á.
•x‰i‹B•FC“c”¨ˆÉ“sŽqC•Ÿ“c‰xŽqC‘å’ˉpŽiC‘å‹v•Û[li“àjC‹Ê’uŒ›ˆê: ‘æ43‰ñ_“Þ쌧“à‰ÈˆãŠw‰ïW’k‰ï (89.00.00), —tŽR.
1454. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”å”AŠí‰È—̈æ‚Å‚ÌŽÄ—è“’‚ÌŽg—pŒoŒ±. ΋´WCŽO–ØM’ji”åj: ‘æ5‰ñ—Õ°“Œ—mˆãŠwŒ¤‹†‰ï (89.05.26), “Œ‹ž.
1455. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÚAt“®–¬‹·ó‚ɑ΂·‚éPTA.
‰““¡‚C‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC’J“c—ˆê˜Yi•új: ‘æ1‰ñŠÖ“ŒInterventional RadiologyŒ¤‹†‰ï
(89.08.05), “Œ‹ž, “ú–{ŒŒŠÇ‘¢‰eInterventional RadiologyŒ¤‹†‰ïŽGŽ, 4(2): 128, 1989.
1456. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚“x‚ÌŽ…‹…‘Ìt‰ŠA”A׊ÇEŠÔŽ¿«t‰Š‚𔺂Á‚½Castleman•a‚Ì1—á. ”äŠé”\”VC–쑺K”ÍC’Ë–{—Y‰îC•ìºCŠ™“cvŽõCŠÚ–샶C¬—Ñ–Li“àj: ‘æ12‰ñ_“Þìt‰ŠŒ¤‹†‰ï (89.09.00), ‰¡•l.
1457. mŒ¤‹†‰ïn iˆê”Êu‰‰j t“à“®–¬•ÂÇ‚É‚æ‚鬎™ŒŒŠÇ«‚ŒŒˆ³Ç‚Ì1—á|•”•ª“It“®–¬Çðp‚Ì—L—p«.
¼Šª”ŽC–x’rdŽ¡C’J“c—ˆê˜YC¬—Ñ–ÎŽ÷C¼ŽR³ŒáC’r“crºC“cŠŽŒÈi•újCãŽR‘×~C’·’Jì—CˆÉ“¡‘ñi´£¬Ž™•a‰@j: ‘æ15‰ñ“ú–{ŒŒŠÇ‘¢‰e
Interventional Radiology Œ¤‹†‰ï (89.09.00), –¼ŒÃ‰®, “ú–{ŒŒŠÇ‘¢‰e Interventional
Radiology Œ¤‹†‰ïŽGŽ, 4(2): 80, 1989.
1458. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰ºŠ{œ”XŽî‚Ì“Eo‚É‚æ‚èƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚ÌŒø‰Ê‚ð”F‚ß‚½¬Ž™CAPDÇ—á. –kžŠ‚Ý‚Ç‚èiŽ™j: ‘æ4‰ñ_“ÞìCAPDŒ¤‹†‰ï (89.09.09), ‰¡•l, —\eW, p.102, 1989.
1459. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž‘±«—²‹N«g”ÁCŽá”N«ŠÖ߃ŠƒEƒ}ƒ`—l‚ÌŠÖ߉Š‚É‘ƒóŽ…‹…‘Ìd‰»Ç‚𔺂Á‚½1’jŽ™—á.
V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ12‰ñ_“Þìt‰ŠŒ¤‹†‰ï (89.09.16), ‰¡•l, t‰ŠÇ—ጤ‹†, 6:
115`119, 1990.
1460. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’ZŠúŠÔ‚É3‰ñ‚Ì‹}«t•s‘S”ì‚ð‹N‚±‚µ‚½ŠÔŽ¿«t‰Š‚Ì‚P’jŽ™—á. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.21), VŠƒ.
1461. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒVƒNƒƒXƒ|ƒŠƒ“‚ð“Š—^‚µ‚½¬Ž™tˆÚAŠ³ŽÒ10—á‚Ì—Õ°“IŒŸ“¢. V‘º•¶’jiŽ™jCŒF–ì˜a—Yi”åjC–kžŠ‚Ý‚Ç‚èC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ.
1462. mŒ¤‹†‰ïn iˆê”Êu‰‰j —cŽá‹y‚Ñ‚T—ƒbƒg‚É‚¨‚¯‚ét•s‘S‚Ìis‚ɂ‚¢‚Ä|tˆŸ‘S“Eƒ‚ƒfƒ‹‚ð—p‚¢‚Ä‚ÌŒŸ“¢|.
V‘º•¶’jiŽ™jCŽðˆä‹Ši”åjCˆÉ¨“¹mC㌴N•viŒà‰H‰»Šw¶•¨ˆãŠwŒ¤‹†Šj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ.
1463. mŒ¤‹†‰ïn iˆê”Êu‰‰j t•s‘Sƒ‚ƒfƒ‹‚ɑ΂·‚éŒoŒû‹z’…ÜAST-120“Š—^‚̉e‹¿‚ÉŠÖ‚·‚錤‹†|Ž…‹…‘ÌŒŒs“®‘Ô‚ÉŠÖ‚·‚錟“¢|. ‹g“c‹`Ki ϶‰ï‰¡•lŽs“ì•”•a‰@jCŽðˆä‹Ši”åj: ‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ.
1464. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰ºŠ{”XŽî‚Ì“Eo‚Å•nŒŒ‚̉ü‘P‚ð‚Ý‚½‚PÇ—á|Recombinant
Erythropoietin(r-EPO)‚Ì”½‰ž«‚̉ü‘P|. –kžŠ‚Ý‚Ç‚èCV‘º•¶’jCˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj:
‘æ11‰ñ¬Ž™t•s‘SŒ¤‹†‰ï (89.09.22), VŠƒ, —\eWCp.102, 1989.
1465. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”DPoŽY‚É‚æ‚è’˜‚µ‚Œy‰õ‚µ‚½“Á”«•‚Žî‚Ì1—á. Žç‰®—˜‰ÀC–쑺K”ÍC’Ë–{—Y‰îC‘å‹v•Û[li“àj: ‘æ21‰ñ“Œ‹ž—Õ°‘̉tŒ¤‹†‰ï (89.10.14), “Œ‹ž.
1466. mŒ¤‹†‰ïn iˆê”Êu‰‰j tˆÚAlHŒŒŠÇ•«‡p‚É‚¨‚¯‚鶗“I‘gDÚ’…Ü‚Ì—L—p«‚ɂ‚¢‚Ä. “ü]Œ[C‰¡“c^“ñCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.
1467. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’á‘Ìd¬Ž™‚ÌtˆÚA‚ÌŽèpŽè‹ZiƒrƒfƒIj. ‰““¡’‰—Yi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.
1468. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¶‘Ìdonor‚Ìt“EœpiƒrƒfƒIj. ‰““¡’‰—Yi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.
1469. mŒ¤‹†‰ïn iˆê”Êu‰‰j –h‰qˆã‘å”å”AŠí‰È‚Ås‚Á‚Ä‚¢‚鶑ÌtˆÚA‚ÌŽèpŽè‹Z‚ɂ‚¢‚Ä. ‘ò‘º³”VC´…rŽŸC씨KŽkC‚”ö‰ë–çCó–ì—F•FC’·‘q˜a•FC‰Æ“c˜a•vC‘ºˆäŸC’†‘ºGi”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.
1470. mŒ¤‹†‰ïn iˆê”Êu‰‰j “àƒVƒƒƒ“ƒg•”lHŒŒŠÇ‚É‹U“®–¬áŽ‚ª‘½”‚µ‚½1—á. ‹g“cˆê¬C•ìƒC–å˜e˜abCŒF–ì˜a—YC‰““¡’‰—YCŽðˆä‹Ši”åj: ‘æ4‰ñtˆÚAŒŒŠÇŠO‰ÈŒ¤‹†‰ï (89.11.03), •xŽR.
1471. mŒ¤‹†‰ïn iˆê”Êu‰‰j tƒTƒ“ƒSóŒ‹Îǂɑ΂·‚éESWL‚ÌŽ¡—ÃŒoŒ±. rìFCΓc—T‘¥C‹v•Û¯ˆêC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ3‰ñ“ú–{Endourology ESWLŒ¤‹†‰ï (89.11.27), ‹ž“s.
1472. mŒ¤‹†‰ïn iˆê”Êu‰‰j AST-120‚ª”A׊ǂɋy‚Ú‚·‰e‹¿‚ÌŒŸ“¢. V‘º•¶’jiŽ™jCŽðˆä‹Ši”åjCˆÉ¨“¹mC㌴N•viŒà‰H‰»Šwj: ”A“ÅÇ•a‘ÔŒ¤‹†‰ï (89.12.02), Šò•Œ.
1473. mŒ¤‹†‰ïn iˆê”Êu‰‰j CAPDŠ³Ž™‚É‚¨‚¯‚ét«œˆÙ‰h—{ǂɂ‚¢‚Ä‚ÌŒŸ“¢.
ˆÉ“¡–¯ŒbC–kžŠ‚Ý‚Ç‚èCV‘º•¶’jCΊٕ•vC”Ñ‚Šì‹v—YC‰Í¼‹IºiŽ™jC–x’rdŽ¡i•újCŽðˆä‹Ši”åj: ¬Ž™CAPDŒ¤‹†‰ï
(90.01.13), ‰¡•l, —\eWCp.10, 1990.
1474. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒ‰t“§Í“±“üŽžA‹¹•”‚wüŠŒ©‚ɂ‚¢‚Ä. ˜a“cŒ¹ŽiC–¾Î•q•FCŠ¡•”‚ЂƂÝC÷ˆä–¾”üCŒBŠ|L“ñC“y‰®ÍC‘å‹v•Û[li“àj: ‘æ822‰ñç—tˆãŠw—á‰ïA‘æ23‰ñ”xŠàŒ¤‹†Ž{Ý—á‰ï (90.01.15), ç—t.
1475. mŒ¤‹†‰ïn iˆê”Êu‰‰j pŒã‘Šú‚Ét‹@”\’ቺCŒŒ¬”ÂŒ¸C•nŒŒ‚ð‚«‚½‚µCOKT3‚ª’˜Œø‚ð’悵‚½¬Ž™¶‘ÌtˆÚA‚Ì‚P—á.
V‘º•¶’jCŽR“cr•FCŠÖª“OC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jC“ü]Œ[C‰¡“c^“ñCŒF–ì˜a’jC^‰ºß•vC‰““¡’‰—YCŽðˆä‹ŠC¬ŽÄŒ’i”åj:
‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï (90.01.26), ‘å’Ã, —\eWCp.69, 1990.
1476. mŒ¤‹†‰ïn iˆê”Êu‰‰j tˆÚAŒã‚ÉCMVŠ´õÇ‚ð’悵‚½2—á.
Žç‰®—˜‰ÀC‰J‹{Œ«ˆêC“´“c‰fŽqC“c‘º_ŽOCŠ™“cvŽõC‘å‹v•Û[lC–Øì“c—²ˆêi“àjCŒY•”P’jC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjC“ü]Œ[CŒF–ì˜a—YC^‰ºß•vC
‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï (90.01.27), ‘å’Ã, —\eW, p.110, 1990.
1477. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtÇ‚É‚¨‚¯‚éŠÔŽ¿•a•Ï‚Ì•]‰¿. ‰Í¼‹IºC–kžŠ‚Ý‚Ç‚èiŽ™jCŽðˆä‹Ši”åj: Œú¶ÈSgáŠQŒ¤‹†•½¬Œ³”N“xu¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†v (90.01.31), “Œ‹ž.
1478. mŒ¤‹†‰ïn iˆê”Êu‰‰j CAPDŠ³ŽÒ‚É‚¨‚¯‚郊ƒ“‹z’…Ü‚Æ‚µ‚Ä‚ÌCaCO3‚ÌŒø‰Ê‚¨‚æ‚Ñ•›ì—p‚ɂ‚¢‚Ä.
ˆÉ“¡–¯ŒbC”Ñ‚Šì‹v—YiŽ™jCŽðˆä‹Ši”åj: Œú¶ÈSgáŠQŒ¤‹†•½¬Œ³”N“xu¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚Æ’·ŠúŠÇ—‚̃VƒXƒeƒ€‰»‚ÉŠÖ‚·‚錤‹†v
(90.01.31), “Œ‹ž.
1479. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™CAPDŠ³ŽÒ‚̎Љ‹A.
Žðˆä‹Ši”åjC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºCV‘º•¶’jC”Ñ‚Šì‹v—YCˆÉ“¡–¯ŒbiŽ™jCŒF–ì˜a—Yi”åj:
Œú¶ÈSgáŠQŒ¤‹†•½¬Œ³”N“xu¬Ž™tŽ¾Š³‚Ìis‘jŽ~‚µ’·ŠúŠÇ—‚̃VƒXƒeƒ€‚ÉŠÖ‚·‚錤‹†v (90.01.31), “Œ‹ž.
1480. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtÇ‚Ìis«‚ÌŒ©‹É‚ß|’†“™“xˆÈã‚Ì’`”’”AÇ—á‚ɂ‚¢‚Ä. ¬—Ñ–LC”äŠé”\”VCŠÚ–샶C•ìºi“àj: Œú¶È“Á’莾Š³’²¸Œ¤‹†”Çuis«táŠQv•½¬Œ³”N“xŒ¤‹†”•\‰ï (90.02.00), “Œ‹ž.
1481. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘ŠúŽ¡—Ãi—\–h‘Îô’†Sj‚ÉŠÖ‚·‚錤‹†. Žðˆä‹Ši”åjC‰Í¼‹IºiŽ™j: ut•s‘Sˆã—ÃŒ¤‹†Ž–‹Æv•½¬Œ³”N“xŒ¤‹†‹ÆÑ”•\‰ï (90.02.02), “Œ‹ž.
1482. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”DP‘O”¼Šú‚É”A’`”’‚ªoŒ»‚µƒlƒtƒ[ƒ[ÇŒóŒQ‚Ö‚Æi“W‚µ‚½2Ç—á. Š™“cvŽõC¬àVŒ°ˆêC“c‘º_ŽOC•ìºC”äŠé”\”VCŠÚ–샶C¬—Ñ–Li“àj: ‘æ13‰ñ_“Þìt‰ŠŒ¤‹†‰ï (90.02.03), ‰¡•l.
1483. mŒ¤‹†‰ïn iˆê”Êu‰‰j IgAtǂ̔ǂ©‚çˆÚA‚Ü‚Å. V‘º•¶’jC–kžŠ‚Ý‚Ç‚èC‰Í¼‹IºiŽ™jCŽðˆä‹Ši”åj: ‘æ13‰ñ_“Þìt‰ŠŒ¤‹†‰ï (90.02.03), ‰¡•lC —\eWCp.6, 1990.
1484. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ä”R‚ðŒJ‚è•Ô‚µ‚½ƒ‹[ƒvƒXt‰Š‚Ì1—á. ãŽRŽO‘ãŽqC•ìºCŠ™“cvŽõC¬—Ñ–LC”äŠé”\”Vi“àj: ‘æ11‰ñ_“Þìt‰ŠŒ¤‹†‰ï (90.03.04), ‰¡•l,
1485. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”÷¶•¨“ñŽŸ‘ãŽÓŽY•¨‚̖Ɖu—}§ì—pA“Á‚Ét‰Š”Ç‚¨‚æ‚Ñi“W‚Ì—}§‚ɂ‚¢‚Ä. ‘å‹v•Û[lCŠ™“cvŽõi“àjC^è‹`•FiŽÀ“®Œnj: Œú¶ÈŽ©ŒÈ–ƉuŽ¾Š³Ž¡—Öò‚ÌŠJ”Œ¤‹†”Ç‘æ6‰ñ‘‰ï (90.03.16), “Œ‹ž.
1486. mŒ¤‹†‰ïn iˆê”Êu‰‰j PAN17DX‚ł̒ᕪŽq—Ê’`”’‚Ìœ‹Ž”\‚ÌŒŸ“¢.
¬ŽR½itƒZƒ“ƒ^[jCŒF–ì˜a—Yi”åjC“ì•”³lC—Ñ‹v”üŽqCéˆä°”üC´…”ÍŽqC‘Š CˆêitƒZƒ“ƒ^[jCŽðˆä‹Ši”åj:
‘æ5‰ñƒnƒCƒpƒtƒH[ƒ}ƒ“ƒX¥ƒƒ“ƒuƒŒƒ“Œ¤‹†‰ï (90.03.17), “Œ‹ž.
1487. mŒ¤‹†‰ïn iˆê”Êu‰‰j t«ã”笑̋@”\˜´iÇ‚É‚¨‚¯‚é“Eoã”笑̂̕a—‘gDŠw“IŒŸ“¢.
™–{‹v”VCHŽR’¨•vC“à“c‹v‘¥CŒY•”“ŒŽ¡C‰¡“c˜a•FC²“¡ŒõŽjiŠOjCŠ™“cvŽõC’Ë–{—Y‰îC‘å‹v•Û[li“àj: ‘æ37‰ñ_“ÞìtŒ¤‹†‰ï
i89.00.00), _“Þì.
1488. mŒ¤‹†‰ïn iˆê”Êu‰‰j tĈÚAÇ—á‚ÌŒŸ“¢.
²“¡ŒõŽjC‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jCˆ¢‘]OˆêiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø
“oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ22‰ñtˆÚA—Õ°ŒŸ“¢‰ï i89.02.17), ˆÉ•Û, ˆÚA, 24(6): 664, 1989.
1489. mŒ¤‹†‰ïn iˆê”Êu‰‰j tˆÚ—Õ°‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG
4܇•¹“Š—^–@.
ŒY•”P’jCŒY•”“ŒŽ¡C‰¡“c˜a•FC‘듇í‰ëC’†ŽR‹`‰îC²“¡ŒõŽjiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø
“oi‘ŸˆÚjC“à“c‹v‘¥i“Œ‘åj: ‘æ12‰ñ—Õ°ˆÚA–ƉuŒ¤‹†‰ï i89.06.10), “Œ‹ž.
1490. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”]Ž€Š³ŽÒ‚©‚ç‚Ìt“Eo‚ÌH•v.
’†ŽR‹`‰îC¡ˆäŒ‰C‘듇í‰ëCŒY•”P’jC‰¡“c˜a•FC²“¡ŒõŽjiŠOjC“à“c‹v‘¥i“Œ‘åjCE“cÍiŠOjCŒF–ì˜a—YC‰““¡’‰—Yi”åjC‘å‹v•Û[li“àj:
‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï i90.01.26), ‘å’Ã, tˆÚA—Õ°ŒŸ“¢‰ïŽ, 23: 22, 1990.
1491. mŒ¤‹†‰ïn iˆê”Êu‰‰j Žr‘ÌtˆÚA‚É‚¨‚¯‚éciclosporine, mizoribine, steroid, ALG
4܇•¹“Š—^–@.
ŒY•”P’jC’†ŽR‹`‰îC¡ˆäŒ‰C‰¡“c˜a•FC²“¡ŒõŽjCE“cÍiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø“oi‘ŸˆÚjC“à
“c‹v‘¥i“Œ‘åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï i90.01.26), ‘å’Ã, tˆÚA—Õ°ŒŸ“¢‰ïŽ, 23: 58, 1990.
1492. mŒ¤‹†‰ïn iˆê”Êu‰‰j tĈÚAÇ—á‚ÌŒŸ“¢.
²“¡ŒõŽjC¡ˆäŒ‰C‘듇í‰ëC’†ŽR‹`‰îCŒY•”P’jCE“cÍiŠOjCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—Yi”åjCŠ™“cvŽõC‘å‹v•Û[li“àjC“n•”_“ñC”–Ø“o
i‘ŸˆÚjC‰¡“c˜a•FiŠOjC“à“c‹v‘¥i“Œ‘åj: ‘æ23‰ñtˆÚA—Õ°ŒŸ“¢‰ï i90.01.26), ‘å’Ã, tˆÚA—Õ°ŒŸ“¢‰ïŽ, 23: 60,
1990.
<<108 ¶BŠí>>
1493. mŒ´’˜n T-3262 (tosafloxacin tosilate)‚Ì‘O—§‘B‘gD“à•ª•z‚ÌŒŸ“¢. ’r“cŽ C¼‘º´ŽuC΋´Wi”åj: Chemotherapy, 37(9): 1149`1153, l989.
1494. mŒ´’˜n ƒÁ-Seminoprotein‚ɑ΂·‚郂ƒmƒNƒ[ƒiƒ‹R‘Ì‚ÌŒ¤‹†. “¡–ì’WlC΋´WC¬ŽÄŒ’i”åjC¯‡Ž¡C‘Šˆé’å˜aCˆÀ“cŒ’ŽŸ˜YiŒc‘åjC\‰ÍFiƒRƒXƒ‚‘Œ¤j: “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 81(1): 37`44, l990.
1495. mŒ´’˜n Mechanism for the Removal of Residual Cytoplasm from
Spermatids during Mouse Spermiogenesis. ŽðˆäNOCŽR‰È³•½i‰ðj: Anat. Rec.,
223(1): 43`48, 1989.
1496. mŒ´’˜n Analgesia and Anesthesia during Labor in Japan and Developed
Countries. Vˆä³•vC¼“‡³”ŽC’F‰pŽ÷iŽY•wj: Asia-Oceania J. Obstet. Gynecol., 15(3):
213`221, 1989.
1497. mŒ´’˜n Proliferation and Responsiveness to Estrogen of Human
Endometrial Cancer Cells under Serum-free Culture Conditions. Holinka,
C.F.(Mount Sinai Univ.)CˆÀ¼Œ·C`GŽ÷iŽY•wjCKimmel, N.(Mount Sinai
Univ)C‘ –{”ŽsiŽY•wjCGurpide, E.(Mount Sinai Univ.): Cancer Research, 49(12):
3297`3301, 1989.
1498. mŒ´’˜n Stimulatory Effects of 4-hydroxytamoxifen on Proliferation
of Human Endometrial Adenocarcinoma Cells (Ishikawa Line).
ˆÀ¼Œ·iŽY•wjCHolinka, C.F.(Mount Sinai Univ.)C‘ –{”ŽsiŽY•wjCGurpide, E.(Mount
Sinai Univ.): Cancer Research, 49(9): 2362`2365, 1989.
1499. mŒ´’˜n Changes in Endoplasmic Reticulum during Spermiogenesis in
the Mouse. ’†–{’¼CŽðˆäNOi‰ðj: Cell Tissue Res., 257: 279`284, 1989.
1500. mŒ´’˜n Quantitative Estimation of an ƒ¿2 Pregnancy-associated
Protein in Normal Pregnancy by Electroimmunoassay.
’†‹Œõ¶iŽY•wjCˆ”ü³“Ti•l¼ˆã‰È‘åjC‘]ª—R”üŽqi¶‰»ŠwŒnjCVˆä³•viŽY•wj: Clin. Chim. Acta, 182:
103`108, 1989.
1501. mŒ´’˜n Žq‹{“à–ŒŠà‚̃XƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“Š´Žó«‚Æ‚»‚Ìì—p‹@˜. `GŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vC‘ –{”ŽsiŽY•wj: Human Cell, 2(3): 265`271, 1989.
1502. mŒ´’˜n Effects of Serine and Glycine on Proliferation of an
Ishikawa Cell Veriant. “n•ÓƒiŽY•wjCHolinka, C.F.CˆÀ¼Œ·C‘ –{”ŽsiŽY•wjCGurpide, E.:
J. Steroid Biochem., 34(1-6): 165`168, 1989.
1503. mŒ´’˜n ’鉤؊JpŒã‚ÌŠÇ—;–k—¢‘åŠw•a‰@‚ÌŽÀÛ. ¼“‡³”ŽCª–{‘‘ˆêCVˆä³•viŽY•wj: ƒyƒŠƒlƒCƒ^ƒ‹ƒPƒA, 8(6): 513`519, 1989.
1504. mŒ´’˜n Žq‹{Œz•”ˆÙŒ`¬‚Ìf’f‚ÆŽ¡—Ã. ã–V•qŽqC˜e“c–M•vC²X–Ø‹I[C—Ñ—æŽqCX‘òFsCŠp“cV•½C‘ –{”ŽsCVˆä³•viŽY•wj: Šà‚Ɖ»Šw—Ö@, 16(4): 1592`1597, 1989.
1505. mŒ´’˜n Žq‹{‘ÌŠàƒzƒ‹ƒ‚ƒ“—Ö@‚Ìì—p‹@˜.
‘ –{”ŽsC`GŽ÷C‰Á“¡—ÇŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCˆÀ¼Œ·C“n•ÓƒiŽY•wjCHolinka, C.F., Gurpide,
E.: Šà‚Ɖ»Šw—Ö@, 16(4): 1851`1857, 1989.
1506. mŒ´’˜n NSTiCST‚ðŠÜ‚Þj. ¼“‡³”ŽiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(‘): 413`419, 1989.
1507. mŒ´’˜n Œv‰æ•ª•Ø‚É‚æ‚霔ՈʬÑ|“Á‚É•ª•ØŒo‰ß‚ɂ‚¢‚Ä|. ¼“‡³”ŽC–ì“c–FlC’F‰pŽ÷C“‡“cMGiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 39(2): 273`279, 1990.
1508. mŒ´’˜n ”ŠO‘‚Ì•êŽq‹~‹}‘̧. ¼“‡³”ŽiŽY•wj: ŽüŽYŠúˆãŠw, (—Õ‘): 333`336, 1989.
1509. mŒ´’˜n Žá”NŽq‹{‘ÌŠà‚Ì—Õ°•a—Šw“IŒŸ“¢. ã–V•qŽqC‘å‰ÍŒ´‘C“y‰®Œ³ˆêC‘ –{”ŽsCVˆä³•viŽY•wj: “ú–{ŠàŽ¡—Êw‰ïŽ, 24(10): 2362`2368, 1989.
1510. mŒ´’˜n Žq‹{“à–ŒÇ‚É‚¨‚¯‚錌’†CA19-9‘ª’è‚Ì—Õ°“IˆÓ‹`. “n•ÓƒCã–V•qŽqC`GŽ÷C‘ –{”ŽsiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 42(2): 155`161, 1990.
1511. mŒ´’˜n Žq‹{‘ÌŠà‚É”º‚·‚é“à–Œ‘BÇ|‘ÌŠà‚Ì”¶‚Æ—\Œã”»’è‚ÌŽw•W‚Æ‚µ‚Ă̈Ӌ`‚ɂ‚¢‚Ä|. ‘ –{”ŽsCã–V•qŽqC`GŽ÷C‘å‰ÍŒ´‘iŽY•wj: “ú–{•wl‰È•a—EƒRƒ‹ƒ|ƒXƒRƒs[Šw‰ïŽGŽ, 7(2): 179`184, 1989.
1512. mŒ´’˜n • •ÇŒ¸ˆ³‘•’u‚ÌŽg—pŒoŒ±‚Æ‚»‚ÌŒø‰Ê. ‹ªˆüC—âˆÛtC‘·ˆÔC¼“‡³”ŽCVˆä³•viŽY•wj: •ª•Ø‚Æ–ƒŒ, (65°66): 18`22, 1989.
1513. mŒ´’˜n ³í”D•w‚ÌŒŒ’†•›bó‘Bƒzƒ‹ƒ‚ƒ““®‘Ô. •xŠ~˜a”üCΓc—™CŽRèŒõOi–k—¢ƒ‰ƒ{jCã–V•qŽqC“‡“cMGiŽY•wj: —Õ°•a—, 37(11): 1269`1273, 1989.
1514. mŒ¤‹†•ñi•¶•”Èjn RƒKƒ“ƒ}[ƒZƒ~ƒmƒvƒƒeƒCƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é‘O—§‘B–ƉuƒVƒ“ƒ`ƒOƒ‰ƒtƒB[. “¡–ì’WlC–{“c’¼NC‘ºŽR‰ëˆêi”åj: •½¬Œ³”N“x‰ÈŠwŒ¤‹†”ï•â•‹àŽÀÑ•ñ‘Cl989.
1515. m‚»‚Ì‘¼‚Ì•ñn ŽY•wl‰È—̈æ‚É‚¨‚¯‚郌[ƒU[ˆãŠw‹y‚Ñ’†‘‚̈óÛ‹L. ‘ –{”ŽsiŽY•wj: “ú–{ƒŒ[ƒU[ˆãŽ, 9(4): 40`42, 1989.
1516. mÇ—á•ñn Œo’¼’°“I’´‰¹”g’f‘w–@‚ª—L—p‚Å‚ ‚Á‚½ƒ~ƒ…[ƒ‰[ŠÇ”X–E‚Ì1—á. ŒüˆäLÆC‘å–x—CŒàŠ²ƒC“¡–ì’WlC΋´Wi”åj: JSUM Proceedings, (10): 783`784, 1989.
1517. mÇ—á•ñn Ä”Žq‹{ŒzŠà‚ɑ΂µ‚ÄCDDP-Peplomysin•¹—p‰»Šw—Ö@‚ª—LŒø‚Å‚ ‚Á‚½1—á.
Šp“cV•½Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: Oncology & Chemotherapy, 5(3): 288`292,
1989.
1518. mÇ—á•ñn “Á”«”DP‰©át‚Ì1Ç—á. —§‰ª˜aOCA–ìM…C–ì“c–FlC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 73`77, 1989.
1519. mÇ—á•ñn ’˜–¾‚ÈŠO‰A•”•‚ŽîAt‹@”\áŠQ‚𔺂Á‚½dÇ”DP’†“ÅÇ‚Ì1—á.
Šâ’JO–¾C–ì“c–FlC—§‰ª˜aOC¯“c—²CA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wjC‰Á“¡–FŽi‰Á“¡ƒ}ƒ^ƒjƒeƒBƒNƒŠƒjƒbƒNj:
“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 47`51, 1990.
1520. mÇ—á•ñn Žq‹{ŒzŠà‚ÌS”X“]ˆÚ‚Ì3—á‚ÌS”X‰t×–EŠŒ©. â–{ˆÉ“¤”üCã–V•qŽqC‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡i—ÕŒŸj: “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(6): 885`889, 1989.
1521. mÇ—á•ñn –k—¢‘åŠw•a‰@CPC,@‘æ147‰ñ: Žq‹{ŒzŠà‚ɑ΂·‚骎¡ŽèpŒã‹}Œƒ‚È“]‹A‚ð‚½‚Ç‚Á‚½1—á. ‘ –{”ŽsCŽÂŒ´—m‰îiŽY•wjC‹àŽq‘i•a—j: –k—¢ˆãŠw, 19(2): 281`283, 1989.
1522. mÇ—á•ñn Primary Transitional Cell Carcinoma of the Prostate. A
Case Report; Imaging and Histologic Considerations.
“¡–ì’WlC‰F“s‹{‘ñŽ¡C‘ˆä‘¥ºC“ü]Œ[Cò”ŽˆêC‰¡ŽR‰p“ñC΋´WC¬ŽÄŒ’i”åjC‘å•”½i•a—j: –k—¢ˆãŠw, 19(4): 452`456,
1989.
1523. m‘àn ‘O—§‘BƒVƒ“ƒ`ƒOƒ‰ƒtƒB[. “¡–ì’Wli”åj: Medical English, 6(10): 4`5, 1989.
1524. m‘àn ‘O—§‘B”ì‘åÇ‚Ì—Õ°|Šú‘Ò‚³‚ê‚é•Û‘¶“IŽ¡—Ö@. ΋´Wi”åj: ƒ‚ƒ_ƒ“ƒƒfƒBƒVƒ“, 18(8): 47`50, 1989.
1525. m‘àn i“ÁWj•aŠú•a‘Ô‚©‚ç‚Ý‚½–òÜ‚Ì‘I‘ð‚Æ“Š—^–@|‘O—§‘B‰Š|. ’r“cŽ C¬ŽÄŒ’i”åj: ˆãŠw‚Æ–òŠw, 21(4): 633`638, 1989.
1526. m‘àn Žq‹{‘ÌŠà‚Ìf’f–@|×–Ef‚Æhysteroscopy|. ã–V•qŽqC‘å‰ÍŒ´‘C‘ –{”ŽsC“‡“cMGiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(4): 972`977, 1989.
1527. m‘àn Žq‹{‘ÌŠàŒŸf‚ÌŽÀÛ. Vˆä³•vC‘ –{”ŽsiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(4): 978`984, 1989.
1528. m‘àn Hysterofiberscopy. ã–V•qŽqC‘ –{”ŽsiŽY•wj: ŽY‰È‚Æ•wl‰È, 56(‘): 215`218, 1989.
1529. m‘àn dÇ”DP’†“ÅÇ‚É‚¨‚¯‚é’鉤؊J–ƒŒ. Vˆä³•vC’F‰pŽ÷C’Jº”ŽC¼“‡³”ŽiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 38(9): 1341`1348, 1989.
1530. m‘àn ‹~‹}ˆ’u|‘ÙŽ™;œ”Ոʕª•Ø|. ’F‰pŽ÷C“‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 19(—Õ‘): 162`166, 1989.
1531. m‘àn •wl‰ÈŠàf—Âɂ¨‚¯‚é in vitro Œ¤‹†‚̉ž—p. ‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`˜aŽqiŽY•wjC”Ñ“c’q”ŽC—јa•Fi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj: ‘gD”|—{, 16(3): 98`104, 1990.
1532. m‘àn Žq‹{‘Ì•”‘BŠà‚Ì×–Ef‚É‚æ‚é‘gD•ª‰»“x”»’è. ‘ –{”ŽsiŽY•wjC‘å–ì‰pŽ¡C¡ˆä’‰˜Ni—ÕŒŸj: “ú–{—Õ°×–EŠw‰ïé‹ÊŽx•”‰ïŽ, (6°7): 4`7, 1989.
1533. m‘àn •wl‰ÈŠà”Ç‚ÌNatural history; Žq‹{‘ÌŠà. ‘ –{”ŽsCã–V•qŽqC`GŽ÷C‘å‰ÍŒ´‘iŽY•wj: —Õ°•wl‰ÈŽY‰È, 44(3): 209`213, 1990.
1534. muÀn ”å”AŠí‰È—̈æ‚̉摜f’f|‘O—§‘BŠà(2). “¡–ì’WlC΋´Wi”åj: —Õ°‰æ‘œ, 5(6): 94`99, 1989.
1535. muÀn ˜V”NŽÒ‚̉摜f’f|˜V”NŽÒ‚Ì”å”AŠíŽ¾Š³‚̉摜f’f. “¡–ì’WlC¬ŽÄŒ’i”åj: ˜V‰»‚ÆŽ¾Š³, 2(12): 2499`2505, 1989.
1536. mŠwp‘n iŽ·•Mj Diagnostic Ultrasound of the Prostate; Transrectal
Ultrasonography in the Diagnosis of Primary Transitional Cell Carcinoma
of the Prostate: A Case Report, p.157`161, “¡–ì’WlC΋´WC¬ŽÄŒ’i”åj. •ÒW Martin
Resnick (Case Western Univ.)•Ò, Elsevier, New York, 89.10.00”s.
1537. mŠwp‘n iŽ·•Mj ŽY•wl‰Èf—à Q & A; ‰–Ž_ƒŠƒgƒhƒŠƒ“‚ÌŽg‚¢•û, p.106`107, ¼“‡³”ŽiŽY•wj. •ÒW Šâ“c³°iŽœŒbˆã‘åj‘¼•Ò, ˜Z–@o”ÅŽÐ, “Œ‹ž, 89.00.00 ”s.
1538. mŠwp‘n iŽ·•Mj ŽY•wl‰Èf—à Q & A; ’ǘ^‘æ16†;Žq‹{‘ÌŠàŒŸf, p.1444`1445‚Ì3, ‘ –{”ŽsiŽY•wj. •ÒW Šâ“c³°iŽœŒbˆã‘åj‘¼•Ò, ˜Z–@o”ÅŽÐ, “Œ‹ž, 89.00.00 ”s.
1539. mŠwp‘n iŽ·•Mj ‚ª‚ñf—à Q & A; ‘æ12†, Žq‹{‘Ì‚ª‚ñ‚Ìf’f•û–@, p.952`955, ‘ –{”ŽsiŽY•wj. •ÒW ”Ñ’Ë‹I•¶C‘¼•Ò, ˜Z–@o”ÅŽÐ, “Œ‹ž, 89.00.00 ”s.
1540. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽY•wl‰ÈŽ¡—ÃŽwj; ƒŒ[ƒU[Ž¡—Ë@Ší, p.23`24, ‘ –{”ŽsiŽY•wj. •ÒW ¬–쳕Fi“Œ‘åjC•“c‰À•Fi“Œ—ˆã‘åj•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.06.01 ”s.
1541. mŠwp‘n iŽ·•Mj Drug TherapyƒRƒ“ƒpƒNƒgƒVƒŠ[ƒY(8)”D•w‚Ö‚Ì“Š–ò; oŽYŽž–ƒŒ‚Ì–â‘è“_, p.237`243, ¼“‡³”ŽiŽY•wj. ƒ~ƒNƒX, “Œ‹ž, 89.12.15 ”s.
1542. mŠw‰ïn i“Á•Êu‰‰j Žq‹{“à–Œ×–Ef‚ÌÅ‹ß‚Ì“®Œü. ‘ –{”ŽsiŽY•wj: ‘æ7‰ñ“ú–{—Õ°×–EŠw‰ï•ŸˆäŒ§Žx•”ŠwpW‰ï (90.03.17), •Ÿˆä.
1543. mŠw‰ïn i‹³ˆçu‰‰j Žq‹{‘Ì•”×–Ef‚ð‚ß‚®‚Á‚Ä. ã–V•qŽqiŽY•wj: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ï (89.09.30), ‰¡•l.
1544. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{“à–Œ×–Ef‚É‚¨‚¯‚é–Ɖu×–E‰»Šw‚̉ž—p|“Á‚Ƀzƒ‹ƒ‚ƒ“Žó—e‘̂ɂ‚¢‚Ä|.
‘å–ì‰pŽ¡i•a‰@•a—•”jC`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC
“ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 177, l989.
1545. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{‘ÌŠà‚É”º‚·‚é“à–Œ‘BÇ|Žq‹{‘ÌŠà‚ÆŽq‹{“à–Œ‘BÇ‚Ì‘gDŠw“I–â‘è“_|.
‘ –{”ŽsCã–V•qŽqC`GŽ÷C‘å‰ÍŒ´‘iŽY•wj: ‘æ18‰ñ“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Šw‰ï (89.07.28), “Œ‹žC ´˜^WCp.22,
1989.
1546. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{‘Ì•”‰ŠúŠà‚Ì×–Ef|Žq‹{Œz•”¥‘Ì•”‘BŠàA‚»‚̉Šú•a•Ï‚ð‚ß‚®‚Á‚Ä|. ‘ –{”ŽsiŽY•wj: ‘æ3‰ñ“ú–{—Õ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï (89.09.09), ¼–{C ƒvƒƒOƒ‰ƒ€Cp.17, 1989.
1547. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Œv‰æ–ƒŒ•ª•Ø‚̃ƒŠƒbƒg¥ƒfƒƒŠƒbƒg. ¼“‡³”ŽiŽY•wj: ‘æ30‰ñ“ú–{•ê«‰q¶Šw‰ï (89.10.27), “Œ‹ž, •ê«‰q¶, 30(4): 560, 1989.
1548. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{‘ÌŠàŒŸf‚ÌŽÀÛ‚Æ“W–]G‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€uŠàŒŸf‚ÌŽÀÛ‚Æ“W–]v. ‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€C1989.
1549. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Žq‹{“à–Œ‘BÇ‚Ì”»’èŠî€i‹³ˆçƒVƒ“ƒ|ƒWƒEƒ€j. ‘å–ì‰pŽ¡i•a‰@•a—•”jC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 606, 1989.
1550. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŒzŠÇ–DkpŽ{s—á‚Ì—¬‘ŽY‚ÉŠÖ‚·‚錟“¢. –ì“c–FlC’F‰pŽ÷CA–ìM…C’Jº”ŽCª–{‘‘ˆêC‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ266‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.02.17), ‰¡•l.
1551. mŠw‰ïn iƒpƒlƒ‹j ƒGƒXƒgƒƒQƒ“ŽY¶‚ðŽ¦‚µ‚½—‘‘ƒ—Þ“à–ŒŠà‚Ì1—á.
ŽRŒû“T—˜C‰º“c—²•vCã–V•qŽqC‘å‰ÍŒ´‘C²“¡—Ï–çC‘ –{”ŽsiŽY•wjCŠâŸºŒ[ˆêi•a—j: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï
(89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 636, 1989.
1552. mŠw‰ïn iƒpƒlƒ‹j ‘O—§‘BŽîᇃ}|ƒJ|‚Ì”Œ»‚ÉŠÖ‚·‚é•a—Šw“IŒ¤‹†. ²“¡giŒ`‘ÔŒnjCŒK”ö’èmC‹T’J“Oi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.31), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 144, 1990.
1553. mŠw‰ïn iƒpƒlƒ‹j ‘O—§‘BŒ´”¬×–EŠà‚Ì1–UŒŸ—á. ²“¡³Ž÷i“àjC‹àŽq‘C‚ˆä’qŽqCŒÃ’J–[Ž}CŠâŸºŒ[ˆêC‹T’J“OC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.3l), •Ÿ‰ª.
1554. mŠw‰ïn iƒpƒlƒ‹j ”ñZ«“ûŠÇŠà‚ÆZ«“ûŠÇŠà‚Ì×–EŠw“I”äŠrŒŸ“¢.
‘å–ì‚ß‚®‚ÝC‘å–ì‰pŽ¡i•a‰@•a—•”jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï i89.11.17),
‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 665, 1989.
1555. mŠw‰ïn iƒpƒlƒ‹j “û‘B‚̃Aƒ|ƒNƒŠƒ“Šà‚Ì1Ç—á. ˆäìˆç‘ãC‘å–ì‰pŽ¡i•a‰@•a—•”jC’|’†°KiŠOjC‘ –{”ŽsiŽY•wj:
‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïHŠú‘å‰ïŠwpu‰‰‰ï i89.11.17), ‰¡•l, “ú–{—Õ°×–EŠw‰ïŽGŽ, 28(5): 672, 1989.
1556. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Žq‹{“à–Œ×–Ef‚É‚æ‚é‘ÌŠà—\Œã”»’è|—\Œã‚©‚ç‚Ý‚½×–Ef|.
`GŽ÷C‘ –{”ŽsCã–V•qŽqC‘å‰ÍŒ´‘C‰º“c—²•vCVˆä³•viŽY•wjC‘å–ì‰pŽ¡C”\¨•x²ŽqCo‘º—TŽqi—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï
(89.06.16), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 184, l989.
1557. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Žq‹{“à–ŒŠà‚̃XƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“Š´Žó«‚Æ‚»‚Ìì—p‹@˜|×–E”|—{‚ƃzƒ‹ƒ‚ƒ“Œ¤‹†|.
`GŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vC‘ –{”ŽsiŽY•wj: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), ‰¡•lC
‘gD”|—{Œ¤‹†C8(1): 50, l989.
1558. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Effects of Estradiol, Hydroxytamoxifen and Growth
Factors on Proliferation of Human Endometrial Adenocarcinoma Cells in
Culture. ˆÀ¼Œ·iŽY•wjCHolinka, C.F.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åjC`GŽ÷iŽY•wjCMurphy,
L.J.iƒ}ƒjƒgƒo‘åjC‘ –{”ŽsiŽY•wjCGurpide, E.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åj: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29),
‰¡•lC ‘gD”|—{Œ¤‹†C8(1): 75, l989.
1559. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà‚É‚¨‚¯‚é“à–Œ‘BÇ‚ÆŠeŽí—\ŒãˆöŽq‚Ì‘ŠŠÖ.
‘å‰ÍŒ´‘Cã–V•qŽqC‘ –{”ŽsC“y‰®Œ³ˆêCŠp“cV•½C’†Œ´—DlCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03), ‰ªŽRC
“ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-120, l989.
1560. mŠw‰ïn iˆê”Êu‰‰j –Ɖu×–E‰»Šw–@‚É‚æ‚éŽq‹{‘ÌŠà×–EƒXƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“Žó—e‘̂ƃzƒ‹ƒ‚ƒ“‰ž“š”\‚Ì’è—Ê“I‰ðÍ.
`GŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jCŒË‰êè‹`–¾C‰–’Ép”VC—é–Ø^CVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï
(89.04.03), ‰ªŽRC “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-245, l989.
1561. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚ÌGlycogen‘ãŽÓ‚É‚¨‚æ‚Ú‚·ƒXƒeƒƒCƒhƒzƒ‹ƒ‚ƒ“‚̉e‹¿.
`˜aŽqC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03),
‰ªŽRC “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-441, l989.
1562. mŠw‰ïn iˆê”Êu‰‰j ƒ„ƒOƒŒ[ƒU[Eƒoƒ‹[ƒ“–@‚É‚æ‚éŽq‹{o“àŽ¡—Âւ̎Ž‚Ý.
˜e“c–M•vCò‹M•¶C²X–Ø‹I[CçÝŽ–«Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.04), ‰ªŽRC
“ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽC41(Suppl.): S-324, l989.
1563. mŠw‰ïn iˆê”Êu‰‰j Development of Monoclonal Antibody to Gamma
Seminoprotein and its Application for Immunohistochemical Study in
Prostatic Tissue. “¡–ì’Wli”åjCŒK”ö’èmi•a—jC΋´WC¬ŽÄŒ’i”åj: AUA Eighty Fourth Annual
Meeting (89.05.07`11), ƒ_ƒ‰ƒX.
1564. mŠw‰ïn iˆê”Êu‰‰j The Effect of Transurethral Prostatic Resection on
the Serum Gamma Seminoprotein Level. “¡–ì’WlC–؋`˜aC‘ºŽR‰ëˆêCˆÉ“¡‹ÏC¬ŽÄŒ’i”åj: AUA
Eighty Fourth Annual Meeting (89.05.07`11), ƒ_ƒ‰ƒX.
1565. mŠw‰ïn iˆê”Êu‰‰j ƒk[ƒhƒ}ƒEƒXˆÚAƒqƒgŽq‹{‘ÌŠà‚̃XƒeƒƒCƒh”½‰ž«.
‰Á“¡—ÇŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CX‘òFsiŽY•wj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï‘‰ï (89.06.01), “Œ‹ž,
“ú–{“à•ª”åŠw‰ïŽGŽ, 65(4): 243, 1989.
1566. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚̃OƒŠƒR[ƒQƒ“‘ãŽÓ‚É‚¨‚¯‚éƒvƒƒQƒXƒ`ƒ“‚ÆEGF‚Ìì—p.
`˜aŽqC‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•viŽY•wj: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï‘‰ï (89.06.02), “Œ‹ž,
“ú–{“à•ª”åŠw‰ïŽGŽ, 65(4): 368, 1989.
1567. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ—Þ’†tŠà‚É‚¨‚¯‚é×–E‘œ‚Ìוª—Þ‚ÆŠjŒv‘ª.
“y‰®Œ³ˆêCã–V•qŽqC˜e“c–M•vC—Ñ—æŽqC‹–ØM”VC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15), “Œ‹žC
“ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 159, l989.
1568. mŠw‰ïn iˆê”Êu‰‰j ‰ŠúŽq‹{‘ÌŠà‚Ì×–E‘œ|“Á‚É‹Ø‘w”ñZŠà‚Ì×–EŠŒ©‚ɂ‚¢‚Ä|.
X‘òFsC‘ –{”ŽsCã–V•qŽqC—Ñ—æŽqC‘å‰ÍŒ´‘C‰Á“¡—ÇŽ÷iŽY•wjC‘å–ì‰pŽ¡i—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15),
“Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 195, l989.
1569. mŠw‰ïn iˆê”Êu‰‰j ŠjŒv‘ª‚É‚æ‚émixed Mullerian tumor‚ÌŒŸ“¢.
ò‹M•¶C‰º“c—²•vC‘ –{”ŽsC—Ñ—æŽqC˜e“c–M•viŽY•wjC‘å–ì‰pŽ¡C‘å–ì‚ß‚®‚Ýi—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.15),
“Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 199, l989.
1570. mŠw‰ïn iˆê”Êu‰‰j Žq‹{“à–Œ×–Ef‹U‰A«—á‚ÌŒŸ“¢.
‘å‰ÍŒ´‘Cã–V•qŽqC‘ –{”ŽsCX‘òFsCŠp“cV•½CVˆä³•viŽY•wjC‘å–ì‰pŽ¡C¡ˆä’‰˜Ni—ÕŒŸj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï
(89.06.15), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 206, l989.
1571. mŠw‰ïn iˆê”Êu‰‰j Œz•”‘BŠà‚Ìf’fŠm’è‘O‚Ì×–E‘œ‚ÌŒŸ“¢. Šp“cV•½Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ30‰ñ“ú–{—Õ°×–EŠw‰ï‘‰ï (89.06.16), “Œ‹žC “ú–{—Õ°×–EŠw‰ïŽGŽC28(2): 149, l989.
1572. mŠw‰ïn iˆê”Êu‰‰j Œv‰æ–ƒŒ•ª•Ø‚É‚æ‚霔ՈʊǗ¬Ñ|•ª•ØŒo‰ß‚ɂ‚¢‚Ä|.
–ì“c–FlC’F‰pŽ÷C’Jº”ŽCA–ìM…C—é–Ø^C‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï
(89.06.18), “Œ‹ž.
1573. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ–¢nŠïŒ`Žî‚Ì2—á.
Šâ’JO–¾C‰º“c—²•vC‘å‰ÍŒ´‘C–ì“c–FlC•{•s“ñ’jCŽRŒû“T—˜Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj:
‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 60,
l989.
1574. mŠw‰ïn iˆê”Êu‰‰j Žq‹{ŒzŠà‚ÌŽ¡—ìÑ. ‘ –{”ŽsCã–V•qŽqC˜e“c–M•vC‰º“c—²•vCŠp“cV•½CVˆä³•viŽY•wj:
‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 98,
l989.
1575. mŠw‰ïn iˆê”Êu‰‰j Ä”Žq‹{ŒzŠà‚ɑ΂·‚鉻Šw—Ö@‚ÌŒŸ“¢.
Šp“cV•½Cã–V•qŽqC‘ –{”ŽsC`GŽ÷C‰º“c—²•vC’Òˆä“ÄCVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï
(89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 99`100, l989.
1576. mŠw‰ïn iˆê”Êu‰‰j 50Ζ¢–ž‚Ì‘ÌŠàŠ³ŽÒ‚Ì‘‰ÁŒXŒü‚Æ‚»‚Ì“Á’¥‚ɂ‚¢‚Ä.
‘å‰ÍŒ´‘C‘ –{”ŽsCã–V•qŽqC‰º“c—²•vCŽRŒû“T—˜CVˆä³•viŽY•wj: ‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18),
“Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 100`101, l989.
1577. mŠw‰ïn iˆê”Êu‰‰j ’Ê‹CŒŸ¸AŽq‹{—‘ŠÇ‘¢‰eŽ{s—á‚É‚¨‚¯‚é• o‹¾ŠŒ©‚ÌŒŸ“¢.
Îì‰ëˆêC—é–Ø^C”Ñ–ì÷“ñC’†‹Œõ¶CVˆä³•viŽY•wjCì“à”ŽlC‹ß“¡M—²CŽO’JmC‚‹´³•qi‘å˜aŽs—§•a‰@j:
‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹žC “ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñC(50): 106,
l989.
1578. mŠw‰ïn iˆê”Êu‰‰j Effects of Serine and Glycine on Proliferation of
Human Endometrial Adenocarcinoma Cells (Ishikawa) in Serum-free Media.
“n•ÓƒCˆÀ¼Œ·iŽY•wjCHolinka, C.F.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åjC‘ –{”ŽsiŽY•wjCGurpide, E.iƒ}ƒEƒ“ƒgƒTƒCƒiƒC‘åj:
‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.30), ‰¡•lC ‘gD”|—{Œ¤‹†C8(1): 101, l989.
1579. mŠw‰ïn iˆê”Êu‰‰j ŋߌoŒ±‚µ‚½‘Šú”Ç‚ÌdÇ”DP’†“ÅÇ‚Ì2—á.
Šâ’JO–¾C–ì“c–FlC—§‰ª˜aOC¯“c—²CA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ261‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï
(89.07.08), ¬“cŒ´.
1580. mŠw‰ïn iˆê”Êu‰‰j _Œo•Û‘¶äNã÷‘O—§‘B‘S“Eœp‚Ì1—á|ƒŠƒWƒXƒLƒƒƒ“‚É‚æ‚épŒã‚Ì•]‰¿|.
ŠÑˆä•¶•FC‰ª–{dâXC‰i“cŠ²’ji”åjC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jC{ŽRˆê•äi”åjCŽÖ‘ò»i•a—j: ‘æ464‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï
(89.07.13), “Œ‹ž, “ú–{”å”AŠí‰ÈŠw‰ïŽGŽ, 81(1): 146, 1990.
1581. mŠw‰ïn iˆê”Êu‰‰j ƒNƒƒ~ƒtƒFƒ“”r—‘ŒQ‚ÆŽ©‘R”r—‘ŒQ‚É‚¨‚¯‚é”DP‘Šú‚Ì•ê‘ÌŒŒ’†ƒzƒ‹ƒ‚ƒ“’l‚ÌŒŸ“¢.
Îì‰ëˆêC•{•s“ñ’jC’†‹Œõ¶iŽY•wjCì“à”Žli‘å˜aŽs—§•a‰@jC¬“c؇Žqi‰Á”[Šâ•a‰@j: ‘æ7‰ñ“ú–{Žó¸’…°Šw‰ïŠwpu‰‰‰ï
(89.07.16), •Ÿˆä.
1582. mŠw‰ïn iˆê”Êu‰‰j Žq‹{Œz•”Žîᇂɑ΂·‚郌[ƒU[—Ö@‚Æ‚»‚ÌŒã‚Ì”DP—á.
ò‹M•¶C˜e“c–M•vC²X–Ø‹I[C‘ –{”ŽsC“‡“cMGiŽY•wj: ‘æ18‰ñ“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Šw‰ï (89.07.29), “Œ‹ž,
“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Ž, 7(2): 207, 1989.
1583. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠàFIGOV¥‹Œ•ª—Þ‚Ì”äŠr.
ã–V•qŽqC‘å‰ÍŒ´‘C‘ –{”ŽsC`GŽ÷C‰º“c—²•vCŠp“cV•½C’Òˆä“ÄiŽY•wj: ‘æ18‰ñ“ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Šw‰ï (89.07.29),
“Œ‹ž, “ú–{•wl‰È¥•a—¥ƒRƒ‹ƒ|Ž, 7(2): 209`210, 1989.
1584. mŠw‰ïn iˆê”Êu‰‰j —‘ŠÇ«•s”D‚ɑ΂·‚éƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[‚¨‚æ‚ÑpŒã‘Šúsecond-look
laparoscopy‚É‚æ‚鎡—Âɂ‚¢‚Ä. ì“à”ŽlCŽO’JmC‹ß“¡M—²C‚‹´³•qCÎì‰ëˆêC’†‹Œõ¶iŽY•wj:
‘æ12‰ñŽY•wl‰Èƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ï (89.08.03), ŽŽ™“‡.
1585. mŠw‰ïn iˆê”Êu‰‰j • o‹¾‚ÅŠm’èf’f‚𓾂½Rokitansky-Kuster-HauserÇŒóŒQ‚Ì1—á.
Îì‰ëˆêC’†‹Œõ¶iŽY•wjCì“à”Žli‘å˜aŽs—§•a‰@j: ‘æ29‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŠwpu‰‰‰ï (89.08.04), ŽŽ™“‡.
1586. mŠw‰ïn iˆê”Êu‰‰j ƒqƒXƒeƒƒtƒ@ƒCƒo[ƒXƒR[ƒv‚ð—p‚¢‚½ƒŒ[ƒU[—Ö@‚ÌŽŽ‚Ý.
˜e“c–M•vCò‹M•¶C²X–Ø‹I[CçÝŽ–«Cã–V•qŽqC‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ29‰ñ“ú–{ŽY‰È•wl‰È“àŽ‹‹¾Šw‰ïŠwpu‰‰‰ï
(89.08.05), ŽŽ™“‡C ´˜^WCp.41.
1587. mŠw‰ïn iˆê”Êu‰‰j • o‹¾Ž{s—á‚É‚¨‚¯‚éŽq‹{—‘ŠÇ‘¢‰eŠŒ©‚ÌŒŸ“¢|…«¥–û«‘¢‰eÜ‚Ì”äŠr.
ì“à”ŽlCŽO’JmC‹ß“¡M—²C‚‹´³•qCÎì‰ëˆêC’†‹Œõ¶C”Ñ–ì÷“ñiŽY•wj: ‘æ34‰ñ“ú–{•s”DŠw‰ïŠwpu‰‰‰ï (89.09.02), ˆ®ì,
“ú–{•s”DŠw‰ïŽGŽ, 34(3): 685, 1989.
1588. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ“ƒhƒƒQƒ“‰ßè«”r—‘áŠQ—á‚Ì—Õ°“IŒŸ“¢.
Îì‰ëˆêCçÝŽ–«C•{•s“ñ’jC’†‹Œõ¶Cì“à”ŽlC”Ñ–ì÷“ñiŽY•wj: ‘æ34‰ñ“ú–{•s”DŠw‰ïŠwpu‰‰‰ï (89.09.03), ˆ®ì,
“ú–{•s”DŠw‰ïŽGŽ, 34(3): 603, 1989.
1589. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ–¢•ª‰»ãó×–EŽî‚Ì1—á. —§‰ª˜aOCã–V•qŽqCò‹M•¶C`GŽ÷C‘ –{”ŽsiŽY•wj: ‘æ3‰ñ“ú–{—Õ°×–EŠw‰ïŠÖ“Œ˜A‡‰ïŠwpW‰ï (89.09.09), ¼–{C ƒvƒƒOƒ‰ƒ€Cp.7`8, 1989.
1590. mŠw‰ïn iˆê”Êu‰‰j Œ´”«äNã÷ƒAƒ~ƒƒCƒh[ƒVƒX‚Ì1—á. ‘v¬_C“à“c–LºC’†ðO—²CŒàŠ²ƒCr–ØrsC‘ˆä‘¥ºC‰¡ŽR‰p“ñC^‰ºß•vC΋´WC¬ŽÄŒ’i”åj: ‘æ465‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.09.21), “Œ‹ž.
1591. mŠw‰ïn iˆê”Êu‰‰j Lysis of Adhesions at Second-look Laparoscopy
Following Reconstructive Pelvic Surgery.
ì“à”ŽlCŽO’JmC‹ß“¡M—²C‚‹´³•qCÎì‰ëˆêi‘å˜aŽs—§•a‰@jC”Ñ–ì÷“ñC’†‹Œõ¶iŽY•wj: World Congress of
Gynecologic Endoscopy (89.09.22), Washington, D.C.
1592. mŠw‰ïn iˆê”Êu‰‰j Žq‹{Œz•”‘BˆÙŒ^×–E‚ª”F‚ß‚ç‚êf’f‚É‹ê—¶‚µ‚½1—á.
‰Í‘ºŸ{ŽqCÂŽR—ÑìC“n•Óƒ}ƒŠC–¥—Ö®Žqiì肪‚ñŒŸfƒZƒ“ƒ^[jCâ–{ˆÉ“¤”üiŽY•wjC‹g“c’å—˜iì肪‚ñƒZƒ“ƒ^[jCX‘òFsiŽY•wjC‰ª“‡OKi_
“Þ삪‚ñƒZƒ“ƒ^[jC‘ –{”ŽsiŽY•wjC“V_”ü•viˆÇ‰_“°•a‰@j: ‘æ8‰ñ“ú–{—Õ°×–EŠw‰ï_“Þ쌧Žx•”’n•û‰ï (89.09.30), ‰¡•lC
´˜^WCp.10, 1989.
1593. mŠw‰ïn iˆê”Êu‰‰j
RƒÁ-seminoproteinƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚É‚æ‚é–Ɖu‘gD‰»Šw“IŒŸ“¢i‘æ3•ñj‘O—§‘BŠà“]ˆÚ‘ƒA‘O—§‘B‚Ì”ñ‘BŠà‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
ŒüˆäLÆC“¡–ì’WlC‰F“s‹{‘ñŽ¡C’†ðO—²C‘ºŽR‰ëˆêC‹PºC‰¡ŽR‰p“ñC‰““¡’‰—YC΋´Wi”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï
(89.10.06), “Œ‹ž.
1594. mŠw‰ïn iˆê”Êu‰‰j ESWL‚É‚æ‚é”AŠÇŒ‹Î‚ÌŽ¡—ÃA“àŽ‹‹¾Žèp•¹—pÇ—á‚ÌŒŸ“¢. ‹v•Û¯ˆêCΓc—T‘¥CrìFC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.
1595. mŠw‰ïn iˆê”Êu‰‰j Œã• –ŒŒ´”‘ÙŽ™«Šà‚Ì1—á. –{“c’¼NCŒÃ”¨½”VCŒàŠ²ƒC¬—ÑŒ’ˆêC^‰ºß•vC΋´WC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.
1596. mŠw‰ïn iˆê”Êu‰‰j ”A“¹Œ`¬pŒã‚Ì”AŽ¸‹Ö‚ɑ΂µ‚Ä”A“¹UŽq•”‚ÉlH”A“¹Š‡–ñ‹ØAMS800‚ðÝ’u‚µ‚ÄŽ¡—µ‚¦‚½1—á.
“¡–ì’WlCÝŠy•q–çC{ŽRo•äC‘v¬_C‘å–x—C‰¡ŽR‰p“ñC^‰ºß•vC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06),
“Œ‹ž.
1597. mŠw‰ïn iˆê”Êu‰‰j tŠà‚Ì’·ŠúÄ”‚ð”F‚ß‚½3—á. {ŽRˆê•äC‰ª–{dâXC‰i“cŠ²’jCŠÑˆä•¶•Fi”åjC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jCŽÖ‘ò»CÄ–Ø–ÎŽ÷i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.
1598. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŒã‹‘┽‰ž‚ɑ΂·‚éOKT-3‚Ì—LŒø«‚Æ•›ì—p‚ɂ‚¢‚Ä. “ü]Œ[C‰¡“c^“ñCŒF–ì˜a—YC^‰ºß•vC‰““¡’‰—YC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.
1599. mŠw‰ïn iˆê”Êu‰‰j Coexistence of Hyperplasia to Endometrial Carcinoma.
ã–V•qŽqC‘ –{”ŽsC‘å‰ÍŒ´‘C`GŽ÷CVˆä³•viŽY•wj: 2nd Meeting of the International
Gynecologic Cancer Society (89.10.09), Toronto, Abstracts, p.220, 1989.
1600. mŠw‰ïn iˆê”Êu‰‰j Alteration of the Treatment for Early Carcinoma of
the Cervix. ‘ –{”ŽsCã–V•qŽqC˜e“c–M•vC‰º“c—²•vC—Ñ—æŽqCVˆä³•viŽY•wj: 2nd Meeting of the
International Gynecologic Cancer Society (89.10.09), Toronto,
Abstracts, p.255, 1989.
1601. mŠw‰ïn iˆê”Êu‰‰j Œo’¼’°“I’´‰¹”g’f‘w–@‚ª—L—p‚Å‚ ‚Á‚½ƒ~ƒ…[ƒ‰[ŠÇ”X–E‚Ì1—á. ŒüˆäLÆC‘å–x—CŒàŠ²ƒC“¡–ì’WlC΋´Wi”åj: ‘æ55‰ñ“ú–{’´‰¹”gˆãŠw‰ï (89.10.19), •Ÿ‰ª.
1602. mŠw‰ïn iˆê”Êu‰‰j •ª•Ø’†‚Ìvariable decelerationoŒ»—vˆö‚ÉŠÖ‚·‚錟“¢.
A–ìM…Cª–{‘‘ˆêC’Jº”ŽC–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ12‰ñŽY‰È•wl‰ÈME§˜b‰ï (89.10.20),
‘åã.
1603. mŠw‰ïn iˆê”Êu‰‰j Žq‹{Œz•”¬×–EŠà”|—{Š”(HCSC-1)‚É‚¨‚¯‚é_Œo“à•ª”åƒ}[ƒJ[‚Ì•ª”å’²ß.
‰º“c—²•vC‘ –{”ŽsC‰Á“¡—ÇŽ÷C`GŽ÷C`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïH‹GŠwp‘å‰ï (89.10.20),
ŽD–y, “ú–{“à•ª”åŠw‰ïŽ, 65(9): 883, 1989.
1604. mŠw‰ïn iˆê”Êu‰‰j EDAP LT-01‚É‚æ‚é”AŠÇŒ‹Î130—á‚ÌŽ¡—ÃŒoŒ±. ‰F“s‹{‘ñŽ¡Cìã’B‰›C_è—TC–å˜e˜abC^‰ºß•vi”åj: ‘æ41‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï (89.10.20`22), ’·è.
1605. mŠw‰ïn iˆê”Êu‰‰j ‘O—§‘BŠà‚ðŠÜ‚Þd•¡ˆ««Žîᇊ³ŽÒ‚̶–½—\Œã‚ÌŒŸ“¢.
‘ò‘º³”VCó–ì—F•FC¬“c“‡–M’jC’·‘q˜a•FC‰Æ“c˜a•vC‘ºˆäŸC’†‘ºGi”åj: ‘æ41‰ñ“ú–{”å”AŠí‰ÈŠw‰ï¼“ú–{‘‰ï (89.10.20`22),
’·è, —\eW, p.47, 1989.
1606. mŠw‰ïn iˆê”Êu‰‰j tƒVƒ“ƒ`ƒOƒ‰ƒ€‚É‚¨‚¯‚é123I-OIH‚Æ131I-OIH‚Ì—Õ°“I”äŠr.
ŒàŠ²ƒC“¡–ì’WlC΋´Wi”åjCΈ䟌ÈC’†‘òŒ\Ž¡CˆË“cˆêdi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï (89.10.21), ‘å’Ã, ŠjˆãŠw,
26: 1086, 1989.
1607. mŠw‰ïn iˆê”Êu‰‰j Effects of Oral Prostaglandin E2, Laminaria, and
their Combination as the Means for Preinduction Priming in Electively
Induced Labors. ¼“‡³”ŽC–ì“c–FlC‹ªˆüC ’F‰pŽ÷C‹gŒ´ˆêC“‡“cMGiŽY•wj: The 2nd World
Symposium: Computers in the Care of the Mother, Fetus and Newborn
(89.10.24), ‹ž“s, J. Perinat. Med., 17(Suppl.): 112, 1989.
1608. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–E‚̃OƒŠƒR[ƒQƒ“‘ãŽÓ‚ɑ΂·‚鉩‘̃zƒ‹ƒ‚ƒ“ì—p‚̉ðÍ.
`˜aŽqC‘ –{”ŽsC`GŽ÷iŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vC“n•ÓƒiŽY•wj: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.24),
–¼ŒÃ‰®, ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.182, 1989.
1609. mŠw‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠà×–EEGFŽó—e‘̂̉ðÍ.
`GŽ÷C‘ –{”ŽsC`˜aŽqiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC‰º“c—²•vCŒË‰êè‹`–¾iŽY•wj: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.25),
–¼ŒÃ‰®, ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.190, 1989.
1610. mŠw‰ïn iˆê”Êu‰‰j “à–Œ‘BÇ‚ð‡•¹‚·‚é‘ÌŠà‚Ì‘‰ÁŒXŒü‚ɂ‚¢‚Ä.
‘å‰ÍŒ´‘C‘ –{”ŽsCã–V•qŽqC`GŽ÷CŠp“cV•½CŽRŒû“T—˜CVˆä³•viŽY•wj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.25), –¼ŒÃ‰®,
“ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 1930, 1989; 25(2): 232, 1990.
1611. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éŽq‹{ŒzŠà‚ÌŽ¡—ìÑ.
Šp“cV•½C‘ –{”ŽsCã–V•qŽqC`GŽ÷C‰º“c—²•vC—Ñ—æŽqCª–{—æŽqCVˆä³•viŽY•wj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.27),
–¼ŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 2131, 1989; 25(2): 416, 1990.
1612. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒŠàSecond look operation‚̬Ñ.
’Òˆä“ÄCã–V•qŽqC‰º“c—²•vC˜e“c–M•vCçÝŽ–«C‘ –{”ŽsCVˆä³•viŽY•wj: ‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.27), –¼ŒÃ‰®,
“ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 2139, 1989; 25(2): 424, 1990.
1613. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒŠà‰»Šw—Ö@‚ÌŒø‰Ê”»’è‚É‚¨‚¯‚éŽîᇃ}[ƒJ[CA125‚̈Ӌ`‚ÉŠÖ‚·‚éŠî‘b“IŒŸ“¢.
”Ñ“c’q”Ži¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åjC`GŽ÷C‰º“c—²•vC‘ –{”ŽsCVˆä³•viŽY•wjC—јa•FC•l“cGi¹ƒ}ƒŠƒAƒ“ƒiˆã‰È‘åj:
‘æ27‰ñ“ú–{ŠàŽ¡—Êw‰ï‘‰ï (89.10.27), –¼ŒÃ‰®, “ú–{ŠàŽ¡—Êw‰ïŽGŽ, 24(9°2): 2215, 1989; 25(2):
496, 1990.
1614. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éITP‡•¹”DP¥•ª•Ø‚ÌŒŸ“¢. ¯“c—²C–ì“c–FlCA–ìM…Cª–{‘‘ˆêC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.
1615. mŠw‰ïn iˆê”Êu‰‰j ³í”D•w‚Ì•ê‘ÌŒŒ‚Æä`‘ÑŒŒ‚̃wƒpƒvƒ‰ƒXƒ`ƒ“ƒeƒXƒg‚ÌŠÖŒW‹y‚уrƒ^ƒ~ƒ“K2ŒoŒû“Š—^‚̉e‹¿‚ɂ‚¢‚Ä.
Šâ’JO–¾C–ì“c–FlCA–ìM…C’Jº”ŽC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï
(89.10.29), ‘å‹{.
1616. mŠw‰ïn iˆê”Êu‰‰j —‘ŠÇŠà6—á‚Ì—Õ°•a—Šw“IŒŸ“¢. ‹v“ˆ‘¥sCã–V•qŽqC‘O“c@“¿C’†Œ´—DlC‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€CNo.110, 1989.
1617. mŠw‰ïn iˆê”Êu‰‰j Žq‹{ŒzŠàS”X“]ˆÚ—á‚Ì—Õ°•a—Šw“IŒŸ“¢.
â–{ˆÉ“¤”üCã–V•qŽqC‰º“c—²•vC‘å‰ÍŒ´‘CŠp“cV•½CŽRŒû“T—˜C‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï
(89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€CNo.27, 1989.
1618. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒ—Þ’†tŠà‚Ì—Õ°•a—Šw“IŒŸ“¢.
“y‰®Œ³ˆêCã–V•qŽqC`GŽ÷C’Òˆä“ÄCŠâ’JO–¾C¡ˆä‰ë•vC‹–ØM”VC‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï
(89.10.29), ‘å‹{C ƒvƒƒOƒ‰ƒ€CNo.47, 1989.
1619. mŠw‰ïn iˆê”Êu‰‰j MRI‚É‚¨‚¯‚éŽq‹{‘ÌŠà‚Ìis“x”»’è.
ŽRŒû“T—˜C‘å‰ÍŒ´‘C`GŽ÷C‰º“c—²•vCã–V•qŽqC¡ˆä‰ë•vC‘ –{”ŽsiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï
(89.10.29), ‘å‹{C ´˜^WCNo.30, 1989.
1620. mŠw‰ïn iˆê”Êu‰‰j The Pregnancy after Laser Therapy for the Treatment
of Uterine Cervical Neoplasia. ˜e“c–M•vCò‹M•¶C‘ –{”ŽsC²X–Ø‹I[C“‡“cMGiŽY•wj: 8th
Congress of the International Society for Laser Medicine and Surgery
(89.11.05), Taipei, Surgical and Medical Lasers, 2(2-3): 139, 1989.
1621. mŠw‰ïn iˆê”Êu‰‰j Trial of Laser Hysteroscopy. ò‹M•¶C˜e“c–M•vC²X–Ø‹I[C‘ –{”ŽsiŽY•wj:
8th Congress of the International Society for Laser Medicine and
Surgery (89.11.05), Taipei, Surgical and Medical Lasers, 2(2-3): 141,
1989.
1622. mŠw‰ïn iˆê”Êu‰‰j Žq‹{“à–ŒŸ÷‰t«‘BŠà‚Ì×–EŠŒ©. —§‰ª˜aOCã–V•qŽqC`GŽ÷CçÝŽ–«C—Ñ—æŽqC‘ –{”ŽsC‰Á“¡—ÇŽ÷iŽY•wj:
‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 623, 1989.
1623. mŠw‰ïn iˆê”Êu‰‰j Žq‹{“à–Œ×–Ef‚Å„’肵“¾‚½Žq‹{“à–ŒŠÔŽ¿“÷Žî‚Ì1—á.
ã•Ð•½º“ñCã–V•qŽqCŽÂŒ´—m‰îC˜e“c–M•vC’Òˆä“ÄC¡ˆä‰ë•vC‘ –{”ŽsiŽY•wj: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï (89.11.16),
‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 629, 1989.
1624. mŠw‰ïn iˆê”Êu‰‰j ƒTƒCƒgƒuƒ‰ƒVÌŽæ‚É‚æ‚éŽq‹{ŒzŠÇ×–Ef.
—Ñ—æŽqC‘ –{”ŽsCã–V•qŽqCò‹M•¶CŠp“cV•½CŠâ’JO–¾Câ–{ˆÉ“¤”üiŽY•wjC‘å–ì‰pŽ¡C‰¡ŽR‘åi•a‰@•a—•”j: ‘æ28‰ñ“ú–{—Õ°×–EŠw‰ïH‹G‘å‰ï
(89.11.16), ‰¡•l, “ú–{—Õ°×–EŽ, 28(5): 642, 1989.
1625. mŠw‰ïn iˆê”Êu‰‰j d–ŒŠO–ƒŒ•ª•Ø‚Ì•ª•Ø—\Œã‚ÉŠÖ‚·‚錟“¢. A–ìM…C—§‰ª˜aOC–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ264‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (89.12.16), ‰¡•l.
1626. mŠw‰ïn iˆê”Êu‰‰j ãO–ÑŠà‚Æ—‘‘ƒ—Þ’†tŠà‚ª“¯Žžd•¡‚µ‚½1—á. ²“¡—Ï–çCã–V•qŽqCŠp“cV•½C`GŽ÷Cª–{—æŽqC‰º“c—²•vC‘ –{”ŽsC“cŒû–¾iŽY•wj: ‘æ265‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.01.20), ‰¡•l.
1627. mŠw‰ïn iˆê”Êu‰‰j ”DP’†Šú‚É‹}«• Ç‚Ì‚½‚ßtermination‚ðs‚Á‚½1—á. ¯“c—²C’Jº”ŽC–ì“c–FlCª–{—æŽqC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ266‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.02.17), ‰¡•l.
1628. mŠw‰ïn iˆê”Êu‰‰j —‘‘ƒŠàŽ¡—ÃŒã‚Ì”DP¥oŽY—á. Šâ’JO–¾Cò‹M•¶C’Òˆä“ÄCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ267‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (90.03.17), ‰¡•l.
1629. mŠw‰ïn iˆê”Êu‰‰j ¸Žq•úo‰ß’ö‚É‚¨‚¯‚é Ectoplasmic specialization ‚̕ω».
ŽðˆäNOCŽR‰È³•½i‰ðj: ‘æ94‰ñ“ú–{‰ð–UŠw‰ï‘‰ï i89.04.03), ‹{è, ‰ð–UŠwŽGŽ, 64(4): 204, 1989.
1630. mŠw‰ïn iˆê”Êu‰‰j ¸Žq•úo‹y‚Ñ×–EŽ¿ˆâŽc‚ÌŽæ‚螂݉ߒö‚É‚¨‚¯‚é Ectoplasmic specialization
‚Ì“®‘Ô. ŽðˆäNOCŽR‰È³•½i‰ðj: ‘æ22‰ñ“ú–{”¶¶•¨Šw‰ï i89.06.22), ŽD–y, —\eW, p.75, l989.
1631. mŠw‰ïn iˆê”Êu‰‰j “€Œ‹Š„’f–@‚É‚æ‚é¸ã”ç×–EŠj‚Ì—§‘ÌŠÏŽ@. ’†–{’¼i‰ðj: ‘æ22‰ñ“ú–{”¶¶•¨Šw‰ï i89.06.23), ŽD–y, Develop. Growth & Differ., 31(4): 416, l989.
1632. mŒ¤‹†‰ïn i“Á•Êu‰‰j Ø”—‘ŽY¥‘OŠú”j…. ¼“‡³”ŽiŽY•wj: ‰¡{‰êŽsŽY•wl‰Èˆã‰ï (89.07.12), ‰¡{‰ê.
1633. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‰»Šw—Ö@Ü‚Ì‘O—§‘B‘gD“à•ª•z‚ÌŒŸ“¢. ’r“cŽ C¼‘º´ŽuC΋´Wi”åj: ‘æ1‰ñ‘O—§‘B‰ŠƒVƒ“ƒ|ƒWƒEƒ€ (89.08.26), “Œ‹ž.
1634. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‚—îŽÒ‚É‚¨‚¯‚éŽq‹{‘Ì‚ª‚ñŒŸf‚Ì–â‘è“_G‚—îŽÒŽq‹{‚ª‚ñŒŸf‚Ì”–â‘è. ‘ –{”ŽsiŽY•wj: ‘æ20‰ñ•wl‰ÈW’cŒŸfƒVƒ“ƒ|ƒWƒEƒ€ (89.11.18), “Œ‹žC ‹L˜^WCp.10`11, 1989.
1635. mŒ¤‹†‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ƒGƒXƒgƒƒQƒ“‚ÆŽq‹{‘ÌŠàGX”NŠú‚Ì–ò•¨—Ö@. ‘ –{”ŽsiŽY•wj: X”NŠúˆãŠwŒ¤‹†‰ï‘æ4‰ñŠwpW‰ï (89.11.26), “Œ‹žC —vŽ|WCp.3`4, 1989.
1636. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒŒ[ƒU[Ž¡—Â̌»‹µ|ƒAƒƒŠƒJ‚ÌŽ{Ý‚ÌŒ»‹µ|. ˜e“c–M•viŽY•wj: ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï (89.06.21), ‘Š–ÍŒ´.
1637. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘O—§‘B”ì‘åÇpŒã‚Ì‘O—§‘BŠà‚ɂ‚¢‚Ä. ‰i“cŠ²’jC‰ª–{dâXCŠÑˆä•¶•Fi”åjC“¡–{‹±Žmi¹˜H‰Á‘Û•a‰@jC{ŽRˆê•äi”åj: ‘æ6‰ñ_“Þì‘O—§‘BŽîᇌ¤‹†‰ï (89.07.08), ‰¡•l.
1638. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘ŠúŽq‹{‘ÌŠà‚Ì×–Ef’f. ‘ –{”ŽsCX‘òFsCã–V•qŽqiŽY•wj: Œú¶È‘΂ª‚ñí—ªŒ¤‹†Ž–‹Æu‚ª‚ñ‚Ì“ñŽŸ—\–h‚ÌŒø‰Ê“I‚ÈŽÀŽ{‚É‚¨‚¯‚éŠî‘b“I‚ÈŒ¤‹†vi“V_”Çj”ljï‹c (89.07.18).
1639. mŒ¤‹†‰ïn iˆê”Êu‰‰j Žq‹{‘ÌŠàISHIKAWAŠ”‚̃k[ƒhƒ}ƒEƒXˆÚAŽîᇂɂ¨‚¯‚éƒzƒ‹ƒ‚ƒ“”½‰ž«.
‰Á“¡—ÇŽ÷C‘ –{”ŽsiŽY•wjC•l–ì”üŒbŽqi‘gD”|—{ƒZƒ“jC`GŽ÷CX‘òFsC‰º“c—²•viŽY•wj: ‘æ7‰ñƒqƒg×–EŒ¤‹†‰ï‘å‰ï (89.08.29),
“Œ‹ž, Human Cell, 2(3-Suppl.): 32, 1989.
1640. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ä”—‘‘ƒŠà‚ɑ΂·‚éPE—Ö@. ŽR“c“T—˜C‰º“c—²•vCŠp“cV•½C²“¡—Ï–çCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ2‰ñ_“ÞìŽY•wl‰ÈŽîᇌ¤‹†‰ï (89.09.29), ‰¡•l.
1641. mŒ¤‹†‰ïn iˆê”Êu‰‰j p‘O‰»Šw—Ö@Ž{s—á‚ÌCA125, CA19-9‚Ì„ˆÚ‚Æ“Eo•W–{‚Ì•a—ŠŒ©‚ÉŠÖ‚·‚錟“¢.
’Òˆä“ÄCã–V•qŽqC`GŽ÷CŠp“cV•½C‘å‰ÍŒ´‘C‰º“c—²•vC‘ –{”ŽsiŽY•wj: “ú–{•wl‰Èˆ««Žîᇉ»Šw—Ö@Œ¤‹†‰ï‘æ2‰ñŠwpW‰ï
(89.11.11), “Œ‹ž, ´˜^WCp.40, 1989.
1642. mŒ¤‹†‰ïn iˆê”Êu‰‰j •wl‰Èˆ««Žîᇂɑ΂·‚éCDDP-THP-CPA—Ö@‚Ì•›ì—p‚ÉŠÖ‚·‚錟“¢.
çÝŽ–«C‰º“c—²•vC¡ˆä‰ë•vCã–V•qŽqC˜e“c–M•vC`GŽ÷C‘ –{”ŽsiŽY•wj: “ú–{•wl‰Èˆ««Žîᇉ»Šw—Ö@Œ¤‹†‰ï‘æ2‰ñŠwpW‰ï
(89.11.11), “Œ‹žC ´˜^WCp.50, 1989.
1643. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ä”‚ðŒJ‚è•Ô‚·‚àPSK“Š—^‚ðs‚¢’·Šú¶‘¶‚µ‚Ä‚¢‚éŽq‹{ŒzŠà‚Ì1—á. ŽRŒû“T—˜C‰º“c—²•vCçÝŽ–«C’Òˆä“ÄC‘ –{”ŽsiŽY•wj: ‘æ13‰ñŠàŽ¡—ç˜b‰ï (89.12.02), ‰¡•l.
1644. mŒ¤‹†‰ïn iˆê”Êu‰‰j —‘‘ƒŽîᇂÌf’f‚É‚¨‚¯‚éŽîᇃ}[ƒJ[CA72-4‚Ì—L—p«‚ɂ‚¢‚Ä.
²“¡—Ï–çC`GŽ÷C‰º“c—²•vCŠp“cV•½C—Ñ—æŽqCã–V•qŽqC‘ –{”ŽsiŽY•wj: ‘æ6‰ñŽY•wl‰ÈŽîᇃ}[ƒJ[Œ¤‹†‰ï (90.02.02), “Œ‹žC
´˜^WCp.55, 1990.
1645. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹Ø‘w”ñZ‘Ì‚ª‚ñ‚Ì‘gDŠw“I”wŒi. ‘ –{”ŽsCã–V•qŽqC‘å‰ÍŒ´‘iŽY•wj: Œú¶È‘΂ª‚ñí—ªŒ¤‹†Ž–‹Æu‚ª‚ñ‚Ì“ñŽŸ—\–h‚ÌŒø‰Ê“I‚ÈŽÀŽ{‚É‚¨‚¯‚éŠî‘b“I‚ÈŒ¤‹†vi“V_”Çj”ljï‹c (90.02.13), “Œ‹ž.
1646. mŒ¤‹†‰ïn iˆê”Êu‰‰j Significance of Elective Induction of Labor and its Problem. ¼“‡³”ŽiŽY•wj: ‘æ4‰ñ‰¡{‰êŽY•wl‰ÈŒ¤‹†‰ï (90.02.21), ‰¡{‰ê.
1647. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{“à–Œ×–Ef. ‘ –{”ŽsiŽY•wj: ˆÇ—Ñ‘åŠw•ÛŒ’Šw•”×–EŒŸ¸Žm—{¬uÀ (89.04.28), “Œ‹ž.
1648. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{Œz•”‘BŠà. ‘ –{”ŽsiŽY•wj: ŠàŒ¤‹†‰ï•t‘®×–EŒŸ¸Žm—{¬Š (89.05.24), “Œ‹ž.
1649. mŒ¤‹†‰ïn iŒöŠJuÀj ‘ÌŠàŒŸf‚ÌŽÀÛ. ‘ –{”ŽsiŽY•wj: _“Þ쌧‚ÀŒSŽY•wl‰Èˆã‰ï—á‰ï (89.05.30), Œú–Ø.
1650. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{‘ÌŠà‚Ìf’fA‰uŠwAŽ¡—Âɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: ]ŒËìŽY•wl‰ÈˆãŽt‰ïŽåÃ]“Œ¥ç—t¼ƒuƒƒbƒN‡“¯‘²ŒãŒ¤C‰ï (89.06.14), “Œ‹ž.
1651. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{‘ÌŠà|Å‹ß‚Ì“®Œü‚Æ‚»‚Ìf’f. ‘ –{”ŽsiŽY•wj: ìèŽsŽY•wl‰Èˆã‰ï—á‰ï (89.07.15), ìè.
1652. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{‘Ì‚ª‚ñ‚Ì×–Ef‚ɂ‚¢‚Ä. ‘ –{”ŽsiŽY•wj: “ú–{•ê«•ÛŒìˆã‹¦‰ïɪŒ§Žx•”Žq‹{ŠàŒŸfˆãŽtŒ¤C‰ï (89.08.12), ɪ.
1653. mŒ¤‹†‰ïn iŒöŠJuÀj Žèp‚ð‚µ‚È‚¢Ž¡—Ö@:@Žq‹{Œz•”‚Ì‘ŠúŠà¥‘OŠà•a•Ï‚ɑ΂·‚é•Û‘¶—Ö@. ‘ –{”ŽsiŽY•wj: _“Þ쌧‘åŠwŒöŠJuÀ (89.10.28), ‘Š–ÍŒ´, “¯u‹`—vj, p.41`43, 1989.
1654. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{Œz•”A‘Ì•”‘BŠà‚Ì×–Ef. ‘ –{”ŽsiŽY•wj: •½¬Œ³”N“xŒú¶È‚ª‚ñ—\–h‹ZpEˆõiˆãŽtjŒ¤C‰ï (90.02.07), “Œ‹ž.
1655. mŒ¤‹†‰ïn iŒöŠJuÀj Žq‹{ŠàŒŸf. ‘ –{”ŽsiŽY•wj: “Œ‹ž“s’¬“cŽsˆãŽt‰ï (90.03.12), ’¬“c.
<<109 ‹ØœŠi>>
1656. mŒ´’˜n •ÏŒ`«ŒÒŠÖßÇ‚ÌŽ©‘RŒo‰ß‚Ì‚wüŠw“IŒ¤‹†. •Ä–{ŒõˆêCŽ…–ž·Œ›C»•ÓŠ®Ž¡CŠÖŒû¹˜aC¼ŽR—TCŽR–{^i®ŠOj: Hip Joint, 15: 39`43, 1989.
1657. mŒ´’˜n Corrosion Fatigue Properties of surgical Implants in a
Living Body. X“c^Žji¶‘ÌHjCù“c’¼i“ŒH‘åjCH. HayahsiC’Ë–{s’ji®ŠOj: J. Biomed. Maters
Res., 22(6): 529`540, 1988.
1658. mŒ´’˜n Chinese Enternal Fixation Treatment for Fractures of the
Distal End of the Radius. “ñŒ©r˜YCŽR–{^i®ŠOj: J. Hand. Surgery, 14(6):
1028`1032, 1989.
1659. mŒ´’˜n Problems in the Management of Open Articular Fractures of
the Ankle. Ž…–ž·Œ›Cù–{Œ›’jC¬—Ñ–¾³C»•ÓŠ®Ž¡C‘O“cŒ’“ñCŽO—Ö´ŽuCã“cºŒáCŽR–{^i®ŠOj: JJTOM, 37(10):
630`636, 1989.
1660. mŒ´’˜n In Vivo Corrosion Fatigue Behaviors of Surgical Implants.
X“c^Žji¶‘ÌHjCH. HayashiCù“c’¼i“ŒH‘åjC’Ë–{s’ji®ŠOj: Proc. 31st. Jpn. Cong. Maters
Res., p.195`199, 1988.
1661. mŒ´’˜n Evaluation of Wear Toxicity in Biomaterials with Cell
Culture Method. ù“c’¼i“ŒH‘åjCT. Imaizumi CX“c^ŽjC”nŸº´Ž‘i¶‘ÌHj: Proc. 31st. Jpn.
Cong. Maters Res., p.200`205, 1988.
1662. mŒ´’˜n Corrosion Fatigue Test for SUS316 Stainless Steel in
Quasi-Living Body Fluid. X“c^ŽjCù“c’¼i¶‘ÌHjC–쑺ŒM: Proc. 32nd. Jpn. Cong.
Maters. Res., 70`74, 1989.
1663. mŒ´’˜n Effects of FK-506 on Collagen Arthritis in Mice.
‚ŠÝŒ›“ñCŽR–{^C¼‘º–¾lCŽRèŠÞC‹à‘òC˜ÅŸºF•vCŠLŒ´MãEi®ŠOj: Transplantation Proceedings, 21(1):
1063`1065, 1989.
1664. mŒ´’˜n ŠOŒã‚ÌŽî’¯¥áu’ɂɑ΂·‚éƒtƒ‹ƒ‹ƒrƒvƒƒtƒFƒ““\•zÜ(EP-A)‚Ì—Õ°•]‰¿. –،ՋgC‰Í˜H“nC›Œ´KŽqCŽOD–M’BCŽR–{^C¬ì’¨–çi®ŠOj: ‰ŠÇC9(3): 255`262, 1989.
1665. mŒ´’˜n ŽèŠÖß•”œx‘Ñ‘¹‚Ǝ誕sˆÀ’èÇ. “ñŒ©r˜YCŽR–{^i®ŠOj: ŠÖߊO‰ÈC8(11): 1579`1584, 1989.
1666. mŒ´’˜n Multiple Pinning–@‚ð‘æˆê‘I‘ð‚Æ‚µ‚½‘å‘ÚœŒz•”“à‘¤œÜÜ‘N—á‚ÌŽ¡—Ã. ŠÖŒû¹˜aC‰Í–춒ˆC{ìŒMC’·–샓ñC–©òC¬—Ñ—ÇGCŠ}Œ´rºi®ŠOj: ŠÖߊO‰ÈC8(4): 447`455, 1989.
1667. mŒ´’˜n Œ¨Ž¾Š³‚ɑ΂·‚éMRI. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCù–{Œ›’jC•Ä–{ŒõˆêC’Ë–{s’jCŽR–{^i®ŠOjC’r“crºi•új: ŠÖ“Œ®ÐŽC20(5): 441`443, 1989.
1668. mŒ´’˜n ŠÏŒŒ“IŽ¡—Âðs‚Á‚½½œœÜ‚Ì—Õ°¬Ñ. ¼‘º–¾lCù–{Œ›’jC‚ŠÝŒ›“ñC»•ÓŠ®Ž¡C‰¡ŽRˆê•FCŽR–{^i®ŠOj: ŠÖ“Œ®ÐŽC20(6): 548`552, 1989.
1669. mŒ´’˜n ‰~“›“B‚Ë‚¶‰¡Ž~‚ß–@‚ð—p‚¢‚½Condylo-cephalic Nailing‚ɂ‚¢‚Ä. ŽO—Ö´ŽuCù–{Œ›’jC–k’ÜLmC‘O“cŒ’“ñCŽ…–ž·Œ›CŽR–{^i®ŠOj: œÜC11: 116`120, 1989.
1670. mŒ´’˜n ”牺ˆø‚«Šñ‚¹|ü’÷Œ‹–@‚É‚æ‚é•GŠWœœÜ‚ÌŽ¡—Ã. Ž…–ž·Œ›Cù–{Œ›’jCŽR–{^C»•ÓŠ®Ž¡C‰¡ŽRˆê•Fi®ŠOj: œÜC11: 125`131, 1989.
1671. mŒ´’˜n žôœŒz•”œÜ‚ɑ΂·‚é‚í‚ê‚í‚ê‚ÌŽ¡—Õûj. ¬—Ñ–¾³CŽ…–ž·Œ›Cù–{Œ›’jC‚ŠÝŒ›“ñCŽR–{^C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: œÜC11: 203`206, 1989.
1672. mŒ´’˜n ‰~“›Œ^‘“à“B‚ÌŠJ”‚ɂ‚¢‚Ä. ù–{Œ›’jCŽR–{^CŽ…–ž·Œ›C¬—Ñ–¾³CŽO—Ö´ŽuC–k’ÜLmC‘O“cŒ’“ñi®ŠOj: œÜC11: 382`387, 1989.
1673. mŒ´’˜n ã˜rœŠOãè÷‰ŠiƒeƒjƒX•Ij‚ÌŠO‰È“IŽ¡—Ã. “ñŒ©r˜YC‹v•ÛŽ›‘å–çC’Ë–{s’jCŽR–{^i®ŠOj: _“ÞìŠÖߊO‰ÈŠw‰ïŽ, 4: 25`29, 1989.
1674. mŒ´’˜n Fuji Computed Radiography‚ð—p‚¢‚½•GŠÖß‘¢‰e|‘O\Žšx‘Ñ‘¹‚Ìf’f|. “ñŒ©r˜YC’Ë–{s’jC¬—Ñ–¾˜YC‘O”V‰€‘½KCŽR–{^i®ŠOj: _“Þì®ÐˆãŽC2(1): 87`89, 1989.
1675. mŒ´’˜n ‹âsœ‚ð—p‚¢‚½lHŠÖß‚ÌÄ’uŠ·. •Ä–{ŒõˆêCŽ…–ž·Œ›CŽR–{^i®ŠOj: ®Œ`ŠO‰Èi•Êû:lHŠÖß‚ÌÄŽèp¥Ä’uŠ·j, (16): 93`99, 1989.
1676. mŒ´’˜n œÜŽ¡–ü‚ð‘jŠQ‚·‚é—ÍŠw“IŽhŒƒ. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒX, 10: 21`25, 1988.
1677. mŒ´’˜n –jñ“B–@‚É‚æ‚é‘å‘ÚœŒz•”“à‘¤œÜ‚ÌŒŸ“¢. ¬—Ñ–¾³CŽR–{^CŽ…–ž·Œ›Cù–{Œ›’jC“ì‘òˆç—YCŠÖŒû¹˜ai®ŠOj: ®Œ`¥ÐŠQŠO‰ÈC32(7): 873`876, 1989.
1678. mŒ´’˜n ŽèŠÖß•”‚wüf’f|ŽèªœœŒ`‘Ô‚¨‚æ‚ю誕sˆÀ’èÇ‚ð’†S‚Æ‚µ‚Ä|. “ñŒ©r˜YC¬—Ñ–¾³CŽá—ÑL”VC’Ë–{s’ji®ŠOj: ®Œ`¥ÐŠQŠO‰ÈC32(8): 977`981, 1989.
1679. mŒ´’˜n œ‘eé ǂɑ΂·‚éADFR—Ö@|ŠeŽíœ‰–’è—Ê–@‚É‚æ‚錟“¢. ŽR“¿‹`˜YC“‡Kˆè•vC‹v•ÛŽ›‘å–çC’Ë–{s’jC‚ŠÝŒ›“ñC—L•xŠ°i®ŠOj: ‘æ10‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï•ñW, p.88`94, 1989.
1680. mŒ´’˜n ãøœè÷ŠÔ—²‹NœÜ‚ɑ΂·‚éŒo”ç“IœÚ‡p. ˆÀ’BŒöC‹v•ÛŽ›‘å–çC‘OŒ´G•vC‘º“cŒ‰C“ñŒ©r˜YC’Ë–{s’jC‘O”V‰€‘½KC–x“à•x—YCŽR–{^i®ŠOj: “Œ‹ž•GŠÖߊw‰ï‰ïŽC10: 31`39, 1989.
1681. mŒ´’˜n •ÏŒ`«ŒÒŠÖßǂɑ΂·‚éƒLƒAƒŠœ”՜؂èp‚̶‘ÌHŠw‚©‚ç‚Ý‚½ŒŸ“¢. •Ä–{ŒõˆêC¼ŽR—TCŽ…–ž·Œ›CŽR–{^i®ŠOjCX“c^Žji¶‘ÌHj: “Œ“ú–{—Õ®‰ïŽC1(1): 354`357, 1989.
1682. mŒ´’˜n ŽÚ‘¤ŽèªL‹ØäFÇŒóŒQ. “ñŒ©r˜YCŽá—ÑL”VC¬—Ñ–¾³C‘å—F³FC’Ë–{s’ji®ŠOj: “Œ“ú–{—Õ®‰ïŽC1(1): 511`515, 1989.
1683. mŒ´’˜n Žèªœ”XŽî—l‰A‰e‚Ì‚wüŠw“IŒŸ“¢. ¬—Ñ–¾³C“ñŒ©r˜YC‘å–ìŽiCŽá—ÑL”VC’Ë–{s’jCŽR–{^i®ŠOj: “Œ“ú–{—Õ®‰ïŽC1: 278`281, 1989.
1684. mŒ´’˜n An Analysis of Wrist Joint Movement in the Crab-eated
Monkey|With Special Emphasis on the Supporting Function and Movement
Control Ability of Ligamentous Structure. “ñŒ©r˜YCŽá—ÑL”VC’Ë–{s’ji®ŠOj:
“úŠÖŠOŽC8(2): 187`196, 1989.
1685. mŒ´’˜n ‹—œœÜ‚ÌŽ¡—ÃŒoŒ±. ¼ŽR—TCŽ…–ž·Œ›Cù–{Œ›’jC¬—Ñ–¾³CˆÀ’BŒöCH—t—CŽR–{^i®ŠOj: “úЉïŽC37(10): 660`663, 1989.
1686. mŒ´’˜n Anatomical and Functional Study of Wrists|Comparative Study
of Crab-eating Monkey and Human. Žá—ÑL”VC“ñŒ©r˜Yi®ŠOj: “úŽè‰ïŽ, 6(1): 131`139,
1989.
1687. mŒ´’˜n Abductor Pollicis Longs Tendon Transfar for Augumentation of
Index Abdunction. “ñŒ©r˜YCŽá—ÑL”VC•Ä–{Œõˆêi®ŠOjC”nŸº´Ž‘i¶‘ÌHj: “úŽè‰ïŽ, 6(3): 443`447,
1989.
1688. mŒ´’˜n Estensor Carpi Ulnaris Syndrome: A Proposal of a New
Clinical Entity. “ñŒ©r˜YCŽá—ÑL”VC‘å—F³FC’Ë–{s’jCŽR–{^i®ŠOj: “úŽè‰ïŽ, 6(3): 499`504,
1989.
1689. mŒ´’˜n •ÏŒ`«•GŠÖßǂɑ΂·‚éƒsƒƒLƒVƒJƒ€“îp‚Ì‘½Ž{Ý—Õ°ŽŽŒ±¬Ñ|ŽÀ’nˆã‰Æ‚É‚æ‚é‘S‘ŽŽŒ±|. ŽR–{^i®ŠOjC‘¼142–¼: –ò—‚ÆŽ¡—ÃC17(3): 1021`1033, 1989.
1690. mŒ´’˜n •ÏŒ`«•GŠÖßǂɑ΂·‚éE-0710‚Ì—Õ°•]‰¿|‰Šú—Õ°‘æ‡U‘ŠŽŽŒ±|. ŽR–{^Cù–{Œ›’jC¬—Ñ–¾³C“y‰®“ÖC–ìŒû‘¾ˆêC‰¤‹žŽqCŽR芲—YCã“cºŒáC’J‹`•Fi®ŠOj: –ò—‚ÆŽ¡—ÃC17(4): 1643`1651, 1989.
1691. mŒ´’˜n E-0710‚Ì•ÏŒ`«•GŠÖßǂɑ΂·‚é—p—ÊŒŸ“¢ŽŽŒ±¬Ñ|‘½Ž{Ý“ñd–ÓŒŸ–@‚É‚æ‚錟“¢|. ŽR–{^C–،ՋgC‰Í˜H“nCŽO‰YK—YC‰F“cì‰pˆêC¼–{~CÎì´ˆêi®ŠOj: –ò—‚ÆŽ¡—ÃC17(4): 1653`1671, 1989.
1692. mŒ´’˜n •ÏŒ`«•GŠÖßǂɑ΂·‚éE-0710‚Ì—Õ°•]‰¿|Indomethacin‚ð‘ÎÆ–ò‚Æ‚µ‚½‘½Ž{Ý“ñd–ÓŒŸ”äŠrŽŽŒ±|.
ŽR–{^C‰Í˜H“nCŽO‰YK—YC‰F“cì‰pˆêC¼–{~CÎì´ˆêi®ŠOj: –ò—‚ÆŽ¡—ÃC17(5): 2277`2301, 1989.
1693. mŒ´’˜n ˜’ÉÇAŒzŒ¨˜rÇŒóŒQ‚¨‚æ‚ÑŒ¨ŠÖߎüˆÍ‰Š‚ɑ΂·‚éRPY-001‚Ì—Õ°•]‰¿|Indomethacin‚Æ‚Ì“ñd–ÓŒŸ”äŠrŽŽŒ±|.
ŽR–{^C‰Í˜H“nC¡ˆä–]CŽOD–M’BCŽR“cŸ‹vC•–Ø—ÇŽC¬ì’¨–çi®ŠOj: –ò—‚ÆŽ¡—ÃC17(7): 3347`3373, 1989.
1694. mŒ´’˜n …‰j‚É‚æ‚éƒXƒ|[ƒcáŠQ. ‚ŠÝŒ›“ñC“ñŒ©r˜YC‹v•ÛŽ›‘å–çCŽR–{^i®ŠOj: —Õ°ƒXƒ|[ƒcˆãŠw, 6: 41`43, 1989.
1695. mŒ´’˜n R¶ÜƒZƒtƒ]ƒiƒ€ƒiƒgƒŠƒEƒ€‚ð“Y‰Á‚µ‚½PMMAœƒZƒƒ“ƒg‚Ì‹“xŽŽŒ±. X“c^Žji¶‘ÌHjC—L•xŠ°i®ŠOj: —Õ°®Œ`ŠO‰È, 24(10): 1199`1205, 1989.
1696. m’Z•ñn SUS316ƒXƒeƒ“ƒŒƒX|‚Ì”æ˜J‹““®‚É—^‚¦‚é—n‘¶y‘f‚̉e‹¿. X“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼i¶‘ÌHjC–쑺ŒM: lHŠÖߌ¤‹†‰ïŽ, 19: 84, 1989.
1697. mŒ¤‹†•ñn ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï‚ÉŽQ‰Á‚µ‚Ä. X“c^Žji¶‘ÌHj: ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ, 10(2): 101`102, 1986.
1698. mŒ¤‹†•ñiŒú¶Èjn tˆÚAŒã‚Ì‘å‘Úœ“ª‰óŽ€|cyclosporin AŽg—p—á‚ÌŒŸ“¢|. ŽR–{^C¬—Ñ–¾³CŽ…–ž·Œ›Cù–{Œ›’ji®ŠOj: Œú¶È“Á’莾Š³œ‰óŽ€Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.135`137, 1989.
1699. mŒ¤‹†•ñiŒú¶Èjn tˆÚAŒã‚Ì‘å‘Úœ“ª‰óŽ€|cyclosporin A“Š—^ŒQ‚ÌŒŸ“¢|. ŽR–{^CŠÖŒû¹˜aCŽ…–ž·Œ›C¬—Ñ–¾³i®ŠOj: Œú¶È“Á’莾Š³œ‰óŽ€Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.265`268, 1989.
1700. mÇ—á•ñn —¼¿œŒ‹ß—ô—£œÜ‚Ì1—á. ”’èËWiŒ`ŠOjCŽOŒ´‹v”ÍC––‹g‹`”ŒC›Œ´½C“n•ÓŒ’ˆêC¬—Ѻi‘—§‰¡•l•a‰@j: —Õ°ƒXƒ|[ƒcˆãŠw, 6: 73`75, 1989.
1701. mÇ—á•ñn Prosthetic Replacement due to Giant-cell Tumor in the
Proximal Humerus: A Case Report. ‚ŠÝŒ›“ñCŽÂŒ´Osi®ŠOj: Clin. Orthop., 247:
106`110, 1989.
1702. mÇ—á•ñn lHŒÒŠÖßÄ’uŠ·p(revision)Žžƒ\ƒPƒbƒg”j‘¹‚Ì‚Ý‚ç‚ꂽ1—á‚ɂ‚¢‚Ä. ŽR“c—F‹vC“ß{–ìG“ñC—L•xŠ°Cã“cºŒái®ŠOj: ŠÖß‚ÌŠO‰È, 16: 111`116, 1989.
1703. mÇ—á•ñn ƒuƒVƒ‰ƒ~ƒ““Š—^’†‚É–Œ«tÇ‚ð‡•¹‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. ŒÜ‰ê‹M’jC—L•xŠ°C‚ŠÝŒ›“ñCŽO—Ö´ŽuCrˆä‹`Fi®ŠOjC¬—Ñ–LCŠ™“cvŽõi“àj: ŠÖ“ŒƒŠƒEƒ}ƒ`, 21: 51`61, 1989.
1704. mÇ—á•ñn ‘æˆê’†Žèœœ“ª‰óŽ€‚Ì1—á. —˜ªì‰ërC“ñŒ©r˜YC¬—Ñ–¾³C–k’ÜLmi®ŠOj: ŠÖ“Œ®ÐŽ, 20(6): 521`524, 1989.
1705. mÇ—á•ñn —Lçꜜ܂ɑæ5Žw‹ü‹ØäF’f—ô‚ð‡•¹‚µ‚½1—á. •“cŒo—mC’†‘ºˆêmC“ñŒ©r˜Yi®ŠOj: ŠÖ“Œ®ÐŽ, 20: 95`97, 1989.
1706. mÇ—á•ñn Šç–ÊœœÜ‚ɑ΂·‚éƒ~ƒjƒvƒŒ[ƒg‚ÌŽg—pŒoŒ±. ÷ˆäŽ¡²iŒ`ŠOj: é‹ÊŒ§ˆãŠw‰ïŽGŽ, 24(4): 938`941, 1989.
1707. mÇ—á•ñn æùœ‘O•û“Ë‹NœÜ‚Ì2—á. ŽR“c—F‹vC¬—Ñ–¾³C–kŒ©Œ\ŽiCŽ…–ž·Œ›i®ŠOj: _“Þ쌧®Œ`ЊQŠO‰ÈˆãŠw‰ïŽ, 2(1): 63`67, 1989.
1708. mÇ—á•ñn Van der HocveÇŒóŒQ‚Ì1—á. ‰Ô“ˆ”ü“ÞŽqC‹v•ÛŽ›‘å–çC“n•Ó®CÄ“¡Æ•FC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: _“Þ쌧®Œ`ЊQŠO‰ÈˆãŠw‰ïŽ, 2(1): 94`97, 1989.
1709. mÇ—á•ñn ‰Eã˜rœ‚É”¶‚µ‚½ Periosteal Chondroma ‚Ì1—á. ÎŒ´GˆêiŒ`ŠOjCˆÉ’n’m³ŒõCˆäŒ´¬’jCŽO“‡^ˆêiŽY‹Æˆã‘åj: ®Œ`ŠO‰È‚ÆЊQŠO‰È, 37: 1763`1766, 1989.
1710. m‘àn œ”՜܂̕ۑ¶—Ö@. »•ÓŠ®Ž¡i®ŠOj: M.B. Orthop., 12: 11`15, 1989.
1711. m‘àn lHŠÖߥ‚±‚ê‚©‚ç‚ÌlHŠÖß. X“c^Žji¶‘ÌHjCŽR–{^i®ŠOj: Pharma Medica, 7(7): 53`59, 1989.
1712. m‘àn ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW|‚Æ‚Ìo‡‚¢;¶‘Ì‚ÉŠw‚Ô‚±‚ê‚©‚ç‚Ì‹@ŠBHŠw. X“c^Žji¶‘ÌHj: ƒgƒ‰ƒCƒ{ƒƒW, 25(9): 25`26, 1989.
1713. m‘àn ˆã—Âɂ¨‚¯‚éƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW. ”nŸº´Ž‘i¶‘ÌHj: ƒgƒ‰ƒCƒ{ƒƒW, 3(9): 8`11, 1989.
1714. m‘àn ŠÖ߂̃gƒ‰ƒCƒ{ƒƒW[i¶‚«‚Ä‚¢‚éŒXŽÎ‹@”\ƒVƒXƒeƒ€j. ’Ë–{s’ji®ŠOj: ƒgƒ‰ƒCƒ{ƒƒW[, 25: 12`16, 1989.
1715. m‘àn œ‚Æ”æ˜J. X“c^Žji¶‘ÌHj: ƒoƒCƒIƒƒJƒjƒYƒ€Šw‰ïŽ, 11(3): 83`88, 1987.
1716. m‘àn ŒÜ\Œ¨|•}‹`|i“ÁWjŒ¨‚Ì’É‚Ý‚Æ‹@”\áŠQ. ‚ŠÝŒ›“ñi®ŠOj: ŠÖߊO‰È, 8(10): 1477`1482, 1989.
1717. m‘àn ‘å‘Úœ“ªçˆ‚èǂɑ΂·‚霒[ŒÅ’èpi“ÁWj‘å‘Úœ“ªçˆ‚èÇ. Ž…–ž·Œ›i®ŠOj: ŠÖߊO‰È, 8(11): 1637`1644, 1989.
1718. m‘àn •ÏŒ`«ŠÖßǂɑ΂·‚é–ò•¨—Ö@. ’Ë–{s’ji®ŠOj: œ¥ŠÖߥx‘Ñ, 2(2): 191`200, 1989.
1719. m‘àn ŠÖß’É: ‰ŠúÇŒó‚̂Ƃ炦•û‚ƉŠúŽ¡—Ã. Ž…–ž·Œ›i®ŠOj: Ž¡—Ã, 71: 393`399, 1989.
1720. m‘àn –€ŽC¥–€–Õ‚Ì—§ê‚©‚ç‚Ý‚½ƒCƒ“ƒvƒ‰ƒ“ƒgÞ—¿‚̶‘Ì“K‡«•]‰¿. X“c^Žji¶‘ÌHj: ®Œ`ŠO‰È, 41(2): 222, 1990.
1721. m‘àn ƒƒ{ƒbƒg‚É‚æ‚éx‘Ñ‘¹‚Ìf’fi“ÁW/ƒXƒ||ƒc‚Æ‘O\Žšx‘Ñ‘¹j. “¡]—T“¹i¶‘ÌHj: —Õ°ƒXƒ||ƒcˆãŠw, 6(12): 1309`1314, 1989.
1722. m‘àn ”ñƒXƒeƒƒCƒhR‰ŠÇÜ‘I‘ð‚̃|ƒCƒ“ƒg (3)•ÏŒ`«ŠÖßÇ. —L•xŠ°i®ŠOj: —Õ°ˆã, 15: 1594`1596, 1989.
1723. m‘àn i“ÁWj“§ÍŠ³ŽÒ‚ÌŽèpŠÅŒìƒ}ƒjƒ…ƒAƒ‹|‚w‡V®Œ`ŠO‰È|. Ž…–ž·Œ›i®ŠOjCˆÉ“¡•¶ŽqiŠÅŒì•”j: —Õ°“§Í, 5(8): 227`247, 1989.
1724. m‘àn “Á”«‘å‘Úœ“ª‰óŽ€‚Ìf—Ã. Ž…–ž·Œ›CŽR–{^i®ŠOj: —Õ°–Ɖu, 21: 713`725, 1989.
1725. muÀn “¯Žíœi‹âsœjˆÚA|‹âsœˆÚA‚Ì“Á’¥. Ž…–ž·Œ›i®ŠOj: ‚¢‚¸‚Ý, 36(6): 20`21, 1989.
1726. muÀn “ü–åuÀ:‚wü‚Ì“Ç‚Ý•û ‘æ3Í Œ¨¥ŒÒ. ‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ƒŠƒEƒ}ƒ`‰È, 1(3): 363`374, 1989.
1727. mŠwp‘n iŽ·•Mj “ú–{‹@ŠBŠw‰ï”NŠÓ; ƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒW|, 92: 849, X“c^Žji¶‘ÌHj. •ÒW “ú–{‹@ŠBŠw‰ï•ÒC “Œ‹žC89.00.00”s.
1728. mŠwp‘n iŽ·•Mj Advance in Biomaterials; The Corrosion Fatigue
Properties of Surgical Implants in a Living Body, 8: 381`386,
X“c^Žji¶‘ÌHjCH. HayashiCù“c’¼i“ŒH‘åjC’Ë–{s’ji®ŠOj. •ÒW C. de PutterCG.L. LangeCK.
de GrootCA.J.C. Lee•ÒC ElsevierCAmsterdamC88.00.00”s.
1729. mŠwp‘n iŽ·•Mj ‘“à“B‚É‚æ‚éœÜŽèpG—˜_‚ÆŽÀÛ, ŽR–{^CŽ…–ž·Œ›Cù–{Œ›’ji®ŠOj. “ì]“°, “Œ‹žC89.04.10”s.
1730. mŠwp‘n iŽ·•Mj }à“à‰Èf’fŽ¡—ÃuÀ. 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ‚wüŠŒ©¥œ. —L•xŠ°i®ŠOj. •ÒW ˆÀ”{’BC‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹žC89.06.10”s.
1731. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`Šw; 18. •ÏŒ`«ŠÖßÇ, p.924`951, ŽR–{^CŽ…–ž·Œ›i®ŠOj. “¯•¶‘‰@C“Œ‹ž, 89.07.00”s.
1732. mŠwp‘n iŽ·•Mj Diclofenac (Voltaren) and Cartilage in Osteoarthritis;
Prospects for Cartilage Therapy, ŽR–{^i®ŠOj. •ÒW Moskowitz, R. &
Hirohata, K.•Ò, Hogrofe & Huber, Toronto, 89.00.00”s.
1733. mŠwp‘n iŽ·•Mj œ‹âs; Ž…–ž·Œ›C¬—Ñ–¾³i®ŠOj. ŠÄC ŽR–{^i–k—¢‘åŠwjŠÄC, ƒqƒ…[ƒ}ƒ“ƒeƒBƒƒB, 90.03.24”s.
1734. m‹³‰È‘n iŽ·•Mj _’†®Œ`ŠO‰ÈŠwi‰ü’ù‘æ21”Åj; ®Œ`ŠO‰È“If’f–@AŠÖß‚Ì\‘¢‚Æ‹@”\A“̑ãŽÓ, ŽR–{^i®ŠOj. •ÒW “VŽ™–¯˜a•Ò, “ìŽR“°C“Œ‹ž, 89.11.00”s.
1735. m‹³‰È‘n iŽ·•Mj _’†®Œ`ŠO‰ÈŠwi‰ü’ù‘æ21”Åj; œŠÖ߂̃oƒCƒIƒƒJƒjƒNƒX, ’Ë–{s’ji®ŠOj. •ÒW “VŽ™–¯˜a•Ò, “ìŽR“°C“Œ‹ž, 89.11.00”s.
1736. m‹³‰È‘n iŽ·•Mj _’†®Œ`ŠO‰ÈŠwi‰ü’ù‘æ21”Åj; ŠÖߎ¾Š³, —L•xŠ°i®ŠOj. •ÒW “VŽ™–¯˜a•Ò, “ìŽR“°C“Œ‹ž, 89.11.00”s.
1737. mŠwpÜn “ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ïC‘æ1‰ñƒoƒCƒIƒ}ƒeƒŠƒAƒ‹‰ÈŠw§—ãÜu”æ˜JœÜ—\’m‚ÉŠÖ‚·‚é—ÍŠw“IŒ¤‹†v. X“c^Žji¶‘ÌHj.
1738. m‘•]n ƒoƒCƒIƒƒJƒjƒNƒX‚æ‚è‚Ý‚½®Œ`ŠO‰È. X“c^Žji¶‘ÌHj: ®Œ`ŠO‰È, 40(6): 934, 1989.
1739. mŠw‰ïn i“Á•Êu‰‰j Isoelastic Total Hip Replacement: Clinical
Experiences and its Biomechanical Characteristics. Ž…–ž·Œ›CŽR–{^CKashiwagi,
D.C•Ä–{Œõˆêi®ŠOjCX“c^Žji¶‘ÌHj: 33rd Annual Meeting of the Korean Orthopedic
Association (89.10.19`21), Seoul, Korea.
1740. mŠw‰ïn i‹³ˆçu‰‰j The Experience of Soft-tissue Expander. “àÀ‰hŽ÷iŒ`ŠOj: ‘æ2‰ñƒCƒ‰ƒ“Œ`¬ŠO‰ÈŠw‰ï (89.05.17), ƒeƒwƒ‰ƒ“.
1741. mŠw‰ïn i‹³ˆçu‰‰j ˆ««Žîᇂ̉摜f’fi•a—Šw“IŠŒ©‚Ƃ̑Δäj 5. œ. ¼—Ñ—²i•új:
‘æ25‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï (89.09.29), –¼ŒÃ‰®, ‘æ25‰ñ“ú–{ˆãŠw•úŽËüŠw‰ïH‹G—Õ°‘å‰ï¥–¼ŒÃ‰®¥ƒvƒƒOƒ‰ƒ€¥—\eW,
p.47, 1989.
1742. mŠw‰ïn i‹³ˆçu‰‰j •ÏŒ`«ŠÖßÇ‚Ìis‚ÆŽ¡—Ã. Ž…–ž·Œ›i®ŠOj: •½¬Œ³”N“x‘啪Œ§®Œ`ŠO‰È—Õ°®Œ`ŠO‰Èˆã‰ï (89.10.07), ‘啪.
1743. mŠw‰ïn i‹³ˆçu‰‰j •ÏŒ`«ŠÖßÇ‚Ì•a‘Ô‚ÆŽ¡—Ã. ŽR–{^i®ŠOj: ‘æ1‰ñ–k‹ãBA’}–L’n‹æ®Œ`ŠO‰ÈW’k‰ï (90.03.09), –k‹ãB.
1744. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –«ŠÖ߃ŠƒEƒ}ƒ`Œz’Å•a•Ï‚ÆŽèp—Ö@. —L•xŠ°i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S212, 1989.
1745. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j lHŠÖß‚ÌŽèpŽè’iA‚±‚ê‚©‚ç‚ÌlHŠÖß. Ž…–ž·Œ›i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.
1746. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Implant‹à‘®Þ—¿‚Ì‘Ì“à•…H‚É‚æ‚é”æ˜J‹“x—ò‰». X“c^Žji¶‘ÌHjC–쑺ŒMCù“c’¼i“ŒH‘åj:
‘æ11‰ñƒoƒCƒIƒƒJƒjƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€ (89.07.13`15), “y‰YC —\eW, p.185`194, 1989.
1747. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j œÜŽ¡—ÂƃƒJƒjƒJƒ‹ƒXƒgƒŒƒX•À‚Ñ‚Éœ‘eé Ç‚ÆŒz•”œÜ.
X“c^Žji¶‘ÌHjCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ7‰ñ“ú–{œ‘ãŽÓŠw‰ï (89.07.27`29), “Œ‹žC “ú–{œ‘ãŽÓŠw‰ïŽ,
7(3): 63, 1989.
1748. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŠŠ‰tC“îœClHŠŠ‰t‚ÌŠÏ“_‚©‚ç‚Ý‚½ŠÖß‚ÌŠŠ.
”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼i“ŒH‘åj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.09.01), “Œ‹žC
“ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(7): S887,@1989.
1749. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘å‘Úœè÷•”Aè÷ã•”œÜ‚ÌŽ¡—ÃŒoŒ±.
“ì‘òˆç—YCr–Ø’ˆêC¼‘º–¾lC‰¡ŠÖ~C¬—Ñ–¾³C‘å–ìŽiCŽ…–ž·Œ›CŽR–{^i®ŠOjCV“¡³‹Pi‹~–½j: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï
(89.10.18`19), L“‡, “úЈãŽ, 38(3): 52, 1990.
1750. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Application of Robotics to Palpation of Injury of
Knee Ligaments|Devolopment of a New Method of Knee Instability Test.
“¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: 110th ASME (American Society of
Mechanical Engineers) Winter Annual Meeting (89.12.10`15), San
Francisco.
1751. mŠw‰ïn iƒpƒlƒ‹j ‘å‘Úœ“ªçˆ‚èÇ‚ÌŽ¡—Ã:‚Ë‚¶ŒÅ’è–@. Ž…–ž·Œ›i®ŠOjC^ŠpºŒái‘啪ˆã‘åjC–I’J«Žji‰¡•l“실ϕa‰@j:
‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S33, 1989.
1752. mŠw‰ïn iƒpƒlƒ‹j ‚킪‘‚Ì®Œ`ŠO‰È”F’èˆã§“x‚ɂ‚¢‚Ä|Œ¤CŽ{Ý‚ÆŒ¤C•û–@‚ɂ‚¢‚Ä|. ŽR–{^i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S443, 1989.
1753. mŠw‰ïn iƒpƒlƒ‹j ƒƒ{ƒbƒg‚É‚æ‚éx‘Ñ‘¹‚Ìf’f. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj:
‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.15), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S412, 1989.
1754. mŠw‰ïn iƒpƒlƒ‹j —h“®‰~ŒÊ‰^“®‚É‚æ‚è\¬‚µ‚½‹UŠÖß‚Ì‹@”\‚ÆŒ`‘Ô.
“¡]—T“¹i¶‘ÌHjC’|“à“ÖŽqi¶‰»ŒnjC”nŸº´Ž‘i¶‘ÌHjCŽ…–ž·Œ›CŽR–{^i®ŠOjC’†ŽR“Oi“‡’ûìŠjCù“c’¼i“ŒH‘åj:
‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï (89.08.31`09.01), “Œ‹žC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(7): 896, 1989.
1755. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ‚wüŠŒ©‚É‚æ‚éRƒŠƒEƒ}ƒ`Ü‚Ì—Õ°“IˆÓ‹`. —L•xŠ°i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.
1756. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚霉–—ʂ̕ω»i‘æ6•ñjQCT‚É‚æ‚錟“¢.
—L•xŠ°CŽR“¿‹`˜YC•Ä–{ŒõˆêC“ì‘òˆç—Yi®ŠOjC÷ˆä´ŽqCŠâ”g–ÎC‘–쳈êi•új: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27),
“Œ‹ž.
1757. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚Ås‚Á‚½“ÚA‚ɂ‚¢‚Ä. ŒÃŽR“o—²CÎŒ´GˆêC—é–Ø•q•FC‰eŽRL”üC‰–’JMKiŒ`ŠOj: “ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï, _ŒË.
1758. mŠw‰ïn iˆê”Êu‰‰j ƒCƒ“ƒvƒ‰ƒ“ƒgÞ—¿‚Ì–€–Õ“Å«C‹[Ž—¶‘̊‹«‚É‚¨‚¯‚é‹à‘®ƒCƒIƒ“‚Ì‘I‘ð“I—no.
¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnj: ‘æ33Šú“ú–{ŠŠŠw‰ï (88.05.12`13), “Œ‹žC —\eW,
p.249`252, 1988.
1759. mŠw‰ïn iˆê”Êu‰‰j ‹[Ž—¶‘Ì“à•…HŠÂ‹«‰º‚É‚¨‚¯‚éSUSA316ƒXƒeƒ“ƒŒƒX|‚Ì”æ˜J‹“x‚Ì‘ª’è.
X“c^Žji¶‘ÌHjCù“c’¼i“ŒH‘åjC–쑺ŒM: ‘æ32‰ñÞ—¿Œ¤‹†˜A‡u‰‰‰ï (88.12.08`09), ‹ž“sC —\eW,
p.115`116, 1988.
1760. mŠw‰ïn iˆê”Êu‰‰j ŽèŠÖß‚wüf’f‚ɂ‚¢‚Ä. “ñŒ©r˜YCŽá—ÑL”VC¬—Ñ–¾³C‹v•ÛŽ›‘å–çC’Ë–{s’ji®ŠOj: ‘æ3‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŠw‰ï (89.02.00), ŽRŒ`.
1761. mŠw‰ïn iˆê”Êu‰‰j “ꕶŽž‘ãl‰ºŽˆœ‚Ì’·‚³‚̶‰E·. •½–{‰Ã•i‰ðj: “ú–{‰ð–UŠw‰ï (89.04.01), ‹{èC ‰ð–UŠwŽGŽC64(4): 362, l989.
1762. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚錨½ŠÖß’E‰P‚ÌŽ¡—ÃŒoŒ±. ‚ŠÝŒ›“ñC•Ä–{ŒõˆêC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S145, 1989.
1763. mŠw‰ïn iˆê”Êu‰‰j ŠÈˆÕŒÅ’è‘•‹ï‚É‚æ‚é˜V”NŽÒ¥žôœ––’[œÜ‚ÌŽ¡—Ã.
“ñŒ©r˜YC‹v•ÛŽ›‘å–çC•Ä–{ŒõˆêCŽR“¿‹`˜YC’Ë–{s’ji®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï (89.04.14`16), ‰YˆÀC
“ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S549, 1989.
1764. mŠw‰ïn iˆê”Êu‰‰j ãøœè÷ŠÔ—²‹NœÜ‚̔ǃƒJƒjƒYƒ€‚Æ‚»‚ÌŽ¡—ìÑ.
‹v•ÛŽ›‘å–çC’Ë–{s’jC“ñŒ©r˜YCŽR“¿‹`˜YC•Ä–{ŒõˆêC‹ß“¡‘׈êCˆÀ’BŒöCŽO—Ö´ŽuCã“cºŒáCŽR–{^i®ŠOj: ‘æ62‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠwpW‰ï
(89.04.14`16), ‰YˆÀC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(2): S90, 1989.
1765. mŠw‰ïn iˆê”Êu‰‰j 󑤓ª“®–¬—̈æ‚Ì”ç•Ù‚É‚æ‚éŠááÙ‹y‚Ñ•@—ƒ‚ÌÄŒš.
“àÀ‰hŽ÷C÷ˆäŽ¡²C‰FˆäŒª“ñCçÝŽ½C•“cŒö—˜C”Ñ“c„C‰–’JMKiŒ`ŠOj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï (89.04.21), ‰YˆÀ,
“ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9(—Õ‘): 201, l989.
1766. mŠw‰ïn iˆê”Êu‰‰j ŽÚ‘¤ŽèªL‹ØäFÇŒóŒQ. “ñŒ©r˜YCŽá—ÑL”VC‘å—F³FC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.
1767. mŠw‰ïn iˆê”Êu‰‰j ƒJƒjƒNƒC‰ŽŽèŠÖß•”‚̉ð–U“IŠÏŽ@il‚Æ‚Ì”äŠr‚É‚¨‚¢‚Äj. Žá—ÑL”VC“ñŒ©r˜YC‘å—F³FC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.
1768. mŠw‰ïn iˆê”Êu‰‰j ŽèŽwŠO“]‹@”\ÄŒš‚ɑ΂·‚éäFˆÚsp. “ñŒ©r˜YCŽá—ÑL”VC¬—Ñ–¾³C•Ä–{ŒõˆêC’Ë–{s’ji®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.
1769. mŠw‰ïn iˆê”Êu‰‰j •ÏŒ`«•IŠÖßǂɑ΂·‚éžôœ’ZkpiƒrƒfƒIj. “ñŒ©r˜Yi®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.
1770. mŠw‰ïn iˆê”Êu‰‰j Žè‚ÌŠO‰È—̈æ‚É‚¨‚¯‚é‚wüCRŽB‰e–@‚̉ž—p. •Ä–{ŒõˆêC“ñŒ©r˜YC‹v•ÛŽ›‘å–çC’Ë–{s’jC¬—Ñ–¾³i®ŠOj: ‘æ32‰ñ“ú–{Žè‚ÌŠO‰ÈŠw‰ï‘‰ï (89.05.11`13), –k‹ãB.
1771. mŠw‰ïn iˆê”Êu‰‰j •ÏŒ`«ŠÖßǃ}ƒEƒX‚É‚¨‚¯‚é–Ɖu”½‰ž‚ÌŠÖ—^. ‘O“cŒ’“ñC‚ŠÝŒ›“ñC”Ñ’ËŒ’Ž™CŽRèŠÞC¼‘º–¾lCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.
1772. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX‚̃Rƒ‰[ƒQƒ“ŠÖ߉Š‚É‹y‚Ú‚·15-deoxyspergualin‚̉e‹¿.
‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽRèŠÞC¼‘º–¾lC•Ä–{ŒõˆêCŽR–{^C˜ÅŸºF•vCŠLŒ´Mhi®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï
(89.05.25`27), “Œ‹ž.
1773. mŠw‰ïn iˆê”Êu‰‰j
ŒŒ´ˆÚ“ü‚É‚æ‚éƒRƒ‰[ƒQƒ“ŠÖ߉Š‚ɑ΂·‚écyclosporin‚̉e‹¿|FK506‚Æ‚Ìì—p‹@˜‚Ì”äŠr‚ɂ‚¢‚Ä|.
‹{Œ´F–¾C˜ÅŸºF•vC—L“ce‰›CVˆä–]C™‰ª—mˆêC‚ŠÝŒ›“ñCŠLŒ´Mhi®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27),
“Œ‹ž.
1774. mŠw‰ïn iˆê”Êu‰‰j lHŠÖß‚ÆlHœŒz‚ÌŠŠ‚Æ‚»‚̉ž—p. ’Ë–{s’jC“ñŒ©r˜YC‹v•ÛŽ›‘å–çC•Ä–{ŒõˆêCŽR“¿‹`˜Yi®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.
1775. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŽèŠÖߊŠ–ŒØœp‚ÌŽèŠÖ߈À’è«‚É‹y‚Ú‚·‰e‹¿‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêC—L•xŠ°C‚ŠÝŒ›“ñC“ñŒ©r˜YCŽR–{^i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.
1776. mŠw‰ïn iˆê”Êu‰‰j VARAf’fŠî€‚ÌŒŸ“¢i‘æ2•ñj. ¼ŽR—TC—L•xŠ°C–x“à•x—YC“¡“c³CŽR–{^i®ŠOj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï (89.05.25`27), “Œ‹ž.
1777. mŠw‰ïn iˆê”Êu‰‰j ‘½”«“]ˆÚ‚𗈂µ‚½Œã• –ŒŒ´”‚Æl‚¦‚ç‚ê‚éMFH‚Ì1–UŒŸ—á. ˆÉ“ŒŽüìC–x“àŒPC“ì‘òˆç—YC¬—Ñ–¾³C‘å–ìŽii®ŠOjCŠâŸºŒ[ˆêC“n•Ó´Ž¡i•a—j: ‘æ518‰ñŠÖ“Œ®ÐŒŽ—á‰ï (89.05.27), “Œ‹ž.
1778. mŠw‰ïn iˆê”Êu‰‰j 圕”åñጂ̎¡—Õûj. ÎŒ´GˆêiŒ`ŠOj: ‘æ14‰ñŠO‰È˜A‡Šw‰ï (89.06.21), ‘åã.
1779. mŠw‰ïn iˆê”Êu‰‰j —L’É«•ª—ô•GŠWœ‚ɑ΂·‚éŽèp—Ö@. ‹v•ÛŽ›‘å–çC“ñŒ©r˜YCb”ãGŽÀC“‡Kˆè•vC‘OŒ´G•vCŽO—Ö´ŽuC’Ë–{s’ji®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.
1780. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX‚̃Rƒ‰[ƒQƒ“ŠÖ߉Š‚É‹y‚Ú‚·15-deoxyspergualin‚̉e‹¿. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽRèŠÞC¼‘º–¾lC•Ä–{ŒõˆêCŽO—Ö´ŽuCŽR–{^i®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.
1781. mŠw‰ïn iˆê”Êu‰‰j ŒÒŠÖß‚É”¶‚µ‚½synovial chondromatosis‚Ì3—á. ŽR“c—F‹vCŽ…–ž·Œ›C¬—Ñ–¾³C‘å–ìŽiC–kŒ©Œ\ŽiCŽR–{^i®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.
1782. mŠw‰ïn iˆê”Êu‰‰j Žè‚ÌŠO‰È—̈æ‚É‚¨‚¯‚é‚wücomputed radiography (CR)‚̉ž—p.
•Ä–{ŒõˆêC“ñŒ©r˜YC‹v•ÛŽ›‘å–çC’Ë–{s’jC¬—Ñ–¾³CŽR“¿‹`˜YCŽR–{^i®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.
1783. mŠw‰ïn iˆê”Êu‰‰j ’·Šú“§ÍŠ³ŽÒ‚É”¶‚µ‚½äF’f—ô‚ÌŒŸ“¢. ¬—Ñ–¾³CŽ…–ž·Œ›CŽR–{^C“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.
1784. mŠw‰ïn iˆê”Êu‰‰j ãøœ‚É”¶‚µ‚½insufficiency fracture‚Ì1—á. –Ø‘º³“C‹v•ÛŽ›‘å–çCˆÀ’BŒöC‰Ô“ˆ”ü“ÞŽqC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ18‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.06.24), “Œ‹ž.
1785. mŠw‰ïn iˆê”Êu‰‰j Development of the Apparatus of the Knee Instability
Test by the Use of the Arm-Robot.
“¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jC‹v•ÛŽ›‘å–çC“ñŒ©r˜YCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: First International
Congress of Knee and Orthopaedic Sports Medicine Section of Western
Pacific Orthpaedic Association (WPOA) (89.07.04`06), ‰¡•lC AbstractCp.19,
1989.
1786. mŠw‰ïn iˆê”Êu‰‰j ƒXƒL[‚É‚æ‚鉺Žˆ‚ÌŠO|10”N‘O‚Æ‚Ì”äŠr|.
‹v•ÛŽ›‘å–çC’Ë–{s’jC“ñŒ©r˜YCŽO—Ö´ŽuCå‚Œ´—L’jC‹{“c—fCÄ“¡º•FC‘OŒ´G•vCˆÀ’BŒöC¬—Ñ–¾˜YC‘O”V‰€‘½KC“n•Ó®C‚ŠÝŒ›“ñCŽR–{^i®ŠOj:
‘æ15‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ï (89.07.07), ŽD–y.
1787. mŠw‰ïn iˆê”Êu‰‰j ƒXƒ|[ƒc‚É‚æ‚éŽèŽwáŠQ. “ñŒ©r˜YC‹v•ÛŽ›‘å–çC‚ŠÝŒ›“ñC¬—Ñ–¾³C’Ë–{s’ji®ŠOj: ‘æ15‰ñ“ú–{®Œ`ŠO‰ÈƒXƒ|[ƒcˆãŠw‰ï (89.07.07), ŽD–y.
1788. mŠw‰ïn iˆê”Êu‰‰j Ulnar inpingementÇŒóŒQ‚ð’悵‚½žôœ––’[œÜ‚ÌŽ¡—ÃŒoŒ±. m•r–FŽ÷C•Ä–{ŒõˆêC“ñŒ©r˜YC–Ø‘º³“C‹v•ÛŽ›‘å–çC’Ë–{s’ji®ŠOj: ‘æ76‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.07.08), ªŠÝ.
1789. mŠw‰ïn iˆê”Êu‰‰j Š°œ‰PœÜ‚ÌŒŸ“¢. ‰¡ŠÖ~C–Ø‘º³“C“n•Ó®C“ì‘òˆç—YC¬—Ñ–¾³CŽ…–ž·Œ›CŽR–{^i®ŠOj: ‘æ76‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.07.08), ªŠÝ.
1790. mŠw‰ïn iˆê”Êu‰‰j ‘å‘Úœœ“ªœÜ‚ÌŽ¡—ÃŒoŒ±. —é–Ø~C¬—Ñ–¾³C‘å–ìŽiCŽO—Ö´ŽuCŽRèŠÞCŽR–{Œ›ˆêCŽ…–ž·Œ›i®ŠOj: ‘æ76‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.07.08), ªŠÝ.
1791. mŠw‰ïn iˆê”Êu‰‰j •IŠÖߌ‹Šj‚ɃTƒ‹ƒRƒCƒh[ƒVƒX—l”ç]‚𔺂Á‚½1—á. ‘å–ìŽiC¬—Ñ–¾³C”ªŠª“~•FC—L•xŠ°i®ŠOj: ‘æ13‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï (89.07.29), ‰¡•l.
1792. mŠw‰ïn iˆê”Êu‰‰j
•ÏŒ`«ŠÖßǃ}ƒEƒXiC57BLƒ}ƒEƒXj‚¨‚æ‚у}ƒEƒX‚̃Rƒ‰[ƒQƒ“ŠÖ߉Š‚É‚¨‚¯‚é‡UŒ^ƒRƒ‰[ƒQƒ“‚ɑ΂·‚é–Ɖu”½‰ž‚ÌŠÖ—^.
‘O“cŒ’“ñC‚ŠÝŒ›“ñC”Ñ’ËŒ’Ž™CŽRèŠÞC¼‘º–¾lCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï
(89.08.31`09.01), “Œ‹ž, “ú®‰ïŽi´j, 63(7): 1140, 1989.
1793. mŠw‰ïn iˆê”Êu‰‰j ³íŽÒ‚¨‚æ‚Ñ•ÏŒ`«ŠÖßÇŠ³ŽÒ‚É‚¨‚¯‚錌´’†ƒPƒ‰ƒ^ƒ“—°Ž_’l.
‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽ…–ž·Œ›CŽR–{^i®ŠOjCŒÜäzsMC–x“c‹±Žqi¶‰»jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï
(89.08.31`09.01), “Œ‹ž, “ú®‰ïŽi´j, 63(7): 952, 1989.
1794. mŠw‰ïn iˆê”Êu‰‰j ƒƒ{ƒbƒg‚ð—p‚¢‚½x‘Ñ‘¹f’f‘•’u‚ÌŠJ”.
“¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jC‹v•ÛŽ›‘å–çC“ñŒ©r˜YCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ï
(89.08.31`09.01), “Œ‹žC “ú–{®Œ`ŠO‰ÈŠw‰ïŽGŽC63(7): 1081, 1989.
1795. mŠw‰ïn iˆê”Êu‰‰j ŠÖß‘¢‰e‚É‚æ‚é‘O\Žšx‘Ñ‚Ìf’f. ‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC‹{“c—fCå‚Œ´—L’jC–kŒ©Œ\ŽiC‹v•Û•×CÄ“¡º•FC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.
1796. mŠw‰ïn iˆê”Êu‰‰j QCT–@‚É‚æ‚éÒ’Å‘eé Ç‚¨‚æ‚Ñ–«ŠÖ߃ŠƒEƒ}ƒ`‚Ìœ‰–—ʂ̕ω»‚ɂ‚¢‚Ä. —L•xŠ°CŽR“¿‹`˜YC•Ä–{ŒõˆêC‘å–ìŽiC“ì‘òˆç—Yi®ŠOjC÷ˆä´ŽqCŠâ”g–Îi•új: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.
1797. mŠw‰ïn iˆê”Êu‰‰j •I•”ŠÇÇŒóŒQ‚ÌŽ¡—ÂƂ»‚Ì–â‘è“_. “ñŒ©r˜YC¬—Ñ–¾³C•Ä–{ŒõˆêC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.
1798. mŠw‰ïn iˆê”Êu‰‰j Charnley-MullerŒ^lHŒÒŠÖß5”NˆÈãŒo‰ß—á‚ÌŒŸ“¢. •Ä–{ŒõˆêCŽ…–ž·Œ›Cã“cºŒáC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ38‰ñ“Œ“ú–{—Õ°®Œ`ŠO‰ÈŠw‰ï (89.09.10), ˆ®ì.
1799. mŠw‰ïn iˆê”Êu‰‰j tˆÚAŒã‚Ì‘å‘Úœ“ª‰óŽ€|cyclosporine A“Š—^ŒQ‚ÌŒŸ“¢. ŠÖŒû¹˜aCŽ…–ž·Œ›C¬—Ñ–¾³C‰¡ŽRˆê•FCŽR–{^i®ŠOjC‰¡“c˜a•FiŠOj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11`13), “Œ‹ž.
1800. mŠw‰ïn iˆê”Êu‰‰j lHŠÖßÞ—¿‚Ì–€–Õ‚É‚¨‚¯‚镵ˆÍ‹C‚̉e‹¿. ¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHj: ‘æ33‰ñÞ—¿Œ¤‹†˜A‡u‰‰‰ï (89.09.13`14), “Œ‹žC —\eW, p.157`158, 1989.
1801. mŠw‰ïn iˆê”Êu‰‰j A Controlled Study of Lymphocytophoresis for
Refractory Rheumatoid Arthritis. —L•xŠ°C‘å–ìŽiCã“cºŒáC–kŒ©Œ\Žii®ŠOjC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[j:
16th ILAR Congress of Rheumatology (89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.
1802. mŠw‰ïn iˆê”Êu‰‰j Comparative Studies of the Effect of Cyclosporin A
and FK506 on Collagen Arthritis in Mice.
‚ŠÝŒ›“ñCŽRèŠÞC¼‘º–¾lC•Ä–{ŒõˆêC‘O“cŒ’“ñCŽR–{^i®ŠOj: 16th ILAR Congress of Rheumatology
(89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.
1803. mŠw‰ïn iˆê”Êu‰‰j Multicentric Evaluation of Tiaprofenic Acid in
Osteoarthritic Patients Using of OA Knee Score. ŽR–{^i®ŠOjCAoki, T.COno,
K.CSugioka, Y.CKoshino, T.: 16th ILAR Congress of Rheumatology
(89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.
1804. mŠw‰ïn iˆê”Êu‰‰j Multicentric Evaluation of Periarthritis
Scapulohumeralis Using Shoulder Evaluation Sheets. Yamamoto, R.CMikasa,
M.COgawa, K.CMorioka, K.C‚ŠÝŒ›“ñi®ŠOjCTabata, S.: 16th ILAR Congress of
Rheumatology (89.09.17`23), ƒŠƒIƒfƒWƒƒƒlƒCƒ.
1805. mŠw‰ïn iˆê”Êu‰‰j IsoelasticlHŒÒŠÖß‚ÌŽg—pŒoŒ±. •Ä–{ŒõˆêCã“cºŒáCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOj: ‘æ73‰ñ’†•”“ú–{®Œ`ЊQŠO‰ÈŠw‰ï (89.10.12`13), ‚¼.
1806. mŠw‰ïn iˆê”Êu‰‰j •GŠÖß—ÍŠwŽŽŒ±ƒƒ{ƒbƒg‚ÌŠJ”.
“¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC–kŒ©Œ\ŽiC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åjCrˆäLŽ¡iŽO•H“d‹Cj: ‘æ11‰ñ“ú–{MEŠw‰ïH‹G‘å‰ï
(89.10.17`18), ŽD–yC ˆã—p“dŽq‚ƶ‘ÌHŠw, 27(2): 158, 1989.
1807. mŠw‰ïn iˆê”Êu‰‰j ŽèŽw‚É”¶‚µ‚½“÷Žî‚Ì1—á. ¼X“N˜YC‘å–ìŽiC¬—Ñ–¾³CŽRèŠÞCŽR–{Œ›ˆêC“ñŒ©r˜Yi®ŠOj: ‘æ521‰ñŠÖ“Œ®Œ`ЊQˆãŠw‰ïŒŽ—á‰ï (89.10.25).
1808. mŠw‰ïn iˆê”Êu‰‰j ‹[Ž—‘̉t’†‚É‚¨‚¯‚élHŠÖßÞ—¿‚Ì–€–Õ‚É”º‚¤‹à‘®ƒCƒIƒ“‚Ì—no.
¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnj: ‘æ34Šú“ú–{ŠŠŠw‰ï (89.10.25`26), •xŽRC —\eW,
p.507, 1989.
1809. mŠw‰ïn iˆê”Êu‰‰j Cefuzonam SodiumiƒRƒXƒ‚ƒVƒ“j‚ð“Y‰Á‚µ‚½PMMAœƒZƒƒ“ƒg‚Ì‹“x.
X“c^ŽjC”nŸº´Ž‘i¶‘ÌHjCù“c’¼i“ŒH‘åj: ‘æ11‰ñƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï (89.10.27`28), ‹ž“sC —\eW, p.18,
1989.
1810. mŠw‰ïn iˆê”Êu‰‰j ‰¡Ž~‚߃lƒW‚ð—p‚¢‚½lHŒÒŠÖßœ“ª‚ÌV‚µ‚¢ŒÅ’è–@.
”nŸº´Ž‘C“¡]—T“¹i¶‘ÌHjCŽ…–ž·Œ›CŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ11‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï‘å‰ï (89.10.28),
‹ž“sC —\eW, p.47, 1989.
1811. mŠw‰ïn iˆê”Êu‰‰j •Ð‘¤«“Á”«‰º‘ÚŠO”P‚Ì1—á. ‹v•Û•×C‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC‹{“c—fCå‚Œ´—L’jC¼Œ³‰ë•FC¬‹{Gˆê˜YC“ñŒ©r˜YC’Ë–{s’jC‹ß“¡‘׈êi®ŠOj: ‘æ77‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.11.04), ‰¡•l.
1812. mŠw‰ïn iˆê”Êu‰‰j œ”Õ‚¨‚æ‚ёΑ¤‰ºŽˆ‘½”œÜ‚Ì1—á. “n•Ó“NÆC“ì‘òˆç—YC¬—Ñ–¾³C‘å–ìŽiC¼‘º–¾lCŽ…–ž·Œ›i®ŠOjCV“¡³‹Pi‹~–½j: ‘æ77‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (89.11.04), ‰¡•l.
1813. mŠw‰ïn iˆê”Êu‰‰j ã˜rœŠOãè÷‰Š‚ɑ΂·‚é Boyed Žèp|p’†ŠŒ©‚ð’†S‚É|. “ñŒ©r˜YC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ17‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.10`11), ‘åã.
1814. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚霉–—Ê‚ÌQCT–@‚É‚æ‚錟“¢. —L•xŠ°C•Ä–{Œõˆêi®ŠOjC÷ˆä´ŽqCŠâ”g–Îi•új: ‘æ17‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.10`11), ‘åã.
1815. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŠÖߊŠ–ŒØœŒã‚ÌŽèŠÖ߈À’諂ɑ΂·‚é‰e‹¿‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêC“ñŒ©r˜YC’Ë–{s’jC—L•xŠ°C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ17‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.10`11), ‘åã.
1816. mŠw‰ïn iˆê”Êu‰‰j Banked Bone Grafting: Clinical Study on Allograft in
Corporation. Ž…–ž·Œ›CŽR–{^C‘å–ìŽiC‰¡ŽRˆê•FCã“cºŒái®ŠOj: 1st Meeting of Asia-Pacific
Assoc. of Surgical Tissue Banking (89.11.16), Bangkok, Thailand.
1817. mŠw‰ïn iˆê”Êu‰‰j Massive Osteoarticular Allograft in Treatment for
Malignant or Aggressive Bone Tumors. ‘å–ìŽiCŽ…–ž·Œ›CŽR–{^i®ŠOj: 1st Meeting of
Asia-Pacific Assoc. of Surgical Tissue Banking (89.11.16), Bangkok,
Thailand.
1818. mŠw‰ïn iˆê”Êu‰‰j Cold Preservation of Rat Limb in Euro-Collin's
Solution with CoQ10 Pretreatment. ‰¡ŽRˆê•FCŽ…–ž·Œ›CŽR–{^C‚ŠÝŒ›“ñCã“cºŒái®ŠOj: 1st
Meeting of Asia-Pacific Assoc. of Surgical Tissue Banking (89.11.16),
Bangkok, Thailand.
1819. mŠw‰ïn iˆê”Êu‰‰j ¶çG”^ávÇ‚É”º‚Á‚½•a“I’ÁœœÜ‚Ì1—á. ‹´–{˜a“TC‚ŠÝŒ›“ñC‘å–ìŽiC“ß{–ìG“ñCŽRèŠÞi®ŠOj: ‘æ19‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.11.18), “Œ‹ž.
1820. mŠw‰ïn iˆê”Êu‰‰j œ“àŽ‰–bŽî‚Ì3—á. ŽR–{Œ›ˆêC—é–Ø~CŽRèŠÞC‘å–ìŽiC¬—Ñ–¾³CŽ…–ž·Œ›CŽR–{^i®ŠOj: ‘æ19‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ï (89.11.18), “Œ‹ž.
1821. mŠw‰ïn iˆê”Êu‰‰j —LçêœçêœÜ5—á‚ÌŽ¡—ÃŒoŒ±. “n•Ó®C“ì‘òˆç—YCr–Ø’ˆêC¬—Ñ–¾³C“ñŒ©r˜YCŽR–{^i®ŠOj: ‘æ19‰ñ“ú–{ƒŠƒEƒ}ƒ`ŠÖߊO‰ÈŠw‰ï (89.11.18), “Œ‹ž.
1822. mŠw‰ïn iˆê”Êu‰‰j ƒKƒ“ƒOƒŠƒIƒ“‚É‚æ‚éž™‰º‹Ø–ƒáƒ‚Ì1—á. ŽÂŒ´OsC‚ŠÝŒ›“ñC“ì‘òˆç—YC¬—Ñ–¾³C¼‘º–¾lCrˆä‹`FCŽRŒû—Ǭi®ŠOj: ‘æ522‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (89.12.16).
1823. mŠw‰ïn iˆê”Êu‰‰j ‰ºŠ{œœÜ‚ɑ΂·‚éƒ~ƒjƒvƒŒ[ƒg‚ÌŽg—pŒoŒ±. ÷ˆäŽ¡²iŒ`ŠOj: é‹ÊŒ§ˆãŠw‰ï (90.01.21), ‰Y˜a.
1824. mŠw‰ïn iˆê”Êu‰‰j •GŠÖßSk‚𔺂Á‚½Kashin-Beck•a‚Ì1—á. å‚Œ´—L’jC‹v•ÛŽ›‘å–çC“‡Kˆè•vCb”ãGŽÀC‹v•Û•×C¬‹{Gˆê˜YC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ523‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (90.01.27), “Œ‹ž.
1825. mŠw‰ïn iˆê”Êu‰‰j —¼‘¤½œ‰“ˆÊ’[Øœp‚ðŽ{s‚µ‚½¶çG”^ávÇ«ŠÖßÇ‚Ì1—á. –q–ìk•¶C‚ŠÝŒ›“ñC‘å–ìŽiC“ì‘òˆç—YCã“cºŒáC‹àˆä“¿²CŽ…–ž·Œ›i®ŠOj: ‘æ523‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (90.01.27), “Œ‹ž.
1826. mŠw‰ïn iˆê”Êu‰‰j ‘å‘Úœ‰“ˆÊ•”œ“î‚ÌŽîᇊ‚ɜ܂𶂶‚½2—á. •½“c‰ë—TC‘å–ìŽiC¡–ì~C‹´–{˜a“TCŽ…–ž·Œ›i®ŠOj: ‘æ524‰ñŠÖ“Œ®Œ`ЊQŠO‰ÈŠw‰ïŒŽ—á‰ï (90.02.24), “Œ‹ž.
1827. mŠw‰ïn iˆê”Êu‰‰j Žè‚Ì‚ˆ³’“ü‘¹‚Ì1—á. ŒIŒ´–«C¬—Ñ–¾³C‰¡ŠÖ~C“ñŒ©r˜Yi®ŠOj: ‘æ78‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (90.03.03), ‰¡•l.
1828. mŠw‰ïn iˆê”Êu‰‰j ŠÏŒŒ“IŽ¡—Âðs‚Á‚½½œ‹UŠÖß‚ÌŽ¡—ÃŒoŒ±. ¼‘º–¾lC“ì‘òˆç—YCŽRŒû—ǬCr–Ø’ˆêC‚ŠÝŒ›“ñCŽ…–ž·Œ›CŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ78‰ñ_“Þ쮌`ЊQŠO‰Èˆã‰ï (90.03.03), ‰¡•l.
1829. mŠw‰ïn iŒöŠJuÀj ¶‘̂ƃgƒ‰ƒCƒ{ƒƒW. ”nŸº´Ž‘i¶‘ÌHj: ‘æ67Šú“ú–{‹@ŠBŠw‰ï’Ê푉ïu‰‰‰ï¥æ’[‹ZpƒtƒI|ƒ‰ƒ€ (90.03.31), “Œ‹ž, Ž‘—¿W, Vol. D, p.221`223, 1990.
1830. mŒ¤‹†‰ïn i“Á•Êu‰‰j —â“€•Û‘¶“¯ŽíœˆÚAiœ‹âsj‚ɂ‚¢‚Ä. ŽR–{^i®ŠOj: _“ÞìƒIƒXƒeƒ“Œ¤‹†u‰‰‰ï (90.03.01).
1831. mŒ¤‹†‰ïn i‹³ˆçu‰‰j œÜŽ¡—Âɋy‚Ú‚·—ÍŠw“IˆöŽq‚Ìì—p. ”nŸº´Ž‘i¶‘ÌHj: ‘æ15‰ñœÜŒ¤‹†‰ï (89.07.16), ‰ªŽRC —\eWCp.133, 1989.
1832. mŒ¤‹†‰ïn i‹³ˆçu‰‰j •ÏŒ`«ŠÖßÇ‚Ì•a‘Ô‚ÆŽ¡—Ã. ŽR–{^i®ŠOj: ŒF–{ƒŠƒEƒ}ƒ`ŠÖߎ¾Š³Œ¤‹†‰ï (89.10.07), ŒF–{.
1833. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‘“à“B‚É‚æ‚éœÜŽ¡—ÂÌH•v. Ž…–ž·Œ›i®ŠOj: ŒF–{œÜŒ¤‹†‰ï (89.10.14), ŒF–{.
1834. mŒ¤‹†‰ïn i‹³ˆçu‰‰j œŽ¾Š³‚Ɖ摜f’f. ¼—Ñ—²i•új: •½¬Œ³”N“x_“Þ쌧f—ÕúŽËü‹ZpuK‰ï (89.10.15), ‰¡•l.
1835. mŒ¤‹†‰ïn i‹³ˆçu‰‰j RA‚ÌŠO‰È“I—Ö@. —L•xŠ°i®ŠOj: “ú–{ƒŠƒEƒ}ƒ`à’c_“Þì’n‹æƒŠƒEƒ}ƒ`‹³ˆçŒ¤C‰ï (89.11.05), ‰¡•l.
1836. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‘“à“B‚̌Œè—Í‚Æ‚»‚Ì‘Îô. ŽR–{^i®ŠOj: ‘æ2‰ñ–¼ŒÃ‰®Žs‘完`ŠO‰È“¯–å‰ï (89.12.09), –¼ŒÃ‰®.
1837. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —ÍŠw“IŽhŒƒ‚É‚æ‚éŠÖß‚ÌŒ`¬.
’†ŽR“Oi“‡’ûìŠjCù“c’¼i“ŒH‘åjC“¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjCŽR–{^i®ŠOjC’|“à“ÖŽqi¶‰»Œnj:
‘æ9‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (89.03.11), “Œ‹žC —\eW, p.3, 1989.
1838. mŒ¤‹†‰ïn iˆê”Êu‰‰j SUS316ƒXƒeƒ“ƒŒƒX|‚Ì”æ˜J‹““®‚É—^‚¦‚é—n‘¶Ž_‘f‚̉e‹¿.
X“c^Žji¶‘ÌHjC’Ë–{s’ji®ŠOjCù“c’¼i“ŒH‘åjC–쑺ŒM: ‘æ19‰ñlHŠÖߌ¤‹†‰ï (89.02.03`04), “Œ‹žC —\eW,
p.68, 1989.
1839. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖßÞ—¿‚Ì–€–ÕŽŽŒ±. ”nŸº´Ž‘CX“c^Žji¶‘ÌHjCŽR–{^i®ŠOjCù“c’¼C‘O‘ò”Œ•Fi“ŒH‘åj: ‘æ9‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€ (89.03.11), “Œ‹ž.
1840. mŒ¤‹†‰ïn iˆê”Êu‰‰j •G‚Ìosteochondral fracture‚ÌŽ¡—ÃŒoŒ±.
‹v•ÛŽ›‘å–çC’Ë–{s’jC“ñŒ©r˜YCb”ãGŽÀC‘OŒ´G•vC“n•Ó®CˆÀ’BŒöCŽO—Ö´ŽuC¬—Ñ–¾˜YC‘O”V‰€‘½KCŽR–{^i®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï
(89.07.14`15), ‰ªŽR, œÜ, 11: 1989.
1841. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰~“›“B‚Ë‚¶‰¡Ž~‚ß–@‚ð—p‚¢‚½‘å‘Úœ“]Žq•”œÜ‚ÌŽ¡—Ã.
“ì‘òˆç—YCŽRèŠÞC¼‘º–¾lCŽO—Ö´ŽuC¬—Ñ–¾³C‘å–ìŽiCŽ…–ž·Œ›CŽR–{^i®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15),
‰ªŽR, œÜ, 11: 1989.
1842. mŒ¤‹†‰ïn iˆê”Êu‰‰j d“x‘å‘ÚœŠJ•úœÜ‚Ì1—á. Ž…–ž·Œ›i®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15), ‰ªŽR, œÜ, 11: 1989.
1843. mŒ¤‹†‰ïn iˆê”Êu‰‰j “¯‘¤ã˜rœA‘O˜rœœÜ(floating elbow)‚ÌŒŸ“¢.
¬—Ñ–¾³C“ì‘òˆç—YC‰¡ŽRˆê•FCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14`15), ‰ªŽR,
φ, 11: 1989.
1844. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ¨ŠÖߎ¾Š³‚ɑ΂·‚é’´‰¹”gŒŸ¸–@|äF”Â’f—ô‚ð’†S‚Æ‚µ‚Ä|. ‚ŠÝŒ›“ñC‘O“cŒ’“ñCŽR–{^i®ŠOjC‰L–ì˜a‘¥CHŽR‚¢‚í‚«i‘Š–ÍH‘åj: ‘æ1‰ñ“ú–{®Œ`ŠO‰È’´‰¹”gŒ¤‹†‰ï (89.07.29), ‘åã.
1845. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒŠƒEƒ}ƒ`ŽèŠÖߊŠ–ŒØœp‚ÌŒŸ“¢. •Ä–{ŒõˆêC“ñŒ©r˜YC’Ë–{s’jC—L•xŠ°C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ18‰ñ“Œ“ú–{ƒŠƒEƒ}ƒ`‚ÌŠO‰ÈŒ¤‹†‰ï (89.08.05), H“c.
1846. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ\ƒPƒbƒg‚É–â‘è‚Ì‚ ‚Á‚½lHŒÒŠÖßÄ’uŠ·pŽ{s‚Ì2—á. ã“cºŒáC—L•xŠ°CŠÖŒû¹˜aCŽR“c—F‹vi®ŠOj: ‘æ18‰ñ“Œ“ú–{ƒŠƒEƒ}ƒ`‚ÌŠO‰ÈŒ¤‹†‰ï (89.08.05), H“c.
1847. mŒ¤‹†‰ïn iˆê”Êu‰‰j •GŠW‘å‘ÚŠÖߓʂ̌Ÿ“¢‚Æ•GŠWœœØ‚èp. ‹v•ÛŽ›‘å–çi®ŠOj: ‘æ4‰ñŠÖ߃tƒH[ƒ‰ƒ€ (89.08.30), “Œ‹ž.
1848. mŒ¤‹†‰ïn iˆê”Êu‰‰j •G—ÍŠwŽŽŒ±ƒƒ{ƒbƒg‚ÌŽŽì. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjC’Ë–{s’jCŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ16‰ñ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï (89.09.02), “Œ‹ž.
1849. mŒ¤‹†‰ïn iˆê”Êu‰‰j —h“®‰~ŒÊ‰^“®‚É‚æ‚è\¬‚µ‚½‹UŠÖß‚Ì–€ŽC‹““®. “¡]—T“¹C”nŸº´Ž‘i¶‘ÌHjCŽ…–ž·Œ›CŽR–{^i®ŠOjCù“c’¼i“ŒH‘åj: ‘æ16‰ñ®Œ`ŠO‰ÈƒoƒCƒIƒƒJƒjƒNƒXŒ¤‹†‰ï (89.09.02), “Œ‹ž.
1850. mŒ¤‹†‰ïn iˆê”Êu‰‰j œŽîᇂɑ΂·‚铯Ží•Û‘¶œˆÚA; osterochondral ‚¨‚æ‚Ñsegmental
graft‚ÌŒoŒ±. ‘å–ìŽiCŽ…–ž·Œ›CŽR–{^Cã“cºŒáC¬—Ñ–¾³C»•ÓŠ®Ž¡C’Ë–{s’ji®ŠOj: ‘æ8‰ñœ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï
(89.09.14`15), “Œ‹ž.
1851. mŒ¤‹†‰ïn iˆê”Êu‰‰j RatŒãŽˆ‚ð—p‚¢‚½•¡‡‘gD‚Ì•Û‘¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|’Pƒ—â‹p•Û‘¶‚ÌŒÀŠE‚ÆRŽ_‰»Ü‚Ì—LŒø«‚ɂ‚¢‚Ä|.
‰¡ŽRˆê•FCŽ…–ž·Œ›C‚ŠÝŒ›“ñCŽR–{^i®ŠOj: ‘æ8‰ñœ¥ŠÖߥ“î•”‘gDˆÚAŒ¤‹†‰ï (89.09.14`15), “Œ‹ž.
1852. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ‹»—U”«ŠÖ߉Š¥CPPD’¾’…Ç. –Ø“c–FŽ÷CŠâŸºŒ[ˆêi•a—j: _“Þì•a—ˆã‰ï (89.09.28), ‰¡•l.
1853. mŒ¤‹†‰ïn iˆê”Êu‰‰j •ÏŒ`«•GŠÖßǂɑ΂·‚éäCœ•”•ªØœp‚ÌŽŽ‚Ý.
“ñŒ©r˜YC’Ë–{s’jC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC–kŒ©Œ\ŽiCˆÀ’BŒöC‹{“c—fCå‚Œ´—L’jC“n•Ó®i®ŠOjC”nŸº´Ž‘CX“c^ŽjC“¡]—T“¹i¶‘ÌHj:
‘æ9‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (89.09.30), ‰¡•l.
1854. mŒ¤‹†‰ïn iˆê”Êu‰‰j Power-lifting‚É‚æ‚趂¶‚½Clay Shoveller's Fracture‚Ì1—á. ‹v•ÛŽ›‘å–çi®ŠOj: ‘æ11‰ñ“Œ“ú–{ƒXƒ|[ƒcˆãŠwŒ¤‹†‰ï (89.10.01), “Œ‹ž.
1855. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒWƒ‡ƒMƒ“ƒO‚É‚æ‚éáŠQi‘æ‚P•ñj. ‚ŠÝŒ›“ñi®ŠOj: ‘æ11‰ñ“Œ“ú–{ƒXƒ|[ƒcˆãŠwŒ¤‹†‰ï (89.10.01), “Œ‹ž.
1856. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆŸ’E‰P«ŒÒŠÖßǂɑ΂·‚é‘å‘ÚœŠO”½‹ü‹ÈœØ‚èp‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêCŽ…–ž·Œ›Cã“cºŒáC’Ë–{s’jCŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ16‰ñ“ú–{ŒÒŠÖߌ¤‹†‰ï (89.11.23`24), •Ÿ‰ª.
1857. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å‘ÚœŒz‰óŽ€‚ɑ΂·‚éŽxŽœ’ŒˆÚAp‚ÌŽ¡—ÃŒoŒ±. ¬—Ñ–¾³CŽR–{^CŽ…–ž·Œ›C“ì‘òˆç—YC—é–Ø~Cù–{Œ›’ji®ŠOj: ‘æ16‰ñ“ú–{ŒÒŠÖߌ¤‹†‰ï (89.11.23`24), •Ÿ‰ª.
1858. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒÜ\Œ¨‚É‚¨‚¯‚éMRIŠŒ©. ‚ŠÝŒ›“ñC‘O“cŒ’“ñC•Ä–{ŒõˆêC‰Ô“ˆ”ü“ÞŽqC¼‘º–¾lCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^i®ŠOjC’r“crºi•új: ‘æ16‰ñ“ú–{Œ¨ŠÖߌ¤‹†‰ï (89.11.23`24), •Ÿ‰ª.
1859. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖß‚ÌŠŠ‚Æ‚»‚̉ž—p. ’Ë–{s’ji®ŠOj: ‘Š–ÍŒ´ŽsˆãŽt‰ïŠO‰È®Œ`ŠO‰Èˆã‰ï (89.12.02), ‘Š–ÍŒ´.
1860. mŒ¤‹†‰ïn iˆê”Êu‰‰j “]ˆÚ«œŽîᇂª‹^‚í‚ꂽ’pœ”æ˜JœÜ‚Ì1—á. ŒIŒ´–«CŠÖŒû¹˜aCr–Ø’ˆêCŽR“¿‹`˜YC“ì‘òˆç—YC¬—Ñ–¾³CŽ…–ž·Œ›i®ŠOj: ‘æ11‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï (90.01.13), ‰¡•l.
1861. mŒ¤‹†‰ïn iˆê”Êu‰‰j —¼‘¤•GœëŠ³—á‚ɑ΂·‚é‘SlH•GŠÖß’uŠ·p‚É‚æ‚é‘Ήž. ’Ë–{s’jC‹v•ÛŽ›‘å–çC–kŒ©Œ\ŽiC“ñŒ©r˜YC•Ä–{ŒõˆêCŽO—Ö´Žui®ŠOj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s.
1862. mŒ¤‹†‰ïn iˆê”Êu‰‰j MullerŒ^lHŒÒŠÖß5”NˆÈãŒo‰ß—á‚Ì‚wüŠw“IŒŸ“¢. •Ä–{ŒõˆêCŽ…–ž·Œ›C’Ë–{s’jCŽR–{^Cù–{Œ›’ji®ŠOj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s.
1863. mŒ¤‹†‰ïn iˆê”Êu‰‰j R¶ÜCefuzonam sodium (Cosmosin)‚ð“Y‰Á‚µ‚½PMMAœƒZƒƒ“ƒg‚Ì‹“xŽŽŒ±.
X“c^Žji¶‘ÌHjC—L•xŠ°i®ŠOj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s, —\eW, p.67, 1990.
1864. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖßÞ—¿‚Ì‹[Ž—‘Ì“à‰t’†‚Å‚Ì–€–Õ. ¼‘ò“N˜NCù“c’¼i“ŒH‘åjCX“c^ŽjC”nŸº´Ž‘i¶‘ÌHj: ‘æ20‰ñlHŠÖߌ¤‹†‰ï (90.02.02`03), ‹ž“s, —\eW, p.68, 1990.
1865. mŒ¤‹†‰ïn iˆê”Êu‰‰j ã˜rœŠO¥“àè÷‰Š‚ɑ΂·‚éŠO‰È“I—Ö@. “ñŒ©r˜YC•Ä–{ŒõˆêC’Ë–{s’jC¬—Ñ–¾³CŽR–{^i®ŠOj: ‘æ2‰ñ“ú–{•IŠÖߌ¤‹†‰ï (90.02.10), “Œ‹ž.
1866. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‚©‚©‚¦‚ ‚°ƒXƒgƒŒƒXŽB‰e‚É‚æ‚éACL‘¹‚ÌŒŸ“¢. –kŒ©Œ\ŽiC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC‹g–ìŽõ˜YC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ11‰ñ“Œ‹ž•GŠÖߌ¤‹†‰ï (90.02.17), “Œ‹ž.
1867. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒL[ƒ“ƒxƒbƒN•a‚ɑ΂·‚éstrut bone graft‚ÌŽŽ‚Ý. “ñŒ©r˜YC¬—Ñ–¾³C•Ä–{ŒõˆêCŽá—ÑL”VC‹v•ÛŽ›‘å–çCŽO—Ö´ŽuC’Ë–{s’jCŽR–{^i®ŠOj: ‘æ4‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï (90.02.17), “Œ‹ž.
1868. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰¼œ‰„’·–@‚É‚æ‚é•êŽwÄŒš‚Ì1—á. ¬—Ñ–¾³C“ñŒ©r˜YC“n•ÓX‹vi®ŠOj: ‘æ4‰ñ“Œ“ú–{Žè‚ÌŠO‰ÈŒ¤‹†‰ï (90.02.17), “Œ‹ž.
1869. mŒ¤‹†‰ïn iˆê”Êu‰‰j •GŠÖß…Žî‚ð‰”Çó‚Æ‚µ‚½ˆ««•F“÷Žî‚Ì1—á. ¼X“N˜YC‘å–ìŽiCŽRèŠÞC—é–Ø~C—L•xŠ°i®ŠOj: ‘æ15‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï (90.02.24), ‰¡•l.
1870. mŒ¤‹†‰ïn iˆê”Êu‰‰j lHŠÖß “®•”Þ‚Ì“K«•]‰¿C“Á‚É‹à‘®ƒCƒIƒ“—no‚É‹y‚Ú‚·ƒAƒ‹ƒuƒ~ƒ“‚̉e‹¿‚ɂ‚¢‚Ä.
X“c^Žji¶‘ÌHjCˆäã—tŽqi—\–hˆãŠwŒnjC”nŸº´Ž‘i¶‘ÌHjC¼‘ò“N˜NCù“c’¼i“ŒH‘åj: ‘æ10‰ñƒoƒCƒIƒgƒ‰ƒCƒ{ƒƒWƒVƒ“ƒ|ƒWƒEƒ€
(90.03.03), “Œ‹ž, —\eW, p.1, 1990.
1871. mŒ¤‹†‰ïn iˆê”Êu‰‰j Vargas•Ï–@‚É‚æ‚錨½ŠÖß’E‰P‚ÌŽ¡—ÃŒoŒ±. r–Ø’ˆêC‚ŠÝŒ›“ñC•Ä–{ŒõˆêC“ì‘òˆç—YC‘O“cŒ’“ñCŽ…–ž·Œ›C’Ë–{s’ji®ŠOj: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.
1872. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒÒŠÖߎèp‚É‚¨‚¯‚釕¹Ç. •Ä–{ŒõˆêC’†‘ºˆêmCŽ…–ž·Œ›C’Ë–{s’jC—L•xŠ°CŽR–{^i®ŠOj: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.
1873. mŒ¤‹†‰ïn iˆê”Êu‰‰j •GŠWœ’E‰P‚É”º‚¤osteochondral fracture‚Ì—L–³. ‹v•ÛŽ›‘å–çCå‚Œ´—L’jC–kŒ©Œ\ŽiC‹{“c—fC“ñŒ©r˜YC’Ë–{s’ji®ŠOj: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.
1874. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘å‘Ú’¼‹Ø‚̃Aƒ~ƒƒCƒh[ƒVƒX‚É‚æ‚éŒÒŠÖßáŠQ‚𗈂µ‚½‚P“§Í—á. “n•ÓX‹vCŽ…–ž·Œ›CŽR–{Œ›ˆêC•“cŒo—mC¬—Ñ–¾³i®ŠOjC÷ˆäŒ’Ž¡: ‘æ10‰ñ_“ÞìŠÖߊO‰ÈŒ¤‹†‰ï (90.03.31), ‰¡•l.
1875. m“Á‹–n “ú–{CœƒZƒƒ“ƒg—p•â•‹ï. X“c^Žji¶‘ÌHjC‘å‘òF–¾CçH˜a‹viƒeƒ‹ƒ‚j.
1876. mŠw‰ï‰ï“ªi‰ï’·jn “ú–{®Œ`ŠO‰ÈŠw‰ïiŽÐ’c–@lj:‘æ4‰ñ“ú–{®Œ`ŠO‰ÈŠw‰ïŠî‘bŠwpW‰ïi89.08.31`09.01j. ŽR–{^i®ŠOj.
<<110 Š´ŠoŠí‚Ɣ畆>>
1877. mŒ´’˜n Requirement of Serum Factors for Wound Closure of Embryonic
Skin in vitro. Kistler, A.C’–Œ´ß”V‰îiŒ`ŠOj: Ann. Plast. Surg., 23: 479`487,
1989.
1878. mŒ´’˜n lŠÔƒhƒbƒNŽófŽÒ‚Ì”N—î•Êƒ‰¹’®—Í. ‰ª–{–qlCÝŠy“N–çC–àŽRˆÀOC•½ŽR•ûrCΈä–L‘¾iŽ¨•@j: Audiology Japan.
1879. mŒ´’˜n Regulation of Mammalian Melanogenesis by Tyrosinase
Inhibition. ‹TŽRFˆê˜Yi”çjCJimenez, M.CMuller J.CIshida, Y.CHeavy, V.J.(NIH):
Differentiation, 42(12): 28`36, 1989.
1880. mŒ´’˜n Comparative Ultrastructural Study of Rabbit Muller Cells in
Vitro and Situ. Žá‘q‰ë“oiŠájC Wallace S. Foulds (Univ. of Glasgow): Eye,
2(12): 664`669, 1988.
1881. mŒ´’˜n Senile Erythroderma with Serum Hyper IgE. óˆär–íC–x“à•ÛGi”çj: Intern. J. Dermatol., 28(4): 255`258, 1989.
1882. mŒ´’˜n Bilateral Slowly Progressive Big Blind Spot Syndrome. Žá‘q‰ë“oCŒÃ–ì‹v”üŽqiŠáj: J. Clin. Neuro-Ophtalmol., 9(3): 141`143, 1989.
1883. mŒ´’˜n A Monoclonal Antibody, SKH1, Reacts with 40Kd Sweat
Gland-associated Antigen. —é–Ø—T‰îC‹´–{Œ’C‰Á“¡ˆê˜YC¼‰ª´C‰q“¡ŒõC¼ŽR–Εvi”çjC_è•Ûi–¼Žs‘åj: J.
Cutan. Pathol., 16: 66`71, 1989.
1884. mŒ´’˜n Tumoral Calcinosis in Scleroderma. •ÐŽRˆê˜NC“Œˆê‹ICŒüˆäGŽ÷C¼‰ª´C¼ŽR–Εvi”çj: J. Dermatol., 16(1): 82`85, 1989.
1885. mŒ´’˜n Drug-induced Chronic Pigmented Purpura. ¼‰ª´C•ÐŽRˆê˜NC‘‘òŠ²’jC‰¡ŠÖ”Ž—YCŽR–Εvi”çj: J. Dermatol., 16(3): 220`222, 1989.
1886. mŒ´’˜n A Case of Sclerosing Lymphangitis of the Lip. ˆî‘ºŒ\ˆêC—é–Ø—T‰îC¼‰ª´C¼ŽR–Εvi”çj: J. Dermatol., 17(2): 127`129, 1990.
1887. mŒ´’˜n Poikiloderma-like Lesion on the Neck in Atopic Dermatitis.
ŒüˆäGŽ÷C¼‰ª´C㑺m•vC•ÐŽRˆê˜NC¼ŽR–Εvi”çj: J. Dermatol., 17(2): 85`91, 1990.
1888. mŒ´’˜n Deposition of the Membrane Attack Complex of Complement in
Pemphigus Vulgaris and Pemphigus Foliaceus Skin. ì–¼½ŽiCGeoghegan,
W.D.CJordon, R.E.C¼ŽR–Εvi”çj: J. Invest. Derm., 92: 588`592, 1989.
1889. mŒ´’˜n Herpes Simplex Virus 1 Infection Upregulates Stress Protein
Expression in Cultured Retinal Neurons. Peter G.E. Kennedy (Univ. of
Glasgow), Žá‘q‰ë“oiŠájCWallace S. FouldsC Geoffrey B. Clements (Univ. of
Glasgow): J. Neurol. Neurosurg. Psychiatr., 53: 72`75, 1990.
1890. mŒ´’˜n A Case of Phenobarbital-induced Optic Neuropathy. –{ŠÔŒ[ŽOCŽá‘q‰ë“oCÎì“NiŠáj: Neuro-ophthalmology, 9(6): 357`360, 1989.
1891. mŒ´’˜n A Quasistatic Study of Pupil and Accommodation After-Effects
Following Near Vision. “y‰®–M•FC‰LŽ”ˆê•FCÎì“NiŠáj: Ophtalmic & Physiological
Optics, 9(4): 385`391, 1989.
1892. mŒ´’˜n “÷‰èŽî—l‘gD‘œ‚ð’悵‚½‹u]«”~“Å]. “”I‹BC㑺‰ëŽqC“”I^—CÄ“¡—²ŽOi”çj: STDC16: 10`13, 1989.
1893. mŒ´’˜n 10¹ŒŽ—î‚©‚ç13¹ŒŽ—î˜V‰»‘£iƒ}ƒEƒX…»‘̂̉Á—ω». ¼–{_”VC‰F‰ê–ÎŽOC‹{“cŠ²•vCÎì“NiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 6(12): 1851`1853, 1989.
1894. mŒ´’˜n Œã“V«‚ɔǂµ‚½‚ÆŽv‚í‚ê‚éDuaneÇŒóŒQ‚Ì1—á. ŠÖ’JŽ¡‹vC‹ß“¡‰À•vCŒü–ì˜a—YiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 6(6): 885`888, 1989.
1895. mŒ´’˜n ƒuƒ‰ƒ“ƒnƒƒ‰EƒJƒ^ƒ‰[ƒŠƒXŒ‹–Œ‰Š|¬Ž™‚¨‚æ‚јVl‚É‚¨‚¯‚錋–Œ‰Š‚ÌŒ´ˆö‚Æ‚µ‚Ä. â–{‘¥•qiŠáj: ‚ ‚½‚炵‚¢Šá‰È, 6(7): 1067`1069, 1989.
1896. mŒ´’˜n –k—¢‘åŠw•a‰@Šá‰È‚É‚¨‚¯‚éŽãŽ‹Š³ŽÒ‚ÌŒŸ“¢. ’m–쇎qC–x”ÍŽqCˆÉ“¡‰ëŽqCŠÝ“cç•äŽqC–ؔÉC‰LŽ”ˆê•FCÎì“NiŠáj: Šá‰È—Õ°ˆã•ñ, 84(2): 243`247, 1990.
1897. mŒ´’˜n “ï’®‚𔺂Á‚½‘å“®–¬‰ŠÇŒóŒQ11Ç—á‚ÌŒŸ“¢. ˆî–ØŸ‰pCÝŠy“N–çC‰ª–{–qlC“¿‘Œú“ñC“¡–ì–¾lCΈä–L‘¾CŠ™“c—˜•FiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°C82(4): 537, 1989.
1898. mŒ´’˜n ¶–[”S‰tŽî‚É‚æ‚鶖ԖŒ’†S“®–¬•ÂÇÇ‚Ì1—á. ‹g“cŠ°iŠájCFŠ™·ˆêC“c•Ó“™i“s—§_Œo•a‰@j: _ŒoŠá‰È, 5(3): 319`325, 1988.
1899. mŒ´’˜n Šá‹…UṂ̎¡—Ãi‘æ1•ñjjŽ¡—Ö@. ¬‘òŽ¡•viŠáj: _ŒoŠá‰È, 6(2): 207`216, 1989.
1900. mŒ´’˜n Šáâ|ŠO‚ɇ•¹‚µ‚½“àŠá‹Ø–ƒáƒ‚Ì—Õ°Œo‰ß. ‰œ‰pOCŒü–ì˜a—YCÎì“NC’·’JìKŽqCŠÝ“cç•äŽqiŠáj: _ŒoŠá‰È, 6(4): 422`429, 1989.
1901. mŒ´’˜n ”畆ŒŒŠÇ‰Š‚Ì—Õ°“IŒ¤‹†i‘æ4•ÒjAnaphylactoid Purpura‚̖ƉuŠw“I”wŒi. ‰Á“¡ˆê˜YCóˆär–íC‘‘òŠ²’jCÄ“¡—²ŽOCì–¼½Žii”çjC‘¾“c”ü’ÃŽqi—ÕŒŸj: ¼“ú–{”畆‰ÈC51(5): 927`932, 1989.
1902. mŒ´’˜n
ƒrƒtƒHƒiƒ][ƒ‹iƒ}ƒCƒRƒXƒ|[ƒ‹‰tj‚É‚æ‚éŠpŽ¿‘BŒ^‘«”’á‚ɑ΂·‚é—Õ°Œø‰Ê‚ÌŒŸ“¢|10%”A‘f“îpiƒEƒŒƒp[ƒ‹j•¹—pŒQ‚Æ‚Ì”äŠrŒŸ“¢‚ð‰Á‚¦‚Ä|.
“cÀO”VC’†‘ºŒ’ˆêCŠâè‰ëC¼ŽR–Εvi”çj: ¼“ú–{”畆‰ÈC51(6): 1207`1210, 1989.
1903. mŒ´’˜n SLE, PSSŠ³ŽÒŒŒŸ÷’†‘æ‡[ˆöŽqAƒÀ°ƒgƒƒ“ƒ{ƒOƒƒuƒŠƒ“‚Ì‘ª’èˆÓ‹`. —é–Ø—T‰îC‘‘òŠ²’jC¼ŽR–Εvi”çj: ¼“ú–{”畆‰ÈC51: 268`271, 1989.
1904. mŒ´’˜n ‘gD”|—{–@‚ð—p‚¢‚½l‚¨‚æ‚Ñ“®•¨hair bulb-dermal papilla cell‚̶•¨Šw“I“Á’¥‚̉ðÍ.
Ÿ‰ªŒ›¶C’|èLˆê˜YC‰q“¡ŒõC–x“à•ÛGCˆî‘ºŒ\ˆêi”çj: “ú–{ƒŠƒfƒBƒAƒIƒŠƒŠ[‹¦‰ï63”N“x”N•ñCp.71`73, 1989.
1905. mŒ´’˜n ³í‘ÎŒõ”½‰ž‚̉Á—î‚É‚æ‚é•Ï‰»;@VŒ^‘oŠá«ÔŠOü“dŽq“µEŒv(C2515)‚ð—p‚¢‚½ŒŸ“¢. ’·’JìKŽqCÎì“NiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(10): 955`961, 1989.
1906. mŒ´’˜n ƒlƒRŠá—Ö‹Ø_ŒoŽx”z‚ÌŒ`‘ÔŠw“IŒ¤‹†|‚»‚̉^“®ƒjƒ…[ƒƒ“AŽx”z—L‘_Œo‚¨‚æ‚Ñ‹ØüˆÛ|. â–{‘¥•qCŒü–ì˜a—YC‰F‰ê–ÎŽOiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(10): 969`977, 1989.
1907. mŒ´’˜n ƒ^ƒoƒR‹i‰Œ‚ÌŽ‹Šo“Å«. ‰œ‰pOC•Ÿ“‡ˆêÆC²ŒÃ”ŽPC“ï”g—´lCŽá‘q‰ë“oiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(5): 617`624, 1989.
1908. mŒ´’˜n çtçsŠJŽUƒXƒeƒbƒv‰ž“š‚ÌŽw”ŠÖ”‹ßŽ—‚É‚æ‚é‰ðÍ. ŽR“c“OlC‰LŽ”ˆê•FCÎì“NiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(8): 859`864, 1989.
1909. mŒ´’˜n ƒAƒgƒs[«”畆‰ŠŠ³ŽÒ‚̃_ƒj“\•zŽŽŒ±A•a—‘gDŠw“IŒŸ“¢. ˆÉ“¡“ÄCŒüˆäGŽ÷C¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC100(1): 63`69, 1990.
1910. mŒ´’˜n ¬lŒ^ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“’ŽË‚É‚æ‚鎡—Ãi‡Tj|—Õ°“IŒŸ“¢|. ŒüˆäGŽ÷C¼‰ª´C㑺m•vCˆÉ“¡“ÄC–ìŒûr•FC“¡–{iC¼ŽR–ΕvCHŽR–Îi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC100(3): 425`432, 1990.
1911. mŒ´’˜n ¬lŒ^ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“’ŽË‚É‚æ‚鎡—Ãi‡Uj|ì—p‹@˜|. ŒüˆäGŽ÷C¼‰ª´C–ìŒûr•FC“¡–{iC¼ŽR–ΕvCHŽR–Îi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC100(3): 433`439, 1990.
1912. mŒ´’˜n ”A’`”’—z«‚ðŽ¦‚µ‚½‘Sg«‹”çÇ‚Ì—Õ°“IŒŸ“¢. ‹ß“¡Ž •vC“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çjC“¡ˆäˆêŽjC¬—Ñ–Li“àj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(10): 1105`1110, 1989.
1913. mŒ´’˜n ˆ««•FŽî×–E•À‚Ñ‚É‘gD’†‚̃Á-glutamyl transferase‚Ì“Á«‚ɂ‚¢‚Ä. •Ä–{N‘ C‹ß“¡Ž •vC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(11): 1139`1144, 1989.
1914. mŒ´’˜n ˆ««ŒŒŠÇ“à”ç×–EŽî‚ɑ΂·‚éƒCƒ“ƒ^[ƒƒCƒLƒ“2‹Ç’—Ö@‚ÌŒŸ“¢. ‘‘òŠ²’jC‘åìŽiCˆî‘ºŒ\ˆêC“Œˆê‹ICóˆär–íC–x“à•ÛGC¼‰ª´C¼ŽR–ΕvC‰Á“¡’m’‰i”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(12): 1459`1466, 1989.
1915. mŒ´’˜n ”|—{ƒqƒg–Ñ“û“ª×–E‚É‚¨‚¯‚éƒAƒ“ƒhƒƒWƒFƒ“Œ‹‡’`”’‚Ì‹ÇÝ‚Ædihydrotestosterone‚̉e‹¿‚ÌŒŸ“¢.
Ÿ‰ªŒ›¶Cˆî‘ºŒ\ˆêC¼‰ª´C¼ŽR–Εvi”çjC¬ì’‰•¶ià–a‰»Ï•iŒ¤‹†Šj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(5): 529`536, 1989.
1916. mŒ´’˜n ‘Sg«g”Á«àÁá‡(SLE)‚É‚¨‚¯‚éRƒJƒ‹ƒWƒIƒŠƒsƒ“R‘Ì‚ÌoŒ»•p“x‚Æ—Õ°ÇóA—Õ°ŒŸ¸¬Ñ‚Æ‚ÌŠÖ˜A«. ‰¹ŽR˜aéC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(5): 537`541, 1989.
1917. mŒ´’˜n …áv«—Þ“Vávጅáv‰t’†‚Ìleukotriene (LT)B4‚¨‚æ‚ÑÞLTC4. ì–¼½ŽiC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(6): 659`664, 1989.
1918. mŒ´’˜n qí«“Vávጔ畆‚É‚¨‚¯‚é•â‘Ìmembrane attack complex‚ÌŒ`¬. ì–¼½ŽiC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(7): 833`836, 1989.
1919. mŒ´’˜n ”畆¬•ª‚ð”FŽ¯‚·‚éƒqƒgŒ^ƒ‚ƒmƒNƒƒi[ƒ‹Ž©ŒÈR‘Ì‚Ìì». ‰q“¡ŒõC’Ë–{G‘¾˜YC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(7): 853`860, 1989.
1920. mŒ´’˜n ”畆^‹ÛÇ‚É‚¨‚¯‚é–Ɖu‘gD‰»Šw“IŒŸ“¢. “cÀO”VCŠâè‰ëC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(9): 1007`1020, 1989.
1921. mŒ´’˜n …‹â‚É‚æ‚é‘Sg«ÚG”畆‰Š||Œo”ç‹zŽû‚Å‚àÄ”‚·‚éI óˆär–íC’|èLˆê˜YC–ìŒûr•FC•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆C31(‘6): 221`224, 1989.
1922. mŒ´’˜n ŒûO¥Œûo”S–Œ•a•Ï. ¼ŽR–Εvi”çj: ”畆‰È‚Ì—Õ°C31(8): 1161`1166, 1989.
1923. mŒ´’˜n Subacute Cutaneous Lupus Erythematosus (SCLE). “”I‹BCŽ›–{”ÍŽqCÄ“¡—²ŽOi”çj: ”畆‰È‚Ì—Õ°C31: 1261`1265, 1989.
1924. mŒ´’˜n ‹}«ˆê‰ß«ƒŠƒ“ƒp•‚Žî‚Ì1—á. “”I‹BC㑺‰ëŽqCÄ“¡—²ŽOi”çj: ”畆‰È‚Ì—Õ°C31: 657`660, 1989.
1925. mŒ´’˜n ––½_ŒoÇó‚𔺂Á‚½systemic lupus erythematosus. “”I‹BC‹TŽRFˆê˜YC‰q“¡Œõi”çj: ”畆•af—ÃC11: 681`684, 1989.
1926. mŒ´’˜n Variation in Degree of Auricular Flare for the Analysis of
Protrusion of Ears in a Random Japanese Population. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw,
19(2): 276`280, 1989.
1927. mŒ´’˜n Quantity of Phalangeal Hairs in a Random Japanese Population. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(3): 321`326, 1989.
1928. mŒ´’˜n ”|—{”畆ˆÚA‚ÌŠî‘b“IŒ¤‹†|‡WŒ^ƒRƒ‰[ƒQƒ“‚Ì•\”ç×–EƒRƒƒj[Œ`¬‚Ö‚ÌŒø‰Ê‚ɂ‚¢‚Ä|. ‘å’J’˱”VCŒÃŽR“o—²C’–Œ´ß”V‰îiŒ`ŠOj: –k—¢ˆãŠw, 20(2): 121`131, 1990.
1929. mŒ´’˜n ŽÎŽ‹EŽãŽ‹EŠáU‚Ì‚½‚ß‚ÌŽ‹”\ŒP—û. ¬—уŽqCŒü–ì˜a—YC¼Œ´ŒbŽqC¬‘òŽ¡•viŠáj: —Šw—Ö@, 6(5): 327`334, 1989.
1930. mŒ´’˜n ŽwŠÖß‹’¼‚𔺂Á‚½ƒAƒuƒ~œŒÅ’…Ç. ‹àŽqŒ÷C•½ŽR•ûrC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: —Õ°Ž¨‰ÈC16(1): 74`78, 1989.
1931. mŒ´’˜n ’†Ž¨ƒRƒŒƒXƒeƒŠƒ““÷‰èŽîÇ‚Ì—Õ°“IŒŸ“¢. ˆî–ØŸ‰pCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: —Õ°Ž¨‰ÈC16(3): 6`13, 1989.
1932. mŒ´’˜n ”畆ŒŒŠÇ‰Š‚ÌŒŒŠÇáŠQ‚Æ•â‘Ì. ì–¼½Žii”çj: —Õ°”畆‰ÈC43(6): 538`542, 1989.
1933. mŒ´’˜n Etretinate‚Ì“à•ž‚ª‘tŒø‚µ‚½Genodermatose‚Æ‚µ‚Ä‚ÌAcanthosis Nigricans. “”I‹BC㑺‰ëŽqCÄ“¡—²ŽOC‘ºm•vi”çj: —Õ°”畆‰ÈC43: 39`42, 1989.
1934. mŒ´’˜n ”畆•a•Ï‚Ìf’fŽè‹Z. •ÐŽRˆê˜NCŽ›–{”ÍŽqC¼‰ª´C¼ŽR–Εvi”çj: —Õ°–ƉuC21(Suppl.14): 301`309, 1989.
1935. m’Z•ñn A Trichilemmoma Cell Line Congenevate Interleukin-l-alpha.
¼‰ª´C•ÐŽRˆê˜NC‰q“¡Œõi”çjC ‘D“n’‰’ji—Õ•a—j: Dermatologica, 179(Suppl. 1): 135`136,
1989.
1936. m’Z•ñn The 1988 Japanese Neuro-ophthalmology Society Meeting. Žá‘q‰ë“oiŠáj: J. Clin. Neuro-Ophthalmol., 9(3): 211`213, 1989.
1937. m’Z•ñn u‘Ñóáv]v•a‘Ô‚ÆŽ¡—à (5)Šá‰È—̈æ‚É‚à‘½Ê‚È•a‘œ. Œü–ì˜a—YiŠáj: Modern Medicine, 19(2): 34`39, 1990.
1938. m’Z•ñn “úŒoƒƒfƒBƒNƒCƒY(7)Šá‰È. Žá‘q‰ë“oiŠáj: Nikkei Medical, (1989.5.10): 29`30, 1989.
1939. m’Z•ñn Oral Florid Papillomatosis‚ÌŽ¡—Ã;@CO2ƒŒ[ƒU[‚ÆEtretinate‚Ì•¹—p—Ö@. ˆÉ“¡“Äi”çj: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(12): 785, 1989.
1940. m’Z•ñn Šw‰ïˆóÛ‹L:@‘æ42‰ñ“ú–{—Õ°Šá‰ÈŠw‰ïˆê”Êu‰‰u_ŒoŠá‰ÈvƒZƒbƒVƒ‡ƒ“128`138. Œü–ì˜a—YC–ؔÉiŠáj: Šá‰È, 31(3): 371`374, 1989.
1941. m’Z•ñn ’¼ü‰Á‘¬“x•‰‰×‚Ì—Õ°ŒŸ¸‰ž—p. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: ‘æ2‰ñ‰F’ˆˆãŠwƒVƒ“ƒ|ƒWƒEƒ€MERSSŒ¤‹†‰ï; ’¼ü‰Á‘¬“x‚ɑ΂·‚é‘O’ëŠí‚Ì–ðŠ„Cp.82`90, 1989.
1942. m’Z•ñn Vogt-¬–ö°Œ´“c•a. “”I‹BC㑺‰ëŽqCŽ›–{”ÍŽqC“”I^—CÄ“¡—²ŽOi”çj: ”畆‰È‚Ì—Õ°, 31: 1685`1686, 1989.
1943. m’Z•ñn ”|—{”畆. ‰–’JMKCŒÃŽR“o—²iŒ`ŠOj: —Šw—Ö@ƒWƒƒ[ƒiƒ‹, 23(7): 491, 1989.
1944. m’Z•ñn Bilateral Big Blind Spot Syndrome‚Ì1—á. ŒÃ–ì‹v”üŽqCŽá‘q‰ë“oC‹{“cŠ²•viŠájC“’“cŒ“ŽŸi‰¡•lŽs‘åj: —Õ°Šá‰È, 43(7): 1130`1131, 1989.
1945. mŒ¤‹†•ñn l¶’·Šú–Ñ“û“ª×–E‚̶•¨Šw“I“Á’¥‚̉ðÍ‚ÆlH”畆‚Ìì». Ÿ‰ªŒ›¶C’|èLˆê˜YC‰q“¡ŒõCˆî‘ºŒ\ˆê˜Yi”çj: º˜a63,64”N“x‰ÈŠwŒ¤‹†”ï•â•‰ïiˆê”ÊŒ¤‹†‚bjŒ¤‹†¬‰Ê•ñ‘, 1989.
1946. mŒ¤‹†•ñn Candida albicans‚É‚æ‚é“àˆö«^‹Û«Šá“à‰Š‚ÌŽ¡—Ã;ƒAƒ“ƒzƒeƒŠƒVƒ“‚aŒ‹–Œ‰º’ŽË‚Ì—LŒø«. –Ø‘º^–çC“¡ˆä‰ë˜NCŒü–ì˜a—YiŠáj: —Õ°Šá‰È, 43(12): 1825`1831, 1989.
1947. mŒ¤‹†•ñn Ò‘¬”]•Ï«Ç‚É‚¨‚¯‚铵EáŠQ‚ɑ΂·‚錟“¢|•›ŒðŠ´_ŒoŒn‚ɂ‚¢‚Ä|. ‹g“cŠ°iŠáj: —Õ°Œ¤‹†•ñ‘, º˜a62”N“x, 1987.
1948. mŒ¤‹†•ñiŒú¶Èjn ‰uŠw•ª‰È‰ï•ñ. ÝŠy“N–çiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 23`24, 1989.
1949. mŒ¤‹†•ñiŒú¶Èjn “Ë”«“ï’®’®—͌Œ莞‚̃Aƒ“ƒP|ƒg’²¸‚ɂ‚¢‚Ä. ÝŠy“N–çCŒÃ‘òTˆêC‰ª–{–qlC•½ŽR•ûriŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 115`116, 1989.
1950. mŒ¤‹†•ñiŒú¶Èjn ŠOƒŠƒ“ƒpá‘‚É‚¨‚¯‚é•Û‘¶“IŽ¡—ÃÇ—á‚ÆŽèpŽ¡—ÃÇ—á‚ÌŒŸ“¢.
ÝŠy“N–çC‹àŽqŒ÷C‰ª–{–qlC”ª–؈ê‹LC“¿‘Œú“ñC²–씣C“¡–ì–¾lCŒÃ‘òTˆêiŽ¨•@j:
‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 141`142, 1989.
1951. mŒ¤‹†•ñiŒú¶Èjn ”½•œ«•½táŠQ‚Ì’®—Í•ª•z. ÝŠy“N–çC•½ŽR•ûrC‹àŽqŒ÷C‰ª–{–qliŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 165`167, 1989.
1952. mŒ¤‹†•ñiŒú¶Èjn “Á”«—¼‘¤«Š´‰¹“ï’®‚̈æ’l㌟¸. ÝŠy“N–çC•½ŽR•ûrC‰ª–{–qlCŒÃ‘òTˆêiŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 169`171, 1989.
1953. mŒ¤‹†•ñiŒú¶Èjn Š´‰¹“ï’®‚Ì–ò•¨Ž¡—Â̌»ó, ÝŠy“N–çC‰ª–{–qlC‹àŽqŒ÷C•½ŽR•ûrCˆî–ØŸ‰piŽ¨•@j: ‹}«‚“x“ï’®’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†‹ÆÑ•ñ‘C(63): 193`194, 1989.
1954. mŒ¤‹†•ñiŒú¶Èjn qí«“Vávጂ¨‚æ‚Ñ—Ž—tó“Vávጔ畆‚É‚¨‚¯‚é•â‘Ìmembrane attack complex‚ÌŒ`¬. ì–¼½Žii”çj: Œú¶È“Á’莾Š³Šó“«Ž¾Š³’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.153`158, 1989.
1955. mŒ¤‹†•ñiŒú¶Èjn …áv«—Þ“Vávጅáv‰t’†‚Ìleukotriene (LT)B4 ‚¨‚æ‚Ñ LTC4. ì–¼½Žii”çj: Œú¶È“Á’莾Š³Šó“«Ž¾Š³’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.215`220, 1989.
1956. mŒ¤‹†•ñiŒú¶Èjn ‘Sg«‹”çÇ‚É‚¨‚¯‚éRƒJƒ‹ƒWƒIƒŠƒsƒ“R‘Ì‚ÌoŒ»•p“x‚Æ—Õ°Çó‚Æ‚ÌŠÖ˜A«.
¼ŽR–ΕvC•ÐŽRˆê˜NC‹ß“¡Ž •vCŽ›–{”ÍŽqC‰q“¡ŒõC¼‰ª´CVˆätŽ}i”çj: Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘,
p.87`90, 1989.
1957. mŒ¤‹†•ñiŒú¶Èjn ”A’`”’—z«‚ðŽ¦‚µ‚½‘Sg«‹”çÇ‚Ì—Õ°“IŒŸ“¢. ¼ŽR–ΕvC•ÐŽRˆê˜NC¼‰ª´C‰q“¡ŒõCŽ›–{”ÍŽqC‹ß“¡Ž •vCVˆätŽ}i”çj: Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.163`169, 1989.
1958. mÇ—á•ñn ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“—Ö@|¬lŒ^ 2Ç—á‚ÌŽ¡—ÃŒoŒ±|. ŒüˆäGŽ÷C¼‰ª´C–ìŒûr•Fi”çj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 9(11): 740`742, 1989.
1959. mÇ—á•ñn ‹ÇŠ”ç•Ù‚É‚æ‚é‘¢ä`p. ‘厜–í—T”VC’†‘ºŒ³MCˆÀ•x‹`“NiŒ`ŠOj: Œ`¬ŠO‰È, 32(4): 357`361, 1989.
1960. mÇ—á•ñn Axial Frontal Flap ‚ÌŒoŒ±. ‘厜–í—T”VC’†‘ºŒ³MCˆÀ•x‹`“NiŒ`ŠOj: Œ`¬ŠO‰È, 32(8): 853`857, 1989.
1961. mÇ—á•ñn ˆê‘¤«“®Šá_Œo•s‘S–ƒáƒ‚𔺂Á‚½‹}«‘½”«ª_ŒoÇiƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQj‚Ì1—á. ‹g“cŠ°iŠájC²“¡Œ’ˆêC“c•Ó“™i“s—§_Œo•a‰@j: _ŒoŠá‰È, 5(4): 450`459, 1988.
1962. mÇ—á•ñn œƒJƒŠƒGƒX’¼ã”畆‚ɶ‚¶‚½—Þ“÷Žî—lŒ‹ŠjŒ‹ß. —é–Ø—T‰îC“cÀG”Vi”çj: ¼“ú–{”畆‰È, 52: 31`35, 1990.
1963. mÇ—á•ñn ƒ€ƒ`ƒ“’¾’…‚𔺂Á‚½üó‘Ûá‚̬l—á. ‘¾“cK‘¥C㑺m•vC¼–{KŽqC‰Í‘ºrŒõi”çj: ”畆‰È‚Ì—Õ°, 31(10): 1430`1431, 1989.
1964. mÇ—á•ñn ƒIƒLƒTƒgƒ~ƒhiƒZƒ‹ƒeƒNƒgj‚É‚æ‚é–ò]. ì–¼½Žii”çj: ”畆‰È‚Ì—Õ°, 31(10): 1436`1437, 1989.
1965. mÇ—á•ñn SLE‚Æ‘½”«‹Ø‰Š‚Ì Overlap Syndrome. ‹{–{G–¾CÄ“¡‚·‚Ýi•½’Ë‹¤Ï•a‰@jCŽá—Ñ–õ‹vi“àjC’†“ˆOi‰¡•lŽs‘åj: ”畆‰È‚Ì—Õ°, 31(4): 485`489, 1989.
1966. mÇ—á•ñn qí«Š£á‚ɇ•¹‚µ‚½’É•—‚Ì1—á||Š£áŠ³ŽÒ‚É”º‚¤‚”AŽ_ŒŒÇ‚Æ’É•—‚ÌŠÖŒW‚ɂ‚¢‚Ä||. Žíˆä—Ç“ñC“Œˆê‹IC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ”畆‰È‚Ì—Õ°, 31(9): 1231`1236, 1989.
1967. mÇ—á•ñn ‹›—Øá—lg”çÇ‚ðŽv‚킹‚½ˆŸ‰”Œ‡–RÇ. ‘¾“cK‘¥C“Œˆê‹IC•ÐŽRˆê˜NCŒüˆäGŽ÷C¼‰ª´C¼ŽR–Εvi”çj: ”畆‰È‚Ì—Õ°, 31(9): 1257`1260, 1989.
1968. mÇ—á•ñn Ž‘±‡–°—Ö@‚ª‘tŒø‚µ‚½MunchhausenÇŒóŒQ‚Ì1—á. Šâè‰ëC’Ë–{G‘¾˜Yi”çjC’ç–M•FC™ŽRˆêi¸j: ”畆‰È‚Ì—Õ°, 31(9): 1281`1285, 1989.
1969. mÇ—á•ñn …‹â‚É‚æ‚é‘Sg«ÚG”畆‰Š. óˆär–íC–ìŒûr•FC•ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 11(11): 966`969, 1989.
1970. mÇ—á•ñn ”畆ƒNƒŠƒvƒgƒRƒbƒNƒXÇ. Šâè‰ëC“cÀO”Vi”çjC‹v•ÄŒõi•a—jCˆ¢•””ü’mŽqi—ÕŒŸjC•ìºC‘å‹v•Û[li“àj: ”畆•af—Ã, 11: 605`608, 1989.
1971. mÇ—á•ñn Mondor•a. —é–Ø—T‰îi”çj: ”畆•af—Ã, 11: 875`878, 1989.
1972. mÇ—á•ñn Œ‹ß«g”Á—l”ç]‚ð’悵‚½SjogrenÇŒóŒQ. ‘¾“cK‘¥C•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆•af—Ã, 12(1): 41`44, 1990.
1973. mÇ—á•ñn ŠÔŽ¿«t‰Š‚𔺂Á‚½SjogrenÇŒóŒQ. •‹{”ü‰ÀŽqC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ”畆•af—Ã, 12(1): 57`60, 1990.
1974. mÇ—á•ñn IgAtÇA‚ƒÁƒOƒƒuƒŠƒ“ŒŒÇ«Ž‡”Á‚𔺂Á‚½SjogrenÇŒóŒQ. –ìŒûr•FC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 12(1): 61`64, 1990.
1975. mÇ—á•ñn Sclerodermatomyositis, toxoplasmaR‘Ì‚’l‚𔺂Á‚½SjogrenÇŒóŒQ. “”I^—C‹ß“¡Ž •vC•ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 12(1): 65`68, 1990.
1976. mÇ—á•ñn SjogrenÇŒóŒQ—lÇó‚ð’悵‚½AIDS. ‘åìŽiC‰¹ŽR˜aéC‰q“¡ŒõC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çjCŠ™“cvŽõi“àj: ”畆•af—Ã, 12(1): 69`72, 1990.
1977. mÇ—á•ñn ƒXƒM‰Ô•²ÇŠ³ŽÒ‚É‚Ý‚ç‚ꂽŽ¼]«•Ï‰». óˆär–íC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆•af—Ã, 12(3): 231`234, 1990.
1978. mÇ—á•ñn ŠÂóg”Á‚ðŽå‘i‚Æ‚µ‚½SjogrenÇŒóŒQ. ‰q“¡ŒõC•ÐŽRˆê˜NCŽ›–{”ÍŽqCˆî‘ºŒ\ˆêi”çj: ”畆•af—Ã, 12: 33`36, 1990.
1979. mÇ—á•ñn ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚É”º‚¤Œ‹ß«g”Á—l”ç]‚Ì1—á. ‘¾“cK‘¥C•ÐŽRˆê˜NC¼‰ª´i”çj: —Õ°”畆‰È, 43(11): 1115`1118, 1989.
1980. mÇ—á•ñn ¸_ÇóA–Ôó•ê”ÁAŒŒ¬”ÂŒ¸‚ð”F‚ß‚½¬Ž™’jŽq‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì1—á. ‰¹ŽR˜aéC•ÐŽRˆê˜NCã’Ë^—C‹ß“¡Ž •vCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: —Õ°”畆‰È, 43(5): 445`448, 1989.
1981. m—Õ°Ž¡Œ±n ƒAƒgƒs[«”畆‰Š‚ɑ΂·‚é‹g‘Ž_|Ž_ƒvƒŒƒhƒjƒ]ƒƒ“ƒ[ƒVƒ‡ƒ“‚ÌŽg—pŒoŒ±. ŒüˆäGŽ÷C¼ŽR–Εvi”çj: Prog. Med., 9(4): 1393`1398, 1989.
1982. m—Õ°Ž¡Œ±n ‘Ñóáv]‚ɑ΂·‚éƒCƒ_ƒƒ“ùiƒtƒƒNƒ^ƒtƒFƒjƒ“j‚Ì—Õ°•]‰¿. •ÄŒ³N‘ C’†‘ºŒšˆêi”çj: f—ÂÆV–ò, 26(7): 208`212, 1989.
1983. m—Õ°Ž¡Œ±n VDTÇŒóŒQ‚É‚¨‚¯‚钲ߋ@”\áŠQ‚ƃIƒtƒ^3L‚Ì—Õ°Œø‰Ê‚ɂ‚¢‚Ä. Žá‘q‰ë“oCŠÝ“cç•äŽqCÎì“NiŠáj: f—ÂÆV–ò, 26(9): 1645`1653, 1989.
1984. m—Õ°Ž¡Œ±n ¬lŒ^ƒAƒgƒs[«”畆‰Š‚ɑ΂·‚éRƒAƒŒƒ‹ƒM[Ü‚Ì—L—p«‚ÌŒŸ“¢|ƒXƒeƒƒCƒhŠO—pÜ’P“ƂƃIƒLƒTƒgƒ~ƒh•¹—p‚Ì”äŠrŽŽŒ±|. ŒüˆäGŽ÷i”çjC¬lŒ^ƒAƒgƒs[«”畆‰ŠŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51(5): 995`1002, 1989.
1985. m—Õ°Ž¡Œ±n TV-02“îp‚ÌŠp‰»Ç‚ɑ΂·‚é—Õ°¬Ñ. •ÐŽRˆê˜Ni”çjCTV-02“îpŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51(6): 1182`1189, 1989.
1986. m—Õ°Ž¡Œ±n TV-02“îp‚ÌŽŠ“K»Ü”Z“xݒ莎Œ±. ‰q“¡ŒõC¼ŽR–ΕvC㑺m•vi”çjCTV-01“îpŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51: 310`316, 1989.
1987. m—Õ°Ž¡Œ±n Š£áŠ³ŽÒ‚ɑ΂·‚éTV-02“îpˆÀ‘S«Šm”FŽŽŒ±. ‰q“¡ŒõC¼ŽR–ΕvC㑺m•vC•ÐŽRˆê˜Ni”çjCTV-02“îpŒ¤‹†‰ï: ¼“ú–{”畆‰È, 51: 317`324, 1989.
1988. m—Õ°Ž¡Œ±n Žè¥‘«”’á‚ɑ΂·‚éFK-936‚Ì—Õ°•]‰¿|Well-controlled Comparative
Study‚É‚æ‚é1% Clotrimazole»Ü‚Æ‚Ì”äŠrŒŸ“¢|. ¼ŽR–ΕvC“cÀO”VC’†‘ºŒ’ˆêCŠâè‰ëi”çjCFK-936‹¤“¯Œ¤‹†”Ç:
–ò—‚ÆŽ¡—Ã, 17(12): 247`256, 1989.
1989. m‘àn The Clinical Picture and Treatment of Tinnitus. ÝŠy“N–çiŽ¨•@j: Asian Medical Journal, 133(1): 21`26, 1990.
1990. m‘àn AdieÇŒóŒQ. Œü–ì˜a—YCŽí–{N”ViŠáj: Clinical Neuroscience, 7(7): 730`732, 1989.
1991. m‘àn ”]Š²áŠQ‚Ì_ŒoŠá‰È“If’f. Œü–ì˜a—YiŠáj: Equilibrium Research, 47(1): 27`30, 1988.
1992. m‘àn ”畆Ž¾Š³‚ÌŒûo”S–Œ’×á‡. ‰q“¡Œõi”çj: JOHNS, 5(7): 38`43, 1989.
1993. m‘àn ÚG”畆‰Š. ŒüˆäGŽ÷i”çj: Medicament News, 1258: 2`4, 1989.
1994. m‘àn “µEˆÙí‚Ìf‚©‚½. ’Ò‘ò‰F•FCŒü–ì˜a—YiŠáj: Modern Physician, 9(9): 1159`1161, 1989.
1995. m‘àn “ÁW|Šá‚ÆŽY‹Æ‰q¶|“Á‚ÉVDTì‹Æ. Îì“NiŠáj: Ophthalmology Update, 4(4): 2`12, 1989.
1996. m‘àn ƒAƒgƒs[«”畆‰Š‚Ì—Õ°‚Æ‚»‚ÌŽÀ‘Ô. ¼‰ª´i”çj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 10(118): 24`27, 1990.
1997. m‘àn ¬lŒ^ƒAƒgƒs[«”畆‰Š‚ÌŽ¡—Âɑ΂·‚éŒoŒûƒAƒŒƒ‹ƒM[Ü‚Ì—L—p«. ŒüˆäGŽ÷i”çj: ƒAƒŒƒ‹ƒM[‚Ì—Õ°, 9(14): 1048, 1989.
1998. m‘àn ƒAƒ~ƒƒCƒh[ƒVƒX. ŒüˆäGŽ÷i”çj: ƒNƒŠƒjƒJ, 16(8): 55`59, 1989.
1999. m‘àn ׋ۃƒNƒ`ƒ“—Ö@. ŒüˆäGŽ÷i”çj: ƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi[, 79: 16`18, 1989.
2000. m‘àn ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚̔畆Çó. •ÐŽRˆê˜NC¼ŽR–Εvi”çj: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(11): 709`712, 1989.
2001. m‘àn Šá‰È‚ÌŠî‘b: ‘²ŒãŒ¤Cˆã‚Ì‚½‚ß‚É.@‡Z._ŒoŠá‰È‚ÌŠî‘b.@(2)Šá‹Ø‚Ì\‘¢‚Æ‹@”\. Žá‘q‰ë“oC‰ª–ì’q•¶iŠáj: Šá‰È, 31(11): 1255`1263, 1989.
2002. m‘àn “ÁW: æ“V«Šá‹…‰^“®ˆÙí; DuaneÇŒóŒQ. –ؔÉCŒü–ì˜a—YiŠáj: Šá‰È, 31(5): 523`530, 1989.
2003. m‘àn Šá‹…‰^“®‚Æ”’B|‚»‚ÌŠî‘b‚Æ—Õ°|. ŠÖ’JŽ¡‹vCŒü–ì˜a—YiŠáj: Šá‰ÈMook, 38: 179`189, 1989.
2004. m‘àn VDTì‹Æ‚ÆŠá”æ˜J. Îì“NC–ؔÉiŠáj: Šá‰ÈMook, 39: 94`104, 1989.
2005. m‘àn ŠOŠá‹Ø‚̃tƒB[ƒhƒoƒbƒN(Proprioception). Œü–ì˜a—Y,Vˆä“cF—TiŠáj: Šá‰ÈMook, 41: 229`241, 1989.
2006. m‘àn å@–ƒ]. ¼‰ª´i”çj: Œ»‘ãˆã—Ã, 21(4): 65`68, 1989.
2007. m‘àn ”畆•a•Ï‚̬—§‹@˜. ¼‰ª´i”çj: ÅVˆãŠw, 45(2): 249`252, 1990.
2008. m‘àn ŒÛŽºŒ`¬p‚Ì—ðŽj. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, (14): 1`8, 1989.
2009. m‘àn ŒÛ–Œ–ü’…ǂɑ΂·‚éŒÛŽºŒ`¬p. ÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, (14): 85`89, 1989.
2010. m‘àn Œûo“à‰ŠÇ|…ávÇiqí«“VáváŒA—Þ“VáváŒA‚»‚Ì‘¼j|. ì–¼½Žii”çj: Ž¨•@—Õ°, 82(11): 1523`1526, 1989.
2011. m‘àn ׋ۃƒNƒ`ƒ“’ŽË‚É‚æ‚鎡—Ã. ŒüˆäGŽ÷i”çj: ¬Ž™“à‰È, 22(5): 27`30, 1990.
2012. m‘àn Šá‹…‰^“®Œn‚ɉe‹¿‚·‚é_Œo–ò•¨. ‹g“cŠ°iŠáj: _ŒoŠá‰È, 4(4): 385`398, 1987.
2013. m‘àn “à•ª”å«Šá‹…‰^“®áŠQ; “à•ª”å«Šá‹Øƒ~ƒIƒpƒ`[. Œü–ì˜a—YiŠáj: _ŒoŠá‰È, 6(2): 167`178, 1989.
2014. m‘àn Šá‰ÈŒŸ¸. ‹g“cŠ°iŠáj: ‘Ž‡—Õ°, 35(4): 691`693, 1986.
2015. m‘àn Ž¨–‚̗հ. ÝŠy“N–çiŽ¨•@j: “ú–{ˆãŽt‰ïŽGŽ, 101(5): 783`786, 1989.
2016. m‘àn ”DP«áy]. ¼‰ª´i”çj: “ú–{ˆãŽ–V•ñ, (3420): 25`28, 1989.
2017. m‘àn ×–E‚̃XƒgƒŒƒX‰ž“š‚ÆŠá. Žá‘q‰ë“oiŠáj: “ú–{Šá‰ÈŠw‰ïŽGŽ, 93(5): 511`523, 1989.
2018. m‘àn _ŒoŠá‰È‚©‚ç‚Ý‚½ŽÎŽ‹|•aˆö‚ÆŽ¡—Ö@‚É’–Ú‚µ‚Ä. Œü–ì˜a—YiŠáj: “ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï•ñ, 26(3): 3`17, 1989.
2019. m‘àn –ƉuŽó—e‘Ì‚Æ‚µ‚Ä‚Ì•\”ç. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: ”畆•af—Ã, 11(11): 935`945, 1989.
2020. m‘àn –Ñ“û“ª|–Ñ‚Ì”¶A¬’·‚É‚¨‚¯‚é–ðŠ„|. Ÿ‰ªŒ›¶i”çj: ”畆•af—Ã, 11(12): 1020`1025, 1989.
2021. m‘àn ¡“ú‚̘b‘èFŽ‹_Œo‰Š‚ÌŽ¡—Ã. Žá‘q‰ë“oiŠáj: —Õ°Šá‰È, 43(11): 1733`1737, 1989.
2022. m‘àn ƒŠƒEƒ}ƒ`‰Èf—Ã}ƒjƒ…ƒAƒ‹E”畆•a•Ï. ‰q“¡ŒõC¼ŽR–Εvi”çj: —Õ°–Ɖu, 21(Suppl. 14): 200`209, 1989.
2023. muÀn ‚܂΂½‚«‚ÌŽ©“®’²ß‚Ì‚µ‚‚Ý‚Í‚Ç‚¤‚È‚Á‚Ä‚¢‚é‚Ì‚©. Vˆä“cF—TCŒü–ì˜a—YiŠáj: Clinical Neuroscience, 7(5): 115, 1989.
2024. muÀn Ž‹—ÍáŠQAŠá‹Ø–ƒáƒ‚ð‚ß‚®‚Á‚Ä. —¢‹g‰c“ñ˜Yi‘—§¸__ŒoƒZƒ“ƒ^[jCŒü–ì˜a—YiŠájC“c‘ã–M—Yi–k‘åjCŽÄè_i‘—§¸__ŒoƒZƒ“ƒ^[j: Clinical Neuroscience, 8(2): 208`222, 1990.
2025. muÀn ”]. ¼‰ª´i”çj: Mebio, 6(6): 119`124, 1989.
2026. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒOi”畆‹Ø‰Šj. ŒüˆäGŽ÷i”çjC‹ß“¡Œ[•¶i“àjC¯ŽiiˆêiMB‘åjCˆÀ“¡³KiŒF–{‘åjCŸ–ÚãEi‹ž“s•{—§ˆã‘åj: Medicina, 26(13): 2610`2616, 1989.
2027. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒOi‘Sg«ƒAƒ~ƒƒCƒh[ƒVƒXj. ŒüˆäGŽ÷i”çjC—ˆ¶“NC—é–؉hˆêiVŠƒ‘åjCŸ–ÚãEi‹ž“s•{—§ˆã‘åjCˆÀ“¡³KiŒF–{‘åj: Medicina, 27(1): 158`163, 1990.
2028. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒOiPeutz-Jeghers Syndromej. ŒüˆäGŽ÷i”çjCÔ”öM–¾C‹ß“¡—͉¤ŽŠi‹à‘ò‘åjC¯ŽiiˆêiMB‘åjCŸ–ÚãEi‹ž“s•{—§ˆã‘åj: Medicina, 27(2): 296`301, 1990.
2029. muÀn ’®—Í‘œ‚Æ”N—î•Ê•½‹Ï’l. ‰ª–{–qliŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È Mook, (12): 11`18, 1989.
2030. muÀn ƒ}ƒCƒRƒvƒ‰ƒYƒ}Š´õÇ‚É”º‚¤”畆Çó. ‰q“¡Œõi”çj: “ú–{ˆãŽt‰ïŽGŽ, 102: ss65`68, 1989.
2031. muÀn •¡Ž‹‚ɑ΂·‚é–âf‚ÆŠÈ•Ö‚ÈfŽ@–@. Œü–ì˜a—YiŠáj: “ú–{ˆãŽ–V•ñ, (3413): 130`131, 1989.
2032. muÀn Ž‹_Œo‰ŠiÇj‚Ìf’f‚ÆŽ¡—Ã. ’†”ö—YŽOi‹ß‹E‘åjCŠ`²•ÄŽŸiç—t‘åjC‰Í‡ˆêdiŽœŒbˆã‘åjCŽO‘ºŽ¡i•ºŒÉˆã‘åjCŽá‘q‰ë“oiŠáj: “ú–{Šá‰È‹I—v, 40(4): 587`595, 1989.
2033. muÀn ”畆‚̃AƒŒƒ‹ƒM[AƒAƒŒƒ‹ƒM[«ÚG”畆‰Š‚ƃAƒgƒs[«”畆‰Š‚ÌŽ¼]”½‰ž. ¼‰ª´i”çj: ”畆‚Æ”ü—e, 21(1): 25`30, 1989.
2034. muÀn ƒAƒgƒs[«”畆‰Š‚Ì–â‘è“_. ¼‰ª´i”çjC‹{–{³Œõi“Œ‹ž“sj: ”畆•af—Ã, 11(3): 257`265, 1989.
2035. muÀn ¬lŒ^ƒAƒgƒs[«”畆‰Š‚Í׋ۃƒNƒ`ƒ“Ž¡—Ö@‚Å‚©‚È‚è‰ü‘P‚Å‚«‚é. ŒüˆäGŽ÷i”çj: •é‚炵‚ÆŒ’N, 44(11): 36`37, 1989.
2036. mŠwp‘n i•ÒWEŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; VDT‚ÆŠá, p.26`28; Šá‚ÆŽ©—¥_Œo, p.40`41;
‹ßŽ‹”½‰ž‚Æ‚»‚Ì’†•, p.54`55; œŠO‚·‚ׂ«Ç—á, p.95`96, Îì“NiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï,
“Œ‹ž, 89.09.15 ”s.
2037. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; A. Šá‚̉ð–U, p.35`39, Œü–ì˜a—YiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”s.
2038. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; I. ’²ß, p.56`58; P. ‹üÜ:, p.75`76, ‰LŽ”ˆê•FiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”s.
2039. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; I°J. çtçs|Å‹ß‚Ìl‚¦•û‚¨‚æ‚Ñ‘ª’è–@, p.59`61; ‡U°C.
Šá’É‚Æ“ª’É‚Ì— ‚É‚ ‚鎾Š³, p.86`88, Žá‘q‰ë“oiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15
”s.
2040. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; O. Ž‹‹@”\ˆÙí‚Æ‘SgÇó, p.73`74; R. VDT‚Æ”N—î, p.79, –ؔÉiŠáj. •ÒW Îì“Ni–k—¢‘åEŠáj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”s.
2041. mŠwp‘n iŽ·•Mj –Ô–¬—–ŒŽ¾Š³‚Ì—Õ°•a—; ƒVƒ“ƒi[’†“ÅEƒNƒƒƒLƒ“–Ô–ŒÇ, p.140`143, Œü–ì˜a—YiŠáj. •ÒW ’––“–Ði‹ã‘åj‘¼C•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.00.00 ”s.
2042. mŠwp‘n iŽ·•Mj Œ»‘ã”畆‰ÈŠw‘åŒn; •\”çˆÚA, p.37`46, ŒÃŽR“o—²iŒ`ŠOj. ’†ŽR‘“X, 89.00.00”s.
2043. mŠwp‘n iŽ·•Mj ƒAƒŒƒ‹ƒM[«”畆Ž¾Š³; ÚGƒAƒŒƒ‹ƒM[‚ƇTŒ^”½‰ž‚ÌŽ¼]”½‰ž, ¼‰ª´i”çj. •ÒW ‹g“c•F‘¾˜Yi’·è‘åj•ÒC ‹¦˜aŠé‰æ’ÊM, “Œ‹ž, 89.09.30”s.
2044. m‹³‰È‘n iŽ·•Mj ŽY‹Æ“à‰ÈŠw|_ŒoE‹ØŒn; Ž‹ŠoáŠQ, p.356`359, Œü–ì˜a—YiŠáj. •ÒW ‘c•ƒ]ˆí˜YC‘¼•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.00.00 ”s.
2045. m‹³‰È‘n iŽ·•Mj Aesthetic Breast Surgery; Aesthetic Breast Surgery in
Orientals, ‘å’|®”VC‰–’JMKiŒ`ŠOj. •ÒW Nicholas Georgiade (Duke Univ.) •Ò,
Williams & Wilkins, Baltimore, 89.00.00 ”s.
2046. m‹³‰È‘n iŽ·•Mj ”畆Ž¾Š³ÅV‚ÌŽ¡—Ã'89°'90; …ávÇ, p.115`116, ì–¼½Žii”çj. •ÒW ¼ŽR–Εvi–k—¢‘åjC‘¼•ÒC “ì]“°, “Œ‹ž, 89.00.00”s.
2047. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj ˜V”NŽÒ‚ÆŽ¨•@ˆôA‰È¥Ž¨•@ˆôA‰È“ªŒz•”ŠO‰È Mook No.12, •ÒW ÝŠy“N–çi–k—¢‘åj•ÒC ‹àŒ´o”Å, 89.04.00”s.
2048. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj ƒI|ƒWƒIƒƒW|(2), —Õ°Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È‘S‘‚S‚a4b,1989, •ÒW ÝŠy“N–çi–k—¢‘åj•ÒC ‹àŒ´o”Å, 89.10.20”s.
2049. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Ž¨•@ˆôA‰Èf—à Questions & Answers ‘æ11†;
“ªˆÊC“ªˆÊ•ÏŠ·ŠáU‚Ìf’f“IˆÓ‹`C11: 351‚Ì2`351‚Ì5, “¿‘Œú“ñiŽ¨•@j. ˜Z–@o”Å, –¼ŒÃ‰®, 89.04.19”s.
2050. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj A Color Atlas of Dermato-Immunohistocytology;
Sweat Gland, p.28`29; Desmosome, p.40`41, ‰q“¡Œõi”çj. •ÒW Hiroaki
Uekiiìèˆã‘åjCHideo YaoitaiŽ©Ž¡ˆã‘åjC Wolfe Medical Publications, Ltd.,
London, England, 89.00.00”s.
2051. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ƒXƒeƒƒCƒhÜ‚Ì‘I‚Ñ•û‚ÆŽg‚¢•û; ”畆‰È—̈æ‚ł̃XƒeƒƒCƒh—Ö@, ¼‰ª´i”çj. •ÒW –î–ìŽO˜Yi•xŽRˆã‰È–ò‰È‘åj•ÒC “ì]“°, “Œ‹ž, 90.01.10”s.
2052. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj ”畆ŠO—pÜ‚Ì‘I‚Ñ•û‚ÆŽg‚¢•ûC ¼‰ª´i”çj. “ì]“°, “Œ‹ž, 89.03.01”s.
2053. mŠw‰ïn i“Á•Êu‰‰j A Comparison of Eye Strain in VDU Operators and Hard
Copy Workers-|An Objective Determination by Means of Near Triad
Response. Îì“NiŠáj: XII Congress of Asia Pacific Academy of Ophthalmology
(89.06.01), Seoul.
2054. mŠw‰ïn i“Á•Êu‰‰j Ž¨•@ˆôA‰È—̈æ‚ÌŽå‘i‚ÆD‘i. ÝŠy“N–çiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ïŽŽ™“‡’n•û•”‰ï (89.12.17), ŽŽ™“‡.
2055. mŠw‰ïn i‹³ˆçu‰‰j ƒ}ƒ‰ƒbƒZƒ`ƒAŠ´õǂɂ‚¢‚Ä. ŒüˆäGŽ÷i”çj: _“Þ쌧”畆‰Èˆã‰ï‘æ70‰ñ—á‰ï i89.12.02j, ‰¡•l.
2056. mŠw‰ïn i‹³ˆçu‰‰j ƒXƒeƒƒCƒhŠO—pÜ’P“ƂƃZƒ‹ƒeƒNƒg•¹—p‚Ì”äŠrŽŽŒ±¬Ñ. ŒüˆäGŽ÷i”çj: _“Þ쌧”畆‰Èˆã‰ï‘æ71‰ñ—á‰ï i90.02.25j, Š™‘q.
2057. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Šá‹…‰^“®áŠQ‚Æ‚»‚̈Ӌ`:@“úíf—Âɂ¨‚¯‚éf’fŽè‹ZGŒ©—Ž‚Æ‚³‚ꂪ‚¿‚ÈŠá‹…‰^“®ŠŒ©. ‹g“cŠ°iŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.13), ‹ž“s.
2058. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Šá‹…‰^“®áŠQ‚Æ‚»‚̈Ӌ`:@…•½Šá‹…‰^“®Œn‚Ì_Œo‹@\GPPRFÇŒóEMLFÇŒó‚ɂ‚¢‚Ä. Œü–ì˜a—YiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.13), ‹ž“s.
2059. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ê–Ž•—Þ”’“àá‚̬‘÷”Ç—lŽ®‚©‚ç‚Ý‚½…»‘Ì\’z‚ɂ‚¢‚Ä. ‰F‰ê–ÎŽOiŠáj: ‘æ28‰ñ“ú–{”’“àáŠw‰ï (89.06.24), ‹ž“s.
2060. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘˜_F_ŒoŠá‰È‚©‚ç‚Ý‚½ŽÎŽ‹|•aˆö‚ÆŽ¡—Ö@‚É’–Ú‚µ‚Ä|. Œü–ì˜a—YiŠáj: ‘æ6‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ïuK‰ï (89.06.25), ‘åã.
2061. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Še˜_F’²ßEçtçs‚ÆŽÎŽ‹. ŠÖ’JŽ¡‹viŠáj: ‘æ6‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ïuK‰ï (89.06.25), ‘åã.
2062. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Šá‹…‰^“®ˆÙí‚Ì—Õ°G‹Ø–³—ÍÇAŠáâ|‹Ø‰ŠAæ“VˆÙí. Œü–ì˜a—YiŠáj: ‘æ27‰ñ–k“ú–{Šá‰ÈŠw‰ï (89.07.15), ŽD–y.
2063. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j •½t‹@”\áŠQ‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. “¡–ì–¾liŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.
2064. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j 3.–Ô–Œ‚É‚¨‚¯‚é_Œo“`’B•¨Ž¿,(4)”|—{×–E‚ð—p‚¢‚½‰ðÍ. Žá‘q‰ë“oiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2065. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒjƒ…[ƒƒ“‚ƃOƒŠƒA‚Ì‘ŠŒÝì—p‚ƶ—Šˆ«•¨Ž¿||–Ô–Œ‚Ì‘nŽ¡–ü‹@\‚ð‘z’肵‚Ä||. Žá‘q‰ë“oiŠáj: ‘æ7‰ñ‘ۊጤ‹†‰ï‹c“ú–{•”‰ï (89.12.10), ‘åã.
2066. mŠw‰ïn iƒpƒlƒ‹j —L‹@—ÓÜ’†“ł̈ÙíŠá‹…‰^“®”¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†|GABAƒjƒ…[ƒƒ“‚̖Ɖu‘gDŠw“IŒ¤‹†|. Îì“NC¬“ˆ—ÇGCŠÖ’JŽ¡‹vC‘ìd•viŠájC’[ì•×iŠâŽèˆã‘åj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.
2067. mŠw‰ïn iƒpƒlƒ‹j ‘½”«d‰»Ç‚É‚¨‚¯‚銦—âŽhŒƒ‚Ì‘¼Šo“I•]‰¿. ’Ò‘ò‰F•FCŠâØ”ü—˜C–ؔÉCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.
2068. mŠw‰ïn iƒpƒlƒ‹j —‘‰©—l‰©”Á•Ï«‚¨‚æ‚Ñ–Í—lƒWƒXƒgƒƒtƒB[‚𗼊á‚ɒ悵‚½1—á. ‰ª–ì’q•¶C•Ÿ“c•q‰ëC‹{“cŠ²•vCÎì“NiŠáj: ‘æ55‰ñ’†•”Šá‰ÈŠw‰ï (89.09.09), “¿“‡.
2069. mŠw‰ïn iƒpƒlƒ‹j æ“V«—Γàá‚ð‡•¹‚µ‚½’†SŠj•a floppy infant ‚Ì1—á.
’†ŽR’q•FiŠájCÎì”ü˜aŽqCŽs£—mŽqi‘Š–Í–ì•a‰@jCŽí“c–F˜YiŠájC“‡ŠÑˆèC¡ˆäƒDiŽ™j: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14),
–¼ŒÃ‰®.
2070. mŠw‰ïn iƒpƒlƒ‹j Pattern VEPŒŸ¸‚É‚¨‚¯‚é“d‹ÉˆÊ’u‚ÌŒŸ“¢. “n•Ó”ü’qŽqC‹g–{gŽqi—ÕŒŸjC’m–쇎qCŽá‘q‰ë“oiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2071. mŠw‰ïn iƒpƒlƒ‹j ŒuŒõŠá’ê‘¢‰e‚ňÙí‚Ì‚Ý‚ç‚ꂽŽ‹Œð³•”‹ß–Tè‹’«•a•Ï. ’†‘ò³”ŽCŽá‘q‰ë“oC‰ª–ì’q•¶CÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2072. mŠw‰ïn iƒpƒlƒ‹j ŋߌoŒ±‚µ‚½Šç–Ê‚Ì”’á‚ɂ‚¢‚Ä. ‘¾“cK‘¥C“cÀO•¶i”çj: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï i00.00.00j, ‰«“ê.
2073. mŠw‰ïn iƒpƒlƒ‹j Ž©ŒÈ–Ɖu«—nŒŒ«•nŒŒŠ³ŽÒ‚ɔǂµ‚½”畆ƒNƒŠƒvƒgƒRƒbƒNƒXÇ.
‹ß“¡Ž •vC‘¾“cK‘¥CŠâè‰ëC“”I^—C“cÀO”VC¼ŽR–Εvi”çjCˆ¢•””ü’qŽqC‚–Øç’ßi—ÕŒŸj: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï
i89.09.22j, ‰«“ê.
2074. mŠw‰ïn iƒpƒlƒ‹j Biological Characteristics of Gamma Glutamyl
Transferase in Malignant Melanoma. ‹ß“¡Ž •vC•ÄŒ³N‘ C‰q“¡ŒõC¼ŽR–Εvi”çj: 2nd
International Conference on Melanoma i89.10.16`19j, Venice, Italy.
2075. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Morphological Demonstration of Ocular Muscle
Proprioception in the Human Extraocular Muscles. Œü–ì˜a—YiŠáj: International
Workshop on Proprioception of the Ocular Muscles 1986 (00.00.00), Acta
Ehime University Press, 19`26, 1989.
2076. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Influence of Body Temperature Change on Optic
Neuritis. Žá‘q‰ë“oiŠáj: Association for Eye Research 30th Meeting &
Ecofs Meeting (89.10.06), ƒtƒ‰ƒ“ƒX.
2077. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚¢ŠÈˆÕŒ^ƒCƒŠƒXƒR[ƒ_[. Îì‹ÏC’Ò‘ò‰F•FC’·’JìKŽqCÎì“NiŠájC‘å˜a“c—²i‹~–½j: ‘æ4‰ñŠá‰ÈMEŠw‰ï (89.04.15), “Œ‹ž.
2078. mŠw‰ïn iˆê”Êu‰‰j “µE‚̉Á—î•Ï‰»‚ÉŠÖ‚·‚錤‹†|“µE–ÊÏA‘ÎŒõ”½‰ž‚Ì•ªÍŒ‹‰Ê|. ’·’JìKŽqCÎì“NiŠájCŒÑ“c’¼ri•l¼ƒzƒgƒjƒNƒXj: ‘æ4‰ñŠá‰ÈMEŠw‰ï (89.04.15), “Œ‹ž.
2079. mŠw‰ïn iˆê”Êu‰‰j ’܉ºŠOœŽî‚ɂ‚¢‚Ä. ŒÃŽR“o—²C‰FˆäŒª“ñCçÝŽ½C“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOjC¬—Ѻi‘—§‰¡•l•a‰@j: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï (89.04.21), ‰YˆÀ.
2080. mŠw‰ïn iˆê”Êu‰‰j F‘f•WŽ¯–@‚©‚ç‚Ý‚½ƒ}ƒEƒXŠáŠO«”’“àá‚Ì”¶‹@˜. ‰F‰ê–ÎŽOC–œÂi’†‘ˆã‰È‘åjC¼–{_”VCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.
2081. mŠw‰ïn iˆê”Êu‰‰j ”|—{ƒ~ƒ…[ƒ‰[×–E‚ɑ΂·‚éD,L-2-Aminoadipic acid ‚ÌCa2+ƒCƒIƒ“‚ð‰î‚µ‚½‰e‹¿‚ɂ‚¢‚Ä. Žá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.11), ‹ž“s.
2082. mŠw‰ïn iˆê”Êu‰‰j ˆÙíŠá‹…‰^“®‚ÆŠáU‚ÌǗጟ“¢|Opsoclonus‚ɂ‚¢‚Ä|.
‹g”ö’mC”ª–؈ê‹LC•½ŽR•ûrC¼‰ª–¾—TC“¡–ì–¾lCŒÜ“‡ˆê‹gC“¿‘Œú“ñiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.11), ‘åãC
“ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1730, 1989.
2083. mŠw‰ïn iˆê”Êu‰‰j ƒlƒR‚’¼‰^“®‹Ø‚Ì“®Šá_ŒoŠj‚É‚¨‚¯‚é’†•‹ÇÝ|double labeling–@‚É‚æ‚錤‹†|. ‹ß“¡‰À•vCŠÖ’JŽ¡‹vC¬“ˆ—ÇGCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.12), ‹ž“s.
2084. mŠw‰ïn iˆê”Êu‰‰j ƒlƒR‹y‚уTƒ‹‚É‚¨‚¯‚é’†”]‚©‚ç–Ñ—l‘Ì‚ÉŽŠ‚é’¼ÚüˆÛ˜A—. –Ø‘º^–çCVˆä“cF—TCŒü–ì˜a—YCÎì“NiŠáj: ‘æ93‰ñ“ú–{Šá‰ÈŠw‰ï (89.05.12), ‹ž“s.
2085. mŠw‰ïn iˆê”Êu‰‰j Šp–Œã”ç•\–Ê’E‰H«‚Ì—Õ°•]‰¿. ´…Œhˆê˜YiŠáj: ’†‰Ø–¯‘Šá‰ÈŠw‰ï‘æ25‰ñŠwpu‰‰‰ï (89.05.29), ‘ä“ì.
2086. mŠw‰ïn iˆê”Êu‰‰j Divergence Palsy--MRI Analysis. ¼–{_”VCÎì“NiŠáj: XII
Congress of Asia Pacific Academy of Ophthalmology (89.06.01), Seoul.
2087. mŠw‰ïn iˆê”Êu‰‰j ƒGƒA[ƒKƒ“ŠáŠO‚Ì8—á. –]ŒŽˆêCŽá‘q‰ë“oC“©ŽRG•viŠáj: ‘æ6‰ñŠÖ“ŒŠá‰ÈŠw‰ï (89.06.11), “Œ‹ž.
2088. mŠw‰ïn iˆê”Êu‰‰j “ª•”ŠOŒã‚̈ê‰ß«•ûŒüŒð‘ã«ŠáUÇ—á. ’·À‰p–¾C“¿‘Œú“ñC‹g”ö’mC“¡–ì–¾lCŒÜ“‡ˆê‹giŽ¨•@j: ‘æ68‰ñ_“Þì’n•û•”‰ï (89.06.17), ¬“cŒ´.
2089. mŠw‰ïn iˆê”Êu‰‰j |‘¤–À˜H”j‰óŒã‚Ì—Õ°Œo‰ß|dS“®—h‚©‚ç‚Ý‚Ä. ¯–ìŒ÷C“¿‘Œú“ñC‹g”ö’mC“¡–ì–¾lC¼‰ª–¾—TC”ª–؈ê‹LiŽ¨•@j: ‘æ68‰ñ_“Þì’n•û•”‰ï (89.06.17), ¬“cŒ´.
2090. mŠw‰ïn iˆê”Êu‰‰j ˜V‰»‘£iƒ}ƒEƒX…»‘Ì‚Ì“ÁˆÙ‚ȉÁ—ω». ¼–{_”VC‰F‰ê–ÎŽOC‹{“cŠ²•vCÎì“NiŠájC•À–Ø–ž•vCŽR‰º‚©‚È‚Ö: ‘æ28‰ñ“ú–{”’“àáŠw‰ï (89.06.24), ‹ž“s.
2091. mŠw‰ïn iˆê”Êu‰‰j Novel Saccade‚Ì—U”–@‚Ǝ㎋‚ւ̉ž—p. ‚‹´–MŽqC–]ŒŽˆêCŽR“c“OlC¬—уŽqCVˆä“cF—TCÎì“NiŠáj: ‘æ45‰ñ“ú–{ŽãŽ‹ŽÎŽ‹Šw‰ï (89.06.24), ‘åã.
2092. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽeŠú‘nŽ¡–ü‚É‚¨‚¯‚é‘gD‚Ì‘nŽûk”\. ’–Œ´ß”V‰îiŒ`ŠOjC–{—Ñ—R”üŽqi¶‰»Œnj: “ú–{”¶¶•¨Šw‰ï‘æ22‰ñ‘å‰ï (89.06.24), ŽD–y, —vŽ|W, p.155, 1989.
2093. mŠw‰ïn iˆê”Êu‰‰j ö•šŠáU‚Ì‹óŠÔŽü”g”“Á«‚ɂ‚¢‚Ä. ’·’JìKŽqCŠÖ’JŽ¡‹vC¬“ˆ—ÇGC¬’¬—SŽqCÎì“NiŠáj: ‘æ59‰ñ‹ãBŠá‰ÈŠw‰ï (89.07.01), “ß”e.
2094. mŠw‰ïn iˆê”Êu‰‰j Œã“V«‚ɔǂµ‚½‚ÆŽv‚í‚ê‚éDuaneÇŒóŒQ‚Ì1—á. ŠÖ’JŽ¡‹vC‹ß“¡‰À•vCŒü–ì˜a—YiŠáj: ‘æ59‰ñ‹ãBŠá‰ÈŠw‰ï (89.07.01), “ß”e.
2095. mŠw‰ïn iˆê”Êu‰‰j _Œo‘©‚ÌáŠQ‚É‚æ‚é—¼ãŽÎ‹Ø–ƒáƒ. ŠâØ”ü—˜C‹g“cŠ°iŠáj: ‘æ59‰ñ‹ãBŠá‰ÈŠw‰ï (89.07.01), “ß”e.
2096. mŠw‰ïn iˆê”Êu‰‰j ‰–‘fŒn•Y”’Ü’†“Å‚É‚æ‚郉ƒbƒgŽ‹_Œo‚ւ̉e‹¿. •Ÿ“‡ˆêÆC‰œ‰pOiŠáj: ‘æ27‰ñ–k“ú–{Šá‰ÈŠw‰ï (89.07.14), ŽD–y.
2097. mŠw‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒh‹Ç’‚Æ•úŽËü—Ö@‚ðŽŽ‚Ý‚½V¶Ž™Šáâ|“à‹‘å–Ñ׌ŒŠÇŽî. Îì‹ÏCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ27‰ñ–k“ú–{Šá‰ÈŠw‰ï (89.07.15), ŽD–y.
2098. mŠw‰ïn iˆê”Êu‰‰j Primary Culture of Keratinocytes on Substrate Coated
with Basement Membrane Components. ŒÃŽR“o—²C’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOj: The 5th
Congress of the Asian Pacific Reconstructive Surgery (89.09.08),
Istanbul, Turkey.
2099. mŠw‰ïn iˆê”Êu‰‰j Œ‡–R«Ž‹_ŒoÇ‚Æ‘‰t’†ƒrƒ^ƒ~ƒ“‚a12. ‰œ‰pOC•Ÿ“‡ˆêÆC¼–{_”VC‹{“cŠ²•vCÎì“NiŠáj: ‘æ55‰ñ’†•”Šá‰ÈŠw‰ï (89.09.09), “¿“‡.
2100. mŠw‰ïn iˆê”Êu‰‰j ‘O’ë_Œo‰Š‚ÌÇó‚ð’悵‚½ƒ‰ƒ€ƒ[ƒCƒnƒ“ƒgÇŒóŒQ‚̈ê—á. –ìŒû_’jCˆäŒû–F–¾C‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.
2101. mŠw‰ïn iˆê”Êu‰‰j Direct Effect of DL-2-Amino Adipic Acid Mediated by
Cakiumion on Cultured Muler Cells. Žá‘q‰ë“oiŠájCŽR–{¸iŠÅŒìŠw•”j: Association for
Eye Research 30th Meeting & Ecofs Meeting (89.10.04), ƒtƒ‰ƒ“ƒX.
2102. mŠw‰ïn iˆê”Êu‰‰j ö•šŠáU‚̃Rƒ“ƒgƒ‰ƒXƒgŠ´“x“Á«‚ɂ‚¢‚Ä||æ“VŠáU‚Æ‚Ì”äŠr. ’·’JìKŽqCŠÖ’JŽ¡‹vC¬’¬—SŽqCÎì“NiŠáj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.
2103. mŠw‰ïn iˆê”Êu‰‰j Šá‹Ø–³—ÍÇ‚Ì‘SgˆÚs—á‚Ì•ªÍ. ‰ª–ì’q•¶C’†‘ò³”ŽCŒü–ì˜a—YCÎì“NiŠáj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.
2104. mŠw‰ïn iˆê”Êu‰‰j ‹}Œƒ‚È”]zŠÂ•s‘S‚É‚æ‚Á‚ÄoŒ»‚·‚éˆÙíŠá‹…‰^“®‚ɂ‚¢‚Ä. Îì‹ÏC’Ò‘ò‰F•FCŒü–ì˜a—YiŠájCŒÜ\—’•Û’jiŽD–yˆã‘åjCŠå’J˜a”Ni“àj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.
2105. mŠw‰ïn iˆê”Êu‰‰j Sˆö«“àŽÎŽ‹f’f‚É‚¨‚¯‚éƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹“_“HÃ’‚̉ž—p. ‰œ‰pOiŠájC“àŠC—²C›àV~C’†‘ºŒjŽqCàV‚Ó‚ÝŽqC–ìç²—R”üŽqCà_‘º”üŒbŽqi‘åãˆã‘åj: ‘æ43‰ñ“ú–{—Õ°Šá‰ÈŠw‰ï (89.10.14), –¼ŒÃ‰®.
2106. mŠw‰ïn iˆê”Êu‰‰j ¬l‚ÌŽ‹_Œo“û“ª‰Š‚Ì—Õ°“I“Á’¥. ‰ª–ì’q•¶CŽá‘q‰ë“oC’†‘ò³”ŽCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2107. mŠw‰ïn iˆê”Êu‰‰j “Á”«Ž‹_Œo‰Š‚ÌŽ©‘RŒo‰ß‚ƃpƒ‹ƒX—Ö@‚ɂ‚¢‚Ä. Žá‘q‰ë“oC‰ª–ì’q•¶CŽR“c“OliŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2108. mŠw‰ïn iˆê”Êu‰‰j Tubringen flicker Test‚ð—p‚¢‚½•s“¯Ž‹ŽãŽ‹‚ÆŽ‹_ŒoŽ¾Š³‚ÌŽ‹‹@”\•]‰¿‚ÌŽŽ‚Ý.
¬—уŽqCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2109. mŠw‰ïn iˆê”Êu‰‰j ƒTƒ‹ãŠááÙ‹“‹Ø‚ÌŽx”zˆŸŠj‚ɂ‚¢‚Ä. ŠÖ’JŽ¡‹vC¬“ˆ—ÇGCŒü–ì˜a—YiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.20), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2110. mŠw‰ïn iˆê”Êu‰‰j “œ”A•aŠ³ŽÒ‚É‚¨‚¯‚é‘ÎŒõ”½‰ž‚ɂ‚¢‚Ä||“Á‚É“œ”A•a«–Ô–ŒÇ‚Ì‚È‚¢ŽÒ||. ’·’JìKŽqC—ѳ—YCÎì“NiŠáj: ‘æ42‰ñ“ú–{Ž©—¥_ŒoŠw‰ï (89.10.21), “Œ‹ž.
2111. mŠw‰ïn iˆê”Êu‰‰j Œã“ª—t”’Ž¿•a•Ï‚Å‹¤’Ê‚µ‚½Ž‹ŠoŠá‹…‰^“®ŒnáŠQ‚ðŽ¦‚µ‚½¬Ž™‚Ì2Ç—á. ¼–q–¾”üC“¡ˆä‰ë˜NCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.21), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2112. mŠw‰ïn iˆê”Êu‰‰j ˆê‘¤‚Ì“®Šá_ŒoEŠO“]_ŒoáŠQ‚𗈂µ‚½”]Š²•a•Ï‚Ì1—á. ‹g“cŠ°iŠájC´…r•vC—ÑG–¾i“s—§_Œo•a‰@j: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.21), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2113. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíŽ¾Š³‚É‚¨‚¯‚钲߂̀ÓI“Á«‹L˜^‚Æ“®“I“Á«‹L˜^. Œ´’¼lC“©ŽRG•vCŠÝ“cç•äŽqCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2114. mŠw‰ïn iˆê”Êu‰‰j ö•šŠáU‚ÌŠÉ™‘Š‘¬“x. ¼Œ´ŒbŽqC–x”ÍŽqC‚‹´–MŽqCŒ´’¼lCŽR“c“OlCÎì“NiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2115. mŠw‰ïn iˆê”Êu‰‰j ߌ㫃zƒ‹ƒlƒ‹ÇŒóŒQ‚Ì2—á. ŠâØ”ü—˜iŠájC’߉ªˆê‰pi•{’†•a‰@jC‹g“cŠ°iŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È, 6(‘•â), 1989.
2116. mŠw‰ïn iˆê”Êu‰‰j ‘½”«d‰»Ç‚É‚¨‚¯‚éflicker VECP||Ž‹_Œo‰Š‚Æ‚Ì”äŠr||.
‹g–{gŽqC“n•Ó”ü’qŽqi—ÕŒŸjC’m–쇎qC¬—уŽqCŽá‘q‰ë“oiŠáj: ‘æ27‰ñ“ú–{_ŒoŠá‰ÈŠw‰ï (89.10.22), “Œ‹ž, _ŒoŠá‰È,
6(‘•â), 1989.
2117. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚鎨¬œŠïŒ`‚ÌŒŸ“¢iŠOŽ¨“¹CŒÛ–Œ³í—á‚ð’†S‚Éj.
’†ŽR–¾mC•½ŽR•ûrCŒÃ‘òTˆêC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: ‘æ17‰ñ“ú–{—Õ°Ž¨‰ÈŠw‰ï‘‰ï (89.10.27), “Œ‹žC —Õ°Ž¨‰È,
16(2): 106, 1989.
2118. mŠw‰ïn iˆê”Êu‰‰j ƒRƒŒƒXƒeƒŠƒ““÷‰èŽî‚Æ“÷‰è‚ð‚Æ‚à‚È‚¤–«’†Ž¨‰Š‚Ì”äŠrŒŸ“¢. ²–씣Cˆî–ØŸ‰pC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: ‘æ17‰ñ“ú–{—Õ°Ž¨‰ÈŠw‰ï‘‰ï (89.10.27), “Œ‹žC —Õ°Ž¨‰È, 16(2): 35, 1989.
2119. mŠw‰ïn iˆê”Êu‰‰j ‡•¹•aŒ^‚ðŽ‚½‚È‚¢’†Ž¨ƒRƒŒƒXƒeƒŠƒ““÷‰èŽîÇ‚Ì’®—Í‘œ‚©‚ç‚ÌŒŸ“¢. ˆî–ØŸ‰pCÝŠy“N–çC‰ª–{–qlC²–씣iŽ¨•@j: ‘æ17‰ñ“ú–{—Õ°Ž¨‰ÈŠw‰ï‘‰ï (89.10.27), “Œ‹žC —Õ°Ž¨‰È, 16(2): 36, 1989.
2120. mŠw‰ïn iˆê”Êu‰‰j æ“V«•\”ç…ávÇ2—á‚Ì—Õ°“IŒŸ“¢.
‘º¼GŽ÷CˆäŒ…^—R”üC•—’£KŽiC‰Í‘º½ŽŸCŠÖª“OC–ì“n³•FCŠ—Œ´FC¬ŒûO‹BC”ª‘ãŒö•viŽ™jC‘¾“cK‹KC‰Í–ì–MŽqC‰q“¡Œõi”çjCŽR–{OŽqC²“¡—Y
“ñiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï (89.10.28), ‘å‹{.
2121. mŠw‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚ÌŠ´‰¹«“ï’®‚ƘVl«“ï’®. ‰ª–{–qlCÝŠy“N–çCŒÃ‘òTˆêC•½ŽR•ûriŽ¨•@j: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’mC
2122. mŠw‰ïn iˆê”Êu‰‰j “ú–{lœ“±è‡’l‚Ì“™‰¿ƒtƒH|ƒXƒŒƒxƒ‹|ISO7566‚ւ̔ᔻ. ’|“à‹`•viŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’m.
2123. mŠw‰ïn iˆê”Êu‰‰j “Á”«—¼‘¤«Š´‰¹“ï’®i“Á“ïj‚̈æ’l㌟¸i‘æ2•ñj. •½ŽR•ûrCŒÃ‘òTˆêC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’m.
2124. mŠw‰ïn iˆê”Êu‰‰j •ûŒüŒð‘ã«ãŒü«“ªˆÊŠáUÇ—á‚ÌŒŸ“¢. ’·À‰p–¾C‹g”ö’mC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.
2125. mŠw‰ïn iˆê”Êu‰‰j ”½•œ‚·‚é‚ß‚Ü‚¢Ç—á‚Ì’·ŠúŠÏŽ@—á‚ɂ‚¢‚Ä. •½ŽR•ûrC‹g”ö’mC“¡–ì–¾lC“¿‘Œú“ñCŒÜ“‡ˆê‹gC”ª–؈ê‹LiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.
2126. mŠw‰ïn iˆê”Êu‰‰j ³Œ·”g’¼ü‰Á‘¬“xŽhŒƒ‚É‚æ‚鎨Ίí‹@”\ŒŸ¸–@CBPPNÇ—á‚ÌŒŸ“¢.
“¡–ì–¾lC¯–ìŒ÷CV“cŒ’‘¾˜YC¼ŽRkˆê˜YC¼‰ª–¾—TC•½ŽR•ûrC’·À‰p–¾C‹g”ö’mC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23),
“Þ—Ç.
2127. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“‚É‚æ‚èÇóŒy‰õ‚ð‚Ý‚½ƒXƒgƒŒƒvƒgƒ}ƒCƒVƒ“’†“Å‚É‚æ‚é‚ß‚Ü‚¢‚Ì1—á. ¼‰ª–¾—TC“¿‘Œú“ñC“¡–ì–¾lC‹g”ö’mC¯–ìŒ÷iŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.24), “Þ—Ç.
2128. mŠw‰ïn iˆê”Êu‰‰j Ocular MyoclonusÇ—á‚Ì_ŒoŽ¨‰ÈŠw“IŒŸ“¢. ‹g”ö’mC¼‰ª–¾—TCV“cŒ’‘¾˜YC¯–ìŒ÷C•½ŽR•ûrC’†ŽR–¾mC“¡–ì–¾lCŒÜ“‡ˆê‹gC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.25), “Þ—Ç.
2129. mŠw‰ïn iˆê”Êu‰‰j ¿ˆÊdS“®—h‚É‚æ‚镽táŠQ‚̉ðÍ. “àŽR–õi–k—¢Œ¤‹†ŠjCˆ¢•”—EŸi—ÕŒŸjC“¿‘Œú“ñiŽ¨•@j: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.25), “Þ—Ç.
2130. mŠw‰ïn iˆê”Êu‰‰j A New Type of Corneal Endothelial Dystrophy. ´…Œhˆê˜YC—ѳ—YCÎì“NiŠáj: ‘æ30‰ñ’†‰Ø–¯‘Šá‰ÈŠw‰ï (89.11.25), ‘ä–k.
2131. mŠw‰ïn iˆê”Êu‰‰j ‹ßŒ©”½‰žáz¹‚Ì2Ç—á. ˆÉ“¡K]CÎì‹ÏC¼–{_”VCŒü–ì˜a—YCÎì“NiŠájC²“¡Šìˆê˜Yi¸j: ‘æ30‰ñ“ú–{Ž‹”\‹¸³Šw‰ï (89.11.26), “Œ‹ž.
2132. mŠw‰ïn iˆê”Êu‰‰j —L‹@—ÓÜ’†“ł̈ÙíŠá‹…‰^“®”¶‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†||GABAƒjƒ…[ƒƒ“‚̖Ɖu‘gDŠw“IŒ¤‹†||.
¬“ˆ—ÇGCÎì“NCŠÖ’JŽ¡‹vC‘ìd•viŠájC’[ì•×iŠâŽèˆã‘åj: ‘æ7‰ñ‘ۊጤ‹†‰ï‹c“ú–{•”‰ï (89.12.09), ‘åã.
2133. mŠw‰ïn iˆê”Êu‰‰j ‹}«Š´‰¹“ï’®‚ð‰”Çó‚Æ‚µ‚½–îóÖ¬“´ŒŒðÇ‚Ì1—á.
Ä“¡‘åC•½ŽR•ûrC’†ŽR–¾mC’·À‰p–¾C‹g”ö’mC‰ª–{–qlC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j:
“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.
2134. mŠw‰ïn iˆê”Êu‰‰j Ž¨‚ÌŠïŒ`‚ð‚Æ‚à‚È‚¤‘¤Œzá‘‚Ì1—á. ‰iˆä_–¤CV“cŒ’‘¾˜YC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ70‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (89.12.16), ‰¡•l.
2135. mŠw‰ïn iˆê”Êu‰‰j Degloving injury ‚É‚¨‚¯‚épŽ®‚Ì‘I‘ð. ÎŒ´GˆêC‹àˆäN–¤CˆÀ•x‹`“NCˆÉ“¡³ŽkiŒ`ŠOj: “ú–{Žè‚ÌŠO‰ÈŠw‰ï (89.95.00), –k‹ãB.
2136. mŠw‰ïn iˆê”Êu‰‰j Šp–ŒŽ‰–b’¾’…ǂ̬ˆö‚Æ‚»‚Ì–hŽ~‘Îô. ´…Œhˆê˜YCŒü–ì˜a—YCˆ¢‘]ŽqiŠáj: ‘æ14‰ñŠp–ŒƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.02.01), ‰YˆÀ.
2137. mŠw‰ïn iˆê”Êu‰‰j “–‰È‚É‚¨‚¯‚éãüLÇŽèpŒã‚ÌŠ³ŽÒ‚ɑ΂·‚éƒAƒ“ƒP[ƒg’²¸‚ɂ‚¢‚Ä. ŽÄ“c—T’Bi’©“ú‘åŠwjC‚‹´Œ³iŒ`ŠOj: ‘æ15‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï“ŒŠC’n•û‰ï (90.02.24), –¼ŒÃ‰®, ´˜^W, p.4, 1990.
2138. mŠw‰ïn iˆê”Êu‰‰j Cholinergic Involvement of Behcet's
Disease|Regression of Ocular Attack by Systemic Use of Atropine
Nitrate. ‰ºì•Ó˜alC•Ÿ“c•q‰ëiŠáj: XXVI International Congress of Ophthalmology
(90.03.23), ƒVƒ“ƒKƒ|[ƒ‹.
2139. mŠw‰ïn iˆê”Êu‰‰j Ž™“¶‰¹º‚ÌŠî–{Žü”g”. ŒÓ˜A¶iŽ¨•@j: “ú–{A“ª‰ÈŠw‰ï (90.03.24), “Œ‹ž.
2140. mŠw‰ïn iˆê”Êu‰‰j Angioimmuinoblastic Lymphadenopathy
(AILD)—l‚s×–EƒŠƒ“ƒpŽî‚Ì1—á. Šâè‰ëC‰q“¡ŒõC’|èLˆê˜YC¼‰ª´i”çjC“¡–ì—R”üC•ìºi“àj: ‘æ263‰ñ“ú–{”畆‰ÈŠw‰ï•Ÿ‰ª’n•û‰ï
i89.03.00j, •Ÿ‰ª.
2141. mŠw‰ïn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“—Ö@. ŒüˆäGŽ÷C–ìŒûr•FC‰¡ŠÖ”Ž—YCŸ‰ªŒ›¶i”çjCדc‚Ì‚¼‚ÝC—`…—²iŽ™j: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.
2142. mŠw‰ïn iˆê”Êu‰‰j Growth Hormone Neurosecretory Dysfunction (GHND)
‚É‚æ‚é¬lÇ‚É‚Ý‚ç‚ꂽ•F•\”çŽî. ‰H‹àdŠìC‰¡ŠÖ”Ž—YCŸ‰ªŒ›¶i”çjCדc‚Ì‚¼‚ÝC—`…—²iŽ™j: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï
i89.04.15j, “¡‘ò.
2143. mŠw‰ïn iˆê”Êu‰‰j ”’á‹Û«–ÑጂÌ1—á. “”I^—CŠÖª“ÖŽqC㑺m•vi”çjCˆ¢•””ü’mŽqi—ÕŒŸj: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.
2144. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚Ì•êe‚æ‚趂܂ꂽV¶Ž™ƒGƒŠƒeƒ}ƒg[ƒfƒX. ‰q“¡ŒõC•ÐŽRˆê˜Ni”çjC¬ŒûO‹BiŽ™j: ‘æ656‰ñ“ú–{”畆‰ÈŠw‰ï“Œ‹ž’n•û‰ï i89.04.15j, “¡‘ò.
2145. mŠw‰ïn iˆê”Êu‰‰j ”|—{”畆‚ÌŠî‘b“IŒ¤‹†; ‰‘ã”|—{‚É‚¨‚¯‚é•\”ç×–E‚ÌL“W‘B. ŒÃŽR“o—²C’–Œ´ß”V‰îC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i89.04.20j, ‰YˆÀ.
2146. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽeŠú‘nŽ¡–ü 2. in vitro ƒ‚ƒfƒ‹‚Å‚Ý‚ç‚ê‚é‘gD‚Ì”½‰ž«‚Ì‘Ù—î“I•Ï“®.
’–Œ´ß”V‰îC’·”öŒb—ŽqC‰F’Öؗ´ˆêC‰–’JMKiŒ`ŠOjC–{—Ñ—R”üŽqi¶‰»Œnj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ïŠwpW‰ï i89.04.20j, ‰YˆÀ,
´˜^W, p.208, 1989.
2147. mŠw‰ïn iˆê”Êu‰‰j Trichilerumoma Cell Line can Synthesize Interleukin 1
alpha. ¼‰ª´i”çjC‘D“n’‰’ji—Õ•a—jC‰q“¡ŒõC•ÐŽRˆê˜Ni”çjCSato, Y.: Tricontinental Meeting of
ESDR, JSID and SID i89.04.29j, Washington, D.C., USA.
2148. mŠw‰ïn iˆê”Êu‰‰j Phenotypic Heterogeneity of JB/MS Murine Melanoma
Cells, and Purification and Characterization of a Melangenil Inhibitor.
‹TŽRFˆê˜Yi”çjCLaw, L.W.CTanaka, S.CHeaving, V.J. (NIH): American Association
for Cancer Research and Japanese Cancer Association Joint Meeting
i89.05.00j, Hawaii, USA, J. Cell Physiol., 137: 35`44, 1988.
2149. mŠw‰ïn iˆê”Êu‰‰j ”DP«áy]‚Æ‚»‚Ì—ÞÇi34—á‚ÌWŒvj. ‰Í–ì–MŽqC•ÄŒ³N‘ C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò.
2150. mŠw‰ïn iˆê”Êu‰‰j ‘gDŠw“I‚É•\”ç•Ï‰»‚𔺂¤Œ´ˆö•s–¾‚ÌF‘f’¾’…Ç|‚Æ‚‚É pigmentatio macularis
multiplex idiopathica ‚ɂ‚¢‚Ä|. •ÄŒ³N‘ C‰Í–ì–MŽqC¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï
i89.05.11j, ‹à‘ò, “ú–{”畆‰ÈŠw‰ïŽGŽ, 99(13), 1989.
2151. mŠw‰ïn iˆê”Êu‰‰j UVB‚É‚æ‚è—U”‚³‚ꂽ“VáváŒA—Þ“Vávጕa•Ï‚É‚¨‚¯‚é•â‘Ì‚Ì–ðŠ„. ì–¼½ŽiC¼ŽR–Εvi”çj:
‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò, “ú–{”畆‰ÈŠw‰ïŽGŽ, 99(13): 298A, 1989.
2152. mŠw‰ïn iˆê”Êu‰‰j ‹¹‘BŽî‚ð‡•¹‚µ‚½G•½‘Ûá‚Ì2—á. •‹{”ü‰ÀŽqC’¾‘—YCŠâè‰ëC“”I‹BCŒüˆäGŽ÷C‹àŠÛ“NŽRi”çjCX“c—TlC•½ˆäŽO˜Yi‹¹ŠOj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.12j, ‹à‘ò.
2153. mŠw‰ïn iˆê”Êu‰‰j Mycoplasma‚É‚æ‚éZo«g”Á. ‰¡ŠÖ”Ž—YCóˆär–íC‰q“¡Œõi”çjC‘åι–çC“L–ØGC•½Î‘iŽ™j: “ú–{¬Ž™”畆‰ÈŠw‰ï i89.06.11j, “Œ‹ž.
2154. mŠw‰ïn iˆê”Êu‰‰j ‰ÆŒn“à‚ɔǂµ‚½ƒEƒ‹ƒV”畆‰Š‚Ì4—á. ‰¡ŠÖ”Ž—YC‰q“¡ŒõC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.
2155. mŠw‰ïn iˆê”Êu‰‰j MunchhausenÇŒóŒQ‚Ì1—á. –ìŒûr•FC‰¡ŠÖ”Ž—YC‰q“¡ŒõC•ÐŽRˆê˜Ni”çjCŽRéˆê˜Yi¸j: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.
2156. mŠw‰ïn iˆê”Êu‰‰j ‰A•”áu’ÉÇ‚Ì1—á. ‰¹ŽR˜aéC‚–ìWC•ÐŽRˆê˜NC¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.
2157. mŠw‰ïn iˆê”Êu‰‰j ‰AŒsŒ‹Šj]‚Ì1—á. ‘¾“cK‘¥C‚–ìWC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´i”çjCˆî–ìM•viÀŠÔŽsj: “ú–{”畆‰ÈŠw‰ï‘æ657‰ñ“Œ‹ž’n•û‰ï i89.06.17j, ìè.
2158. mŠw‰ïn iˆê”Êu‰‰j Lipodystrophic Centrifugaris Abdominalis Zenfantilis.
Ÿ‰ªŒ›¶C¼‰ª´C¼ŽR–Εvi”çj: 5th International Congress of Pediatric Dermatology
i89.07.11`15j, Milan.
2159. mŠw‰ïn iˆê”Êu‰‰j A Case of Congenital Syphilis. ì–¼½ŽiC‚–ìWC¼ŽR–Εvi”çj: 5th
International Congress of Pediatric Dermatology i89.07.13j, Milan.
2160. mŠw‰ïn iˆê”Êu‰‰j ˆ««•FŽî×–E‚̃ƒ‰ƒjƒ“F‘fŽY¶”\‚ÆMSH receptor‚Ì‘ŠŠÖŠÖŒW‚ɂ‚¢‚Ä.
‹TŽRFˆê˜Yi”çjCHearing, V.J. (NIH): “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.
2161. mŠw‰ïn iˆê”Êu‰‰j •\”ç‚É‚¨‚¯‚éEpidermal Growth Factor Receptor (EGF-R)‚Ì‹ÇÝ. ‹ß“¡Ž •vC•ÄŒ³N‘ i”çj: “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.
2162. mŠw‰ïn iˆê”Êu‰‰j
ŠeŽí”|—{ã”çŒnŽîá‡×–E‚ÌHLA-DRRŒ´‚Ì”Œ»‚ɑ΂·‚égamma-interferon‚ƃrƒ^ƒ~ƒ“D3‚ÌŒø‰Ê. “”I‹BCŸ‰ªŒ›¶C‰q“¡Œõi”çj:
“ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.
2163. mŠw‰ïn iˆê”Êu‰‰j ƒzƒ‹ƒ}ƒŠƒ“ŒÅ’è•W–{‚ɑ΂µ‚Ä”½‰ž«‚ð—L‚·‚éRƒPƒ‰ƒ`ƒ“ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì컂̎Ž‚Ý. ‰Á“¡ˆê˜Yi”çjC‹´–{Œ’iƒEƒGƒCƒ“ƒXƒe[ƒg‘åŠwj: “ú–{”畆‰ÈŠw‰ï‘æ658‰ñ“Œ‹ž’n•û‰ï i89.07.15j, “Œ‹ž.
2164. mŠw‰ïn iˆê”Êu‰‰j ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚ÆMCTD‡•¹—á‚É‚Ý‚ç‚ꂽ“ÁˆÙ‚Ȕ畆Çó. óˆär–íC•ÐŽRˆê˜Ni”çj: ‘æ53‰ñ“ú–{”畆‰ÈŠw‰ï“Œ“ú–{Šwp‘å‰ï i89.09.10j, ’}”g.
2165. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‚Ì‚s×–EŒn”畆ƒŠƒ“ƒz[ƒ}. Šâè‰ëCóˆär–íCŸ‰ªŒ›¶C’|èLˆê˜Yi”çjC“‡–{—R‹IŽqC”ª‘ãŒö•viŽ™jC‘D“n’‰’ji—Õ•a—j: ‘æ53‰ñ“ú–{”畆‰ÈŠw‰ï“Œ“ú–{Šwp‘å‰ï i89.09.10j, ’}”g.
2166. mŠw‰ïn iˆê”Êu‰‰j ”Má•”‚É”¶‚µ‚½Verrucas carcinoma‚Ì1—á.
ó’J‰ë•¶CŠâè‰ëC‘¾“cK‘¥Cóˆär–íC•ÐŽRˆê˜NC¼‰ª´i”çjCät“n’‰’ji—Õ•a—j: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j,
‰¡•l.
2167. mŠw‰ïn iˆê”Êu‰‰j HPVRŒ´—z«‚ðŽ¦‚µ‚½‘«’ê•\”ç”XŽî‚Ì2—á. ŽR“ckŽŸiŠÖ“Œ˜JЕa‰@jCŒüˆäGŽ÷C•xàV‘¸‹VC•ÄŒ³N‘ i”çj: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.
2168. mŠw‰ïn iˆê”Êu‰‰j Sweet•a‚Æl‚¦‚ç‚ꂽ1—á. ’ËŒ´“NÆCŠâè‰ëC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.
2169. mŠw‰ïn iˆê”Êu‰‰j ”S–Œ‘Ûá‚Ì1—á|ŒŒ´amylase’l‚ªŽ¡—ÃŒo‰ß‚É‘ŠŠÖ‚µ‚½SjogrenÇŒóŒQ•¹”—á|.
Žíˆä—Ç“ñC‘¾“cK‘¥CŠâè‰ëC•ÐŽRˆê˜NCŒüˆäGŽ÷i”çj: “ú–{”畆‰ÈŠw‰ï‘æ659‰ñ“Œ‹ž’n•û‰ï i89.10.21j, ‰¡•l.
2170. mŠw‰ïn iˆê”Êu‰‰j ”Ó”«”畆ƒ|ƒ‹ƒtƒBƒŠƒ“Ç‚Ì2—á. ‰¹ŽR˜aéC•ÐŽRˆê˜NCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï’†•”Žx•”‘‰ïŠwp‘å‰ï i89.10.21`22j, ‘åã.
2171. mŠw‰ïn iˆê”Êu‰‰j Suppression of Gamma-interferon Induced HLA-DR
Antigen Expression on Keratinocyte Cell Lines by 1.25(OH)2 Vitamin D3.
“”I‹BCŸ‰ªŒ›¶C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: 2nd Clinically Oriented Research Symposium
i89.11.10j, ‹ž“s.
2172. mŠw‰ïn iˆê”Êu‰‰j Interferon Modulate the Expression of Hormone
Receptors on the Surface of Murine Melanoma Cells. ‹TŽRFˆê˜Yi”çjCHeaviy,
V.J. (NIH): 2nd Clinically Oriented Research Symposium i89.11.10j, ‹ž“s,
J. Clin. Invest., 83: 213`221, 1989.
2173. mŠw‰ïn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰Š‚Æ’E–Ñ. –ìŒûr•FCŸ‰ªŒ›¶C‰¹ŽR˜aéC¼‰ª´C¼ŽR–Εvi”çj: ‘æ14‰ñ“ú–{Œ¤‹†”畆‰ÈŠw‰ï‘‰ï i89.11.11j, ‹ž“s.
2174. mŠw‰ïn iˆê”Êu‰‰j ‘B«“VávጂÌ1—á. ì–¼½ŽiC㑺m•vi”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.
2175. mŠw‰ïn iˆê”Êu‰‰j qí«“Vávጂæ‚èg”Á«“VávጂֈÚs‚ÌŒ©‚ç‚ꂽ1—á. ‚‹´¸ŽiC‰¹ŽR˜aéCŠâè‰ëC•ÐŽRˆê˜NCì–¼½Žii”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.
2176. mŠw‰ïn iˆê”Êu‰‰j ’´‰¹”g—Ö@‚ª‘tŒø‚µ‚½postthrombotic syndrome. ó’J‰ë•¶CŠâè‰ëC—é–Ø—T‰îC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.
2177. mŠw‰ïn iˆê”Êu‰‰j äSŠà‚Ì1—á. óˆäŽõŽqC‘¾“cK‘¥CŠâè‰ëCŽíˆä—Ç“ñC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.
2178. mŠw‰ïn iˆê”Êu‰‰j ¶Ž¨‘O•”‚É‚Ý‚ç‚ꂽmixed tumor‚Ì1—á. ŽR“ckŽŸCŒüˆäGŽ÷C•xàV‘¸‹VC—é–Ø—T‰îi”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹žŒ¤‹†’n•û‰ï i89.11.18j, ‰¡•l.
2179. mŠw‰ïn iˆê”Êu‰‰j Ž•“÷Žî’¯‚æ‚èf’f‚³‚ꂽ‹}«œ‘’P‹…«”’ŒŒ•a‚Ì1—á.
–îŒûŒúC‰¹ŽR˜aéCŠâè‰ëCóˆär–íC•ÐŽRˆê˜NC¼ŽR–Εvi”çjC‰–’J–ÎCŽR‰º‚¦‚èŽqi“àj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï
i89.11.18j, ‰¡•l.
2180. mŠw‰ïn iˆê”Êu‰‰j F‘f«áy]|–k—¢‘å‰ß‹Ž10”NŠÔ‚Ì“Œv“IŠÏŽ@|. “¡“c—T‰îCŸ‰ªŒ›¶CŠâè‰ëC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.
2181. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒxƒh•a•Ï‚Ì’ÇÕ’²¸. —é–Ø—T‰îC‰¹ŽR˜aéCóˆär–íC‰Á“¡ˆê˜YC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l.
2182. mŠw‰ïn iˆê”Êu‰‰j The Effects of Differentiation on the Tumorgenic and
Metastatic Phenotype of Murine Melanoma Cells. ‹TŽRFˆê˜Yi”çjCHearing, V.J.
(NIH): “ú–{”畆‰ÈŠw‰ï‘æ660‰ñ“Œ‹ž’n•û‰ï i89.11.18j, ‰¡•l, Differentiation, 42(12):
28`30, 1989.
2183. mŠw‰ïn iˆê”Êu‰‰j ³íl‚Ì‚’¼Ž‹‰^“®«ŠáU‚ɂ‚¢‚Ä. ˆ¢•”—EŸC²‹´–M•FC‰LŽ”~Žqi—ÕŒŸjCŽO•x“N˜YC’·’JìˆêŽqi“àjC“¡–ì–¾lC“¿‘Œú“ñiŽ¨j: ‘æ48‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i89.11.23), “Þ—Ç.
2184. mŠw‰ïn iˆê”Êu‰‰j Õ“®«Šá‹…‰^“®‰ðÍ‚Ö‚ÌV‚µ‚¢ŽŽ‚Ý. ŽO•x“N˜YC’·’JìˆêŽqCŒÃ˜a‹vKi“àjC“¿‘Œú“ñiŽ¨jCˆ¢•”—EŸi—ÕŒŸj: ‘æ48‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï i89.11.23), “Þ—Ç.
2185. mŠw‰ïn iˆê”Êu‰‰j F‘f«áy]|–k—¢‘åŠw‰ß‹Ž10”NŠÔ‚Ì“Œv“IŠÏŽ@|. “¡“c—T‰îCŠâè‰ëCŸ‰ªŒ›¶i”çj: “ú–{”畆‰ÈŠw‰ï‘æ271‰ñ•Ÿ‰ª’n•û‰ï i89.11.23j, •Ÿ‰ª.
2186. mŠw‰ïn iˆê”Êu‰‰j Opsoclonus—lŠá‹…‰^“®A’ZŠúŒð‘ã«ŠáU‚ð’悵‚½1—á.
f‘ò’BŽuCŒ˘aŽqC’·’JìˆêŽqCŒÃ˜a‹vKi“àjCˆ¢•”—EŸi—ÕŒŸjC“¡–ì–¾lC“¿‘Œú“ñiŽ¨j: ‘æ48‰ñ“ú–{•½t_Œo‰ÈŠw‰ï‘‰ï
i89.11.25), “Þ—Ç.
2187. mŠw‰ïn iˆê”Êu‰‰j Interleukin 1 alpha and 6 Expression in Psoriatic
Skin. ‘¾“cK‘¥C¼‰ª´i”çjC‘D“n’‰’ji—Õ•a—jC¼ŽR–Εvi”çj: The 6th Japan-Korea Joint Meeting
of Dermatology i89.11.5`6j, “Œ‹ž.
2188. mŠw‰ïn iˆê”Êu‰‰j A Case of Livedo with Ulceration Associated with
Multiple Cereberal Infarctions and Elevated Anti-cardiolipin Antibody.
‰¹ŽR˜aéC•ÐŽRˆê˜NC—é–Ø—T‰îC¼‰ª´C¼ŽR–Εvi”çj: The 6th Japan-Korea Joint Meeting of
Dermatology i89.11.5`6j, “Œ‹ž.
2189. mŠw‰ïn iˆê”Êu‰‰j ¬lŒ^ƒAƒgƒs[«”畆‰Š‚É‚¨‚¯‚é׋ۂ̖ðŠ„. –ìŒûr•Fi”çj: _“Þ쌧”畆‰Èˆã‰ï‘æ70‰ñ—á‰ï i89.12.02j, ‰¡•l.
2190. mŠw‰ïn iˆê”Êu‰‰j Š£á•\”ç‚É‚¨‚¯‚éIL-1‚¨‚æ‚Ñ6ƒƒbƒZƒ“ƒWƒƒ[RNA”Œ»‚ÌŒŸ“¢. ‘¾“cK‘¥C¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ661‰ñ“Œ‹ž’n•û‰ï i89.12.16j, “Œ‹ž.
2191. mŠw‰ïn iˆê”Êu‰‰j ”畆׬ŒŒŠÇ‰Š‚Ì—Õ°‘gDŠw“IŒŸ“¢. óˆär–íC‰Á“¡ˆê˜YCì–¼½ŽiC—é–Ø—T‰îi”çj: “ú–{”畆‰ÈŠw‰ï‘æ661‰ñ“Œ‹ž’n•û‰ï i89.12.16j, “Œ‹ž.
2192. mŠw‰ïn iˆê”Êu‰‰j “÷‰èŽî«‰ŠÇ‚É‚¨‚¯‚éNK×–E‚Ì–ðŠ„. ‹´–{–¾•Fi”çjCEpstein, W.L.(¶ØÌ«ÙƱ‘åj: “ú–{”畆‰ÈŠw‰ï‘æ661‰ñ“Œ‹ž’n•û‰ï i89.12.16j, “Œ‹ž.
2193. mŠw‰ïn iˆê”Êu‰‰j ˆ««•FŽî‚ÌŽo–…—á. “¡“c—T‰îCŠâè‰ëC•ÐŽRˆê˜NC•ÄŒ³N‘ i”çjC¼X“N˜NC‘å–ìŽii®ŠOjCÎì~iŠOj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2194. mŠw‰ïn iˆê”Êu‰‰j Tribenoside (Hemocuron R)‚É‚æ‚é–ò]‚Ì2—á. –ìŒûr•FC’ËŒ´“NÆCóˆär–íC•ÐŽRˆê˜Ni”çj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2195. mŠw‰ïn iˆê”Êu‰‰j œ‘«ƒvƒƒgƒ|ƒ‹ƒtƒBƒŠƒ“Ç. ’؈äL”üC•ÄŒ³N‘ Cóˆär–íi”çjCìè‚¢‚ÂÝiŠáj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2196. mŠw‰ïn iˆê”Êu‰‰j qí«˜TáŒ. óˆär–íC•ÄŒ³N‘ CŸ‰ªŒ›¶C‘ºˆä³Œ³i”çj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2197. mŠw‰ïn iˆê”Êu‰‰j ”牺ŽîáŽ‚ð‰”‚Æ‚µŒ´”‘ƒ‚ª”x‚Æl‚¦‚ç‚ꂽ“]ˆÚŠà‚Ì2—á. –îŒûŒúC‹ß“¡Ž •vCŠâè‰ëC•ÐŽRˆê˜Ni”çjC‰ºì‰ë•¶i“ŒŽÅ—ÑŠÔ•a‰@j: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2198. mŠw‰ïn iˆê”Êu‰‰j Cowden•a (multiple hamartoma syndrome). ‚–ìWC“”I‹BC•ÄŒ³N‘ i”çjC–ØìŽOŽl˜YiŠOj: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2199. mŠw‰ïn iˆê”Êu‰‰j TEN‚Ì1—á. ‹TŽRFˆê˜Yi”çjC”ö—§Žé”üC–؉º³Žqi‰Í–k•a‰@j: “ú–{”畆‰ÈŠw‰ï‘æ662‰ñ“Œ‹ž’n•û‰ï i90.01.20j, ‰¡•l.
2200. mŠw‰ïn iˆê”Êu‰‰j ”畆׬ŒŒŠÇ‰Š‚Ì—Õ°“IŒŸ“¢|“Á‚ɬl—á‚Ì“Á’¥‚ɂ‚¢‚Ä|. óˆär–íC‰¡ŠÖ”Ž—YC—é–Ø—T‰îC‰Á“¡ˆê˜YCì–¼½ŽiC‘‘òŠ²’ji”çj: ‘æ13‰ñ”畆–¬ŠÇ§˜b‰ï i90.01.25j, ‘q•~.
2201. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒxƒh•a•Ï‚É‚¨‚¯‚é—Õ°A‘gD‘œA”]“àŒŒŠÇ•a•ÏARƒJƒ‹ƒWƒIƒŠƒsƒ“R‘Ì‚ÌŠÖ˜A«‚ɂ‚¢‚Ä. —é–Ø—T‰îC‰¹ŽR˜aéC•ÐŽRˆê˜NC¼ŽR–Εvi”çj: ‘æ13‰ñ”畆–¬ŠÇ§˜b‰ï i90.01.25j, ‘q•~.
2202. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É”F‚ß‚ç‚ꂽ”畆’×ᇂ̌Ÿ“¢. Žíˆä—Ç“ñCóˆär–íC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ13‰ñ”畆–¬ŠÇ§˜b‰ï i90.01.25j, ‘q•~.
2203. mŠw‰ïn iˆê”Êu‰‰j Žè¶g”ÁAlivedo‚ð”F‚ßARƒŠƒ“Ž‰Ž¿R‘Ì—z«‚Ì’jŽqäPŒ´•a‚Ì2—á. ‰¹ŽR˜aéC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ37‰ñ“ú–{”畆‰ÈŠw‰ïɪ’n•û‰ï i90.02.04j, •l¼.
2204. mŠw‰ïn iˆê”Êu‰‰j ŽhÂŽÒ‚É‚Ý‚ç‚ꂽ“úŒõ]. óˆär–íC•ÐŽRˆê˜NC¼‰ª´i”çj: ‘æ37‰ñ“ú–{”畆‰ÈŠw‰ïɪ’n•û‰ï i90.02.04j, •l¼.
2205. mŠw‰ïn iˆê”Êu‰‰j ƒNƒƒ‚ƒVƒR[ƒVƒX‚Ì1—á||ƒCƒgƒ‰ƒRƒiƒ][ƒ‹Žg—p—á||. óˆäŽõŽqCŠâè‰ëC“cÀO”VC¼ŽR–Εvi”çjC‚–Øç’ßCˆ¢•””ü’mŽqi—ÕŒŸj: ‘æ27‰ñ_“Þìˆã^‹Û§˜b‰ï i90.02.10j, ‰¡•l.
2206. mŠw‰ïn iˆê”Êu‰‰j Staphylococcal Botryomycosis‚Ì1—á. ’؈äL”üCŠâè‰ëC“cÀO”VC•ÐŽRˆê˜NC¼ŽR–Εvi”çjC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ27‰ñ_“Þìˆã^‹Û§˜b‰ï i90.02.10j, ‰¡•l.
2207. mŠw‰ïn iˆê”Êu‰‰j Cat-scratch Disease. ’؈äL”üC‰q“¡ŒõC¼‰ª´i”çjC‚‹{t’ji—ÕŒŸj: “ú–{”畆‰ÈŠw‰ï‘æ663‰ñ‡“¯—Õ°“Œ‹ž’n•û‰ï i90.02.17j, “Œ‹ž.
2208. mŠw‰ïn iˆê”Êu‰‰j ”ñ’èŒ^g”Á‚É‚æ‚è”xŠà‚𔌩‚µ‚½1—á. ó’J‰ë•¶C’ËŒ´“NÆCŽíˆä—Ç“ñC‰Á“¡ˆê˜Yi”çj: “ú–{”畆‰ÈŠw‰ï‘æ272‰ñ•Ÿ‰ª’n•û‰ï i90.03.11j, •Ÿ‰ª.
2209. mŠw‰ïn iˆê”Êu‰‰j ƒo[ƒWƒƒ[•aA‹”çÇASLE‚̃ŒƒCƒm[Çó‚ɑ΂·‚éÉŽ_ƒCƒ\ƒ\ƒ‹ƒrƒhƒe[ƒvÜ‚ÌŽ¡—ÃŒø‰Ê‚ɂ‚¢‚Ä. ‚‹´¸ŽiC‰¹ŽR˜aéC‹ß“¡Ž •vC‰Á“¡ˆê˜Yi”çj: “ú–{”畆‰ÈŠw‰ï‘æ272‰ñ•Ÿ‰ª’n•û‰ï i90.03.11j, •Ÿ‰ª.
2210. mŠw‰ïn iˆê”Êu‰‰j “û—cŽ™ƒAƒgƒs[«”畆‰Š‚Ì’ÇÕ’²¸. –ìŒûr•FCŒüˆäGŽ÷C¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.
2211. mŠw‰ïn iˆê”Êu‰‰j ^”ç”÷¬ŒŒŠÇ“à”ç×–E(DMEC)‚ÌcAMP‚É‚æ‚é×–E‘BŒø‰Ê‚ÌŒŸ“¢. ‘‘òŠ²’jC‘åìŽiCóˆär–íC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.
2212. mŠw‰ïn iˆê”Êu‰‰j RƒAƒ~ƒƒCƒhƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì‚Ìì»A‹y‚Ñ‚»‚Ì‘gD‰»Šw“IŒŸ“¢. ‰Á“¡ˆê˜YC‰q“¡ŒõC‹´–{–¾•FCŒüˆäGŽ÷i”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.
2213. mŠw‰ïn iˆê”Êu‰‰j Pathogenesis of Blackfoot Disease--Effects of
Trivalent Arsenic on Cultured Human Umbilical Vein Endothelial
Cells---. ’‘dCóˆär–íC“”I‹BC—é–Ø—T‰îC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j,
“Œ‹ž.
2214. mŒ¤‹†‰ïn i“Á•Êu‰‰j ŠáˆÊ‚Æ‚‚Éu‚’¼Šá‹…‰^“®v‚̈Ùí‚ð’†S‚É. Îì“NiŠáj: ‘æ640‰ñ“Œ‹ž“sŠá‰ÈW’k‰ï (89.04.28), “Œ‹ž.
2215. mŒ¤‹†‰ïn i“Á•Êu‰‰j “µEE’²ßAŋ߂̘b‘è. Îì“NiŠáj: ‘æ74‰ñŽRŒûŒ§Šá‰Èˆã‰ïH‹G‘‰ïŽRŒûŒ§Šá‰ÈW’k‰ï (89.11.05), ¬ŒS.
2216. mŒ¤‹†‰ïn i“Á•Êu‰‰j VDT‚ÆŠáA‚Æ‚‚ɋߌ©”½‰ž‚Æ‚ÌŠÖŒW. Îì“NiŠáj: ŽOdŒ§Šá‰Èˆã‰ïuK‰ï (90.01.15), ŽOd.
2217. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒeƒNƒmƒXƒgƒŒƒXŠáÇ. Îì“NiŠáj: ç—tŒ§Šá‰Èˆã‰ïŠwpu‰‰‰ï (90.01.21), ç—t.
2218. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒeƒNƒmƒXƒgƒŒƒXŠáÇ. Îì“NiŠáj: é‹ÊŒ§Šá‰Èˆã‰ï‹³ˆçu‰‰ (90.01.28), ‘å‹{.
2219. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‚æ‚‚Ý‚ç‚ê‚éŽq‚Ç‚à‚̊ᎾŠ³. Œü–ì˜a—YiŠáj: ‘æ76‰ñ—Õ°¬Ž™ˆãŠw§˜b‰ï (90.02.25).
2220. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒRƒ“ƒsƒ…[ƒ^[Žž‘ã‚ÌŠw“¶‚Ì–Ú‚ÌŒ’N. Îì“NiŠáj: “Œ‹ž“sŠá‰Èˆã‰ïŠwZ•ÛŒ’Šwpu‰‰‰ï (90.03.08), “Œ‹ž.
2221. mŒ¤‹†‰ïn i“Á•Êu‰‰j Ž‹_ŒoŽ¾Š³‚Æ“û“ªŠŒ©. Žá‘q‰ë“oiŠáj: –h‰qˆã‘åŠá‰ÈŠwpW‰ï (90.03.14), é‹Ê.
2222. mŒ¤‹†‰ïn i“Á•Êu‰‰j VDTì‹Æ‚É”º‚¤áŠQ‚ɂ‚¢‚Ä. Îì“NiŠáj: •½¬Œ³”N“x_“Þ쌧ˆãŽtŽY‹Æˆã•”‰ïŒ¤C‰ï (90.03.29), ‰¡•l.
2223. mŒ¤‹†‰ïn i“Á•Êu‰‰j Clinical Ecology‚ÆŠá‰È. Îì“NiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.
2224. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒtƒFƒjƒgƒCƒ“‚Ì–ò]. “”I‹BCóˆär–íC’|èLˆê˜YC¼‰ª´C¼ŽR–Εvi”çj: ‘æ14‰ñ–ƉuƒZƒ~ƒi[ i90.01.27j, “Œ‹ž.
2225. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠJ‹Æˆã‚É•K—v‚ÈŠá‰ÈŠw‚Ì’mŽ¯|‚—ŽÐ‰ï‚ðŒ}‚¦‚Ä|. Œü–ì˜a—YiŠáj: ‘å˜a—Õ°ˆãŠw’k˜b‰ï‘æ217‰ñŒ¤C‰ï (89.04.12), ‘å˜a.
2226. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “úíŒoŒ±‚·‚éŠááÙ‚Ì‹@”\ˆÙíA‚»‚ÌŠî‘b‚Æ—Õ°. Œü–ì˜a—YiŠáj: ‘æ11‰ñ_“Þ쌧Šá‰È—Õ°’k˜b‰ï (89.07.23), ìè.
2227. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠááÙ‰^“®‚ÌŠî‘b‚Æ—Õ°. Œü–ì˜a—YiŠáj: ‘æ1‰ñ‰¡•lŽs‘å_ŒoƒZƒ~ƒi[ (89.09.22), ‰¡•l.
2228. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ‹»–¡‚ ‚éŠá‹…‰^“®ˆÙí‚ð’Ê‚µ‚Ä. Œü–ì˜a—YiŠáj: ‘æ1‰ñMB‘åŠw–k—¢‘åŠwŒðŠ·Œ¤‹†‰ï (89.10.28), ¼–{.
2229. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “Ë‘R•¡Ž‹‚𗈂·Ž¾Š³‚Ìf’f‚ÆŽ¡—Ã. Îì“NiŠáj: ‘æ19‰ñŠá‰È‹³ˆçƒ[ƒ~ƒi[ƒ‹ (89.12.09), ‘åã.
2230. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ’²ß‚ÌV‚µ‚¢ŒŸ¸–@. ‰LŽ”ˆê•FiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.
2231. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “dŽqŒ°”÷‹¾‚Ì•a—f’f‚ւ̃Aƒvƒ[ƒ`||”畆Žîᇂɂ‚¢‚Ä. ‰q“¡Œõi”çj: “ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwp•”‰ï•½¬Œ³”N“xŠwpW‰ï i90.03.24j, “Œ‹ž.
2232. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Contact Desmatitis and Aging. ¼‰ª´i”çj: International Conference on Skin Aging i89.06.17j, “Œ‹ž.
2233. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Immunologic Role of Dermis. ¼‰ª´i”çj: Symposium on Immunodermatology i89.09.12j, Seoul.
2234. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”畆‚̉ŠÇ‚̃ƒfƒBƒG[ƒ^[. ¼‰ª´i”çj: ‘æ2‰ñ”畆–ò•¨¶—ŠwŒ¤‹†‰ï i89.10.07j, “Œ‹ž.
2235. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ‹–Œ‰ºpseudolymphoma‚Ì1—á. ”óŒû—T•FC²ŒÃ”ŽPC‘ìd•vC–ؔÉiŠáj: _“ÞìW’k‰ï (86.07.26).
2236. mŒ¤‹†‰ïn iˆê”Êu‰‰j –¬—–ŒŒŒŠÇŽî‚̉摜f’f‚ɂ‚¢‚Ä. –]ŒŽˆêCŽá‘q‰ë“oiŠáj: ‘æ11‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.04.06), ‰¡•l.
2237. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”ìŒú«‘–Œ‰Š‚É‚ÄŽ‹—ÍáŠQ‚ð‹N‚±‚µ‚½‚ÆŽv‚í‚ꂽ1—á. ‹ß“¡‰À•vCŠÖ’JŽ¡‹viŠájC²“¡³KióŠÔ‘‡•a‰@j: ‘æ11‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.04.06), ‰¡•l.
2238. mŒ¤‹†‰ïn iˆê”Êu‰‰j FisherÇŒóŒQ‚Ì’²ßáŠQ‚ɂ‚¢‚Ä. Œ´’¼lC“©ŽRG•vCÎì“NiŠáj: ‘æ42‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.05.28), ‰¡•l.
2239. mŒ¤‹†‰ïn iˆê”Êu‰‰j –³‹Û«‘–Œ‰ŠA‚¤‚ÁŒŒ“û“ª‚ðŽ¦‚µ‚½ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á. ¡“c–LCŽá‘q‰ë“oiŠáj: ‘æ42‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.05.28), ‰¡•l.
2240. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž‘±«‚Ìâ‘ΓµE‹’¼‚ð‚«‚½‚µ‚½1Ç—á. Œ´’¼lCŽá‘q‰ë“oCŒü–ì˜a—YiŠáj: ‘æ16‰ñ_ŒoŠá‰È•×‹‰ï (89.06.14), “Œ‹ž.
2241. mŒ¤‹†‰ïn iˆê”Êu‰‰j Myotonic dystrophy‚ÌŠá’ê•a•Ï. ’Ò‘ò‰F•FC’m–쇎qC¼Œ´ŒbŽqiŠáj: ‘æ43‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.07.08), ‰¡•l.
2242. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©‘RŠ°‰ð‚µ‚½‹×–E«“®–¬‰Š‚É‚æ‚鎋_ŒoÇ. Žs•Ó‹`ÍCŽá‘q‰ë“oCÎì“NiŠáj: ‘æ43‰ñ_“Þ쌧Šá‰ÈW’k‰ï (89.07.08), ‰¡•l.
2243. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œ´ˆö•s–¾‚ÌŠ´‰¹“ï’®‚Ì”N—î•Ê’®—Í. ‰ª–{–qlCÝŠy“N–çCŒÃ‘òTˆêC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ1‰ï‘‰ï (89.08.12), “Œ‹ž.
2244. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Á“ï‚̈æ’lã’®—ÍŒŸ¸i‘æ3•ñj. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlCŒÃ‘òTˆêiŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ1‰ï‘‰ï (89.08.12), “Œ‹ž.
2245. mŒ¤‹†‰ïn iˆê”Êu‰‰j Šáâ|ƒRƒŒƒXƒeƒŠƒ““÷‰èŽî‚Ì1Ç—á. ’†‘ò³”ŽCŽá‘q‰ë“oCÎì“NiŠájCŠâŸºŒ[ˆêi•a—j: ‘æ24‰ñŠá‰È—Õ°•a—‘gDŒ¤‹†‰ï (89.09.08).
2246. mŒ¤‹†‰ïn iˆê”Êu‰‰j X-Yƒgƒ‰ƒbƒJ[‚ð—p‚¢‚½ŒÅŽ‹”÷“®‚Ì‘ª’è. Ä“¡—²C–ؔÉCÎì“NC¼–q–¾”üiŠáj: ‘æ7‰ñVDTŒ¤‹†‰ï (89.10.13), –¼ŒÃ‰®.
2247. mŒ¤‹†‰ïn iˆê”Êu‰‰j VDTì‹Æ‚ð’†S‚Æ‚·‚éŠá¸”æ˜JŠ³ŽÒ‚ÌŽ©—¥_ŒoáŠQ‚ɂ‚¢‚Ä||“_ŠáƒeƒXƒg‚É‚æ‚铵E‚©‚ç‚̃Aƒvƒ[ƒ`.
¡“c–LC¬“ˆ—ÇGC–ؔÉCÎì“NCŠÝ“cç•äŽqCˆÉ“¡K]iŠáj: ‘æ7‰ñVDTŒ¤‹†‰ï (89.10.13), –¼ŒÃ‰®.
2248. mŒ¤‹†‰ïn iˆê”Êu‰‰j Congenital Eyelid Retraction ‚Ì2—á. ”óŒû—T•FCŒü–ì˜a—YiŠáj: ‘æ18‰ñ“È–ØW’k‰ï (89.11.10), “È–Ø.
2249. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž©“®–D‡Ší(Staple)‚Æ‘nŽ¡–ü. ŽR“c’¼lC“àÀ‰hŽ÷CÎŒ´GˆêC¼‘q’m”VC‰–’JMKiŒ`ŠOj: ‘nŽ¡–üŒ¤‹†‰ï (89.12.02), ‹v—¯•Ä.
2250. mŒ¤‹†‰ïn iˆê”Êu‰‰j äNã÷Šà‚ÌŠáâ|“à“]ˆÚ‚ð‚«‚½‚µ‚½1—á. Žs•Ó‹`ÍC“©ŽRG•vC”µ–ì’·•¶iŠáj: ‘æ4‰ñŠáâ|Ž¾Š³ƒVƒ“ƒ|ƒWƒEƒ€ (89.12.03).
2251. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’±Œ`œ“´”S‰t”XŽî‚Æ‘OŒð’Ê“®–¬áŽ‚ð‡•¹‚µ‚½1—á. ”µ–ì’·•¶C“©ŽRG•vCŽs•Ó‹`ÍiŠáj: ‘æ4‰ñŠáâ|Ž¾Š³ƒVƒ“ƒ|ƒWƒEƒ€ (89.12.03).
2252. mŒ¤‹†‰ïn iˆê”Êu‰‰j VDTì‹Æ‚ð’†S‚Æ‚·‚éŠá¸”æ˜JŠ³ŽÒ‚ÌŽ©—¥_ŒoáŠQ‚ɂ‚¢‚Ä||“_ŠáƒeƒXƒg‚É‚æ‚铵E‚©‚ç‚̃Aƒvƒ[ƒ`||.
–ؔÉC¬“ˆ—ÇGCÎì“NCŠÝ“cç•äŽqCˆÉ“¡K]iŠáj: “ú–{ŽY‹Æ‰q¶Šw‰ïVDTì‹ÆŒ¤‹†‰ï‘æ8‰ñŒ¤‹†‰ï (89.12.06), “Œ‹ž.
2253. mŒ¤‹†‰ïn iˆê”Êu‰‰j Epstein-Barr Virus‚É‚æ‚é‚ÆŽv‚í‚ê‚éNeuro-retinitis‚Ì1—á.
”–ØLÆCŽs•Ó‹`ÍCŽá‘q‰ë“oiŠáj: ‘æ12‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.12.21), ‘Š–ÍŒ´.
2254. mŒ¤‹†‰ïn iˆê”Êu‰‰j –Ɖu—}§Ü’·Šú“Š—^Œã‚ɔǂµ‚½ƒTƒCƒgƒƒKƒƒEƒCƒ‹ƒX–Ô–ŒÇ‚Ì1—á. “¡“c“NCÎì‹ÏCŽá‘q‰ë“oiŠáj: ‘æ12‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.12.21), ‘Š–ÍŒ´.
2255. mŒ¤‹†‰ïn iˆê”Êu‰‰j Š®‘S’E‰P…»‘Ì‚ðÉŽq‘ÌŽèp‚É‚æ‚蜋Ž‚µ‚½1—á. “¡ˆä‰ë˜NC•Ÿ“c•q‰ëiŠáj: ‘æ12‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.12.21), ‘Š–ÍŒ´.
2256. mŒ¤‹†‰ïn iˆê”Êu‰‰j çtçsŠá‹…‰^“®‚̃Gƒ‰[ƒVƒOƒiƒ‹. ŽR“c“OlC‰LŽ”ˆê•FiŠáj: 1990”N“~ŠúŽ‹ŠoŒ¤‹†‰ï (90.00.00), Vision, 2(1): 18, 1990.
2257. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒqƒg‚ÌŠOŠá‹Ø‹Ø–aŽ‚ÌŒ`‘ÔŠw“IŒ¤‹†|(2)•a“I󋵂ɂ¨‚¯‚é‹Ø–aŽ‚̕ω». Œü–ì˜a—YCVˆä“cF—TC–Ø‘º^–çiŠáj: Šá‹ØŽ©ŒÈŽó—eŠí‚ÌŠî‘b“I‚¨‚æ‚Ñ—Õ°“I‰ž—p‚ÌŒ¤‹†; ‘‡Œ¤‹†A”ljï‹c (90.01.13), ¼ŽR.
2258. mŒ¤‹†‰ïn iˆê”Êu‰‰j –îóÖ¬“´ŒŒðÇ‚Ì1—á. Ä“¡‘åCÝŠy“N–çC‰ª–{–qlC•½ŽR•ûrC“¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.
2259. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Ë”«“ï’®ŒŒ‰tŒŸ¸ŠŒ©‚ÌŒŸ“¢i‘æ‚P•ñj. ‰ª–{–qlCÝŠy“N–çCŒÃ‘òTˆêC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.
2260. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒhŽ‘±“Š—^Š´‰¹“ï’®‚ÌŒŸ“¢. ŒÃ‘òTˆêCÝŠy“N–çC‰ª–{–qlC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.
2261. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Ë”«Š´‰¹“ï’®‚ÌŒŸ“¢|Žá”NŒ^‚ƬlŒ^‚ɂ‚¢‚Ä. •½ŽR•ûrCÝŠy“N–çC‰ª–{–qlCŒÃ‘òTˆêiŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï (90.02.03), “Œ‹ž.
2262. mŒ¤‹†‰ïn iˆê”Êu‰‰j Oculo-kinetic Perimetry—ΓàኳŽÒ‚ɑ΂·‚鎋–쌟¸. “©ŽRG•vCŽá‘q‰ë“oiŠáj: ‘æ7‰ñ_“Þ쌧—Γàá’k˜b‰ï (90.02.17).
2263. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’†SŠj•afloppy infant‚ɇ•¹‚µ‚½æ“V«—Γàá‚ÌŽ¡—Âɂ‚¢‚Ä. ’†ŽR’q•FCŽí“c–F˜YiŠáj: ‘æ7‰ñ_“Þ쌧—Γàá’k˜b‰ï (90.02.17).
2264. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹•ŒŒ«‚©’E‘«‚©ŠÓ•Ê‚É–À‚Á‚½Ä”«Ž‹_ŒoÇ. ìè‚¢‚ÂÝC¡“c–LCŽá‘q‰ë“oiŠáj: ‘æ45‰ñ_“Þ쌧Šá‰ÈW’k‰ï (90.02.18), ‰¡•l.
2265. mŒ¤‹†‰ïn iˆê”Êu‰‰j _ŒoŠá‰ÈŠw“I‚ÉÇŒó‚ðŽ¦‚µ‚½¬Ž™‚ÌMCTD‹^‚¢—á. ª–{“OiŠáj: ‘æ18‰ñ_ŒoŠá‰È•×‹‰ï (90.03.07), “Œ‹ž.
2266. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž‹_Œo‰Š‚Æ‚µ‚Ä’·ŠúŠÔŽ¡—³‚ê‚Ä‚¢‚½ˆÆã•”‘–ŒŽî. ”µ–ì’·•¶CVˆä“cF—TiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.
2267. mŒ¤‹†‰ïn iˆê”Êu‰‰j 7”NŠÔ‚É6‰ñ‚ÌŽ‹—͒ቺ‚𗈂µ‚½‘½”«d‰»Ç‚Ì1—á. ‹g‰i½ŽqC‰ª–ì’q•¶C’m–쇎qC¼Œ´ŒbŽqC–ؔÉiŠáj: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.
2268. mŒ¤‹†‰ïn iˆê”Êu‰‰j óŠÔ‘‡•a‰@Šá‰ÈŽóf‚É‚Ý‚ç‚ꂽ‰æ‘œf’f—z«—á. ‘ìd•vC‹ß“¡‰À•viŠájC‰Í“à‰ëÍióŠÔ‘‡•a‰@j: ‘æ13‰ñ–k—¢‘åŠwE_“Þ쌧Šá‰Èˆã‰ï‡“¯ƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.03.29), ‘Š–ÍŒ´.
2269. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒAƒgƒs[«”畆‰Š‚Ì׋ۃƒNƒ`ƒ“—Ö@. ŒüˆäGŽ÷C–ìŒûr•FC¼‰ª´C¼ŽR–Εvi”çj: ‘æ1‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ït‹G—Õ°W‰ï i89.04.14j, “Œ‹ž.
2270. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹ÈÜüó‹›—Øá‚ÌeŽq—á. ‰¹ŽR˜aéC¼‰ª´i”çj: ‘æ4‰ñŠp‰»ÇŒ¤‹†‰ï i89.06.03j, “Œ‹ž.
2271. mŒ¤‹†‰ïn iˆê”Êu‰‰j Pleomorphic Lymphomatoid Papulosis (PLP).
Šâè‰ëCóˆär–íC’|èLˆê˜Yi”çjC‘D“n’‰’ji—Õ•a—j: ‘æ8‰ñ”畆‚̃Šƒ“ƒtƒH[ƒ}Œ¤‹†‰ï i89.07.00j, •Ÿ‰ª, ”畆ƒŠƒ“ƒtƒH[ƒ},
IX, 1990.
2272. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒXƒM‰Ô•²ÇŠ³ŽÒ‚É‚Ý‚ç‚ꂽŽ¼]«•a•Ï‚ÌŒŸ“¢. óˆär–íC‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: ‘æ19‰ñRŒ´Œ¤‹†‰ï i89.07.01j, ’ÃŽs.
2273. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒAƒŒƒrƒAƒ`ƒ“‚Ì–ò]. “”I‹BC’|èLˆê˜YC¼‰ª´C¼ŽR–Εvi”çj: ‘æ19‰ñRŒ´Œ¤‹†‰ï i89.07.01j, ’ÃŽs.
2274. mŒ¤‹†‰ïn iˆê”Êu‰‰j MCTD‚Ì—Õ°Œo‰ß‚ÌŒŸ“¢i“–‰È‚ÅŒoŒ±‚µ‚½15—á‚ɂ‚¢‚Äj.
‹ß“¡Ž •vC‘¾“cK‘¥C“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NC‰q“¡ŒõC㑺m•vCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çj:
Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“xƒZƒ~ƒi[ i89.08.26j, ŒS㔪”¦CŠò•Œ.
2275. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹”çÇ‚ÌŽ¡—Âƌo‰ß|“–‰È‚Å‚ÌŒoŒ±—ái“Á‚ɃXƒeƒƒCƒhŽ¡—ÂɊւµ‚Äj|.
‹ß“¡Ž •vC‘¾“cK‘¥C“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NCVˆätŽ}C‰q“¡ŒõC㑺m•vC¼‰ª´C¼ŽR–Εvi”çj: ‘æ4‰ñäPŒ´•aŒ¤‹†‰ï
i90.01.26j, ‘q•~.
2276. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒyÇŒ^SLE‚̔畆Çó‚ɂ‚¢‚Ä‚Ì—Õ°“IŒŸ“¢|subacute LE vs subacute
cutaneous LE|. ‰q“¡ŒõC‹ß“¡Ž •vC²X–Ø–MŽqC“”I^—CŽ›–{”ÍŽqCVˆätŽ}C•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj:
‘æ4‰ñäPŒ´•aŒ¤‹†‰ï i90.01.26j, ‘q•~.
2277. mŒ¤‹†‰ïn iˆê”Êu‰‰j •\”ç×–EŠj‚ɖƉuƒOƒƒuƒŠƒ“‚Ì’¾’…‚ð”F‚ß‚½MCTD. ‹ß“¡Ž •vC•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ç•½¬2”N“x”ljï‹c i90.01.31j, “Œ‹ž.
2278. mŒ¤‹†‰ïn iˆê”Êu‰‰j “Vávጂ̑ˆ«ˆöŽq‚Æ‚µ‚Ä‚ÌŽ‡ŠOü. ì–¼½ŽiC‚‹´¸ŽiCŠâè‰ëC•ÐŽRˆê˜Ni”çj: Œú¶È“Á’莾Š³‹H“«Ž¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï i90.02.10j, ‹ž“s.
2279. mŒ¤‹†‰ïn iŒöŠJuÀj ‘Ì•½t‚ÌŒŸ¸. “¿‘Œú“ñiŽ¨•@j: ‘æ19‰ñ“ú–{•½t_Œo‰ÈŠw‰ï•½t‹@”\‹ZpuK‰ï (89.07.27), ìè.
<<111 ‚»‚Ì‘¼>>
2280. mÇ—á•ñn ˜Vl«“ï’®‚Ì“Á’¥. ‰ª–{–qliŽ¨•@j: JOHNS, 5(12): 1723`1727, 1989.
2281. mÇ—á•ñn Œûo¥ã’×ᇕa•Ï‚ÌŠÓ•Êf’f. ‚‹´œAbiŽ¨•@j: JOHNS, 5(7): 947`951, 1989.
2282. mÇ—á•ñn “Á”«—¼‘¤«Š´‰¹“ï’®. ‰ª–{–qlC•½ŽR•ûriŽ¨•@j: JOHNS, 6(1): 75`78, 1990.
2283. m—Õ°Ž¡Œ±n ƒqƒgŒûŠWG“‚É‚¨‚¯‚é•a—‘gDŠw“IŒ¤‹†|“Á‚É”N—î•Ï‰»‚ɂ‚¢‚Ä|. Œ´“cGˆêiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 92: 1049`1064, 1989.
2284. m‘àn —ÞŽ—•a•Ï‚Æ‚ÌŠÓ•Ê‚Ì—v“_. ‚‹´œAbiŽ¨•@j: JOHNS, 6(2): 153`157, 1990.
2285. m‘àn Œ`¬ŠO‰È—̈æ‚É‚¨‚¯‚é Prostaglandin E1 ‚ÌŽg—pŒoŒ±. ’†‘ºŒ³MCˆÀ•x‹`“NC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOj: Œ»‘ãˆã—Ã, 32: 694`699, 1990.
2286. mŠw‰ïn iƒpƒlƒ‹j Œûo“à–ŒŒ´”adenoid squamous cell carcinoma‚Ì1—á.
–Ø“c–FŽ÷i“àjCŠâŸºŒ[ˆêi•a—jC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^[jC‹T’J“OC‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.29),
•Ÿ‰ª.
2287. mŠw‰ïn iˆê”Êu‰‰j š‹‰º‚É‚¨‚¯‚é㜉^“®‚Ì”N—î•Ï‰»i‘æ3•ñj.
‹àŽqŒ÷CΈä–L‘¾CŒ´“cGˆêCŒÃì_ŽOC‚‹´œAbCÝŠy“N–çiŽ¨•@jCV”ü¬“ñi“Œ‘åj: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.12), ‘åãC
“ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1613, 1989.
2288. mŠw‰ïn iˆê”Êu‰‰j d“Ä‚ÈŒo‰ß‚ð‚½‚Ç‚Á‚½Œz•”Š´õǂɂ‚¢‚Ä. ˆäŒû–F–¾C’†ŽR–¾mC’·À‰p–¾CŒÃì_ŽOC‚‹´œAbiŽ¨•@j: ‘æ68‰ñ_“Þì’n•û•”‰ï (89.06.17), ¬“cŒ´.
2289. mŠw‰ïn iˆê”Êu‰‰j [Œz•”Š´õÇ. ˆäŒû–F–¾C’†ŽR–¾mCŒÃì_ŽOC‚‹´œAbCΈä–L‘¾iŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 19, 1989.
2290. mŠw‰ïn iˆê”Êu‰‰j Œûo‚Ì”S‰t”X–E‚Ì—Õ°“IŒŸ“¢. ‚‹´œAbC“¿‘Œú“ñCÝŠy“N–çiŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 32, 1989.
2291. mŠw‰ïn iˆê”Êu‰‰j •›ˆô“ªŠÔŒ„_ŒoâŽî‚ÌŒŸ“¢. ¼‰ª–¾—TC‚‹´œAbCŒ´“cGˆêCˆî–ØŸ‰pC•½ŽR•ûriŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 48, 1989.
2292. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgã‚Ì•a—‘gDŠw“IŒ¤‹†i”S–Œã”ç‚Ì”N—î•Ï‰»‚ð’†S‚Éj. ’†ŽR–¾mC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çCŒ´“cGˆêiŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 55, 1989.
2293. mŠw‰ïn iˆê”Êu‰‰j 㪳’†•”‚É‚¨‚¯‚é‘B‘gD‚Ì•a—‘gDŠw“IŒ¤‹†. Š™“c—˜•FCŒ´“cGˆêC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: ŒûoEˆô“ª‰ÈŠw‰ï (89.09.01), ‘åã, ŒûoEˆô“ª‰È, 2(1): 56, 1989.
2294. mŠw‰ïn iˆê”Êu‰‰j Two Cases of Congenital Stapes Fixation with Sympha
Langism. ‹àŽqŒ÷C‰ª–{˜NŽqCÝŠy“N–çiŽ¨•@j: 14th World Congres of Otorhinolaryngology
Head and Neck Surgery (89.09.12), Madrid, 14th World Congres of
Otorhinolaryngology Head and Neck Surgery, Abstracts, p.133.
2295. mŠw‰ïn iˆê”Êu‰‰j ãˆô“ªŠïŒ`Žî‚̈ê—á. ¼ŽRkˆê˜YC•½ŽR•ûrC’†‘º—vC‹àŽqŒ÷CŒÃ‘òTˆêC‰ª–{–qliŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.
2296. mŠw‰ïn iˆê”Êu‰‰j Œûo”S–Œ•a•Ï‚ð’悵‚½–ò]‚̈êÇ—á. ”n‰z’q_CΈä–L‘¾C²–씣iŽ¨•@j: ‘æ69‰ñ_“Þì’n•û•”‰ï (89.09.30), ‘Š–ÍŒ´.
2297. mŠw‰ïn iˆê”Êu‰‰j SEPŒŸ¸‚É‚¨‚¯‚éŽü”g”“Á«. ’†‘º–LŽqC‹g–{gŽqi—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 133, 1989.
2298. mŠw‰ïn iˆê”Êu‰‰j Cinefluorographic Analysis of Dysphagia.
ŒÃì_ŽOCΈä–L‘¾CÝŠy“N–çC‹àŽqŒ÷iŽ¨•@j: ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï (89.10.17), “Œ‹žC ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï—\eW,
p.70.
2299. mŠw‰ïn iˆê”Êu‰‰j Movement Pattern of the Hyoid Lione in the Swallowing
and It's Aging. ‹àŽqŒ÷CΈä–L‘¾CŒÃì_ŽOCÝŠy“N–çCV”ü¬“ñiŽ¨•@j: ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï (89.10.17),
“Œ‹žC ‘æ6‰ñ¢ŠE‹CŠÇH“¹‰ÈŠw‰ï—\eW, p.72.
2300. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™‹}«â¿œ“´‰Š‚ÌŒŸ“¢. ¼‰ª–¾—Ti‰¡•lÔ\Žš•a‰@jCÝŠy“N–çC”ª”ö˜a—YiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.20), ” ª.
2301. mŠw‰ïn iˆê”Êu‰‰j ƒqƒg•@’†Šu‚Ì‘gDŠw“IŒ¤‹†i‘æ2•ñj. ˆî–ØŸ‰pC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.20), ” ª.
2302. mŠw‰ïn iˆê”Êu‰‰j ‘å‹C‚̊‹«•Ï‰» 2.•@o’Ê‹C“x|‰·“x‚É‚æ‚é‰e‹¿i‘æ2•ñj|. ²–씣CΈä–L‘¾CV“cŒ[ŽŸ˜YC“¡–ì–¾lC¼’[TˆêiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.21), ” ª.
2303. mŠw‰ïn iˆê”Êu‰‰j ƒnƒ“ƒgÇŒóŒQ‚Ì’®—ÍáŠQ‚ɂ‚¢‚Ä. ŒÃ‘òTˆêC•½ŽR•ûrC‰ª–{–qlCÝŠy“N–çiŽ¨•@j: “ú–{ƒI|ƒWƒIƒƒW|Šw‰ï (89.11.15), ˆ¤’m.
2304. mŠw‰ïn iˆê”Êu‰‰j ‚ß‚Ü‚¢‚Å”•a‚µ‚½Creutzfeldt-Jakob•a‚Ì‚P—á. “¿‘Œú“ñC“¡–ì–¾lC‹g”ö’miŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: “ú–{•½t_Œo‰ÈŠw‰ï (89.11.23), “Þ—Ç.
2305. mŠw‰ïn iˆê”Êu‰‰j A“ªBŠJ‚É‚æ‚é“û—cŽ™‚Ì‹C“¹‹·ó‚ÌŽ¡—Ã. –ö‘CŽÄè½C¬ìŽ“ñiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.
2306. mŠw‰ïn iˆê”Êu‰‰j Ž¨‰º‘BŽî’¯‚©‚çŽn‚Ü‚Á‚ÄL”Í‚ÈŒz•”‰óŽ€‚𗈂µ‚½1Ç—á. Š™“c—˜•FC“c‘ã’¼Ž÷C‰Í‡ƒˆê˜YiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.
2307. mŠw‰ïn iˆê”Êu‰‰j —¼‘¤“û–[‚É“¯Žž«‚É”¶‚µ‚½”ñZ«“ûŠÇŠà‚Ì1—á.
²“¡ˆêŠìC’|’†°KC]“ª´“¿C•Ð“c‰Ä–çC‘êK‹ÏC¼ŽR•Û”äŒÃC–ØìŽOŽl˜YCˆäŒ´ŒúC¼ˆäŒ’CŠ“cç”ü”TCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé
”\Ž÷iŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï i89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 642, 1989.
2308. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Œz•”Žî’°‚ÆŽ¨•@ˆôA‰È|“úí—Õ°‚Å‚æ‚‚Ý‚éæ“V«¥‰ŠÇ«”X–E«Ž¾Š³‚ɂ‚¢‚Ä|. ‚‹´œAbiŽ¨•@j: ‘æ3‰ñ“ú–{Ž¨•@ˆôA‰ÈŠw‰ïê–åˆãuK‰ï (89.11.19), –¼ŒÃ‰®, ‘æ3‰ñ“úŽ¨•@ê–åˆãuK‰ïŽ,@1989.
2309. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é“ûŠàŠÌ“]ˆÚ—á‚ÌŒŸ“¢. ’|’†°KCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé”\Ž÷iŠOj: ‘æ50‰ñ“ûŠàŒ¤‹†‰ï i89.07.00), ŽD–y.
2310. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚鋹œÓƒŠƒ“ƒpß“]ˆÚ—z«—á‚ÌŒŸ“¢. ’|’†°KCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé”\Ž÷CE“cÍiŠOj: ‘æ51‰ñ“ûŠàŒ¤‹†‰ï i90.02.00), ‘åã.
2311. mŒ¤‹†‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é•a—“ÁŽêŒ^“ûŠàÇ—á‚ÌŒŸ“¢. ’|’†°KCΓc˜a•viŠOjC‘åê³–¤iŠÅŒìŠw•”jC”äŠé”\Ž÷CE“cÍiŠOj: _“Þì“û‘Bbó‘BŒ¤‹†‰ï i90.03.00), ‰¡•l.
<<201 Š´õÇEŠñ¶’Ž>>
2312. mŒ´’˜n Studies on Effects of Paromomycin Sulphate, Bithionol,
Mebendazole and Flubendazole in the Treatment of Mice Infected with
Plerocercoids of Diphyllobothrium erinaei. –qƒC –ö‘ò\Žl’jiŠñj: Jpn. J. Trop.
Med. Hyg., 17(3): 237`241, 1989.
2313. mŒ´’˜n —Žq”A“¹äNã÷‰ŠÇ—á‚ɑ΂·‚é7432-S‚Ì—p–@¥—p—Ê‚ÌŒŸ“¢.
L£’‹»C‘呺´—²C‹g‰ª‘ôCŒF–{‰x–¾iŽD–yˆã‰È‘åjC‰¡ŽR‰p“ñi”åjC¼‘º¹Gi–kŒ©Ô\Žš•a‰@jC–{ŠÔº—YCŽO‘¶iˆ®ìÔ\Žš•a‰@jC‹{–{TˆêC
“c‹{‚GC‚’ËŒcŽŸi»ìŽs—§•a‰@jC–سŽ¡CÄ“¡½ˆêC“ì•”–¾–¯i‹ú˜HÔ\Žš•a‰@jC–å–ì‰ë•vC‰ªŽRŒåi¬’M–k¶•a‰@jC‰Á“¡CŽ¢C’O“c‹ÏiŽOŽ÷‰ï•a
‰@jC“‡‘ººŒáC“c’‡‹I–¾CŽðˆä–ÎiŽD–y’üM•a‰@jC–Ø‘º•¶GCˆäì‹ÓŽsi—¤ãŽ©‰q‘àŽD–y’n‹æ•a‰@jC—ÑŒªŽ¡C‹{”ö‘¥bi‹ä’mˆÀŒú¶•a‰@jC]‰Ä’©¼CŠâ
‘ò»•Fi‰¤Žq‘‡•a‰@j: “ú–{‰»Šw—Ö@Šw‰ïŽ, 37(11°s1): 351`374, l989.
2314. mŒ´’˜n Possible Role of Streptococcus pyogenes in Mucocutaneous
Lymph Node Syndrome ‡[. Immunological Tolerance to S.
pyogenes-associated Antigens Seems Essential to Induction of MCLS.
‘å‘òLFi”÷jCŽR‰Y¸C’r˜eM’¼iŠÅŒìŠw•”jC”ª‘ãŒö•viŽ™jCHŽR•‹vi”÷j: Acta Paediatr. Jpn., 31(4):
462`468, 1989.
2315. mŒ´’˜n Possible Role of Streptococcus Pyogenes in Mucocutaneous
Lymph Node Syndrome ‡\. Quantitation by ELISA of Streptococcal Pyrogenic
Exotoxin in the Serum of MCLS Patients.
‰Í‡^‹|i—\–hˆãŠwŒnjC‘å‘òLFi”÷jCŽR‰Y¸C’r˜eM’¼iŠÅŒìŠw•”jC”ª‘ãŒö•vC•½Î‘iŽ™jCWatanabe M.i–kŒ¤jCHŽR•‹vi”÷j:
Acta Paediatr. Jpn., 31(5): 529`536, 1989.
2316. mŒ´’˜n Comparative Efficacy of Flubendazole and Mebendazole on
Encysted Larvae of Trichinella spiralis (USA strain) in the Diaphragm
of Mice and Rats. –qƒC–ö‘ò\Žl’jiŠñj: J. Helminthol., 62(1): 35`39, 1988.
2317. mŒ´’˜n Chemotherapeutic Effects of Praziquantel, Niclosamide,
Mebendazole and Bithionol on Larvae and Adults of Hymenolepis nana in
Mice. –qƒC –ö‘ò\Žl’jiŠñj: Jpn. J. Parasitology, 38(4): 236`239, 1989.
2318. mŒ´’˜n Š´õǂɑ΂·‚郊ƒ|ƒ\|ƒ€••“üR¶Ü‚ÌŽ¡—ÃŒø‰Ê@3) ŽÀŒ±“I[Ý«ƒJƒ“ƒWƒ_Ç‚É‚¨‚¯‚郊ƒ|ƒ\|ƒ€••“üƒAƒ€ƒzƒeƒŠƒVƒ“B‚ÌŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢. ùŒ´•Žui”÷j: Š´õÇŠwŽGŽ, 63(12): 1301`1307, 1990.
2319. mŒ´’˜n “à‘Ÿ^‹Ûǂ̔Ǖa—‚ÉŠÖ‚·‚錤‹†|ˆÕŠ´õŽw”‚Ì—L—p«‚ɑ΂·‚é•]‰¿(1)|. –]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jCÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ^‹Û‚Æ^‹ÛÇC30(3): 160`172, 1989.
2320. mŒ´’˜n ƒXƒ|ƒƒgƒŠƒR|ƒVƒX‚̔Ǖa—‚ÉŠÖ‚·‚錤‹†. ‚£FŽqCã–쌫ˆêi’}”g‘åjC‹v•ÄŒõi•a—j: “Œ‹ž—Žqˆã‰È‘åŠwŽGŽ, 59(8): 891`897, 1989.
2321. mŒ´’˜n •²––’ŽËÜ‚ÌŠeŽí—n‰ð–@‚É‚¨‚¯‚é”÷¶•¨‰˜õ‚ÌŽÀŒ±“IŒ¤‹†. Ύ˳‰pC“‡“cŽœ•Fi–òÜ•”j: •a‰@–òŠwC15(5): 359`364, 1989.
2322. mŒ´’˜n Ž‡ŠOüÆŽË‚É‚æ‚é—¬…‚Ö‚ÌŽE‹ÛŒø‰Ê‚Æ‚»‚ÌŽ‘±«‚ɂ‚¢‚Ä‚ÌŒ¤‹†. Ύ˳‰pi–òÜ•”jCHŽR•‹vi”÷j: –k—¢ˆãŠwC19(2): 235`245, 1989.
2323. m’Z•ñn ‚킪‘‚Ì“à‘Ÿ^‹ÛÇ‚Ì•a—Šw“IŒ¤‹†. ‰œ•½‰ë•Fi•a—j: •a‘Ô¶—, 8(1): 946`948, 1989.
2324. mÇ—á•ñn ‰E㉺Žˆ•s‘S–ƒáƒ‚ðŒ_‹@‚É”Œ©‚³‚ꂽ‹‘å”]”^ᇂ̂P—á. ˆÀ•ÛŒ«ˆêCˆäŒ…^—R”üC‘åι–çCŠ`À—R•FCŒÃ“¡G—mCV’J®‹vCãp—z‘¾˜YiŽ™j: ‘Š–ÍŒ´ŽsˆãŽt‰ï•ñC302(1): 30`32, 1990.
2325. mÇ—á•ñn ŒuŒõR‘Ì•â‘Ì–@‹y‚Ñy‘fR‘ÌABC–@‚Åf’f‚µ“¾‚½ˆÝ”~“Å‚Ì2—á.
ˆÉ“¡‹ÏC^‹ÊŽõ”ü¶C“¡ˆä•ÛŽ¡C¼–{ˆÌ’jC›’m–çC‰ª“c–LŽŸi“àjCŒÜŒŽ—–Îi‰º“s‰ê‘‡•a‰@jC•Ÿ“‡”ÍŽqi“¯ˆ¤‹L”O•a‰@j:
“ú–{Á‰»Ší“àŽ‹‹¾Šw‰ïŽGŽ, 31(10): 2665`2669, 1989.
2326. m‘àn “à‘Ÿ^‹ÛÇ‚ÌŒ»‹µ‚Æ‘Îô|Šª“ªŒ¾. ‰œ•½‰ë•Fi•a—j: Progress in Medicine, 9(10): 2559`2560, 1989.
2327. m‘àn “à‘Ÿ^‹Ûǂɑ΂·‚éˆÕŠ´õ«‚Ì•]‰¿–@|–{Ç‚Ì‘Šúf’f‚ÉŽ‘‚·‚邽‚ß‚É|. ‹v•ÄŒõi•a—jC–]ŒŽ^‹|i–òÜj: Progress in Medicine, 9(10): 2581`2588, 1989.
2328. m‘àn “à‘Ÿ^‹Ûǂ̧‹š‚ÉŠÖ‚í‚é”–â‘è. ‹v•ÄŒõi•a—j: ƒ}ƒCƒRƒgƒLƒVƒ“, 29: 1`4, 1989.
2329. m‘àn ”畆‚ÉŠñ¶‚·‚éŠñ¶’ŽÇ‚ÌÅ‹ß‚Ì“®Œü. ˆÉ“¡—mˆêiŠñj: ˆãŠw‚Ì•à‚ÝC151(2): 91`94, 1989.
2330. m‘àn ŋߘb‘è‚ÌŠ´õ«•aŒ´”÷¶•¨|^‹Û. ‰œ•½‰ë•Fi•a—j: ŒŸ¸‚Æ‹Zp, 17(6): 559`562, 1989.
2331. m‘àn Š´õÇ‚Ì•a—Šw“IŒŸ¸–@. ‹v•ÄŒõC”©ŽRŒbŽqi•a—j: ŒŸ¸‚Æ‹Zp, 17(6): 706`711, 1989.
2332. m‘àn ”D•w‚¨‚æ‚ÑV¶Ž™‚ÌGBSŠ´õÇ‚Æ‚»‚Ì‘Îô. –åˆäL‹ÅCmŽu“c”ŽŽiiŽ™j: ŽY•wl‰È‚ÌŽÀÛC38(8): 1135`1139, 1989.
2333. m‘àn •êŽqŠ´õ‚Ìŋ߂̘b‘è| BŒQ—n˜A‹Û| –åˆäL‹ÅiŽ™jC•Û‰È´i“Œ‹ž—Žqˆã‘åj: ŽüŽYŠúˆãŠwC19(11): 1549`1553, 1989.
2334. m‘àn BŒQ—n˜A‹ÛŠ´õÇ‚ÌŒ»ó|‘æ2‰ñ‘S‘ƒAƒ“ƒP|ƒg’²¸Œ‹‰Ê|. •Û‰È´C—é–Ø—tŽqC“s‚à‚ÆŽqCŠC–ìŽõ”üi“Œ‹ž—Žqˆã‘åjC–åˆäL‹ÅCmŽu“c”ŽŽiiŽ™j: ¬Ž™‰È—Õ°C42(6): 1251`1255, 1989.
2335. m‘àn ^‹Û|•a—‚Ì—§ê‚©‚ç. ‰œ•½‰ë•FC‹v•ÄŒõi•a—j: ’_‚ÆäX, 10(7): 1089`1096, 1989.
2336. m‘àn ƒlƒp|ƒ‹‰¤‘‚ÌŠ´õÇ|Š´õÇŠî‘b’²¸’c‚Ì•ñ‚æ‚è|. ˆÉ“¡—mˆêiŠñj: ”M‘ÑC22: 83`88, 1989.
2337. m‘àn ƒRƒbƒz‚ÌPostulates‚Æìè•a‚ÌAŒQ—n˜A‹ÛŠ´õÇà ‡T) Germ Theory‚Ì•Ï‘J. ŽR‰Y¸iŠÅŒìŠw•”jCHŽR•‹vi”÷j: –k—¢ˆãŠw, 20(1): 1`5, 1990.
2338. m‘àn ƒRƒbƒz‚ÌPostulates‚Æìè•a‚ÌAŒQ—n˜A‹ÛŠ´õÇà ‡U)ìè•a‚ÍAŒQ—n˜A‹Û‚É‚æ‚銴õÇ‚Æl‚¦‚½‚¢. ŽR‰Y¸iŠÅŒìŠw•”jCHŽR•‹vi”÷j: –k—¢ˆãŠw, 20(1): 6`12, 1990.
2339. m‘àn [Ý«^‹ÛŠ´õÇ‚Ìf’f;@ŒŒ´Šw“If’f–@‚ÌŒ»ó. ‹v•ÄŒõCÎìçŒbŽqi•a—jCˆ¢•””ü’mŽqi—ÕŒŸj: —Õ°ˆã, 15(5): 552`555, 1989.
2340. muÀn Š´õ–hŽ~‚Æ‚»‚Ì—\–h‡@‹Nˆö”÷¶•¨‚¨‚æ‚ÑŠ´õŒo˜H. ¼“c—zi—Õ•a—j: NICUC3(3): 5`11, 1990.
2341. muÀn ^‹ÛŠ´õÇ‚Ìf’f‚ÆŽ¡—ÃiÅ‹ß‚ÌŽ‹“_‚æ‚èj. ‹v•ÄŒõi•a—jC´…Šì”ª˜Yi“Œ‹ž—Žqˆã‘åj: Today's Therapy '89, 13(3): 79`87, 1989.
2342. mŠwp‘n iŽ·•Mj Aspergillosis |ƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Æ‚»‚ÌŽü•Ó; ŽÀŒ±“I”xƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ, p.38`45, ‹v•ÄŒõi•a—j. •ÒW ’r–{G—Yi‡‘åj•Ò, ‹¦˜aŠé‰æ’ÊM, “Œ‹ž, 89.11.30”s.
2343. mŠwp‘n iŽ·•Mj Aspergillosis |ƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Æ‚»‚ÌŽü•Ó; “à‘ŸƒAƒXƒyƒ‹ƒMƒ‹ƒXÇ‚Ì”‘Š, p.78`82, ‰œ•½‰ë•FC‹v•ÄŒõi•a—j. •ÒW ’r–{G—Yi‡‘åj•Ò, ‹¦˜aŠé‰æ’ÊM, “Œ‹ž, 89.11.30”s.
2344. mŠwp‘n iŽ·•Mj bˆãŠ´õ•aŠw; f’fCp.47`53C
›–ìN‘¥i–ƒ•z‘åjC“ŒŒ´–«i–kŒ¤jCŒ´“c—Ǻiƒtƒ@ƒCƒU|»–òjC‘å‘òLFi”÷jCŒ´Œ³éCŠÝ쳄i–ƒ•z‘åjC“n•Ó’‰’ji“Œ”_‘åjC“cŒû–MŽji”_…
Èj. •ÒW ›–ìN‘¥i–ƒ•z‘åj•ÒC Œ[–¾o”Å, “Œ‹ž, 89.10.01”s.
2345. m‹³‰È‘n iŽ·•Mj S—Óà‰ÈŠw; ‘ŸŠí•ÊŠ´õÇ, p.1098`1116, ”è’õ•vC”Ñ‘–í¶i“àj. •ÒW ˆ¢•”—TC‰–ì—Dˆê•Ò, ‹àŒ´o”Å, “Œ‹ž, 89.01.25”s.
2346. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ƒ}ƒ‹ƒz”畆‰ÈƒZƒ~ƒi| No. 78; “ú–{‚Å‹ß”N’–Ú‚³‚ê‚é”畆‰È—̈æ‚ÌŠñ¶’ŽÇ, 78: 16`20, ˆÉ“¡—mˆêiŠñj. •ÒW ‹¦˜aŠé‰æ, ‘åã, 89.04.30.”s.
2347. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj [Ý«^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã; ‰uŠw|–UŒŸ—á‚æ‚è|, p.1`16, ‰œ•½‰ë•Fi•a—j. •ÒW ã“c‘×iŽœŒbˆã‘åjC´…Šì”ª˜Yi“Œ‹ž—Žqˆã‘åj•Ò, ƒƒfƒBƒJƒ‹ƒWƒƒ|ƒiƒ‹ŽÐ, “Œ‹ž, 89.11.00”s.
2348. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj [Ý«^‹ÛÇ‚Ìf’f‚ÆŽ¡—Ã; f’f|f’f‚̎臂ƌŒ´f’f|, p.25`38,
‹v•ÄŒõi•a—j. •ÒW ã“c‘×iŽœŒbˆã‘åjC´…Šì”ª˜Yi“Œ‹ž—Žqˆã‘åj•Ò, ƒƒfƒCƒJƒ‹ƒWƒƒ|ƒiƒ‹ŽÐ, “Œ‹ž, 89.11.00”s.
2349. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn i•ÒWCŠÄCCŽ·•Mj ”÷¶•¨ŠwŽ«“T; ìã³–çi•ª¶j. •ÒW “ú–{”÷¶•¨Šw‹¦‰ï•ÒC ŠÄC ìã³–çi–k—¢‘åjC‘¼ŠÄCC ‹Z•ñ“°o”ÅŽÐ, 89.08.23”s.
2350. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ”÷¶•¨ŠwŽ«“T; •úü‹ÛÇ,‘¼20€–Ú, ‰œ•½‰ë•Fi•a—j. •ÒW “ú–{”÷¶•¨Šw‰ï•ÒC ‹Z•ñ“°o”Å, “Œ‹ž, 89.08.00”s.
2351. mŠw‰ïn iˆê”Êu‰‰j ‚ç‚¢‹Û‚̃}ƒEƒX‚̃}ƒNƒƒtƒ@|ƒW‚É‚¨‚¯‚é“®‘Ԃɂ‚¢‚Ä. ‘å‘òLFCHŽR•‹vi”÷jC¼‰ª³“Ti‘—§‘½–€Œ¤j: “ú–{‚ç‚¢Šw‰ï (89.04.00), ŒÃìC “ú–{‚ç‚¢Šw‰ïŽGŽC58(1): 51, 1989.
2352. mŠw‰ïn iˆê”Êu‰‰j Že‹ŒŒ´“Y‰Á‹y‚Ñ–³“Y‰Á”|—{‰t‚ɉ—‚¯‚é Dipetalonema viteae ¬’Ž‚̈ێ‚ÉŠÖ‚·‚錤‹†.
–qƒC–ö‘ò\Žl’jiŠñjCPaul P. Weinstein iƒm|ƒgƒ‹ƒ_ƒ€‘åj: ‘æ58‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (89.04.03), “Œ‹žC
Šñ¶’ŽŠwŽGŽC38(‘): 44,l989.
2353. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“ZŒŒ‹z’ŽŠ´õƒ}ƒEƒX‚ɑ΂·‚éHHH‚ÌŽ¡—ÃŒø‰Ê‹y‚ÑŽ¡—ÃŒã‚ÌELISAR‘̉¿‚Ì•Ï“®.
“mŒRCˆÉ“¡—mˆêiŠñjC’·“c–[Žqi—\–hˆãŠwŒnj: ‘æ58‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (89.04.04), “Œ‹žC Šñ¶’ŽŠwŽGŽC38(‘):
93,l989.
2354. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“ªð’ŽƒvƒŒƒƒZƒ‹ƒRƒCƒh‚Ì’`”’•ª‰ðy‘f|Šˆ«•”ˆÊ‚ÌŒŸõ.
’†‘ºŒ’iŠñjC•–¾Žqi—\–hˆãŠwŒnjC–ö‘ò\Žl’jiŠñj: ‘æ58‰ñ“ú–{Šñ¶’ŽŠw‰ï‘å‰ï (89.04.04), “Œ‹žC Šñ¶’ŽŠwŽGŽC38(•â):
86,l989.
2355. mŠw‰ïn iˆê”Êu‰‰j
•²––’ŽËÜ‚ÌŠeŽí—n‰ð–@iƒLƒbƒg»•i‚ðŠÜ‚Þj‚É‚¨‚¯‚é”÷¶•¨‰˜õ‚ÌŽÀŒ±“IŒ¤‹†i‘æ2•ñj“Á‚É’ŽËŠí‚̈Ⴂ‚ɂ‚¢‚Ä.
Ύ˳‰pC“‡“cŽœ•FC‘¾“c‹v”üŽqC‰¡“cœÄˆêC‘哇”ü˜aŽqC‹àŽqCŽqC¬—Ñç—mŽqi–òÜ•”j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05),
–¼ŒÃ‰®.
2356. mŠw‰ïn iˆê”Êu‰‰j AMPH‚Ì‘å—ÊŒoŒû“Š—^Œã‚Ì—¬ŒŒ’†ƒJƒ“ƒWƒ_RŒ´‚ÌÁ’·|“Š—^–@‚ÌÝ’è‚ÉŽ‘‚·‚邽‚ß‚É|.
ÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ63‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (89.04.19), ·‰ªC Š´õÇŠwŽGŽC(—Õ‘): 85,
1989.
2357. mŠw‰ïn iˆê”Êu‰‰j “à‘Ÿ^‹Ûǂ̔Ǖa—‚ÉŠÖ‚·‚錤‹†|”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éˆÕŠ´õ«”»•ÊŽ®|.
–]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ63‰ñ“ú–{Š´õÇŠw‰ï‘‰ï (89.04.20), ·‰ªC
Š´õÇŠwŽGŽ, 63(8): 958`959,1989.
2358. mŠw‰ïn iˆê”Êu‰‰j ”A—R—ˆ‚̗Δ^‹Û‚ÉŠÖ‚·‚錟“¢. ¼‘º´ŽuC{ŽRˆê•äC‰¡ŽR‰p“ñC’r“cŽ Cˆî—tŒbŽqC΋´Wi”åjC•½“c‘×—Çi—ÕŒŸj: ‘æ37‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï (89.05.19), “Œ‹ž.
2359. mŠw‰ïn iˆê”Êu‰‰j ŒƒÇ‚ÈŒo‰ß‚ð‚Æ‚Á‚½–ƒ]‡•¹”DP‚Ì1—á. ¯“c—²C–ì“c–FlCA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ260‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï (89.05.20), ‰¡•l.
2360. mŠw‰ïn iˆê”Êu‰‰j dÇŠ³ŽÒ‚É‚¨‚¯‚éƒQƒ“ƒ^ƒ}ƒCƒVƒ“‚Ì“Š—^–@‚ÌŒŸ“¢. ’†‘º‹±ŽqC‹ß“¡—¯”üŽqi–òÜ•”jC¬—Ñ–¾–Fi“àjC’©’·•¶–íi–òÜ•”jC‘å˜a“c—²i‹~–½j: ‘æ16‰ñ“ú–{W’†Ž¡—Êw‰ï (89.06.07`10), ˆ®ì.
2361. mŠw‰ïn iˆê”Êu‰‰j Recent status of group B streptococcus infection in
Japan. •Û‰È´C—é–Ø—tŽqCKobayashi, M.CŠC–ìŽõ”üi“Œ—ˆã‘åjC–åˆäL‹ÅiŽ™j: 19th International
Congress of Pediatrics (89.07.25), Paris, 19th ICP abstract, p.200,
1989.
2362. mŠw‰ïn iˆê”Êu‰‰j Cryptococcus neoformans ‚ÌŒŒ´Œ^•Ê‚ÉŠÖ‚·‚錟“¢.
ÎìçŒbŽqi—ÕŒŸjC’†“ˆ”ü‹IC‹v•ÄŒõC‰œ•½‰ë•Fi•a—jCˆ¢•””ü’mŽqi—ÕŒŸj: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22), ‰«“ê,
´˜^WCp.101, 1989.
2363. mŠw‰ïn iˆê”Êu‰‰j Œ¢ƒNƒŠƒvƒgƒRƒbƒNƒXÇ‚É‚¨‚¯‚錌´’†‚ÌRŒ´‰¿‚Ì„ˆÚ. â–{‹žŽqC‘¼iH–òƒZƒ“ƒ^|jC‹v•ÄŒõi•a—j: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22), ‰«“ê, ´˜^WCp.89, 1989.
2364. mŠw‰ïn iˆê”Êu‰‰j “à‘Ÿ^‹Ûǂ̔Ǖa—‚ÉŠÖ‚·‚錤‹†|”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éˆÕŠ´õ«”»•ÊŽ®‚Ì•]‰¿i‘æ2•ñj|.
–]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jCÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï (89.09.22`23),
‰«“êC ´˜^W, p.75, 1989.
2365. mŠw‰ïn iˆê”Êu‰‰j ˆ««Žîᇂɂ¨‚¯‚郿2 Macroglobulin‚Ì•s‹Ïˆê«‚Æ‚»‚ÌŽY¶‚ÉŠÖ‚·‚錟“¢.
‚èŒõ‹Ii—Õ•a—jCŽsìŒbŽqC‘åŠÑ—TŽqi‘‡—Õ°ŒnjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05),
‹ž“sC —Õ°•a—, 37(•â): 74, 1989.
2366. mŠw‰ïn iˆê”Êu‰‰j
ìè•a‚Æ‹Û‘ÌŠO“Å‘f:Œ´ˆö‚ɘA‚È‚éƒzƒXƒtƒ@ƒ`ƒaƒ‹¥ƒCƒmƒVƒg|ƒ‹CƒzƒXƒzƒŠƒp|ƒ[C(PLC),IgMƒvƒƒeƒA|ƒ[Šˆ«RŒ´‘¼‚ÌŒ¤‹†“WŠJ‚ɂ‚¢‚Ä.
‘å’Ép“ñiŽ™jC–{ŠÔDC¬—Ñ–M•FC“¡‘ò—Ï•FCŒõ‰ª’m‘«C¯–ì‰x˜Y: ‘æ62‰ñ“ú–{׋ۊw‰ïŠÖ“Œ’n•ûŽx•”‘‰ï (89.10.13), …ã,
“ú–{׋ۊw‰ïŽGŽ, 45(2): 600, 1990.
2367. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“—ô“ªð’ŽƒvƒŒƒƒZƒ‹ƒRƒCƒh‚ÌŽ_«pH—̈æ‚É‚¨‚¯‚鎩ŒÈ•”•ª—Z‰ðŒ»Û
’†‘ºŒ’iŠñjC•–¾Žqi—\–hˆãŠwŒnjC–ö‘ò\Žl’jiŠñj: ‘æ59‰ñ“ú–{Šñ¶’ŽŠw‰ï“Œ“ú–{‘å‰ï (89.10.25), “Œ‹ž, u‰‰—vŽ|,
p.28, 1989.
2368. mŠw‰ïn iˆê”Êu‰‰j ƒpƒLƒXƒ^ƒ“‰ñ‹³‹¤˜a‘‚É‚¨‚¯‚銴õÇ‚ÌŒ»‹µ.
ˆÉ“¡—mˆêiŠñjC‘]“cŒ¤“ñCŽs콈êC–Ø‘º´ŽŸi‰¡•lŽs‘åjC•½–ì˜ii’é‹ž‘åj: ‘æ48‰ñ“ú–{ŒöO‰q¶Šw‰ï‘‰ï (89.10.26), ’}”g,
“ú–{ŒöO‰q¶Šw‰ïŽ, 36(10): 284, l989.
2369. mŠw‰ïn iˆê”Êu‰‰j ’°‰Š‹ÛŠ´õ‚É‚æ‚Á‚Ä—U“±‚³‚ê‚é• oZo×–E‚Ì”«ó‚̉ðÍ.
ùŒ´•ŽuC’†—¢˜a”üC‹Ê“àGˆêi”÷jC’r˜eM’¼CŽR‰Y¸iŠÅŒìŠw•”jC‘å‘òLFCHŽR•‹vi”÷j: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14),
ŽD–yC “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^C19: 484, 1989.
2370. mŠw‰ïn iˆê”Êu‰‰j Dipetalonema viteae ¬’Ž‚Ì’·Šú‚ɂ킽‚鎎Œ±ŠÇ“àˆÛŽ‚ÉŠÖ‚·‚錤‹†. –qƒiŠñj: ‘æ31‰ñ“ú–{”M‘шãŠw‰ï‘‰ï (89.11.18), –¼ŒÃ‰®, “ú–{”M‘шãŠw‰ïŽGŽ, 17(‘): 43, l989.
2371. mŠw‰ïn iˆê”Êu‰‰j ƒpƒLƒXƒ^ƒ“‰ñ‹³‹¤˜a‘‚ÌŠñ¶’ŽÇ.
ˆÉ“¡—mˆêiŠñjC‘]“cŒ¤“ñCŽs콈êC–Ø‘º´ŽŸi‰¡•lŽs‘åjC•½–ì˜ii’é‹ž‘åj: ‘æ31‰ñ“ú–{”M‘шãŠw‰ï‘‰ï (89.11.19), –¼ŒÃ‰®,
“ú–{”M‘шãŠw‰ïŽGŽ, 17(‘): 86, l989.
2372. mŠw‰ïn iˆê”Êu‰‰j ƒ\ƒPƒCƒwƒ‹ƒjƒAªŽ¡pŒã‚É”¶‚µ‚½äNã÷ŽüˆÍ‰ŠÇ«“÷‰èŽî‚Ì1—á. ´…rŽŸC‘ò‘º³”VC¬“c“‡–M’jC’†‘ºGi”åj: ‘æ35‰ñ–h‰q‰q¶Šw‰ï (90.02.07`08), “Œ‹ž.
2373. mŠw‰ïn iˆê”Êu‰‰j Ý‘îlHŒÄ‹zŠí—Ö@‚ł̌ċzŠí‰ñ˜H‚Ì׋ۉ˜õ‚ÌŒŸ“¢.
Ύ˳‰pi–òÜ•”jCŽO‰YNŽ¡i—ÕŒŸjC‰Z¶LˆêiMEƒZƒ“ƒ^[jC‚“ˆ‰Á‘ãŽqC‰““¡MŽqiŠÅŒì•”jC“c‹{^Žqi‘‡‘Š’kjC–Ø“¡‹žŽqiŠÅŒì•”jCדc
–«CÄ“¡–L˜ai“àjC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—jC“‡“cŽœ•Fi–òÜ•”jC“n•Ó•qi–ƒj: ‘æ5‰ñ“ú–{ŠÂ‹«Š´õŠw‰ï (90.02.09),
“Œ‹ž.
2374. mŠw‰ïn iˆê”Êu‰‰j ìè•aŠ³ŽÒ‚É‚¨‚¯‚éR‘ÌŽY¶”\‚̈Ùí‚Æ–{•a‚ÌAŒQ—n˜A‹ÛŠ´õÇà.
HŽR•‹vC‘å‘òLFC‹v•Û“cFˆêi”÷jCŽR‰Y¸iŠÅŒìŠw•”j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.27), “¿“‡C
“ú–{׋ۊwŽGŽC45(1): 167, 1990.
2375. mŠw‰ïn iˆê”Êu‰‰j ƒVƒNƒƒXƒ|ƒŠƒ“A‚Ì’°‰Š‹ÛŠ´õÇ‚É‹y‚Ú‚·Œø‰Ê‚ÌŒŸ“¢.
’†—¢˜a”üCùŒ´•ŽuC‹Ê“àGˆêi”÷jC’r˜eM’¼CŽR‰Y¸iŠÅŒìŠw•”jC‘å‘òLFCHŽR•‹vi”÷j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.28),
“¿“‡C “ú–{׋ۊwŽGŽC45(1): 318, 1990.
2376. mŠw‰ïn iˆê”Êu‰‰j ŽÀŒ±“IƒTƒ‹ƒ‚ƒlƒ‰Ç‚ÌŒ¤‹†CŠ´Žó«Œn‚Æ’ïR«Œnƒ}ƒEƒX‚Ì”äŠr‚ɂ‚¢‚Ä.
‘å‘òLFi”÷jC¬ŽR“à—mŽqi—\–hˆãŠwŒnjCùŒ´•ŽuCHŽR•‹vi”÷j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.28), “¿“‡C
“ú–{׋ۊwŽGŽC45(1): 319, 1990.
2377. mŠw‰ïn iˆê”Êu‰‰j dÇ”sŒŒÇŠ³Ž™‚Å‚Ì Vancomycin ‚ÌŽg—pŒoŒ±iŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì•K—v«‚ɂ‚¢‚Äj.
ŠÖª“OCŠ—Œ´FC–åˆäL‹ÅC¬ŒûO‹BC”ª‘ãŒö•viŽ™jC¼“c—zi—Õ•a—jC‹gŽR—F“ñi–òŠw•”jC‚‹´‰Á‘ãŽqi—ÕŒŸjC‹ß“¡—¯”üŽqC–]ŒŽ^‹|i–òÜj:
‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.07.04), ‘å‹{.
2378. mŠw‰ïn iˆê”Êu‰‰j ìè•aŽ™‚æ‚è“ÁˆÙ“I‚É•ª—£‚³‚ꂽƒ¿—nŒŒ«×‹Û‚ÌŽå‚Æ‚µ‚Ķ‰»Šw“I«ó‚ɂ‚¢‚Ä.
‘å’Ép“ñiŽ™jC²“¡ŽOçŽqC¯–ì‰x˜YC‘ê‘ò‹àŽŸ˜YC“¡‘ò—Ï•FCŒõ‰ª’m‘«C¡‘º–ÎsC¶“c–Î: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï i90.03.29),
“¿“‡, “ú–{׋ۊw‰ïŽGŽ, 45(1): 463, 1990.
2379. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‘gD“àŠñ¶^‹Û‚Ì aging ‚ɂ‚¢‚Ä. ‰œ•½‰ë•Fi•a—j: ‘æ3‰ñç—t^‹ÛŠ´õÇŒ¤‹†‰ï (88.07.16), ç—t, ‘æ3‰ñç—t^‹ÛŠ´õÇŒ¤‹†‰ï‹L˜^W, p.47`56, 1989.
2380. mŒ¤‹†‰ïn i“Á•Êu‰‰j [Ý«^‹ÛÇ‚ÌŒ»ó|‚»‚Ìf’f‚ÆŽ¡—Ã|. ‹v•ÄŒõi•a—j: ‘啪ˆãŽt‰ï (89.07.26), ‘啪.
2381. mŒ¤‹†‰ïn i“Á•Êu‰‰j “à‘Ÿ^‹ÛÇ‚Ì‘gDf’f. ‰œ•½‰ë•Fi•a—j: ‘æ27‰ñ_“Þìˆã^‹Û’k˜b‰ï (90.02.10), ‰¡•l.
2382. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”D•w‚̃EƒCƒ‹ƒXŠ´õ. “‡“cMGiŽY•wj: ‘æ2‰ñŽÀ’nˆã‰Æ‚Æ•ŽY•w‚Ì‚½‚ß‚ÌŽüŽYŠúƒZƒ~ƒi[ (89.07.30), ŽD–y.
2383. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj RŒ´ŒŸoŒn‚É‚¨‚¯‚郉ƒeƒbƒNƒX‹ÃW”½‰ž. ‹v•ÄŒõi•a—j: ‘æ10‰ñŠÖ“Œ’n•û^‹Û§˜b‰ï (89.06.03), “Œ‹ž.
2384. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‰E㉺Žˆ•s‘S–ƒáƒ‚ðŒ_‹@‚É”Œ©‚³‚ꂽ‹‘å”]”^ᇂ̂P—á. ˆÀ•ÛŒ«ˆêCˆäŒ…^—R”üC‘åι–çCŠ`À—R•FCŒÃ“¡G—mCV’J®‹vCãp—z‘¾˜YiŽ™j: ‘æ129‰ñ‘Š–ÍŒ´Žs¬Ž™‰Èˆã‰ïŒŽ—᧘b‰ï (89.00.00), ‘Š–ÍŒ´.
2385. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹É¬–¢nŽ™‚É‚¨‚¯‚éƒNƒ‰ƒ~ƒWƒAƒgƒ‰ƒRƒ}ƒ`ƒXR‘Ì‚ÌŒŸ“¢.
–åˆäL‹ÅCÄ“¡KˆêiŽ™jC¼“c—zCâ“Œ—R‹Ii—Õ•a—jC‚‹{t’ji—ÕŒŸj: ‘æ7‰ñƒNƒ‰ƒ~ƒWƒAŒ¤‹†‰ï (89.04.18), ·‰ª,
—Õ°‚ƃEƒCƒ‹ƒX, 17(32): 366, l989.
2386. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ‰ƒ€ƒ[ƒCƒnƒ“ƒgÇŒóŒQ‚Ì’®—Í‘œ. ŒÃ‘òTˆêCÝŠy“N–çC‰ª–{–qlC•½ŽR•ûriŽ¨•@j: Œú¶È“Á’莾Š³‹}«‚“x“ï’®’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ1‰ï‘‰ï (89.08.12), “Œ‹ž.
2387. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”A—R—ˆƒOƒ‰ƒ€—z«•s’èž…‹Û‚ɂ‚¢‚Ä. ¼‘º´ŽuC’r“cŽ C΋´WCˆî—tŒbŽqi”åjC‘å‘òLFi”÷j: _“Þ슴õÇŒ¤‹†‰ï (89.09.09), ‰¡•l.
2388. mŒ¤‹†‰ïn iˆê”Êu‰‰j ìè•aŠ³ŽÒ‚ÅŠÏŽ@‚³‚ê‚éˆÙí‚ÈR‘ÌŽY«”\‚̬ˆö‚ð’T‚é. HŽR•‹vC‘å‘òLFi”÷jC”ª‘ãŒö•viŽ™j: ‘æ9‰ñ“ú–{ìè•aŒ¤‹†‰ï (89.10.27), ‰F“s‹{.
2389. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”A—R—ˆ‚ÌCitrobacter‘®‚ɂ‚¢‚Ä. ¼‘º´ŽuC’r“cŽ Cˆî—tŒbŽqC΋´Wi”åjC•½“c‘×—Çi—ÕŒŸjC‘å‘òLFi”÷j: ‘æ27‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï (90.02.03), ‰¡•l.
2390. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”’ŒŒ•aŠ³ŽÒ‚É‚¨‚¯‚éˆÕŠ´õ«”»•ÊŽ®‚Ì—L—p«‚ÉŠÖ‚·‚錤‹†.
M‰ª”ü»ŽqC–]ŒŽ^‹|C‰Á‰ê’J”£C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC“¿O‰p¶C‰–’J–ÎC“¡–ì—R”üCŒÃ’J—²CŽR‰º‚¦‚èŽqi“àjCÎìçŒbŽqC‹v•ÄŒõC‰œ•½‰ë
•Fi•a—j: ‘æ27‰ñ_“Þ쌧Š´õÇŒ¤‹†‰ï (90.02.10). ‰¡•l.
2391. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ}ƒ“ƒ\ƒ“ZŒŒ‹z’ŽŠ´õƒ}ƒEƒX‚ð—p‚¢‚½ hybridoma ‚ÌŒ`¬ó‹µ. ˆÉ“¡—mˆêiŠñjC’·“c–[Žqi—\–hˆãŠwŒnjC–ö‘ò\Žl’jiŠñj: “ú•ÄˆãŠwŠñ¶’Ž•”‰ï (90.02.24), “Œ‹ž.
2392. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽŽŒ±ŠÇ“à”|—{‚É‚æ‚èƒ~ƒNƒƒtƒBƒ‰ƒŠƒAŽY¶”\‚̒ቺ‚µ‚½ Dipetalonema viteae
¬’Ž‚̃XƒiƒlƒYƒ~‚ւ̈ÚA‚É‚æ‚é‰ñ•œ. –qƒC–ö‘ò\Žl’jiŠñjCPaul P. Weinstein iƒm|ƒgƒ‹ƒ_ƒ€‘åj: “ú•ÄˆãŠwŠñ¶’Ž•”‰ï
(90.02.24), “Œ‹ž.
2393. mŒ¤‹†‰ïn iŒöŠJuÀj ƒlƒp|ƒ‹‰¤‘‚ÌŠ´õÇ‚ÌŒ»ó. ˆÉ“¡—mˆêiŠñj: ‘æ2‰ñŒú¶ÈˆÏ‘õŒ¤C‰ï (89.07.27), “Œ‹ž.
<<202 V¶•¨>>
2394. mŒ´’˜n Cessation of Autonomous Proliferation of Mouse lymphoma EL4
by Fusion with a T Cell line. ‹v•Û“cFˆêi”÷jC‰Á“¡GŽ÷iŽÀ’†Œ¤j: Int. J. CancerC45(3):
540`545, 1990.
2395. mŒ´’˜n Use of Nude Mice in Experimental Neutron Caputure Therapy
With 10B-BPA. Norikazu Tamaokii“ŒŠC‘åjCMasato Uedai_ŒË‘åjC‹Ê“àGˆêi”÷jCKumiko
Yamamotoi“ŒŠC‘åjCYutaka Mishimai_ŒË‘åj: Pigment Cell Research, 2: 343`344,
1989.
2396. mŒ´’˜n Šà‚̉摜f’f‚É‚¨‚¯‚éV‚µ‚¢“WŠJ; –ƉuŠjˆãŠwŒŸ¸|RI•WŽ¯ƒ‚ƒmƒNƒ[ƒiƒ‹R‘Ì (96.5, ZME-018)
‚É‚æ‚鈫«•FŽî‚̃Cƒ[ƒWƒ“ƒO‚ð’†S‚É|. Έ䟌Èi•újC¼ŽR–Εvi”çjC¬ŽR“c“ú‹gŠÛiŠàŒ¤jC‰““¡Œ[Œái‹ž‘åj: Šà‚Ɖ»Šw—Ö@,
16(4): 1194`1203, 1989.
2397. mŒ´’˜n CastlemanƒŠƒ“ƒpŽî‚Ì‘gDŠw“IŒŸ“¢. ’·À‰p–¾iŽ¨•@jC£ì²‹vi‰ðjC¼ŽRkˆê˜YC‹g”ö’mC‰ª–{–qliŽ¨•@jCŽR‰È³•½i‰ðjC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°C82(12): 1757`1765, 1989.
2398. mŒ´’˜n –k—¢‘åŠw•a‰@‚É‚¨‚¯‚铪Œz•”‚ª‚ñ‚Ì“Œv“IŠÏŽ@@‘æ1•ñ@13”NŠÔ‚Ì‚ª‚ñ‚ÌŽÀ‘Ô’²¸‚æ‚è. ‚‹´œAbC‰ª–{–qlC”ª”ö˜a—YiŽ¨•@jC‹T’J“Oi•a—j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈC61(12): 1107`1111, 1989.
2399. mŒ´’˜n ˆ««Žîᇂɔº‚¤ƒ¿2 Macroglonbulin‚Ì•s‹Ïˆê«‚Æ‚»‚ÌŽY¶‚ÉŠÖ‚·‚錤‹†. ‚èŒõ‹IC‘å’J‰pŽ÷i—Õ•a—j: ¶•¨•¨—‰»Šw, 33(4): 87`94, 1989.
2400. mŒ´’˜n ‚—î‚ÌŠàŠ³ŽÒ‚ɑ΂·‚鎡—ÃŽwj|•Û‘¶Ž¡—Â̈ӎ¯|. ‚‹´œAbiŽ¨•@j: “ªŒz•”Žîá‡, 15(1): 6`10, 1988.
2401. mŒ´’˜n bó‘BŽîᇂ̗հ“IŒŸ“¢|—×Ú‘ŸŠí‚ÉZ‚µ‚½ˆ««Žîᇂð’†S‚É|. ’†ŽR–¾mCˆî–ØŸ‰pCŒ´“cGˆêCŒÃì_ŽOC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: “ú‹CH‰ï•ñC40(5): 431`437, 1989.
2402. mÇ—á•ñn Œ´”«‘O“ª“´Šà‚Ì2Ç—á. Š™“c—˜•FC‚‹´œAbC‰ª–{–qlC”ª”ö˜a—YCˆî–ØŸ‰pC’†ŽR–¾liŽ¨•@j: Ž¨•@ˆôA‰È—Õ°, 82(9): 1259`1264, 1989.
2403. m‘àn ˜Vl‚̈««Žîá‡;Ž¡—Â̒ˆÓ‚ƎЉ‹A. ‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, 12: 293`300, 1989.
2404. m‘àn Šà«áu’É¥Žèp—Ö@‚Ì“K‰ž‚ÆŒÀŠE. ‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 61(10): 819`821, 1989.
2405. m‘àn ˆ««ƒŠƒ“ƒpŽî‚ɑ΂·‚駊àÜ‚Ì‘I‘ð. ”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 62(3): 197`201, 1990.
2406. m‘àn ˆ««Žîá‡f’f‚Ìi•à; ŠjˆãŠwŒŸ¸–@. Έ䟌Èi•új: —Õ°¬l•a, 19(11): 1857`1864, 1989.
2407. m–|–ón iŽ·•Mj ƒKƒ“ˆâ“`Žq‚̉ð–¾; ƒEƒCƒ‹ƒX‚É‚æ‚锃Kƒ“iR. ƒ_ƒ‹ƒxƒRj, p.6`17, ‘ –{”ŽsiŽY•wj. •ÒW ”¨’†³ˆêi‹ž‘åj•Ò, “úŒoƒTƒCƒGƒ“ƒX, “Œ‹ž, 89.06.23 ”s.
2408. mŠw‰ïn iƒpƒlƒ‹j ˆÝŒ´” Immature teratoma ‚Ì1“ûŽ™—á. Œ´^lC‰Í‘º½ŽŸCŽl‘q³”ŽC^“º‘¾˜YC“‡–{—R‹IŽqiŽ™jCΓc˜a•viŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.20), VŠƒ.
2409. mŠw‰ïn iƒpƒlƒ‹j ‹}‘¬‚È‘‘å‚ð‚Ý‚½‰EŒ¨ŠÖß•”Žîá‡. V’Ã’J^li“àjCŠâŸºŒ[ˆêC‹T’J“Oi•a—j: “ú–{®Œ`ŠO‰ÈŠw‰ïœ¥“î•”ŽîᇊwpW‰ï (89.07.22), •Ÿ‰ª, “ú®‰ïŽ, 53(6): S841, 1989.
2410. mŠw‰ïn iˆê”Êu‰‰j Ò‘Lipoma‚Ì‚P“ûŽ™—á. ¯–ì–r•vC²“¡‰ë•FCŒ´^lCŽl‘q³”ŽC“‡–{—R‹IŽqiŽ™j: ‘æl78‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï (89.04.15), ‰¡•l.
2411. mŠw‰ïn iˆê”Êu‰‰j Acid Soluble Glycoproteins in Malignancies. ‘å’J‰pŽ÷i—Õ•a—jC¬o’©’ji–k—¢ƒ‰ƒ{j: ‘æ13‰ñ‘Û—Õ°•a—Šw‰ï (89.05.19), ƒtƒ|ƒŒƒ“ƒX.
2412. mŠw‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‚¨‚æ‚Ñ‚»‚Ì—ÞŽ—•a•Ï‚̉摜‰ðÍ“IŒv‘ª“IŒ¤‹†. –{‹´ˆèŽqC‚ˆä’qŽqC‹àŽq‘C‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ25‰ñŠÌ‘ŸŠw‰ï (89.06.01), ‹à‘ò, ŠÌ‘Ÿ, 30(Suppl.): 87, 1989.
2413. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚¢“ûƒKƒ“Žîᇃ}|ƒJ|:ƒ€ƒ`ƒ“—l“œ’`”’‚Ì—Õ°“IˆÓ‹`‚ɂ‚¢‚Ä.
“àŽRKMC“n•Ó—Ç•FC‚èŒõ‹IC‘å’J‰pŽ÷i—Õ•a—jCˆêŽç‰À‘ãŽqC•xŠ~˜a”üC{“¡–F³iƒuƒŠƒXƒgƒ‹j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï
(89.09.30), ‘Š–ÍŒ´C –k—¢ˆãŠw, 19(6): 642, 1989.
2414. mŠw‰ïn iˆê”Êu‰‰j V‚µ‚¢“ûŠàŽîᇃ}|ƒJ|Cƒ€ƒ`ƒ“—l“œ’`”’(CA M26, CA M29) ‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä.
“àŽRKMC“n•Ó—Ç•FC‚èŒõ‹IC‘å’J‰pŽ÷i—Õ•a—jC–{ŠÔÕvC‰v“c’å•Fi“Œ‹ž’üM•a‰@jC“n•”™PC•“c”Ž”Vi]“Œ•a‰@jCˆêŽç‰À‘ãŽqC•xŠ~˜a”üC{“¡–F
³iƒuƒŠƒXƒgƒ‹j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 296, 1989.
2415. mŠw‰ïn iˆê”Êu‰‰j “ûŠà‘gDDNA‚É‚¨‚¯‚éŠàˆâ“`Žq‘•‚ÉŠÖ‚·‚錟“¢.
–î—R‰ÀC’·’JìºC“c‘ò—TŒõC–Ø•½FŽ¡i–k—¢ƒ‰ƒ{jCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—jC’|’†°KCΓc˜a•vC‘åê³–¤iŠOj:
‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 69, 1989.
2416. mŠw‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‹y‚Ñ‚»‚Ì—ÞŽ—•a•Ï‚̉摜‰ðÍ‚É‚æ‚é‘gDŒv‘ª“IŒ¤‹† (2).
–{‹´ˆèŽqC‚ˆä’qŽqC‹àŽq‘C“n•Ó´Ž¡C‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ24‰ñ“ú–{ŠÌ‘ŸŠw‰ï“Œ•”‰ï (89.10.21), ’·–ì, ŠÌ‘Ÿ
30(Suppl.2): 113, 1989.
2417. mŠw‰ïn iˆê”Êu‰‰j Superoxide
Dismutase—lŠˆ«‚ð’æ‚·‚éƒNƒŒƒXƒ`ƒ“‚Ì•ªŽq\‘¢‹y‚ÑSOD—lŠˆ«‚ð‚µ‚ß‚·BRM‚ɂ‚¢‚Ä. ’†‘º‘‰qC’†“‡—mˆêi•ª¶j:
‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.23), –¼ŒÃ‰® C —\eW, p.2091, 1989.
2418. mŠw‰ïn iˆê”Êu‰‰j ˆ««ƒŠƒ“ƒpŽî‚É‚¨‚¯‚éT×–ERŒ´Žó—e‘Ì”Œ»‚ÌŒŸ“¢.
Š}ˆäŒ‰i•a—jC˜a“c’m‰vi—Õ•a—jC¬–ì‰ë•vi•ª¶jC‹T’J“Oi•a—j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.24), –¼ŒÃ‰®,
“ú–{ŠàŠw‰ï‘‰ï‹LŽ–, p.329, 1989.
2419. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒXƒŠƒ“ƒpŽî‚ÆRŒ´ˆË‘¶«T×–EŠ”‚Æ‚Ì×–E—Z‡‚É‚æ‚éŽîᇑB‚Ì’âŽ~. ‹v•Û“cFˆêi”÷jC‰Á“¡GŽ÷iŽÀ’†Œ¤j: ‘æ48‰ñ“ú–{ŠàŠw‰ï (89.10.24), –¼ŒÃ‰®C “ú–{ŠàŠw‰ï‘‰ï‹LŽ–C48: 112, 1989.
2420. mŠw‰ïn iˆê”Êu‰‰j Glomus Jugulare Tumors in Japan. “¿‘Œú“ñC“¡–ì–¾liŽ¨•@j: ‡T.
Symposium fur Scull Base Surgery (89.10.25), Berlin, ‡T. Symposium fur
Scull Base Surgery Abastracts, 1989.
2421. mŠw‰ïn iˆê”Êu‰‰j ˆ««Žîᇂɂ¨‚¯‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(PTHrP)ˆâ“`Žq”Œ».
˜a“c’m‰vi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—jCŠ}ˆäŒ‰i•a—j: ‘æ48‰ñ“ú–{ŠàŠw‰ï‘‰ï (89.10.25),
–¼ŒÃ‰®C ‘‰ï‹LŽ–, p.253, 1989.
2422. mŠw‰ïn iˆê”Êu‰‰j •›tœ‘Ž‰–bŽî‚Ì1—á. {ŽRo•äC“à“c–LºC–{“c’¼NCŒàŠ²ƒC‘v¬_CÝŠy•q–çCŒÃ”¨½”VC‰¡ŽR‰p“ñC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åj: ‘æ466‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ‹ž’n•û‰ï (89.12.07), “Œ‹ž.
2423. mŠw‰ïn iˆê”Êu‰‰j ˆÝŠà‚ð‡•¹‚µ‚½äNã÷Šà‚Ì1—á. ÝŠy•q–çCŒÃ”¨½”VCŒàŠ²ƒC“ü]Œ[C“à“c–LºC΋´WC¬ŽÄŒ’i”åj: ‘æ1‰ñ“ú–{”å”AŠí‰ÈŠw‰ï_“Þì’n•û‰ï (90.02.17), ‰¡•l.
2424. mŠw‰ïn iˆê”Êu‰‰j Œûo“à‚É”¶‚µ‚½Verrcous Carcinoma‚Ì2Ç—á.
’·À‰p–¾C¬–ì—YˆêC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï
(90.03.03), “¡‘ò.
2425. mŠw‰ïn iˆê”Êu‰‰j ‹H‚È㪕”ŽîáŽ|œ‘gD«‚Ì1—á|. ‰iˆä_ŒÈC‹àŽqŒ÷C‚‹´œAbiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.
2426. mŠw‰ïn iˆê”Êu‰‰j A“ªŠà‚Ì•úŽËü‰»Šw—Ö@“¯Žž•¹—p‚̬Ñ. ‚‹´œAbC”ª”ö˜a—YC‰ª–{–qliŽ¨•@j: “ú–{A“ª‰ÈŠw‰ï (90.03.23), “Œ‹ž.
2427. mŠw‰ïn iˆê”Êu‰‰j A“ª”’F•a•Ï‚Ì—Õ°‘œ‹y‚Ñ‘gDŠw“IŒŸ“¢. ‹àŽqŒ÷CŒÃì_ŽOC‚‹´œAbiŽ¨•@j: “ú–{A“ª‰ÈŠw‰ï (90.03.23), “Œ‹ž.
2428. mŠw‰ïn iˆê”Êu‰‰j ŒûoG•½ã”çŠà×–E‚ɑ΂·‚郂ƒmƒNƒ|ƒiƒ‹R‘Ì‚Ìì» i‡Uj–Ɖu“dŒ°‚É‚æ‚éŠÏŽ@.
ªŠÝ–¾Gi“Œ‹žˆãŽ•‘åjC‘¼C£ì²‹vi‰ðj: ‘æ31‰ñŽ•‰ÈŠî‘bˆãŠw‰ï i89.09.01), “¿“‡C Ž•‰ÈŠî‘bˆãŠw‰ïŽGŽC3l(•â): 68,
l989.
2429. mŠw‰ïn iˆê”Êu‰‰j Von Rocklinghausen •a‚ɇ•¹‚µ‚½ã‰º•”ŽîᇂÌ1—á.
–쑺ƒŽqCŠâèŒ\ŽqC‘º¼GŽ÷C–xŒû‘דTC“‡–{—R‹IŽqiŽ™jC“àÀ‰hŽ÷iŒ`ŠOj: ‘æ181‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þì’n•û‰ï i89.11.18j,
‰¡•l.
2430. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ò’ÅŠÇ“àŽ‰–bŽî‚Ì1—á.
Žl‘q³”ŽC¯–ì–r•vCŒ´^lC“‡–{—R‹IŽqC”ª‘ãŒö•viŽ™jCí”ՉÈêC‹kŽ ‘i”]ŠOjC–x’rdŽ¡i•új: ‘æ22‰ñ“ú–{¬Ž™•úŽËüŒ¤‹†‰ï
(89.05.11), ‰z’JC “ú–{¬Ž™•úŽËüŒ¤‹†‰ïŽGŽ, 5(2): 56`57, 1989.
2431. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÌ×–EŠà‚̉摜‰ðÍ‚É‚æ‚é×–EŒv‘ª“IŒ¤‹†|“Á‚ÉŠO‰ÈØœ—á‚Æ–UŒŸ—á‚É‚¨‚¯‚é·‚ÌŒŸ“¢. –{‹´ˆèŽqC‚ˆä’qŽqC‹àŽq‘C‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ25‰ñ“ú–{ŠÌŠàŒ¤‹†‰ï (89.05.31), ‹à‘ò.
2432. mŒ¤‹†‰ïn iˆê”Êu‰‰j Diethylstilbesterol
Phosphate‚É‹Nˆö‚·‚é‚Æl‚¦‚ç‚ꂽ‰©át‚𔺂¤ŠÌ‹@”\áŠQ‚ð’悵‚½‘O—§‘BŠàstage D2‚Ì1—á.
ŒüˆäLÆC“¡–ì’WlCÝŠy•q–çCŒàŠ²ƒC’†ðO—²C‰¡ŽR‰p“ñC‰““¡’‰—YC΋´WC¬ŽÄŒ’i”åj: ‘æ6‰ñ_“Þì‘O—§‘BŽîᇌ¤‹†‰ï
(89.07.08), ‰¡•l.
2433. mŒ¤‹†‰ïn iˆê”Êu‰‰j Šî’ê–ŒŒ`¬‚ð”F‚ß‚½ƒqƒg‘å’°Šà—R—ˆ×–EŠ”‚ÌŽ÷—§ ’†‰p’ji•a—jCŽR‰º˜a–çC“n•Óˆê]i“Œ•a‰@•a—•”j: ‘æ7‰ñƒqƒg×–EŒ¤‹†‰ï (89.08.29), “Œ‹ž.
2434. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒqƒg‘å’°Šà—R—ˆ×–EŠ”‚ÌŽ÷—§‚Æ«ó. ŽR‰º˜a–çi“Œ•a‰@•a—jC’†‰p’ji•a—jC“n•Óˆê]i“Œ•a‰@•a—j: ‘æ7‰ñƒqƒg×–EŒ¤‹†‰ï‘å‰ï (89.08.29), “Œ‹ž, Human Cell, 2(3): 41, 1989.
2435. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆÝ”Õ“à‰¡–ä‹Ø“÷Žî‚Ì1’jŽ™—á. Œ´^lC^“º‘¾˜YC”Ñ‚Šì‹v—YiŽ™jC‘º“cWˆê˜Yi•újC¡ˆä’‰˜Ni•a‰@•a—jC‘å•”½i•a—j: ‘æ23‰ñ“ú–{¬Ž™•úŽËüŒ¤‹†‰ï (89.09.27), –¼ŒÃ‰®.
2436. mŒ¤‹†‰ïn iˆê”Êu‰‰j Žîᇃ}|ƒJ|EPFKƒeƒXƒgE‚Æ’S‚ª‚ñ¶‘Ì‘¤‚Ì“œ‘ãŽÓ•Ï’²‚Æ‚Ì‹¤’Ê—vˆöEHydrogenn Ionic
Stress (HIS)E‚ɂ‚¢‚Ä. ’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶•¨‰»ŠwŒnjC’†“‡—mˆêi•ª¶j: ‘æ9‰ñŽîᇃ}|ƒJ|Œ¤‹†‰ï
(89.10.22), –¼ŒÃ‰® C —\eW, p.B24, 1989.
2437. mŒ¤‹†‰ïn iˆê”Êu‰‰j “÷Šá“IŒŒ”A‚ðŒ_‹@‚É”Œ©‚³‚ꂽ Renal cell carcinoma ‚Ì‚P’jŽ™—á.
‘º¼GŽ÷Cדc‚Ì‚¼‚ÝC“‡–{—R‹IŽqiŽ™jCΓc˜a•viŠOjC–x’rdŽ¡i•újCŠâŸºŒ[ˆêi•a—j: ‘æ5‰ñ“ú–{¬Ž™‚ª‚ñŒ¤‹†‰ï i89.11.28j,
“Œ‹žC —\eW, p.70, 1989.
<<203 ‰ŠÇEƒAƒŒƒ‹ƒM[E–ƉuEäPŒ´•a>>
2438. mŒ´’˜n Anticardiolipin Antibody in Henoch-Schoenlein Purpura and
Related Vascular Disorders. •ÐŽRˆê˜NC‘‘òŠ²’jC¼‰ª´C¼ŽR–Εvi”çj: Arch. Dermatol.
Res., 281: 296`298, 1989.
2439. mŒ´’˜n Evidence for the Involvement of a Plasma Kallikrein-Kinin
System in the Immediate Hypotension Produced by Endotoxin in
Anaesthetized Rats. ŽŽæMC”n“ˆ³—²CR. Odoi-Adomei–ò—jCN.
Sunaharai‘å“ú–{»–òjC“à“c‘×Oi’†ŠO»–òj: Br. J. Pharmacol., 98: 1383`1391, 1989.
2440. mŒ´’˜n Relative Strength of the Mitogenic and
Interleukin-2-production-inducing Activities of Staphylococcal
Exotoxins Presumed to be Causative Exotoxin of Toxic Shock Syndrome:
Toxic Shock Syndrome Toxin-1 and Enterotoxins A, B and C to Murine and
Human T Cells. Uchiyama, T.CKamagata, K.i“Œ‹ž—Žqˆã‘åjCYan, X-J.CKawachi,
A.CFujikawa, H.CIgarashi, H.C‘å‹v•Û[li“àj: Clin. exp. Immunol., 75:
239`244, 1989.
2441. mŒ´’˜n Modulation of Plasma Exudation by PGE2 and That of Leukocyte
Migration by LTB4 in Inflammatory Models.
ŽŽæMCŒ´“c–FÆCã–ìWŒ›C”n“ˆ³—²C¬“c—²Ž¡C쑺“¹Žqi–ò—j: Dermatologica, 179(Suppl.): 60`63,
1989.
2442. mŒ´’˜n Activation of Human T Cells by Toxic Shock Syndrome Toxin-1:
The Toxin-Binding Structures Expressed on Human Lymphoid Cells Acting
as Accessory Cells are HLA Class ‡U Molecules.
“àŽR’|•FC¡¼Œ’ˆêCÄ“¡T“ñCr–¾”ü“ÞŽqCŠÞ¬Œ†C“¡ì_CŒÜ\—’‰p•vi“Œ—ˆã‘åjC‰Á“¡GlC¬”¦•¶–íC”–Ø“oiˆÚA–ƉujC’–Žq‰pri“ŒŠC‘åj:
Eur. J. Immunol., 19: 1803`1809, 1989.
2443. mŒ´’˜n Development of CD4+CD8+ Cells in Athymic Nude Mice.
‹Ê“àGˆêi”÷jCNorikazu TamaokiCSonoko Habui“ŒŠC‘åj: Immune-Deficient Animals in
Experimental Medicine, 6: 102`106, 1989.
2444. mŒ´’˜n Two Distinct Subtypes of the HLA-DRW12 Haplotypes in the
Japanese Population Detected by Nucleotide Sequence Analysis and
Oligonucleotide Genotyping.
ˆ¢•”Í•vi–kŒ¤jCˆÉ“Œˆê˜YC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC‹àŽq„‹vCˆÉ“¡IˆêC‰Á“¡GlC”–Ø“oC¬”¦•¶–íiˆÚA–Ɖuj:
ImmunogeneticsC30: 422`426, 1989.
2445. mŒ´’˜n Neonatal Lupus Erythematosus with a High Anticardiolipin
Antibody Titer. •ÐŽRˆê˜NC‹ß“¡Ž •vCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj: J. Am. Acad. Derm., 21(3):
490`492, 1989.
2446. mŒ´’˜n Annular Erythema Associated with Primary Sjogren Syndrome:
Analysis of T Cell Subsets in Cutaneous Infiltrates.
•ÐŽRˆê˜NCóˆär–íC¼‰ª´C¼ŽR–Εvi”çj: J. Am. Acad. Derm., 21(6): 1218`1221, 1989.
2447. mŒ´’˜n Dietary Maline Lipids Suppress Murine Autoimmune Disease.
Robinson, D.R.(Massachusetts General Hospital)CŠÚ–샶i“àjCKnoell,
C.COlesiak, W.CXu, L.CHirai, A.CGuo, M.CColvin, R.B.(Massachusetts
General Hospital): J. Intern. Med., 225(Suppl.): 211`216, 1989.
2448. mŒ´’˜n Lipid Mediators of Inflammatory and Immune Reactions.
Robinson, D.R.(Massachusetts General Hospital)CŠÙ–샶i“àjCPatel, B.CHirai,
A.(Massachusetts General Hospital): J. Parenter. Enteral. Nutr.,
12(Suppl. 6): 37S`42S, 1988.
2449. mŒ´’˜n Production and Characterization of A Human Monclonal
Antibody Recognizing A New Antigen Expressed on Some Lymphoid Cells.
’r˜eM’¼iŠÅŒìŠw•”jC‹Ê“àGˆêi”÷jCŽR‰Y¸iŠÅŒìŠw•”jC‚‹´œAbiŽ¨•@jC’–Žq‰pri“ŒŠC‘åj: Jpn. J. Cancer Res.,
81: 153`160, 1990.
2450. mŒ´’˜n Low Responsiveness of Lymphocytes from Normal Individuals
against the Stimulation with Pokeweed Mitogen. ät“n’‰’jCâ“Œ—R‹IC‘å’J‰pŽ÷i—Õ•a—j:
Kitasato Arch. Exp. Med., 62(2-3): 133, 1989.
2451. mŒ´’˜n Dietary Maline Lipids after the Course of Autoimmune
Disease. Robinson, D.R.(Massachusetts General Hospital)CŠÚ–샶i“àjCPatel,
B.CHirai, A.(Massachusetts General Hospital): Prog. Clin. Biol. Res.,
282: 295`303, 1988.
2452. mŒ´’˜n Oligonucleotide-Genotyping as a Method of Detecting the
HLA-DR2 (DRW15)-DW2, -DR2 (DRW15)-DW12, -DR4-DW15, and -DR4-DgKT2h
Haplotypes in the Japanese Population.
¬”¦•¶–íiˆÚA–ƉujCˆÉ“Œˆê˜Yi—\–hˆãŠwŒnjC‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCA.L.IshimotoiˆÚA–ƉujCˆ¢•”Í•v
i–kŒ¤jC”–Ø“oiˆÚA–Ɖuj: Tissue AntigensC33: 550`558, 1989.
2453. mŒ´’˜n Immunosuppressive Mode of Action of Deoxyspergualin in Mice,
as Compared with Cyclosporine A and Mizoribine.
‘å‹v•Û[li“àjC^è‹`•FiŽÀ“®ŒnjCŠ™“cvŽõC²“¡’¼”VCˆäãŒcˆêC”~’J’¼Ž÷i“àj: Transpl. Proc., 21:
1085`1087, 1989.
2454. mŒ´’˜n ƒCƒk‚Ì‘gD“K‡«RŒ´‚Æt“¯ŽíˆÚA‚ÉŠÖ‚·‚錤‹†|Microlymphocytotoxicity Test
‚É‚æ‚éDLA‰ðÍ|.
¡ˆä‹M”üŽqC‰Æ“c˜a•vCó–ì—F•FC‚”ö‰ë–çC¬“c“‡–M’jC“¡‰ªr•vC‘ºˆäŸC’†‘ºGC¬—ÑŒ«Cˆ¢“¡‚Ý‚âŽqi–h‰qˆã‘åjC“n•”_“ñiˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç
‚èi—\–hˆãŠwŒnj: ˆÚAC24(4): 376`380, 1989.
2455. mŒ´’˜n Clq Solid-Phase EIA ‚ð—p‚¢‚½Circulating Immune Complex (CIC)
‚Ì‘ª’è‚ÉŠÖ‚·‚é—Õ°“I—L—p«‚ÌŒŸ“¢|Šî‘b“IŒŸ“¢C‚È‚ç‚Ñ‚É•a‘Ô‚É‚¨‚¯‚é•Ï“®. ”«‘º˜a’jC–F“cvi—ÕŒŸjC‘å’J‰pŽ÷C‚èŒõ‹Ii—Õ•a—j:
Šî‘b‚Æ—Õ°, 23(4): 5629`5638, 1989.
2456. mŒ´’˜n Œz•”ƒŠƒ“ƒpߌ‹Šj‚Ì—Õ°“Œv“IŒŸ“¢. ’†ŽR–¾mC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È—Õ°C82(6): 871, 1989.
2457. mŒ´’˜n Yeast glucan“Š—^‚É‚æ‚郉ƒbƒg”牺‘gD‚¨‚æ‚уŠƒ“ƒpß“à“÷‰èŽîŒ`¬‚ÉŠÖ‚·‚é‘gDŠw“I‚È‚ç‚Ñ‚É“dŽqŒ°”÷‹¾“IŒ¤‹†. Šâè‰ëi”çj: H“cˆãŠwC16(2): 415`439, 1989.
2458. mŒ´’˜n Sjogren ÇŒóŒQ‚̔畆Çó‚Æ‚»‚Ì—Õ°“IŒŸ“¢. •ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: “ú–{”畆‰ÈŠw‰ïŽGŽC99(6): 717`723, 1989.
2459. mŒ´’˜n ƒ‰ƒeƒbƒNƒX‹ÃW–@‚É‚æ‚錌´ƒŠƒEƒ}ƒ`ˆöŽq‘ª’è‚ÌŠî‘b“IŒŸ“¢|COBAS MIRA‚ւ̉ž—p|. ÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjC“àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: “ú–{—Õ°ŒŸ¸Ž©“®‰»Šw‰ï‰ïŽ, 13(6): 741`745, 1988.
2460. mŒ´’˜n äPŒ´•a‚É‚¨‚¯‚éRƒrƒƒ“ƒ`ƒ“R‘ÌARƒTƒCƒgƒPƒ‰ƒ`ƒ“R‘Ì‚Æ‚»‚Ì—Õ°“IˆÓ‹`. —é–Ø‹M”ŽC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 184`191, 1989.
2461. mŒ´’˜n ”DP¥oŽY‚Ì‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚É‹y‚Ú‚·‰e‹¿. –k‘º–’mŽqC‰ª“cƒC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 302`310, 1989.
2462. mŒ´’˜n ¬‡«Œ‹‡‘gD•a‚É‚¨‚¯‚é”xüˆÛÇ‚ÆR×–EœŠiR‘Ì. —é–Ø‹M”ŽC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 623`629, 1989.
2463. mŒ´’˜n Piroxicam‚É‚æ‚éŒÅ’è–ò]:ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚ÌŒo‰ß’†‚ɶ‚¶Subacute cutaneous lupus
erythematosus (SCCE) —l‚Ì‘œ‚ð’悵‚½Ç—á. •ÐŽRˆê˜NC’|èLˆê˜YC¼‰ª´C¼ŽR–Εvi”çj: ”畆C31(‘6):
21`24, 1989.
2464. mŒ´’˜n ƒƒCƒRƒgƒŠƒGƒ“‚̃‰ƒWƒIƒCƒ€ƒmƒAƒbƒZƒC–WŠQ•¨Ž¿‚ÌŠÈ•Ö‚Èœ‹Ž–@‚ÌŒŸ“¢‚Æ‚»‚̶‘ÌŽŽ—¿‚ւ̉ž—p. ã–ìWŒ›i–ò—jC²X–ØK“ñi“àjCŽŽæMi–ò—j: –k—¢ˆãŠw, 19(3): 327`335, 1989.
2465. mŒ´’˜n –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ”A’†‚̃Cƒ“ƒ^[ƒƒCƒLƒ“1(IL-1)•À‚Ñ‚ÉIL-1—}§Šˆ«. ‘O“c’å‘¥CÔ¯“§C”è’õ•vi“àj: –k—¢ˆãŠw, 19: 246`253, 1989.
2466. mŒ´’˜n ¬Ž™‹CŠÇŽxšb‘§Š³ŽÒ‚Ì––½ŒŒƒŠƒ“ƒp‹…‚É‚¨‚¯‚éFc‚ƃŒƒZƒvƒ^|‚ÌŒŸ“¢|Flow Cytometry, “ñdŒuŒõõF–@‚É‚æ‚é‰ðÍ. â“Œ—R‹ICät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 37(4): 397`400, 1989.
2467. m’Z•ñn A Site of Action of Dexamethasone on Leukocyte Extravasation
in Microcirculation. ŽŽæMC¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒj: Agents and Actions, 29(1/2):
24`26, 1990.
2468. m’Z•ñn A Significant Role of Plasma Kallikrein-Kinin System in
Plasma Exudation of Rat Carrageenin-Induced Pleurisy.
ŽŽæMC”n“ˆ³—²CŒ´“c–FÆCã–ìWŒ›i–ò—j: Kinins, V(Part A): 137`144, 1989.
2469. m’Z•ñn Mechanism of Bradykinin-Induced Nociceptive Response. ŽŽæMCS. YongC”n“ˆ³—²Cã–ìWŒ›i–ò—j: Kinins, V(Part A): 255`259, 1989.
2470. m’Z•ñn Degradation of Hageman Factor by Chymotrypsin-Like Protease
Released from Rat Mast Cells during Degranulation.
”n“ˆ³—²i–ò—jC’J‹`•Fi®ŠOjCŽŽæMi–ò—j: Kinins, V(Part A): 487`492, 1989.
2471. m’Z•ñn Inhibition Mechanism of Dexamethasone in Leukocyte
Extravasation in Hamster Cheek Pouch. ¬“c—²Ž¡CŽŽæMi–ò—j: Microcirculation
Annual 1989, p.27`28, 1989.
2472. mŒ¤‹†•ñn ‹”çÇ‚É‚¨‚¯‚é‘«‚wüŠŒ©‚Ì—Õ°“IˆÓ‹`. ”è’õ•vCã“cŠ°”VCÔ¯“§i“àj: º˜a63”N“x“ÁŽêŽ¾•ai“ï•aj‚ÉŠÖ‚·‚錤‹†•ñ‘, p.76`82, 1989.
2473. mŒ¤‹†•ñi•¶•”Èjn •a‘Ô‚É‚¨‚¯‚郃CƒRƒgƒŠƒGƒ“—Þ‚Ì–ðŠ„‚Æ5°ƒŠƒ|ƒLƒVƒQƒi|ƒ[‘jŠQ–ò‚ÌŽ¡—Âւ̉ž—p.
ŽŽæMCŒ´“c–FÆC“à“c‘×OCã–ìWŒ›C”n“ˆ³—²C¬“c—²Ž¡C쑺“¹ŽqC¼ŽR˜a’ji–ò—j:
º˜a61`63”N“x•¶•”ȉȊwŒ¤‹†”ï•â•‹àiˆê”Ê(B)jŒ¤‹†•ñ‘, p.1`31, 1989.
2474. mŒ¤‹†•ñi•¶•”Èjn ”÷¬zŠÂ‚©‚ç‚Ý‚½‘ŸŠízŠÂ‘½Œ`Šj”’ŒŒ‹…‚ÌŒŒŠÇŠO—V‘–‹@˜‹y‚Ñ”S–ŒáŠQ. ŽŽæMi–ò—j:
º˜a63”N“x•¶•”ȉȊwŒ¤‹†”ï“Á’茤‹†uŒŒŠÇ‘ãŽÓvuŒŒŠÇ‚Ì×–E¶•¨Šw“I•ªŽq¶•¨Šw“I•À‚Ñ‚É‘ãŽÓŠw“IŒ¤‹†v, p.307`309, 1989.
2475. mŒ¤‹†•ñi•¶•”Èjn NSAID‚Ìì—p‹@˜. ŽŽæMi–ò—j: º˜a63”N“x•¶•”ȉȊwŒ¤‹†”ï“Á’茤‹†˜a•¶˜_•¶W‡UuŒŒŠÇ‚Ì×–E¶•¨Šw“IC•ªŽq¶•¨Šw“I‚È‚ç‚Ñ‚É‘ãŽÓŠw“IŒ¤‹†v, p.158`166, 1989.
2476. mŒ¤‹†•ñi•¶•”Èjn ‰ŠÇƒ‚ƒfƒ‹‚É‚¨‚¯‚郃fƒCƒG|ƒ^|‚ÌŽžŠÔŒo‰ß‚ƶ‘ÌŒ°”÷‹¾‚É‚æ‚鑽Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚̉ðÍ.
ŽŽæMCŒ´“c–FÆCã–ìWŒ›C¬“c—²Ž¡C”n“ˆ³—²C쑺“¹Žqi–ò—j:
•¶•”ȉȊwŒ¤‹†”(B)º˜a63”N“xŒ¤‹†•ñ‘C×–EC•ªŽqƒŒƒxƒ‹‚Ì‹@\‚ðŠî‘b‚É‚µ‚½Mediator‚̉ŠÇƒ‚ƒfƒ‹‚É‚¨‚¯‚鑇“I‰ðÍ
|Mediator‚ÌŽžŠÔŒo‰ß‚Æ‘ŠŒÝì—p‚̉ðÍ, p.10`13, 1989.
2477. mŒ¤‹†•ñiŒú¶Èjn ‹”çÇ‚É‚¨‚¯‚é”xüˆÛÇ‚Ì—Õ°“IŒ¤‹†1: —Õ°‘œ‚ÆŒŸ¸¬Ñ. ‹ß“¡Œ[•¶C‚•i®ÆC—é–Ø‹M”ŽC”è’õ•vi“àj: Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.133`136, 1989.
2478. mŒ¤‹†•ñiŒú¶Èjn ‹”çÇ‚É‚¨‚¯‚é”xüˆÛÇ‚Ì—Õ°“IŒ¤‹†2: ”xüˆÛÇ‚Ì„ˆÚ. ‹ß“¡Œ[•¶C‚•i®ÆC—é–Ø‹M”ŽC”è’õ•vi“àj: Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ǻ˜a63”N“xŒ¤‹†•ñ‘, p.137`141, 1989.
2479. mŒ¤‹†•ñiŒú¶Èjn MCTD‚Ì—Õ°Œo‰ß‚ÌŒŸ“¢i“–‰È‚ÅŒoŒ±‚µ‚½15—á‚ɂ‚¢‚Äj.
‹ß“¡Ž •vC‘¾“cK‘¥C“”I^—CŽ›–{”ÍŽqC•ÐŽRˆê˜NC‰q“¡ŒõC㑺m•vCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çj:
Œú¶È“Á’莾Š³‹”çÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“xŒ¤‹†•ñ‘, 1989.
2480. mÇ—á•ñn Boop‚ªæs‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. –쑺³¢C—Ñ”ü’ÃŽ}CÎìÍC—é–ØŒúC–î“ߣM—YC‰ª“cƒC”è’õ•vi“àj: ŠÖ“ŒƒŠƒEƒ}ƒ`|‹»–¡‚ ‚éÇ—á‚Æ‚»‚Ì–â‘è“_, ‘æ22W, p.183`190, 1989.
2481. mÇ—á•ñn ‹¹–Œ‰Š‚ð‡•¹‚µ‚½SLE‚Ì1—á. ‰ª“cƒi“àj: ‘Š–ÍŒ´ŽsˆãŽt‰ï•ñ, 289: 1`4, 1989.
2482. mÇ—á•ñn ƒXƒŠƒ“ƒ_ƒbƒN‚É‚æ‚è—U”‚³‚ꂽ–³‹Û«‘–Œ‰Š‚Ì1—á. “à“cŒ›Cã“cŠ°”VC‹ß“¡Œ[•¶C”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 178`183, 1989.
2483. mÇ—á•ñn “Á”«–å–¬ˆ³˜´iÇ‚ð‡•¹‚µ‚½‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ì1—á. —é–ØŒúC‚•i®ÆC‰ª“cƒC‹ß“¡Œ[•¶i“àjC‘å•”½i•a—jC”è’õ•vi“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 668`674, 1989.
2484. m—Õ°Ž¡Œ±n ‘Sg«‹”çÇ‚¨‚æ‚Ñ—Þ‰Ž¾Š³‚É”º‚¤ã•”Á‰»ŠÇÇó‚ɑ΂·‚éƒtƒ@ƒ‚ƒ`ƒWƒ“iƒKƒXƒ^[j‚ÌŽ¡—ÃŒø‰Ê‚ÌŒŸ“¢.
•ÐŽRˆê˜NC“”I^—CŽ›–{”ÍŽqCVˆätŽ}C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: Prog. Med., 9: 1380`1385, 1989.
2485. m‘àn –Ɖu‚ÌŠî‘b,HLARŒ´‚Ì–ðŠ„. ”–Ø“oiˆÚA–Ɖuj: Clinical Neuroscience, 7(2): 133`137, 1989.
2486. m‘àn V‚µ‚¢Ž¡—Öò¥Ž¡—Ö@|Methotrexate. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: Medical Practice, 6: 1109`1111, 1989.
2487. m‘àn ³‚µ‚¢Ž¡—Öò‚ÌŽg‚¢•û‚ÌŽÀÛ|”ñƒXƒeƒƒCƒhR‰ŠÇÜ. ”è’õ•vi“àj: Medical Practice, 6: 1123`1126, 1989.
2488. m‘àn ƒAƒŒƒ‹ƒM|«Ž¾Š³‚Ì•a‘Ô; ‰ŠÇ”½‰ž‚ƃAƒŒƒ‹ƒM|. ã–ìWŒ›CŽŽæMi–ò—j: Modern Physician, 9(10): 1321`1323, 1989.
2489. m‘àn äPŒ´•a‚Ì”xüˆÛÇ‚Æ‚»‚ÌŽ¡—Ã. ‰ª“cƒCŠÔ’†‹v”üC”è’õ•vi“àj: ƒJƒŒƒ“ƒgƒeƒ‰ƒs[, 7: 715`720, 1989.
2490. m‘àn CRESTÇŒóŒQ. ‹ß“¡Œ[•¶i“àj: ƒŠƒEƒ}ƒ`‰È, 1: 643`650, 1989.
2491. m‘àn PM/DM‚É‚¨‚¯‚é—Õ°ŒŸ¸‚͂ǂ̂悤‚ȃVƒXƒeƒ€‚Å‚·‚·‚ß‚ç‚ê‚é‚©A•a‘œ‚Æ‚ÌŠÖŒW‚Í. ‰ª“cƒC”è’õ•vi“àj: ƒŠƒEƒ}ƒ`‰È, 2: 329`333, 1989.
2492. m‘àn •aŠú¥•a‘Ô‚©‚ç‚Ý‚½–òÜ‚Ì‘I‘ð‚Æ“Š—^–@; ‘½”«‹Ø‰Š. ’·’JìˆêŽqi“àjC”W’†ªÆi‘—§¸__ŒoƒZƒ“ƒ^[j: ˆãŠw‚Æ–òŠw, 22(5): 1155`1159, 1989.
2493. m‘àn Chemotactic Factor. ã–ìWŒ›CŽŽæMi–ò—j: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(1): 4, 1989.
2494. m‘àn ”÷¬zŠÂ‚É‚¨‚¯‚錌ŠÇ“à”ç×–E‚Ì–ðŠ„|ŒŒŠÇ“§‰ß«˜´i‚Æ‘½Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–|. ŽŽæMC¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒj: ‰ŠÇ, 9(2): 79`83, 1989.
2495. m‘àn ƒƒCƒRƒgƒŠƒGƒ“‚Ì”wŒã‚É‚ ‚é‚à‚Ì. ŽŽæMi–ò—j: Œ»‘ãˆã—Ã, 21(10): 3004, 1989.
2496. m‘àn ŒŒŠÇ‰ŠAŽ¡—Ö@‚Ìi•à|“à‰È‚Ì—§ê‚©‚ç. ”è’õ•vC‰ª“cƒi“àj: Œ»‘ãˆã—Ã, 21: 3287`3289, 1989.
2497. m‘àn ƒeƒmƒLƒVƒJƒ€. •ŸˆäŒõ•¶C×–ìF˜YC”è’õ•vi“àj: Œ»‘ãˆã—Ã, 22: 298`301, 1989.
2498. m‘àn i˜˜_j–«ŠÖ߃ŠƒEƒ}ƒ`‚É‘Šúf’f¥‘ŠúŽ¡—Â͂ ‚蓾‚é‚©. ”è’õ•vi“àj: ÅVˆãŠw, 44: 1773`1774, 1989.
2499. m‘àn ƒŠƒEƒ}ƒ`«‘½”‹Ø’É. ‹ß“¡Œ[•¶i“àj: ÅVˆãŠw, 44: 1861`1866, 1989.
2500. m‘àn RAŽ¡—ÂÌi•à‚Æ–â‘è“_|–Ɖu—}§Ü. Ô¯“§Cã“cŠ°”VC”è’õ•vi“àj: ÅVˆãŠw, 44: 1918`1923, 1989.
2501. m‘àn äPŒ´•a|i•à‚Æ–â‘è“_: Žå—v‚È‘ŸŠí•a•Ï. ‰ª“cƒi“àj: ÅVˆãŠw, 45(2): 283`287, 1990.
2502. m‘àn äPŒ´•a|i•à‚Æ–â‘è“_: Žü•ÓŽ¾Š³; RƒŠƒ“Ž‰Ž¿R‘ÌÇŒóŒQ. ‰ª“cƒi“àj: ÅVˆãŠw, 45(2): 351`356, 1990.
2503. m‘àn äPŒ´•a|i•à‚Æ–â‘è“_; ˜˜_. ”è’õ•vi“àj: ÅVˆãŠw, 45: 217, 1990.
2504. m‘àn ƒ‹[ƒvƒX• –Œ‰Š. ‹ß“¡Œ[•¶C¼¬“c^C”è’õ•vi“àj: ÅVˆãŠw, 45: 288`292, 1990.
2505. m‘àn ŽO³_ŒoáŠQ. •ŸˆäŒõ•¶C”è’õ•vi“àj: ÅVˆãŠw, 45: 301`306, 1990.
2506. m‘àn äPŒ´•a‚ƈ««Žîá‡. ‚•i®ÆC”è’õ•vi“àj: ÅVˆãŠw, 45: 313`317, 1990.
2507. m‘àn •aŒ^f’f‚̉”\«‚Æ‚»‚Ì—Õ°“IˆÓ‹`|‹”çÇ. ”è’õ•vC‹ß“¡Œ[•¶C•Û‰È”Ž“oC‚•i®Æi“àj: ÅVˆãŠw, 45: 326`333, 1990.
2508. m‘àn äPŒ´•a—̈æ‚Ì“®Œü. ”è’õ•vC‹ß“¡Œ[•¶C‰ª“cƒi“àj: Ž¡—Ã, 72: 101`107, 1989.
2509. m‘àn Šà«áu’É|Á‰Š’Á’ÉÜ. ‰ª“cƒC”è’õ•vi“àj: Ž¨A“ªŒz, 61: 841`844, 1989.
2510. m‘àn ‰ºb‰î‰»ŠwÜŽèp. ”ª”ö˜a—YiŽ¨•@j: Ž¨•@ˆôA‰Èf—à Question & Answers, (12): 619‚Ì2`619‚Ì5, 1990.
2511. m‘àn ƒZƒ‹ƒtƒgƒŒƒ‰ƒ“ƒX‚É‚¨‚¯‚鋹‘BŠîŽ¿×–E‚Ì–ðŠ„. ‹Ê“àGˆêi”÷j: ŽÀŒ±ˆãŠw, 17(12): 1404`1407, 1989.
2512. m‘àn •s–O˜aŽ‰–bŽ_‚ƶ‘Ì‚Ì’²ß‹@”\|‰ŠÇ‚â–ƉuŒn‚̧Œä‚̉”\«‚à|. ŽŽæMi–ò—j: H‚̉Ȋw, (138): 47`57, 1989.
2513. m‘àn –òÜ”M. ”è’õ•vi“àj: f—ÃŽè’ , 105: 16, 1989.
2514. m‘àn ˆâ“`Žq‘•–@‚Æ”z—ñ“ÁˆÙ“IƒIƒŠƒSƒkƒNƒŒƒIƒ`ƒh‚ð—p‚¢‚½HLAˆâ“`Žq‚Ì‘½Œ^«‚̉ðÍ. ¬”¦•¶–íC”–Ø“oiˆÚA–Ɖuj: ’`”’Ž¿¥ŠjŽ_¥y‘f, 34(15): 1989`2002, 1989.
2515. m‘àn ƒ”ƒBƒWƒ…ƒAƒ‹f’f|–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì‘Šúf’f. ‰ª“cƒi“àj: “úŒoƒƒaƒJƒ‹, 1: 64`68, 1989.
2516. m‘àn RAƒeƒXƒg¥RAHAƒeƒXƒg‚Ì“Ç‚Ý•û. ”è’õ•vi“àj: “ú–{ˆãŽ–V•ñ, (3391): 176, 1989.
2517. m‘àn ‰ºb‰î‰»ŠwÜŽèp|ƒgƒŠƒNƒ|ƒ‹|Ž_‚̉ž—p|. ”ª”ö˜a—YCÝŠy“N–çiŽ¨•@j: “ú–{ˆãŽ–V•ñ, (3394): 15`18, 1989.
2518. m‘àn Šw‰ï‹L|ƒŠƒEƒ}ƒ`Šw‰ï. ”è’õ•vi“àj: “ú–{ˆãŽ–V•ñ, (3412): 47`48, 1989.
2519. m‘àn ’PŠÖß’É‚Æ–«ŠÖ߃ŠƒEƒ}ƒ`. ”è’õ•vi“àj: “ú–{ˆãŽ–V•ñ, (3416): 137`138, 1989.
2520. m‘àn —Õ°u‹`|‹”çÇ. ”è’õ•vC‚•i®Æi“àj: “ú–{ˆãŽ–V•ñƒWƒ…ƒjƒA”Å, 290: 3`6, 1990.
2521. m‘àn ƒŒƒZƒvƒ^|‚Æ‚µ‚Ä‚ÌMHC•ªŽq ”–Ø“oiˆÚA–Ɖuj: “ú–{—Õ°, 47(‘): 694`704, 1989.
2522. m‘àn –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚é–ò•¨—Ö@‚ÌÅ‹ß‚Ì“®Œü. ”è’õ•vC‰ª“cƒCÔ¯“§Cã“cŠ°”VC•ŸˆäŒõ•¶i“àj: “ú–{—Õ°–ƉuŠw‰ï‰ïŽ, 12: 349`361, 1990.
2523. m‘àn SjogrenÇŒóŒQ‚Ì–â‘è“_. •ÐŽRˆê˜Ni”çj: ”畆•af—Ã, 12(1): 24`32, 1990.
2524. m‘àn ƒfƒ†ƒAƒ‹ƒCƒ“ƒqƒrƒ^|. ŽŽæMi–ò—j: —Õ°ˆã, 15(9): 1613`1615, 1989.
2525. m‘àn ‰ŠÇ‚ƃTƒCƒgƒJƒCƒ“. Ô¯“§CL“c˜a‰iC”è’õ•vi“àj: —Õ°ˆã, 15: 1730`1732, 1989.
2526. m‘àn ”ñƒXƒeƒƒCƒhR‰ŠÇ–ò‚Ìì—p‹@˜|Å‹ß‚Ì—‰ð‚Æ–â‘è“_|. ”è’õ•vi“àj: —Õ°ˆã, 15: 6`10, 1989.
2527. m‘àn iÀ’k‰ïj”ñƒXƒeƒƒCƒhR‰ŠÇ–ò‚ÌŽg‚¢•û. “ŒžŠ‹BiŒc‘åjC“ŒˆÐi¹ƒ}ƒŠ‘åjC”è’õ•vi“àjCŒÜ\—’ŽO’Ã’ji“s—§—{ˆç‰@j: —Õ°ˆã, 15: 93`107, 1989.
2528. m‘àn RƒŠƒEƒ}ƒ`–ò. ‰ª“cƒC”è’õ•vi“àj: —Õ°ˆã, 16: 8`11, 1990.
2529. m‘àn «—ˆCtˆÚA‚ł̶’…—¦100“‚͉”\‚©|–ƉuŠw“I—§ê‚©‚ç|. ”–Ø“oiˆÚA–Ɖuj: —Õ°“§Í, 5(4): 475`480, 1989.
2530. m‘àn ‘Sg«‹”çÇ‚Ìf—Ã. ”è’õ•vC–쑺³¢CŠÖŽRØ•äi“àj: —Õ°–Ɖu, 21(14): 571`578, 1989.
2531. m‘àn IL-1ƒÀ—R—ˆ‚̃|ƒŠƒyƒvƒ`ƒh‚Ìì—p. Ô¯“§C‘O“c’å‘¥C”è’õ•vi“àj: —Õ°–Ɖu, 21: 1619`1625, 1989.
2532. m‘àn TNF‚ƉŠÇ. Ô¯“§C‰““¡•½mC”è’õ•vi“àj: —Õ°–Ɖu, 21: 620`632, 1989.
2533. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒO. ‹ß“¡Œ[•¶i“àj: Medicina, 26: 2256`2261, 1989.
2534. muÀn –Ú‚Å‚Ý‚éƒgƒŒ[ƒjƒ“ƒO. ‹ß“¡Œ[•¶i“àj: Medicina, 26: 2425`2428, 1989.
2535. muÀn ‚±‚ꂾ‚¯‚Í’m‚Á‚Ä‚¨‚«‚½‚¢ŒŸ¸‚̃|ƒCƒ“ƒg‘æ4WC–ƉuŒŒ´ŒŸ¸¥CRPiC”½‰ž«ƒ^ƒ“ƒpƒNj. ¼“c—zi—Õ•a—j: MedicinaC26(‘10): 1750`1752, 1989.
2536. muÀn –ƉuƒOƒƒuƒŠƒ“‚Æ‚»‚̈ÙíÇ. ‘å’J‰pŽ÷i—Õ•a—j: ŒŒ´”½‰ž‚Ì‚ ‚ä‚ÝC10(5): 87`95, 1989.
2537. muÀn –ò]‚É‚¨‚¯‚é–ƉuŠw. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú”狦ƒWƒƒ[ƒiƒ‹, 12(1): 13`18, 1989.
2538. muÀn …ávÇ‚É‚¨‚¯‚é–ƉuŠw. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú”狦ƒWƒƒ[ƒiƒ‹, 12(2): 16`20, 1989.
2539. muÀn RClqR‘Ì. ‘å’J‰pŽ÷i—Õ•a—j: “ú–{—Õ°C601(‘): 485`486, 1990.
2540. muÀn CRP,SAP. ‘å’J‰pŽ÷i—Õ•a—j: —Õ°ˆãC15(‘): 1140`1144, 1989.
2541. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`Šw; ‡U.‰ŠÇC2.’ᕪŽqChemical MediatorC1)ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“ŒQ‚̶‡¬‚ƉŠÇ‚É‚¨‚¯‚é–ðŠ„Cp.139`151C ŽŽæMi–ò—j. “¯•¶‘‰@, 89.07.00”s.
2542. mŠwp‘n iŽ·•Mj ¡“ú‚̈•û; äPŒ´•aA‚»‚Ì‘¼‚Ì‘SgŽ¾Š³AƒŠƒEƒ}ƒ`«‘½”‹Ø’ÉÇ‚È‚Ç, p.526`531, ‹ß“¡Œ[•¶i“àj. •ÒW “ì]“°, “Œ‹ž, 90.00.00”s.
2543. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`¥äPŒ´•a‚̖Ɖu—Ö@|Å‹ß‚Ìi•à|; ”ñƒXƒeƒƒCƒhR‰ŠÇÜ, p.117`127, ”è’õ•vi“àj. •ÒW ‰–ì—DˆêC •Ò, ˆã–òƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 89.06.10”s.
2544. mŠwp‘n iŽ·•Mj –«ŠÖ߃ŠƒEƒ}ƒ`; Š³ŽÒ‚ւ̃Aƒvƒ[ƒ`, p.5`12, ”è’õ•vi“àj. •ÒW …“‡—T•Ò, “ì]“°, “Œ‹ž, 89.09.15”s.
2545. mŠwp‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ‹”çÇ, p.150`155, ‹ß“¡Œ[•¶i“àj. •ÒW ŒFŒ´—YˆêC‘¼•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.00.00”s.
2546. mŠwp‘n iŽ·•Mj –ƉuAƒAƒŒƒ‹ƒM[AƒŠƒEƒ}ƒ`•aŠw; ‹”çÇA‘½”«‹Ø‰Š¥”畆‹Ø‰Š, p.161`183, ‹ß“¡Œ[•¶i“àj. •ÒW ”è’õ•vCŽë–쯌á•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.00.00”s.
2547. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`AäPŒ´•a‚̖Ɖu—Ö@|Å‹ß‚Ìi•à; ‘Sg«‹”çÇ, p.204`210, ‹ß“¡Œ[•¶i“àj. •ÒW ‰–ì—DˆêC•Ò, ˆãŠwƒWƒƒ[ƒiƒ‹ŽÐ, “Œ‹ž, 89.00.00”s.
2548. mŠwp‘n iŽ·•Mj ƒŠƒEƒ}ƒ`Šw; ‘Sg«is«‹”çÇ, p.651`657, ‹ß“¡Œ[•¶i“àj. •ÒW ‰–ì—DˆêC•Ò, “¯•¶‘‰@, “Œ‹ž, 89.00.00”s.
2549. mŠwp‘n iŽ·•Mj ƒvƒ‹ƒ~ƒGˆãŠwŠe˜_A“à‰ÈAŠO‰ÈA¬Ž™‰ÈA‡[.ƒAƒŒƒ‹ƒM[«Ž¾Š³AäPŒ´•aA–Ɖu•a; ‹”çÇA”畆‹Ø‰ŠA‘½”«‹Ø‰Š, p.42`48, ‹ß“¡Œ[•¶i“àj. •ÒW …“‡—TC•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.00.00”s.
2550. mŠwp‘n iŽ·•Mj Common Disease Series –«ŠÖ߃ŠƒEƒ}ƒ`; –ò•¨—Ö@|–Ɖu—}§Ü, p.140`143, ‰ª“cƒi“àj. •ÒW …“‡—TC•Ò, “ì]“°, “Œ‹ž, 89.00.00”s.
2551. mŠwp‘n iŽ·•Mj VŠO‰ÈŠw‘ÌŒn12; ‘ŸŠíˆÚA|ˆÚA–Ɖu‚ÌŠî‘bCp.33`80C ”–Ø“oiˆÚA–Ɖuj. ’†ŽR‘“X, “Œ‹ž, 89.06.30”s.
2552. mŠwp‘n iŽ·•Mj Immunobiology of HLA; DR4 Recognized by PLT ClonesC‡U:
210`211C ‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj. •ÒW B.Dupont•ÒC
Springer Verlag, N.Y., 89.00.00”s.
2553. m‹³‰È‘n iŽ·•Mj –Ɖu¥ƒAƒŒƒ‹ƒM[¥ƒŠƒEƒ}ƒ`•aŠw; ”è’õ•vi“àjCŽë–쯌á. ˆãŠw‘‰@, “Œ‹ž, 89.04.01”s.
2554. m‹³‰È‘n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; äPŒ´•a, ‰ª“cƒi“àj. •ÒW ²“¡“oŽu˜YC•Ò, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.00.00”s.
2555. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ŒŸ¸‚©‚ç‚Ý‚½f’f‚Ìi‚ß•û|Á‰»ŠÇ‚wüŠŒ©,
p.236`241; ƒŠƒEƒ}ƒ`¥äPŒ´•a‚ÌŠˆ“®«‚Ì‚«‚ß•û‚ÆŽ¡—Ã, p.264`267, ”è’õ•vi“àj. •ÒW ŒFŒ´—YˆêC‘¼•Ò,
ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.06.10”s.
2556. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj }à:“à‰Èf’fŽ¡—ÃuÀ 12. ƒŠƒEƒ}ƒ`«Ž¾Š³; ƒŒƒCƒm[Œ»Û, ‰ª“cƒi“àj. •ÒW ˆÀ”{’B•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.09.00”s.
2557. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; ‘½”«‹Ø‰Š, p.549`550, ‰ª“cƒi“àj. •ÒW “ú–쌴d–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 90.01.00”s.
2558. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; –«ŠÖ߃ŠƒEƒ}ƒ`, p.554`556;@is«‘Sg«d‰»Çi‹”çÇj, p.557`558, ‹ß“¡Œ[•¶i“àj. •ÒW “ú–쌴d–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 90.01.00”s.
2559. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ‘½Ü•¹—p—Ö@‚Ì’ˆÓ“_; –«ŠÖ߃ŠƒEƒ}ƒ`, p.153`160, ”è’õ•vi“àj. •ÒW ´…’¼—e•Ò, ƒVƒNƒX, “Œ‹ž, 89.09.25”s.
2560. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj VŽå—v’¥Œó‚©‚ç‚Ý‚½ŒŸ¸‚Ìi‚ß•û; ƒŒƒCƒm[Œ»Û, ‰ª“cƒC”è’õ•vi“àj. •ÒW ¼“cdŽOC•Ò, V‹»ˆãŠwo”ÅŽÐ, “Œ‹ž, 90.01.10”s.
2561. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj –«ŠÖ߃ŠƒEƒ}ƒ`‚Æ’·Šú—Ö@|‚æ‚è—Ç‚«Quality of Life‚Ì‚½‚ß‚É|;
•›ì—p‘Îô|ƒŠƒXƒN¥ƒxƒlƒtƒBƒbƒg‚Ì—§ê‚©‚ç|, p.96`103, ‹ß“¡Œ[•¶C”è’õ•vi“àj. •ÒW –{ŠÔŒõ•vC•Ò, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽÐ,
‘åã, 90.02.01”s.
2562. mŠw‰ïn i“Á•Êu‰‰j Purification and Characterization of a Murine
Melanoma Derived Inhibitory Factor of Tyrosinase. ‹TŽRFˆê˜Yi”çjCTanaka,
S.CHearing, V.J. (NIH): Tricontinental Meeting of ESDR, JSID and SID
i89.04.26j, Washington, D.C., USA, J. Investigative Dermatology, 92:
455, 1989.
2563. mŠw‰ïn i“Á•Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`(RA)Š³ŽÒŠŠ–Œ×–E‚ÌIL-6ŽY¶—U“±‚Ì‹@˜. ‰““¡•½mCÔ¯“§Cã“cŠ°”VC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2564. mŠw‰ïn i‹³ˆçu‰‰j ƒL[ƒm[ƒgƒŒƒNƒ`ƒƒ[: DMARDs, ‚»‚Ì–â‘è“_. ”è’õ•vi“àj: ‘æ1‰ñ’†•”ƒŠƒEƒ}ƒ`Šw‰ï i89.11.04).
2565. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”ñR‘Ì«‚̉t«’ïRˆöŽq. ìã³–çi•ª¶j: ‘æ16‰ñ“ú–{׋ۊw‰ïŠÖŒWŽx•”‘‰ï (89.06.03), “Œ‹žC “ú–{׋ۊwŽGŽC44(5): 739`740, 1989.
2566. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‰ŠÇ”½‰ž‚Æ—Õ°ŒŸ¸(2)C-”½‰ž«’`”’(CRP). ¼“c—zi—Õ•a—j: ‘æ1‰ñ“ú–{—Õ°•a—Šw‰ïŠÖ“ŒbM‰zŽx•”‘‰ï (89.10.28), VŠƒ.
2567. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒƒCƒRƒgƒŠƒGƒ“‚̂Ђ«‚¨‚±‚·•a‘Ô‚Æ‚»‚̧Œä. ŽŽæMC¬“c—²Ž¡Cã–ìWŒ›C¼ŽR˜a’ji–ò—j:
‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï (90.03.25-28), “Œ‹žC Jpn. J. Pharmacol., 52(suppl.): 44,
1990.
2568. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘Šú‚É‰ðŒˆ‚·‚ׂ«•a•Ï‚̔Nj@˜‚ÆŽ¡—Ã:‹”çÇ•a•Ï. ‹ß“¡Œ[•¶i“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2569. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j A Novel Drug Delivery System for the Treatment of
Rheumatic Diseases, Lipo-PGE1 for the Treatment of Peripheral Vascular
Diseases. ”è’õ•vi“àj: XVIIth ILAR Congress of Rheumatology i89.09.17-23),
Rio de Janeiro, Brazil.
2570. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Systemic Scleroderma, Clinical Subsets.
”è’õ•vC‹ß“¡Œ[•¶C‚•i®Æi“àj: XVIIth ILAR Congress of Rheumatology i89.09.17-23),
Rio de Janeiro, Brazil.
2571. mŠw‰ïn iƒpƒlƒ‹j CD4+CD8+ Thymocytes Can Develop into CD4+CD8- and
CD4-CD8+ Cells. ‹Ê“àGˆêCNorikazu TamaokiCSonoka Habui“ŒŠC‘åj: 7th
International Congress of Immunology (89.08.04), Berlin (West),
Abstracts, 7: 197, 1989.
2572. mŠw‰ïn iƒpƒlƒ‹j BCG-stimulated Lymphocytes Induce Microvascular
Endothelial Cell Injury by LAK Activity. óˆär–íC‘àVŠ²’jC¼‰ª´C¼ŽR–Εvi”çj: 2nd
International Dermatology Symposium i89.10.11j, Berlin, West Germany.
2573. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ‘½Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚̈ê˜A‚̉ߒö‚̉ðÍ. ¬“c—²Ž¡CŽŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.156, 1989.
2574. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ‹¹‘B“ÁˆÙ“IŽ©ŒÈ”FŽ¯ƒNƒ|ƒ“‚Ì‘I‘ð“Iœ‹Ž‚ÉŠÖ‚·‚錤‹†|VƒÀ6—z«×–E‚ðŽw•W‚Æ‚µ‚Ä|.
‹Ê“àGˆêC²“¡Œ’lCŠ_¶‰€Žqi“ŒŠC‘åj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.15), ŽD–y, “ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19:
111, 1989.
2575. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (1)ƒ‹[ƒvƒXt‰Š|”Ç‹@˜‚ÆŽ¡—Ã|; (5)ƒ‹[ƒvƒXt‰Š‚ÌŽ¡—ÂÌi•àuƒ~ƒ]ƒŠƒrƒ“—Ö@v.
‹ß“¡Œ[•¶i“àjC–{ŠÔŒõ•vC‰¡’£—´ˆêC”è’õ•vi“àjC‹´–{”ŽŽjCHŒŽ³Žj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2576. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (2)–Ɖu’²ßÜ‚Ìì—p“_‚Æ“Š—^–@u’á—p—ÊMTX‚¨‚æ‚Ñcyclophosphamide‚Ìì—p‹@\‚ÌŒŸ“¢v. Ô¯“§Cã“cŠ°”VC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2577. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (2)–Ɖu’²ßÜ‚Ìì—p“_‚Æ“Š—^–@u–Ɖu’²ßÜ‚ÌŠÔŸ[“Š—^–@v. ”è’õ•vC‰ª“cƒi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2578. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj
(5)R‰ŠÇ¥RƒŠƒEƒ}ƒ`–ò‚ÌŽ¡—Èâ“`ŠwuRƒŠƒEƒ}ƒ`–òi(ARD)‚ÌŒø‰Ê‚¨‚æ‚Ñ•›ì—p‚ÆHLARŒ´‚Æ‚ÌŠÖŒWv.
‰ª“cƒC—é–ؒ唎i“àjC‰œ“c‚Ý‚³‚ði—\–hˆãŠwŒnjC‘å’J•¶—Yi‘ŸˆÚjC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï
i89.05.25°27), “Œ‹ž.
2579. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (11)äPŒ´•aŒ¤‹†‚É‚¨‚¯‚éƒoƒCƒIƒeƒNƒmƒƒW[‚̉ž—pu‰ŠÇ«ƒTƒCƒgƒJƒCƒ“(IL-1,
TNF)‚Ìì—p‚Æ‚»‚̃ŒƒZƒvƒ^[‚Ì”Œ»’²ß‹@˜v. Ô¯“§C‰““¡•½mC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï
i89.05.25°27), “Œ‹ž.
2580. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (13)RƒŠƒEƒ}ƒ`Ü‚Ì—Õ°•]‰¿|V‚µ‚¢–â‘è“_‚ɂ‚¢‚Ä|,
8)’xŒø«RƒŠƒEƒ}ƒ`–ò•]‰¿‚Ì«—ˆ,@ˆË—Š”Œ¾(1)u•]‰¿€–Úv. ‰ª“cƒC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï
i89.05.25°27), “Œ‹ž.
2581. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj (15)RƒŠƒEƒ}ƒ`ÜuTNF‚É‚æ‚éD’†‹…Šˆ«Ž_‘fŽY¶—U“±‚É‹y‚Ú‚·RƒŠƒEƒ}ƒ`–ò‚̉e‹¿v. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2582. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Profiles of Anti-nuclear Antibodies in Scleroderma
Sepctrum Disorders. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: International Workshop on the
Molecular and Cell Biology of Autoantibodies and Autoimmunity
i89.07.00).
2583. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj –Ɖu’²ß–òu–Ɖu’²ß–ò‚ÌŠÔŒ‡“Š—^–@v. ‰ª“cƒC”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.
2584. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Pathogenesis of Systemic Sclerosis: Effects of
Cytokines on the Proliferation of Skin Fibroblast from Scleroderma
Patients and Normal Controls. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: XVIIth ILAR Congress
of Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.
2585. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Pathogenesis of Systemic Sclerosis: Detection of
Autoantibody to l7-kD Centromeric Antigen Using Immunoblotting in the
Scleroderma Spectrum. ‚•i®ÆC‹ß“¡Œ[•¶C”è’õ•vi“àj: XVIIth ILAR Congress of
Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.
2586. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj Immunosuppressor Therapy of Lupus Nephritis:
Clinical Efficacy of a New Immunosuppressive Agent, Mizoribine, on
Lupus Nephritis-long Term Trial. ‹ß“¡Œ[•¶i“àjC–{ŠÔŒõ•vC‰¡’£—´ˆêC”è’õ•vi“àjC‹´–{”ŽŽjCHŒŽ³Žj:
XVIIth ILAR Congress of Rheumatology i89.09.17-23), Riode Janeiro,
Bradil.
2587. mŠw‰ïn iˆê”Êu‰‰j ”DPˆÛŽ‚ÉŠÖ—^‚·‚éHLA–Ɖu—Ö@‚Ìì—p‹@˜. “c’†’‰•vCŽü‹X‹»C“V–ìMlC‘q“‡•x‘ãC’ñ‹I•vCˆÉ“¡Ž¡‰pi‘—§‘å‘ •a‰@jCˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.02), ‰ªŽR.
2588. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíƒXƒM‰Ô•²RŒ´‰t—͉¿‚ÌŒŸ“¢|SBPŠÜ—ʂƔ畆”½‰žè‡’l.
“¡–ì–¾liŽ¨•@jCˆÀŽ}_C‘O“c—T“ñC‘ì“N•vC’·’Jì^‹IC“cŠŒ›Ž¡CHŽRˆê’jCM‘¾—²•vi‘—§‘Š–ÍŒ´•a‰@j:
‘æ1‰ñ“ú–{ƒAƒŒƒ‹ƒM|Šw‰ït‹G—Õ°W‰ï (89.04.14), “Œ‹žC ƒAƒŒƒ‹ƒM|C38(2): 212, 1989.
2589. mŠw‰ïn iˆê”Êu‰‰j COBAS MIRA ‚É‚æ‚錌´•â‘̉¿‘ª’è‚ÌŒŸ“¢.
‹Iì‹v”üŽqC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸjCät“n’‰’jC“àŽRKMi—Õ•a—j: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.29), ŒSŽRC
‰q¶ŒŸ¸C38(3): 471, 1989.
2590. mŠw‰ïn iˆê”Êu‰‰j Effects of PAF on Leukocyte Migration and
Microvessels. ŽŽæMC”n“ˆ³—²C¬“c—²Ž¡i–ò—jC‰iˆäˆê¬i–ƒjC‚Œ´ŽO’qŽqi¶•¨‰»ŠwŒnj: Third
International Conference on Platelet-Activating Factor and Structurally
Related Alkyl Ether Lipid (89.05.08-12), Tokyo.
2591. mŠw‰ïn iˆê”Êu‰‰j Action of Dexamethasone on Leukocyte Extravasation in
Microcirculation. ŽŽæMC¬“c—²Ž¡i–ò—j: 11th European Workshop on Inflammation
(89.05.18-19), Copenhagen, DenmarkC Agents and ActionsC29(1/2): 24`26,
1990.
2592. mŠw‰ïn iˆê”Êu‰‰j ŽüŽYŠú‚É‚¨‚¯‚錌´IgE’l‚Ì‘ª’è|’á”Z“xIgE’l‘ª’è–@‚É‚æ‚錟“¢|.
â“Œ—R‹IC¼“c—zCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—jCŠ—Œ´FC¬ŒûO‹BC–åˆäL‹ÅiŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.03), “Œ‹žC
´˜^W, p.125, 1989.
2593. mŠw‰ïn iˆê”Êu‰‰j ŒŒŸ÷‚É‚æ‚éƒuƒ‰ƒWƒLƒjƒ“•ª‰ðŒo˜H‚ÌŽí·. “‡çŽqi¶•¨‰»ŠwŒnjC”n“ˆ³—²CŽŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.127, 1989.
2594. mŠw‰ïn iˆê”Êu‰‰j ‘½Œ`Šj”’ŒŒ‹…ŒŒŠÇŠO—V‘–‚É‚¨‚¯‚銈«Ž_‘f‚âƒvƒƒeƒA|ƒ[‚ÌŠÖ—^. ¬“c—²Ž¡CŒ´“c–FÆCŽŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï (89.07.20-21), “Œ‹žC —\eW, p.157, 1989.
2595. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgƒJƒIƒŠƒ“‹¹–Œ‰Š‚É‚¨‚¯‚é“ñ‘Š«‚ÌŒŒŸ÷ƒLƒjƒ“—V—£‚Ì‹@˜.
”n“ˆ³—²i–ò—jC–x—mŽOiƒVƒIƒmƒM»–òjC‚Œ´ŽO’qŽqi¶•¨‰»ŠwŒnjC쑺“¹Žq CŽŽæMi–ò—j: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï
(89.07.20-21), “Œ‹žC —\eW, p.182, 1989.
2596. mŠw‰ïn iˆê”Êu‰‰j Host-Parasite Relationship in Murine Salmonellosis.
‘å‘òLFCHŽR•‹vi”÷j: 7th International Congress of Immunology (89.08.01),
Berlin (West).
2597. mŠw‰ïn iˆê”Êu‰‰j Spontaneous, Trasferable, and Degenerative
Polyarthritis in Male NZB/KN Mice.
’†‘º‘‰qi•ª¶jC”è’õ•vi“àjCã“cŠ°”Vi‰qjC‚ŠÝŒ›“ñC’Ë–{s’ji®ŠOjC”¯N—YiŽÀ“®j: 7th International
Congress of Immunology (89.08.02), Berlin (West).
2598. mŠw‰ïn iˆê”Êu‰‰j DNA‰ðÍ‚É‚æ‚Á‚ÄŒŸo‚³‚ꂽ“ú–{l‚É‚¨‚¯‚é“ñ‚‚ÌDRW12ƒTƒuƒ^ƒCƒv‚ɂ‚¢‚Ä.
ˆÉ“Œˆê˜YC¬”¦•¶–íC‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjCˆ¢•”Í•vi–kŒ¤jC”–Ø“oiˆÚA–Ɖuj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï
(89.09.11), “Œ‹ž, ˆÚA, 24(—Õ‘): 182, 1989.
2599. mŠw‰ïn iˆê”Êu‰‰j
ƒCƒktˆÚA‚É‚¨‚¯‚ép‘OƒŠƒ“ƒp‘gDÆŽËDonorœ‘×–EˆÚ“ü‹y‚ÑFK506•¹—p‚É‚æ‚éDonor“ÁˆÙ“I–Ɖu—}§‚̉ðÍ.
“n•”_“ñC‹|í‹žŽqC”–Ø“oiˆÚA–ƉujC²“¡ŒõŽjiŠOjC‰€“c˜a•Fi‹¹ŠOj: ‘æ25‰ñ“ú–{ˆÚAŠw‰ï‘‰ï (89.09.11), “Œ‹ž, ˆÚA,
24(—Õ‘): 322, 1989.
2600. mŠw‰ïn iˆê”Êu‰‰j Clinical Application of Trichloroacetic Acid to
Allergic Rhinitis. ”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: 14th World Congres of
Otorhinolaryngology Head and Neck Surgery (89.09.14), Madrid, 14th
World Congres of Otorhinolaryngology Head and Neck Surgery, Abstracts,
p.218, 1989.
2601. mŠw‰ïn iˆê”Êu‰‰j ˆÚA•Ð‚Æ‚µ‚Ä‚Ì‘ÙŽ™|‘Ù¶ˆÛŽ‚ÉŠÖ‚·‚éRƒCƒfƒCƒIƒ^ƒCƒvR‘Ì‚Ì–ðŠ„. ˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 19(6): 644, 1989.
2602. mŠw‰ïn iˆê”Êu‰‰j SLEŠ³ŽÒ‚É‚¨‚¯‚éCR1‚ƖƉu•¡‡‘Ì‚ÌŠÖ˜A«. ”«‘º˜a’ji—ÕŒŸjC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 170, 1989.
2603. mŠw‰ïn iˆê”Êu‰‰j ‰ºb‰î‰»ŠwÜŽèp|Ž¡—ÃŒø‰Ê‚ÌŒŸ“¢|. ˆäŒû–F–¾CV“cŒ’‘¾˜YC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@j: “ú–{•@‰ÈŠw‰ï (89.10.20), ” ª.
2604. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ¬‡ƒŠƒ“ƒp‹…”|—{”½‰ž‚É‚¨‚¯‚éT×–EƒTƒuƒZƒbƒg‚Ì•Ï“®.
‰Á“¡GliˆÚA–ƉujCŠÖŒûŽˆêiŽœŒbˆã‘åjC‰º“c—EŽ¡iƒuƒŠƒXƒgƒ‹jC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14),
ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 147, 1989.
2605. mŠw‰ïn iˆê”Êu‰‰j Toxic Shock Syndrome
Toxin-1‚̓AƒNƒZƒTƒŠ|×–E‚ÌHLAƒNƒ‰ƒX‡U•ªŽq‚ÉŒ‹‡‚µ‚ÄT×–E‚ðŠˆ«‰»‚·‚é.
¡¼Œ’ˆêC“àŽR’|•FC•H–¾”ü“ÞŽqCÄ“¡T“ñCŠÞ¬Œ†C“¡ì_CŒÜ\—’‰p•vi“Œ—ˆã‘åjC‰Á“¡GlC¬”¦•¶–íC”–Ø“oiˆÚA–ƉujC’–Žq‰pri“ŒŠC‘åj:
‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 324, 1989.
2606. mŠw‰ïn iˆê”Êu‰‰j HLA-DRgJX6": DNA‰ðÍ‚Å–¾‚ç‚©‚É‚³‚ꂽ“ú–{lDRgƒuƒ‰ƒ“ƒNhŒ^‚̈ê‚‚ɂ‚¢‚Ä.
¬”¦•¶–íiˆÚA–ƉujCˆ¢•”Í•vi–kŒ¤jC‘å‹v•Û‚Ý‚Ç‚èCˆÉ“Œˆê˜YC‰œ“c‚Ý‚³‚ði—\–hˆãŠwŒnjC‘å’J•¶—YC‹àŽq„‹vC”–Ø“oiˆÚA–Ɖuj:
‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 440, 1989.
2607. mŠw‰ïn iˆê”Êu‰‰j Fractionated Lymphoid Irradiation
(FLI)‘Oˆ’uƒCƒk‚ªŠl“¾‚·‚étˆÚA•Ð–Ɖu•s‰ž“š«‚ÉŠÖ‚í‚étDonor‚©‚ç‚Ìœ‘×–EˆÚ“ü‚Ì–ðŠ„.
“n•”_“ñiˆÚA–ƉujC‹|í‹žŽqi—\–hˆãŠwŒnjC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC
‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 448, 1989.
2608. mŠw‰ïn iˆê”Êu‰‰j ”½•œ—¬ŽY‚É‚¨‚¯‚éHLA-DRRŒ´•p“x‚̉ðÍ.
ˆÉ“¡IˆêiˆÚA–ƉujC“c’†’‰•vC’ç‹I•vi‘—§‘å‘ •a‰@jC”–Ø“oiˆÚA–Ɖuj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï (89.11.14), ŽD–yC
‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ïŠwpW‰ï‹L˜^, 19: 500, 1989.
2609. mŠw‰ïn iˆê”Êu‰‰j ”½•œ—¬ŽY‚ɑ΂·‚é–Ɖu—Ö@‚Ìì—p‹@˜|RHLAR‘Ì‚Ìd—v«‚ɂ‚¢‚Ä|.
“c’†’‰•vC’ç‹I•vC‘q“‡•x‘ãCˆÉ“¡Ž¡‰pi‘—§‘å‘ •a‰@jCˆÉ“¡IˆêC”–Ø“oiˆÚA–Ɖuj: ‘æ4‰ñ“ú–{ˆãŠw¶B–ƉuŠw‰ï (89.11.30),
–¼ŒÃ‰®.
2610. mŠw‰ïn iˆê”Êu‰‰j •@o”|—{‚É‚æ‚éV¶Ž™Žº‚Ì´Œ‰“x‚̃‚ƒjƒ^ƒŠƒ“ƒO‚ÉŠÖ‚·‚錟“¢. b‰êŠ°ŽqC²“¡—T”üC“ü]‹ÅŽqiŠÅŒì•”jC–L“ciŽqiŠÅŒìŠw•”jC¼“c—zi—Õ•a—j: ‘æ3‰ñ_“Þì•ê«‰q¶Šw‰ï (90.02.03), ‰¡•l.
2611. mŠw‰ïn iˆê”Êu‰‰j 67GaƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚ÅŽw“E‚µ“¾‚½‹ØƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ì1—á.
¼Šª”ŽCΈ䟌ÈC’†‘òŒ\Ž¡C›MˆêC“cŠŽŒÈC¼ŽR³ŒáC¬—Ñ–ÎŽ÷CˆË“cˆêdC¼—Ñ—²i•új: ‘æ32‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï
(90.03.10), “Œ‹ž.
2612. mŠw‰ïn iˆê”Êu‰‰j Con A ŽhŒƒŠ”‰»T×–E(CEM)•\–Êã‚ÌCD57(Leu7)‚¨‚æ‚ÑCD11b(Mo-1)‚Æ‚»‚Ì‹@”\.
’r˜eM’¼iŠÅŒìŠw•”jC‹Ê“àGˆêi”÷jC¼è‹MŽqCŽR‰Y¸iŠÅŒìŠw•”jC’–Žq‰pri“ŒŠC‘åj: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.27),
“¿“‡, “ú–{׋ۊwŽGŽ, 45(1): 233, 1990.
2613. mŠw‰ïn iˆê”Êu‰‰j Phenotypic Heterogeneity of JB/MS Murine Melanoma
Cells: Purification and Characterization of a Melanogenic Inhibitor.
‹TŽRFˆê˜Yi”çjCLaw, L.W.CTanaka, S.CHearing, V.J. (NIH): Panamerican Society
for Pigment Cell Research i89.04.00j, Bethesda, USA, Pigment Cell
Research, 2: 449, 1989.
2614. mŠw‰ïn iˆê”Êu‰‰j Neutrophil-mediated Detachment of Dermal
Microvascular Endothelial Cells. ‘‘òŠ²’jCóˆär–íC‘åìŽiC¼‰ª´C¼ŽR–Εvi”çj:
Tricontinental Meeting of ESDR, JSID and SID i89.04.26j, Washington,
D.C., USA.
2615. mŠw‰ïn iˆê”Êu‰‰j Regulation of Epidermal Cell Growth by Mast Cell
Derived Mediators in Atopic Dermatitis. •ÐŽRˆê˜NC‰¡ŠÖ”Ž•vCì–¼½ŽiC¼‰ª´C¼ŽR–Εvi”çj:
Tricontinental Meeting of ESDR, JSID and SID i89.04.26j, Washington,
D.C., USA.
2616. mŠw‰ïn iˆê”Êu‰‰j ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚É‚¨‚¯‚éŒûO¶ŒŸ‚Ì—Õ°“IˆÓ‹`. •ÐŽRˆê˜NCŽ›–{”ÍŽqCVˆätŽ}C‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj: ‘æ88‰ñ“ú–{”畆‰ÈŠw‰ïŠwp‘å‰ï i89.05.11j, ‹à‘ò.
2617. mŠw‰ïn iˆê”Êu‰‰j Œ‹ß«g”Á‚ª‘OŒi‚É—§‚Á‚½ˆ««ƒŠƒ“ƒpŽî‚Ì1—á. L“c˜a‰iC—é–Ø‹M”ŽC—é–ØŒúC‹ß“¡Œ[•¶C”è’õ•vC“cè‹`ºi“àj: ‘æ382‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.05.13), “Œ‹ž.
2618. mŠw‰ïn iˆê”Êu‰‰j ‹¹•”‚wü㑽”‚·‚éŽîáŽó‰A‰e‚ª”F‚ß‚ç‚ꂽ‰óás«”^”çÇ‚ð‡•¹‚µ‚½–«ŠÖ߃ŠƒEƒ}ƒ`‚Ì1—á. —é–ؒ唎C‘å–ì‹v”üC¬—Ñ–M–FC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2619. mŠw‰ïn iˆê”Êu‰‰j SLE‚Ì”x•a•Ï‚ÉŠÖ‚·‚é—Õ°“IŒŸ“¢. ŠÔ’†‹v”üC‰ª“cƒCŠÖŽRØ•äC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2620. mŠw‰ïn iˆê”Êu‰‰j PSS, PM-DM, MCTD‚É‚¨‚¯‚é”DP‚Æ‚»‚ÌŒ‹‰Ê. —Ñ”ü’ÃŽ}C‹ß“¡Œ[•¶C–k‘º–’mŽqC”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2621. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚émethotrexate (MTX)•GŠÖßo“à’“ü—Ö@‚ÌŒŸ“¢. ã“cŠ°”VC•ŸˆäŒõ•¶CÎìÍCÔ¯“§C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2622. mŠw‰ïn iˆê”Êu‰‰j ‘Sg«ƒGƒŠƒeƒ}ƒg[ƒfƒX(SLE)‚Ì’†•_ŒoáŠQ(CNS)‚ÉŠÖ‚·‚é—Õ°“I¥–ƉuŠw“IŒŸ“¢. ÎìÍC‰ª“cƒC–쑺³¢C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2623. mŠw‰ïn iˆê”Êu‰‰j ‹”çÇ‚É‚¨‚¯‚é”xüˆÛÇ‚Ì„ˆÚ. ‚•i®ÆCL“c˜a‰iC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2624. mŠw‰ïn iˆê”Êu‰‰j “º‚ÌüˆÛ‰è×–E‚É‹y‚Ú‚·‰e‹¿. ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2625. mŠw‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒhƒ~ƒIƒpƒ`[‚ÌProspective study. —é–ØŒúC—é–Ø‹M”ŽC‰ª“cƒC”è’õ•vi“àj: ‘æ17‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i89.06.07°09), L“‡.
2626. mŠw‰ïn iˆê”Êu‰‰j SLEˆÈŠO‚ÌäPŒ´•a‚É‚¨‚¯‚é–³‹Û«œ‰óŽ€Ç(AN)‚Ì—Õ°“IŒŸ“¢. •äâ–ÎC‰ª“cƒC—é–Ø‹M”ŽC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ17‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i89.06.07°09), L“‡.
2627. mŠw‰ïn iˆê”Êu‰‰j RƒZƒ“ƒgƒƒƒAR‘̖̂Ɖuƒvƒƒbƒg–@‚É‚æ‚錟o. ‚•i®ÆC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ17‰ñ“ú–{—Õ°–ƉuŠw‰ï‘‰ï i89.06.07°09), L“‡.
2628. mŠw‰ïn iˆê”Êu‰‰j Myasthenia gravis ‚ɑ΂µ‚Ä‹¹‘B‚Ì•úŽËüŽ¡—ÃŒãSLE”Ç‚µ‚½1—á. ¼¬“c^CF쳋MC”è’õ•vi“àjC‘¼: ‘æ383‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.06.10),
2629. mŠw‰ïn iˆê”Êu‰‰j ‹”çÇ’P‹…—R—ˆƒTƒCƒgƒJƒCƒ“‚ÆüˆÛ‰è×–E‚Ì‘B. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: ‘æ21‰ñ“ú–{Œ‹‡‘gDŠw‰ï‘‰ï i89.07.10), “Œ‹ž.
2630. mŠw‰ïn iˆê”Êu‰‰j ŒŒŠÇ“à”ç×–E‚ÌTNFŽó—e‘Ì‚ÆIL-6ŽY¶. ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.
2631. mŠw‰ïn iˆê”Êu‰‰j TNF‚É‚æ‚éD’†‹…Šˆ«‰»‚É‹y‚Ú‚·RƒŠƒEƒ}ƒ`–ò‚̉e‹¿. ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.
2632. mŠw‰ïn iˆê”Êu‰‰j œ‰è×–EŠ”‚É‚¨‚¯‚éIL-1ƒŒƒZƒvƒ^[‚Ì”Œ»’²ß. ŽOã—RCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.
2633. mŠw‰ïn iˆê”Êu‰‰j RAŠ³ŽÒŠŠ–Œ×–E‚ÌIL-6ŽY¶’²ß‹@˜‚ÌŒŸ“¢. …’J—fŽqCÔ¯“§C”è’õ•vi“àj: ‘æ10‰ñ“ú–{‰ŠÇŠw‰ï i89.07.20, 21), “Œ‹ž.
2634. mŠw‰ïn iˆê”Êu‰‰j Cyclic-AMP Up-regulate the Expression of the
Receptors for Both Interleukin l and Tumor Necrosis Factor.
Ô¯“§Cã“cŠ°”VC‰““¡•½mC”è’õ•vi“àj: 7th International Congress of Immunology
i89.07.30-08.05), Berlin.
2635. mŠw‰ïn iˆê”Êu‰‰j Effects of Interleukin l (IL-1) and Tumor Necrosis
Factor (TNF) on Human Vascular Endotherial Cells (EC).
‰““¡•½mCÔ¯“§C”è’õ•vi“àj: 7th International Congress of Immunology
i89.07.30-08.05), Berlin.
2636. mŠw‰ïn iˆê”Êu‰‰j Induction of Interleukin-6/BSF2 Production of
Osteoblast like Cell by Interleukin 1 and Tumor Necrosis Factor.
ã“cŠ°”VCÔ¯“§C”è’õ•vi“àj: 7th International Congress of Immunology
i89.07.30-08.05), Berlin.
2637. mŠw‰ïn iˆê”Êu‰‰j ƒTƒCƒgƒJƒCƒ“‚ÌŒŒŠÇ“à”ç×–E‹@”\‚É‹y‚Ú‚·‰e‹¿. ‰““¡•½mCÔ¯“§C”è’õ•vi“àj: ‘æ11‰ñ_“Þ쌧–Ɖu§˜b‰ï i89.09.02).
2638. mŠw‰ïn iˆê”Êu‰‰j ŠJ• ‚µ‚½ŠÌ¶ŒŸ‚ň««ƒŠƒ“ƒpŽî‚̇•¹‚ðØ–¾‚µ“¾‚½SLE‚Ì1—á.
‘å–ì‹v”üC’†ˆä‹v—YC—é–ؒ唎C–k‘º–’mŽqC‹gˆäº•vC‹k“c‹P—YC‚‹´—B˜YC”è’õ•vi“àj: ‘æ385‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï
i89.09.09), “Œ‹ž.
2639. mŠw‰ïn iˆê”Êu‰‰j ƒwƒ‹ƒyƒX”]‰Š‚ª‹^‚í‚ꂽCNSƒ‹[ƒvƒX‚Ì1—á. ‰¡ŠÖ”Ž—YC‰¹ŽR˜aéC•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´C¼ŽR–ΕvCVˆätŽ}i”çj: ‘æ53‰ñ“ú–{”畆‰ÈŠw‰ï“Œ“ú–{Šwp‘å‰ï i89.09.10j, ’}”g.
2640. mŠw‰ïn iˆê”Êu‰‰j Clinical Efficacy of a New Immunosuppressive Agent:
HE-69 (Mizoribine), on Lupus Nephritis.
–{ŠÔŒõ•vCHŒŽ³ŽjC‰¡’£—´ˆêC‹´–{”ŽŽjC”è’õ•vC‹ß“¡Œ[•¶C“üŒðºˆê˜Y: XVIIth ILAR Congress of
Rheumatology i89.09.17-23), Rio de Janeiro, Brazil.
2641. mŠw‰ïn iˆê”Êu‰‰j Studies on a Mechanism of Action and Clinical
Usefulness of Lobenzarit Disodium (CCA) in Rheumatoid Arthritis.
Ichikawa, Y.C”è’õ•vi“àjCTorikai, K.CKatagiri, K.CTakano, T.CHomma, M.:
XVIIth ILAR Congress of Rheumatology i89.09.17-23), Rio de Janeiro,
Brazil.
2642. mŠw‰ïn iˆê”Êu‰‰j –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒŠŠ–Œ×–E‚ÌIL-6ŽY¶‚É‹y‚Ú‚·IL-1, TNF‚È‚ç‚тɃÁ-INF‚Ìì—p. Ô¯“§C‰““¡•½mCã“cŠ°”VC”è’õ•vi“àj: ‘æ385‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i89.09.28).
2643. mŠw‰ïn iˆê”Êu‰‰j CNS-SLE‚É‚¨‚¯‚éNeurofilamentR‘Ì‚Ì—Õ°“IˆÓ‹`. ‰ª“cƒCÎìÍC”è’õ•vi“àj: ‘æ385‰ñ“ú–{ƒAƒŒƒ‹ƒM[Šw‰ï‘‰ï i89.09.28).
2644. mŠw‰ïn iˆê”Êu‰‰j ƒjƒ…[ƒ‚ƒVƒXƒeƒBƒX¥ƒJƒŠƒj”x‰Š‚ð‡•¹‚µ‚½äPŒ´•a. ‰ª“cƒCL“c˜a‰iC”è’õ•vi“àj: ‘æ17‰ñ“à‰ÈŠw‚Ì“W–] i89.10.14°15).
2645. mŠw‰ïn iˆê”Êu‰‰j Monoclonal R DNP IgE R‘Ì‚É‚æ‚鎼]•a•Ï‚Ì—U“±‚Æ‚»‚̧Œä. •ÐŽRˆê˜NCŽíˆä—Ç“ñC‰¡ŠÖ”Ž—YC¼‰ª´i”çj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï i89.11.00j, ŽD–y.
2646. mŠw‰ïn iˆê”Êu‰‰j •ª‰»—U“±ˆöŽq‚É‚æ‚éHL-60×–E‚ÌTNFƒŒƒZƒvƒ^[”Œ»—U“±. Ô¯“§C‰““¡•½mCã“cŠ°”VC”è’õ•vi“àj: ‘æ19‰ñ“ú–{–ƉuŠw‰ï‘‰ï¥ŠwpW‰ï i89.11.14°16).
2647. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒXˆ««•FŽî—R—ˆ‚̃`ƒƒWƒi[ƒ[—}§ˆöŽq‚Ì«Ž¿‚Ƹ». ‹TŽRFˆê˜Yi”çjC“c’†CŽiCHearing, V.J. (NIH): ‘æ5‰ñ“ú–{F‘f×–EŠw‰ï i89.12.00j, •Ÿ‰ª.
2648. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒ“ƒp߶ŒŸ‚Ńwƒ}ƒgƒLƒVƒŠƒ“‘Ì‚ðØ–¾‚µA’˜–¾‚ÈŒŒ¬”‘‰Á‚𔺂Á‚½SLE‚Ì1—á. •äâ–ÎC‹g“cTCÎìÍC‰ª“cƒC”è’õ•vC“cè‹`ºi“àj: ‘æ388‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i89.12.09).
2649. mŠw‰ïn iˆê”Êu‰‰j JRA‚ÌŒo‰ß’†‚ÉSLE‚Ì”Ç‚ðŒ©‚½1—á. ŠÖŽRØ•äCÎìÍC—é–ØŒúCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ15‰ñ_“Þ샊ƒEƒ}ƒ`ˆã‰ï i90.02.24), ‰¡•l.
2650. mŠw‰ïn iˆê”Êu‰‰j Basedow•aA‹¹•”‘å“®–¬áŽ‚ð‡•¹‚µ‚½¶çG”^áv«œŠÖ߉Š‚Ì1—á. ¼¬“c^CXì‘CÎìr”VCs–؈ø^²CÄ“¡‹`—YC”è’õ•vi“àj: ‘æ390‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï i90.03.10), ŽR—œ.
2651. mŠw‰ïn iˆê”Êu‰‰j Zinc Enhances the Interleukin-1 Activity Produced by
Epidermal Cells in Culture. ŸŠ“약C‘¾“cK‘¥C•ÐŽRˆê˜NC‰q“¡ŒõC¼‰ª´C¼ŽR–Εvi”çj:
“ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.
2652. mŠw‰ïn iˆê”Êu‰‰j ÚG‰ß•qÇ‚ð—U“±‚·‚éRŒ´“ÁˆÙ“Iƒwƒ‹ƒp[‚s×–EŠ”‚ÌŽ÷—§‚Æ‚»‚ÌŠˆ«‰»‹@\‚̉ðÍ. ‰¡ŠÖ”Ž—YC•ÐŽRˆê˜NC¼‰ª´i”çj: “ú–{”畆‰ÈŠw‰ï‘æ664‰ñ“Œ‹ž’n•û‰ï i90.03.17j, “Œ‹ž.
2653. mŠw‰ïn iŒöŠJuÀj Š³ŽÒ‚ƉƑ°‚Ì‚½‚ß‚ÌŒöŠJu‰‰uŒ»Ý‚ÌŽ¡—Â̖â‘è“_v. ”è’õ•vi“àj: ‘æ33‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï i89.05.25°27), “Œ‹ž.
2654. mŒ¤‹†‰ïn iˆê”Êu‰‰j PCR-SSO–@‚É‚æ‚éHLA-DRƒQƒmƒ€ƒ^ƒCƒsƒ“ƒO.
¬”¦•¶–íCˆÉ“Œˆê˜YiˆÚA–ƉujCˆÀ•”Í•vi–kŒ¤jC‹àŽq„‹viˆÚA–ƉujC‘å‹v•Û‚Ý‚Ç‚èi—\–hˆãŠwŒnjC”–Ø“oiˆÚA–Ɖuj:
‘æ33‰ñ‘gD“K‡Œ¤‹†‰ï (89.09.10), “Œ‹ž.
2655. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹}«‰ŠÇ‚É‚¨‚¯‚錌ŠÇ“§‰ß«˜´i. ŽŽæMi–ò—j: ‘æ2‰ñtŽ¾Š³Ž¡—ÖòŠJ”‚ÉŠÖ‚·‚é’}”gƒtƒH|ƒ‰ƒ€ (90.03.09), ’}”g.
2656. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX‚É‚¨‚¯‚éIgE mediated skin reaction‚ÌŒŸ“¢. •ÐŽRˆê˜NC¼‰ª´i”çj: ‘æ9‰ñ–Ɖu‚ƃAƒŒƒ‹ƒM[‚Ì‚ ‚ä‚Ý i89.05.20j, ‘åã.
2657. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹”çÇ‚É‚¨‚¯‚é‘«‚wüŠŒ©‚Ì—Õ°“IˆÓ‹`. ”è’õ•vCã“cŠ°”Vi“àj: •½¬Œ³”N“x“Œ‹ž“s“ÁŽêŽ¾•ai“ï•ajŒ¤‹†ŒŸ“¢‰ï i89.06.03), “Œ‹ž.
2658. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ^ƒoƒR‚É‚æ‚éå@–ƒ]‚Ì1—á. ‰¡ŠÖ”Ž—YCóˆär–íC•ÐŽRˆê˜NC¼‰ª´C¼ŽR–Εvi”çj: ‘æ19‰ñRŒ´Œ¤‹†‰ï i89.07.01j, ’ÃŽs.
2659. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹‘åäBŽî‚𔺂¤PH‡•¹PSS‚Ì1—á. –쑺³¢CÎìÍC•äâ–ÎCÔ¯“§C‰ª“cƒC‹ß“¡Œ[•¶C”è’õ•vi“àj: ‘æ30‰ñŠÖ“ŒƒŠƒEƒ}ƒ`Œ¤‹†‰ï i89.12.09).
2660. mŒ¤‹†‰ïn iˆê”Êu‰‰j äPŒ´•aŠeŽ¾Š³‚É‚¨‚¯‚é–³‹Û«œ‰óŽ€Ç‚̊댯ˆöŽq‚Ì”äŠrŒŸ“¢. •äâ–ÎC‰ª“cƒC”è’õ•vi“àj: Œú¶È“Á’莾Š³A“Á”«‘å‘Úœ“ª‰óŽ€Ç’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ”ljï‹c i90.01.25°26).
2661. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÂóg”Á‚ð’悵‚½ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ì—Õ°“IŒŸ“¢. •ÐŽRˆê˜NCŽ›–{”ÍŽqCVˆätŽ}C¼‰ª´C¼ŽR–Εvi”çj: ‘æ4‰ñäPŒ´•aŒ¤‹†‰ï i90.01.26j, ‘q•~.
2662. mŒ¤‹†‰ïn iˆê”Êu‰‰j RnRNPR‘Ì—z«Š³ŽÒ‚Ì—Õ°Œo‰ß. ‹ß“¡Œ[•¶C‚•i®ÆC”è’õ•vi“àj: Œú¶È“Á’莾Š³A¬‡«Œ‹‡‘gD•a(MCTD)’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï i90.01.29).
2663. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹”çÇ‚É‚¨‚¯‚é––½_ŒoáŠQ. ‚•i®ÆC‹ß“¡Œ[•¶C”è’õ•vi“àj: Œú¶È“Á’莾Š³A‹”çÇ’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ”ljï‹c i90.01.31°02.01).
2664. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”ñtÇSLE‚ɑ΂·‚éCyclophosphamide (CY)—Ö@‚ÌŒø‰Ê.
‰ª“cƒCÎìÍC•äâ–ÎC”è’õ•vi“àj: Œú¶È“Á’莾Š³AŽ©ŒÈ–ƉuŽ¾Š³’²¸Œ¤‹†”Ç•½¬Œ³”N“x‘æ2‰ñ‘‰ï i90.02.02°03), “Œ‹ž.
<<204 ¬’·E”ˆçE‰h—{>>
2665. mŒ´’˜n ”ñ“ÁˆÙ«‘½”«¬’°’×á‡Ç‚ɑ΂·‚éÝ‘îŒo’°¬•ª‰h—{—Ö@‚ÌŽÀÛ. Žðˆä—RC”È–ö•S‡ŽqC’|“à”üŒbŽqiŠÅŒì•”jC’|‹g—R‰ÁŽuCŸ–””º‰hi“àjC¬ìK—YC“‡“cŽœ•Fi–òÜ•”j: JJPEN, 11(7): 893`895, 1989.
2666. mŒ´’˜n ––ŠúŠàŠ³ŽÒ‚ɑ΂·‚éÝ‘îÖ¬‰h—{‚ÉŠÖ‚·‚錟“¢.
ã–쑈ê˜YC‘å’J„³C“Œ”ŽC’[ŽR䎟C—é–س“¹C²X–͖ؔ¾C‰Á“¡NsC“ˆ”ömCŽOd–슰ŠìC匴÷C‘åê³–¤C”äŠé”\Ž÷iŠOjC¬ìK—YC“‡“cŽœ•F
i–òÜ•”jCŠp“c‡ŽqiŠÅŒì•”j: –k—¢ˆãŠw, 19(6): 612`616, 1989.
2667. m’Z•ñn ƒVƒ“ƒ|ƒWƒEƒ€‡T‚Ì‚Ü‚Æ‚ß|¬Ž™•½t‹@”\‚Ì”’B‚ÆŒP—û|. “¿‘Œú“ñiŽ¨•@j: ¬Ž™Ž¨•@ˆôA‰ÈC10(1): 8`9, 1989.
2668. mÇ—á•ñn •Øo‚̃^ƒCƒ~ƒ“ƒO‚É‹ê—¶‚µ‚½dÇ”DP’†“ÅÇAITP‡•¹‚Ì”DP’†ŠúIUGR‚Ì1—á.
’F‰pŽ÷CŒË‰êè‹`–¾C–ì“c–FlCª–{‘‘ˆêC“cŠ‹`WC‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ,
26(1): 21`28, 1989.
2669. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Medical Topics Series 2 —Õ°‰h—{'89;
‚—îŽÒ‚É‚¨‚¯‚é‰h—{—Ö@Cp.121`131C ²“¡“oŽu˜Yi¶—jC”’‘é‘’jiˆã—pî•ñj. •ÒW ã“c®•Fi‘åã‘åj•ÒC ƒƒfƒCƒJƒ‹ƒrƒ…|ŽÐ,
‘åã, 89.11.30”s.
2670. mŠw‰ïn iˆê”Êu‰‰j “dŽqŽ«“TƒVƒXƒeƒ€iQRSj‚ð—p‚¢‚½‰h—{Žw“±ƒVƒXƒeƒ€.
”’‘é‘’jC’|“ດŽC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC¼“cÝŒ«iƒAƒLƒ‰ƒbƒNƒXj: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï
(89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 127, 1989.
2671. mŠw‰ïn iˆê”Êu‰‰j ƒpƒ\ƒRƒ“‚É‚æ‚éHŽ–—Ö@‰î•ƒVƒXƒeƒ€.
”’‘é‘’jC‹{Œ´‰p•vC’|“ດŽC’ß“c—z˜aC’r“cŒ›ºiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.03), “Œ‹ž,
‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.841`842, 1990.
<<205 ‘ÙŽ™EV¶Ž™Eæ“VˆÙíEŠïŒ`>>
2672. mŒ´’˜n •ª•ØŽž‚̈Ùí‘ÙŽ™S””}. ¼“‡³”ŽiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 38(7): 1023`1029, 1989.
2673. mŒ´’˜n NST‚¨‚æ‚Ñ‘ÙŽ™ŽhŒƒ‚É‚æ‚éfetal distress‚Ì—\’m. ¼“‡³”ŽCª–{‘‘ˆêiŽY•wj: ŽY•wl‰È‚ÌŽÀÛ, 39(1): 13`17, 1990.
2674. mŒ´’˜n ‘ŽY‚ƕꎙŠ´õ. “‡“cMGC’F‰pŽ÷C–ì“c–FliŽY•wj: ŽüŽYŠúˆãŠw, 19(11): 1587`1592, 1989.
2675. mŒ´’˜n SFD‚ÌdÇ“x‚É‚æ‚éV¶Ž™‚Ì“K‰ž‚ÆŠÇ—. ¬ŒûO‹BCŠ—Œ´FC‚“cŽj’jC–ì“n³•FCmŽu“c”ŽŽiiŽ™j: ŽüŽYŠúŠw‰ïŽGŽ, 7: 136`147, 1989.
2676. mŒ´’˜n ‘ŽY’áo¶‘ÌdŽ™‚ÌRDS”Ç‚ÉŠÖ‚·‚éŽY‰È—vˆö‚ÆŽ™‚Ì—\Œã‚ɂ‚¢‚Ä. A–ìM…C’F‰pŽ÷C’Jº”ŽC–ì“c–FlC‹gŒ´ˆêC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 16`20, 1989.
2677. mŒ´’˜n “–‰@‚É‚¨‚¯‚éæ“V«…“—Ç‚Ì—Õ°“IŒŸ“¢. —§‰ª˜aOC¯“c—²CA–ìM…C–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 52`56, 1990.
2678. mŒ´’˜n Color Doppler –@‚¨‚æ‚Ñ Pulsed Doppler
–@‚É‚æ‚éo¶‘Šú‚̬nŽ™‚¨‚æ‚Ñ–¢nŽ™‚Ì“®–¬ŠÇ‚ð‰î‚·‚é’Z—ŒŒ—¬‚Ì•ªÍ. ¬ŒûO‹BCŠ—Œ´FC‚“cŽj’jC•½Î‘C”ª‘ãŒö•viŽ™j:
“ú–{V¶Ž™Šw‰ïŽGŽ, 25(2): 323`329, 1989.
2679. m’Z•ñn –¢nŽ™•ª•Ø‚ƒ鉤؊J;‚»‚Ì¡“ú“I’茩. Vˆä³•vC¼“‡³”ŽiŽY•wj: ˆãŠw‚Ì‚ ‚ä‚Ý, 149(2): 99, 1989.
2680. mÇ—á•ñn ‘gDŠw“I‚Ɉ««‚Æl‚¦‚ç‚ꂽ¬Ž™non-functioning pheochromocytoma‚Ì1—á.
Γc˜a•vC¬ŽÅÍ„C–ÈŠÑ•¶•vCˆ¢‘]OˆêiŠOjC“‡–{—R‹IŽqCדc‚Ì‚¼‚ÝiŽ™jC‘å•”½i•a—j: ¬Ž™ŠO‰È, 21(11): 1205`1209,
1989.
2681. mÇ—á•ñn •ª—£Žèp‚ÌŒoŒ±—áFˆê•û‚ªŽ€–S‚µ‚½‹¹• Œ‹‡‘Ì‚¨‚æ‚Ñ“ñ“ª“ñŽˆŽl˜rŒ‹‡‘Ì‚ÌŒoŒ±. ’†ðr•vC‹k“s_•½i“Œ‘åjCHŽR—miŽŽ™“‡‘åjCΓc˜a•viŠOjC‘¼: ¬Ž™ŠO‰È, 21(5): 515`522, 1989.
2682. mÇ—á•ñn æ“V«Œz•”á‘E:V¶Ž™—á‚ɂ‚¢‚Ä|‘¤Œz”X–E‚Ì2V¶Ž™—á|. Γc˜a•vCˆ¢‘]OˆêCŠÔ’†½iŠOj: ¬Ž™ŠO‰È, 21(7): 791`796, 1989.
2683. mÇ—á•ñn —r…‰ß‘½¥‘ÙŽ™…Žî‚ð‚«‚½‚µ‚½‘Ù”ÕŒŒŠÇŽí‚Ì1—á. –ì“c–FlC’F‰pŽ÷C’†Œ´—DlC¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(1): 51`54, 1989.
2684. mÇ—á•ñn ŒƒÇ‚ÈŒo‰ß‚ð‚Æ‚Á‚½–ƒ]‡•¹”DP‚Ì1—á. ¯“c—²C–ì“c–FlCA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ, 26(2): 42`46, 1990.
2685. mÇ—á•ñn MNŽ®ŒŒ‰tŒ^•s“K‡‚É‚æ‚é‚ÆŽv‚í‚ꂽV¶Ž™—nŒŒ«Ž¾Š³‚Ì1Ç—á.
–ì“c–FlC’F‰pŽ÷CA–ìM…C¼“‡³”ŽC“‡“cMGiŽY•wjC¬ŒûO‹BiŽ™jC¼“c—zi—Õ•a—j: “ú–{ŽY‰È•wl‰ÈŠw‰ï_“Þì’n•û•”‰ï‰ïŽ,
26(2): 57`60, 1990.
2686. m—Õ°Ž¡Œ±n ŒûŠW”S–Œ•Ù–@‚ÌpŒãŒ¾Œê¬Ñ. —é–ØŒbŽqC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jC’·’Jì˜aŽqiz–KÔ\Žš•a‰@jCV”ü¬“ñiŽ¨•@jC’¹Ž”ŸsC‰–’JMKiŒ`ŠOjCãÎOi‹ß‘åj: “ú–{ŒûŠW—ôŠw‰ïŽGŽ, 14(1): 123`131, 1989.
2687. m‘àn V¶Ž™“à‰ÈŽ¾Š³‚É‚¨‚¯‚é ECMO ‚̉ž—p. ¬ŒûO‹BiŽ™j: ˆãŠw‚Ì‚ ‚ä‚Ý, 150(8): 523`526, 1989.
2688. m‘àn ‚킪‹³Žº‚É‚¨‚¯‚é‘ÙŽ™ŠÇ—. Vˆä³•vC‹gŒ´ˆêCª–{‘‘ˆêC“cŠ‹`WiŽY•wjC‘O“c“OiŠÅŒìŠw•”j: ŽY•wl‰ÈŽ¡—Ã, 58(5): 574`577, 1989.
2689. m‘àn Persistent Fetal Circulation (PFC) |Œ´ˆöCf’fCŽ¡—Ã|. ¬ŒûO‹BiŽ™j: ¬Ž™‰È, 30(10): 1131`1145, 1989.
2690. m‘àn zŠÂŠÇ—. ¬ŒûO‹BiŽ™j: ¬Ž™ŠÅŒì, 12(10): 1286`1296, 1989.
2691. muÀn ƒxƒr|‚Ì‚½‚ß‚ÌV¥‚‚·‚èuÀ|“®–¬ŠÇ•Â½–ò|. ¬ŒûO‹BiŽ™j: NICU, (4): 66`72, 1990.
2692. muÀn “®–¬ŠÇŠJ‘¶Ç‚Ì•a‘Ô¶—. ¬ŒûO‹BiŽ™j: NICU, 2(10): 30`38, 1989.
2693. muÀn ‘ÙŽ™‰¼Ž€‚Ìf’f‚ÆŽ¡—Ã. ¼“‡³”ŽiŽY•wj: “ú–{ŽY‰È•wl‰ÈŠw‰ïŽGŽ, 41(7): N°116`119, 1989.
2694. mŠwp‘n iŽ·•Mj ƒvƒ‹ƒ~ƒGŽY•wl‰ÈŠe˜_; V¶Ž™‰¼Ž€CV¶Ž™‚̌ċzŠíŽ¾Š³CV¶Ž™‚ÌS‘Ÿ¥ŒŒŠÇŽ¾Š³C•ª•Ø‘¹,
p.265`278, “‡“cMGC’F‰pŽ÷iŽY•wj. •ÒW H’J´i“Œ‹žˆã‘åj•Ò, ˆãŽ•–òo”Å, “Œ‹ž, 89.11.10 ”s.
2695. m‹³‰È‘n iŽ·•Mj NICUƒ}ƒjƒ…ƒAƒ‹; ’´‰¹”g’f‘wŒŸ¸|2.S, p.280`286, ¬ŒûO‹BiŽ™j. •ÒW V¶Ž™ˆã—ØA—‰ï•ÒC ‹àŒ´o”Å, “Œ‹ž, 89.05.15”s.
2696. m‹³‰È‘n iŽ·•Mj V¶Ž™‚Ìf—ÂƌŸ¸; 8. ’´‰¹”g, b. S‘Ÿ, p.357`366, ¬ŒûO‹BiŽ™j. •ÒW ¬ì—Y”V—ºC‘½“c—TCmŽu“c”ŽŽiC •ÒC “Œ‹žˆãŠwŽÐ, “Œ‹ž, 89.10.30”s.
2697. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj NICUƒ}ƒjƒ…ƒAƒ‹; Žå—v’¥Œó‚ɑ΂·‚éf’fŠw“IƒAƒvƒ|ƒ`‚ÆŠÇ—|šM“ûáŠQCšq“fC• •”–c–žCp.73`80, –åˆäL‹ÅiŽ™j. •ÒW V¶Ž™ˆã—ØA—‰ï•ÒC ‹àŒ´o”Å, “Œ‹ž, 89.05.15”s.
2698. mŠw‰ïn i‹³ˆçu‰‰j Ô‚¿‚á‚ñ‚É“d˜b‚µ‚Ă݂悤. “‡“cMGiŽY•wj: ‘æ3‰ñ_“Þ쌧•ê«‰q¶Šw‰ï (90.02.03), ‰¡•l.
2699. mŠw‰ïn i‹³ˆçu‰‰j V¶Ž™‚Ì“K‰ž¶—|zŠÂ‚Ì“K‰ž|. ¬ŒûO‹BiŽ™j: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï i89.07.02), “Œ‹ž.
2700. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ŽüŽYŠú‚É‚¨‚¯‚é–¢nŽ™”]áŠQ‚Ì—\–h|Intrapartum‚©‚ç|. ’F‰pŽ÷iŽY•wj: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.04), “Œ‹žC ƒvƒƒOƒ‰ƒ€Cp.102`103, 1989.
2701. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j gŽüŽYŠú‚Ì–ƒŒhƒnƒCƒŠƒXƒNŽ™‚Ì‘Îô. ¬ŒûO‹BC–ì“n³•FiŽ™j: ŠÖ“ŒbM‰z–ƒŒŠw‰ï (89.10.07), “Œ‹ž.
2702. mŠw‰ïn iƒpƒlƒ‹j o¶‘Of’f‚Å‘˜‹ö‚µ‚½ƒ^|ƒi|ÇŒóŒQ‚Ì‚P—á.
–î•”“TŽqCät“n’‰’jC˜a“c’m‰vi—Õ•a—jCŽsìŒbŽqi‘‡—Õ°ŒnjCät“n•üŽqC‘å–쓹Žqi—ÕŒŸjC‹gŒ´‹žŽqC¼M»C‘O“c“OiŽY•wjC‘å’J‰pŽ÷i—Õ•a
—j: ‘æ35‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (88.10.20), ŽRŒû.
2703. mŠw‰ïn iƒpƒlƒ‹j ”]ŽºŽüˆÍ«”’Ž¿“(PVL)‚É‚¨‚¯‚鎥‹C‹¤–‰摜f’f‚Ì—L—p«‚ÌŒŸ“¢. –쑺ƒŽqiŽ™j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ïŠwpW‰ï (89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 245, 1989.
2704. mŠw‰ïn iƒpƒlƒ‹j –³“ª–³S‘Ì‚Ì2–UŒŸ—á. ‚ˆä’qŽqC‘å•”½C‰œ•½‰ë•Fi•a—j: ‘æ79‰ñ“ú–{•a—Šw‰ï‘‰ï (90.03.29), •Ÿ‰ª, “ú–{•a—Šw‰ï‰ïŽ, 79(1): 131, 1990.
2705. mŠw‰ïn iˆê”Êu‰‰j HPLC‚É‚æ‚é”A’†—tŽ_ŠÖ˜AƒvƒeƒŠƒWƒ“—U“±‘Ì•ªÍ‚ÌŒŸ“¢‚Æ‚»‚Ì—Õ°“IˆÓ‹`.
“àŽRKMC“n•Ó—Ç•FC‘å’J‰pŽ÷i—Õ•a—jC‘O“c’‰LC÷ˆäŒc‘¢C”·—EŽŠi—ÕŒŸj: ‘æ35‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (88.10.20), ŽRŒû,
—Õ°•a—, 36(•â): 96, 1988.
2706. mŠw‰ïn iˆê”Êu‰‰j ƒVƒoƒ„ƒM‘ÙŽe‚É‚¨‚¯‚éŒo•êbŽ_‘f“Š—^‚Ì‘ÙŽeŒŒ‰tƒKƒX“®‘Ԃւ̉e‹¿. ‹gŒ´ˆêCŒ¹“c’C—YCA–ìM…C’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj: ‘æ41‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ï‘‰ï (89.04.03), ‰ªŽRD
2707. mŠw‰ïn iˆê”Êu‰‰j ”DPŠeT‚É‚¨‚¯‚é‘ÙŽ™•t‘®•¨‚ÌŒŸ“¢‹y‚Ñ‘ÙŽ™‚Æ‚ÌŠÖŒW‚ɂ‚¢‚Ä.
¯“c—²C–ì“c–FlC—§‰ª˜aOCA–ìM…CóˆämŽiC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj:
‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹ž.
2708. mŠw‰ïn iˆê”Êu‰‰j “–‰@‚É‚¨‚¯‚é…“—ÇÇ—á‚Ì—Õ°“IŒŸ“¢.
—§‰ª˜aOC¯“c—²CA–ìM…C–ì“c–FlCª–{‘‘ˆêC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wj:
‘æ77‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.06.18), “Œ‹ž.
2709. mŠw‰ïn iˆê”Êu‰‰j •ª•ØŽž‚Ì•ê‘Ì‚Ö‚ÌŽ_‘f“Š—^‚ªä`‘ÑŒŒ‚ÌŒŒ‰tƒKƒX“®‘Ô‚Ö—^‚¦‚é‰e‹¿. ‹gŒ´ˆêC¯“c—²CŠâ’JO–¾C‹ªˆüCª–{‘‘ˆêC¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ25‰ñ“ú–{V¶Ž™Šw‰ï‘‰ï (89.07.04), “Œ‹ž.
2710. mŠw‰ïn iˆê”Êu‰‰j Œã• –ŒŒ´”‘ÙŽ™«Šà‚Ì1—á. ŒàŠ²ƒCŒÃ”¨½”VC–{“c’¼NC“¡–ì’WlC^‰ºß•vC΋´WC¬ŽÄŒ’i”åj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´.
2711. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽeŠú‘nŽ¡–ü; ŠÔ[D×–E‚Ì«Ž¿. –{—Ñ—R”üŽqi¶‰»ŒnjC’–Œ´ß”V‰îiŒ`ŠOj: “ú–{“®•¨Šw‰ï‘æ60‰ñ‘å‰ï (89.10.04), ‹ž“s, Zoological Science, 6(6): 1201, 1989.
2712. mŠw‰ïn iˆê”Êu‰‰j The Change of Atrial Natriuretic Peptide during
Graded Fetal Hypoxia. ‹gŒ´ˆêCA–ìM…Cª–{‘‘ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: The 2nd World
Symposium: Computers in the Care of the Mother, Fetus and Newborn
(89.10.24), ‹ž“s.
2713. mŠw‰ïn iˆê”Êu‰‰j Ø”—‘ŽY”D•w‚©‚ço¶‚µ‚½Ž™‚Ì’·Šú—\Œã‚ɂ‚¢‚Ä. ’Jº”ŽCA–ìM…C–ì“c–FlC—§‰ª˜aOC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.
2714. mŠw‰ïn iˆê”Êu‰‰j ŒûŠW—ôƒ`|ƒ€ƒAƒvƒ|ƒ`‚ÆŒ¾ŒêŠÇ—.
—é–ØŒbŽqC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jCV”ü¬“ñi“Œ‘åjC’¹Ž”ŸsiŒ`ŠOj: “ú–{‰¹ºŒ¾ŒêˆãŠw‰ï (89.11.11), ˆ¤’mC
‘æ34‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï‘‡Šwpu‰‰‰ï—\eW, p.126, 1989.
2715. mŠw‰ïn iˆê”Êu‰‰j –j”S–Œ‹Ø•Ù–@‚É‚æ‚éŒûŠWŒ`¬p‚ÌpŒã•]‰¿‚¨‚æ‚ÑpŽ®‚̉ü—ǂɂ‚¢‚Ä.
’†–kMºC‘O“c‰Ø˜Yi_“Þ쌧—§‚±‚Ç‚àˆã—ÃZƒ“ƒ^[jC‘厜–í—T”VC‰F’Öؗ´ˆêiŒ`ŠOjC‘Oì“ñ˜Yi‰¡•lŽs‘åj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï
i89.04.21), ‰YˆÀ.
2716. mŠw‰ïn iˆê”Êu‰‰j Ž²Œã«‘½æäÇ‚ÌpŒã•]‰¿. ‰FˆäŒª“ñCˆÉ“¡³ŽkC”’èËWCŽÄ“c—T’BC‰–’JMKiŒ`ŠOj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i89.04.21), ‰YˆÀ, “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9(—Õ‘): 268, 1989.
2717. mŠw‰ïn iˆê”Êu‰‰j ¶Œã24ŽžŠÔˆÈ“à‚ɔǂµ‚½V¶Ž™‰¡Šu–Œƒwƒ‹ƒjƒA—á‚ÌŒŸ“¢|Ž€–S—á‚ð’†S‚Æ‚µ‚Ä|.
Γc˜a•vC‘å‹{“Œ¶Cˆ¢‘]OˆêiŠOjC¬ŒûO‹BCŠÖª“OCŠ—Œ´FiŽ™j: ‘æ26‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ï‘‰ï i89.06.08), ç—t,
“ú–{¬Ž™ŠO‰ÈŠw‰ïŽ, 25(3): 473, 1989.
2718. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgãó×–EÄW‡‘Ì‚©‚ç–Ñ•ï‚ðŒ`¬‚³‚¹‚鎎‚Ý. “n•Ó^—ŽqC’·”öŒb—ŽqC’–Œ´ß”V‰îiŒ`ŠOj:
“ú–{“®•¨Šw‰ï‘æ60‰ñ‘å‰ï i89.10.04), ‹ž“s, Zoological Science, 6(6): 1201, 1989.
2719. mŠw‰ïn iˆê”Êu‰‰j ƒT|ƒtƒ@ƒNƒ^ƒ“ƒg–³Œø—á‚Ì—Õ°‘œ. ¬ŒûO‹BC–ì“n³•FCŠ—Œ´FC’†‘ºP•äCÄ“¡KˆêC–åˆäL‹ÅC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.27), ‘å‹{.
2720. mŠw‰ïn iˆê”Êu‰‰j dÇ”sŒŒÇŠ³Ž™‚Å‚Ì Vancomycin ‚ÌŽg—pŒoŒ±iŒŒ’†”Z“xƒ‚ƒjƒ^ƒŠƒ“ƒO‚Ì•K—v«‚ɂ‚¢‚Äj.
ŠÖª“OCŠ—Œ´FC–åˆäL‹ÅC¬ŒûO‹BC”ª‘ãŒö•viŽ™jC¼“c—zi—Õ•a—jC‹gŽR—F“ñi–òŠw•”jC‚‹´‰Á‘ãŽqi—ÕŒŸjC‹ß“¡—¯”üŽqC–]ŒŽ^‹|i–òÜj:
‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.27), ‘å‹{.
2721. mŠw‰ïn iˆê”Êu‰‰j ’´–¢nŽ™ SFD ‚Ì—Õ°ŒŸ“¢. Š—Œ´FC¬ŒûO‹BC–åˆäL‹ÅCÄ“¡KˆêC’†‘ºP•äC»‰ŸÂC–ì“n³•FiŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.27), ‘å‹{.
2722. mŠw‰ïn iˆê”Êu‰‰j ”XŽîó‘Ù•Ö«• –Œ‰Š‚Ì5—á‚É‚¨‚¯‚é•a‘Ô¥ŠÇ—‚ɂ‚¢‚Ä.
ã–ìM–íC¬ŒûO‹BC’†‘ºP•äC–åˆäL‹ÅCŠ—Œ´FC–ì“n³•FCˆÀ•ÛŒ«ˆêCŠ`À—R•FC”ª‘ãŒö•viŽ™jCΓc˜a•viŠOj: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï
i89.10.28), ‘å‹{.
2723. mŠw‰ïn iˆê”Êu‰‰j ‹‘å‚È Nasopharyngeal teratoma ‚Ì1Ç—á. ‘åι–çC–ì“n³•FC’†‘ºP•äC¬ŒûO‹BC”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.28), ‘å‹{.
2724. mŠw‰ïn iˆê”Êu‰‰j “®–¬ŠÇ“àŒŒ—¬”gŒ`•ªÍ‚Ì—Õ°“IˆÓ‹`. ¬ŒûO‹BCŠ—Œ´FCÄ“¡KˆêC’†‘ºP•äC•½Î‘C”ª‘ãŒö•viŽ™j: ‘æ34‰ñ–¢nŽ™V¶Ž™Šw‰ï i89.10.28), ‘å‹{.
2725. mŠw‰ïn iˆê”Êu‰‰j Ò’ÅŠïŒ`‚𔺂¤’¼’°ãè–åd•¡Ç‚Ì1—á. Γc˜a•vC–x—²CŒÃ“cˆê“¿iŠOjCŠâŸºŒ[ˆêi•a—j: ‘æ24‰ñ“ú–{¬Ž™ŠO‰ÈŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i89.11.11), ‘O‹´.
2726. mŒ¤‹†‰ïn i“Á•Êu‰‰j ŽüŽYŠú‚Ìŋ߂̃gƒsƒbƒNƒX. ¼“‡³”ŽiŽY•wj: •ŸˆäŽsŽY•wl‰Èˆã‰ï (89.06.30), •Ÿˆä.
2727. mŒ¤‹†‰ïn i“Á•Êu‰‰j ‘ÙŽ™‰¼Ž€‚ÌŠÇ—. ¼“‡³”ŽiŽY•wj: “ú–{•ê«•ÛŒìˆã‹¦‰ïå‘äŽOƒuƒƒbƒNŠwpu‰‰‰ï (89.08.25), å‘ä.
2728. mŒ¤‹†‰ïn i“Á•Êu‰‰j ŽüŽYŠúˆãŠw‚ÌÅ‹ß‚Ìi•à. “‡“cMGiŽY•wj: ‘æ4‰ñH“cŒ§ŽüŽYŠú¥V¶Ž™ˆã—ÃŒ¤‹†‰ï‘‰ï (89.10.14), H“c.
2729. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j NST‚ÌV‚µ‚¢f’f¥ƒNƒ‰ƒX•ª—Þ. “‡“cMGiŽY•wj: ‘æ2‰ñŽÀ’nˆã‰Æ‚Æ•ŽY•w‚Ì‚½‚ß‚ÌŽüŽYŠúƒZƒ~ƒi[ (89.07.29), ŽD–y.
2730. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œv‰æ•ª•Ø‚É‚¨‚¯‚镪•Ø‘O’´‰¹”gŒŸ¸‚̈Ӌ`. A–ìM…Cª–{‘‘ˆêC‹ªˆüC–ì“c–FlC’Jº”ŽC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: •ª•ØŠÇ—Œ¤‹†‰ï (89.07.02), “Œ‹ž.
2731. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘ÙŽ™‰¼Ž€‚ÌŠÇ—. ¼“‡³”ŽiŽY•wj: ”’‹‰¶ˆã‰È‘åŠwŠwpŒð—¬–K–â’cu‰‰‰ï (89.08.14), ’·tŽs.
2732. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒƒÇ‚ÈŒo‰ß‚ð‚Æ‚Á‚½–ƒ]‡•¹”DP. ¯“c—²C–ì“c–FlC’Jº”ŽCA–ìM…C‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ296‰ñŽl…‰ï (89.09.20), “Œ‹ž.
2733. mŒ¤‹†‰ïn iˆê”Êu‰‰j NST, CST‚Æ‘Ù“àŽ¡—Ã. ¼“‡³”ŽiŽY•wj: ‘Š–ÍŒ´ŽsŽY•wl‰Èˆã‰ï (89.09.20), ‘Š–ÍŒ´, ‘Š–ÍŒ´ŽsˆãŽt‰ï•ñ, (299): 14`15, 1989.
2734. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽY•wl‰È‚É‚¨‚¯‚éŋ߂̃gƒsƒbƒNƒXiŽå‚Æ‚µ‚Ä”DP’†°•ª•ØŽž‚Ì‘ÙŽ™‰¼Ž€‚ÌŠÇ—‚ɂ‚¢‚Äj. ¼“‡³”ŽiŽY•wj: ‚À¥ŠC˜V–¼ŽY•wl‰Èˆã‰ï (89.11.28), Œú–Ø.
2735. m‚»‚Ì‘¼iŒ¤‹†‰ï‰ï’·jn ‘æ6‰ñ“ú–{“ñ•ªÒ’ÅŒ¤‹†‰ï‰ï’·, 1989.7.1, –î“cŒ«ŽOi”]ŠOj.
<<206 “à•ª”åE‘ãŽÓ>>
2736. mŒ´’˜n Sensitive Assay of Cytochrome P450SCC Activity by
High-Performance Lquid Chromatography. ›–ìKŽqCX“‡’¼•FiŠÅŒìŠw•”jC’r“c•ä‚C–x]Ž •vi¶‰»j:
Anal. Biochem., 182: 327`333, 1989.
2737. mŒ´’˜n Amino Acid Sequence and Relative Biological Activity of Eel
Atrial Natriuretic Peptide. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶jC“n•Ó‘ìŽiCK. NakajimaCS.
Sakakibaraiƒyƒvƒ`ƒhŒ¤j: Biochem. Biophys. Res. Commun., 164(1): 537`543,
1989.
2738. mŒ´’˜n Usefulness of Anaerobic Threshold in Estimating Intensity of
Exercise for Diabetics. ‰Í˜HWˆêC“¡“c–F–MC–‹`’‰i“àjC”’‘é‘’ji¶—jC‹v•Û”Žºi–òŠw•”j: Diabetes
Res. Clin. Prac., 6: 303`309, 1989.
2739. mŒ´’˜n Relationship between Age-adjusted Heart Rate and Anaerobic
Threshold in Estimating Exercise Intensity in Diabetics.
“¡“c–F–MC‰Í˜HWˆêC‹àXWC“Iê´˜aC–‹`’‰i“àjC’|“ດŽiˆãîjCΈäŒö“¹i“àj: Diabetes Res. Clin. Prac.,
8: 60`74, 1990.
2740. mŒ´’˜n Brain Natriuretic Peptide-Like Immunoreactivity Is Present
in Human Plasma.
•xŠ~˜a”üi–k—¢ƒ‰ƒ{jC•½“cŒ‹Šìi“Œ‹žˆãŽ•‘åjCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jCŠÛ–Ε¶ºi“Œ‹žˆãŽ•‘åj: FEBS
Letters, 250(2): 235`237, 1989.
2741. mŒ´’˜n ”|—{‚É‚æ‚éƒqƒgbó‘B×–E‹@”\‚ÌŒ¤‹†|bó‘BŠà×–E‚Ìî•ñŽó—e“`’B‹@\‚̈Ùí|. ˆ¢•”D•¶i“àj: Human Cell, 2(3): 238`245, 1989.
2742. mŒ´’˜n Epidermal Growth Factor (EGF) Receptors in Plasma Membranes
of Normal and Diseased Human Thyroid Glands. ‹àXWCˆ¢•”D•¶C–‹`’‰i“àjCY.
ManabeCˆÉ“¡š •FiˆÉ“¡•a‰@j: J. Clin. Endocrinol. Metab., 68(5): 899`903, 1989.
2743. mŒ´’˜n The Role of ras Oncogene Product p21 in Human Thyroid
Tissue. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àj: Kitasato Arch. Exp. Med., 62(1): 72`74, 1989.
2744. mŒ´’˜n ƒoƒZƒhƒE•aŠáÇ‚É‚¨‚¯‚éRŠá‹ØR‘Ì‚Ì“ÁˆÙ«‚Æ‚»‚ÌRŒ´‚ÌŒŸ“¢.
ˆ¢•”D•¶C–ìX‘º–í¶C‚“cˆê‘¾˜YC‹àXWC–‹`’‰i“àjCˆäã—mˆêCˆÉ“¡š •FiˆÉ“¡•a‰@j: Modern Physician, 9(11):
1586`1590, 1989.
2745. mŒ´’˜n Burst forming unit erythroid (BFU-E)
‘ª’èŒn‚É‚¨‚¯‚é×–E‘BŽhŒƒŒø‰Ê‚æ‚è‚Ý‚½gGrowth without GH" Ç—á‚Ìg’·”ˆç‘£i‚Ì‹@˜|’Pƒ«”ì–ž‚Æ‚Ì”äŠrŒŸ“¢|.
‘åŽR‹XGC›šà†‹ÊC‰¡“csŽjC—`…—²iŽ™j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°C37(6): 471`475, 1989.
2746. mŒ´’˜n ƒqƒgbó‘B×–E‚É‚¨‚¯‚郉ƒX‚ª‚ñˆâ“`Žq‚Ì”Œ»‚ƈâ“`ŽqŽY•¨p21‚Ì‹@”\‚ÉŠÖ‚·‚錤‹†. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjCˆÉ“¡š •FiˆÉ“¡•a‰@j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°iH‹G‘Š§j, 37: 121`128, 1989.
2747. mŒ´’˜n ƒ}ƒXƒXƒNƒŠ|ƒjƒ“ƒO‚Å”Œ©‚³‚ꂽæ“V«bó‘B‹@”\’ቺNJ³Ž™‚É‚¨‚¯‚é¸__ŒoŠw“I—\Œã‘S‘’²¸¬Ñ.
’†“‡”Ž“¿C²“¡_ˆêC’–ŒÒO–¾iç—t‘åjC¼‰YM•vi–k‘åjC‰ª’ëMˆêi‘åŠÙŽs—§‘‡•a‰@jCŒÜ\—’—Ti“Œ–k‘åjC‰¡ŽRV‹giŽRŒ`‘åjC‰ª•”ˆê˜YiŽ©Ž¡ˆã
‘åjCŽRŒûCˆêié‹ÊŒ§—§¬Ž™ˆã—ÃZƒ“ƒ^|jC“y‰®—Ti“s—§´£¬Ž™•a‰@jC‘º“cŒõ”Íi“Œ‹ž—Žqˆã‘åjC‘åŽR‹XGiŽ™jCX“N•vi‘—§—×{Š“Œ¼–{•a
‰@jCΕ˜a³i•xŽRŒ§—§’†‰›•a‰@jC²“¡•Ûi‹à‘ò‘åjCÄ“¡‹vŽqi–¼ŒÃ‰®Žs‘åjC‘å–î‹IºiŽ ‰êˆã‘åjC•Sˆä‹œi‹ž‘åjC‹g‰ªÍi“ޗLjã‘åjC¬¼˜aF
i‘åãˆã‘åjC‚‹´—˜˜ai_ŒË‘åjC‹½ŽiŽŒÈi•ºŒÉŒ§—§‚±‚Ç‚à•a‰@jC¼”ü˜aiL“‡Ô\ŽšEŒ´”š•a‰@jC’–•û”ŽŽqi•Ÿ‰ª‘åjC–ì“c³‹IiŽY‹Æˆã‘åjCsŽÀ
¬“¿i‹v—¯•Ä‘åjCŠŒ´^li‘啪Œ§—§•a‰@jC¼ŽR@˜ZiŒF–{‘åjC¬–쯌áiŽŽ™“‡‘åj: “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(9): 2011`2016,
1989.
2748. mŒ´’˜n “œ”A•a«‰óásÄ”—á‚Ì—Õ°“I“Á’¥‚È‚ç‚Ñ‚ÉÄ”ŠëŒ¯ˆöŽq. –‹`’‰C‹àXWC“¡“c–F–MC“Iê´˜aC‰Í˜HWˆêCŽç‰®’B”üCâ–{—mŽqC–ìX‘º–í¶C‘å˜a“c—¢i“àj: –k—¢ˆãŠw, 19(5): 510`517, 1989.
2749. mŒ´’˜n “œ”A•a‚É‚¨‚¯‚é”A’†ƒAƒ‹ƒuƒ~ƒ“”rŸ•; timed overnight urine‚É‚æ‚錟“¢.
–‹`’‰CŽç‰®’B”üC‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC‹àXWCˆ¢•”D•¶C‚“cˆê‘¾˜YC–ìX‘º–í¶C‘å˜a“c—¢C•½ˆä–@”Ži“àj: –k—¢ˆãŠw,
19(6): 575`582, 1989.
2750. mŒ´’˜n ŠeŽí•‰‰×ŽŽŒ±‚É‚¨‚¯‚éRRŠÔŠu‚ÌŽ©“®Œv‘ªƒVƒXƒeƒ€‚Ìì¬. ’|“ດŽC’r“cŒ›ºiˆã—pî•ñjC“¡“c–F–Mi“àjC“c’†ŠÚ–¾”Ži¶•¨•¨—Œnj: –k—¢ˆãŠw, 19: 336`339, 1989.
2751. mŒ´’˜n ƒCƒ“ƒXƒŠƒm[ƒ}6—á‚ÌäXB×–E‹@”\‚È‚ç‚Ñ‚É‹ÇÝf’f. â–{—mŽqC‚“cˆê‘¾˜YC–Ø“cŒõLCŽç‰®’B”üC‰Í˜HWˆêC‹àXWC“Iê´˜aCˆ¢•”D•¶C“¡“c–F–MC–‹`’‰i“àj: –k—¢ˆãŠw, 20(1): 74`82, 1990.
2752. mŒ´’˜n ƒqƒgbó‘BŠà‚Ì‘B‚ƃzƒ‹ƒ‚ƒ“‚É‚æ‚é‚»‚̧Œä|Šàˆâ“`Žq‚Ì”Œ»‚Æî•ñŽó—e“`’B‹@\‚̈Ùí‚ɂ‚¢‚Ä|. ˆ¢•”D•¶i“àj: —Õ°¬l•a, 19(10): 1787`1788, 1989.
2753. mŒ´’˜n ˆ««Žîᇂɔº‚¤‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŽä‹N‚·‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(Parathyroid Hormone Related
Protein; PTHrP); V‚µ‚¢ƒzƒ‹ƒ‚ƒ“«Žîᇃ}|ƒJ|‚Æ‚µ‚Ä‚ÌPTHrP‚ÌŒŸ“¢. ˜a“c’m‰vC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—,
38(3): 288`293, 1990.
2754. m’Z•ñn ’·ŠúŠÔ‚ɂ킽‚霑ãŽÓˆÙí‚É‚¨‚¯‚霔玿‚Ìœ‰–—Ê‘ª’è‚Ì—L—p«. ÷ˆä´ŽqC¼—Ñ—²i•újC—L•xŠ°i®ŠOjCŠâ”g–Îi•újCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjC‘–쳈êi•új: “ú–{ˆãŠw•úŽËüŠw‰ïŽGŽ, 50(1): 81`83, 1990.
2755. m’Z•ñn ŠeŽí“à•ª”åŽîᇂɂ¨‚¯‚é–Ɖu‘gD‰»Šw“IŒŸ“¢|ECG,NEM‚ð’†S‚Æ‚µ‚Ä|. ²”Œ”ü“ÞŽqCŽsì‚‚íi•a‰@•a—jCŠâŸºŒ[ˆêC‰œ•½‰ë•Fi•a—j: •a—‹Zp, (39): 10`12, 1989.
2756. mŒ¤‹†•ñi•¶•”Èjn Žîᇃ}|ƒJ|‚Æ‚µ‚Ä‚Ì•›bó‘Bƒzƒ‹ƒ‚ƒ“—l’`”’(PTH-LP)‚ÌŠî‘b“IC—Õ°“IŒŸ“¢. ˜a“c’m‰vi—Õ•a—j: •¶•”ȧ—㌤‹†(A)Œ¤‹†•ñ‘, 1989.
2757. mÇ—á•ñn 3”NˆÈã‚ɂ킽‚èGH”ñˆË‘¶«‚Ì—ÇD‚Èg’·‘‰Ái8.8 cm/”Nj‚ðŽ¦‚µ‚Ä‚¢‚é“Á”«‰º‚‘Ì‹@”\’ቺǂÌ6Î’jŽ™—á.
‰¡“csŽjC‘åŽR‹XGC›šà†‹ÊC—`…—²iŽ™j: ƒzƒ‹ƒ‚ƒ“‚Æ—Õ°i“à•ª”å‹»–¡‚ ‚éÇ—áC‘æ13Wj,(‘): 49`51, 1989.
2758. mÇ—á•ñn An Autopsy Case of Erythropoietic Protoporphyria with
Liver Cirrhosis. ’†‰p’jC£ìŒªˆêC–{‹§C‰ªTˆê˜YC‰œ•½‰ë•Fi•a—j: –k—¢ˆãŠw, 19(4): 445`451,
1989.
2759. m—Õ°Ž¡Œ±n ƒyƒvƒVƒmƒQƒ“RIAƒLƒbƒg‚Ì—Õ°‰ž—p.
‰ª”ŽCŽO–؈ê³i“Œ‘åjCŽODH”ni•l¼ˆã—ÃZƒ“jC‰ª•”Ž¡–íi“àjC•ž•”Mi‹à‘ò‘åjCìˆäŒ[Žsi‹ž•{ˆã‘åjC’†‘òŽO˜Yi–¼ŒÃ‰®‘åjC‹{è•Ûi–k‘åjC
’J“àºiŽD–yˆã‘åjCÎXÍi“Œ–k‘åjC²X–ØNliŒQ‘åjC•Ÿ•x‹v”Vi’}”g‘åjC¼”ö—Ti“ú‘åjCΈ䟌Èi•újC‹àŽq‰h‘ i•l¼ˆã‘åjC—L‹gŠ°iˆ¤’m
‚ª‚ñƒZƒ“jCX‰ê–{Ki‹ž‘åjCX•’åi‘åã‘åjCX“c—¤Žiiìèˆã‘åjCŠÝ–{^–çiL“‡‘åjC•l–{Œ¤iˆ¤•Q‘åjC™’¬Œ\‘ i‹ã‘åjC‘å]ŒcŽ¡iŽY‹Æˆã
‘åj: —Õ°¬l•a, 19(4): 531`537, 1989.
2760. m‘àn “œ”A•a‚̃}ƒl[ƒWƒƒ“ƒg; ƒtƒ@[ƒXƒgƒ`ƒ‡ƒCƒX‚Ì~ˆ³–ò. –‹`’‰C‹àXWi“àj: Chronic Disease, (1): 119`121, 1990.
2761. m‘àn “ÁW; ŒoŒûÜ‚Ì–ò—¥—p–@¥•ž–ò¥Žw“±ABGÜ‚Ì“K‰ž‚Æ—p–@ã‚Ì—¯ˆÓ“_. “¡“c–F–MCŽç‰®’B”üC–‹`’‰i“àj: Practice, 6: 388`391, 1989.
2762. m‘àn ‘ŠútÇitǃAƒ‹ƒuƒ~ƒ“”AŠúj‚Ì–ò•¨—Ö@. –‹`’‰C“Iê´˜ai“àj: Ž¡—Ã, 71: 111`116, 1989.
2763. m‘àn ¬lÇ. —`…—²iŽ™j: ¬Ž™‰Èf—à 1989‘Š§†¢¬Ž™‚ÌŽ¡—ÃŽwj '89£,@52: 541`544, 1989.
2764. m‘àn IDDM‚É‚¨‚¯‚éƒCƒ“ƒXƒŠƒ“—Ö@|ƒCƒ“ƒXƒŠƒ“»Ü‚ÌŽí—Þ‚Æ‘I‘ð–@|. ‰¡“csŽjiŽ™j: ¬Ž™“à‰È,@22(2): 223`228, 1990.
2765. m‘àn “œ”A•a; ‡•¹Ç‚Æ‚»‚Ì‘Îô. ‰ª”ŽCÔÀˆÀ•vC‹TŽR˜aŽqC–‹`’‰i“àjC¼‰ªŒ’•½: “à‰È, 64: 87`104, 1989.
2766. m‘àn ƒCƒ“ƒXƒŠƒ“; ‚Æ‚‚É–«t•s‘Só‘Ô‚É‚¨‚¯‚éäXB×–E‹@”\‚ƃCƒ“ƒXƒŠƒ“’ïR«‚Ì‹@˜‚ɂ‚¢‚Ä. –‹`’‰C“¡“c–F–MCŽç‰®’B”üi“àj: —Õ°“§Í, 5: 171`177, 1989.
2767. mŠwp‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj 1989; ‹}«¥ˆŸ‹}«bó‘B‰Š, ˆ¢•”D•¶i“àj. •ÒW ˆîŠ_‹`–¾C‘¼•Ò, ˆãŠw‘‰@, “Œ‹ž, 89.02.15 ”s.
2768. mŠwp‘n iŽ·•Mj ‘æ23‰ñ“œ”A•aŠw‚Ìi•àA“œ”A•a‚̗×{Žw“± 1989; “œ”A•aŠ³ŽÒA“ÁŽêŠÇ—‚Ì–â‘è“_;tÇŠ³ŽÒ‚ÌŠÇ—,
p.113`119, –‹`’‰C“Iê´˜ai“àj. •ÒW “ú–{“œ”A•aŠw‰ï•Ò, f’f‚ÆŽ¡—ÃŽÐ, “Œ‹ž, 89.00.00 ”s.
2769. mŠwp‘n iŽ·•Mj Endocrinology of Birds|Molecular to Behavioral;
Hormonal Regulation of Water and Sodium Intake in Birds,@p.171`183,
’|ˆä˘Yi¶—jCHideshi Kobayashii‘S–òH‹Æj. •ÒW Masaru Wadai“Œ‹žˆãŽ•‘åjCSusumu
Ishiii‘‘åjCC.G. Scanes (Ruters Univ.)•ÒC Japan Scientific Societies
Press, “Œ‹ž, 90.01.00”s.
2770. m‚»‚Ì‘¼‚Ì’˜‘n i•ÒWj Proceedings of the Japan Society for Comparative
Endocrinology, •ÒW •½–ì“N–çi“Œ‘åjC’|ˆä˘Yi–k—¢‘åj•ÒC “ú–{”äŠr“à•ª”åŠw‰ï, “Œ‹ž, 89.12.00”s.
2771. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj “à•¶”åƒP|ƒXƒXƒ^ƒfƒB|48—á‚ÌPO Œ¤C@‘æ2”Å;
“û–[Žî‘储‚æ‚Ñ«ŠíoŒŒ‚ð’悵‚½2Î7‚©ŒŽ‚Ì—Ž™Cp.34`38, —`…—²iŽ™j. •ÒW ´…’¼—ei’é‹ž‘åjC”Ñ–ìŽj˜Yiº˜a‘åj•ÒC ˆãŠw‘‰@,
“Œ‹ž, 89.05.01”s.
2772. mŽ‹’®Šoo”Å•¨n iŽ·•Mj ˆãŠw¶‚Ì‚½‚߂̬Ž™‰ÈŠwŽÊ^W; ‘ãŽÓC“à•ª”厾Š³Cp.31`40, ‘åŽR‹XGiŽ™j. •ÒW óˆä—˜•vi“Œ‹ž—Žqˆã‘åjCÔâ“Oié‹Êˆã‘åj•ÒC ’†ŠOˆãŠwŽÐ, “Œ‹ž, 89.04.01”s.
2773. mŠw‰ïn i“Á•Êu‰‰j ˆ««Žîᇂɔº‚¤‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŽä‹N‚·‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(Parathyroid Hormone
Related Protein; PTHrP); V‚µ‚¢ƒzƒ‹ƒ‚ƒ“«Žîᇃ}|ƒJ|‚Æ‚µ‚Ä‚ÌPTHrP‚ÌŒŸ“¢. ˜a“c’m‰vi—Õ•a—j:
‘æ1‰ñ“ú–{—Õ°•a—Šw‰ïŠÖ“ŒbM‰zŽx•”‘‰ï (89.10.28), VŠƒ.
2774. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒqƒgbó‘B‰‘ã”|—{Œn‚É‚æ‚é×–Eî•ñŽó—e“`’B‹@\‚ÌŒ¤‹†. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjC‹T’J“Oi•a—j: ‘æ62‰ñ“ú–{‘gD”|—{Šw‰ï‘å‰ï (89.06.29), _“Þì.
2775. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ”ñ‹@”\«“à•ª”åŽîá‡Fbó‘B”ñ‹@”\«‘BŽî‚̶‰»Šw“I“Á«.
ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjC‹T’J“Oi•a—jC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïH‹GŠwp‘‰ï (89.10.21),
ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 859, l989.
2776. mŠw‰ïn iƒpƒlƒ‹j Intestinal Movement Video-Solarbattery-Computerized.
‘ëàV’¼’èi¶—jC‰Á“¡NsiŠOjC‘åŠÑMi¶—j: 31st International Congress of Physiological
Sciences (89.07.14), Helsinki, Finland, Proc. Intna. Union of Physiol.
Sci. 17, p.502`503, 1989.
2777. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj “œ”A•a«tǔLjöŽq‚Æ‚µ‚Ä‚ÌS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚ɂ‚¢‚Ä. “Iê´˜aCâ–{—mŽqCŽç‰®’B”üC‰Í˜HWˆêC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï (89.04.22), ‹à‘ò.
2778. mŠw‰ïn iˆê”Êu‰‰j œ”½‰žŒ^‚ð’悵‚½‹U«•›bó‘B‹@”\’ቺÇType Ib‚Ì1—á.
ˆ¢•”D•¶Câ–{—mŽqCŽç‰®’B”üC‹àXWC‰Í˜HWˆêC“Iê´˜aC‚“cˆê‘¾˜YC“¡“c–F–MC–‹`’‰i“àj: ‘æ10‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï
(89.01.28), _“Þì.
2779. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚ÌS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“(ANP)—l•¨Ž¿.
’|ˆä˘Yi¶—jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj: ‘æ66‰ñ“ú–{¶—Šw‰ï‘å‰ï (89.04.06), ‰ªŽRC Jpn. J.
Physiol., 39(Suppl.): 689, 1989.
2780. mŠw‰ïn iˆê”Êu‰‰j Anaerobic Threshold (AT)‚©‚ç‚Ý‚½“œ”A•aŠ³ŽÒ‚̌ċz‹@”\.
‰Í˜HWˆêC“¡“c–F–MC’J–{‹ž”üCâ–{—mŽqCŽç‰®’B”üC“Iê´˜aC–‹`’‰i“àjC”’‘é‘’ji¶—j: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï
(89.04.21), ‹à‘ò, “œ”A•a, 34(Suppl. 1): 164, l989.
2781. mŠw‰ïn iˆê”Êu‰‰j “œ”A•aŽ¡—Â̂½‚ß‚ÌŽŠ“K‰^“®‹“x‚ÌŒˆ’è–@|Anaerobic
Threshold‚É‚¨‚¯‚éS””‚Æ”N—î•ÊS””‚Ì”äŠr|.
“¡“c–F–MC‰Í˜HWˆêC’J–{‹ž”üCâ–{—mŽqCŽç‰®’B”üC“Iê´˜aC–‹`’‰i“àjC‰““¡‹±ŽqC”’‘é‘’ji¶—j: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï
(89.04.21), ‹à‘ò, “œ”A•a, 34(Suppl. 1): 164, l989.
2782. mŠw‰ïn iˆê”Êu‰‰j ”A’†ƒAƒ‹ƒuƒ~ƒ“”rŸ•—¦‚Ì•Ï“®ŒW”‚¨‚æ‚Ñ”÷—ʃAƒ‹ƒuƒ~ƒ“”A‚ɉe‹¿‚·‚éˆöŽq‚ɂ‚¢‚Ä. Žç‰®’B”üCâ–{—mŽqC‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{“œ”A•aŠw‰ï‘‰ï (89.04.22), ‹à‘ò.
2783. mŠw‰ïn iˆê”Êu‰‰j Biologically and Immunologically Active Atrial
Natriuretic Peptide (ANP) in the Eel Heart. ’|ˆä˘Yi¶—jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: 11th
International Symposium on Comparative Endocrinology (89.05.16),
Malaga, Spain, Abstracts, p.255, 1989.
2784. mŠw‰ïn iˆê”Êu‰‰j
‰Æ‘°«‚ƒRƒŒƒXƒeƒ|ƒ‹ŒŒÇ(FH)‚̃XƒNƒŠ|ƒjƒ“ƒO|‘æ3•ñCä`‘ÑŒŒCƒKƒXƒŠ|ŒŒC‘ƒRƒŒƒXƒeƒ|ƒ‹‚’l—á‚ÌŒo‰ß‹y‚ÑFH—á‚Æ‚Ì”äŠr|.
–xŒû‘דTC•½Î‘C–åˆäL‹ÅCÄ“¡KˆêC”ª‘ãŒö•viŽ™jC¼“c—zi—Õ•a—jC¬o’©’ji–k—¢ƒ‰ƒ{j: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï
(89.05.18), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93: 517, 1989.
2785. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™“œ”A•a‚É‚¨‚¯‚éy‘f‘ª’è–@‚É‚æ‚錌’† l,5 Anhydroglucitol (AG)
‘ª’è‚Ì—Õ°“I—L—p«‚ɂ‚¢‚Ä. ‘åŽR‹XGC‰¡“csŽjC›šà†‹ÊC—`…—²iŽ™jC–÷“ೕFi“ú–{‰»–òj: ‘æ92‰ñ“ú–{¬Ž™‰ÈŠw‰ï‘‰ï
(89.05.19), VŠƒC “ú–{¬Ž™‰ÈŠw‰ïŽGŽC93(3): 579, 1989.
2786. mŠw‰ïn iˆê”Êu‰‰j Effect of anaesthesia on endocrine metabolic response
to lower abdominal surgery. “c’†—ºC‘ºã‰ëŽqC–쌩ŽREi–ƒj: ‘æ9‰ñ¢ŠE–ƒŒŠw‰ï (89.05.22`28),
U.S.A..
2787. mŠw‰ïn iˆê”Êu‰‰j ¬’·ƒzƒ‹ƒ‚ƒ“—Ö@’†‚̃^|ƒi|ÇŒóŒQ(TS)‚É‚¨‚¯‚é–ƉuŠw“IŒŸ“¢.
‰¡“csŽjC—`…—²C‘åŽR‹XGCŽÄŽRŒ[ŽqC›šà†‹ÊiŽ™j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ï‘‰ï (89.06.01), “Œ‹žC
“ú–{“à•ª”åŠw‰ïŽGŽC65(4): 304, 1989.
2788. mŠw‰ïn iˆê”Êu‰‰j ƒoƒZƒhƒE•abó‘B‚É‚¨‚¯‚é—}§«G’`”’‚̕ω»‚Æ‚»‚Ì‹@˜‚ɂ‚¢‚Ä.
ˆ¢•”D•¶Câ–{—mŽqC‹àXWC‚“cˆê‘¾˜YC–‹`’‰i“àjC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïŠwp‘‰ï
(89.06.03), “Œ‹ž, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(4): 380, l989.
2789. mŠw‰ïn iˆê”Êu‰‰j —cŽáƒ‰ƒbƒg‚ÌŽ‹°‰º•”CäXCÁ‰»ŠÇ‚É‚¨‚¯‚éGrowth Hormone Releasing
Hormone-Like Immunoreactivity (GHRH-LI)‚Ì•ª•z‚Æ‚»‚Ì“ú—î‚É‚æ‚é•Ï‰». ‘åŽR‹XGCŽÄŽRŒ[ŽqC—`…—²iŽ™j:
‘æ62‰ñ“ú–{“à•ª”åŠw‰ï (89.06.03), “Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽC65(4): 433, 1989.
2790. mŠw‰ïn iˆê”Êu‰‰j Comparison of Heart Rate at Anaerobic Threshold (AT)
with Age-adjusted Heart Rate for Evaluating Optimal Exercise Intensity
in Diabetics. “¡“c–F–MC‰Í˜HWˆêCŽç‰®’B”üC“Iê´˜ai“àjC”’‘é‘’ji¶—jC–‹`’‰i“àj: American
Diabetes Association, 49th Meeting (89.06.03-06), Detoroit, Diabetes
Program, 38(Suppl. 2): 156A, 1989.
2791. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgŒŒ’†Endothelin‚̃‰ƒWƒIƒCƒ€ƒmƒAƒbƒZƒC.
ˆÀ“¡Œ¤ŽiC•xŠ~˜a”üi–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC]Xr–¾CŽµ—¢^‹`C•½“cŒ‹ŠìCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj:
‘æ26‰ñ“ú–{—Õ°‘ãŽÓŠw‰ï‘‰ï (89.06.09), ‘åã, Proceedings, 26: 122`123, 1989.
2792. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒWƒIƒCƒ€ƒmƒAƒbƒZƒC(RIA)‚É‚æ‚éBrain Natriuretic Peptide(BNP)‚Ì‘ª’è.
•xŠ~˜a”üCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC]Xr–¾CŽµ—¢^‹`C•½“cŒ‹ŠìCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj:
‘æ26‰ñ“ú–{—Õ°‘ãŽÓŠw‰ï‘‰ï (89.06.09), ‘åã, Proceedings, 26: 228`229, 1989.
2793. mŠw‰ïn iˆê”Êu‰‰j ‰©FƒuƒhƒE‹…‹Û”sŒŒÇA‘–Œ‰Š‚ÅŽ€–S‚µ‚½“œ”A•a‚Ì1Ç—á. ‰Í˜HWˆêC’J–{‹ž”üCŽç‰®’B”üC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ383‰ñ“ú–{“à‰ÈŠw‰ïŠÖ“Œ’n•û‰ï (89.06.10), “Œ‹ž.
2794. mŠw‰ïn iˆê”Êu‰‰j The Development of Pancreatic and Gastrointestinal
Growth Hormone Releasing Hormone-Like Immunoreactivity (GHRH-LI) in
Neonatal Rats. ‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqiŽ™j: ‘æ71‰ñƒAƒƒŠƒJ“à•ª”åŠw‰ï (71th Annual Meeting of
the Endocrine Society) (89.06.21), Seattle, U.S.A., Abstracts, p.106,
1989.
2795. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgbó‘B”|—{×–E‚É‚¨‚¯‚éATPŽhŒƒŽž‚Ì×–E“àƒJƒ‹ƒVƒEƒ€”Z“x‚̕ω». ‹àXWCˆ¢•”D•¶C–‹`’‰i“àj: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´.
2796. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚ÌS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“‚̶•¨Šˆ«. ’|ˆä˘Yi¶—jC¼“c‘•ci¶•¨•¨—ŒnjC‚‹´–¾‹`i•ª¶j: ‘æ15‰ñ–k—¢ˆãŠw‰ï‘‰ï (89.09.30), ‘Š–ÍŒ´C –k—¢ˆãŠw, 19(6): 645, 1989.
2797. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒMS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚̈ꎟ\‘¢‚Æ‚»‚̔䊈«.
’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶jC“n•Ó‘ìŽiiƒyƒvƒ`ƒhŒ¤j: ‘æ60‰ñ“ú–{“®•¨Šw‰ï‘å‰ï (89.10.06), ‹ž“sC Zoological
Science, 6(6): 1186, 1989.
2798. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒg”î‘OŠú‚Ì LH, PRL•ª”å‚É‹y‚Ú‚·ƒEƒŒƒ^ƒ“–ƒŒ‚̉e‹¿‚ɂ‚¢‚Ä. ŒÃŠÚêˆêiŽÀ“®j: “ú–{“à•ª”åŠw‰ï (89.10.20), ŽD–yC “ú–{“à•ª”åŠw‰ïŽGŽC65(9): 88l, l989.
2799. mŠw‰ïn iˆê”Êu‰‰j 17,20-desmolaseŒ‡‘¹ÇPartial defect (type 1)‚Æl‚¦‚ç‚ê‚é9Î’jŽ™—á.
‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqC›šà†‹ÊC‰¡“csŽjiŽ™j: ‘æ62‰ñ“ú–{“à•ª”åŠw‰ïH‹G‘å‰ï (89.10.21), ŽD–y, “ú–{“à•ª”åŠw‰ïŽGŽ,
65(9): 979, 1989.
2800. mŠw‰ïn iˆê”Êu‰‰j Familial Isolated Growth Hormone Deficiency (IGHD)
Type 3 without Any Immunodeficiency in Two Male Siblings.
‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqC›šà†‹ÊC‰¡“csŽjiŽ™j: Third Joint Meeting of the European Society
for Pediatric Endocrinology and Lawson Wilkins Pediatric Endocrinology
Society (89.10.30), Jerusalem, Hormone Research, 31(Suppl.1): 30, 1989.
2801. mŠw‰ïn iˆê”Êu‰‰j Ontogeny of Growth Hormone Releasing Hormone-Like
Immunoreactivity (GHRH-LI) in the Hypothalamus, Pancreas and
Gastrointestinal Tract in Rat. ‘åŽR‹XGC—`…—²CŽÄŽRŒ[ŽqiŽ™j: Third Joint Meeting of
the European Society for Pediatric Endocrinology and Lawson Wilkins
Pediatric Endocrinology Society (89.11.01), Jerusalem, Hormone
Research, 31(Suppl.1): 19, 1989.
2802. mŠw‰ïn iˆê”Êu‰‰j ƒVƒgƒNƒƒ€P-450SCC‚É‚æ‚é3-one-4-enƒXƒeƒƒCƒh‚Ì‘ãŽÓ‚Æ”½‰ž’†ŠÔ‘Ì‚Ì•ª—£.
›–ìKŽqCX“‡’¼•FiŠÅŒìŠw•”jC–x]Ž •vi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9): 853,
1989.
2803. mŠw‰ïn iˆê”Êu‰‰j ’†«”TŽŠŽ_«‚Ì“™“d“_‚ð‚à‚•›t”玿P-450SCC‚Ì•ªŽq‘½—l‘Ì‚Ì’²»‚Æ«Ž¿.
–x]Ž •vC“n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqi¶‰»ŒnjC›–ìKŽqiŠÅŒìŠw•”j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw,
61(9): 853, 1989.
2804. mŠw‰ïn iˆê”Êu‰‰j ƒXƒeƒƒCƒhŽY¶×–E‚Ìy‘f‘gD‰»Šw“IõF‚ÆŽY¶ƒXƒeƒƒCƒh—Ê‚Æ‚ÌŠÖŒW. ’r“c•ä‚C–x]Ž •vi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1043, 1989.
2805. mŠw‰ïn iˆê”Êu‰‰j IDDMtÇ‚É‚¨‚¯‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh(ANP)‚ɂ‚¢‚Ä. “Iê´˜aC‘å˜a“c—¢C–ìX‘º–í¶CŽç‰®’B”üC‰Í˜HWˆêC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.
2806. mŠw‰ïn iˆê”Êu‰‰j “œ”A•a‚É‚¨‚¯‚é”÷—ʃAƒ‹ƒuƒ~ƒ“”A‚ÌŒo‰ß‚ɂ‚¢‚Ä. Žç‰®’B”üC‘å˜a“c—¢C–ìX‘º–í¶C‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ32‰ñ“ú–{t‘ŸŠw‰ï‘‰ï (89.11.09), •l¼.
2807. mŠw‰ïn iˆê”Êu‰‰j 17,20-desmolase•”•ªŒ‡‘¹Ç(Zachmann Type 1)‚Æl‚¦‚ç‚ê‚é9Î’jŽ™—á.
‘åŽR‹XGCŽÄŽRŒ[ŽqC›šà†‹ÊC‰¡“csŽjC—`…—²iŽ™j: ‘æ23‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (89.11.10), b•{, ´˜^W, p.45,
1989.
2808. mŠw‰ïn iˆê”Êu‰‰j V¶Ž™ƒ‰ƒbƒg‚ÌÁ‰»ŠÇ‚É‚¨‚¯‚éSomatostatinˆâ“`Žq”Œ»‚ɂ‚¢‚Ä. ŽÄŽRŒ[ŽqC‘åŽR‹XGC›šà†‹ÊC—`…—²iŽ™j: ‘æ23‰ñ“ú–{¬Ž™“à•ª”åŠw‰ï (89.11.10), b•{, —\eW, p.96, 1989.
2809. mŠw‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚Ì”]‚É‘¶Ý‚·‚éS–[«ƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh—l•¨Ž¿.
’|ˆä˘Yi¶—jC¼“c‘•ci¶•¨•¨—ŒnjC‚‹´–¾‹`i•ª¶jCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{j: ‘æ14‰ñ“ú–{”äŠr“à•ª”åŠw‰ï‘å‰ï (89.11.18),
’·èC Proc. Jpn. Soc. Comp. Endocrinol., 4: 16,1989.
2810. mŠw‰ïn iˆê”Êu‰‰j Radioimmunoassay‚É‚æ‚éBNP—l–ƉuŠˆ«‚Ì‘ª’è.
•xŠ~˜a”üCˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jCŠÛ–Ε¶ºi“Œ‹žˆãŽ•‘åj: “ú–{“à•ª”åŠw‰ï‘‰ï (89.11.21),
“Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 903, 1989.
2811. mŠw‰ïn iˆê”Êu‰‰j ”A’†Endothelin‚Ì‘¶Ý.
ˆÀ“¡Œ¤Žii–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC•½“cŒ‹Šì—YCŠÛ–Ε¶ºi“Œ‹žˆãŽ•‘åj: “ú–{“à•ª”åŠw‰ï‘‰ï (89.11.21),
“Œ‹žC “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 908, 1989.
2812. mŠw‰ïn iˆê”Êu‰‰j ƒqƒg³í‚¨‚æ‚ÑŠàbó‘B”|—{×–E‚É‚¨‚¯‚éATPŽhŒƒŽž‚Ì×–E“àƒJƒ‹ƒVƒEƒ€”Z“x‚̕ω».
‹àXWCˆ¢•”D•¶C–‹`’‰i“àjC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ32‰ñ“ú–{“à•ª”åŠw‰ïbó‘B•ª‰È‰ï (89.11.25), ŒQ”n,
“ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 1058, 1989.
2813. mŠw‰ïn iˆê”Êu‰‰j ƒzƒ‹ƒ‚ƒ“ŽY¶bó‘BŽîᇂ̶‰»Šw“I“Á«.
ˆ¢•”D•¶C‹àXWC‚“cˆê‘¾˜YC–‹`’‰i“àjC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ32‰ñ“ú–{“à•ª”åŠw‰ïbó‘B•ª‰È‰ï (89.11.25),
ŒQ”n, “ú–{“à•ª”åŠw‰ïŽGŽ, 65(9): 1079, 1989.
2814. mŠw‰ïn iˆê”Êu‰‰j WernerÇŒóŒQ‚ɇ•¹‚µ‚½NIDDM‚Ì1—á. ‹àXWC•½ˆä–@”ŽC‘å˜a“c—¢C–ìX‘º–í¶C‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ27‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (90.01.27), “Œ‹ž.
2815. mŠw‰ïn iˆê”Êu‰‰j ‰Šú“œ”A•a«tǂɑ΂·‚éACE‘jŠQÜ‚ÌŒø‰Ê.
“Iê´˜aC•½ˆä–@”ŽC‘å˜a“c—¢C–ìX‘º–í¶CŽç‰®’B”üC‰Í˜HWˆêC‹àXWC“¡“c–F–MC–‹`’‰i“àj: ‘æ27‰ñ“ú–{“œ”A•aŠw‰ïŠÖ“ŒbM‰z’n•û‰ï
(90.01.27), “Œ‹ž.
2816. mŠw‰ïn iˆê”Êu‰‰j æ“V«’_“¹•Â½Ç‚ÆŠÓ•Ê¢“ï‚Å‚ ‚Á‚½‘J‰„‰©át‚𔺂Á‚½æ“V«Œ´”«•›t”玿‹@”\’ቺǂÌ1—á.
Š`À—R•FC‰¡“csŽjC–ì“n³•FC¬ŒûO‹BC—`…—²iŽ™j: ‘æ182‰ñ“ú–{¬Ž™‰ÈŠw‰ï_“Þ쌧’n•û‰ï (90.02.17), ‰¡•l.
2817. mŠw‰ïn iˆê”Êu‰‰j ˆ««Žîᇂɔº‚¤‚ƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ðŽä‹N‚·‚é•›bó‘Bƒzƒ‹ƒ‚ƒ“ŠÖ˜A’`”’(PTHrP)‚ÌŒŸ“¢i‘æ2•ñj.
ŽsìŒbŽqi‘‡—Õ°ŒnjC˜a“c’m‰vC¼“c—zC‘å’J‰pŽ÷i—Õ•a—j: ‘æ16‰ñ—Õ°‰»ŠwŒŸ¸‚ÉŠÖ‚·‚é“~ŠúƒZƒ~ƒi| (90.03.06), ŠâŽè.
2818. mŒ¤‹†‰ïn iˆê”Êu‰‰j “œ”A•a‚É‚¨‚¯‚é”A’†”÷—ʃAƒ‹ƒuƒ~ƒ“‘ª’è‚Ì—Õ°“IˆÓ‹`. Žç‰®’B”üC‘å˜a“c—¢C–ìX‘º–í¶C‰Í˜HWˆêC‹àXWC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ6‰ñ_“Þì“œ”A•aŒ¤‹†‰ï (89.07.08), ‰¡•l.
2819. mŒ¤‹†‰ïn iˆê”Êu‰‰j œ‘ãŽÓˆÙí‚Ì•]‰¿. ÷ˆä´Žqi•új: ‘æ151‰ñ“Œ‹žˆãŠw•¨—Œ¤‹†‰ïƒZƒ~ƒi[ (89.09.11), “Œ‹ž.
2820. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”玿œœ‰–’è—Ê‚Ìd—v«. ÷ˆä´ŽqCŠâ”g–ÎC¼—Ñ—²C‘–쳈êi•újC—L•xŠ°i®ŠOjCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åj: ‘æ8‰ñœ‚Æœ‘ãŽÓŒ¤‹†‰ï (89.10.07), ‘åã.
2821. mŒ¤‹†‰ïn iˆê”Êu‰‰j bó‘BŽîᇂ̓Á«‚ÉŠÖ‚·‚é–Ɖu‘gDŠw“IŒŸ“¢. ˆ¢•”D•¶C‹àXWC–‹`’‰i“àjCŒY•”“ŒŽ¡iŠOjC‹T’J“Oi•a—jC”öèC•CˆÉ“¡š •FiˆÉ“¡•a‰@j: ‘æ6‰ñbó‘B•a‘Ô¶—Œ¤‹†‰ï (89.12.02), “Œ‹ž.
2822. mŒ¤‹†‰ïn iˆê”Êu‰‰j “œ”A•a«×¬ŒŒŠÇǂɑ΂·‚é”DP‚̉e‹¿i‘æ4•ñj. ‘å˜a“c—¢CŽç‰®’B”üC‰Í˜HWˆêC“Iê´˜aC“¡“c–F–MC–‹`’‰i“àj: ‘æ5‰ñ“œ”A•a‚Æ”DP‚ÉŠÖ‚·‚錤‹†‰ï (89.12.02), “Œ‹ž.
2823. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ª•”ŠOŒãA’ጌ“œ‚ðŒ_‹@‚É”Œ©‚³‚ꂽ”ĉº‚‘Ì‹@”\’ቺǂÌ1—á.
–ìX‘º–í¶C•½ˆä–@”ŽCŽç‰®’B”üC‰Í˜HWˆêC‹àXWCˆ¢•”D•¶C‚“cˆê‘¾˜YC“¡“c–F–MC–‹`’‰i“àj: ‘æ17‰ñ“à•ª”å‘ãŽÓŒ¤‹†‰ï
(89.12.09), “Œ‹ž.
2824. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒ’†C”A’†Endothelin—l–ƉuŠˆ«•¨Ž¿‚ɂ‚¢‚Ä.
ˆÀ•”‹žŽqCˆÀ“¡Œ¤ŽiC•xŠ~˜a”üC{“¡–F³i–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶jC]Xr–¾CŽµ—¢^‹`C•½“cŒ‹ŠìCŠÛ–Ε¶ºi“ŒˆãŽ•‘åj:
‘æ17‰ñ“à•ª”å‘ãŽÓŒ¤‹†‰ï (89.12.09), “Œ‹žC ´˜^W, p.55`57, 1989.
2825. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒEƒiƒMANP‹y‚ÑBNP‚Ì\‘¢‚Æ‚»‚̔䊈«. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶jC“n•Ó‘ìŽiiƒyƒvƒ`ƒhŒ¤j: ‘æ5‰ñANPŒ¤‹†‰ï (90.02.16), ‘åã.
2826. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒEƒiƒM‚̃iƒgƒŠƒEƒ€—˜”Aƒzƒ‹ƒ‚ƒ“ƒtƒ@ƒ~ƒŠ|. ’|ˆä˘Yi¶—jC‚‹´–¾‹`i•ª¶j: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´C –k—¢ˆãŠw, 20(2): 184, 1990.
2827. mŒ¤‹†‰ïn iˆê”Êu‰‰j Brain Natriuretic Peptide (BNP) ‚̃uƒ^S‘Ÿ‚É‚¨‚¯‚鑶ݗlŽ®.
•xŠ~˜a”üi–k—¢ƒ‰ƒ{jC’|ˆä˘Yi¶—jCìã³–çi•ª¶j: ‘æ3‰ñANPŒ¤‹†‰ï (90.02.23), ‘Š–ÍŒ´C –k—¢ˆãŠw, 20(2):
185, 1990.
<<207 ˜V‰»>>
2828. mŒ´’˜n ˜Vl‚Ìš‹‰º. ŒÃì_ŽOiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MookC12: 145`150, 1989.
2829. m‘àn ˜Vl‚Æ•›•@o‰Š. ”ª”ö˜a—YiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È MOOK, 12: 258`264, 1989.
<<208 ŠOE’†“ÅEŽ–ŒÌ>>
2830. mŒ´’˜n Injuries from Falls in Patients with Mental Disorders.
Žá—ÑL”Vi®ŠOjCV“¡³‹PC‘å˜a“c—²i‹~–½j: J. Jpn. Surg. Trauma, 3: 290`294, 1989.
2831. mŒ´’˜n Subacute Toxicity of (-)15-deoxyspergualin in BALB/c Mice.
I. Hematological Study.
‘å‹v•Û[li“àjC^è‹`•FiŽÀ“®ŒnjCˆäãŒcˆêi“àjCŒ´—ŒbŽqC•½”ü–çŽqi‘‡—Õ°ŒnjCŠ™“cvŽõi“àjCZhang, H.i•a—j: J.
Toxicol. Sci., 14: 237`245, 1989.
2832. mŒ´’˜n Subacute Toxicity of (-)15-deoxyspergualin in BALB/c Mice.
‡U. Histological Study. Zhang, H.i•a—jC
ˆäãŒcˆêi“àjC^è‹`•FiŽÀ“®ŒnjCŒ´—ŒbŽqi‘‡—Õ°ŒnjCŠ™“cvŽõC‘å‹v•Û[li“àj: J. Toxicol. Sci., 14:
247`255, 1989.
2833. mŒ´’˜n äB‘¹‚Ì•Û‘¶“IŽ¡—Âɂ¨‚¯‚éTranscatheter Arterial Embolization‚Ì–ðŠ„.
–x’rdŽ¡C‘Oì˜a•FCó—˜–õC¡ˆäPC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½j: “ú–{ŠOŒ¤‹†‰ïŽ, 3(3): 276`281, 1989.
2834. m’Z•ñn A Study of the Concentration of Mannitol for the Treatment
of Raised ICP.
“c’†¹‘ãC‹gŽR—F“ñi–òŠw•”jC‹ß“¡—¯”üŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC‘å˜a“c—²i‹~–½jC‚–ØGi‘å˜aŽs—§•a‰@j: Intracranial
Pressure, 7(1): 469`473, 1989.
2835. mÇ—á•ñn ‹—̓lƒIƒ~ƒmƒtƒ@[ƒQƒ“‚b‚É‚æ‚éƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN‚Ì1—á.
”’싳li¸jC“c•Ó‘C‘Š”nˆêˆåC–Ø“cŒõLC“¡–ìé”VC¡ˆäPC¼ŽR´ŒhC–kˆä‘¥•vC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ,
10(2): 246`248, 1989.
2836. mÇ—á•ñn ŠO«¬’°úE‚̬Ž™—á7—á‚ÌŒŸ“¢. “¡–ìé”VC‘Oì˜a•FC™–{Ÿ•FC–x’rdŽ¡C¡ˆäPC‘å˜a“c—²i‹~–½j: • •”‹~‹}f—ÂÌi•à, 9(5): 801`804, 1989.
2837. m‘àn œ”՜܌ã‚̘’É¥¿œ_Œo’É‚Ì•a‘Ô‚ÆŽ¡—Ö@. V“¡³‹Pi‹~–½jCŽ…–ž·Œ›i®ŠOj: Monthly Book, Orthopaedics, 15: 97`106, 1989.
2838. m‘àn ‹¹•”ŠO‚Æ‚»‚̑Ήž. ‘Oì˜a•Fi‹~–½j: ‹~‹}ˆãŠw, 13(10): 1511`1516, 1989.
2839. m‘àn ŠO«ŠÌ”j—ô. ‘Oì˜a•FC™–{Ÿ•Fi‹~–½j: Žèp, 43(6): 763`771, 1989.
2840. m‘àn ‘½”ŠO. ¡ˆäPC‘Oì˜a•Fi‹~–½j: f’f‚ÆŽ¡—Ã, 77(10): 2741`2745, 1989.
2841. mŠwp‘n iŽ·•Mj Œ»‘ã•a—Šw‘åŒn; ƒGƒ`ƒ‹ƒAƒ‹ƒR|ƒ‹, 10(C): 59`69, ‰œ•½‰ë•Fi•a—j. •ÒW ”Ñ“‡@ˆêi–¼‘åjCÎì‰h¢iŽœ‘åjC‰eŽRŒ\ŽOiŒc‘åjC“‡•ô“O˜YCX˜ji“Œ‘åj•ÒC ’†ŽR‘“X, “Œ‹ž, 89.09.30”s.
2842. mŠwp‘n iŽ·•Mj ‹~‹}ˆã—ÂɕK—v‚ȉ摜f’f; ˆãŒ´«‡•¹Ç|‘å“®–¬ƒoƒ‹[ƒ“ƒpƒ“ƒsƒ“ƒOAƒy[ƒXƒ[ƒJ[“d‹É, 3:
p.270`271, |ƒAƒ“ƒMƒICIntervention’†‚ÌŽ–ŒÌ, 3: p.272`273, ‘–쳈êi•új. •ÒW ™–{Š¤iã‘åj•Ò,
ƒƒWƒJƒ‹ƒrƒ…[ŽÐ,“Œ‹ž, 89.05.20 ”s.
2843. m‹³‰È‘n iŽ·•Mj }àA‹~‹}ˆãŠwuÀ:ŠO‹~‹}; ŠÌŠO, 5: 180`185; äBŠO, 5: 186`191, ‘Oì˜a•Fi‹~–½j. •ÒW ™–{iã‘åj•Ò, ƒƒWƒJƒ‹ƒrƒ…[ŽÐ, “Œ‹ž, 89.06.10”s.
2844. m‹³‰È‘n iŽ·•Mj ŠO‰ÈŠw; Šç–Ê‘¹Cp.679`683, ‰©‹àˆäN–¤iŒ`ŠOjC‘Oì˜a•Fi‹~–½j. •ÒW X¹‘¢C‹ÊŒF³‰xC¬àV˜aŒbC™’¬Œ\‘ •ÒC ‚Ö‚é‚·o”Å, “Œ‹ž, 89.04.01”s.
2845. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ‘æ81‰ñE–â‘è, Šùo–â‘è‘æ81‰ñE-1,
ŠÖ˜A–â‘è‘æ81‰ñE-1, p.200`201, ‰©‹àˆäN–¤iŒ`ŠOj. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄC, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž,
89.11.15”s.
2846. mŠw‰ïn iƒpƒlƒ‹j The Recent Advances in Chest Trauma Management.
‘Oì˜a•Fi‹~–½j: The 5th World Congress on Intensive & Critical Care
Medicine (89.09.07), ‹ž“s.
2847. mŠw‰ïn iƒpƒlƒ‹j Heart Stroke, ˆ««‚‘̉·ÇAˆ««ÇŒóŒQ‚É‚¨‚¯‚鎡—Ö@‚Ì‘I‘ð. L£—²ˆêC’ç–M•FC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.
2848. mŠw‰ïn iƒ[ƒNƒVƒ‡ƒbƒvj ŠO«ŠÌAäBAäX‘¹‚Ìf’f‚ÆŽ¡—Ã. ‘Oì˜a•Fi‹~–½j: ‘æ34‰ñ“ú–{Á‰»ŠíŠO‰ÈŠw‰ï‘‰ï (89.07.14), ‹v—¯•Ä.
2849. mŠw‰ïn iˆê”Êu‰‰j ‚“x‚Ì“î•”‘gD‘¹‚𔺂¤ŠJ•ú«œ”՜܂̌Ÿ“¢.
V“¡³‹PC‘Oì˜a•FC¡ˆäPC‘å˜a“c—²i‹~–½jC“ì‘òˆç—Yi®ŠOj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ï‘‰ï (89.10.18), L“‡, “úЈãŽ,
38(3): 113, 1990.
2850. mŠw‰ïn iˆê”Êu‰‰j ‹}«’†“ʼnŠúŽ¡—Â̖â‘è“_‚ÆV‚µ‚¢ŽŽ‚Ý.
ŽR“cr•Fi‹~–½jCŽá—Ñ–õ‹vi“àjC’ç–M•FC“c•Ó‘CL£—²ˆêC•½“cŒõ”Ži‹~–½jC‹ß“¡—¯”üŽqi–òÜ•”jC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j:
‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.
2851. mŠw‰ïn iˆê”Êu‰‰j ”ÄŒŒ‹…Œ¸ACentral Pontine Myelinolysis (CPM)
‚̇•¹‚ª‹^‚í‚ꂽƒWƒNƒƒbƒg’†“Å‚Ì1Ç—á.
–ذ•Fi®ŠOjCŽá—Ñ–õ‹vC“c•Ó‘C–kˆä‘¥•vC•½“cŒõ”Ži“àjC’†‘º‹±Žqi–òÜ•”jCŽRéˆê˜YC¼ŽR’¼‹vC‘å˜a“c—²i‹~–½j:
‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.06), “Œ‹ž.
2852. mŠw‰ïn iˆê”Êu‰‰j ŽlŽˆ“Ý“IŽå—vŒŒŠÇ‘¹‚ÌŒŸ“¢. V“¡³‹PC‘Oì˜a•FC™–{Ÿ•FC¡ˆäPC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.
2853. mŠw‰ïn iˆê”Êu‰‰j ”M‚É‚æ‚鎀–SÇ—á‚ÌŒŸ“¢.
‰FˆäŒª“ñC‰F’Öؗ´ˆêC•“cŒ[C–،Ҋ®miŒ`ŠOjC‘Oì˜a•Fi‹~–½jC‰©‹àˆäN–¤C‰–’JMKiŒ`ŠOj: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï
(89.11.07), “Œ‹žC ‹~‹}ˆãŠwCp.806, 1989.
2854. mŠw‰ïn iˆê”Êu‰‰j Œz‘‘¹‚É‚¨‚¯‚é—\Œã”»’èˆöŽq‚ÌŒŸ“¢. ŽRè‹`‹éC‚–ì½i”]ŠOjC‰““¡¹FC–kŒ´F—YC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï (90.02.17), “Œ‹ž.
2855. mŠw‰ïn iˆê”Êu‰‰j ‘½”ŠOŽ¡—Ã’†‚ÉŒoŒ±‚µ‚½Wernicke”]Ç‚Ì1—á.
•“cŒ[iŒ`ŠOjC–kŒ´F—YC–،Ҋ®mC‰FˆäŒª“ñC’ç–M•FCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‰F’Öؗ´ˆêC‘å˜a“c—²i‹~–½j: ‘æ28‰ñ“ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ï
(90.02.17), “Œ‹ž.
2856. mŒ¤‹†‰ïn iˆê”Êu‰‰j dÇ“ª•”ŠO‚𔺂¤‘½”ŠO‚ÌŠÇ—ã‚Ì–â‘è. –kŒ´F—YCó—˜–õC‚–ì—²–¾C•½“cŒõ”ŽC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.
2857. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠÌŠO‚Ì•Û‘¶“IŽ¡—Â̌ÀŠE. ¡ˆäPCó—˜–õC™–{Ÿ•FCV“¡³‹PC–x’rdŽ¡C‘•ª–ΔŽC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.
2858. mŒ¤‹†‰ïn iˆê”Êu‰‰j •Û‘¶“IŽ¡—Âðs‚Á‚½ŠO«ŠÌ“àŒŒŽî‚Ì—\Œã‚ÉŠÖ‚·‚錟“¢. ¡ˆäPCó—˜–õC™–{Ÿ•FCV“¡³‹PC–x’rdŽ¡C‘•ª–ΔŽC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.
2859. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‘½”ŠOŒã‚Ì‘½‘ŸŠí•s‘S|”Ç‚ÉŠÖ‚·‚éˆöŽq‚ÌŒŸ“¢|. ™–{Ÿ•FCó—˜–õC¼ŽR’¼‹vCV“¡³‹PC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.
2860. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¸_Ž¾Š³‚𔺂Á‚½’Ä—ŽŠO‚ÌŒŸ“¢. Žá—ÑL”Vi®ŠOjCV“¡³‹PC’ç–M•FC‘Oì˜a•FC‘å˜a“c—²i‹~–½jC‹àˆä“¿²C‘å–ìŽii®ŠOj: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y.
2861. mŒ¤‹†‰ïn iˆê”Êu‰‰j äB‘¹‚Ì•Û‘¶“IŽ¡—Âɂ¨‚¯‚éTAE‚Ì–ðŠ„.
–x’rdŽ¡C‘Oì˜a•FCó—˜–õC¡ˆäPC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.01), ŽD–y,
“ú–{ŠOŒ¤‹†‰ïŽ, 3(1): 83, 1989.
2862. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠJ•ú«œ”՜܂̌Ÿ“¢. V“¡³‹PC‘Oì˜a•FC™–{Ÿ•FC‘å˜a“c—²i‹~–½jCŽá—ÑL”VC“ì‘òˆç—Yi®ŠOj: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.02), ŽD–y.
2863. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŠOŠ³ŽÒ‚É‚¨‚¯‚éƒEƒŠƒiƒXƒ^ƒ`ƒ“‚Ì“Š—^‚̈Ӌ`. ó—˜–õC‘Oì˜a•FC¡ˆäPC™–{Ÿ•FCV“¡³‹PC‘å˜a“c—²i‹~–½j: ‘æ3‰ñ“ú–{ŠOŒ¤‹†‰ï (89.06.02), ŽD–y.
2864. mŒ¤‹†‰ïn iˆê”Êu‰‰j œÜ‚ɇ•¹‚µ‚½•Gâ|“®–¬‘¹‚ÌŒŸ“¢. V“¡³‹PC¡ˆäPC‘Oì˜a•Fi‹~–½j: ‘æ3‰ñLimb Salvage Œ¤‹†‰ï (89.07.07), ˆ®ì.
2865. mŒ¤‹†‰ïn iˆê”Êu‰‰j œÜ‚ɇ•¹‚µ‚½‰ºŽˆŽåŠ²“®–¬‘¹‚Ìf’fAŽ¡—Ãã‚Ì–â‘è“_. V“¡³‹PC‘Oì˜a•FC™–{Ÿ•FC¡ˆäPC‘å˜a“c—²i‹~–½jC‘å–ìŽiCŽá—ÑL”Vi®ŠOj: ‘æ15‰ñ“ú–{œÜŒ¤‹†‰ï (89.07.14), ‰ªŽR.
2866. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽOŽŸ‹~‹}ˆã—ÃŽ{Ý‚É‚¨‚¯‚é‹}«’†“Å‚ÌŒŸ“¢|î•ñ’ñ‹Ÿ‚Ì—§ê‚©‚ç|. ‹ß“¡—¯”üŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jCL£—²ˆêC‘å˜a“c—²i‹~–½jC¼ì—²i—Õ•a—j: ‘æ11‰ñ“ú–{’†“ÅŒ¤‹†‰ï (89.07.21), ‘åã.
2867. mŒ¤‹†‰ïn iˆê”Êu‰‰j
’YŽ_…‘fƒiƒgƒŠƒEƒ€“Š—^‚É‚æ‚èCˆêŽž“I‚ÉÇó‚ÌŒy‰õ‚ð‚Ý‚½‚ªC‚»‚ÌŒã”x…Žî‚É‚æ‚莀–S‚µ‚½Aspirin’†“Å‚Ì‚P’jŽ™—á.
דc‚Ì‚¼‚ÝiŽ™jC“¡–ìé”VCŽá—Ñ–õ‹vC¡ˆäPCV“¡³‹PC™–{Ÿ•FC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ11‰ñ“ú–{’†“ÅŒ¤‹†‰ï
(89.07.26), ‘åã, ´˜^W, p.34, 1989.
2868. mŒ¤‹†‰ïn iˆê”Êu‰‰j ¬Ž™• •”“Ý“IŠO‚̉摜f’f. ¬—Ñ–ÎŽ÷C–x’rdŽ¡C¼Šª”ŽC¼ŽR³ŒáC’J“c—ˆê˜YC‰¡ŽR‹v˜NC¼—Ñ—²i•új: “ú–{¬Ž™•úŽËüŒ¤‹†‰ï (89.09.27), –¼ŒÃ‰®, “ú–{¬Ž™•úŽËüŒ¤‹†‰ï´˜^W, p.26, 1989.
2869. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒÀŽÕ’f܉ߗʕž—p‚É‚æ‚èˆê‰ß«‚Ì“´–[ƒuƒƒbƒN‚ð‚Ý‚½–«t•s‘SA’჌ƒjƒ“’áƒAƒ‹ƒhƒXƒeƒƒ“Ç‚Ì1—á.
ŠÖŽRØ•äi“àjC¼ŽR’¼‹vC’†_Œ¹ˆêCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ4‰ñ“ú–{’†“ÅŒ¤‹†‰ï“Œ“ú–{•”‰ï (90.01.20), “Œ‹ž.
2870. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒAƒZƒ^ƒP‘®ƒNƒƒgƒ}ƒ„ƒ_ƒP’†“Å‚Ì2Ç—á. “c’†•üŽqC•½“cŒõ”ŽC’ç–M•Fi‹~–½jC‹ß“¡—¯”üŽqi–òÜ•”jCŽá—Ñ–õ‹vC‘Š”nˆêˆåC‘å˜a“c—²i‹~–½j: ‘æ4‰ñ“ú–{’†“ÅŒ¤‹†‰ï“Œ“ú–{•”‰ï (90.01.20), “Œ‹ž.
<<209 ˆê”ÊÇŒóŒQ>>
2871. mŒ´’˜n G“ŽüˆÍ”^ᇂ̗հ“IŒŸ“¢. ¼‰ª–¾—TCÝŠy“N–çC”ª”ö˜a—YCŒ´“cGˆêC”ª–؈ê‹LCˆî–ØŸ‰piŽ¨•@j: “ú–{G“Œ¤‹†‰ï‰ïŽC28: 162`168, 1989.
2872. mÇ—á•ñn GVHD‚Ì1—á. ŽR–{Œ›ˆêi®ŠOjC™–{Ÿ•FCL£—²ˆêC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: “ú–{‹~‹}ˆãŠw‰ïŠÖ“Œ’n•û‰ïŽ, 10(1): 286`287, 1989.
2873. m‹³‰È‘n iŽ·•Mj ŠO‰ÈŠw; ‹}«• Ç, p.590`598, ”äŠé”\Ž÷C’Ë–{GliŠOj. •ÒW X¹‘¢i“Œ–k‘åjC‘¼•Ò, ‚Ö‚é‚·o”Å, “Œ‹ž, 89.04.01”s.
2874. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈMook, No.12.˜V”NŽÒ‚ÆŽ¨•@ˆôA‰È;
˜Vl‚Ì‘O’ë‹@”\C‹@”\ŒŸ¸¬ÑC”N—î‚Ƴí’lCp.56`64C “¿‘Œú“ñiŽ¨•@j. •ÒW
–쑺‹±–çi“Œ‘åjC–{¯Œµi‹ž‘åjCÝŠy“N–çi–k—¢‘åj•ÒC ‹àŒ´o”Å, “Œ‹ž, 89.04.01”s.
2875. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ˜V”N•af—à Questions & Answers ‘æ11†;
“®—h•aiæ‚蕨Œ‚¢jC11: 1557‚Ì6`1557‚Ì7, “¿‘Œú“ñiŽ¨•@j. •ÒW ‰i–ìˆòC‘¼•ÒC ˜Z–@o”Å, –¼ŒÃ‰®,
89.04.00”s.
2876. mŠw‰ïn iˆê”Êu‰‰j Pseudoflutter-Like Oscillation. “¿‘Œú“ñC‹g”ö’miŽ¨•@j: ‡W. Symposium fur Neuro-Otologie. (89.10.27), Berlin.
2877. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ŠJ‹Æˆã‚É•K—v‚ÈŽ¨•@ˆôA‰ÈŠw‚Ì’mŽ¯|‚—ŽÐ‰ï‚ðŒ}‚¦‚Ä. “¿‘Œú“ñiŽ¨•@j: ‘æ218‰ñ‘å˜a—Õ°ˆãŠw’k˜b‰ïŒ¤C‰ï (89.05.24), ‘å˜a, 1989.
2878. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‚ß‚Ü‚¢Ž¾Š³‚Ìf’f‚Ì‚¨‚Æ‚µ‚ ‚È. “¿‘Œú“ñiŽ¨•@j: ‘æ33‰ñ‘Š•Ž¨ƒr‰ÈŒ¤‹†‰ï (89.07.15), ‘Š–ÍŒ´.
2879. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŽY‰È“IDIC‚ÆŠO‰È“IDIC. ¡ˆäPC‘Oì˜a•Fi‹~–½j: ‘æ4‰ñ‹~–½‹~‹}ˆã—ÃŒ¤‹†‰ï (89.10.21), “Œ‹ž.
<<210 ˆê”ÊŽ¡—Êw‹y‚Ñ–òŒøi–ƒŒ‚ðŠÜ‚Þj>>
2880. mŒ´’˜n Chronopharmacokinetic Study of Valproic Acid in Man;
Comparison of Oral and Rectal Administration. ‹gŽR—F“ñi–òŠw•”jC’†–ìdsC¬ì’¨–çiˆ¤•Q‘åj:
J. Clin. Pharmacol., 29(11): 1048`1052, 1989.
2881. mŒ´’˜n Œ`ó‹L‰¯‡‹à‚Ì•â‘•‹ï‚ւ̉ž—p. ‘O“c^Ž¡i“àj: ‹à‘®, p.22`26, 1990.
2882. mŒ´’˜n –³’É•ª•Ø‚ÌŒ»ó. ¼“‡³”ŽCVˆä³•viŽY•wj: ŽY•wl‰ÈŽ¡—Ã, 58(6): 637`641, 1989.
2883. mŒ´’˜n ‘O’ê_Œo‰Š|f’f‚Ì—v“_‚Æ•—]ƒEƒBƒ‹ƒXŠ´õ‚Æ‚ÌŠÖ˜A«‚ɂ‚¢‚Ä|.
“¡–ì–¾lC“¿‘Œú“ñC‰ª–{–qlC’|“à‹`•vC”ª–؈ê‹LCŒÜ“‡ˆê‹gC‰®‹XWCŒ´“cGˆêCŒÃ‘òTˆêiŽ¨•@jCˆÉ•Û´ŽqCó–ì˜a]C‰LŽ”~ŽqC—é–Ø~ŽqC‚‹{t’j
i—ÕŒŸj: Ž¨•@ˆôA‰ÈE“ªŒz•”ŠO‰ÈC61(3): 173`179, 1989.
2884. mŒ´’˜n ‚ß‚Ü‚¢•½táŠQ‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: Ž¨•@ˆôA‰ÈE“ªŒz•”ŠO‰ÈC61(4): 257`264, 1989.
2885. mŒ´’˜n ‘åŠw•a‰@‚É‚¨‚¯‚é”D•wŒŸf‚̃‹ƒ`ƒ“ŒŸ¸. “‡“cMGiŽY•wj: ŽüŽYŠúˆãŠw, 20(1): 25`29, 1990.
2886. mŒ´’˜n ƒoƒ‹ƒvƒŽ_ƒiƒgƒŠƒEƒ€¿Ü‚Ì–òÜŠw“IŒ¤‹†. ’†‘º‹±Žqi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”j: •a‰@–òŠwC15(3): 175`180, 1989.
2887. mŒ´’˜n dÇ”DP’†“ÅÇ‚É‚¨‚¯‚é’鉤؊J–ƒŒ–@‚ÌŒŸ“¢. ’Jº”ŽC–ì“c–FlC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGCVˆä³•viŽY•wjC’|’†’qºC“c’†—ºi–ƒj: •ª•Ø‚Æ–ƒŒ, (65°66): 25`32, 1989.
2888. mŒ´’˜n Methotrexate“îp‚̈À’è«‚¨‚æ‚у‰ƒbƒg‚É‚¨‚¯‚éŒo”ç‹zŽû. Ύ˳‰pC”ö’¹Ÿ–çi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC•½ŽR•ŽiC’©’·•¶–íi–òÜjC¼ŽR–Εvi”çj: –k—¢ˆãŠwC19(6): 604`611, 1989.
2889. m’Z•ñn Phase 1 StudyŽÀŽ{ã‚Ì”–â‘è. ŽÄ“c‹v—Yi“àj: ƒtƒ@ƒ‹ƒ}ƒVƒA, 24: 28`29, 1988.
2890. mŒ¤‹†•ñi•¶•”Èjn Ž¨«‚ß‚Ü‚¢‚ɑ΂·‚锽•œ“àŽ¨ŽhŒƒŽ¡—ÃŒø‰Ê‚ÌŠî‘b“IŒ¤‹†. “¿‘Œú“ñiŽ¨•@j: º˜a63”N“x‰ÈŠwŒ¤‹†”ï•â•‹àiˆê”ÊŒ¤‹†‚bjŒ¤‹†•ñ‘Cp.1`24, 1989.
2891. mŒ¤‹†•ñiŒú¶Èjn –ò•¨“®‘ÔŽŽŒ±ƒKƒCƒhƒ‰ƒCƒ“iˆÄj. ˆ¾’Ñ‘Žii“Œ‹ž–ò‰È‘åjCŽO‰YŽõ’jiŽ™jC‘¼: –ò•¨“®‘ÔŽŽŒ±i‹zŽû¥•ª•z¥‘ãŽÓ¥”rŸ•j‚ÉŠÖ‚·‚éƒKƒCƒhƒ‰ƒCƒ“Œ¤‹†”Ç•ñ‘C1989.
2892. mÇ—á•ñn ‡U“x”M‘n‚ɑ΂·‚郊ƒ]ƒ`[ƒ€“îp‚Ì—Õ°Œø‰Ê.
ìãd•FC’Ë“c’å•vi‹à‘òˆã‘åjC“ï”g—YÆC–ì“cD‹éi’·è‘åjC‰¬–ì—mˆêCŒF’JŒ›•vi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åjC‰–’JMKC‰FˆäŒª“ñiŒ`ŠOjCˆäãW•¶CXŒû
—²•Fiìèˆã‘åj: “ú–{”MŠw‰ï‰ïŽ, 15(2): 109`117, 1989.
2893. m—Õ°Ž¡Œ±n ƒoƒNƒXƒ^[ƒCƒ“ƒtƒ…[ƒU[‚É‚æ‚é5Fu‚¨‚æ‚уŒƒyƒ^ƒ“‚ÌŽ‘±“Š—^. ‘å’J„³C”äŠé”\Ž÷iŠOjC“‡“cŽœ•Fi–òÜ•”j: Jpn. J. Parenter. Enter. Nutr., 11(4): 425`432, 1989.
2894. m—Õ°Ž¡Œ±n ”M‘n‚ɑ΂·‚郊ƒ]ƒ`[ƒ€“îp‚Ì—Õ°Œø‰Ê.
ìãd•FC’Ë“c’å•vi‹à‘òˆã‘åjC“ï”g—YÆC–ì“cD‹éi’·è‘åjC‰¬–ì—mˆêCŒF’JŒ›•vi¹ƒ}ƒŠƒAƒ“ƒiˆã‘åjC‰–’JMKC‰FˆäŒª“ñiŒ`ŠOjCXŒû—²•Fiìè
ˆã‘åj: ÅVˆãŠw, 44: 1962`1964, 1989.
2895. m—Õ°Ž¡Œ±n ƒ‹[ƒvƒXt‰Š‚ɑ΂·‚éƒ~ƒ]ƒŠƒrƒ“‚Ì—Õ°•]‰¿(1)|ƒvƒ‰ƒZƒ{‚ð‘ÎÆ‚Æ‚µ‚½‘½Ž{Ý’P–ÓŒŸ”äŠrŽŽŒ±|. –{ŠÔŒõ•vCHŒŽ³•vC‰¡’£—´ˆêC‹´–{”ŽŽjC”è’õ•vC‹ß“¡Œ[•¶i“àjC“üŒðºˆê˜Y: —Õ°ˆã–ò, 5: 795`824, 1989.
2896. m—Õ°Ž¡Œ±n ƒ‹[ƒvƒXt‰Š‚ɑ΂·‚éƒ~ƒ]ƒŠƒrƒ“‚Ì—Õ°•]‰¿(2)|’P–ÓŒŸ”äŠrŽŽŒ±‚©‚ç‚ÌŒp‘±“Š—^|. –{ŠÔŒõ•vC‹ß“¡Œ[•¶i“àjCHŒŽ³•vC‰¡’£—´ˆêC‹´–{”ŽŽjC”è’õ•vi“àjC“üŒðºˆê˜Y: —Õ°ˆã–ò, 5: 825`835, 1989.
2897. m—Õ°Ž¡Œ±n Second Interium Report of the Nation-Wide Collaborative
Study on the Long-term Effects of Bromocriptine in the Treatment of
Parkinsonian Patients. Nakanishi, T.i’}”g‘åjCIwata, M.i“Œ‘åjCGoto,
I.i‹ã‘åjCKanazawa, I.i’}”g‘åjCŒÃ˜a‹vKi“àjCMannen, T.i“Œ‘åjCMizuno,
Y.i‡“V“°‘åjCNishitani, H.: —Õ°ˆã–ò, 5: 825`835, 1989.
2898. m‘àn —Õ°HŠw‹ZŽm‚Ì‹Æ–±”͈͂Ǝ󂯓ü‚ê. “n•Ó•qi–ƒj: Clinical Engineering, 1(1): 44`48, 1990.
2899. m‘àn lHŒÄ‹zŠí‚ÌW’†ŠÇ—‚Æ•ÛŽç“_ŒŸ. L£–«C“íé¢iMEƒZƒ“ƒ^[j: Clinical Engineering, 1(1): 57`61, 1990.
2900. m‘àn lHŒÄ‹z—Ö@‚͂ǂ̂悤‚È󋵂ŕK—v‚©. “n•Ó•qi–ƒj: Clinical Engineering, 1(2): 94`98, 1990.
2901. m‘àn ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‘ãŽÓ‚ÌŠî‘b’mŽ¯‚Æ—Õ°ŒŸ¸‚ւ̉ž—p. ŽŽæMi–ò—j: Laboratory and Clinical Practice, 7(2): 29`40, 1989.
2902. m‘àn Œü¸_–ò‚Ì—LŒø‚ÈŽg‚¢•û‚Æ‚»‚ÌŒoÏ«|‚Æ‚‚ÉR•sˆÀ–ò‚ɂ‚¢‚Ä|. ŽO‰Y’å‘¥i¸j: Prog. Med., 10(2): 269`274, 1990.
2903. m‘àn ŽèpŽº‚É‚¨‚¯‚éЊQ‘Îô‡AŽèpŽº‚É‚¨‚¯‚éÝ”õ¥‹@Ší‚̈À‘S‘Îô. “n•Ó•qi–ƒj: ƒIƒyƒi[ƒVƒ“ƒO, 4(8): 17`22, 1989.
2904. m‘àn ‚¨‚Ú‚¦‚Ä‚¨‚±‚¤IME‹@Ší(1). “n•Ó•qi–ƒjC”Ñ“‡Œõ—YC’r“cŒõŠìCˆî–Ñ”ŽC‘åL˜a–¾C²“¡³Œ›C–쑺’q”VC–{‘½—²C¬—ÑŠ]C”’ˆä“ÖŽjiMEƒZƒ“ƒ^[j: ƒNƒŠƒjƒJƒ‹ƒXƒ^ƒfƒB, 10(11“Á): 1`16, 1989.
2905. m‘àn ‚¨‚Ú‚¦‚Ä‚¨‚±‚¤IME‹@Ší(2). “n•Ó•qi–ƒjC’r“cŒõŠìC“íé¢C¼ì‰·C–쑺’q”VCL£–«C‰Z¶Lˆê C–kŒ´Œ[iMEƒZƒ“ƒ^[j: ƒNƒŠƒjƒJƒ‹ƒXƒ^ƒfƒB, 10(12)“Á•Ê•t˜^: 1`16, 1989.
2906. m‘àn ME ‹@Ší‚Ì’†‰›ŠÇ—. “n•Ó•qi–ƒj: ˆã‰ÈŠíŠBŠw, 60(3): 116`120, 1990.
2907. m‘àn ‡–°–ò‚Ì—Õ°•]‰¿ƒKƒCƒhƒ‰ƒCƒ“‚ɂ‚¢‚Ä. ŽO‰Y’å‘¥i¸j: ˆã–ò•iŒ¤‹†, 21(1): 1`5, 1990.
2908. m‘àn ‚à‚Á‚Æ’m‚肽‚¢ME‹@Ší (3)lHŒÄ‹zŠí Part l €”õ‚©‚ç‘•’…‚Ü‚Å. ‰Z¶LˆêCŽR“c’JߎqC–ìŒû‰À‘ãŽqC“n•Ó•qi–ƒj: ŒŽŠ§ƒi|ƒVƒ“ƒO, 9(8): 894`899, 1989.
2909. m‘àn ‚à‚Á‚Æ’m‚肽‚¢ME‹@Ší‡ClHŒÄ‹zŠí Part 2 ‘•’…’†‚ÌŠÇ—‚ƃPƒA. ‰Z¶LˆêCŽR“c’JߎqC–ìŒû‰À‘ãŽqC“n•Ó•qi–ƒj: ŒŽŠ§ƒi|ƒVƒ“ƒO, 9(9): 1032`1037, 1989.
2910. m‘àn ŒŸ¸ƒtƒ@ƒCƒ‹ Œõ“dŽ®–¬”gŒŸ¸. “•ûLˆêi—ÕŒŸjC“n•Ó•qi–ƒj: ŒŸ¸‚Æ‹Zp, 17(13): 1624`1625, 1989.
2911. m‘àn Ý‘îlHŒÄ‹z—Ö@. “n•Ó•qi–ƒj: Œ»‘ãˆã—Ã, 22(3): 807`814, 1990.
2912. m‘àn —Õ°HŠw‹ZŽm|‚»‚Ì‹Æ–±‚Æ¡Œã‚ÌŠú‘Ò|. “n•Ó•qi–ƒj: _“ÞìˆãŠw‰ïŽGŽ, 17(1): 14`19, 1990.
2913. m‘àn ”DP’†“ÅÇ|ƒˆŒ^|. “‡“cMGiŽY•wj: t‚Æ“§Í, 1989”N—ÕŽž‘Š§†utŽ¾Š³‚Ì–ò•¨—Ö@v: 195`196, 1989.
2914. m‘àn ˆã—ÃŽ{Ý‚É‚¨‚¯‚é—Õ°HŠw•”–å‚Ìd—v«. “n•Ó•qi–ƒj: ‘ÌŠOzŠÂ‹Zp, 15(2): 14`19, 1989.
2915. m‘àn ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“|‚»‚̶‘Ì“à‚É‚¨‚¯‚éˆÊ’u‚¯‚Æ‘S‘Ì‘œ. ŽŽæMi–ò—j: “ú–{–ò—ŠwŽGŽ, 94: 159`171, 1989.
2916. m‘àn Ö°’ÁÃÜAR‚Ä‚ñ‚©‚ñÜ. ŽO‰Y’å‘¥i¸jC’|“எqi–òÜ•”j: —Õ°‚Æ–ò•¨Ž¡—Ãi‘Š§†j, 8(7): 782`789, 1989.
2917. muÀn ‚ß‚Ü‚¢‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. “¿‘Œú“ñiŽ¨•@j: ƒJƒŒƒ“ƒgƒeƒ‰ƒs|, 7(12): 80`84, 1989.
2918. muÀn “ÁW;Ž¨•@ˆôA¥“ªŒz•”—̈æ‚Ì’É‚Ý|‚»‚Ì‹@˜‚Æ—Õ°|’É‚Ý‚ÆŠO—ˆˆ’u. ”ª”ö˜a—YCÝŠy“N–çiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰È, 61(10): 953`955, 1989.
2919. muÀn ’鉤؊J. “‡“cMGC‹gŒ´ˆêiŽY•wj: ŽüŽYŠúˆãŠw, 20(3): 415`418, 1990.
2920. mÀ’k‰ïn "R’s•ð–ò"‚ÌŒ»ó‚Æ«—ˆ‚ð’T‚é. ‘å—F‰pˆêi—•—‰€jCr–،ܘYi“ŒŠC‘åjCŽO‰Y’å‘¥i¸jC´…MiŽœŒbˆã‘åj: Clinical Neuroscience, 7(11): 1226`1239, 1989.
2921. mŠwp‘n iŽ·•Mj •ÛŽçŠÇ—‚ƈÀ‘S‘Îô; –ƒŒ¥W’†Ž¡—Âƃ‚ƒjƒ^ƒŠƒ“ƒO, p.473`483, “n•Ó•qi–ƒj. •ÒW ‰œHîC’r“c˜a”VC–L‰ªGŒPC•ÒC Ž½“°o”Å,@“Œ‹žC89.10.11”s.
2922. mŠwp‘n iŽ·•Mj ˆã—×p‹@Ší‚ÌŒ´—‚ÆŽÀÛ; B.‘ª’è—p‚l‚d‹@Ší, C.Ž¡—×p‚l‚d‹@Ší, Œn“ŠÅŒìŠwuÀ ê–å3, Šî‘bŠÅŒìŠw 3. p.251`266, “n•Ó•qi–ƒj. ˆãŠw‘‰@, “Œ‹ž, 90.01.06”s.
2923. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; tˆÚAŠ³ŽÒ‚̃PƒA, 32: 805`806, ‰““¡’‰—Yi”åj. •ÒW ˆîŠ_‹`–¾iç—t‘åj‘¼•Ò, ŠÄC “ú–쌴d–¾i¹˜H‰Á‘Û•a‰@j‘¼ŠÄC, ˆãŠw‘‰@, “Œ‹žC90.02.15”s.
2924. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ¡“ú‚ÌŽ¡—ÃŽwj; “à‰ÈŽ¾Š³‚É‚æ‚é¸_áŠQ, p.261`262, ŽO‰Y’å‘¥i¸j. •ÒW ˆîŠ_‹`–¾iç—t‘åjC‘½‰ê{K’jiŠÖ“Œ’üM•a‰@jC”öŒ`‰x˜Yi“Œ‘åj•ÒC ˆãŠw‘‰@, “Œ‹ž, 90.02.15”s.
2925. mŽ‹’®Šo‹³Þn i•ÒWj TURP‚̃Rƒc‚ƃCƒ[ƒW(video tape), ‰¡ŽR‰p“ñC“à“c–LºC“¡–ì’WlC¬ŽÄŒ’i”åj. •ÒW ‰¡ŽR‰p“ñ •Ò, ŠÄC ¬ŽÄŒ’ŠÄCC 89.09.00”s.
2926. mŽ‹’®Šo‹³Þn iŠÄCj ‚ß‚Ü‚¢‚̉^“®—Ö@. ŠÄC “¡–ì–¾liŽ¨•@jŠÄCC EisaiŠwpƒrƒfƒI, 90.03.00”s.
2927. mŠw‰ïn i“Á•Êu‰‰j ˆã—Ë@Ší‚Ì•ÛŽçŠÇ—‚ɂ‚¢‚Ä|–k—¢‘åŠw•a‰@‚Å‚ÌŽÀ—á|. “n•Ó•qi–ƒj: ˆã—Ë@Ší§˜b‰ïià’c–@l ˆã—Ë@ŠíƒZƒ“ƒ^|j (89.09.25), “Œ‹ž.
2928. mŠw‰ïn i‹³ˆçu‰‰j áu’ÉŽ¡—Âɂ¨‚¯‚éŋ߂̘b‘è. “n•Ó•qi–ƒj: ‘æ27‰ñ–k—¢‘åŠwˆãŠw•”®Œ`ŠO‰ÈŒŽ—áƒJƒ“ƒtƒ@ƒŒƒ“ƒX (90.02.19), ‘Š–ÍŒ´.
2929. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‹Æ–±”͈͂Ƃ»‚Ì–â‘è“_. “n•Ó•qi–ƒj: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï–é‚Ì’k˜b‰ïu—Õ°HŠw‹ZŽm‚Ì”–â‘èv. (89.05.23.), ‘åã.
2930. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –k—¢‘åŠw“Œ•a‰@‘‡‘Š’k•”–K–âˆã—ÃVƒXƒeƒ€‚ɂ‚¢‚Ä.
Ä“¡–L˜ai“àjC‰““¡MŽqC–x‰z—R‹IŽqC‚“ˆ‰Á‘ãŽqCŽR–{ŒPŽqC“c‹{^ŽqiŠÅŒì•”jC’·‘òOC‰Z¶LˆêiMEƒZƒ“ƒ^[jC•ŸŽR‰Ã|i¸jC–ìŒû‹…Žqi‰h—{
‰ÈjCΎ˳‰pi–òÜ•”jC‰Á“¡ºiˆã—ÉÈjCדc–«C‘O“c^Ž¡CŒÃ˜a‹vKi“àj: ‘æ12‰ñƒvƒ‰ƒCƒ}ƒŠ|¥ƒPƒAŠw‰ïuÝ‘îƒPƒAv.
(89.06.00), ƒvƒ‰ƒCƒ}ƒŠ|¥ƒPƒA, 12: 405`410, 1989.
2931. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —Õ°ŽÀK•a‰@‚ÌŽó“ü‘̧‹Æ–±. “n•Ó•qi–ƒj: ‘æ4‰ñ“ú–{MEŠw‰ïH‹G‘å‰ïu—Õ°HŠw‹ZŽm‚Ì—{¬‚ð‚ß‚®‚‚Äv. (89.10.17), ŽD–y, ˆã—p“dŽq‚ƶ‘ÌHŠw, 27(Suppl. 2): 24, 1989.
2932. mŠw‰ïn iƒpƒlƒ‹j Ý‘îŒÄ‹z—Ö@‚ÌŒ»ó‚Æ«—ˆ. “n•Ó•qi–ƒj: ‘æ5‰ñƒGƒ‹¥ƒGƒX¥ƒeƒBŠw‰ï‘å‰ïu¶–½ˆÛŽŠÇ—‘•’uv. (89.11.25), “Œ‹ž.
2933. mŠw‰ïn iˆê”Êu‰‰j Study of cardiac arrest associated with spinal
anesthesia. ŒÜ\”¨mC“c’†—ºi–ƒj: ‘æ9‰ñ¢ŠE–ƒŒŠw‰ï (88.05.22`28), Washington D.C.,
U.S.A.
2934. mŠw‰ïn iˆê”Êu‰‰j Study on mechanical pressure produced by caryngscopy.
“c’†—ºC‰¤“VŒ³i–ƒjC‹´–{¬Li¶‘ÌHj: ‘æ9‰ñ¢ŠE–ƒŒŠw‰ï (88.05.22`28), Washington D.C., U.S.A.
2935. mŠw‰ïn iˆê”Êu‰‰j ŠeŽíR¶Ü‚Ì’`”’Œ‹‡—¦‚ÌŒŸ“¢i‘æ1•ñj|Œ’íl‚¨‚æ‚ÑtáŠQŠ³ŽÒ‚É‚¨‚¯‚éƒZƒtƒ@ƒƒ`ƒ“‚Ì’`”’Œ‹‡—¦|.
–{‹´–ÎC•ŽRˆêC‹´–{²ŽqC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jCŒF–ì˜a•vi”åj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05),
–¼ŒÃ‰®C u‰‰—vŽ|W11Cp.30, 1989.
2936. mŠw‰ïn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_‚ÌŽžŠÔ–ò•¨“®‘ÔŠw“IŒ¤‹†:ƒ}ƒEƒX‚É‚¨‚¯‚éŒoŒû‹y‚Ñ’¼’°“à“Š—^Žž‚Ì”äŠrŒŸ“¢.
‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC’†–ìdsC¬ì’¨–çiˆ¤•Q‘åj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®C
u‰‰—vŽ|W11Cp.42, 1989.
2937. mŠw‰ïn iˆê”Êu‰‰j ¬Ž™–«t•s‘SŠ³ŽÒ‚ÌtˆÚAp‚Ì–ƒŒŠÇ—.
‘ºã‰ëŽqC–쌩ŽRECŒÜ–¡—ŒbC÷–{çŒbŽqC”’ˆä³rC‰ª“c¹•½C“n•Ó•qC“c’†—ºi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï (89.04.13), ŽRŒû,
–ƒŒ, 38(9,Suppl.): S223, 1989.
2938. mŠw‰ïn iˆê”Êu‰‰j ˆã—ÃKƒX‚̈À‘S|ˆã—ÃKƒXˆÀ‘S¥ŠÇ—ˆÏˆõ‰ï‚ÌÝ—§‚Æ‚»‚Ì–â‘è“_. “n•Ó•qi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï¤ (89.04.14), ŽRŒû, –ƒŒ, 38(9,Suppl.): S.393, 1989.
2939. mŠw‰ïn iˆê”Êu‰‰j Žw’蔌¾|’ጌˆ³–ƒŒ‚Í—L—p‚©. “n•Ó•qi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï (89.04.15), ŽRŒû.
2940. mŠw‰ïn iˆê”Êu‰‰j Pharmacokinetics of Amphotericin B|Analysis of Its
Elimination Process|.
‘º£¨’ÃŽqC–]ŒŽ^‹|C•ŽRˆêC–ؘHŒbi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC‹v•ÄŒõi•a—j: Pan Pacific ‡X
(89.05.07`11), ƒ\ƒEƒ‹C Abstract, p.324, 1989.
2941. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ€ƒzƒeƒŠƒVƒ“B‚Ì‘Ì“à“®‘Ô|Žå‚É”rŸ•‚ɂ‚¢‚Ä|.
–ؘHŒbC‘º£¨’ÃŽqC•ŽRˆêC–]ŒŽ^‹|C’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC‹v•ÄŒõi•a—j:
‘æ4‰ñ–ò•¨ƒ‚ƒjƒ^ƒŠƒ“ƒO‘S‘Œð—¬‰ïC‘æ6‰ñ“ú–{TDMŠwpW‰ï (89.05.12`13), “Œ‹žC TDMŒ¤‹†, 6(1): 33`37,
1989.
2942. mŠw‰ïn iˆê”Êu‰‰j Chronopharmacokinetic Study of Valproic Acid in Man:
Comparison of Oral and Rectal Administration.
‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC’†–ìdsC¬ì’¨–çiˆ¤•Q‘åj: ‡W World Conference on Clinical
Pharmacology & Therapeutics (89.07.25), ¼ƒhƒCƒc, Eur. J. Clin.
Pharmacol., 36(Suppl.): A178, 1989.
2943. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ€ƒzƒeƒŠƒVƒ“B‚Ì‘å—Ê“à•ž‚É‚¨‚¯‚é‘Ì“à“®‘Ô.
‘º£¨’ÃŽqC–]ŒŽ^‹|C•ŽRˆêC–ؘHŒbC’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñi–òŠw•”jC‹v•ÄŒõC‰œ•½‰ë•Fi•a—j: ‘æ33‰ñ“ú–{ˆã^‹ÛŠw‰ï‘‰ï
(89.09.22`23), ‰«“êC ´˜^W, p.130, 1989.
2944. mŠw‰ïn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_–ò•¨“®‘Ô‚É‹y‚Ú‚·“Š—^‚̃^ƒCƒ~ƒ“ƒO:ŒoŒû‹y‚Ñ’¼’°“à“Š—^‚É‚¨‚¯‚éHŽ–ðŒ‚̉e‹¿.
‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC”ª‘ãŒö•viŽ™j: “ú–{–òÜŠw‰ï‘æ5”N‰ï (89.09.28), “Œ‹žC u‰‰—vŽ|W,
p.138`139, 1989.
2945. mŠw‰ïn iˆê”Êu‰‰j ‚—îŽÒ‚É‚¨‚¯‚éTriazolam˜A—pŽž‚ÌŒŒ’†”Z“x‚ÉŠÖ‚·‚錤‹†. Ž›“c‹vŽqi“Œ‹ž•‘ –ì•a‰@jC_’ëdMiŒc‘åjC¼ì—²i—Õ•a—j: ‘‡•a‰@¸_ˆãŠw‰ï (89.10.00).
2946. mŠw‰ïn iˆê”Êu‰‰j TURP‚̃Rƒc‚ƃCƒ[ƒW. ‰¡ŽR‰p“ñC“à“c–LºC“¡–ì’WlC¬ŽÄŒ’i”åj: ‘æ54‰ñ“ú–{”å”AŠí‰ÈŠw‰ï“Œ•”‘‰ï (89.10.06), “Œ‹ž.
2947. mŠw‰ïn iˆê”Êu‰‰j ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ò•¨‚̃‰ƒWƒIƒŠƒZƒvƒ^|ƒAƒbƒZƒC:¸_‰È‚¨‚æ‚Ñ‹~‹}ƒZƒ“ƒ^|Š³ŽÒ‚ւ̉ž—p.
¼ì—²C‘å’J‰pŽ÷i—Õ•a—jCìŒû‹Bi¸jC‹ß“¡—¯”üŽqi–òÜ•”j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.06), ‹ž“sC —Õ°•a—,
37(•â): 193, 1989.
2948. mŠw‰ïn iˆê”Êu‰‰j ŠàI––Šúáu’ÉŠÇ—‚É‚¨‚¯‚é intrapleural block ‚ÌŒoŒ±. “ü‘qOŽqC–쌩ŽREC’|’†’qºC“I–씎C“n•Ó•qC“c’†—ºi–ƒj: ‘æ29‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (89.10.07), “Œ‹ž.
2949. mŠw‰ïn iˆê”Êu‰‰j Gentamicint“Å«‚É‹y‚Ú‚·“Š—^Žž‚̉e‹¿.
‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’†–ìdsiˆ¤•Q‘åj: ‘æ81‰ñ“ú–{–ò—Šw‰ïŠÖ“Œ•”‰ï (89.10.14), “Œ‹žC
“ú–{–ò—Šw‰ïŽ, 94(6): 106, 1989.
2950. mŠw‰ïn iˆê”Êu‰‰j PGE1‚ð—p‚¢‚½dÇ”DP’†“ÅÇ‚Ì’éØ–ƒŒŠÇ—.
—§‰ª˜aOCA–ìM…C¯“c—²C–ì“c–FlC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wjC–쌩ŽREC“c’†—ºi–ƒj:
‘æ78‰ñ“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‘‰ï (89.10.29), ‘å‹{.
2951. mŠw‰ïn iˆê”Êu‰‰j Intra-pleural block‚É‚æ‚éáu’ÉŠÇ—‚ÌŒ¤‹†.
“ü‘qOŽqC“I–씎C–쌩ŽREC“n•Ó•qC“c’†—ºCŒÜ\”¨mi–ƒj: ‘æ9‰ñ“ú–{—Õ°–ƒŒŠw‰ï‘‰ï (89.11.02) “Œ‹žC “ú–{—Õ°–ƒŒŠw‰ïŽ,
9(6): 157, 1989.
2952. mŠw‰ïn iˆê”Êu‰‰j •a‰@“d‹CÝ”õ‚̈À‘S«‚ð‚ß‚´‚µ‚Ä. “n•Ó•qi–ƒjC•y“c³”üC–kŒ©‰À–[i•a‰@j: ‘æ18‰ñ“ú–{“d‹CÝ”õŠw‰ï (89.11.09) “Œ‹žC •a‰@Ý”õ, 32(2): 171`172, 1990.
2953. mŠw‰ïn iˆê”Êu‰‰j R¶•¨Ž¿•¹—p—Ö@‚ÌŽžŠÔ–ò—Šw“IŒ¤‹†. ‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’†–ìdsiˆ¤•Q‘åj: ‘æ33‰ñ“ú–{–òŠw‰ïŠÖ“ŒŽx•”‘å‰ï (89.11.11), “Œ‹žC u‰‰—vŽ|W, p.55, 1989.
2954. mŠw‰ïn iˆê”Êu‰‰j ƒoƒ‹ƒvƒŽ_‚ÌŽžŠÔ–ò•¨“®‘ÔŠw“IŒ¤‹†;ƒ}ƒEƒX‹y‚уqƒg‚É‚¨‚¯‚éŒoŒû‹y‚Ñ’¼’°“à“Š—^‚Ì”äŠrŒŸ“¢.
‹gŽR—F“ñi–òŠw•”jC’©’·•¶–íi–òÜ•”jC’†–ìdsC‘åŒË–ÎOC¬ì’¨–çiˆ¤•Q‘åj: ‘æ10‰ñ“ú–{—Õ°–ò—Šw‰ï (89.11.15), “Œ‹žC
—Õ°–ò—, 21(1): 69`70, 1990.
2955. mŠw‰ïn iˆê”Êu‰‰j ŠÅŒì‚É‚¨‚¯‚éVASŽg—p‚É‚æ‚é’É‚Ý‚Ì•]‰¿. ‰ªèŽõ”üŽqC–x—ÇŽqiŠÅŒìŠw•”jC“n•Ó•qi–ƒjC¬“‡‹±ŽqCŒÃ¯•y”üŽqiŠÅŒìŠw•”j: ‘æ11‰ñ“ú–{áu’ÉŠw‰ï (89.12.02), ‘åã.
2956. mŠw‰ïn iˆê”Êu‰‰j ãŠ{ŠàŽ¡—Âɂ¨‚¯‚é•úŽËüƎ˂̈Ӌ`. ‚‹´œAbiŽ¨•@jC¼—Ñ—²i•új: “ú–{•úŽËüŽîᇊw‰ï (90.01.14), “Œ‹ž, “ú–{•úŽËüŽîᇊw‰ïŽJastro—\eWC1989.
2957. mŠw‰ïn iˆê”Êu‰‰j ‹}«ˆê‘¤«‘O’ëáŠQ‚̉^“®—Ö@.
VˆäŠî—mC’·À‰p–¾C’†ŽR–¾mC–ìŒû_’jCV“cŒ’‘¾˜YC¯–ìŒ÷C“¡–ì–¾lC‹g”ö’mC“¿‘Œú“ñiŽ¨•@j:
“ú–{Ž¨•@ˆôA‰ÈŠw‰ï_“Þ쌧’n•û•”‰ï‘æ71‰ñŽ¨•@ˆôA‰È“ªŒz•”ŠO‰ÈŠwpu‰‰‰ï (90.03.03), “¡‘ò.
2958. mŠw‰ïn iˆê”Êu‰‰j Ý‘î—×{‚Ì‚½‚ß‚Ì‹CŠÇ‹zˆøƒJƒe|ƒeƒ‹|ŠÈˆÕÁ“Å¥•Û‘¶—eŠí‚ÌŽŽì‚Æ‚»‚̉ž—p|.
דc–«i“àjC‰Z¶LˆêiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: ‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï (90.05.28), ‘åã, ˆã‰ÈŠíŠBŠw,
59(Suppl.): 59`60, 1990.
2959. mŠw‰ïn iˆê”Êu‰‰j ME‹@Šíƒgƒ‰ƒuƒ‹ƒ}ƒjƒ…ƒAƒ‹‚̃pƒ\ƒRƒ“—˜—p.
”’ˆä“ÖŽjC¬—ÑŠ]Cˆ¾–ìŠwC‰Z¶LˆêiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjCˆî–Ñ”ŽC’r“cŒõŠìCL£–«Crˆä•¶•viMEƒZƒ“ƒ^[j:
‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï (90.05.28), ‘åã, ˆã‰ÈŠíŠBŠw, 59(Suppl.): 77`78, 1990.
2960. mŠw‰ïn iˆê”Êu‰‰j “dŒ¹Ý”õ‚̈À‘S«.
”Ñ“‡Œõ—YC¼ì‰·C“íé¢C‘åL˜a–¾Cˆî–Ñ”ŽCL£–«C–{‘½—²C’r“cŒõŠìC–쑺’q”VC²“¡³Œ›C–kŒ´Œ[C‰¡aŽŒÈiMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj:
‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï (90.05.28), ‘åã, ˆã‰ÈŠíŠBŠw, 59(Suppl.): 81`82, 1990.
2961. mŠw‰ïn iˆê”Êu‰‰j —Õ°HŠw‹ZŽm‚Ì’a¶|—Õ°‚ÌŒ»ê‚Å‚Ì–ðŠ„‚Æ–â‘è“_|. “n•Ó•qi–ƒj: ‘æ68‰ñ–k—¢ˆãŠw‰ï—á‰ï (90.05.30), ‘Š–ÍŒ´, –k—¢ˆãŠw, 21: 1990.
2962. mŠw‰ïn iˆê”Êu‰‰j zŠÂáŠQ‚ð”F‚ß‚¸‚É‘ãŽÓ«ƒAƒVƒh|ƒVƒX‚ð’悵‚½3Ç—á. rì^”VCŒÜ–¡—ŒbC÷–{çŒbŽqC•lè‚—TC‰ª“c¹•½C–쌩ŽREC“n•Ó•qi–ƒj: ‘æ28‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.09.09j, “Œ‹ž.
2963. mŠw‰ïn iˆê”Êu‰‰j p’†AT‡V»Ü‚ÌŽg—pŒoŒ±. ›’J˜a]CóˆäŽ}C’|’†’qºCŒÜ\”¨mC‘ºã‰ëŽqC–쌩ŽREi–ƒj: ‘æ28‰ñ“ú–{–ƒŒŠw‰ïŠÖ“ŒbM‰z’n•û‰ï i88.09.09j, “Œ‹ž.
2964. mŠw‰ïn iˆê”Êu‰‰j ŽvtŠúŠ³ŽÒ‚ÌÒ’Å–ƒŒŽ€‚ÌŒŸ“¢. “c’†—ºCóˆäŽ}CJin, H.Y.CŒÜ\”¨mC–쌩ŽREi–ƒj: ‘æ7‰ñ“ú–{‘h¶ˆãŠw‰ï i88.09.23`24j, ‰ªŽR.
2965. mŠw‰ïn iˆê”Êu‰‰j Circulatory responses to epidural blockade of treated
and untreated hypertensive patients. Jin, H.Y.C“c’†—ºi–ƒj: ‘æ14‰ñ–k—¢ˆãŠw‰ï‘‰ï
i88.10.01j, ‘Š–ÍŒ´.
2966. mŠw‰ïn iˆê”Êu‰‰j ŽüpŠú‚É‚¨‚¯‚éPGE 1‚ÌŒŒŠÇŠg’£—Ö@–ò‚Æ‚µ‚Ă̈Ӌ`. –쌩ŽREC“c’†—ºi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï i89.04.13`15j, ŽRŒû.
2967. mŠw‰ïn iˆê”Êu‰‰j • •”‘å“®–¬áŽŽèp‚É‚¨‚¯‚éPhentolamine•¹—pd–ŒŠO–ƒŒ–@‚ÌzŠÂ“®‘Ô‚É—^‚¦‚éŒø‰Ê.
–쌩ŽREC‘ºã‰ëŽqCŒÜ\”¨mC’|’†’qºC•lè‚—TC¬‘òÍŽqC“I–씎C–î“c_CVˆä³NC“¡Œ´ŒjŽqC“c’†—ºi–ƒj: ‘æ36‰ñ“ú–{–ƒŒŠw‰ï‘‰ï
i89.04.13`15j, ŽRŒû, –ƒŒ, 38(9,Suppl.): S271, 1989.
2968. mŒ¤‹†‰ïn i“Á•Êu‰‰j ƒgƒ‰ƒ“ƒLƒ‰ƒCƒU[‚ÌŽg‚¢•û. ŽO‰Y’å‘¥i¸j: ‘æ108‰ñ‘å‹ÈŽsˆãŽt‰ïW’k‰ï (88.10.07), ‘å‹È.
2969. mŒ¤‹†‰ïn i“Á•Êu‰‰j •ª•ØŠJŽnŽž‚̃`ƒFƒbƒN¥ƒ|ƒCƒ“ƒg. “‡“cMGiŽY•wj: “Œ–kŽüŽYŠúƒZƒ~ƒi[ (89.07.08), å‘ä.
2970. mŒ¤‹†‰ïn i“Á•Êu‰‰j ”AŽ¸‹Ö‚ÌŽèp|Gittes•Ï–@‚É‚æ‚éäNã÷Œz•”’Ý‚èã‚°p. ‰¡ŽR‰p“ñi”åj: ƒZƒ~ƒi[u”AŽ¸‹Ö‚ÌŽèpv (90.02.17), ‹ž“s.
2971. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ƒ†|ƒUƒTƒCƒh‚©‚猩‚½ƒƒ“ƒeƒiƒ“ƒXƒT|ƒrƒX‚Ì‚ ‚è•û. ‰Z¶LˆêiMEƒZƒ“ƒ^[j: iŠ”jƒAƒgƒ€‘æ11‰ñƒƒ“ƒeƒiƒ“ƒXuK‰ï (89.08.30), ‰Y˜a.
2972. mŒ¤‹†‰ïn i‹³ˆçu‰‰j TURP. ‰¡ŽR‰p“ñi”åj: ‘æ5‰ñ”å”AŠí‰ÈŽèpŽè‹ZŠÖ“Œ’n‹æŒ¤‹†‰ï (89.09.09), “Œ‹ž.
2973. mŒ¤‹†‰ïn i‹³ˆçu‰‰j TURP‚ÌŽèpŽè‹Z‚ɂ‚¢‚Ä. ‰¡ŽR‰p“ñi”åj: ’†‘ŽR¼ÈEndourologyƒZƒ~ƒi[ (89.11.02`04), ’†‘¥ŽR¼ÈA‘¾Œ´Žs.
2974. mŒ¤‹†‰ïn i‹³ˆçu‰‰j –ƒŒ‰È—̈æ‚̈À‘S«‚ð‚ß‚´‚µ‚Ä. “n•Ó•qi–ƒj: ‰¡•lŽs—§‘åŠwˆãŠw•”–ƒŒ‰ÈƒZƒ~ƒi|. (89.12.02), ‰¡•l.
2975. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j —Õ°ŒŸ¸‚ÌŽè‡. ‚‹´œAbiŽ¨•@j: ‘æ33‰ñ‘Š•Ž¨ƒr‰ÈŒ¤‹†‰ï (89.07.15), ‘Š–ÍŒ´.
2976. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj —¼‘¤–À˜H‹@”\‚“x’ቺ—á‚̃ŠƒnƒrƒŠƒe|ƒVƒ‡ƒ“. ¼‰ª–¾—TC“¡–ì–¾lC“¿‘Œú“ñiŽ¨•@j:
‘æ2‰ñ•½tŒP—ûŠî€‰»ˆÄ컂̂½‚߂̃|ƒNƒVƒ‡ƒbƒv (89.08.19), L“‡, Equilibrium Res., 49(1):
160`167, 1990.
2977. mŒ¤‹†‰ïn iˆê”Êu‰‰j Foxic megacolon‚ð’悵‚½’×ᇫ‘å’°‰Š2Ç—á‚Ì–ƒŒŒoŒ±.
¬‘òÍŽqC–쌩ŽREC•lè‚—TCŒÜ–¡—ŒbC‘ºã‰ëŽqC“n•Ó•qi–ƒjC‚‹´r‹BC‘å’J„³iŠOj: ‘æ11‰ñ“ú–{• •”‹~‹}f—ÃŒ¤‹†‰ï
(88.00.00), å‘ä.
2978. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ†|ƒU‚©‚猩‚½ƒeƒŒƒ|ƒ^—˜—p‚ÌŒ»ó‚Æ–â‘è“_. L£–«iMEƒZƒ“ƒ^[j: —Õ°MEˆÀ‘SŒ¤‹†‰ï (89.04.15), “Œ‹ž.
2979. mŒ¤‹†‰ïn iˆê”Êu‰‰j •a‰@ME•”–å‚ð‚Ç‚¤ì‚é‚©–k—¢‘åŠw•a‰@‚Ìê‡. “n•Ó•qi–ƒj: “ú–{MEŠw‰ïê–å•ÊŒ¤‹†‰ï —Õ°MEˆÀ‘SŒ¤‹†‰ï (89.05.26), ‘åã.
2980. mŒ¤‹†‰ïn iˆê”Êu‰‰j PGE1‚ð—p‚¢‚½dÇ”DP’†“ÅÇ‚Ì’éØ–ƒŒŠÇ—. —§‰ª˜aOCA–ìM…C¯“c—²CŠâ’JO–¾C–ì“c–FlCª–{‘‘ˆêC‹gŒ´ˆêC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wj: ‘æ78‰ñ–³’É•ª•ØŒ¤‹†‰ï (89.06.24), “Œ‹ž.
2981. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹ó‹C‰Áˆ³Ž¡—Ã’†A‹ó‹Cˆ³k‹@‚ªŒÌႵ‹Ù‹}ŽÕ’f‘•’u‚ªì“®‚µ‚½1—á.
–{‘½—²C’r“cŒõŠìC¼ì‰·iMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒjCV“¡³‹PC‘å˜a“c—²i‹~–½j: “ú–{‚‹Cˆ³ŠÂ‹«ˆãŠw‰ï‘æ‚P‰ñ‹Zp•”‰ïŒ¤‹†”•\‰ï
(89.11.10), •ÄŽq.
2982. mŒ¤‹†‰ïn iˆê”Êu‰‰j ŒŒ‰t‰Á‰·Ší‚̈Ùí””M. L£–«iMEƒZƒ“ƒ^[jC“n•Ó•qi–ƒj: “ú–{MEŠw‰ïê–å•ÊŒ¤‹†‰ï¥—Õ°MEˆÀ‘SŒ¤‹†‰ï (90.02.17), “Œ‹ž.
2983. mŒ¤‹†‰ïn iˆê”Êu‰‰j Clinical Studies of Synthetic Wound Dressing with
Drug Delivery Capacity. ‰FˆäŒª“ñC‰F’Öؗ´ˆêiŒ`ŠOjC‘Oì˜a•Fi‹~–½jC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj:
‘æ4‰ñƒ}ƒEƒC”M‰ï‹c (90.02.19), ƒnƒƒC, Abstract, p.46, 1989.
2984. mŒ¤‹†‰ïn iŒöŠJuÀj ‚ß‚Ü‚¢Š³ŽÒ‚Ìf—ÂƊŌì‚̃|ƒCƒ“ƒg. “¿‘Œú“ñiŽ¨•@j:
‘æ14‰ñŽ¨•@ˆôA‰ÈƒZƒ~ƒi|EŽ¨•@ˆôA‰ÈŠÅŒì‚̃|ƒCƒ“ƒgiƒvƒ‰ƒ“ƒi|j”•\”NŒŽ“ú(89.09.09), “Œ‹ž,
ƒƒfƒCƒJo”Å:‘æ14‰ñŽ¨•@ˆôA‰ÈƒZƒ~ƒi|,p.13`19, 1989.
2985. mŒ¤‹†‰ïn iŒöŠJuÀj ”D•wfŽ@‚Å‚ÌV‚µ‚¢ƒ`ƒFƒbƒN¥ƒ|ƒCƒ“ƒg1989”N”Å. “‡“cMGiŽY•wj: ÅVŽüŽYŠúˆãŠwƒZƒ~ƒi[u‰f‚©‚番•Ø‚Ü‚Åv‚»‚Ì11 (89.07.22`23), “Œ‹ž.
<<211 ‚»‚Ì‘¼>>
2986. mŒ´’˜n •¡‡”|—{”畆‚Ìì». ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 10(3): 165`180, 1990.
2987. m’Z•ñn ‹³Žº‚¾‚æ‚è|–k—¢‘åŠwˆãŠw•””å”AŠí‰È|. ‰¡ŽR‰p“ñi”åj: —Õ°”å”AŠí‰È, 43: 914Cl989.
2988. m‘àn ‹~–½‹~‹}‚ÌŽÀÛA‹~‹}ŒŸ¸‚Æ‚»‚Ì•]‰¿|‹Ù‹}’´‰¹”gŒŸ¸|. ‘å‹{“Œ¶iŠOjC‘•ª–ΔŽi“àjC‹g“c@‹IiŠOj: f’f‚ÆŽ¡—Ã, 77(10): 2386`2390, 1989.
2989. muÀn ˜b‘è‚ÌŒŸ¸–@|lŠÔƒhƒbƒN|. ‘å’J‰pŽ÷i—Õ•a—j: ‘‡—Õ°C38(‘): 1652`1653, 1989.
2990. mŠwp‘n iŽ·•Mj lH‘ŸŠí‚ÌŒ»ó; lH”畆, 7: 16`22, •–ö”\Œõi¶‘ÌHj. Þ—¿‹Zp‹¦‰ïC89.04.00”s.
2991. mŠwp‘n iŽ·•Mj ¶‘Ì¥ˆã—pƒGƒ‰ƒXƒgƒ}|; lH”畆, p.394`400, •–ö”\Œõi¶‘ÌHj. “ú–{ƒSƒ€‹¦‰ïC89.06.05”s.
2992. mŠwp‘n iŽ·•Mj •a‘Ô¶—; R‹ÛÜ™•ú«‘n”핢܂̊J”, 8: 589`594, •–ö”\Œõi¶‘ÌHj. ‰iˆä‘“XC89.07.01”s.
2993. mŠwp‘n iŽ·•Mj ‚•ªŽq‚ƈã—Ã; lH”畆, p.320`349, •–ö”\Œõi¶‘ÌHj. ŽO“co”ʼnïC89.08.10”s.
2994. mŠwp‘n iŽ·•Mj —Õ°ŽGŽ¥ŠO‰È; V‚µ‚¢lH”畆, 51: 929`935, •–ö”\Œõi¶‘ÌHj. “ì]“°C89.09.01”s.
2995. mŠwp‘n iŽ·•Mj ‚•ªŽqV‘fÞ•Ö——; Œ`¬—pÞ—¿, p.318`322, •–ö”\Œõi¶‘ÌHj. •ÒW ‚•ªŽqŠw‰ï•Ò, ŠÛ‘PC89.09.20”s.
2996. mŠwp‘n iŽ·•Mj ‘@ˆÛ‚ÆH‹Æ; ˆã—×pƒfƒBƒXƒ||ƒUƒuƒ‹•sD•z‚Ì“®Œü, 45: 394`397, •–ö”\Œõi¶‘ÌHj. ‘@ˆÛŠw‰ïC89.09.00”s.
2997. mŠwp‘n iŽ·•Mj 89ÅV‹Zp100‘I¥ƒgƒŠƒK|; ׋ۂ̑B‚ð—}‚¦‚é‘n”í•¢Þ, p.96`97, •–ö”\Œõi¶‘ÌHj. “úŠ§H‹ÆV•·ŽÐC89.00.00”s.
2998. mŠwp‘n iŽ·•Mj ŠO‰Èf—Ã; V‚µ‚¢‘n”í•¢Þ‚Æ”|—{”畆, 31: 1315`1326, •–ö”\Œõi¶‘ÌHj. f’f‚ÆŽ¡—ÃŽÐC89.09.00”s.
2999. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; ŽY•wl‰È‚É‚¨‚¯‚é–â‘è“_, p.93`94, Vˆä³•vCÎì‰ëˆêiŽY•wj. •ÒW Îì“Ni–k—¢‘åj•Ò, ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15 ”s.
3000. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ª–{EiŠOj. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄC, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”s.
3001. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj –òÜ‚É‚æ‚é•›ì—p‚Æ’†“Å; ’®ŠíÇóCp.132`141, “¿‘Œú“ñiŽ¨•@j. •ÒW ´…’¼—ei’é‹ž‘åj•ÒC ƒ~ƒNƒX, “Œ‹ž, 89.07.25”s.
3002. m‚»‚Ì‘¼‚Ì’˜‘i–â‘èWjn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èWC “n•Ó“oiŽ™j. “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”s.
3003. m‚»‚Ì‘¼‚Ì’˜‘i–â‘èWjn iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èWC ”Ñ‚Šì‹v—YiŽ™j. ŠÄC ²“¡“oŽu˜Yi–k—¢‘åjŠÄCC “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15”s.
3004. m–|–ón iŽ·•Mj ƒm|ƒxƒ‹Üu‰‰, 5)¶—Šw¥ˆãŠw; ŒÄ‹z‚ÌŽ_‘f“`’By‘f (O.H.ƒ|ƒ‹ƒuƒ‹ƒN), 5: 39`59,
–x]Ž •vi¶‰»j. •ÒW ìŠì“cˆ¤˜Yiç—t‘åjC“n•ÓŠiC’Ë“c—TŽOiŒc‰ž‘åj•ÒC u’kŽÐ, “Œ‹ž, 85.06.10”s.
3005. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒRƒ‰|ƒQƒ“‚ðƒ}ƒgƒŠƒbƒNƒX‚Æ‚µ‚½•¡‡”|—{•\”ç‚Ìì». •–ö”\Œõi¶‘ÌHjC‘å’|®”VC’†–kMºC‰–’JMKiŒ`ŠOj: ‘æ18‰ñˆã—p‚•ªŽqƒVƒ“ƒ|ƒWƒEƒ€ (89.06.05), “Œ‹ž.
3006. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Development of Synthetic Dressing with Drug
Delivery Capacity. •–ö”\Œõi¶‘ÌHj: ‘@ˆÛŠw‰ï‹{èŠî‹à‘ÛƒVƒ“ƒ|ƒWƒEƒ€ (89.06.28), “Œ‹žC —\eW,
p.A27`A34, 1989.
3007. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒwƒpƒŠƒ“™•ú«–ü’…–hŽ~–Œ‚ÉŠÖ‚·‚錤‹†.
ìˆä’‰’qC‹{“cô’ji‚Œ¤jC–ìˆêF‘×°i‰ªŽR‘åjC•–ö”\Œõi¶‘ÌHj: ‘æ6‰ñ¶‘Ì‘@ˆÛ‚ƶˆãŠwÞ—¿‚ÉŠÖ‚·‚éƒVƒ“ƒ|ƒWƒEƒ€ (89.06.29),
“Œ‹žC —\eW, p.A50, 1989.
3008. mŠw‰ïn iˆê”Êu‰‰j •¡‡”|—{”畆‚Ìì¬: Šî‘b“IŒŸ“¢. •–ö”\Œõi¶‘ÌHjC‘å’|®”VC‰–’JMKiŒ`ŠOj: ‘æ15‰ñ“ú–{”MŠw‰ï (89.05.19), O‘OC u‰‰´˜^, p.81, 1989.
3009. mŠw‰ïn iˆê”Êu‰‰j Composite Skin Substitute Composed of Cultured
Keatinocytes and Fibroblasts Combined with Collagen Matrix.
‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: The 5th Congress of the Asian Pacific
Reconstructive Surgery (89.09.08), Istanbul, Turkey.
3010. mŠw‰ïn iˆê”Êu‰‰j ”NƒTƒbƒJ|‘IŽè‚Ì‘‡“I‘Ì—Í•]‰¿i‘æ1•ñjŒ`‘ÔŠw“I•]‰¿‚Æ—LŽ_‘f&–³Ž_‘f«ƒpƒ|‚Ì•]‰¿.
“n•Ó“oC’†“ˆ‰p•FCŽl‘q³”ŽC–¥‰YŽ‘¥C”~Œ´ŽÀCV‘º•¶’jC–åˆäL‹ÅiŽ™jC‚ŠÝŒ›“ñi®ŠOj: ‘æ44‰ñ“ú–{‘̗͈ãŠw‰ï (89.09.27),
ŽD–y, ‘̗͉Ȋw, 38(6): 582, 1989.
3011. mŠw‰ïn iˆê”Êu‰‰j ƒqƒgüˆÛ‰è×–E‚ƃqƒg•\”ç×–E‚ð‘g‚Ýž‚ñ‚¾•¡‡”|—{”畆. •–ö”\Œõi¶‘ÌHjC‘å’|®”VC’†–kMºC‰–’JMKiŒ`ŠOj: ‘æ38‰ñ‚•ªŽq“¢˜_‰ï (89.10.04), •Ÿˆä.
3012. mŠw‰ïn iˆê”Êu‰‰j ”ŽíŽ¾Š³‚É‚¨‚¯‚郿2 Macroglobulin‚ÌŒ¸‚Æ‚»‚̈Ӌ`‚̂‚¢‚Ä.
‚“ˆ—˜Ž}ŽqiŽOˆä‹L”O•a‰@jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â):
73, 1989.
3013. mŠw‰ïn iˆê”Êu‰‰j •¡‡”|—{”畆‚Ì컂ƕ]‰¿. •–ö”\Œõi¶‘ÌHjC‘å’|®”VC‰–’JMKiŒ`ŠOj: ‘æ11‰ñ“ú–{ƒoƒCƒIƒ}ƒeƒŠƒAƒ‹Šw‰ï (89.10.27), ‹ž“s.
3014. mŒ¤‹†‰ïn i“Á•Êu‰‰j Computed Radiography‚Ì—Õ°‰ž—p. ‘–쳈êi•új: —Õ°‰æ‘œf’f§˜b‰ï (89.06.07), ‘O‹´C —Õ°‰æ‘œf’f§˜b‰ï‹L˜^WC2: l989.
3015. mŒ¤‹†‰ïn iˆê”Êu‰‰j •¡‡”|—{”畆‚ÌŠJ”. ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú’†Œ`¬ŠO‰ÈŒð—¬ŠwpW‰ï (89.11.21), ’·è.
3016. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒRƒ‰[ƒQƒ“‚ðƒ}ƒgƒŠƒbƒNƒX‚Æ‚µ‚½•¡‡”|—{”畆. ‘å’|®”VC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ19‰ñ‘nŽ¡–üŒ¤‹†‰ï (89.12.02), ‹v—¯•Ä.
3017. mŒ¤‹†‰ïn iˆê”Êu‰‰j ”NƒTƒbƒJ|‘IŽè‚Ì‘‡“I‘Ì—Í•]‰¿i‘æ‚P•ñj—LŽ_‘f«•–³Ž_‘f«ƒpƒ|‚Ì•]‰¿.
–åˆäL‹ÅC“n•Ó“oC’†“ˆ‰p•FC”~Œ´ŽÀC–¥‰YŽ‘¥CŽl‘q³”ŽCV‘º•¶’jiŽ™jC‚ŠÝŒ›“ñi®ŠOj: ‘æ10‰ñƒTƒbƒJ|ˆã‰ÈŠwŒ¤‹†‰ï
(90.02.11), “Œ‹ž, ´˜^W, p.44, 1990.
<<301 ¶•¨•¨—Šw>>
3018. mŒ´’˜n Reconstitution of Human Fetal Hemoglobin From Isolated ƒ¿ and
ƒÁ Chains. ¬¼NŽqC—é–Øt’ji¶•¨•¨—‰»j: Biochemistry International, 19(3): 469`476,
1989.
3019. mŠwp‘n iŽ·•Mj ˆâ“`; ŠT“úƒŠƒYƒ€”Œ»‚Ìê‚Æ•ªŽq, 43: 7`11, ’·’J쌚Ž¡i¶—j. ։ؖ[, “Œ‹ž, 89.12.01”s.
3020. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ƒ]ƒEƒŠƒ€ƒV‚Ìs“®‚ÌŠT“úƒŠƒYƒ€‚Æd—Íê. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”Ži¶•¨•¨—Œnj: ‘æ3‰ñ“ú–{‰F’ˆ¶•¨‰ÈŠw‰ï‘å‰ï (89.09.23), “Œ‹ž, u‰‰—vŽ|W, p.11, 1989.
3021. mŠw‰ïn iƒpƒlƒ‹j Circadian Locomotor Activity in an Isolated Cell of
Paramecium. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”ŽCÎìœAi¶•¨•¨—Œnj: 5th Gordon Conference
(89.07.27). Plymouth, U.S.A.
3022. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj Circadian Locomotor Activity in an Isolated Cell
of Paramecium. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”ŽCÎìœAi¶•¨•¨—Œnj: 19th Internat. Conference
Soc. Chronobiology (89.07.25).
3023. mŠw‰ïn iˆê”Êu‰‰j Š^• •”ã”ç×–EŠÔ˜A—‚ɑ΂·‚éd’YŽ_ƒCƒIƒ“‚̉e‹¿. •Ð‘q—²i¶—jC¼“c‘•ci¶•¨•¨—Œnj:
‘æ66‰ñ“ú–{¶—Šw‰ï‘å‰ï (89.04.06), ‰ªŽRC Jpn. J. Physiol., 39(Suppl.): s50,1989.
3024. mŠw‰ïn iˆê”Êu‰‰j ƒAƒ‹ƒR[ƒ‹’E…‘fy‘f‚ɑ΂·‚鎇ŠOüƎ˂̉e‹¿.
‘¾“cŒ°¬C¼—Ñ—²i•újC‘]ª—R”üŽqC‚ŽR‹v”üŽqi¶•¨‰»ŠwŒnj: ‘æ48‰ñ“ú–{ˆãŠw•úŽËüŠw‰ï¥¶•¨•”‰ï‘å‰ï (89.04.07), _ŒËC
“ú–{ˆãŠw•úŽËüŠw‰ï¶•¨•”‰ïŽC2(1): 69`71, l989.
3025. mŠw‰ïn iˆê”Êu‰‰j Emission of Light from Eggs during Early Cleavage.
‘åŠÑMi¶—jC—´è³Žmi¶•¨j: “ú–{”¶¶•¨Šw‰ï (89.06.00), –kŠC“¹C Develop. Growth &
Differ., 31: 415, 1989.
3026. mŠw‰ïn iˆê”Êu‰‰j •úŽËüƎ˂ɑ΂·‚郉ƒbƒg”畆”½‰ž‚Ì•úŽËüŠ´Žó«‚ɂ‚¢‚Ä.
‘¾“cŒ°¬C¼—Ñ—²i•újC‘]ª—R”üŽqi¶•¨‰»ŠwŒnjC’†ŽR–ÎMiŽÀ“®Œnj: “ú–{•úŽËü‰e‹¿Šw‰ï‘æ32‰ñ‘å‰ï (89.09.30), –k‹ãB,
u‰‰—vŽ|W, p.270, 1989.
3027. mŠw‰ïn iˆê”Êu‰‰j ƒ~ƒIƒOƒƒrƒ“‚ÌFolding‚ÉŠÖ‚·‚錤‹†.
ç—t‚©‚¨‚èi“Œ‹ž—‘åjC¬¼NŽqi¶•¨•¨—‰»jC–ØŒ´—TiŽ©Ž¡ˆã‘åj: “ú–{¶•¨•¨—Šw‰ï (89.10.07), “Œ‹žC ¶•¨•¨—,
29(Suppl.): S198, 1989.
3028. mŠw‰ïn iˆê”Êu‰‰j ƒ]ƒEƒŠƒ€ƒV‚Ìs“®ˆÙ튔‚ÌŠT“úƒŠƒYƒ€. ’·’J쌚Ž¡i¶—jC“c’†ŠÚ–¾”Ži¶•¨•¨—Œnj: ‘æ27‰ñ“ú–{¶•¨•¨—Šw‰ï”N‰ï (89.10.07). “Œ‹ž, ¶•¨•¨—, 29(9): s254, 1989.
3029. mŠw‰ïn iˆê”Êu‰‰j ‘ÙŽ™ƒwƒ‚ƒOƒƒrƒ“‚ÌÅ\¬‘¬“x. ¬¼NŽqC—é–Øt’ji¶•¨•¨—‰»j: “ú–{¶‰»Šw‰ï (89.11.05), ‹ž“sC ¶‰»Šw, 61(9): 1145, 1989.
3030. mŠw‰ïn iˆê”Êu‰‰j ƒAƒNƒ`ƒoƒuƒ‹Œ³‘f•ªÍ–@‚É‚æ‚éƒJƒ‹ƒVƒEƒ€ÛŽæ‚Ì‘ª’è. ‘¾“cŒ°¬i•új: “ú–{ˆãŠw•úŽËüŠw‰ï‘æ58‰ñ•¨—•”‰ï‘å‰ï (89.11.12), ˆÉ•Û, “ú–{ˆãŠw•úŽËü•¨—•”‰ïŽ, 9(3): 214, 1989.
3031. mŠw‰ïn iˆê”Êu‰‰j ”÷¬ŠÇ‚ð”j‰ó‚µ‚½FL×–E‚É‚¨‚¯‚éƒgƒ‰ƒ“ƒXƒtƒFƒŠƒ“ƒŠƒTƒCƒNƒŠƒ“ƒO‚ÌŒo˜H.
ä—§–çi‹ž‘åjCŽR‰È³•½i‰ðjC‘å¼rˆêi‹ž‘åj: ‘æ42‰ñ“ú–{×–E¶•¨Šw‰ï i89.10.25j, ‹ž“sC Cell Structure
and Function, 14(6): 993, 1989.
3032. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘O’ë_ŒoŽhŒƒŽž‚̈݉^“®‚Ɖ„‘šq“f’†•‚ɂ‚¢‚Ä. “¿‘Œú“ñC¯–ìŒ÷C“¡–ì–¾liŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: •¶•”ȉȊwŒ¤‹†‘‰ï A;‚ß‚Ü‚¢‚ÆŽ©—¥_Œo”ÇŒ¤‹†‰ï (90.02.11), ‘åã.
3033. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒg“ûŠà‚ɑ΂·‚éSFƒTƒCƒNƒƒgƒƒ“—zŽqü‚ÌÆŽË‚Æ‚»‚ÌŒø‰Ê. ‘¾“cŒ°¬i•új: •½¬Œ³”N“x“Œ‹ž‘åŠwŒ´ŽqŠjŒ¤‹†ŠƒTƒCƒNƒƒgƒƒ“Œ¤‹†‰ï (89.07.20), “c–³.
<<302 ¶•¨‰»Šw>>
3034. mŒ´’˜n Types of Oligosaccharide Sulphation, Depending on Mucus
Glycoprotein Source, Corpus or Antral, in Rat Stomach. ŒÜäzsMC–x“c‹±Žqi¶‰»j:
Biochem. J., 264(3): 805`812, 1989.
3035. mŒ´’˜n Structure and Significance of N-Linked Sugar Unit of Human
Serum Amyloid P Component. •lèG–¾i¶•¨j: Biochim. Biophys. Acta, 1037:
435`438, 1990.
3036. mŒ´’˜n Calcium-Dependent Polymerization of Human Serum Amyloid P
Component is Inhibited by Heparin and Dextran Sulfate. •lèG–¾i¶•¨j:
Biochim. Biophys. Acta, 998: 231`235, 1989.
3037. mŒ´’˜n Studies on the Molecular Structure of Spinach Ferredoxin ‡T.
Comparison of Two Molecular Species of Ferredoxin. D.
Ohmorii‡‘åjC˜@Œ©‰p¢i¶•¨•¨—‰»jCF. Yamakurai‡‘åjCM. MurakamiC K. FujisawaC Y.
TaneokaC T. Ymamurai“Œ‹ž—‘åj: Biochim. Biophys. Acta., 996: 166`172, 1989.
3038. mŒ´’˜n Studies on the Molecular Structure of Spinach Ferredoxin ‡U.
Effects of Urea and Sodium Chloride. ˜@Œ©‰p¢i¶•¨•¨—‰»jCD. Ohmorii‡‘åj:
Biochim. Biophys. Acta., 996: 173`180, 1989.
3039. mŒ´’˜n Plasma Profiles of the N-Terminal Peptide of
Proopiomelanocortin in the Rainbow Trout with Reference to Stress.
‚‹´–¾‹`i•ª¶jCOgasawara Tsuyoshii“Œ‘åjCì“à_Žii…ŽYŠw•”jCHirano Tetsuyai“Œ‘åj: Gen.
Comp. Endocrinol.C77(1): 98`106, 1990.
3040. mŒ´’˜n The Pathway of Ghitamine Oxidation in MC-29 Hepatoma
Mitochondria. T. Matsunoi—\Œ¤jC—é–Øt’ji¶•¨•¨—‰»jCK. Nittai’é‹ž‘åjCT. AokiCK.
IriyamaiŽœŒbˆã‘åj: Jikeikai Med. J., 36: 241`249, 1989.
3041. mŒ´’˜n Heat Production During Early Developmental stages of the
Frog. ‘ëàV’¼’èi¶—jC—´è³Žmi¶•¨jC‘åŠÑMi¶—j: Journal of Thermal Biology, 1989.
3042. mŒ´’˜n Changes in Lipid Composition in the Tail of Rana Catesbeiana
Larvae during Metamorphosis. —´è³Žmi¶•¨jC‘åŠÑMi¶—j: Zoological Science,
1990.
3043. m’Z•ñn Biological Response Modifiers Such as Organo-Germanium
Compounds and Krestin (PS-K) Express the Activity as the Ion Radical
Scavenger. ’†‘º‘‰qC’†“‡—mˆêi•ª¶j: Medical, Biochemical and Chemical Aspects of
Free Radicals, p.519`522, 1989.
3044. m‘àn R‘Ìy‘f. —é–Øt’ji¶•¨•¨—‰»j: ƒoƒCƒIƒTƒCƒGƒ“ƒX‚ƃCƒ“ƒ_ƒXƒgƒŠ|, 47(5): 43`46, 1989.
3045. m‘àn “®•¨×–E‚̃^ƒ“ƒpƒNŽ¿‡¬‚Ì–|–óŠJŽnƒŒƒxƒ‹‚Å‚Ì’²ß. —é–Øt’ji¶•¨•¨—‰»j: ƒoƒCƒIƒTƒCƒGƒ“ƒX‚ƃCƒ“ƒ_ƒXƒgƒŠ|, 47(8): 11`18, 1989.
3046. m‘àn RaRF|•â‘̬•ªC1‚ÉŽ—‚½ŒŒ´ƒŒƒNƒ`ƒ“. ìã³–çi•ª¶j: ¶‰»Šw, 61(6): 482`486, 1989.
3047. m‘àn ƒAƒ~ƒƒCƒhP¬•ª‚ɂ‚¢‚Ä. •lèG–¾i¶•¨j: ¶‰»Šw, 62(1): 45`49, 1990.
3048. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ‰»Šw‘厫“T; –x]Ž •vi¶‰»j. •ÒW ‘å–Ø“¹‘¥C‘å‘ò—˜ºC“c’†Œ³Ž¡C猴Gº@•Ò, “Œ‹ž‰»Šw“¯l, “Œ‹ž, 89.10.20”s.
3049. mŠw‰ïn iˆê”Êu‰‰j Lipid Composition in the Tadpole Tail of Rana
Catesbeiana During Metamorphosis. —´è³Žmi¶•¨j: Zoological Society of Japan
(88.10.10), Zoological ScienceC5(6): 1248, 1988.
3050. mŠw‰ïn iˆê”Êu‰‰j Emission of Light from Frog Eggs during Early
Cleavage. —´è³Žmi¶•¨jC‘åŠÑMi¶—j: The Japanese Society of Developmental
Biologists (89.06.22-24), ŽD–yC Development, Growth &
DifferentiationC31(4): 415, 1989.
3051. mŠw‰ïn iˆê”Êu‰‰j Characterization of Galactosyl Ceramide and
Constituent Glycerophspholipid Fatty Acids during Early Development of
the Japanese Pond Frog, Rana Nigromaculata. —´è³Žmi¶•¨j: 11th
International Congress of the International Society of Developmental
Biologists. Satellite Meeting-early Amphibian Development.
(89.08.18-20), The Netherlands (Utrecht)C —\eWCp.30, 1989.
3052. mŠw‰ïn iˆê”Êu‰‰j New Type of Endo-Glycosidase,
Endo-ƒ¿-N-Acetylgalactosaminidase S from Streptomyces sp. OH-11242
Culture Medium. Šâ£m—ECΈäˆèŽqC–x“c‹±Žqi¶‰»jC“c’†–F•C‘呺’qi–k—¢Œ¤‹†Šj: 10th International
Symposium on Glycoconjugates (89.09.10), Jerusalem, Israel,
Proceedings, p.314, 1989.
3053. mŠw‰ïn iˆê”Êu‰‰j Sulfation of Oligosaccharides on Mucus Glycoproteins
in Rat Stomach. ŒÜäzsMC–x“c‹±Žqi¶‰»j: 10th International Symposium on
Glycoconjugates (89.09.11), Jerusalem, Israel, Proceedings, p.244,
1989.
3054. mŠw‰ïn iˆê”Êu‰‰j Mucus Glycoproteins in the Cardiac, Fundic and
Pyloric Gland Regions of Pig Stomach. ¬Œ´ii¶‰»jCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: 10th
International Symposium on Glycoconjugates (89.09.13), Jerusalem,
Israel, Proceedings, p.164, 1989.
3055. mŠw‰ïn iˆê”Êu‰‰j
”DPƒ‰ƒbƒg‚̃Aƒ‹ƒR|ƒ‹ÛŽæ‚ªŽeƒ‰ƒbƒg‚É‹y‚Ú‚·‰e‹¿|‚»‚̶‰»Šw“IŒ¤‹†i‡Uj2',3'-ŠÂóƒkƒNƒŒƒIƒ`ƒh-3'ƒzƒXƒtƒHƒWƒGƒXƒeƒ‰|ƒ[‚ÌmRNA‚ɂ‚¢
‚Ä. ¬“ˆ‹vŽqi¶‰»jC–k“‡—Œbi¶•¨‰»ŠwŒnjCŒIŒ´³iVŠƒ‘åjC’†‘º˜a¶i¶‰»jC‚‹´N•viVŠƒ‘åjC‹Êˆä—mˆêi¶‰»j:
‘æ32‰ñ“ú–{_Œo‰»Šw‰ï‘å‰ï (89.09.27), ŽD–y, _Œo‰»Šw, 28: 108`109, 1989.
3056. mŠw‰ïn iˆê”Êu‰‰j Phenol”ä‘÷–@‚É‚æ‚é—r…’†ŠE–ÊŠˆ«•¨Ž¿‚Ì‘ª’è‚Æ—r…’†ƒŠƒ“Ž‰Ž¿‚Ì‘ŠŒÝŠÖŒW‚ɂ‚¢‚Ä.
–ì“c–FlCA–ìM…C’Jº”ŽC’F‰pŽ÷C¼“‡³”ŽC“‡“cMGiŽY•wjCÎŒ´˜a•FC–x“c‹±Žqi¶‰»j: ‘æ25‰ñ“ú–{ŠE–ÊŠw‰ï (89.10.07),
H“c.
3057. mŠw‰ïn iˆê”Êu‰‰j ƒ‰ƒbƒgŠÌ‘Ÿ‚ÆS‹Ø‚̃~ƒgƒRƒ“ƒhƒŠƒAŒÄ‹z”\‚É‹y‚Ú‚·ƒAƒ‹ƒJƒŠ‹à‘®‚¨‚æ‚уAƒ‹ƒJƒŠ“y‹à‘®‚̉e‹¿.
“n•Ó“”ü”Ti¶‰»jC‘]ª—R”üŽqi¶‰»ŒnjC–x]Ž •vi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9):
856, 1989.
3058. mŠw‰ïn iˆê”Êu‰‰j ƒGƒC”]‚̃Kƒ“ƒOƒŠƒIƒVƒh. ’†‘º˜a¶C‹Êˆä—mˆêi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03), ‹ž“s, ¶‰»Šw, 61(9): 886, 1989.
3059. mŠw‰ïn iˆê”Êu‰‰j ƒQƒ‹ƒ‰ß‚Æ”–‘wƒNƒƒ}ƒgƒOƒ‰ƒtƒB|‚Ì‘g‡‚¹‚É‚æ‚éO-ƒOƒŠƒRƒVƒhŒ^“œ½‚Ì•ªÍ. ŒÜäzsMC–x“c‹±Žqi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1024, 1989.
3060. mŠw‰ïn iˆê”Êu‰‰j PA‰»”½‰ž‚É‚¨‚¯‚éPA‰»“œ—U“±‘Ì‚©‚ç2-AP‚Ì‘I‘ð“Iœ‹Ž.
Šâ£m—ECΈäˆèŽqi¶‰»jC‰Y“c’ËMŽqi¶‰»ŒnjC–x“c‹±Žqi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw,
61(9): 1024, 1989.
3061. mŠw‰ïn iˆê”Êu‰‰j ƒ€ƒ`ƒ“—R—ˆOH-11242Š””|’nƒIƒŠƒS“œ‚ÌPA‰»—U“±‘Ì‚Ì•ªÍ.
‰Y“c’ËMŽqi¶‰»ŒnjCŠâ£m—ECΈäˆèŽqC–x“c‹±Žqi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.04), ‹ž“s, ¶‰»Šw, 61(9):
1024, 1989.
3062. mŠw‰ïn iˆê”Êu‰‰j ƒ€ƒ`ƒ“‚ð—Bˆê‚Ì’Y‘fŒ¹‚Æ‚·‚éOH-11242Š””|—{‰t’†‚ÉŽY¶‚³‚ê‚éV l-ƒGƒ“ƒhŒ^y‘f|‘æ2•ñ|.
ΈäˆèŽqCŠâ£m—Ei¶‰»jC‰Y“c’ËMŽqi¶‰»ŒnjC–x“c‹±Žqi¶‰»jC“c’†–F•C‘呺’qi–k—¢Œ¤‹†Šj: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï
(89.11.04), ‹ž“s, ¶‰»Šw, 61(9): 1024, 1989.
3063. mŠw‰ïn iˆê”Êu‰‰j PC12×–E‚Ì•ª‰»‚ƃKƒ‰ƒNƒg|ƒX“]ˆÚy‘fŠˆ«‚ɂ‚¢‚Ä. –k“‡—Œbi¶‰»ŒnjC¬“ˆ‹vŽqC‹Êˆä—mˆêi¶‰»j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.05), ‹ž“s, ¶‰»Šw, 61(9): 1157, 1989.
3064. mŠw‰ïn iˆê”Êu‰‰j Advanced Glycation End Products (AGE)‚̶¬‘jŠQ(‡T) Lens
Crystallin ‚ð—p‚¢‚½in vitro Cataractƒ‚ƒfƒ‹‚Ì쬂Ɣ½‰ž‚Ì‘jŠQ. ’†‘º‘‰qi•ª¶jC–쌳‚¯‚¢Žqi¶‰»Œnj:
‘æ62‰ñ“ú–{¶‰»Šw‰ï (89.11.05), ‹ž“s C —\eW, 3PD615, 1989.
3065. mŠw‰ïn iˆê”Êu‰‰j Advanced Glycation End Products
(AGE)‚̶¬‘jŠQ(‡U)Ž_‰Â—n«ƒEƒVƒRƒ‰|ƒQƒ“‚©‚ç‚ÌAGEŒ`¬‚Æ‚»‚Ì‘jŠQ. –쌳‚¯‚¢Žqi¶‰»ŒnjC’†‘º‘‰qi•ª¶j: ‘æ62‰ñ“ú–{¶‰»Šw‰ï
(89.11.05), ‹ž“s C —\eW, 3PD616, 1989.
3066. mŠw‰ïn iˆê”Êu‰‰j –|–óŠJŽnˆöŽqeIF-2‚ÌN-ƒGƒ`ƒ‹ƒ}ƒŒƒCƒ~ƒh”½‰ž«SHŠî‚ɂ‚¢‚Ä.
—é–Øt’ji¶•¨•¨—‰»jCŒüŽRŒb’ÃŽqi¶‰»ŒnjC‹Tˆä—²Ki¶•¨•¨—‰»Œ¤C¶j : “ú–{”_Œ|‰»Šw‰ï1990”N“x‘å‰ï (90.03.31), •Ÿ‰ªC
“ú–{”_Œ|‰»Šw‰ïŽ, 64(3): 315`315, 1990.
<<303 ˆâ“`Šw>>
3067. mŠw‰ïn iˆê”Êu‰‰j –EóŠï‘Ù‚É‚¨‚¯‚éHLAˆâ“`ŽqŒ^‚ÌŒŸõ:in vitro ˆâ“`Žq‘•–@‚̉ž—p.
–î•”“TŽqi—Õ•a—jC¬”¦•¶–íCˆÉ“Œˆê˜YCˆÉ“¡IˆêiˆÚA–ƉujCät“n’‰’ji—Õ•a—jC‘å–쓹Žqi—ÕŒŸjC‘O“c“OiŠÅŒìŠw•”jC‘å’J‰pŽ÷i—Õ•a—j:
‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 70, 1989.
<<304 •ªŽq¶•¨Šw>>
3068. mŒ´’˜n Production of Salivary Type ƒ¿-Amylase in Human Lung Cancer.
Yusuke NakamuraCNaohiro TomitaCTakahiro NishidaCMitsuru EmiCAkira
HoriiCMichio OgawaCTakesada Morii‘åã‘åjCGoro Kasakii“s—§‹îž•a‰@jCTetsuro
OkabeCMichio FujisawaCNakaaki Ohsawai“Œ‘åjC‹T’J“Oi•a—jCKenichi Matsubara
i‘åã‘åj: Gene, 77: 107`112, 1989.
3069. mŒ´’˜n Structures of Two Genes Coding for Melanin-Concentrating
Hormone of Chum Salmon. ‚ŽR‹g‰ii•ª¶jC˜a“c’m‰vi—Õ•a—jCì“à_Žii…ŽYŠw•”jC¬–ì‰ë•vi•ª¶j:
GeneC80: 65`73, 1989.
3070. mŒ¤‹†•ñi…ŽY’¡jn —L—p‹›—ÞŽ‹°‰º•”ƒzƒ‹ƒ‚ƒ“‚ÌDNAƒ‰ƒCƒuƒ‰ƒŠ|‚Ìì¬. ¬–ì‰ë•vi•ª¶j: º˜a63”N“x…ŽYƒoƒCƒeƒN“±“üŠî”Õ®”õŽ–‹Æ•ñ‘, p.45`48, 1989.
3071. m‘àn Detection and Elimination of Endogenous Retroviruses and
Retrovirus-Like Particles in Continuous Cell Lines. ¬–ì‰ë•vi•ª¶j: Dev.
Biol. Stand., 70: 69`81, 1989.
3072. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Prevention of Maillard Reaction and the Reversible
Destruction of Advanced Glycation End Products (AGE) by Novel Organic
Germanium Compounds and Aminoguanidine. ’†‘º‘‰qi•ª¶jC‰F‰ê–ÎŽOC‹{“cŠ²•viŠájCNorihiro
Kakimoto iAsai Germanium Institutej: 4th International Symposium on the
Maillard Reaction (89.09.08), Lausanne, Switzerland.
3073. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Prevention of Maillard Reaction between Crystallin
and Glucose and Induction of Reversible Transparency in Turbid Lens By
Organic Germanium Componds. ’†‘º‘‰qi•ª¶jC‰F‰ê–ÎŽOC‹{“cŠ²•viŠájCNorihiro Kakimoto
iAsai Germanium Institutej: The Fifth Congress of the US-JAPAN
Cooperative Cataract Research (89.11.13), ‹à‘ò —\eWCp.48.
3074. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX•â‘ÌŠˆ«‰»ŽE‹ÛˆöŽqRaRF•¡‡‘Ì’†‚Ìy‘f—l¬•ª‚ɂ‚¢‚Ä.
‚‹´–¾‹`C‹Gˆç‰Øi•ª¶jC‰£—m”üi¶•¨‰»ŠwŒnjCé°Œ›‹`i•ª¶jC“¡“c’õŽOi’}”g‘åjCìã³–çi•ª¶j: ‘æ26‰ñ•â‘̃Vƒ“ƒ|ƒWƒEƒ€
(89.07.16`18), ‘åã, u‰‰W, 26: 97`98, 1989.
3075. mŠw‰ïn iˆê”Êu‰‰j Functional and Structural Similarities of Ra-Reactive
Factor to C1 Component of Complement.
‚‹´–¾‹`C‹v‰ºŽü²C‹Gˆç‰Øi•ª¶jC“¡“c’õŽOi’}”g‘åjC‰£—m”üi¶•¨‰»ŠwŒnjCìã³–çi•ª¶j: ‡]‡Vth International
Complement Workshop (89.09.12), San Diego, U.S.A.C Complement and
Inflammation, 6(5): 404, 1989.
3076. mŠw‰ïn iˆê”Êu‰‰j •â‘ÌŠˆ«‰»ŽE‹ÛˆöŽqRaRF‚ÌRa‘½“œ‘Ì”FŽ¯¬•ª.
Z—F˜aOC“y‹˜aOi•ª¶jC‰£—m”üi¶•¨‰»ŠwŒnjC‚‹´–¾‹`Cìã³–çi•ª¶j: ‘æ62‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (89.10.13),
…ã C “ú–{׋ۊwŽGŽ, 45(2): 603, 1990.
3077. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒXŽE‹ÛˆöŽqRaRFƒTƒuƒRƒ“ƒ||ƒlƒ“ƒg‚Ì•ª—£.
‚‹´–¾‹`C‹Gˆç‰Øi•ª¶jC‰£—m”üi¶‰»ŒnjCé°Œ›‹`Cìã³–çi•ª¶jC“¡“c’õŽOi’}”g‘åj: ‘æ62‰ñ“ú–{¶‰»Šw‰ï‘å‰ï (89.11.03),
‹ž“s C ¶‰»Šw, 61(9): 882, 1989.
3078. mŠw‰ïn iˆê”Êu‰‰j ƒ}ƒEƒX•â‘ÌŠˆ«‰»ŽE‹Ûƒ^ƒ“ƒpƒNŽ¿RaRF•¡‡‘Ì’†‚ÌC4Á”«‚ð—L‚·‚鬕ª.
‚‹´–¾‹`C‹Gˆç‰Øi•ª¶jC‰£—m”üi¶‰»ŒnjC“¡“c’õŽOi’}”g‘åjCìã³–çi•ª¶j: ‘æ63‰ñ“ú–{׋ۊw‰ï‘‰ï (90.03.27), “¿“‡
C “ú–{׋ۊwŽGŽ, 45(1): 159, 1990.
3079. mŒ¤‹†‰ïn iˆê”Êu‰‰j ‹›—Þ‚ÌŽ‹°‰º•”ƒzƒ‹ƒ‚ƒ“‚̈â“`Žq\‘¢. ¬–ì‰ë•vi•ª¶j: “Œ‘åŠC—mŒ¤ƒVƒ“ƒ|ƒWƒEƒ€i‹›‰î—ނ̶•¨Šw¥…ŽYŠw‚ƃoƒCƒIƒeƒNƒmƒƒW|j (89.11.25), “Œ‹žC —\eWCp.12`13, 1989.
<<305 •a‘ÔŠw>>
3080. muÀn ü—Ê•W€‘ª’è–@‚̃h[ƒYƒvƒƒbƒeƒBƒ“ƒOƒVƒXƒeƒ€‚ւ̉ž—p(1). Šâ”g–ÎC‚Œ´êŽCã‘O•ôŽqC–kŽR‹v”üC’†‘º‹`‘¥i•újC‹g’J³•vi“Œ—mƒƒfƒBƒbƒNj: “ú–{ˆãŠw•úŽËüŠw‰ï•¨—•”‰ïŽ, 9(2): 51`59, 1989.
<<306 Œ`‘ÔŠw>>
3081. m‘àn ×–E‹É«Œ`¬‚̃ƒJƒjƒYƒ€. £ì²‹vCŽR‰È³•½i‰ðj: ×–E, 21(10): 371`376, 1989.
3082. muÀn “€Œ‹€’´”–Ø‚É‚æ‚é–Ɖu‘gD‰»Šw. Ÿ–”CiŒ`‘ÔŒnjCŽR‰È³•½i‰ðj: ×–EC21(10): 30`34, 1989.
3083. mŠwp‘n iŽ·•Mj Œ»‘ã•a—Šw‘åŒn; zŠÂáŠQ|Š¥ó“®–¬‚Ì\‘¢‚Æ‹@”\|, 11A, ŒK”ö’èmC¼ŽR•Ûˆêi•a—jC”©ŽRˆê•½i¶—j. ’†ŽR‘“X, “Œ‹ž, 90.03.00”s.
3084. m–|–ón iŽ·•Mj ƒCƒ‰ƒXƒg•a—Šw; ‘æ13Í ”å”AE¶BŠíŒnCp.631`727, ŒK”ö’èmi•a—j. •¶Œõ“°, “Œ‹ž, 89.04.20”s.
3085. mŠw‰ïn iˆê”Êu‰‰j —Öóbó‹Ø‚Ì‘gDŠw“IŒ¤‹†|‘æ3•ñ|.
Έä–L‘¾CŒ´“cGˆêCŒÃì_ŽOC”ª”ö˜a—YC‚‹´œAbCÝŠy“N–çiŽ¨•@jCV”ü¬“ñi“Œ‘åj: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.13), ‘åãC
“ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1724, 1989.
3086. mŠw‰ïn iˆê”Êu‰‰j …‘f•ªŽq‹¤–Âó‘Ô‚Ì“dŽq‘ŠŠÖ. ‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ï (89.10.04), ŽŽ™“‡C 1989”NH‚Ì•ª‰È‰ïu‰‰—\eWC‘æ4•ªû: 49, 1989.
3087. mŠw‰ïn iˆê”Êu‰‰j Bouin ŒÅ’è‰t‚Ì‘–¸Œ^“dŽqŒ°”÷‹¾‚ւ̉ž—p. ’†–{’¼i‰ðj: “ú–{“dŽqŒ°”÷‹¾Šw‰ï i89.06.01), ‘åã, J. Electron Microsc., 38(4): 303, l989.
3088. mŠw‰ïn iˆê”Êu‰‰j ¶Œã”¶‰ß’ö‚É‚¨‚¯‚郉ƒbƒg\“ñŽw’°‚Ì Globule leucocyte ‚ÌŒ`‘Ô‚Æ•ª•z“®‘Ô.
’r“c‚â‚æ‚¢CŽR‰È³•½i‰ðj: ‘æ77‰ñ“ú–{‰ð–UŠw‰ïŠÖ“Œ’n•û‰ï i89.10.21), “Œ‹ž, —\eW, p.33, l989.
3089. mŠw‰ïn iˆê”Êu‰‰j ×–EœŠi‚Í‹É«Œ`¬‚Ì—vˆö‚ƂȂ肤‚é‚©i‡VjƒfƒXƒ‚ƒ\|ƒ€‚Ì‹É«”z’u‚Æ×–EœŠi‚ÌŠÖŒW.
£ì²‹vCŽR‰È³•½i‰ðj: ‘æ42‰ñ“ú–{×–E¶•¨Šw‰ï i89.10.26), ‹ž“s, Cell Structure and Function,
14(6): 908, 1989.
3090. mŠw‰ïn iˆê”Êu‰‰j ƒwƒ~ƒfƒXƒ‚ƒ\|ƒ€‚ð“ÁˆÙ“I‚É”FŽ¯‚·‚郂ƒmƒNƒ|ƒiƒ‹R‘Ì‚Ìì». ªŠÝ–¾Gi“Œ‹žˆãŽ•‘åjC‘¼C£ì²‹vi‰ðj:
‘æ42‰ñ“ú–{×–E¶•¨Šw‰ï i89.10.26), ‹ž“s, Cell Structure and Function, 14(6): 909,
1989.
3091. mŒ¤‹†‰ïn i‹³ˆçu‰‰j “ª•”‰æ‘œ‰ð–UŠw. ›Mˆêi•új: _“Þ쌧•úŽËü‹ZŽt‰ï‘S‘“ˆêuK‰ï (89.09.17), ‰¡•l.
3092. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ×–E‚ð“Ç‚Þ. ŽR‰È³•½i‰ðj: ‘æ38‰ñ“dŽqŒ°”÷‹¾‹ZpŒ¤‹†‰ï i89.12.02), “Œ‹ž.
<<307 ŽÐ‰ïˆãŠw>>
3093. mŒ´’˜n ‘ŸŠí“Eo‚É‚¨‚¯‚鳑ø‚Ì‚ ‚è•û. ‰SFˆêiˆãŠwŒ´˜_j: Clin. Neurosci., 17(12): 92`95, 1989.
3094. mŒ´’˜n In the Matter of John Storar; Soper v. Storar; Eichner v.
Dillon, 420 N.E. 2d 64 (N.Y.1981)
|Ž¡—Ñł¿Ø‚è‚Ì—v¿‚ɑ΂µƒjƒ…|¥ƒˆ|ƒNB‚ªŽ–ˆÄ‚à–@—‚àŒ‹˜_‚àˆÙ‚È‚é“ñ‚‚̔»Œˆ‚ð‘g‚݇‚킹‚Ä”•\‚µ‚½Ž–—á. ‰SFˆêiˆãŠwŒ´˜_j:
ƒAƒƒŠƒJ–@C1989(2): 438`445, 1989.
3095. mŒ´’˜n In the Matter of Claire C. Conroy, 486A. 2d 1209 (N.J. 1983)
|Sg‚Ì•a‚ªd“Ä‚Å—]–½‚àŒÀ‚ç‚ê‚Ä‚¢‚éQ‚½‚«‚è‚̃i|ƒVƒ“ƒO. ƒz|ƒ€ÝZŠ³ŽÒ‚©‚ç•@o‰h—{‚Ì‚½‚߂̃`ƒ…|ƒu‚ðŽæ‚èŠO‚µ‚¤‚é‚©. ‰SFˆêiˆãŠwŒ´˜_j:
ƒAƒƒŠƒJ–@C1989(2): 445`452, 1989.
3096. mŒ´’˜n ‰Æ‘°‚ƈã—Ãi‚PjŒÂ‚ÌĶŽY‚ÆŽí‚ÌĶŽY. ‰SFˆêiˆãŠwŒ´˜_j: ƒP|ƒXŒ¤‹†, 222: 33`52, 1990.
3097. mŒ´’˜n u—Ï—ˆÏˆõ‰ïvl¥‚P. ‰SFˆêiˆãŠwŒ´˜_j: –@—¥Žž•ñ, 61(5): 139`144, 1989.
3098. mŒ´’˜n u—Ï—ˆÏˆõ‰ïvl¥‚Q. ‰SFˆêiˆãŠwŒ´˜_j: –@—¥Žž•ñ, 61(6): 154`159, 1989.
3099. mŒ¤‹†•ñn ‚¶‚ñ”xXüf’f‚ÌŒv—ʉ»‚ÉŠÖ‚·‚é’²¸Œ¤‹†.
‘ŠàVDŽ¡i‰qjC”ÑÀ•i•úŽËüˆãŠw‘‡Œ¤‹†ŠjC‰Á“¡‹v–Li•xŽmŽÊ^ƒtƒBƒ‹ƒ€jC¬”¨G•¶i“Œ‹ž”_H‘åjCÄ“¡éÆi“Œ“ú–{—·‹q“S“¹’†‰›•ÛŒ’ŠÇ—ŠjC
Žu“cŽõ•viŒ]”x˜JЕa‰@jC‚“‡‹vi“Œ‹ž“sŽO‘é•ÛŒ’ŠjC‚“c™¦i‰qjC‚–ì³—Yi•xŽmŽÊ^ƒtƒBƒ‹ƒ€jCŠÙ³’mi’†‰›˜J“ЊQ–hŽ~‹¦‰ïjCŠÚ–ì”V’ji•úŽË
üˆãŠw‘‡Œ¤‹†ŠjCç—t•Û”Vi‘S“ú–{˜J“•ŸŽƒ‹¦‰ïjC’¹˜eƒˆê˜Yi–¼ŒÃ‰®‘åjC–ì•Ó’n“ĘYi¹˜H‰Á‘Û•a‰@jC•Ÿ‹vŒ’“ñ˜Yi•úŽËüˆãŠw‘‡Œ¤‹†ŠjC×
“c—Ti•úŽËü‰e‹¿Œ¤‹†ŠjC¼–{“Oi•úŽËüˆãŠw‘‡Œ¤‹†Šj: ‚¶‚ñ”xXüf’f‚ÌŒv—ʉ»‚ÉŠÖ‚·‚é’²¸Œ¤‹†•ñ‘, p.1`69, 1989.
3100. mŒ¤‹†•ñn ƒhƒ‰ƒCƒNƒŠ|ƒjƒ“ƒOŒã‚̈ߕžŽc—¯Î–ûŒn—nÜ”Z“x. ‚“c™¦C‘ŠàVDŽ¡C‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qjC–å˜e•”ŽC¡ˆäDiŠÅŒìŠw•”jC’†‘ºŒ«iˆã—ÎЉïŠwj: ƒNƒŠ|ƒjƒ“ƒO‚ÆŒöO‰q¶‚ÉŠÖ‚·‚錤‹†•ñ‘Cp.34`40, 1989.
3101. mŒ¤‹†•ñn Œ’N•ÛŽ‘iŠˆ“®‚ÉŠÖ‚·‚é’²¸Œ¤‹†. ‚“c™¦i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwj: Eˆæ‚É‚¨‚¯‚é•ÛŒ’Ž–‹Æ‚ÉŠÖ‚·‚錤‹†Cp.8`23, 1989.
3102. mŒ¤‹†•ñiŠÂ‹«’¡jn ”÷¬ƒAƒXƒxƒXƒg‚Ì‹z“ü‚É‚æ‚鶑̉e‹¿’²¸Œ¤‹†.
—`dŽ¡iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC–ìè˜j‰Ei“ú–{ƒoƒCƒIƒAƒbƒZƒCŒ¤‹†ƒZƒ“ƒ^|jC‚“c™¦i‰qjC_ŽRé•FiŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC¬¼iliƒwƒ‹ƒXjC’J‘¾
”ü—YiŽÄ“c‰ÈŠwŠíŠBH‹Æj: u”÷¬ƒAƒXƒxƒXƒg‚Ì‹z“ü‚É‚æ‚鶑̉e‹¿’²¸Œ¤‹†vŒ‹‰Ê•ñ‘Cp.1`109, 1989.
3103. mŒ¤‹†•ñi˜J“Èjn ƒeƒNƒmƒXƒgƒŒƒX‚ÉŠÖ‚·‚é’²¸Œ¤‹†ÅI•ñ‘.
‘哇³Œõiˆã—Ãî•ñƒVƒXƒeƒ€ŠJ”ƒZƒ“ƒ^|jC‘ŠàVDŽ¡i‰qjC“àŽRŒ[Žii•xŽm’ÊjCì‡i“Œ‹ž—Žqˆã‘åjC_‘ã‰ë°iŽY‹Æˆã‰È‘åjCŒIŒ´‰ë’¼iŒÕƒm–å•a
‰@jC¬“‡_iIBMjC¬•õO‹vi“ŒˆŸ”R—¿H‹ÆjC²X–ØŽž—YiŠÖ“Œ˜JЕa‰@jCŠFì—m“ñiNTTjCŽR–{@•½i˜J“ÈŽY‹ÆˆãŠw‘‡Œ¤‹†Šj:
ƒeƒNƒmƒXƒgƒŒƒX‚ÉŠÖ‚·‚é’²¸Œ¤‹†ÅI•ñ‘, 1990.
3104. mŒ¤‹†•ñi˜J“Èjn ‚”N—î˜J“ŽÒ‚Ì–«Ž¾Š³‘Îô‚ð”z—¶‚µ‚½E‹Æƒ‚ƒfƒ‹‚̉ü—Ç’²¸Œ¤‹†•ñ‘.
ŽR–{@•½iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‘ŠàVDŽ¡i‰qjC²“¡‹Óˆêi“ú–{|ŠÇjC“c’†–ÎiV“ú“SjC’†‘ºŒ’ˆêi–h‰qˆã‘åjC—ÑŠì’jiŒc‘åjCXì—˜•FiŽO•H“d
‹@jC”ªã‹œŽiiº˜a‘åjC’†ŠÙr•vCŒ´’J—²ŽjiŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‘«—§M”VC¬ŠCGŽ¡C²“¡‘¥‰pC‹g•x•ÛŒbi‰ü—Ç’²¸Œ¤‹†•”j:
‚”N—î˜J“ŽÒ‚Ì–«Ž¾Š³‘Îô‚ð”z—¶‚µ‚½E‹Æƒ‚ƒfƒ‹‚̉ü—Ç’²¸Œ¤‹†•ñ‘C1989.
3105. mŒ¤‹†•ñi˜J“Èjn •²‚¶‚ñ‚΂˜Iì‹ÆŽÒ‚̖ƉuˆÙí‚ÉŠÖ‚·‚é—Õ°Œ¤‹†. ‚“c™¦C‘ŠàVDŽ¡i‰qj: •²‚¶‚ñ‚΂˜Iì‹ÆŽÒ‚̖ƉuˆÙí‚ÉŠÖ‚·‚é—Õ°Œ¤‹†•ñ‘Cp.1`30, 1989.
3106. mŒ¤‹†•ñi˜J“Èjn Ò‘‘¹ŽÒ‚ÌŽ¾•a”¶—vˆö‚̉ðÍ|Ò‘‘¹ŽÒ‚Ì«Ši‚Æ—…Š³Ž¾•a‚Æ‚ÌŠÖŒW|.
‚“c™¦i‰qjC–å˜e•”ŽiŠÅŒìŠw•”jC‘ŠàVDŽ¡i‰qjC¡ˆäDiŠÅŒìŠw•”j: ¢Ò‘‘¹ŽÒ‚ÌŽ¾•a”¶—vˆö‚̉ðÍ£Œ¤‹†•ñ‘Cp.1`24,
1989.
3107. m‘àn Health for Today's Youth, Hope for Tomorrow's World|Educate
for Health. â㳓¹C‰Í¼‹IºiŽ™j: World Health Forum, 10(2): 158`159, 1989.
3108. m‘àn ‰^“®•‰‰×‚Æ”æ˜J. ‘ŠàVDŽ¡i‰qj: ‚©‚炾‚̉Ȋw, 148: 43`46, 1989.
3109. m‘àn ƒnƒCƒeƒNŽY‹Æ˜J“ŽÒ‚ÌŒ’N‚ÆŽ¾•a. ‘ŠàVDŽ¡C’F—mC‚“c™¦i‰qj: ƒqƒ…|ƒ}ƒ“ƒTƒCƒGƒ“ƒX, 2(2): 23`29, 1989.
3110. m‘àn •a‰@iˆã—ÃŒ»êj‚É‚¨‚¯‚éì‹ÆŠÂ‹«ŠÇ—. ‚“c™¦i‰qjC–å˜e•”ŽiŠÅŒìŠw•”j: ˆÀ‘SHŠw, 29(1): 2`11, 1990.
3111. m‘àn ’†‚”N—î˜J“ŽÒ‚̶—‹@”\‚ƘJ“ЊQ|•½t‹@”\¥Ž‹Šo”½‰žŽžŠÔ‚ÌŒŸ“¢. ‚“c™¦C‹´–{‹Nˆê˜Yi‰qj: ˆãŠw‚Ì‚ ‚ä‚Ý, 149(13): 934, 1989.
3112. m‘àn ”¼“±‘Ìì‹ÆŽÒ‚É‚¨‚¯‚éƒq‘f‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO|”AC–Ñ”¯CŒŒ‰t‚ð—p‚¢‚½ƒ‚ƒjƒ^ƒŠƒ“ƒO|. ‘ŠàVDŽ¡C‚“c™¦i‰qj: ˆãŠw‚Ì‚ ‚ä‚Ý, 151(20): 113, 1989.
3113. m‘àn ƒAƒXƒxƒXƒg‚É‚æ‚錒N‰e‹¿‚Æ‚»‚Ì“Å«. ‘ŠàVDŽ¡i‰qj: ŒöŠQ‚Æ‘Îô, 25(10): 979`983, 1989.
3114. m‘àn •p‰ñŒ‡‹Î. ‘ŠàVDŽ¡C‚“c™¦i‰qj: Sgˆã—Ã, 1(8): 1158`1163, 1989.
3115. m‘àn ŽY‹Æ•ÛŒ’‚ð’S‚¤lX|V‚µ‚¢Œ’N‘ª’è‚ÆTHPiƒg|ƒ^ƒ‹¥ƒwƒ‹ƒX¥ƒvƒƒ‚|ƒVƒ‡ƒ“ƒvƒ‰ƒ“j|. ‚“c™¦i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwj: •ÛŒ’‚̉Ȋw, 31(6): 389`393, 1989.
3116. m‘àn Eê‚Å‚ÌŒ’Nf’f. ‘ŠàVDŽ¡C‚“c™¦i‰qj: •êŽq•ÛŒ’î•ñ, (19): 86`91, 1989.
3117. muÀn Šª“ªŒ¾|ˆã—ÃŽÒ‘¤‚Ì–ž‘«‚ÆŠ³ŽÒ‘¤‚Ì–ž‘«. ‘O“c^Ž¡i“àj: ‘‡ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“, 17(9): 649, 1989.
3118. mŠwp‘n iŽ·•Mj ‚±‚ê‚©‚ç‚ÌŒ’NŠÇ—; –{Ž‚ÌŠ§s‚É‚ ‚½‚Á‚Ä|Œ’NŠÇ—‚̉Ȋw“I•]‰¿‚ÌŽ‹“_‚æ‚è|, p.2`4, ‚“c™¦i‰qj. •ÒW ‘S‘˜J“‰q¶’c‘̘A‡‰ï•ÒC ‘S‘˜J“‰q¶’c‘̘A‡‰ï, “Œ‹ž, 89.11.30”s.
3119. mŠwp‘n iŽ·•Mj ‚±‚ê‚©‚ç‚ÌŒ’NŠÇ—; æ’[ŽY‹Æ‚É‚¨‚¯‚錒NŠÇ—‚̉ۑè, ‘ŠàVDŽ¡i‰qj. •ÒW ŠÙ³’m•ÒC ‘S‘˜J“‰q¶’c‘̘A‡‰ï, “Œ‹ž, 89.11.30”s.
3120. mŠwp‘n iŽ·•Mj VDTˆãŠwƒ}ƒjƒ…ƒAƒ‹; VDTì‹Æ‚É”º‚¤Ž©ŠoÇó‚ÆŠá‚ÉŠÖ‚·‚é‘i‚¦‚ª‘½‚¢——R, p.18`22, ‘ŠàVDŽ¡i‰qj. •ÒW Îì“Ni–k—¢‘åj•ÒC ‘S“ú–{•a‰@o”ʼnï, “Œ‹ž, 89.09.15”s.
3121. mŠwp‘n iŽ·•Mj VŠO‰ÈŠw‘åŒn (12)‘ŸŠíˆÚA;@ ‘ŸŠíˆÚA‚Æ–@—¥,@p.17`31C ‰SFˆêiˆãŠwŒ´˜_j. •ÒW oŒŽN•vC‘¼, ŠÄC –Ø–{½“ñC˜a“c’B—Y ŠÄC, ’†ŽR‘“X, “Œ‹ž, 89.06.30”s.
3122. mŠwp‘n iŽ·•Mj ”]Ž€‚ðŠw‚Ô,@ ‰SFˆêiˆãŠwŒ´˜_j. “ú–{•]˜_ŽÐ, “Œ‹ž, 89.06.20”s.
3123. mŠwp‘n iŽ·•Mj —Õ°ˆã‚Ì‚½‚ß‚Ì–@ˆãŠw; –@ˆãŠw“ü–å|–@ˆãŠw‚Æ‚Í|Cp.1`4C ‘D”ö’‰Fi–@ˆãj. ’©‘q‘“X, “Œ‹ž, 89.04.20 ”s.
3124. mŠwp‘n iŽ·•Mj —Õ°ˆã‚Ì‚½‚ß‚Ì–@ˆãŠw; ŒŒ‰tŒ^‚¨‚æ‚ÑeŽqŠÓ•Ê, p.117`127CŒÂlŽ¯•Ê‚¨‚æ‚Ñ•¨‘ÌiÕjŒŸ¸, p.129`138C ¬’J~ˆêi–@ˆãj. ’©‘q‘“X, “Œ‹ž, 89.04.20 ”s.
3125. mŠwp‘n iŽ·•Mj ˆãŠw¶‚Ì‚½‚ß‚ÌŠî‘bˆãŠw–â‘èÚ‰ð, Series 9 –@ˆãŠw(‰ü’ù‘æ2”Å); ‡U.
ŒŸŽr¥ŒŸˆÄ‚Æ–@ˆã‰ð–UCp.17`21C‡W. Ž€‘ÌŒ»ÛCp.33`40, ‘D”ö’‰Fi–@ˆãj. •ÒW àVŒû²Žqi“Œ—ˆã‘åj•ÒC ˆãŠw‹³ˆço”ÅŽÐ,
“Œ‹ž, 90.02.28 ”s.
3126. mŠwp‘n iŽ·•Mj ˆãŠw¶‚Ì‚½‚ß‚ÌŠî‘bˆãŠw–â‘èÚ‰ð, Series 9 –@ˆãŠw(‰ü’ù‘æ2”Å); ‡]‡W. ŒŒ‰tŒ^,
p.152`165, ‡]‡X. •s“K‡—AŒŒ¥V¶Ž™—nŒŒ«Ž¾Š³, p.175`187, ‡]‡Y. eŽqŠÓ•Ê, p.189`203C
¬’J~ˆêi–@ˆãj. •ÒW àVŒû²Žqi“Œ—ˆã‘åj•ÒC ˆãŠw‹³ˆço”ÅŽÐ, “Œ‹ž, 90.02.28 ”s.
3127. m‹³‰È‘n iŽ·•Mj ÅVˆãŠw’mŽ¯‚Ì®—|ƒvƒ‹ƒ~ƒGŒöO‰q¶Še˜_; ì‹ÆŠÂ‹«ŠÇ—Cì‹ÆŠÇ—‚¨‚æ‚ÑŒ’NŠÇ—Cp.154`160C
‚“c™¦i‰qjC–å˜e•”ŽiŠÅŒìŠw•”j. •ÒW â–{OiŽOd‘åjC˜a“cUi“Œ‘åj•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 89.07.20”s.
3128. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒWj ‰ü’ùì‹ÆŠÂ‹«‘ª’èQ&A, •ÒW
—`dŽ¡i˜J“ÈŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC‚“c™¦i–k—¢‘奉qjCÀ–ì—YŽuiÀ–ì˜J“ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒgjC¬’rT–çi_“Þ쌧—\–hˆãŠw‹¦‰ïjC¬¼il
i–k—¢¥ƒwƒ‹ƒX¥ƒTƒCƒGƒ“ƒXjC‘åŠÖeC˜I–Ø•Ûi˜J“Ȋ‹«‰ü‘PŽºjC“c’†’C—Yi“ú–{ì‹ÆŠÂ‹«‘ª’苦‰ïj•ÒC “ú–{ì‹ÆŠÂ‹«‘ª’苦‰ï, “Œ‹ž,
89.06.25”s.
3129. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn i•ÒW¥Ž·•Mj V”Å¥ŽY‹Æˆã‚ÌE–± Q & A, •ÒW
‚“c™¦i‰qjC”~‘ò•×i“ú–{—\–hˆãŠw‹¦‰ïjC—`dŽ¡iŽY‹ÆˆãŠw‘‡Œ¤‹†ŠjC“c’†–Îi‘S‘˜J“‰q¶’c‘̘A‡‰ïjC‘¼•ÒC ŽY‹ÆˆãŠwU‹»à’c, “Œ‹ž,
89.06.00”s.
3130. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj “O’ꕪ͊Ǘ‰h—{Žm‘‰ÆŽŽŒ±–â‘èW; Œ’NŠÇ—Cp.245`256C ‘ŠàVDŽ¡i‰qj. •ÒW ‘ŠàVDŽ¡i–k—¢‘åjC‘¼•ÒC ˆãŽ•–òo”Å, “Œ‹ž, 89.04.00”s.
3131. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ƒAƒXƒxƒXƒg‚É’§‚ÞŽOŠÇ—; ƒAƒXƒxƒXƒgì‹ÆŽÒ‚ÌŒ’NŠÇ—, p.158`173, ‘ŠàVDŽ¡i‰qj. •ÒW “‡³Œá•ÒC ’†‰›˜J“ЊQ–hŽ~‹¦‰ï, “Œ‹ž, 89.04.28”s.
3132. m‚»‚Ì‘¼‚Ì’˜‘iŒ[–Ö‘jn iŽ·•Mj ‚¹‚«‘‘¹‚Ì•û‚ÌŒ’NŠÇ—‚Ì‚µ‚¨‚èCp.1`45, ‚“c™¦i‰qjC‹{èˆê‹»i_“Þ쌧‘‡ƒŠƒnƒZƒ“ƒ^|jCòŽR’†ŽOi“ŒŠC‘åjC’†ìˆê•Fi’}”g‘åj. ˜JДN‹à•ŸŽƒ‹¦‰ï, “Œ‹ž, 89.10.20”s.
3133. m‚»‚Ì‘¼i•¶Œ£Ð‰îjn ƒ}ƒCƒNƒƒGƒŒƒNƒgƒƒjƒNƒXŽY‹Æ. ‘ŠàVDŽ¡i‰qj: ˆÀ‘S‰q¶ƒRƒ“ƒTƒ‹ƒ^ƒ“ƒg, 9: 79`80, 1989.
3134. m‚»‚Ì‘¼i˜_’djn ’†‚”N‚ÌŒ’N‚ƃXƒ||ƒc; Eê‚ÍŒ’N‚Ì”MŠî’n‚Å‚ ‚é. ‚“c™¦i‰qj: ‚Ý‚ñ‚Ȃ̃Xƒ||ƒc, 11(9): 4, 1989.
3135. mŠw‰ïn i‹³ˆçu‰‰j ŽY‹Æˆã‚ÆЊQˆãŠw. ‚“c™¦i‰qj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.18), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 39, 1989.
3136. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j ‘O—Õ°¥—Õ°¥ŽÐ‰ï–Ê‚©‚猩‚½V–ò‚Ì–â‘è“_|—Õ°•]‰¿‚ÌŠÏ“_‚©‚ç|. ”è’õ•vi“àj: ‘æ63‰ñ“ú–{–ò—Šw‰ï‘‰ï i90.03.25°28), “Œ‹ž.
3137. mŠw‰ïn iƒpƒlƒ‹j ŠÂ‹«ˆãŠw‚Æ”xŽ¥ŠE‘ª’è. ‘ŠàVDŽ¡C‚“c™¦i‰qjC¬’J½i“Œ‹ž“d‹@‘åj: ‘æ4‰ñ“ú–{¶‘ÌŽ¥‹CŠw‰ï‘å‰ï (89.06.02), “¿“‡.
3138. mŠw‰ïn iˆê”Êu‰‰j ¸_‰È‚Ƃ̃`[ƒ€ƒAƒvƒ[ƒ`‚ɂ‚¢‚Ä. ŒÃŽR“o—²C‰eŽRL”üC—é–Ø•q•FC•“cŒ[C‰–’JMKiŒ`ŠOj: ‘æ32‰ñ“ú–{”ü—eŠO‰ÈŠw‰ï‘‰ï (89.04.20), ‰YˆÀ.
3139. mŠw‰ïn iˆê”Êu‰‰j Eˆæ‚Å‚Ì’èŠúŒ’Nf’f‚ÌŒ‹‰Ê‚©‚ç‚Ý‚½ŒŒˆ³‚ÆŒŒ´Ca,Mg,P‚ÌŠÖŒW.
—é–Ø_ˆêC¬“cŒ›ˆêC’Å–¼•x‘ iŠÖ“Œ˜JЕa‰@jC‚“c™¦i‰qj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.28), ÂXC
Šw‰ïu‰‰—vŽ|WCp.61, 1989.
3140. mŠw‰ïn iˆê”Êu‰‰j ‰^“®ƒXƒgƒŒƒX‚ɑ΂·‚ézŠÂŠíŒn”½‰žCŒŒ’†ƒJƒeƒR|ƒ‹ƒAƒ~ƒ““®‘Ô.
‹´–{‹Nˆê˜YC‚“c™¦C‘ŠàVDŽ¡C•x‰i‰qC’F—mi‰qjCˆäã—tŽqC¡–ì—mŽÀi—\–hˆãŠwŒnjC’†‘ºŒ«iˆã—ÎЉïŠwj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï
(89.04.28), ÂXC Šw‰ïu‰‰—vŽ|WCp.86, 1989.
3141. mŠw‰ïn iˆê”Êu‰‰j Eê‚É‚¨‚¯‚é“ñ‚‚̗}‚¤‚ÂŽÚ“x‚Ì”äŠrŒŸ“¢.
’|“à‚Ђë‚ÝC’J“c‹v”üŽqiƒwƒ‹ƒXjC‚“c™¦C‘ŠàVDŽ¡i‰qjC™‰Y—R”üŽqC–‹I”ü‘ãi—\–hˆãŠwŒnj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï
(89.04.30), ÂXC Šw‰ïu‰‰—vŽ|WCp.204, 1989.
3142. mŠw‰ïn iˆê”Êu‰‰j ƒgƒ‹ƒGƒ“¥ƒLƒVƒŒƒ“‚΂˜IŽÒ‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒOƒf|ƒ^‚ÌŠˆ—p‚ɂ‚¢‚Ä.
¬¼r—YC‘åX‹`•¶C—é–Ø”ü’q‘ãC¬¼iliƒwƒ‹ƒXjC‚“c™¦i‰qj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.30), ÂXC
Šw‰ïu‰‰—vŽ|WCp.289, 1989.
3143. mŠw‰ïn iˆê”Êu‰‰j Ò‘‘¹ŽÒ‚ÌŒ’Nó‘Ԃɉe‹¿‚·‚éˆöŽq‚̉ðÍ.
¡ˆäDC–å˜e•”ŽiŠÅŒìŠw•”jC‚“c™¦C‘ŠàVDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwjC‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï
(89.05.03), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 171, 1989.
3144. mŠw‰ïn iˆê”Êu‰‰j ‰”ì‹ÆŽÒ‚ÌT×–EƒTƒuƒZƒbƒg. ‘ŠàVDŽ¡C‚“c™¦C‘O“cŒúŽuC‹´–{‹Nˆê˜YCŒIŒ´–«C•x‰i‰qC’F—mi‰qj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.03), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 208, 1989.
3145. mŠw‰ïn iˆê”Êu‰‰j ‰^“®ƒXƒgƒŒƒX‚ÆT×–EƒTƒuƒZƒbƒg. ‹´–{‹Nˆê˜YC‚“c™¦C‘ŠàVDŽ¡C•x‰i‰qC’F—mi‰qjC’†‘ºŒ«iˆã—ÎЉïŠwj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.03), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 291, 1989.
3146. mŠw‰ïn iˆê”Êu‰‰j •²‚¶‚ñì‹Æ•ÊŒ’fŒ‹‰Ê‚ÌŒŸ“¢. •x‰i‰qC‚“c™¦C‘ŠàVDŽ¡C‹´–{‹Nˆê˜YC’F—mi‰qj: ‘æ59‰ñ“ú–{‰q¶Šw‰ï‘‰ï (89.05.04), H“cC “ú–{‰q¶Šw‰ïŽC44(1): 554, 1989.
3147. mŠw‰ïn iˆê”Êu‰‰j Ž€ŒãŒo‰ßŽžŠÔ„’è‚ÉŠÖ‚·‚éÄŒŸ“¢i‘æ‡[•ñj|Ž€”Á—̈æ‚É‚Ý‚ç‚ê‚é”畆ˆìŒŒ“_‚̈Ӌ`‚ɂ‚¢‚Ä|.
ŒÃì—FC‘D”ö’‰Fi–@ˆãj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â) : 145, 1989.
3148. mŠw‰ïn iˆê”Êu‰‰j ’‚‘§‹@\‚É‚¨‚¯‚éƒnƒvƒgƒOƒƒrƒ“‚Ì–ðŠ„‚ÉŠÖ‚·‚錤‹†i‡Tj.
’†“cLŽqCàVŒû²Žqi“Œ—ˆã‘åjC¬’J~ˆêC‘D”ö’‰Fi–@ˆãjCŽR‰ºƒPƒTŽqCHŽRŸ‘¥i“Œ—ˆã‘åj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï
(89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 130, 1989.
3149. mŠw‰ïn iˆê”Êu‰‰j •â‘ÌŒn‚Ì–@ˆãŠw“IŒ¤‹†|’‚‘§Žž‚É‚¨‚¯‚éC3‚Ì•Ï“®|.
’†‘º–ΊîCàVŒû²Žqi“Œ—ˆã‘åjC¬’J~ˆêi–@ˆãjC’†ŽR–ÎMiŽÀ“®ŒnjC‘D”ö’‰Fi–@ˆãj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï (89.05.12),
‰ªŽRC “ú–@ˆãŽC43(•â): 166, 1989.
3150. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒ—¬“®‘Ô‚©‚ç‚Ý‚½’‚‘§Ž€‚ÌÄŒŸ“¢i‡Wj|ŽÀŒ±“I‹}‘¬“MŽ€Žž‚ɂ‚¢‚Ä|.
¬’J~ˆêi–@ˆãjCàVŒû²Žqi“Œ—ˆã‘åjC‘D”ö’‰Fi–@ˆãjC’†ŽR–ÎMiŽÀ“®ŒnjC’†“cLŽqi“Œ—ˆã‘åj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï
(89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 170, 1989.
3151. mŠw‰ïn iˆê”Êu‰‰j Å‹ß17”NŠÔ‚ÌŒŸˆÄ—á‚Ì“Œv“IŠÏŽ@.
™]G–¾C‘D”ö’‰FC¬’J~ˆêCŒÃì—FCŒIŒ´•¶’ji–@ˆãjCàVŒû²Žqi“Œ—ˆã‘åjCŒIŒ´Ž—RiŒc‘åj: ‘æ73ŽŸ“ú–{–@ˆãŠw‰ï‘‰ï
(89.05.12), ‰ªŽRC “ú–@ˆãŽC43(•â): 280, 1989.
3152. mŠw‰ïn iˆê”Êu‰‰j ŒŸˆÄ¥‰ð–U—á‚É‚¨‚¯‚é’†“ÅŽ€‚ÌŒ»‹µ. àVŒû²ŽqCŽR‰ºƒPƒTŽqi“Œ—ˆã‘åjC‘D”ö’‰FC¬’J~ˆêCŒÃì—FC™]G–¾CŒIŒ´•¶’ji–@ˆãj: ‘æ58‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.10.07), “Œ‹ž.
3153. mŠw‰ïn iˆê”Êu‰‰j –@ˆã–UŒŸŽž‚É‚¨‚¯‚é‘ŸŠíd—Ê‚Ì“Œv“IŠÏŽ@(‘æ1•ñ). ™]G–¾C¬’J~ˆêCŒÃì—FCŒIŒ´•¶’jC‘D”ö’‰Fi–@ˆãjCàVŒû²Žqi“Œ—ˆã‘åj: ‘æ58‰ñ“ú–{–@ˆãŠw‰ïŠÖ“Œ’n•û‰ï (89.10.07), “Œ‹ž.
3154. mŠw‰ïn iˆê”Êu‰‰j •²‚¶‚ñì‹Æ‚Æ‚¶‚ñ”xŒ’fŒ‹‰Êi‘æ2•ñj. •x‰i‰qC‚“c™¦C‘ŠàVDŽ¡C‹´–{‹Nˆê˜YC’F—mi‰qj: ‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.18), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 77, 1989.
3155. mŠw‰ïn iˆê”Êu‰‰j ˜J“ЊQˆãŠwŒ¤‹†‚ÌŽY‹ÆŽÐ‰ïŠw“IlŽ@.
’†‘ºŒ«iˆã—ÎЉïŠwjC‚“c™¦C‘ŠàVDŽ¡C‘O“cŒúŽuC‹´–{‹Nˆê˜YC•x‰i‰qC’F—mi‰qjC–å˜e•”ŽC¡ˆäDiŠÅŒìŠw•”j:
‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.19), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 130, 1989.
3156. mŠw‰ïn iˆê”Êu‰‰j –«ŠúÒ‘‘¹ŽÒ‚ÌCMIŽ©ŠoÇó“Á«.
¡ˆäDC–å˜e•”ŽiŠÅŒìŠw•”jC•Ÿ•x˜a•vi‘—§Œö‰q‰@jC‚“c™¦C‘ŠàVDŽ¡i‰qjC’†‘ºŒ«iˆã—ÎЉïŠwjC‹´–{‹Nˆê˜YC•x‰i‰qi‰qj:
‘æ37‰ñ“ú–{ЊQˆãŠw‰ïŠwp‘å‰ï (89.10.19), L“‡, “ú–{ЊQˆãŠw‰ïŽ, (—Õ‘): 138, 1989.
3157. mŠw‰ïn iˆê”Êu‰‰j ‹~–½‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚é“]‰@‚ւ̃\[ƒVƒƒƒ‹ƒ[ƒN‰‡•|“Á‚ɉ“Šu’n‚Ö“]‰@‚µ‚½12Ç—á‚ÌlŽ@.
Žæo~ŽqC‰Á“‡–¾iˆã—ÑŠ’kŽºjC‘Š”nˆêˆåC‘Oì˜a•FC‘å˜a“c—²i‹~–½j: ‘æ17‰ñ“ú–{‹~‹}ˆãŠw‰ï‘‰ï (89.11.07), “Œ‹ž.
3158. mŠw‰ïn iˆê”Êu‰‰j ”ü—eŠO‰È‚Æ•ÏŒ`‹°•|ǂɂ‚¢‚Ä. ŒÃŽR“o—²CçÝŽ½C‰FˆäŒª“ñC“àÀ‰hŽ÷C‰–’JMKiŒ`ŠOjCŽRéˆê˜YC΋½‰ªƒi¸j: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï i89.04.20), ‰YˆÀ.
3159. mŠw‰ïn iˆê”Êu‰‰j ’nˆæ‚ÌuÝ‘îˆã—ÃŒŸ“¢‰ïv‚É‚¨‚¯‚鎖—á‚ð’Ê‚µ‚Ẳۑè. ¬–ì•q–¾i‘Š–ÍŒ´ŽÐ‰ï•ŸŽƒ‹¦‹c‰ïjCÄ“¡–L˜ai“àj: ‘æ12‰ñƒvƒ‰ƒCƒ}ƒŠ[ƒPƒAŠw‰ï i89.06.25), –¼ŒÃ‰®.
3160. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚éÝ‘îƒPƒA[ƒVƒXƒeƒ€.
Ä“¡–L˜ai“àjC‰““¡MŽqiŠÅŒì•”jC–x‰z—R‹IŽqi‘‡ˆã—ÑŠ’k•”jC‚“ˆ‰Á‘ãŽqCŽR–{ŒPŽqiŠÅŒìjCדc–«i“àj: ‘æ12‰ñƒvƒ‰ƒCƒ}ƒŠ[ƒPƒAŠw‰ï
i89.06.25), –¼ŒÃ‰®.
3161. mŒ¤‹†‰ïn i“Á•Êu‰‰j —Õ°‚ƈ㎖•´‘ˆ. “c’†—ºi–ƒj: ‘æ14‰ñ‘ÌŠOzŠÂŒ¤‹†‰ï (88.12.03), ‘Š–ÍŒ´.
3162. mŒ¤‹†‰ïn i“Á•Êu‰‰j Countermeasures of Kitasato University Hospital
against Damaging Earth Quakes. ‘åê³–¤iŠÅŒìŠw•”jC‘å˜a“c—²i‹~–½jC–î“cˆê•vi•a‰@Ž––±jCÎŒ´ºi‹¹ŠOj:
Seminario International de Planeamiento (89.08.20), Lima, Peru.
3163. mŒ¤‹†‰ïn i“Á•Êu‰‰j Role of the University Hospital in Emergency Medical
System. ‘å˜a“c—²i‹~–½jC‘åê³–¤iŠÅŒìŠw•”jC–î“cˆê•vi•a‰@Ž––±jCÎŒ´ºi‹¹ŠOj: Seminario International
de Planeamiento (89.08.20), Lima, Peru.
3164. mŒ¤‹†‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –k—¢‘åŠw•a‰@‚Æ’nˆæˆã—Âɂ‚¢‚Ä. ‘å˜a“c—²i‹~–½j: –k—¢‘åŠw•a‰@ŠJ‰@‹L”OƒVƒ“ƒ|ƒWƒEƒ€ (89.07.19), ‘Š–ÍŒ´.
3165. mŒ¤‹†‰ïn iƒpƒlƒ‹j ––Šúˆã—ÂÌÝ‚é‚ׂ«Žp‚ð‹‚ß‚Ä. ‰SFˆêiˆãŠwŒ´˜_j: i89.10.02), “Œ‹ž, ƒWƒ…ƒŠƒXƒg, (945): 17`36, 1989.
3166. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj Biological Monitoring of Arsenic Exposure.
‘ŠàVDŽ¡C‚“c™¦i‰qj: United States-Japan Cooperative Seminer on Biological
Monitoring”•\”NŒŽ“ú(89.08.25), Hawai.
3167. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ”¼“±‘ÌH‹Æ‚É‚¨‚¯‚é‚Бf‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO. ‘ŠàVDŽ¡C‚“c™¦C’F—mi‰qj: “ú–{‰q¶Šw‰ïƒ|ƒNƒVƒˆƒbƒv¥ƒqƒg‚É‚¨‚¯‚é—LŠQ‰»Šw•¨Ž¿‚̶•¨Šw“Iƒ‚ƒjƒ^ƒŠƒ“ƒO (89.11.25), ‘åã.
3168. mŒ¤‹†‰ïn iˆê”Êu‰‰j î•ñ’ñ‹Ÿ‚ÉŠÖ‚·‚éˆãŽt‚ÆŠ³ŽÒŠÖŒW‚ɂ‚¢‚Ä. ‰SFˆêiˆãŠwŒ´˜_j: Œú¶ÈŠ³ŽÒƒT|ƒrƒX‚ÌÝ‚è•û‚ÉŠÖ‚·‚駒k‰ï (88.04.20), “Œ‹ž, Š³ŽÒƒT|ƒrƒXƒKƒCƒhƒ‰ƒCƒ“, p.88`93, 1989.
<<308 ˆãŠwŠT˜_>>
3169. mŒ´’˜n Eà–¾‚Æ“¯ˆÓE‚ɂ‚¢‚Ä‚Ì•ñ.
‰Á“¡ˆê˜Yi¬éŠw‰€jCˆ¢•”³˜aiŽœŒbˆã‘åjCìã³–çi•ª¶jC™–{Š¤iã‘åjC—é–؉i“ñiŽO•H‰»¬jC‘\–숻Žqiì‰ÆjC’†ªçŽ}i–¯‘°ŠwU‹»‰ïjC
’†‘º—Y“ñ˜Yi–¾Ž¡‘åjC‰i£³–¤i“ú–{ˆãŽt‰ïjC–x“cŸ“ñi•ÙŒìŽmj: “ú–{ˆãŽt‰ïŽGŽC103(4): 515`528, 1990.
<<309 ŽÀŒ±“®•¨Šw>>
3170. mŒ´’˜n Prolactin Secretion and Its Response to Stress during the
Estrous Cycle of the Rats. ŒÃŠÚêˆêiŽÀ“®jCˆ°Œ´‹v‘ãi‘‡—Õ°ŒnjC’†–쌒ŽiiŽÀ“®j: Exp. Anim.,
38(4): 313`318, 1989.
3171. mŠw‰ïn iˆê”Êu‰‰j ƒEƒŒƒ^ƒ“–ƒŒ‚É‚æ‚郉ƒbƒg”î‘OŠú‚̃vƒƒ‰ƒNƒ`ƒ“¥ƒT|ƒW‚Ì—}§.
ŒÃŠÚêˆêiŽÀ“®jCˆ°Œ´‹v‘ãi‘‡—Õ°ŒnjC’†–쌒ŽiiŽÀ“®j: ‘æ36‰ñ“ú–{ŽÀŒ±“®•¨Šw‰ï (89.05.30), “Œ‹ž,
u‰‰—vŽ|WCp.113, l989.
3172. mŠw‰ïn iˆê”Êu‰‰j ƒCƒk‚Ì”ñŠJ‹¹‰º‚É‚¨‚¯‚éŽÀŒ±“I•s®–¬ì¬‚ɂ‚¢‚Ä.
”¯N—YiŽÀ“®jC’†ŽR–ÎMCŠÛŽR–ΑPiŽÀ“®ŒnjCˆ°Œ´‹v‘ãi‘‡—Õ°ŒnjC“ޗljÀ—mi¶•¨•¨—ŒnjC˜kì_ŽiiŽÀ“®Œnj: ‘æ108‰ñ“ú–{bˆãŠw‰ï
(89.10.03), ·‰ª, u‰‰—vŽ|WCp.231, l989.
3173. mŠw‰ïn iˆê”Êu‰‰j ‹U”DPƒ‰ƒbƒg‚̃vƒƒ‰ƒNƒ`ƒ“¥ƒT|ƒW‚É‹y‚Ú‚·ƒEƒŒƒ^ƒ“–ƒŒ‚̉e‹¿. ŒÃŠÚêˆêiŽÀ“®jC’†–쌒ŽiiŽÀ“®j: ‘æ108‰ñ“ú–{bˆãŠw‰ï (89.10.03), ·‰ª, u‰‰—vŽ|WCp.66, l989.
3174. mŒ¤‹†‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj ˆ««‚”Mǃ‚ƒfƒ‹ƒuƒ^‚̈笂ƬŒ^‰»‚ɂ‚¢‚Ä. ’†–쌒ŽiiŽÀ“®j: ‘æ13‰ñˆ««‚”MŒ¤‹†‰ï (89.12.10), “Œ‹ž, ´˜^WCp.5, l989.
3175. mŒ¤‹†‰ïn iˆê”Êu‰‰j ’´‰¹”g–@‚É‚æ‚éƒlƒR‚Ì”DPf’f‚ÆŽq‹{’~”^Ç‚Ì‚P—á. ”¯N—YiŽÀ“®jC’·’Jì”ü•ÛC•½”ö‚ß‚®‚ÝiŽÀ“®ŒnjC’†–쌒ŽiiŽÀ“®j: ‘æ5‰ñbˆã‰æ‘œf’fŒ¤‹†‰ï (89.00.00), “Œ‹ž, —vŽ|WCp.9, l989.
3176. mŒ¤‹†‰ïn iˆê”Êu‰‰j ˆ««‚”MÇ•a‘Ôƒ‚ƒfƒ‹ƒuƒ^‚̬Œ^‰»‚ɂ‚¢‚Ä.
”¯N—YiŽÀ“®jC˜kì_ŽiC‚éŽçC‰º‰Í•”L¹iŽÀ“®ŒnjC’†–쌒ŽiiŽÀ“®jC–쌩ŽREC“n•Ó•qC“c’†—ºi–ƒj:
‘æ6‰ñ“ú–{Ž¾Š³ƒ‚ƒfƒ‹“®•¨Œ¤‹†‰ï‘‰ï (89.11.29), “Œ‹ž, ´˜^WCp.55, l989.
<<310 ‘ª’è–@E‹Zp˜_‚È‚Ç>>
3177. mŒ´’˜n ³Œ·”g’¼ü‰Á‘¬“xŽhŒƒ‚É‚æ‚鎨΋@”\ŒŸ¸–@|–À˜H‹@”\‚“xáŠQ—á‚ÌŽ¨Î‹@”\‚ɂ‚¢‚Ä.
“¡–ì–¾lC“¿‘Œú“ñC”ª–؈ê‹LC‹g”ö’mC•½ŽR•ûrCŒÜ“‡ˆê‹giŽ¨•@jC•Ä“c•qi¶•¨•¨—Œnj: Equilibrium
ResearchC48(3): 235`240, 1989.
3178. mŒ´’˜n ––½‘O’ë«‚ß‚Ü‚¢‚ɑ΂·‚郊ƒnƒrƒŠƒe|ƒVƒ‡ƒ“–@i–k—¢‘åŠw_ŒoŽ¨‰È•ûŽ®j.
“¡–ì–¾lC“¿‘Œú“ñC¼‰ª–¾—TCV“cŒ’‘¾˜YC”ª–؈ê‹LC‹g”ö’mC•½ŽR•ûrC’·À‰p–¾C¯–ìŒ÷CŒÜ“‡ˆê‹gCiŽ¨•@j: Equilibrium
ResearchC48(4): 325`331, 1989.
3179. mŒ´’˜n Quantitative Computed Tomographic Evaluation of Femoral Bone
Mineral Content in Renal Osteodystrophy Compared with Radial Photon
Absorptiometry. ÷ˆä´Žqi•újCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCŠâ”g–Îi•újC“à“c‹v‘¥i“Œ‘åˆã‰ÈŒ¤jC¼—Ñ—²i•új:
Investigative Radiology, 24(5): 375`382, 1989.
3180. mŒ´’˜n ƒJ|ƒhŒ^’mŽ¯ƒx|ƒXƒVƒXƒeƒ€‚ðŽg—p‚µ‚½“dŽq‹³‰È‘EQRS¥zŠÂ¶—ŠwE‚Ìì¬. ’|“ດŽiˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC’r“cŒ›ºC‰““¡‹±Žqiˆã—pî•ñjC²“¡—ºiƒAƒLƒ‰ƒbƒNƒXj: ˆã—pî•ñŠw, 9(4): 461`467, 1989.
3181. mŒ´’˜n ‘@ˆÛóƒGƒAƒƒ]ƒ‹ƒ‚ƒjƒ^|‚É‚æ‚é‘å‹C’†ƒAƒXƒxƒXƒg‚Ì‘ª’è. ¬¼iliƒwƒ‹ƒXjC‚“c™¦i‰qj: ŒöŠQ‚Æ‘ÎôC25(10): 990`995, 1989.
3182. mŒ´’˜n “ªŒz•”Žîᇂɂ¨‚¯‚錌´’†G•½ã”çŠàŠÖ˜ARŒ´iSCCRŒ´j‚ɂ‚¢‚Ä. ’·À‰p–¾Cˆî–ØŸ‰pC”ª”ö˜a—YC‰ª–{–qlC‚‹´œAbiŽ¨•@j: Ž¨•@ˆôA‰È¥“ªŒz•”ŠO‰ÈC61(6): 483`487, 1989.
3183. mŒ´’˜n ŒŒ´—tŽ_Œ‹‡’`”’‚Ì•ª—£•ªÍ‚ÉŠÖ‚·‚錤‹†. “àŽRKMC‘å’J‰pŽ÷i—Õ•a—j: —Õ°•a—, 37(5): 533`536, 1989.
3184. m’Z•ñn Measurement of Des-Phe8-Arg9-Bradykinin by
Enzyme-Immunoassay|A Useful Parameter of Plasma Kinin Release.
”n“ˆ³—²Cã–ìWŒ›CN. Sunaharai‘å“ú–{»–òjCŽŽæMi–ò—j: Kinins, V(Part A): 331`335, 1989.
3185. m‚»‚Ì‘¼‚Ì•ñn “ú–{‘gD”|—{Šw‰ï‘æ62‰ñ‘å‰ï. ‘ –{”ŽsiŽY•wj: ‘gD”|—{, 15(11): 374`377, 1989.
3186. mÇ—á•ñn V‚µ‚¢ˆã—×pƒeƒŒƒ|ƒ^ƒVƒXƒeƒ€|‚»‚ÌŠT—v‚Æ¡Œã‚Ì–â‘è“_|. “n•Ó•qi–ƒjCL£–«iMEƒZƒ“ƒ^[j: ˆã‰ÈŠíŠBŠw, 59(6): 296`301, 1989.
3187. mÇ—á•ñn CE¢ŠEŒ©•·˜^A‚±‚ê‚©‚ç‚ÌCE‚Ì‚½‚ß‚ÉA“ú–{‚Ì•a‰@CE•”–å‡A–k—¢‘åŠw•a‰@MEƒZƒ“ƒ^|. “n•Ó•qi–ƒj: ŒŽŠ§Vˆã—Ã, 16(4): 122`123, 1989.
3188. m—Õ°Ž¡Œ±n Ž¨•@ˆôA‰È—̈æ‚̔畆‚ÌÁ“Å–@. ‰ª–{–qliŽ¨•@j: JOHNS, 5(8): 1165`1169, 1989.
3189. m—Õ°Ž¡Œ±n ƒqƒg’¼—§ŽždS“®—h‚Ì‘½•Ï—ʉðÍi‘æ1•ñj|dS“®—h‚©‚ç‚Ý‚½”N—î•Ï‰»|. ”ª–؈ê‹LiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 92(6): 899`908, 1989.
3190. m—Õ°Ž¡Œ±n ƒqƒg’¼—§ŽždS“®—h‚Ì‘½•Ï—ʉðÍi‘æ2•ñj|dS“®—h‚̃pƒ^|ƒ“”FŽ¯|. ”ª–؈ê‹LiŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñ, 92(6): 909`922, 1989.
3191. m‘àn ‰æ‘œf’f|MRI|. ¼Šª”ŽC–x’rdŽ¡i‹~–½jC›Mˆêi•újC‘Oì˜a•Fi‹~–½j: Emergency Nursing, 2(4): 300`306, 1989.
3192. m‘àn ƒgƒƒ“ƒ{ƒLƒTƒ“B2‚Æ6°ƒPƒg°ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“F1ƒ¿‚̈À’è‘ãŽÓ•¨. ŽŽæMi–ò—j: Œ»‘ãˆã—Ã, 21(11): 3250`3253, 1989.
3193. m‘àn ƒvƒƒXƒ^ƒOƒ‰ƒ“ƒWƒ“‚Í‚¢‚©‚É‘ª‚é‚ׂ«‚©. ŽŽæMi–ò—j: Œ»‘ãˆã—Ã, 21(11): 3259, 1989.
3194. m‘àn 90”N‘ãˆã—Ë@Ší‚Í‚±‚ꂾF‹@Ší•ÛŽçŠÇ—‘̧‚ÌŠm—§. “n•Ó•qi–ƒj: Vˆã—Ã, 17(2): 28`29, 1990.
3195. m‘àn ‘å“®–¬‚É‚¨‚¯‚éŽ_«ƒ€ƒR‘½“œ—Þ‚ÌõF–@‚ÌŒŸ“¢. ‘å‹´‚ä‚©‚èCˆÉ“¡®ŽqC‹ß–ì´”üCŽsì‚‚íi•a‰@•a—jCV’Ã’J^li“àjCŒK”ö’èmC‰œ•½‰ë•Fi•a—j: •a—‹Zp, (40): 12`13, 1989.
3196. m‘àn V‚µ‚¢ˆã—×pƒeƒŒƒ|ƒ^ƒVƒXƒeƒ€‚ɂ‚¢‚Ä. “n•Ó•qi–ƒj: –ƒŒ, 38(7): 954`959, 1989.
3197. muÀn C”½‰ž«ƒ^ƒ“ƒpƒN(CRP)|–Ñ׊ǒ¾~–@‚ƃ‰ƒeƒbƒNƒX–Ɖu‹ÃW”ä‘÷–@|. ¼“c—zC‘å’J‰pŽ÷i—Õ•a—j: Med. Technol., 17(9): 961`966, 1989.
3198. muÀn SPECT‘•’u‚̉ñ“]Ž²‚¸‚ꂨ‚æ‚уCƒ[ƒWƒTƒCƒY•Ï“®‚ÉŠÖ‚·‚é“ú펎Œ±.
‹v“c‹Óˆêi‹à‘ò‘åjC—L…¸iç—t‘åjCΈ䟌Èi•újC‰ª–ì^Ž¡i—Œ¤jC¬ŽR“c“ú‹gŠÛiŠàŒ¤jCì㌛ŽiiŽœŒbˆã‘åjC²X–ØNliŒQ‘åjC—é–Ø–L
i“ŒŠC‘åjC“yŠí‰®‘ìŽui‘—§“Œ“ñ•a‰@jC¼ìˆêi“Œ‘åjC¼•½³“¹i‹à‘ò‘åjC¼–{“Oi•úˆãŒ¤jCŒüˆäF•vi‹ž“s‹Z’Z‘åjC–ûˆäMtiç—tŒ§‚ª‚ñƒZ
ƒ“j: Radioisotopes, 39(2): 53`59, 1990.
3199. mŠwp‘n iŽ·•Mj S“d}ƒRƒ“ƒsƒ…|ƒ^f’f; ƒ~ƒjƒRƒ“‰@“àƒVƒXƒeƒ€Cp.64`78C ‹{Œ´‰p•viˆã—pî•ñj. •ÒW ‰ª“‡ŒõŽ¡i“¡“cŠw‰€j•ÒC ’†ŽR‘“X, “Œ‹ž, 89.12.20”s.
3200. mŠwp‘n iŽ·•Mj ‘gD×–E‰»Šw‚Ì‹Zp|×–E–Œ; 5'-nucleotidase, p. 222`227, ŽR‰È³•½i‰ðj. •ÒW ¬ì˜a˜Ni‹ž‘åjC’†ªˆê•äi’·è‘åj•Ò, ’©‘q‘“X, “Œ‹ž, 89.11.25 ”s.
3201. m‚»‚Ì‘¼‚Ì’˜‘iŠTà‘jn iŽ·•Mj ì‹ÆŠÂ‹«•]‰¿‚Ì‹ï‘Ì“Ii‚ß•û|‘ª’è‹L˜^‚̃‚ƒfƒ‹—lŽ®‚ÌŒ©•û‚̃|ƒCƒ“ƒg|C ‚“c™¦i‰qjC‘¼. •ÒW ‘S‘˜J“‰q¶’c‘̘A‡‰ï•ÒC “ú–{ì‹ÆŠÂ‹«‘ª’苦‰ï_“ÞìŽx•”, ‰¡•l, 89.09.00”s.
3202. m‚»‚Ì‘¼‚Ì’˜‘i“ü–å‘jn iŽ·•Mj V¶‰»ŠwŽÀŒ±uÀ12C•ªŽq–ƉuŠw‡Ti–Ɖu×–ECƒTƒCƒgƒJƒCƒ“j; ‘æ1•”
–Ɖu’S“–×–E‚Ì•ª—£CŒŸ’è–@C‘æ1Í ƒŠƒ“ƒp‹…’P—£–@C12:@9`24C ‹Ê“àGˆêi”÷j. •ÒW
‘å‘ò—˜ºi“Œ‘åjC‰œ‘ºNi‡‘åjC–î“cƒˆêi“ŒˆãŽ•‘åjC‰iˆäŽFi“Œ‘åj•ÒC “Œ‹ž‰»Šw“¯l, “Œ‹ž, 89.11.28”s.
3203. m‚»‚Ì‘¼‚Ì’˜‘i‹Zp‘jn iŽ·•Mj õF–@‚Ì‚·‚ׂÄiŒŽŠ§Medical Technology•Êûj; PTAHõF,
p.28`30; ƒVƒ…ƒ‚|ƒ‹”½‰ž¥’_`õF, p.50`53; ƒxƒ‹ƒŠƒ“ÂõF, p.98`99, ŽÂ“cGi“Œ•a‰@•a—j. ˆãŽ•–òo”Å,
“Œ‹ž, 88.07.15”s.
3204. mŽ‹’®Šo‹³Þn iŠÄCj iŽ·•Mj‚ƒJƒƒŠ|—A‰t‚Ì’²®|, “‡“cŽœ•FCΎ˳‰pC¬ìK—Yi–òÜ•”j. ŠÄC “‡“cŽœ•Fi–k—¢jŠÄCC ‹¦˜aŠé‰æ, 90.01.00”s.
3205. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j –Ɖu‘gD‰»Šw”½‰ž‚É‚¨‚¯‚éƒ}ƒCƒNƒƒEƒF|ƒuÆŽË‚Ì•]‰¿. ŽR‰È³•½CŸ–”CCŠÖª‚ê‚¢Žqi‰ðj: ‘æ30‰ñ“ú–{‘gD×–E‰»Šw‰ï i89.10.23j, ‹ž“sC ´˜^WCp.7, 1989.
3206. mŠw‰ïn iˆê”Êu‰‰j •a—¶ŒŸ•W–{‚É‚¨‚¯‚鎉–bŠÌ‚ÌŒv‘ªŠw“IŒŸ“¢. Žs£‹I‘ã”üCˆÉ“¡—R”üŽqC“n•ÓiŽqi“Œ•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (86.05.04), Šò•Œ, ‰q¶ŒŸ¸, 35(3): 572, 1986.
3207. mŠw‰ïn iˆê”Êu‰‰j ƒŠƒ“ƒ^ƒ“ƒOƒXƒeƒ“Ž_ƒwƒ}ƒgƒLƒVƒŠƒ“(PTAH)õF‚ÌŒŸ“¢iõF–@‚ÌŠm”F‹y‚Ñ‚»‚̉ü—Çj.
ŽÂ“cGC‰¡‘ò³ŽuCŽR‰º˜a–çC“n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ36‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (87.05.03), ŽŽ™“‡,
‰q¶ŒŸ¸, 36(3): 477, 1987.
3208. mŠw‰ïn iˆê”Êu‰‰j •a—ŒŸ¸‚É‚¨‚¯‚鸓xŠÇ—‚ɂ‚¢‚Ä. ŽÂ“cGi“Œ•a‰@•a—j: ‘æ5‰ñŽ„—§ˆã‰È‘åŠw—Õ°ŒŸ¸‹ZŽt‰ïŠwpŒ¤C‰ï (88.02.28), “Œ‹ž, ´˜^W, p.33, 1988.
3209. mŠw‰ïn iˆê”Êu‰‰j ˆÝ‰©FŽî‚ÌŠeŽíõF‚É‚æ‚é•a—Šw“IŒŸ“¢.
‰¡‘ò³ŽuCŽÂ“cGCŽR‰º˜a–çC“n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ_“Þ쌧—Õ°‰q¶ŒŸ¸Šw‰ï (88.04.17), •½’Ë,
_“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(2): 44, 1988.
3210. mŠw‰ïn iˆê”Êu‰‰j ‘å’°ƒƒ‰ƒm|ƒVƒX‚É‚¨‚¯‚é•a—‘gDŠw“IŒŸ“¢.
ŽR‰º˜a–çCŽÂ“cGC‰¡‘ò³ŽuC“n•Óˆê]i“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ_“Þ쌧—Õ°‰q¶ŒŸ¸Šw‰ï (88.04.17), •½’Ë,
_“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(2): 46, 1988.
3211. mŠw‰ïn iˆê”Êu‰‰j ’_”XƒRƒŒƒXƒeƒ|ƒVƒX‚Ì•a—‘gDŠw“IŒŸ“¢.
“n•Óˆê]CŽÂ“cGCŽR‰º˜a–çC‰¡‘ò³Žui“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ_“Þ쌧—Õ°‰q¶ŒŸ¸Šw‰ï (88.04.17), •½’Ë,
_“Þ쌧—Õ°‰q¶ŒŸ¸‹ZŽt‰ïŽGŽ, 23(2): 45, 1988.
3212. mŠw‰ïn iˆê”Êu‰‰j ’¼’°ƒJƒ‹ƒ`ƒmƒCƒh‚ɑ΂·‚é–Ɖu‘gDŠw“IŒŸ“¢. “n•ÓiŽqCŽÂ“cGCŽs£´”üi“Œ•a‰@•a—jC’†‰p’ji•a—j: ‘æ37‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (88.07.16), _ŒË, ‰q¶ŒŸ¸, 37(5): 666, 1988.
3213. mŠw‰ïn iˆê”Êu‰‰j «õF‘̈Ùí‚𔺂Á‚½–³S‘Ì‚Ì‚P—á. –î•”“TŽqi—Õ•a—j: “ú–{õF‘ÌŒŸ¸Šw‰ï (88.11.00), “Œ‹ž.
3214. mŠw‰ïn iˆê”Êu‰‰j ŒoŒû’°ŠÇôò‰t‚̈À’è«‹y‚Ñ׋ۉ˜õ‚ÉŠÖ‚·‚錟“¢. ¬ìK—YC‘¾“c‹v”üŽqC“‡“cŽœ•Fi–òÜ•”jCŸ–””º‰hi“àjC”äŠé”\Ž÷iŠOj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05), –¼ŒÃ‰®.
3215. mŠw‰ïn iˆê”Êu‰‰j ü—Ê•W€‘ª’è–@‚̃h[ƒYƒvƒƒbƒeƒBƒ“ƒOƒVƒXƒeƒ€‚ւ̉ž—p(1).
Šâ”g–ÎC‚Œ´êŽCã‘O•ôŽqC–kŽR‹v”üC’†‘º‹`‘¥i•újC‹g’J³•vi“Œ—mƒƒfƒBƒbƒNj: “ú–{ˆãŠw•úŽËüŠw‰ï‘æ57‰ñ•¨—•”‰ï‘å‰ï
(89.04.07), _ŒËC “ú–{ˆãŠw•úŽËüŠw‰ïŽC49(7): 952, l989.
3216. mŠw‰ïn iˆê”Êu‰‰j ‘@ˆÛóƒGƒAƒƒ]ƒ‹ƒ‚ƒjƒ^|(FAM-1)‚É‚æ‚éƒAƒXƒxƒXƒg‚Ì‘ª’è‚ɂ‚¢‚Äi‘æ2•ñj. ¬¼iliƒwƒ‹ƒXjC‚“c™¦i‰qj: ‘æ62‰ñ“ú–{ŽY‹Æ‰q¶Šw‰ï (89.04.28), ÂXC Šw‰ïu‰‰—vŽ|WCp.707, 1989.
3217. mŠw‰ïn iˆê”Êu‰‰j ŒÜŽˆ‘I‘ðŽ®Œê‰¹–¾—Ä“xŒŸ¸—pŒê•\‚ÌŒ¤‹†. ’|“à‹`•viŽ¨•@j: “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‘‰ï (89.05.11), ‘åãC “ú–{Ž¨•@ˆôA‰ÈŠw‰ï‰ï•ñC92(10): 1545, 1989.
3218. mŠw‰ïn iˆê”Êu‰‰j f—ÃŽx‰‡ƒVƒXƒeƒ€‚Æ‚µ‚Ä‚Ì“dŽqƒJƒ‹ƒe‚ÌŽŽ‚Ý.
’|“ດŽC”’‘é‘’jC’ß“c—z˜aC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC“‡Œû’å•viŠÅŒìŠw•”jC¼“cÝŒ«iƒAƒLƒ‰ƒbƒNƒXj:
‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï (89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 120, 1989.
3219. mŠw‰ïn iˆê”Êu‰‰j ˆöŽq•ªÍ‚Ì”]ŒŒŠÇáŠQŠ³ŽÒ‚Ì”]ŒŒ—¬ŠÏŽ@‚ւ̉ž—p. ’†‘òŒ\Ž¡CΈ䟌Èi•új: ‘æ28‰ñ“ú–{MEŠw‰ï (89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 76, l989.
3220. mŠw‰ïn iˆê”Êu‰‰j HPLC–@‚É‚æ‚é”A’†ƒvƒeƒŠƒWƒ“—U“±‘Ì‚Ì•ªÍ‚Æ‚»‚Ì—Õ°“IˆÓ‹`.
“àŽRKMC‚èŒõ‹IC“n•Ó—Ç•FC‘å’J‰pŽ÷i—Õ•a—j: ‘æ41‰ñ“ú–{ƒrƒ^ƒ~ƒ“Šw‰ï‘å‰ï (89.06.09), ŽD–yC ƒrƒ^ƒ~ƒ“, 63(4):
204, 1989.
3221. mŠw‰ïn iˆê”Êu‰‰j Quantitative CT of Distal Femur and Radial Photon
Absorptiometry in the Assessment of Renal Osteodystrophy.
÷ˆä´Žqi•újCŠÛ–Ε¶ºi“Œ‹žˆã‰ÈŽ•‰È‘åjCŠâ”g–Îi•újC“à“c‹v‘¥i“Œ‘åˆã‰ÈŒ¤jC¼—Ñ—²i•új: 17th International
Congress of Radiology (89.07.06), Paris.
3222. mŠw‰ïn iˆê”Êu‰‰j ‰^“®•‰‰×ƒeƒXƒg‚É‚¨‚¯‚éƒpƒ‹ƒXƒIƒLƒVƒ|ƒ^|‚Ì—L—p«‚ɂ‚¢‚Ä.
“n•Ó“oC’†“ˆ‰p•FCŽl‘q³”ŽC–¥‰YŽ‘¥C”~Œ´ŽÀC–åˆäL‹ÅiŽ™jC‚ŠÝŒ›“ñi®ŠOŽ™j: ‘æ86‰ñ–{‘̗͈ãŠw‰ïŠÖ“Œ’n•û‰ï (89.07.08),
’}”gC ‘̗͉Ȋw, 38(5): 215, 1989.
3223. mŠw‰ïn iˆê”Êu‰‰j ˆöŽq•ªÍ‚Ì”xŒŒ—¬“®‘ÔŠÏŽ@‚ւ̉ž—p. ’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•új: ‘æ8‰ñˆã—p‰æ‘œHŠwƒVƒ“ƒ|ƒWƒEƒ€
(89.07.21), ‘åã, Medical Imaging Technology, 7(2): 209`210, 1989.
3224. mŠw‰ïn iˆê”Êu‰‰j Difference of BC Threshold Torce Levels Between
Direct and Equivalent Measurements. ’|“à‹`•viŽ¨•@j: 14th World Congres of
Otorhinolaryngology Head and Neck Surgery (89.09.15), Madrid, 14th
World Congres of Otorhinolaryngology Head and Neck Surgery, Abstracts,
p.162.
3225. mŠw‰ïn iˆê”Êu‰‰j ‚Š´“x–Ɖu“¯’è–@‚ð—p‚¢‚½”÷—ÊM’`”’‚Ì“¯’è|“Á‚É‘½•ô«M’`”’ŒŒÇ‚ɂ‚¢‚Ä. ät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 173, 1989.
3226. mŠw‰ïn iˆê”Êu‰‰j ‰»Šw”Œõ‚ð—p‚¢‚½DNAƒvƒ|ƒuƒAƒbƒZƒC‚ÌŒŸ“¢. “c‘ò—TŒõiƒuƒŠƒXƒgƒ‹jCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 318, 1989.
3227. mŠw‰ïn iˆê”Êu‰‰j ƒEƒ~ƒzƒ^ƒ‹¥ƒ‹ƒVƒtƒFƒŠƒ“—U“±‘Ì‚ð—p‚¢‚½‰»Šw”Œõ–@‚É‚æ‚éD’†‹…ƒX|ƒp|ƒIƒLƒTƒCƒh‘ª’è–@‚ÌŒŸ“¢.
¼“c—zCät“n’‰’jC‘å’J‰pŽ÷i—Õ•a—j: ‘æ36‰ñ“ú–{—Õ°•a—Šw‰ï‘‰ï (89.10.05), ‹ž“sC —Õ°•a—, 37(•â): 335,
1989.
3228. mŠw‰ïn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ|ƒiƒ‹R‘Ì‚É‚æ‚éSalnomella Typhimurium‚ÌRŒ´Œ^•Ê.
¼è‹MŽqC’r˜eM’¼CŽR‰Y¸iŠÅŒìŠw•”jC‘å‘òLFCHŽR•‹vi”÷jC‘¼: ‘æ62‰ñ“ú–{׋ۊw‰ïŠÖ“ŒŽx•”‘‰ï (89.10.13), …ã.
3229. mŠw‰ïn iˆê”Êu‰‰j 123I-IMP SPECT‚̉摜•]‰¿‚ƓljeŠŒ©i”]ŒŒŠÇáŠQ‚ɑ΂·‚é123I-IMP
SPECT‚Ì—Õ°“I—LŒø“x•]‰¿‚ÉŠÖ‚·‚鋤“¯Œ¤‹†j. –ª“‡‘iç—t‘åjC‘¼8Ž{ÝCΈ䟌Èi•új: ‘æ29‰ñ“ú–{ŠjˆãŠw‰ï‘‰ï
(89.10.19`21), ‘å’Ã, ŠjˆãŠw, 26(8): 1026, 1989.
3230. mŠw‰ïn iˆê”Êu‰‰j ƒh[ƒYƒvƒƒbƒ^[‚Ì•W€‘ª’è–@‰»ƒvƒƒOƒ‰ƒ€.
Šâ”g–ÎC¼—Ñ—²C‚Œ´êŽCã‘O•ôŽqi•újC‹g’J³•vi“Œ—mƒƒfƒBƒbƒNj: ‘æ2‰ñ“ú–{•úŽËüŽîᇊw‰ïŠwp‘å‰ï (89.11.07), _ŒË,
“ú–{•úŽËüŽîᇊw‰ïŽ, 1(Suppl. 3): 52, 1989.
3231. mŠw‰ïn iˆê”Êu‰‰j ”Z“x•ÏŠ·ŒW”‚ð—p‚¢‚½ŒŸ’mŠÇ–@‚Ì—LŒø‚ÈŠˆ—p•û–@.
–÷“c\ŽiC‘åX‹`•¶C¬¼iliƒwƒ‹ƒXjCŠâè’õC¬¼—²C‹{–{˜a•qC‚“c™¦i‰qj: “ú–{˜J“‰q¶HŠw‰ï (89.11.17), “Œ‹ž,
Šw‰ï—\eW, p.51`52, 1989.
3232. mŠw‰ïn iˆê”Êu‰‰j ƒpƒbƒVƒuƒTƒ“ƒvƒ‰|‚É‚æ‚éì‹ÆŠÂ‹«‘ª’è‚̉”\«‚ɂ‚¢‚Ä.
—é–Ø”ü’q‘ãC¬¼iliƒwƒ‹ƒXjC‰|–{•Û“TCù¶–«C‹{–{˜a•qC‚“c™¦i‰qj: “ú–{˜J“‰q¶HŠw‰ï (89.11.17), “Œ‹ž, Šw‰ï—\eW,
p.53`54, 1989.
3233. mŠw‰ïn iˆê”Êu‰‰j ƒ‚ƒmƒNƒ|ƒiƒ‹R‘Ì‚Ì—Õ°ŒŸ¸‚ւ̉ž—p;–Ɖu‘gDŠw“I•û–@‚ւ̉ž—p. ŽÂ“cGi“Œ•a‰@•a—j: ‘æ7‰ñŽ„—§ˆã‰È‘åŠw—Õ°ŒŸ¸‹ZŽt‰ïŠwpŒ¤C‰ï (89.11.26), “Œ‹ž, ´˜^W, p.10`11, 1989.
3234. mŠw‰ïn iˆê”Êu‰‰j “dŽqŽ–“TƒVƒXƒeƒ€‚Ì‹@”\Šg’£|“®‰æ‘œ‚̎戵‚Æ‚»‚̉ž—p.
“‡Œû’å•viŠÅŒìŠw•”jC’|“ດŽC’r“cŒ›ºC’ß“c—z˜aC‹{Œ´‰p•viˆã—pî•ñjCÎìrLi“dŽqŒvŽZ‹@ƒZƒ“ƒ^|jC²“¡—ºiƒAƒLƒ‰ƒbƒNƒXj:
‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.02), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.599`602, 1990.
3235. mŠw‰ïn iˆê”Êu‰‰j “dŽqƒJƒ‹ƒeƒVƒXƒeƒ€‚ÌŠJ”.
’|“ດŽC’r“cŒ›ºC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC²“¡—ºiƒAƒLƒ‰ƒbƒNƒXj: ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.03),
“Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.865`868, 1990.
3236. mŠw‰ïn iˆê”Êu‰‰j ”]ŒŒŠÇáŠQ‚ɑ΂·‚é123I-IMP‚É‚æ‚éSPECT‚Ì—Õ°“I—LŒø“x•]‰¿‚ÉŠÖ‚·‚鋤“¯Œ¤‹†|BVC(bias
to variance characteristic)‰ðÍ‚É‚æ‚éf’f‚̂΂ç‚‚«‚Ì•]‰¿. ¼–{“OC”ÑÀ•i•úˆãŒ¤jC‘¼CΈ䟌Èi•új:
‘æ32‰ñ“ú–{ŠjˆãŠw‰ïŠÖ“ŒbM‰z’n•û‰ï (90.03.10), “Œ‹ž.
3237. mŠw‰ïn iˆê”Êu‰‰j ‹¤Å“_ƒŒ|ƒU|Œ°”÷‹¾‚É‚æ‚é‘Á‰tü×–E‚ÌŠJŒû•ª”å‰ß’ö‚ÌŠÏŽ@. £ì²‹vi‰ðj: ‘æ54‰ñŒûo•aŠw‰ïŠwp‘å‰ï i89.00.00j, “Œ‹ž.
3238. mŠw‰ïn iˆê”Êu‰‰j Ý‘î—×{‚Ì‚½‚ß‚Ì‹CŠÇ‹zˆøƒJƒe[ƒeƒ‹ŠÈˆÕÁ“Å•Û‘¶—eŠí‚ÌŽŽì‚Æ‚»‚̉ž—p. דc–«i“àjC“n•Ó•qi–ƒjC‰Z¶LˆêiMEƒZƒ“ƒ^[j: ‘æ64‰ñ“ú–{ˆã‰ÈŠíŠBŠw‰ï‘å‰ï i89.05.28), ‘åã.
3239. mŒ¤‹†‰ïn iˆê”Êu‰‰j Ž¡—×p“dŽqü‚É‚æ‚è…’†‚ɶ‚¶‚銈«Ž_‘f‚ÌŽû—Ê. Šâ”g–Îi•új: ‘æ5‰ñŽ_‘f—R—ˆƒ‰ƒWƒJƒ‹Œ¤‹†‰ï (89.05.17), ‘Š–ÍŒ´.
3240. mŒ¤‹†‰ïn iˆê”Êu‰‰j “ú–{‘gD”|—{Šw‰ï‚ðŽåµ‚Ä. ‘ –{”ŽsiŽY•wj: ‘Š–ÍŒ´ŽsŽY‰È•wl‰Èˆã‰ï7ŒŽ“x’è—áŠwp•”‰ï (89.07.12), ‘Š–ÍŒ´.
3241. mŒ¤‹†‰ïn iˆê”Êu‰‰j QCT‚É‚æ‚阒Œő̊C–ÈŽ¿‚Ìœ‰–—Ê. ÷ˆä´ŽqC¼—Ñ—²i•újC—L•xŠ°i®ŠOjC—§•½eli•új: ‘æ11‰ñ_“ÞìCa¥œ‘ãŽÓŒ¤‹†‰ï (90.01.13), ‰¡•l.
3242. mŠw‰ï‰ï“ªn “ú–{‘gD”|—{Šw‰ï‘æ62‰ñ‘å‰ï, ‘ –{”ŽsiŽY•wj:
<<311 ‚»‚Ì‘¼>>
3243. mŒ´’˜n ”Ä—pŒo’°‰h—{Ü‚Ì•¨«‚ÌŒŸ“¢|‘æ2•ñ|. ¬ìK—YC“‡“cŽœ•Fi–òÜ•”jC’|“à”üŒbŽqiŠÅŒì•”jC–ìŒû‹…Žqi‰h—{•”jCŸ–””º‰hi“àjC”äŠé”\Ž÷iŠOj: JJPEN, 11(7): 886`892, 1989.
3244. mŒ´’˜n Gastric Mucus Secretion in Portal Hypertension.
‹TŽRmˆêiŽRŒ`‘åjC‘¼C¼ŽRŒ›Žqi¶‰»ŒnjCÎŒ´˜a•Fi‰»jC–x“c‹±Žqi¶‰»j: Journal of Gastroenterology and
Hepatology, 4(Suppl. 1): 126`128, 1989.
3245. mŒ´’˜n Development and Evaluation of a Radiological Reporting
System for Use with a Personal Computer. ‘º“cWˆê˜YC‘–쳈êCˆä“›—¤CHigushi,
N.C‘ºŽROi•új: Medical Informatics, 14(1): 71`83, 1989.
3246. mŒ´’˜n Functional Difference in Monoamine Transmitters in the
Behaviorally Abnormal Mouse Mutant (Wriggle Mouse Sagami). Koichi
IshikawaCShinji ShibanokiCTaizo KuboCMiki KogureCYoshiko
Imamurai“ú‘åjC‘å‘òLFi”÷jCMichio Ohmurai‘呺ŽÀ“®Œ¤jCKatsuhiko Mikoshibai‘åã‘åj:
Neuroscience Letters, 103: 343`348, 1989.
3247. mŒ´’˜n Observation of Quantum Beats in Autoionizing Electron
Spectra Created by Slow Na+ -Ne Collisions. A. DanjoiVŠƒ‘åjC¬’r•¶”Ži•¨—j:
Phys. Rev. Lett., 62(7): 741`743, 1989.
3248. mŒ´’˜n •a‰@•a—•”‚Ì“úí‹Æ–±‚É‚¨‚¯‚éƒRƒ“ƒsƒ†|ƒ^|“±“ü‚ÆŠˆ—p‚ɂ‚¢‚Ä. ˆÉ“¡—R”üŽqC“cŠ‰xŽqCŽs£‹I‘ã”üC“n•ÓiŽqi“Œ•a‰@•a—jC’†‰p’ji•a—j: ‰q¶ŒŸ¸, 37(4): 408`414, 1988.
3249. mŒ´’˜n ‹z“ü—Ö@‚É‚¨‚¯‚郀ƒRƒ\ƒ‹ƒoƒ“‰t‚̈À’è«. ‹gŽR—F“ñi–òŠw•”jC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”j: ŒÄ‹zC8(4): 422`425, 1989.
3250. mŒ´’˜n ’…FƒiƒCƒƒ“12‹…‚©‚ç‚Ìõ—¿—no‚Æ“ñŽ_‰»ƒ`ƒ^ƒ“‚ÌŒø‰Ê. –{“cG—²C²’|ˆÀ‹IŽqi“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: Þ—¿‹Zp, 7(4): 136`142, 1989.
3251. mŒ´’˜n ƒRƒ“ƒsƒ…|ƒ^|ƒVƒ~ƒ…ƒŒ|ƒVƒ‡ƒ“‚É‚æ‚镲‘Ì‚Ì•\–ʉüŽ¿‰ß’ö‚̉ðÍ. –{“cG—²CŠ›‰º—S–çi“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: Þ—¿‹Zp, 8(2): 54`60, 1990.
3252. mŒ´’˜n R‹ÛÜ™•ú«‘n”í•¢Þ‚Ì•]‰¿. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9(8): 676`686, 1989.
3253. mŒ´’˜n Biological dressing ‚Æ‚µ‚Ä‚Ì—r–Œi‘Ù¶j‚ÆŒ{—‘–Œi—‘¶j‚ɂ‚¢‚Ä. ‘O“c‰Ø˜YC’†–kMºC‘厜–í—T”ViŒ`ŠOj: “ú–{”MŠw‰ï‰ïŽ, 15(4): 234`239, 1989.
3254. mŒ´’˜n Ã’—p–ƉuƒOƒƒuƒŠƒ“»Ü’†‚ÌRHIVR‘Ì¥HIVRŒ´‚ÌŒŸ“¢. •ŽRˆêi–òÜ•”jC‚‹{t’ji—ÕŒŸjC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‘å’J‰pŽ÷i—Õ•a—j: •a‰@–òŠwC15(3): 167`174, 1989.
3255. mŒ´’˜n ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚¨‚¯‚镲‘Ì•¨«‚ÌŒø‰Ê. –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: •²‘ÌHŠw‰ïŽ, 26(9): 666`671, 1989.
3256. mŒ´’˜n Variational Patterns of Arm Folding in a Random Population of Japanese. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(5): 477`482, 1989.
3257. mŒ´’˜n Mode of Hand Clasping in a Random Japanese Population. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 19(6): 546`550, 1989.
3258. mŒ´’˜n Pattern of Hand-Clapping and its Relation to Handedness in a
Random Population of Japanese. ’r“c•qŽqi‰ðj: –k—¢ˆãŠw, 20(1): 13`16, 1990.
3259. m’Z•ñn –k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@|f’fî•ñƒf[ƒ^ƒx[ƒX•a—ðŠÇ—‚ÌŒ»ó. ‘º“cWˆê˜Yi•új: Innervision, 5(4): 56`57, 1990.
3260. m’Z•ñn ƒŠƒUƒxƒ“ƒhƒ‰ƒCƒVƒƒbƒv‚Ì”z‡•Ï‰»ŽŽŒ±i‘æ1•ñj.
–ؘHŒbC–쑺’mŽqC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñC“c’†¹‘ãi–òŠw•”j: Journal of Japanese Society
of Hospital Pharmacists, 25(9): 1053`1064, 1989.
3261. m’Z•ñn ƒŠƒUƒxƒ“ƒhƒ‰ƒCƒVƒƒbƒv‚Ì”z‡•Ï‰»ŽŽŒ±i‘æ2•ñj.
–ؘHŒbC–쑺’mŽqC‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”jC‹gŽR—F“ñC“c’†¹‘ãi–òŠw•”j: Journal of Japanese Society
of Hospital Pharmacists, 25(10): 1213`1225, 1989.
3262. mŒ¤‹†•ñi•¶•”Èjn d“_—̈挤‹†(1) ‹¹œãœ‹Ø‚Í“Œ‹žŒê‚̉¹’²‚ÌŽÀŒ»‚É‚Ç‚¤‚©‚©‚í‚Á‚Ä‚¢‚é‚©.
“‡“cƒˆêi¶—jCœA£”£i“Œ‘åj:
“ú–{Œê‰¹º‚É‚¨‚¯‚é‰C—¥“I“Á’¥‚ÌŽÀ‘Ô‚Æ‚»‚Ì‹³ˆç‚ÉŠÖ‚·‚鑇“IŒ¤‹†C‘Š‡”ÇŒ¤‹†¬‰Ê’†ŠÔ•ñ‘1989¢“ú–{Œê‰¹º£Œ¤‹†•ñ, (1):
19`20, 1989.
3263. m‘àn Thrombospondin. “àŽRKMi—Õ•a—j: Laboratory and Clinical Practice, 6(1): 4`5, 1988.
3264. m‘àn V‚µ‚¢–òÜŽt‚Ì‹Æ–±‘ÌŒn;¡‚ð‹Æ–±‚Ì“]Š·Šú‚Æ”FŽ¯‚µŠ³ŽÒ‚Ì—˜‰v‚Ì‚½‚ß‚É. Ύ˳‰pi–òÜ•”j: ‚΂ñ‚Ô‚¤, (95): 110`112, 1989.
3265. m‘àn ¸__Œo‰È•a“‚Å‚Ì•ž–òŽw“±‚ðŠJŽn‚µ‚Ä. ’|“எqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”j: ƒNƒŠƒjƒJƒ‹ƒtƒ@|ƒ}ƒV|, 5(18): 10`24, 1989.
3266. m‘àn –k—¢‘åŠw“Œ•a‰@‚É‚¨‚¯‚鈕û쬎x‰‡ƒVƒXƒeƒ€. ‘Š‘ò–¾C’†ŽR–LC“‡“cŽœ•Fi–òÜ•”j: ˆã—ÂƃRƒ“ƒsƒ…|ƒ^, 3(Suppl.1): 73`81, 1990.
3267. m‘àn CT, MRI ‚ð‘ÎÛ‚Æ‚µ‚½¬‹K–Í PACS ‚ÌŠJ”‚Æ•]‰¿|•úŽËüf’fˆã‚©‚ç‚Ý‚½ PACS ‚ÌŒ»ó.
‘º“cWˆê˜YC›MˆêC’J“c—ˆê˜YC¼ŽR³ŒáC¼™É”ŽC’r“cr–¾C“cŠŽŒÈC÷ˆä´ŽqC’†‘òŒ\Ž¡CΈ䟌ÈC¼—Ñ—²i•új: ‰f‘œî•ñƒƒfƒBƒJƒ‹,
21(13): 617`621, 1989.
3268. m‘àn “Š–ò¥Žw“±‹L˜^쬂̎ÀÛ. –Ø‘º—˜”üi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 102`112, 1989.
3269. m‘àn ’ŽË–òŠÇ—‚ÌŽÀÛ. Œú“cKˆê˜YCΎ˳‰pi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 113`125, 1989.
3270. m‘àn •a“‚É‚¨‚¯‚éˆã–ò•iî•ñ’ñ‹Ÿ‚ÌŽÀÛ. –]ŒŽ^‹|i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 126`131, 1989.
3271. m‘àn g100 “_‹Æ–±h‚ÉŠÖ‚·‚éƒAƒ“ƒP[ƒg’²¸Œ‹‰Ê. ¬—Ñ‹P–¾C•ŽRˆêCŒú“cKˆê˜YC’¬“c[i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 132`139, 1989.
3272. m‘àn g100 “_‹Æ–±h‚ɂ悹‚Ä[ˆãŽt, ŠÅŒì•w, Š³ŽÒ‚Ì—§ê‚©‚ç. ‹g‘º”Ž–Mi‹¹ŠOjC“Iê´˜ai“àjC‰ÔˆäŒbŽqiŠÅŒì•”jCÔ¼@¹: ŒŽŠ§–òŽ–, 31(8—Õ‘): 140`143, 1989.
3273. m‘àn ŋ߂̈ã—ʋ«‚ɂ‚¢‚Ä. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 14`17, 1989.
3274. m‘àn g100 “_‹Æ–±h‚Ì¡Œã‚̉ۑè‚Æ“W–]. “‡“cŽœ•Fi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 150`156, 1989.
3275. m‘àn TDM. ‘º£¨’ÃŽqi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 159`164, 1989.
3276. m‘àn “ÁŽê»Ü. –îŒã˜a•vi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 165`171, 1989.
3277. m‘àn ‰h—{ŠÇ—. ˆÉ“¡—msi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 172`179, 1989.
3278. m‘àn ŠO—ˆŠ³ŽÒ‚Ö‚Ì•ž–òŽw“±. ²ìŒ«ˆêi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 180`187, 1989.
3279. m‘àn Š³ŽÒ‚Ö‚ÌW’c‹³ˆç. •—ŠÔKŽOCΎ˳‰pi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 188`193, 1989.
3280. m‘àn ‚¢‚í‚ä‚ég100 “_‹Æ–±h‚Æ‚»‚̈Ӌ`. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 18`21, 1989.
3281. m‘àn ‹~–½‹~‹}ƒZƒ“ƒ^[‚Å‚Ì–òÜŽt‚Ì–ðŠ„. ‹ß“¡—¯”üŽqi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 194`200, 1989.
3282. m‘àn Ý‘îˆã—Â̌»‹µ‚Æ¡Œã. ¬ìK—Yi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 201`206, 1989.
3283. m‘àn ƒAƒƒŠƒJ—Õ°–òÜ‹Æ–±ƒCƒ“ƒTƒCƒhƒŒƒ|[ƒg. ‰Á‰ê’J”£i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 207`211, 1989.
3284. m‘àn g100 “_‹Æ–±h‚Ì“±“ü‚É“–‚½‚Á‚Ä. ù–ì–œ—Žqi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 22`30, 1989.
3285. m‘àn g100 “_‹Æ–±hŽÀ‘H‹³ˆç‚ɂ‚¢‚Ä. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 31`34, 1989.
3286. m‘àn ˆã–ò•iî•ñŠˆ“®. •ŽRˆêi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 35`43, 1989.
3287. m‘àn uV‚½‚È•a‰@–òÜ‹Æ–±‚Ì“WŠJv‚Ì”s‚ÉÛ‚µ‚Ä. ’©’·•¶–íi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 3`13, 1989.
3288. m‘àn •a“‚É‚¨‚¯‚éˆãŽt, ŠÅŒì•w‚Ì‹Æ–±‚Æ—¬‚ê. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 44`47, 1989.
3289. m‘àn ƒJƒ‹ƒe, ŒŸ¸’l‚ÌŒ©•û. ‹gŽR—F“ñi–òŠw•”jC“c’†¹‘ãi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 48`61, 1989.
3290. m‘àn •ž–òŽw“±‚ÌŠî–{. ¬—Ñ‹P–¾i–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 65`67, 1989.
3291. m‘àn –òÜ‹Æ–±‚ƃRƒ“ƒsƒ…[ƒ^. aŒûš Oi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 68`76, 1989.
3292. m‘àn Š³ŽÒî•ñ‚ÌŽûW. Ύ˳‰pi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 79`83, 1989.
3293. m‘àn •ž–òŽw“±‚ÌŽÀÛ(1)|–k—¢‘åŠw•a‰@‚Ìê‡. ²ìŒ«ˆêCù–ì–œ—ŽqC–Ø‘º—˜”üC‹´–{²ŽqC‹{“c—æŽqC‰ªè”ü‘ãŽqC–{‹´–ÎCž³‘ò—R”üi–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 84`96, 1989.
3294. m‘àn •ž–òŽw“±‚ÌŽÀÛ(2)|–k—¢‘åŠw“Œ•a‰@‚Ìê‡. ’|“எqCΎ˳‰pC’†ŽR–LC‘¾“c‹v”üŽqC‘哇”ü˜aŽqC•½ŽR•Žii–òÜ•”j: ŒŽŠ§–òŽ–, 31(8—Õ‘): 97`101, 1989.
3295. m‘àn •a‰@–ò‹Ç‚ÆGCP; Ž¡Œ±R¸ˆÏˆõ‰ï‚ÌŒ»ó‚ð’†S‚É. ’©’·•¶–íC•ŽRˆêi–òÜ•”j: ŒŽŠ§–òŽ–, 32(2): 257`262, 1990.
3296. m‘àn ƒp|ƒLƒ“ƒ\ƒ“•aŠ³ŽÒ‚Ì•ž–ò’²¸‚Æ•ž–òŽw“±. ’†žŒ[ˆêCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”jCŒÃ˜a‹vKi“àj: ŒŽŠ§–òŽ–C31(7): 1427`1431, 1989.
3297. m‘àn •a“Šˆ“®“WŠJ‚Ö‚ÌŒoˆÜ. Ύ˳‰pi–òÜ•”j: ç—tŒ§•a–ò‰ï•ñ, (87): 8`14, 1989.
3298. m‘àn ƒŠƒ“Ž_ƒJƒ‹ƒVƒEƒ€‚̶‘Ì’†‚É‚¨‚¯‚錋»¬’·. ¼–ìVŽmi‰»jCì–ìM”Vi”]ŠOjC‹{‘òŽµ˜Yi“dŒ°ƒZƒ“ƒ^|jC¬Î^ƒi“Œ‹ž—‰È‘åjC–î“cŒ«ŽOi”]ŠOj: “ú–{Œ‹»¬’·Šw‰ïŽ, 16(1): 91`97, 1989.
3299. m‘àn ‰@“à‚É‚¨‚¯‚é•›ì—pŽûW‘̧‚ÌŠm—§|–k—¢‘åŠw•a‰@•›ì—pŒŸ“¢ˆÏˆõ‰ï‚ÌÝ—§‚Æ‚»‚ÌŠˆ“®ó‹µ|. •ŽRˆêC¬—Ñ‹P–¾i–òÜ•”jC“¿‘Œú“ñiŽ¨•@jC²“¡Šìˆê˜Yi¸j: “ú–{•a‰@‰ïŽGŽ, 36(10): 1657`1661, 1989.
3300. m‘àn •ªŽq‚Ì’´—ã‹Nó‘Ô;‚»‚Ì“®“I‰ß’ö‚Æ—ÊŽqŒ‡‘¹—˜_. ’†‘ºGŽ÷i•ªŽqŒ¤jC‚–ØGˆêi•¨—j: “ú–{•¨—Šw‰ïŽ, 45(2): 87`93, 1990.
3301. m‘àn L”͈͌Œ‰t¥”A‰»ŠwŒŸ¸¥–ƉuŠw“IŒŸ¸|‚»‚Ì”’l‚ð‚Ç‚¤“Ç‚Þ‚©|i‰ºŠªj‡Y.Tumor Marker, 13.ƒlƒIƒvƒeƒŠƒ“. “àŽRKMi—Õ•a—j: “ú–{—Õ°C(601): 937`941, 1990.
3302. m‘àn ¡Œã‚Ì–òÜ‹Æ–±|iŠe˜_j’ŽË–ò¬‡‹Æ–±‚ÌŽæ‚è‘g‚Ý•û|. “‡“cŽœ•Fi–òÜ•”j: –òŽ–V•ñ, (1534): 427`431, 1989.
3303. m‘àn Ý‘îˆã—ÂƖòÜŽt. ¬ìK—Yi–òÜ•”j: –òŽ–V•ñ, (1580): 5`6, 1990.
3304. muÀn ˆã—×pˆã–ò•i‚̃o|ƒR|ƒh•\Ž¦‚Ì„i‚ɂ‚¢‚Ä|“ú–{•a‰@–òÜŽt‰ïŠOˆÏˆõ‰ï‚ÌŠˆ“®•ñ‚æ‚è|.
’©’·•¶–íC•ŽRˆêi–òÜ•”jC‘¼ÂŠOˆÏˆõ‰ïˆÏˆõ8–¼: Journal of Japanese Society of Hospital
Pharmacists, 26(1): 108`112, 1990.
3305. muÀn ŒŒ´’`”’. ‘å’J‰pŽ÷i—Õ•a—j: MedicinaC26(‘10): 1850`1851, 1989.
3306. muÀn “d‹C‰j“®. ‘å’J‰pŽ÷i—Õ•a—j: MedicinaC26(‘10): 1852`1854, 1989.
3307. muÀn ƒ`[ƒ€ˆã—Ã. ’†“‡ß•vi¸j: ˆãŠw‚Ì‚ ‚ä‚Ý, 158(1): 74, 1989.
3308. muÀn ”\“®“I‚Ȉã–ò•iî•ñ‚Ì’ñ‹Ÿ. •ŽRˆêC–]ŒŽ^‹|C‘º£¨’ÃŽqC’©’·•¶–íi–òÜ•”j: ˆã–òƒWƒƒ|ƒiƒ‹, 25(10): 2317`2322, 1989.
3309. muÀn •ž–òŽw“±‚ÌŽÀÛ(4j _Œo“à‰È•a“. ‘¾“c‹v”üŽqCΎ˳‰pC’|“எqC“‡“cŽœ•Fi–òÜ•”j: ŒŽŠ§–òŽ–, 32(1): 159`161, 1990.
3310. muÀn •ž–òŽw“±‚ÌŽÀÛ(5j ®Œ`ŠO‰È•a“. ‘哇”ü˜aŽqCΎ˳‰pC’†ŽR–LC’|“எqC“‡“cŽœ•Fi–òÜ•”j: ŒŽŠ§–òŽ–, 32(2): 377`379, 1990.
3311. muÀn ˆã–ò•iî•ñ‚É‚¨‚¯‚é“dŽqŒvŽZ‹@‚̉ž—p. •ŽRˆêC’©’·•¶–íi–òÜ•”jC’ß“c—z˜aiˆã—pî•ñjC•Ÿ–{^—Žqi–òŠw•”jC’|“ດŽiˆã—pî•ñjC²“¡“oŽu˜Yi¶—j: ŒŽŠ§–òŽ–, 32(3): 581`589, 1990.
3312. muÀn –ò‚Ì•›ì—p‚Ì“¯’è. ’©’·•¶–íC•ŽRˆêi–òÜ•”j: “à‰È, 64(4): 608`612, 1989.
3313. mŠwp‘n iŽ·•Mj ŒŸ¸ŠÇ—‘˜_/—Õ°ŒŸ¸‘˜_; ÌŒŒ–@Cp.85`104C “àŽRKMi—Õ•a—jC‘O“c’‰Li—ÕŒŸj. •ÒW ˆÉ“¡‹@ˆêi“ŒŠC‘åjCŒÜ–¡–M‰piº˜a‘åj•ÒC u’kŽÐ, “Œ‹ž, 89.03.20”s.
3314. mŠwp‘n iŽ·•Mj ’´”÷—±ŽqŠJ”‰ž—pƒnƒ“ƒhƒuƒbƒN; “dŽqŒ°”÷‹¾‚É‚æ‚é’´”÷—±Žq‚ÌŠÏŽ@Cp.186`195C ¼–ìVŽmi‰»j. •ÒW ¬Î^ƒi“Œ‹ž—‰È‘åj•ÒC ƒTƒCƒGƒ“ƒXƒtƒH|ƒ‰ƒ€, “Œ‹ž, 89.04.05”s.
3315. m‚»‚Ì‘¼‚Ì’˜‘n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; ‘–쳈êi•új. •ÒW ²“¡“oŽu˜Yi–k—¢‘åj•Ò, “ú–{ˆãŽ–V•ñŽÐ, “Œ‹ž, 89.11.15 ”s.
3316. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ˆãŠw‘厫“Ti‘æ17”Åj; AZANõFC‘¼–ñ30€–Ú, ‰œ•½‰ë•Fi•a—j. “ìŽR“°, “Œ‹ž, 90.02.01”s.
3317. m‚»‚Ì‘¼‚Ì’˜‘iŽ«“Tjn iŽ·•Mj ”÷¶•¨ŠwŽ«“T; ’`”’Ž¿C’`”’Ž¿‡¬Cy‘f“™38€–ÚC —é–Øt’ji¶•¨•¨—‰»j. •ÒW “ú–{”÷¶•¨Šw‹¦‰ï•ÒC ‹Z•ñ“°o”Å, “Œ‹ž, 89.08.23”s.
3318. m‚»‚Ì‘¼n iŽ·•Mj ƒTƒNƒZƒXˆãŽt‘‰ÆŽŽŒ±—Õ°ŽÀ’n–â‘èW; •x‰i½ˆêi‹¹ŠOj. •ÒW ²“¡“oŽu˜Yi–k—¢‘åj•ÒC “ú–{ˆãŽ–V•ñŽÐ,@“Œ‹žC89.11.15”s.
3319. mŠw‰ïn iƒVƒ“ƒ|ƒWƒEƒ€j Radiology Information and Digital Image Management
Systems; Data Base Construction and Clinical Applications. ‘–쳈êi•új: 1st
Nordic-Japan IMAC Symposium (89.03.29), “Œ‹ž.
3320. mŠw‰ïn iƒpƒlƒ‹j IBD (Inflammatory Bowel Disease)Š³ŽÒ‚É‚¨‚¯‚éƒvƒŒƒhƒjƒ]ƒƒ“ŒŒ’†“®‘Ô‚ÌŒŸ“¢.
‰¡“cœÄˆêC’|“எqCM‰ª”ü»ŽqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”jCŽR–{‰À³CŸ–””º‰hi“àjCÎì~C‚‹´r‹BiŠOj: “ú–{–òŠw‰ï‘æ109”N‰ï
(89.04.05), –¼ŒÃ‰®.
3321. mŠw‰ïn iƒpƒlƒ‹j R‹ÛÜ™•ú«ƒ|ƒŠƒƒCƒVƒ“‘n”í•¢Þ‚Ì•]‰¿.
‹à‰h‹gCŒÃŽR“o—²C²“¡Žj˜YC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ32‰ñ“ú–{Œ`¬ŠO‰ÈŠw‰ï‘‰ï (89.04.21), ‰YˆÀ,
“ú–{Œ`¬ŠO‰ÈŠw‰ï‰ïŽ, 9: 310, 1989.
3322. mŠw‰ïn iƒpƒlƒ‹j Intestinal Movement Video-Solor
Battery-Microcomputerized. ‘ëàV’¼’èi¶—jC‰Á“¡NsiŠOjC‘åŠÑMi¶—j: 31st International
Congress of Physiological Sciences (89.07.14), Helsinki, FinlandC
Proceedings of the International Union of Physiological Sciences, (17):
502`503, 1989.
3323. mŠw‰ïn iƒ|ƒNƒVƒ‡ƒbƒvj –Ɖu‘gD‰»ŠwõF‚ɂ‚¢‚Ä‚ÌŽÀ‘Ô’²¸¥WŒvŒ‹‰Ê•ñ. ŽÂ“cGi“Œ•a‰@•a—j: ‘æ35‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (86.05.03), Šò•Œ, ‰q¶ŒŸ¸, 35(7): 998`1009, 1989.
3324. mŠw‰ïn iˆê”Êu‰‰j Independent Double Reading System; Application of
Digital Image Management Data Base. ‘–쳈êCˆä“›–rC¼–{—æŽqC‹àˆä’Ë•¶–¾C¬—ѬŽiC‰““¡‚i•új:
75th Scientific Meeting of Radiological Society of North
America”•\”NŒŽ“ú(89.11.26), Chicago, Radiology, 173(Suppl.): 473, 1989.
3325. mŠw‰ïn iˆê”Êu‰‰j •¡”ƒI|ƒgƒoƒCŽ–ŒÌŽ€‚Ì–UŒŸ—á‚©‚ç‚Ý‚½ƒI|ƒgƒoƒC‘–s‚ÉŠÖ‚·‚éˆÀ‘S«.
àVŒû²Žqi“Œ—ˆã‘åjC‘D”ö’‰FC™]G–¾i–@ˆãjCŽR‰ºƒPƒTŽqi“Œ—ˆã‘åj: “ú–{Œð’ʉȊw‹¦‹c‰ï‘‰ï “Œ‹ž, Œð’ʉȊwŒ¤‹†Ž‘—¿C‘æ30W:
104`107, 1989.
3326. mŠw‰ïn iˆê”Êu‰‰j •a‰@•a—•”‚Ì“úí‹Æ–±‚É‚¨‚¯‚éƒRƒ“ƒsƒ…|ƒ^|“±“ü‚ÆŠˆ—p‚ɂ‚¢‚Ä.
ˆÉ“¡—R”üŽqC“cŠ‰xŽqCŽs£‹I‘ã”üC“n•ÓiŽqi•a‰@•a—jC’†‰p’ji•a—j: ‘æ36‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (87.05.03), ŽŽ™“‡,
‰q¶ŒŸ¸, 36(3): 514, 1987.
3327. mŠw‰ïn iˆê”Êu‰‰j ‘æ“ñ¬ˆÏˆõ‰ï uŠ³ŽÒ‚ւ̈ã–ò•iî•ñ’ñ‹ŸŽž‚ÌŽwjì¬v.
’©’·•¶–íi–òÜ•”jC_‘ãºCrì³–¤C‹ß“¡—R—˜ŽqC‘º“c³OC›–ì—FŽqC“¡ˆärŽuC“ì“cˆÀ‹Ii•a‰@–ò‹Ç‹¦‹c‰ïjC¬—Ñ‹P–¾i–òÜ•”jC–x”ü’qŽqCH“¡‹`
–[CŽR–{M•vi•a‰@–ò‹Ç‹¦‹c‰ïj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.04), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.2, 1989.
3328. mŠw‰ïn iˆê”Êu‰‰j ‰@“à‚É‚¨‚¯‚éˆã–ò•i•›ì—pî•ñŽûW‘̧‚ÌŠm—§.
•ŽRˆêC‘ºãˆèŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC“¿‘Œú“ñiŽ¨•@jC²“¡Šìˆê˜Yi¸j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.04),
–¼ŒÃ‰®C “ú–{•a‰@‰ïŽGŽ, 36(10): 1657`1661, 1989.
3329. mŠw‰ïn iˆê”Êu‰‰j ICU‚É‚¨‚¯‚éAgsŒnR¶Ü‚Ì•a‘Ô•Ê“Š—^•û–@‚ÌŒŸ“¢.
’†‘º‹±ŽqC‹ß“¡—¯”üŽqC•ŽRˆêC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC‘å˜a“c—²i‹~–½j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.05),
–¼ŒÃ‰®C u‰‰—vŽ|W11Cp.31, 1989.
3330. mŠw‰ïn iˆê”Êu‰‰j ¸__Œo‰È“ü‰@Š³ŽÒ‚Ì•ž–òŽw“±‚ÌŒ»ó‚Æ–â‘è“_. •½ŽR•ŽiC’|“எqC“‡“cŽœ•Fi–òÜ•”jCŽO‰Y’å‘¥i¸j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®.
3331. mŠw‰ïn iˆê”Êu‰‰j •a‰@–òÜŽtE”\‚ÌV‚½‚È‚é“WŠJ‚Æ•]‰¿.
ù–ì–œ—ŽqC‰Á‰ê’J”£C–îŒã˜a•vC²ìŒ«ˆêC•ŽRˆêC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”j: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06),
–¼ŒÃ‰®C u‰‰—vŽ|W11Cp.50, 1989.
3332. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@î•ñƒg|ƒ^ƒ‹ƒVƒXƒeƒ€i‘æ1•ñjƒg|ƒ^ƒ‹ƒVƒXƒeƒ€‚ÌŠT—v‚Æ–ò•iƒ}ƒXƒ^|‚Ì\’z.
¬‘î³CaŒû‘OC•—ŠÔKŽOC²“¡“§C¼Œ´”£C‹´–{‚Ђë”üC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC¼‘º³–¾C´…ŽO‘¾˜YiŠé‰æŽºj: “ú–{–òŠw‰ï‘æ109”N‰ï
(89.04.06), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.52, 1989.
3333. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@î•ñƒg|ƒ^ƒ‹ƒVƒXƒeƒ€i‘æ2•ñj’ŽËƒI|ƒ_‚ðŠî–{‚É‚µ‚½’ŽË–ò‹Ÿ‹‹.
Œú“cKˆê˜YC“n•ÓÛŽqC‰Á‰ê’J”£C¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC™è“¹•viŠé‰æŽºj: “ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®C
u‰‰—vŽ|W11Cp.53, 1989.
3334. mŠw‰ïn iˆê”Êu‰‰j Ý‘îˆã—Âɂ¨‚¯‚é–òÜŽt‚Ì–ðŠ„i‘æ1•ñjƒCƒ“ƒXƒŠƒ“Ž©ŒÈ’ŽË‚̈À‘S«‚ÌŒŸ“¢.
‚‹´Œ«¬C²“¡“§C÷“c˜a’jC•—ŠÔKŽOC¬‘î³C¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC—§èŽOç‘ãC‚£•xŽ}iŠÅŒì•”jC‚‹{t’ji—ÕŒŸj:
“ú–{–òŠw‰ï‘æ109”N‰ï (89.04.06), –¼ŒÃ‰®C u‰‰—vŽ|W11Cp.55, 1989.
3335. mŠw‰ïn iˆê”Êu‰‰j •¡‡‹ÃŒÅˆöŽq‘ª’莎–ò‚Ì•]‰¿. —]ŒÎ‹v”üŽqC‘O“c’‰LC”~“c‹v”üC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—j: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.29), ŒSŽRC ‰q¶ŒŸ¸C38(3): 393, 1989.
3336. mŠw‰ïn iˆê”Êu‰‰j —AŒŒ‹Æ–±‚É‚¨‚¯‚éƒRƒ“ƒsƒ…|ƒ^|ŠÇ—ƒVƒXƒeƒ€‚ÌŽg—pŒoŒ±.
óˆäD”üC“yŽu“c^”üC‰““¡—mC”·—EŽŠi—ÕŒŸjC“àŽRKMi—Õ•a—jCŽOd–슰ŠìiŠOj: ‘æ38‰ñ“ú–{—Õ°‰q¶ŒŸ¸Šw‰ï (89.04.29),
ŒSŽRC ‰q¶ŒŸ¸C38(3): 578, 1989.
3337. mŠw‰ïn iˆê”Êu‰‰j A Trial of Drug Information Service by On-line System
in Kitasato University Hospital.
–]ŒŽ^‹|C•ŽRˆêC‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’ß“c—z˜aiˆã—pî•ñj: Pan Pacific ‡X (89.05.07),
ƒ\ƒEƒ‹C Abstract, p.323, 1989.
3338. mŠw‰ïn iˆê”Êu‰‰j Patho-Physiology in Cancer Patients as Reflected by
the PFK Test. ’†‘º‘‰qC’†“‡—mˆêi•ª¶j: 6th International Conference on Human
Tumor Markers (89.05.23), “Œ‹žC Journal of Tumor Marker OncologyC4(2):
138, 1989.
3339. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@ˆã–ò•iW‚̃Rƒ“ƒsƒ…|ƒ^‰».
’ß“c—z˜aC’r“cŒ›ºiˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC’|“ດŽiˆã—pî•ñjC”–ˆäŽjŽqCÎìrLi“dŽqŒvŽZ‹@ƒZƒ“ƒ^|j: ‘æ28‰ñ“ú–{MEŠw‰ï‘å‰ï
(89.05.23), ‘åãC ˆã—p“dŽq‚ƶ‘ÌHŠwC27(“Á•Ê): 144, 1989.
3340. mŠw‰ïn iˆê”Êu‰‰j ‹@”\“I\‰¹áŠQŽ™‚ÌITPA‚ɂ‚¢‚Ä. ‰ª–{˜NŽqC—é–ØŒbŽqCŒ´—R‹IiŽ¨•@j: “ú–{’®”\Œ¾ŒêŠw‰ï (89.05.28), ɪ, ‘æ15‰ñ“ú–{’®”\Œ¾ŒêŠw‰ïŠwpu‰‰‰ï—\eW, p.73, 1989.
3341. mŠw‰ïn iˆê”Êu‰‰j Dry Impact Blending Preparation and Properties of
Encapsulated Powder Polymers. ¬Î^ƒC–{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»j: 5th
International Conference on Pharmaceutical Technology (89.06.01), ƒpƒŠ,
Proceedings, 5: 396`405, 1989.
3342. mŠw‰ïn iˆê”Êu‰‰j ˆã–ò•iî•ñ‚É‚¨‚¯‚é“dŽqŒvŽZ‹@‚̉ž—pi‡Uj.
‹´–{‚Ђë”üC•ŽRˆêC–쑺’mŽqC–]ŒŽ^‹|C‘ºãˆèŽqC¬‘î³C‘º£¨’ÃŽqC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC’ß“c—z˜aiˆã—pî•ñjC¼‘º³–¾CŽR츈êC
´…ŽO‘¾˜YiŠé‰æŽºj: ‘æ39‰ñ“ú–{•a‰@Šw‰ï (89.06.15), ’·–ìC u‰‰W, p.452`453, 1989.
3343. mŠw‰ïn iˆê”Êu‰‰j “_“H‰tŽ©“®ƒZƒbƒeƒBƒ“ƒO‘•’u‚Ì—L—p«‚ɂ‚¢‚Ä‚ÌŒŸ“¢.
‘哇”ü˜aŽqC‘¾“c‹v”üŽqC‰¡“cœÄˆêC‹àŽqCŽqC¬—Ñç—mŽqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”j: ‘æ39‰ñ“ú–{•a‰@Šw‰ï (89.06.15), ’·–ì,
u‰‰W, p.458`459, 1989.
3344. mŠw‰ïn iˆê”Êu‰‰j ŠÅŒì•w—{¬Z‚É‚¨‚¯‚éˆã–ò•iŠÖ˜A‹³ˆç‚ÌŽÀ‘Ô’²¸|–òÜŽt‚Ƃ̃`|ƒ€ˆã—Äi‚Ì•K—v«|.
‹gŽR—F“ñi–òŠw•”jC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”j: ‘æ39‰ñ“ú–{•a‰@Šw‰ï (89.06.16), ’·–ìC u‰‰W, p.612`613,
1989.
3345. mŠw‰ïn iˆê”Êu‰‰j A“ª“EoŒã‚ÌH“¹‰¹ºKn‚ÉŠÖ˜A‚·‚é—vˆö‚ɂ‚¢‚Ä. ‰ª–{˜NŽqC‚‹´œAbiŽ¨•@j: “ú–{“ªŒz•”Žîᇊw‰ï (89.07.01), ‘åã, ‘æ13‰ñ“ú–{“ªŒz•”Žîᇊw‰ïŠwpu‰‰‰ïƒvƒƒOƒ‰ƒ€—\eW, p.174, 1989.
3346. mŠw‰ïn iˆê”Êu‰‰j ’¹‚ð—p‚¢‚½”º|’®ŠoŒn‚̶—S—Šw“IŒ¤‹†i‡Vj. ŽRèŽÌ•vi¶—j: ‘æ7‰ñ“ú–{¶—S—Šw‰ï‘å‰ï (89.07.11), –kŠC“¹C ƒvƒƒOƒ‰ƒ€, p.23, 1989.
3347. mŠw‰ïn iˆê”Êu‰‰j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚æ‚镲‘Ì‚Ì•\–ʉüŽ¿. –{“cG—²C¬Î^ƒi“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»j: “ú–{‰»Šw‰ï–kŠC“¹Žx•”1989”N‰Ä‹GŒ¤‹†”•\‰ï (89.07.22), Žº—–, u‰‰—vŽ|W, p.66, 1989.
3348. mŠw‰ïn iˆê”Êu‰‰j ’ŽËܬ‡‹Æ–±‚É‚¨‚¯‚é׋ۉ˜õ‚ÌŒŸ“¢i‘æ2•ñj. ‹àŽqCŽqC‘¾“c‹v”üŽqC‰¡“cœÄˆêC‘哇”ü˜aŽqC¬—Ñç—mŽqCΎ˳‰pC“‡“cŽœ•Fi–òÜ•”j: ŠÖ“ŒƒuƒƒbƒN‘æ19‰ñŠwp‘å‰ï (89.08.27), ŽR—œ.
3349. mŠw‰ïn iˆê”Êu‰‰j Development of Biosynthetic Bilaminar Wound Dressing
Capable of Releasing an Antibacterial Drug. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj:
‘æ5‰ñƒAƒWƒA¥‘¾•½—mŒ`¬ŠO‰ÈŠw‰ï (89.09.10), ƒCƒXƒ^ƒ“ƒu[ƒ‹, ƒgƒ‹ƒR.
3350. mŠw‰ïn iˆê”Êu‰‰j ƒWƒ‹ƒRƒjƒAƒ]ƒ‹‰üŽ¿•²‘Ì‚Ì’²». –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: ‘æ42‰ñƒRƒƒCƒh‚¨‚æ‚ÑŠE–ʉ»Šw“¢˜_‰ï (89.10.14), b•{, u‰‰—vŽ|W, p.438`439, 1989.
3351. mŠw‰ïn iˆê”Êu‰‰j ‚Œ‹»«ƒŠƒ“Ž_|…‘fƒJƒ‹ƒVƒEƒ€“ñ…˜a•¨‚Ì‹…»ó¬’·. ¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: ‘æ42‰ñƒRƒƒCƒh‚¨‚æ‚ÑŠE–ʉ»Šw“¢˜_‰ï (89.10.14), b•{, u‰‰—vŽ|W, p.516`517, 1989.
3352. mŠw‰ïn iˆê”Êu‰‰j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚¨‚¯‚镲‘Ì‚Ì•t’…‹@\. –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: ‘æ27‰ñ•²‘Ì‚ÉŠÖ‚·‚é“¢˜_‰ï (89.10.19), ç—t, u‰‰—vŽ|W, p.185`188, 1989.
3353. mŠw‰ïn iˆê”Êu‰‰j ‚‘¬‹C—¬’†ÕŒ‚–@‚É‚æ‚éƒJƒvƒZƒ‹•²‘Ì‚Ì’²». –{“cG—²i“Œ‹ž—‰È‘åjC¼–ìVŽmi‰»jC¬Î^ƒi“Œ‹ž—‰È‘åj: 1989”N“xFÞ‹¦‰ïŒ¤‹†”•\‰ï (89.10.30), “Œ‹ž, u‰‰—vŽ|W, p.81`82, 1989.
3354. mŠw‰ïn iˆê”Êu‰‰j œ“±ƒ}ƒCƒN‚ð—p‚¢‚½H“¹”ºŽÒ—pŠgº‘•’u‚ÌŽŽì.
¢–ØG–¾C]Œ©‹±ˆêiE‹ÆŒP—û‘åjC‰ª–{˜NŽqCŒ´—R‹IiŽ¨•@jC–xŒû—˜”VCV”ü¬“ñi“Œ‘åj: “ú–{‰¹ºŒ¾ŒêˆãŠw‰ï (89.11.11), ˆ¤’mC
‘æ34‰ñ“ú–{‰¹ºŒ¾ŒêˆãŠw‰ï‘‡Šwpu‰‰‰ï—\eW, p.129, 1989.
3355. mŠw‰ïn iˆê”Êu‰‰j ’¹‚ð—p‚¢‚½”º|’®ŠoŒn‚̶—S—Šw“IŒ¤‹†i‡WjƒCƒ“ƒR‚ÌlŒ¾Œê‚Ì”º‰¹º. ŽRèŽÌ•vi¶—j: ‘æ53‰ñ“ú–{S—Šw‰ï‘å‰ï (89.11.30), ’}”gC ˜_•¶W, p.491, 1989.
3356. mŠw‰ïn iˆê”Êu‰‰j –k—¢‘åŠw•a‰@î•ñƒg|ƒ^ƒ‹ƒVƒXƒeƒ€i‘æ5•ñj|ˆ•ûƒI|ƒ_‚ÌŽÀÛ2|.
‚‹´Œ«¬C¬‘î³CaŒû‘OC•—ŠÔKŽOC²“¡“§C”ö’¹Ÿ–çC¬—Ñ‹P–¾C’©’·•¶–íi–òÜ•”jC¼‘º³–¾CŽæˆê—EC´…ŽO‘¾˜YiŠé‰æŽºj:
‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.01`03), “Œ‹žC ˜_•¶W, p.489`492, 1990.
3357. mŠw‰ïn iˆê”Êu‰‰j 200°’†‹K–Í•a‰@‚É\’z‚µ‚½•úŽËüŒŸ¸ƒI[ƒ_ƒŠƒ“ƒOƒVƒXƒeƒ€‚ÌŒ»ó‚Æ”–â‘è.
‚¼r“¹C–ö“c’qCã–ì•×CFè‹`OC‘º‰ª¼¶C–î‹v•Ûƒ•½C‘º“cWˆê˜YCˆÀ“ŒH‘¥C•“cŒõ–¾Cù–{Œ›’ji–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@j:
‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.02), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.463`464, 1990.
3358. mŠw‰ïn iˆê”Êu‰‰j •a‰@î•ñƒVƒXƒeƒ€‚É‘g‚Ýž‚ñ‚¾•úŽËüŒŸ¸î•ñƒVƒXƒeƒ€‚ÌŠJ”.
‘º“cWˆê˜YC–î‹v•Ûƒ•½i–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@jC‘å•”½i•a—jC•“cŒõ–¾C‘º‰ª¼¶i–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@j:
‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.02), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.467`468, 1990.
3359. mŠw‰ïn iˆê”Êu‰‰j –k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@‚É‚¨‚¯‚é•a—ðƒf[ƒ^ƒx[ƒX‚ÌŒ»ó.
‰i‹v•Û^C¼’JOŒõC‹v•Û“c–FˆêC‘º“cWˆê˜YCù–{Œ›’jC‘å•”½C•“cŒõ–¾C‰ª“c–¾”üC“àŽR–õi–k—¢Œ¤‹†ŠƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•a‰@j:
‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï (90.02.03), “Œ‹ž, ‘æ9‰ñˆã—Ãî•ñŠw˜A‡‘å‰ï˜_•¶W, p.637`640, 1990.
3360. mŠw‰ïn iˆê”Êu‰‰j ¸_‰È•ž–òŽw“±‚É‚¨‚¯‚é–òÜŽt‚Ì–ðŠ„|–k—¢‘åŠw“Œ•a‰@‚ÌŒoŒ±‚Æ‘S‘ƒAƒ“ƒP|ƒg’²¸‚ÌŒ‹‰Ê‚ɂ‚¢‚Ä|.
’|“எqC”ÑòŒb”üŽqCˆÉ“¡s‘ãC“‡“cŽœ•Fi–òÜ•”jC΋½‰ªƒC‘å’J‹`•vCŽO‰Y’å‘¥i¸j: ‘æ18‰ñ“ú–{¸_•a‰@‹¦‰ï¸_ˆãŠw‰ï
(90.03.22). å‘ä.
3361. mŠw‰ïn iˆê”Êu‰‰j ‹¹œãœ‹Ø‚É‚æ‚锘bŠJŽnŽž‚̃sƒbƒ`’²ß. “‡“cƒˆêi¶—jC–xŒû—˜”VCV”ü¬“ñCœA£”£i“Œ‘åj: ‘æ2‰ñ“ú–{A“ª‰ÈŠw‰ï (90.03.23), “Œ‹žC —\eWCp.80, 1990.
3362. mŠw‰ïn iˆê”Êu‰‰j •ê‰¹‚ª–³º‰»‚³‚ê‚é‚Æ‚«‚Ì—Öóbó‹Ø‚ÌŠˆ“®. “‡“cƒˆêi¶—jC–xŒû—˜”VCV”ü¬“ñCœA£”£i“Œ‘åj: “ú–{‰¹‹¿Šw‰ï (90.03.29), “Œ‹žC ˜_•¶W‡T, p.255`256, 1990.
3363. mŠw‰ïn iˆê”Êu‰‰j ’†‰›Žèp•”ˆã—ËZpˆõ‚Ì“úA“–’¼‹Î–±“à—e‚ɂ‚¢‚Ä.
—é–ØDMC‰ª–{kˆê˜YC¼—ÑŒõC’r“cŒbŽqi’†‰›Žèp•”jCª–{EiŠOjC“c’†—ºi–ƒj: ‘æ11‰ñ“ú–{Žèp•”ˆãŠw‰ï‘‰ï i89.10.27),
ŽRŒ`, “ú–{Žèp•”ˆãŠw‰ïŽ, 10(—Õ‘): 50, 1989.
3364. mŒ¤‹†‰ïn i‹³ˆçu‰‰j Å‹ß‚ÌMR‘•’u‚ÌŒ»‹µ. ›Mˆêi•új: _“Þ쌧f—ÕúŽËü‹ZpuK‰ï (89.09.10), ‰¡•l.
3365. mŒ¤‹†‰ïn i‹³ˆçu‰‰j ˆã—Âɂ¨‚¯‚éV‚µ‚¢“¹‹ïA‰æ‘œf’f. ›Mˆêi•új: _“Þ쌧‘åŠwŒöŠJuÀ (89.10.14), ‘Š–ÍŒ´.
3366. mŒ¤‹†‰ïn iƒpƒlƒ‹j ”÷—ÊŒ³‘f»Ü‚Ì”z‡•Ï‰». “‡“cŽœ•Fi–òÜ•”j: ‘æ5‰ñ—A‰t¥”÷—ʉh—{‘fŒ¤‹†‰ï (89.07.08), “Œ‹ž.
3367. mŒ¤‹†‰ïn iˆê”Êu‰‰j –k—¢Total System. ΋´Wi”åj: ‘æ3‰ñƒwƒ‹ƒXƒGƒOƒ[ƒNƒeƒBƒuƒJƒ“ƒtƒ@ƒŒƒ“ƒX (89.08.27), ƒoƒ“ƒRƒN.
3368. mŒ¤‹†‰ïn iˆê”Êu‰‰j HPNŽ{sŠ³ŽÒ‚ɑ΂·‚é–K–âˆã—Â̕K—v«. ¬ìK—YC“‡“cŽœ•Fi–òÜ•”jCŽR–{ŒPŽqC•Ð•£Œ[ŽqiŠÅŒì•”jC‘å’J„³C”äŠé”\Ž÷iŠOj: ‘æ4‰ñÝ‘îÖ¬‰h—{iHPNjŒ¤‹†‰ï (89.09.02), ‘åã.
3369. mŒ¤‹†‰ïn iˆê”Êu‰‰j Œz‘MRŽ²ˆÊ‘œ‚̉ð–UŠw“IŒŸ“¢: ƒXƒsƒ“ƒGƒR[–@‚ƃOƒ‰ƒWƒFƒ“ƒgƒGƒR[–@‚Ì”äŠr. ‹àˆä’Ë•¶–¾C’J“c—ˆê˜YC‰““¡‚C¬—ѬŽiC¼–{—æŽqCˆä“›–rC‘–쳈êi•új: ‘æ18‰ñ’f‘w‰f‘œŒ¤‹†‰ï (89.10.22).
3370. mŒ¤‹†‰ïn iˆê”Êu‰‰j ƒ}ƒCƒNƒƒRƒ“ƒsƒ…|ƒ^‚ð—p‚¢‚½ŠeŽíˆã—Ãî•ñ’ñ‹ŸƒVƒXƒeƒ€.
’ß“c—z˜aC‹{Œ´‰p•viˆã—pî•ñjC²“¡“oŽu˜Yi¶—jC“c’†—ºi–ƒj: ‘æ7‰ñ–ƒŒ¥W’†Ž¡—ÃRƒ“ƒsƒ…|ƒ^Œ¤‹†‰ï (89.11.18), •xŽR,
´˜^W, p.13, 1989.
3371. mŒ¤‹†‰ïn iˆê”Êu‰‰j R‹ÛÜ™•ú«“ñ‘w\‘¢‘n”í•¢Þ‚ÌŠJ”. ‹à‰h‹gC_‘ò•qC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: “ú’†Œ`¬ŠO‰ÈŒð—¬ŠwpW‰ï (89.11.22), ’·è.
3372. mŒ¤‹†‰ïn iˆê”Êu‰‰j R‹ÛÜ™•ú«‘n”í•¢Þ‚Ì컂ƕ]‰¿. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ19‰ñ‘nŽ¡–üŒ¤‹†‰ï (89.12.02), ‹v—¯•Ä.
3373. mŒ¤‹†‰ïn iˆê”Êu‰‰j Development of Biosynthetic Bilaminar Wound Dressing
Capable of Releasing Antibacterial Drug. ‹à‰h‹gC‰–’JMKiŒ`ŠOjC•–ö”\Œõi¶‘ÌHj: ‘æ4‰ñƒ}ƒEƒC
Burn Conference (90.02.18), ƒnƒƒC, Abstract, p.28, 1989.
3374. mŒ¤‹†‰ïn iˆê”Êu‰‰j •½t‹@”\ŒŸ¸Œ‹‰Ê‚̃f|ƒ^|ƒx|ƒX‰». V“cŒ’‘¾˜YC“¿‘Œú“ñiŽ¨•@j: Ž¨•@ˆôA‰Èî•ñˆ—Œ¤‹†‰ï (90.03.17), “Œ‹ž, Ž¨•@ˆôA‰Èî•ñˆ—Œ¤‹L6‰ñ, 1990.